Citrus Sinensis ID: 010624
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | 2.2.26 [Sep-21-2011] | |||||||
| Q551H4 | 1028 | Serine/threonine-protein | yes | no | 0.577 | 0.284 | 0.420 | 2e-65 | |
| Q6P9R2 | 527 | Serine/threonine-protein | yes | no | 0.614 | 0.590 | 0.405 | 4e-63 | |
| Q5R495 | 527 | Serine/threonine-protein | yes | no | 0.614 | 0.590 | 0.402 | 4e-62 | |
| Q863I2 | 529 | Serine/threonine-protein | no | no | 0.614 | 0.587 | 0.399 | 4e-62 | |
| O88506 | 553 | STE20/SPS1-related prolin | yes | no | 0.632 | 0.578 | 0.392 | 5e-62 | |
| Q9Z1W9 | 556 | STE20/SPS1-related prolin | no | no | 0.628 | 0.571 | 0.395 | 6e-62 | |
| O95747 | 527 | Serine/threonine-protein | yes | no | 0.614 | 0.590 | 0.402 | 7e-62 | |
| Q9UEW8 | 545 | STE20/SPS1-related prolin | no | no | 0.628 | 0.583 | 0.395 | 8e-62 | |
| Q54XL6 | 574 | Serine/threonine-protein | no | no | 0.581 | 0.512 | 0.406 | 1e-59 | |
| O61122 | 478 | Serine/threonine-protein | no | no | 0.513 | 0.543 | 0.390 | 1e-49 |
| >sp|Q551H4|FRAY2_DICDI Serine/threonine-protein kinase fray2 OS=Dictyostelium discoideum GN=fray2 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 250 bits (639), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 130/309 (42%), Positives = 185/309 (59%), Gaps = 17/309 (5%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-DLDSIRRETKT 79
YP Y++ + IG G S +V +AIC+P V AIK IDL+ + L+ IR+E +
Sbjct: 63 NYPNSADQYELKETIGKGGSGLVQRAICLPFQENV-AIKIIDLEHCKNVSLEEIRKEIQA 121
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
MSL HPN++ H SF + LWV+M F+S GS I+ FP G E IA +LKE L
Sbjct: 122 MSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEALK 181
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
A+ Y H G +HRD+K+GNIL DS+G+++L+DFGVSA++ + G GTP
Sbjct: 182 AICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLID------TGETSRNTFVGTP 235
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
WMAPE++ Y + DIWSFGITALELA G+ P + PP K LL+ + +
Sbjct: 236 CWMAPEIME-QVNYDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTL------QNPP 288
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHG 319
+L+ D K+S +FKD+V CL +DPSKRP KL++H FFK K ++ V+++L
Sbjct: 289 PSLE-GDGESKWSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKP-DYLVQHILAK 346
Query: 320 LRSVEERFK 328
L + +R++
Sbjct: 347 LPPLGQRYQ 355
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6P9R2|OXSR1_MOUSE Serine/threonine-protein kinase OSR1 OS=Mus musculus GN=Oxsr1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 131/323 (40%), Positives = 189/323 (58%), Gaps = 12/323 (3%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKERV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L EP IA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L+E L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA--FLATGGDITRNKVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L+ +T +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LTLQN 242
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K EF
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKEFLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGA 336
+ +L ++ ER K+ R G+
Sbjct: 302 EKILQRAPTISERSKKVRRVPGS 324
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R495|OXSR1_PONAB Serine/threonine-protein kinase OSR1 OS=Pongo abelii GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 130/323 (40%), Positives = 188/323 (58%), Gaps = 12/323 (3%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L E IA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L+E L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA--FLATGGDITRNKVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L+ +T +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LTLQN 242
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K EF
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKEFLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGA 336
+ +L ++ ER K+ R G+
Sbjct: 302 EKILQRAPTISERAKKVRRVPGS 324
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 129/323 (39%), Positives = 188/323 (58%), Gaps = 12/323 (3%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINKDDYELQEVIGSGATAVVQAAYCTPKKEKV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L E IA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEATIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L+E L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA--FLATGGDITRNKVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L+ +T +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LTLQN 242
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K E+
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKEYLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGA 336
+ +L ++ ER K+ R G+
Sbjct: 302 EKILQRAPTISERAKKVRRVPGS 324
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88506|STK39_RAT STE20/SPS1-related proline-alanine-rich protein kinase OS=Rattus norvegicus GN=Stk39 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 132/336 (39%), Positives = 196/336 (58%), Gaps = 16/336 (4%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ +P+ +Y++ + IG G +A+V A+C P V AIK I+L++ +T +D + +E +
Sbjct: 63 VGWPICRDAYELQEVIGSGATAVVQAALCKPRQERV-AIKRINLEKCQTSMDELLKEIQA 121
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS SHPN++ + SF V LW+VM +S GS+ II G L E IA +
Sbjct: 122 MSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATI 181
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
LKE L L YLH G +HRD+KAGNIL DGSV++ADFGVSA + + + +
Sbjct: 182 LKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSA--FLATGGDVTRNKVRK 239
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKAD+WSFGITA+ELA G P PP K L+ +T +
Sbjct: 240 TFVGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLM--LTLQN 297
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
E ++ K+ KK+ ++F+ +++ CL +DPSKRP+A +L+K FF+ K E+ +
Sbjct: 298 DPPTLETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKA-KNREYLI 356
Query: 314 KNVLHGLRSVEERFKESRNHVGAEHH----EDEEFE 345
+ +L + +R K+ R G+ H ED ++E
Sbjct: 357 EKLLTRTPDIAQRAKKVRRVPGSSGHLHKTEDGDWE 392
|
May act as a mediator of stress-activated signals. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z1W9|STK39_MOUSE STE20/SPS1-related proline-alanine-rich protein kinase OS=Mus musculus GN=Stk39 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 132/334 (39%), Positives = 195/334 (58%), Gaps = 16/334 (4%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS 81
+P+ +Y++ + IG G +A+V A+C P V AIK I+L++ +T +D + +E + MS
Sbjct: 68 WPICRDAYELQEVIGSGATAVVQAALCKPRQERV-AIKRINLEKCQTSMDELLKEIQAMS 126
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIVLK 135
SHPN++ + SF V LW+VM +S GS+ II G L E IA +LK
Sbjct: 127 QCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILK 186
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E L L YLH G +HRD+KAGNIL DGSV++ADFGVSA + + + +
Sbjct: 187 EVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSA--FLATGGDVTRNKVRKTF 244
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
GTP WMAPEV+ GY FKAD+WSFGITA+ELA G P PP K L+ +T +
Sbjct: 245 VGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLM--LTLQNDP 302
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKN 315
E ++ K+ KK+ ++F+ +++ CL +DPSKRP+A +L+K FF+ K E+ ++
Sbjct: 303 PTLETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKA-KNREYLIEK 361
Query: 316 VLHGLRSVEERFKESRNHVGAEHH----EDEEFE 345
+L + +R K+ R G+ H ED ++E
Sbjct: 362 LLTRTPDIAQRAKKVRRVPGSSGHLHKTEDGDWE 395
|
May act as a mediator of stress-activated signals. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O95747|OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 130/323 (40%), Positives = 187/323 (57%), Gaps = 12/323 (3%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L E IA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L+E L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA--FLATGGDITRNKVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L+ +T +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--LTLQN 242
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K EF
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKEFLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGA 336
+ L ++ ER K+ R G+
Sbjct: 302 EKTLQRAPTISERAKKVRRVPGS 324
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UEW8|STK39_HUMAN STE20/SPS1-related proline-alanine-rich protein kinase OS=Homo sapiens GN=STK39 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 8e-62, Method: Compositional matrix adjust.
Identities = 132/334 (39%), Positives = 195/334 (58%), Gaps = 16/334 (4%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS 81
+P+ +Y++ + IG G +A+V A+C P V AIK I+L++ +T +D + +E + MS
Sbjct: 56 WPICRDAYELQEVIGSGATAVVQAALCKPRQERV-AIKRINLEKCQTSMDELLKEIQAMS 114
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIVLK 135
SHPN++ + SF V LW+VM +S GS+ II G L E IA +LK
Sbjct: 115 QCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILK 174
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E L L YLH G +HRD+KAGNIL DGSV++ADFGVSA + + + +
Sbjct: 175 EVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSA--FLATGGDVTRNKVRKTF 232
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
GTP WMAPEV+ GY FKAD+WSFGITA+ELA G P PP K L+ +T +
Sbjct: 233 VGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLM--LTLQNDP 290
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKN 315
E ++ K+ KK+ ++F+ +++ CL +DPSKRP+A +L+K FF+ K E+ ++
Sbjct: 291 PTLETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKA-KNREYLIEK 349
Query: 316 VLHGLRSVEERFKESRNHVGAEHH----EDEEFE 345
+L + +R K+ R G+ H ED ++E
Sbjct: 350 LLTRTPDIAQRAKKVRRVPGSSGHLHKTEDGDWE 383
|
May act as a mediator of stress-activated signals. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XL6|FRAY1_DICDI Serine/threonine-protein kinase fray1 OS=Dictyostelium discoideum GN=fray1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 126/310 (40%), Positives = 184/310 (59%), Gaps = 16/310 (5%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD-LDSIRRETKTM 80
YP + Y +++ IG G V+KA CIP+ V AIK ++LD+ + + +E K M
Sbjct: 90 YPSQANQYNLIEPIGEGTEGRVFKAYCIPLKENV-AIKVVELDKMDPQFVKDVIKEVKVM 148
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
+ +HPN+++ H SF +++LW+VM ++ GSL I+ +PDG+PE VLK L
Sbjct: 149 NGNNHPNLIHYHTSFLENNQLWLVMDYLGGGSLADIMKFKYPDGIPEVLAVTVLKSLLKG 208
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L YLH+ +HRD+K+ NIL DG+++LADFGVSA ++E + + GTP
Sbjct: 209 LEYLHSHQRIHRDLKSDNILIGEDGAIELADFGVSA-MFEKN-----TCCSRKTIVGTPC 262
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
WMAPE+I S GY+ DIWSFGITA+EL G+PP LPP K + F +
Sbjct: 263 WMAPEII-SERGYNQGVDIWSFGITAIELIRGKPPGYDLPPSKVFM-----NLLFGNSPS 316
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGL 320
+ +DK S +KD+V CL ++PSKRP+A KL++H FK K + V ++LHGL
Sbjct: 317 LQEEEDKG-VCSHLYKDLVDKCLQKEPSKRPNASKLLEHKVFKQAKKN-NYIVSHLLHGL 374
Query: 321 RSVEERFKES 330
E+R++ES
Sbjct: 375 TPCEDRYRES 384
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 111/284 (39%), Positives = 161/284 (56%), Gaps = 24/284 (8%)
Query: 25 DPSSYKILDE-IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP + E IG G V+K I + T+ AIK IDL+ + +++ I++E +S
Sbjct: 7 DPEELYVRQEKIGKGSFGEVFKGINKKTNETI-AIKTIDLEDAEDEIEDIQQEINVLSQC 65
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
P + SF S+LW++M +++ GS+ ++ P E IAI+L+E L L Y
Sbjct: 66 ESPFVTKYFGSFLKGSKLWIIMEYLAGGSVLDLMK---PGPFDEGYIAIILRELLKGLEY 122
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH++G +HRD+KA N+L + G VKLADFGVS + + + GTP+WMA
Sbjct: 123 LHSEGKIHRDIKAANVLLSASGDVKLADFGVSGQLTDQMTKRNT-------FVGTPFWMA 175
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEVI+ TGY KADIWS GITALE+A G PP + L P ++L + D TL+
Sbjct: 176 PEVIK-QTGYDSKADIWSMGITALEMAKGEPPRADLHPMRALFLIP------KDPPPTLE 228
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
FS+ FK+ A CL++DP++RP+A+ L+KH F K K
Sbjct: 229 -----GNFSKGFKEFCALCLNKDPNQRPTAKDLLKHKFIKAAKK 267
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | ||||||
| 255576866 | 517 | serine/threonine protein kinase, putativ | 0.938 | 0.918 | 0.652 | 1e-179 | |
| 224099897 | 508 | predicted protein [Populus trichocarpa] | 0.952 | 0.948 | 0.636 | 1e-178 | |
| 359477707 | 532 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.921 | 0.588 | 1e-164 | |
| 449433273 | 531 | PREDICTED: serine/threonine-protein kina | 0.952 | 0.907 | 0.598 | 1e-160 | |
| 357454639 | 518 | Serine/threonine protein kinase [Medicag | 0.954 | 0.932 | 0.576 | 1e-159 | |
| 356547349 | 566 | PREDICTED: serine/threonine-protein kina | 0.909 | 0.812 | 0.596 | 1e-159 | |
| 296083588 | 453 | unnamed protein product [Vitis vinifera] | 0.869 | 0.971 | 0.592 | 1e-155 | |
| 15233460 | 487 | protein kinase family protein [Arabidops | 0.893 | 0.928 | 0.593 | 1e-153 | |
| 297800792 | 476 | kinase family protein [Arabidopsis lyrat | 0.883 | 0.939 | 0.588 | 1e-150 | |
| 224137922 | 498 | predicted protein [Populus trichocarpa] | 0.916 | 0.931 | 0.533 | 1e-128 |
| >gi|255576866|ref|XP_002529319.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223531243|gb|EEF33088.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 342/524 (65%), Positives = 404/524 (77%), Gaps = 49/524 (9%)
Query: 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK 78
K+Q+PLD SYKIL+EIGVGVSAIVYKAICIP++ST+VAIK+IDLDQSR D D++R ETK
Sbjct: 7 KVQFPLDSDSYKILEEIGVGVSAIVYKAICIPINSTIVAIKSIDLDQSRADFDNLRWETK 66
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
TMSLLSHPNIL AHCSF+V RLWVVMPFMS GSLQSIISS FPDGL EPCI IVLKETL
Sbjct: 67 TMSLLSHPNILKAHCSFTVGRRLWVVMPFMSAGSLQSIISSSFPDGLSEPCITIVLKETL 126
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA-------M 191
+ALSYLH QGHLHRD+KAGNIL DS+G V+LADFGVSASIYE S+ M
Sbjct: 127 NALSYLHRQGHLHRDIKAGNILIDSNGQVRLADFGVSASIYESITGQQGRSSSAGSSRLM 186
Query: 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
+TD+AGTPYWMAPEVI SHTGYSFKADIWSFGITALELAHG PPLSHLP KSL+MK+T+
Sbjct: 187 LTDVAGTPYWMAPEVIHSHTGYSFKADIWSFGITALELAHGCPPLSHLPLSKSLIMKITK 246
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEF 311
RFRFSDYEK + KDK+KKFS++FKD+VASCLDQDPSKRPSA+KL+KH FFKNC KG++F
Sbjct: 247 RFRFSDYEK--QKKDKSKKFSKSFKDLVASCLDQDPSKRPSADKLLKHPFFKNC-KGLDF 303
Query: 312 FVKNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSSPP------VKQRRISGWNFNEE 365
VKNVLHGL +VE+RFKE++ A H D+ ++G VK RRISGWNFNEE
Sbjct: 304 LVKNVLHGLPNVEDRFKENK----AIHGIDKGSDIGDQETENLEEIVKIRRISGWNFNEE 359
Query: 366 GFELDPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRIKKQSESDTNSEES-----NLG 420
GFELDPVFP + + DS+VKQVRFGGET+I DR + SES + E S ++G
Sbjct: 360 GFELDPVFPAGSID-----DSIVKQVRFGGETVI-QDRKIELSESVDSGESSRSLPASIG 413
Query: 421 TQLAVHHQA------------------AESLMALRRSLDEERQQVSNMIALLGGEISRED 462
++ V A LM L++SLDE+RQ+V N+I LLGGE+SRE+
Sbjct: 414 EEIQVTSNARGEDGNGDGDREIDKEAMLGGLMTLKKSLDEQRQKVINLIVLLGGEVSREE 473
Query: 463 QLMQIVERLKMELETERRKNFELEMELEFLKHQISGADNSGGTD 506
QLMQ++ERL+MELE E++K E+EMELEFLK +SGA N G++
Sbjct: 474 QLMQVIERLRMELEIEKQKKSEIEMELEFLKLLVSGAYNGSGSE 517
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099897|ref|XP_002311665.1| predicted protein [Populus trichocarpa] gi|222851485|gb|EEE89032.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 329/517 (63%), Positives = 396/517 (76%), Gaps = 35/517 (6%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKA 60
MAH + + T +Q++QYP+D ++YKILDEIGVGVSA VYKAIC+PM+ST+VAIK
Sbjct: 1 MAHFQDQR------TKSQRVQYPVDSNAYKILDEIGVGVSATVYKAICVPMNSTLVAIKC 54
Query: 61 IDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSC 120
IDLDQSR D DS+RRETKTMSLLSHPNIL +HCSF+VD LW+VMPFMS GSLQSIISS
Sbjct: 55 IDLDQSRADFDSVRRETKTMSLLSHPNILESHCSFTVDRHLWMVMPFMSAGSLQSIISSS 114
Query: 121 FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
FPDGLPEPCIA+VLKE L+ALSYLH+QGHLHRDVKAGNI+ DS+G VKLADFGVSASIYE
Sbjct: 115 FPDGLPEPCIAVVLKEILNALSYLHDQGHLHRDVKAGNIVIDSNGKVKLADFGVSASIYE 174
Query: 181 PSHHHHHGSAM------ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP 234
+ S +TD+AGTPYWMAPEVI SHTGYSFKADIWSFGITALELAHGRP
Sbjct: 175 FNTLERSSSLSCSSRMRLTDLAGTPYWMAPEVIHSHTGYSFKADIWSFGITALELAHGRP 234
Query: 235 PLSHLPPEKSLLMKMTQRFRFSD-YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293
PLSHLPP K+L+MK+T+RFRFSD +E+ K +NKKFS+AFKDMVASCLDQDPSKRPSA
Sbjct: 235 PLSHLPPSKTLIMKITKRFRFSDCHEENHKKSCRNKKFSKAFKDMVASCLDQDPSKRPSA 294
Query: 294 EKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESR------NHVGAEHHEDEEFEV- 346
KL+KHSFFKNC KG+++FVKNVLHGL SVEERFKE++ + G + E+E+ ++
Sbjct: 295 AKLLKHSFFKNC-KGLDYFVKNVLHGLPSVEERFKEAKVLSGISSQSGTDVEEEEKGDID 353
Query: 347 GSS--PPVKQRRISGWNFNEEGFELDPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRI 404
G S VK RRISGWNFNEEGFELDPVFP T+S+ DS S++ ++ P
Sbjct: 354 GDSVIQRVKTRRISGWNFNEEGFELDPVFP---TDSKNDSPSILN-------SLAPVKEE 403
Query: 405 KKQSESDTNSEESNLGTQLAVHHQAA--ESLMALRRSLDEERQQVSNMIALLGGEISRED 462
Q S +G + +Q E L+AL+RSL+E+R+ V+ +I LLGGE ED
Sbjct: 404 MSQVGDHIGVNMSGVGGIVEGLNQVTMLEGLVALKRSLEEQRRHVAIIIGLLGGETDGED 463
Query: 463 QLMQIVERLKMELETERRKNFELEMELEFLKHQISGA 499
Q++Q+ E LK EL+ E++KN +LEMELEF+K ISGA
Sbjct: 464 QMVQMSENLKEELDIEKQKNLKLEMELEFIKIVISGA 500
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477707|ref|XP_002280754.2| PREDICTED: serine/threonine-protein kinase fray2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 319/542 (58%), Positives = 378/542 (69%), Gaps = 52/542 (9%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKA 60
MA HE G + ++QYPL+ +Y+ILDEIGVGVSAIVYKA C+PM+S +VAIK+
Sbjct: 1 MAQHE--------GEASPRVQYPLNSEAYRILDEIGVGVSAIVYKAECLPMNSALVAIKS 52
Query: 61 IDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSC 120
IDLDQSR DLDS+ RE KTMSLLSHPNIL AHCSF+VD RLWVVMPFMS GSLQSII S
Sbjct: 53 IDLDQSRADLDSVLREVKTMSLLSHPNILRAHCSFAVDHRLWVVMPFMSAGSLQSIIGSS 112
Query: 121 FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
FPDGLPEPCIAIVLKETL+ALSYLH+QGHLHRD+KAGNIL DS G+VKLADFGVSA IYE
Sbjct: 113 FPDGLPEPCIAIVLKETLNALSYLHDQGHLHRDIKAGNILVDSTGTVKLADFGVSALIYE 172
Query: 181 PSHHHHHGSA------MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP 234
+ + M+T++ GTPYWMAPEVI SHTGYS KADIWSFGITALELAHGRP
Sbjct: 173 SNTSSGTSGSSSSSSLMLTEVTGTPYWMAPEVIHSHTGYSLKADIWSFGITALELAHGRP 232
Query: 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
PLSHLPP KSL+MK+T+RFRFSDYE++ +++ KFS++FKDMVASCLDQDPSKRPSA+
Sbjct: 233 PLSHLPPSKSLVMKITKRFRFSDYEQSR--SEQSPKFSKSFKDMVASCLDQDPSKRPSAD 290
Query: 295 KLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESR-------NHVGAEHHEDEEFEVG 347
KL+KH FFKNC K EF V VL GL SVE+RFKES+ + + E+E E
Sbjct: 291 KLLKHPFFKNC-KNSEFLVNKVLSGLASVEQRFKESKIRRSLSIKNTDDDGDEEENEESS 349
Query: 348 SSPPVKQRRISGWNFNEEGFELDPVFPFFTTESRADSDSVVKQVRFGGETII--PPDR-- 403
+KQRRISGWNF E+ ELDPVFP TE+ + +QVRF E II P +
Sbjct: 350 MGEIIKQRRISGWNFKEDVLELDPVFP-SETETLSPPR---RQVRFAAEPIIRDPSNESS 405
Query: 404 ------IKKQSESDTNS------EESNLGTQLAV------HHQAAESLMALRRSLDEERQ 445
+ E S E + L Q+ V L L RSL ++R+
Sbjct: 406 SDNPGSSSQSVEGHAGSLAVAVPEGTQLSAQIGVSLAHLDRDGVVRMLRGLTRSLYDQRR 465
Query: 446 QVSNMIALLGG--EISREDQLMQIVERLKMELETERRKNFELEMELEFLKHQISGADNSG 503
V M+ +L G E+SREDQL+Q ERLKMELE E++K E+EME+EFL QIS S
Sbjct: 466 AVGLMLTILTGQEEVSREDQLLQENERLKMELEQEKKKTSEMEMEMEFLSLQISRGSTSA 525
Query: 504 GT 505
+
Sbjct: 526 AS 527
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433273|ref|XP_004134422.1| PREDICTED: serine/threonine-protein kinase fray2-like [Cucumis sativus] gi|449528635|ref|XP_004171309.1| PREDICTED: serine/threonine-protein kinase fray2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1475), Expect = e-160, Method: Compositional matrix adjust.
Identities = 302/505 (59%), Positives = 368/505 (72%), Gaps = 23/505 (4%)
Query: 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+++ Q+PLD +SYKI+DEIGVGVSA+VYKAICIPM+S VVAIKAIDLD+SR D D IRRE
Sbjct: 28 SRRPQFPLDSTSYKIIDEIGVGVSAVVYKAICIPMNSAVVAIKAIDLDRSRADFDDIRRE 87
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
K +SLLSHPNILN+HCSF+VD RLWVVMPFMS GSLQSII+S FPDGLPEPCIAIVL+E
Sbjct: 88 AKILSLLSHPNILNSHCSFTVDRRLWVVMPFMSAGSLQSIITSSFPDGLPEPCIAIVLRE 147
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH------HGSA 190
L ALSYLH+QGHLHRD+KAGNIL DS+GS+KLADFGVS SI+E + S
Sbjct: 148 ILHALSYLHDQGHLHRDIKAGNILIDSNGSIKLADFGVSTSIFESNSKQGVSISPLSTSI 207
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
M+ ++AGTPYWMAPEVI SH GYS KADIWSFGITALELAHGRPPLSHLPP KSLL+K+T
Sbjct: 208 MLKEVAGTPYWMAPEVIHSHNGYSLKADIWSFGITALELAHGRPPLSHLPPSKSLLLKIT 267
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVE 310
+RFRFSDYE K+KNK FS+ FK++VASCLD +PS+RP AEKL+KH FFKN +KG +
Sbjct: 268 RRFRFSDYENHHNSKNKNK-FSKGFKELVASCLDPEPSRRPCAEKLLKHPFFKN-SKGPD 325
Query: 311 FFVKNVLHGLRSVEERFKESR-NHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFEL 369
VK +L GL SVEERFK + + + E+EE E +KQRRISGWNFNE+G EL
Sbjct: 326 LLVKTILQGLPSVEERFKLGKLQRLPSMKTEEEEEEELEKEIIKQRRISGWNFNEDGLEL 385
Query: 370 DPVFP---FFTTESRADSDSVVKQVRFGGETIIPPDRIKKQSESDTNSEESNLGTQLAVH 426
DPVFP E + +S + G + P + ++
Sbjct: 386 DPVFPGEECSIMEEKGSGNS--SECCSGLSDLSSP---VGNERGGGSGGGGGEEEEVVDR 440
Query: 427 HQAAESLMALRRSLDEERQQVSNMIALLGGE----ISREDQLMQIVERLKMELETERRKN 482
LMAL+RSLDE+R+ V ++I L+ GE +SRE+Q+ +++E++ ELE ERR+N
Sbjct: 441 ESIVGGLMALKRSLDEQRRAVGSLIELMEGEKVGEMSREEQMGRLMEKVTRELENERRRN 500
Query: 483 FELEMELEFLKHQISG--ADNSGGT 505
FELEMELEFL+ QIS +N GG
Sbjct: 501 FELEMELEFLRLQISAFHNNNDGGA 525
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454639|ref|XP_003597600.1| Serine/threonine protein kinase [Medicago truncatula] gi|124360373|gb|ABN08386.1| Protein kinase [Medicago truncatula] gi|355486648|gb|AES67851.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1464), Expect = e-159, Method: Compositional matrix adjust.
Identities = 298/517 (57%), Positives = 378/517 (73%), Gaps = 34/517 (6%)
Query: 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR 74
IA+++QYPLD SSYKI+DEIG G SA+VYKAICIP++ST VAIK+IDLD+SR DLD +R
Sbjct: 4 NIAERVQYPLDSSSYKIVDEIGAGNSAVVYKAICIPINSTPVAIKSIDLDRSRPDLDDVR 63
Query: 75 RETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
RE KT+SLLSHPNIL AHCSF+VD+RLWVVMPFM+ GSLQSIIS F +GL E IA++L
Sbjct: 64 REAKTLSLLSHPNILKAHCSFTVDNRLWVVMPFMAGGSLQSIISHSFQNGLTEQSIAVIL 123
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH----------- 183
K+TL+ALSYLH QGHLHRD+K+GNIL DS+G VKLADFGVSASIYE ++
Sbjct: 124 KDTLNALSYLHGQGHLHRDIKSGNILVDSNGLVKLADFGVSASIYESNNSVGACSSYSSS 183
Query: 184 -HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242
+ S + TD AGTPYWMAPEVI SH GYSFKADIWSFGITALELAHGRPPLSHLPP
Sbjct: 184 SSNSSSSHIFTDFAGTPYWMAPEVIHSHNGYSFKADIWSFGITALELAHGRPPLSHLPPS 243
Query: 243 KSLLMKMTQRFRFSDYEK-TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
KSL++ +T+RF+FSD++K + K + KFS+AFKDMVA CL+QDP+KRPSAEKL+KHSF
Sbjct: 244 KSLMLNITKRFKFSDFDKHSYKGHGGSNKFSKAFKDMVALCLNQDPTKRPSAEKLLKHSF 303
Query: 302 FKNCNKGVEFFVKNVLHGLRSVEERFKESRNHVGAE---HHEDEEFEVGSSPPVKQRRIS 358
FKNC KG + VKNVL+GL SVE+R+KE + + + + ++ + S VKQRRIS
Sbjct: 304 FKNC-KGSDVLVKNVLNGLPSVEKRYKEIKAIMDPDSKCKDDGDDDDDESVKNVKQRRIS 362
Query: 359 GWNFNEEGFELDPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRIKKQS----ESDTNS 414
GWNFNE+G EL PVFP + ++ D VVKQVRF E +I D + S E TN+
Sbjct: 363 GWNFNEDGLELVPVFP----KDQSKDDEVVKQVRFEEEKVIQEDAVVTASGTVMEPKTNT 418
Query: 415 EE----SNLGTQLAVHHQAAESLMALRRSLDEERQQVSNMIALLGGE----ISREDQLMQ 466
+ N+G + +L L+ SL++E QV ++ L+GGE +++++Q
Sbjct: 419 SDVVDHENVGGVVKNREATLATLNVLKESLEQELGQVKFLMNLIGGEEIHVAESDEKMVQ 478
Query: 467 IVERLKMELETERRKNFELEMELEFLK-HQISGADNS 502
+ +L+ ELE E++KN +LEM+LE +K H IS A NS
Sbjct: 479 EISKLRTELENEKKKNLQLEMQLENIKLHLISSAANS 515
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547349|ref|XP_003542076.1| PREDICTED: serine/threonine-protein kinase fray2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 291/488 (59%), Positives = 367/488 (75%), Gaps = 28/488 (5%)
Query: 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+++QYPLD SSYK+L+EIG GVSA+VYKA+CIPM+S VAIK+IDLD+SR DLD +RRE
Sbjct: 13 GKRVQYPLDSSSYKLLNEIGEGVSAVVYKALCIPMNSAAVAIKSIDLDRSRPDLDDVRRE 72
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
KT+SLLSHPNIL AHCSF+VD RLWVVMPFM+ GSLQSIIS P+GL EPCIA+VL++
Sbjct: 73 AKTLSLLSHPNILKAHCSFTVDRRLWVVMPFMAAGSLQSIISHSHPNGLTEPCIAVVLRD 132
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM-ITDM 195
TL+ALSYLH QGHLHRD+KAGNIL D++G VKLADFGVSASIYE + S++ TD+
Sbjct: 133 TLNALSYLHGQGHLHRDIKAGNILVDTNGQVKLADFGVSASIYESTTTTSSSSSLKFTDV 192
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
AGTPYWMAPEVI SHTGYSFKADIWSFGITALELAHGRPPLSHLPP KS+++K+T+RFRF
Sbjct: 193 AGTPYWMAPEVIHSHTGYSFKADIWSFGITALELAHGRPPLSHLPPSKSMMLKITKRFRF 252
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKN 315
SD K KKFS+AFKDMVASCLDQDPSKRP+A+KL+KH FFKNC KG +F VKN
Sbjct: 253 SDDFDDKYRKGNGKKFSKAFKDMVASCLDQDPSKRPTADKLLKHPFFKNC-KGTDFLVKN 311
Query: 316 VLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPVFPF 375
VL GL SVE+R++ES+ ++ + + ++ + S VKQRRISGWNFN++G ELDPVFP
Sbjct: 312 VLQGLPSVEKRYRESKGNLHEDDDDGDDDDDDPSMQVKQRRISGWNFNQDGLELDPVFP- 370
Query: 376 FTTESRADSDSVVKQVRFGGETIIPPDRIKKQSESDTNSEESNLGTQLAVHHQAAESLMA 435
+ VK+VRFGGET+I ++ ++++S E L T L
Sbjct: 371 ----------NDVKEVRFGGETVIQQAAGMEKVNNNSSSREGMLAT-----------LNV 409
Query: 436 LRRSLDEERQQVSNMIALLGGEISREDQL--MQIVERLKMELETERRKNFELEMELEFLK 493
L+ SL++E QV ++ + G+ + Q+ Q + RL+ +LE ER KN +LE++L+ K
Sbjct: 410 LKGSLEQELWQVKFLVNTIQGD-HHDTQVPEEQEISRLRAQLENERMKNLQLELQLQTSK 468
Query: 494 -HQISGAD 500
HQ S ++
Sbjct: 469 LHQKSDSN 476
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083588|emb|CBI23577.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1433), Expect = e-155, Method: Compositional matrix adjust.
Identities = 304/513 (59%), Positives = 354/513 (69%), Gaps = 73/513 (14%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKA 60
MA HE G + ++QYPL+ +Y+ILDEIGVGVSAIVYKA C+PM+S +VAIK+
Sbjct: 1 MAQHE--------GEASPRVQYPLNSEAYRILDEIGVGVSAIVYKAECLPMNSALVAIKS 52
Query: 61 IDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSC 120
IDLDQSR DLDS+ RE KTMSLLSHPNIL AHCSF+VD RLWVVMPFMS GSLQSII S
Sbjct: 53 IDLDQSRADLDSVLREVKTMSLLSHPNILRAHCSFAVDHRLWVVMPFMSAGSLQSIIGSS 112
Query: 121 FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
FPDGLPEPCIAIVLKETL+ALSYLH+QGHLHRD+KAGNIL DS G+VKLADFGVSA IYE
Sbjct: 113 FPDGLPEPCIAIVLKETLNALSYLHDQGHLHRDIKAGNILVDSTGTVKLADFGVSALIYE 172
Query: 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP 240
S IT GTPYWMAPEVI SHTGYS KADIWSFGITALELAHGRPPLSHLP
Sbjct: 173 --------SNTIT---GTPYWMAPEVIHSHTGYSLKADIWSFGITALELAHGRPPLSHLP 221
Query: 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
P KSL+MK+T+RFRFSDYE++ +++ KFS++FKDMVASCLDQDPSKRPSA+KL+KH
Sbjct: 222 PSKSLVMKITKRFRFSDYEQSR--SEQSPKFSKSFKDMVASCLDQDPSKRPSADKLLKHP 279
Query: 301 FFKNCNKGVEFFVKNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGW 360
FFKNC K EF V VL RISGW
Sbjct: 280 FFKNC-KNSEFLVNKVL--------------------------------------RISGW 300
Query: 361 NFNEEGFELDPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRIKKQSESDTNSEESNLG 420
NF E+ ELDPVFP TE+ + +QVRF E II + S++ +S +S G
Sbjct: 301 NFKEDVLELDPVFP-SETETLSPPR---RQVRFAAEPIIRDPSNESSSDNPGSSSQSVEG 356
Query: 421 TQLAVH------HQAAESLMALRRSLDEERQQVSNMIALLGG--EISREDQLMQIVERLK 472
Q +H H L L RSL ++R+ V M+ +L G E+SREDQL+Q ERLK
Sbjct: 357 VQ-ELHDEHTNEHAGMRMLRGLTRSLYDQRRAVGLMLTILTGQEEVSREDQLLQENERLK 415
Query: 473 MELETERRKNFELEMELEFLKHQISGADNSGGT 505
MELE E++K E+EME+EFL QIS S +
Sbjct: 416 MELEQEKKKTSEMEMEMEFLSLQISRGSTSAAS 448
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233460|ref|NP_193184.1| protein kinase family protein [Arabidopsis thaliana] gi|2244804|emb|CAB10227.1| kinase like protein [Arabidopsis thaliana] gi|7268154|emb|CAB78490.1| kinase like protein [Arabidopsis thaliana] gi|332658049|gb|AEE83449.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1408), Expect = e-153, Method: Compositional matrix adjust.
Identities = 290/489 (59%), Positives = 355/489 (72%), Gaps = 37/489 (7%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRET 77
K+++PLD +Y+I+ +IGVGVSA VYKAICIPM+S VVAIKAIDLDQSR D DS+RRET
Sbjct: 4 NKLEFPLDAEAYEIICKIGVGVSASVYKAICIPMNSMVVAIKAIDLDQSRADFDSLRRET 63
Query: 78 KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
KTMSLLSHPNILNA+CSF+VD LWVVMPFMSCGSL SI+SS FP GLPE CI++ LKET
Sbjct: 64 KTMSLLSHPNILNAYCSFTVDRCLWVVMPFMSCGSLHSIVSSSFPSGLPENCISVFLKET 123
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM---ITD 194
L+A+SYLH+QGHLHRD+KAGNIL DSDGSVKLADFGVSASIYEP ++ +TD
Sbjct: 124 LNAISYLHDQGHLHRDIKAGNILVDSDGSVKLADFGVSASIYEPVTSSSGTTSSSLRLTD 183
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
+AGTPYWMAPEV+ SHTGY FKADIWSFGITALELAHGRPPLSHLPP KSLLMK+T+RF
Sbjct: 184 IAGTPYWMAPEVVHSHTGYGFKADIWSFGITALELAHGRPPLSHLPPLKSLLMKITKRFH 243
Query: 255 FSDYE--KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFF 312
FSDYE + K NKKFS+AF++MV CL+QDP+KRPSAEKL+KH FFKNC KG++F
Sbjct: 244 FSDYEINTSGSSKKGNKKFSKAFREMVGLCLEQDPTKRPSAEKLLKHPFFKNC-KGLDFV 302
Query: 313 VKNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPV 372
VKNVLH L + E+ F ES+ + + +DEE E VK RRISGWNF E+ +L PV
Sbjct: 303 VKNVLHSLSNAEQMFMESQILIKSVGDDDEEEEEEDEEIVKNRRISGWNFREDDLQLSPV 362
Query: 373 FPFFTTESRADSDSVVKQVRFGGETIIPPDRIKKQSESD-------------TNSEESNL 419
FP TES + S ++ D+ K + E D +N E N
Sbjct: 363 FP--ATESDSSESSPREE-----------DQSKDKKEDDNVTITGYELGLGLSNEEAKNQ 409
Query: 420 GTQLAVHHQ--AAESLMALRRSLDEERQQVSNMIALLGG---EISREDQLMQIVERLKME 474
++ + E L L++SL+ +R +VS +I L G E SRE++L+++VE+LK+E
Sbjct: 410 EGEVVGFDKDLVLEKLKVLKKSLEHQRARVSIIIEALSGDKEEKSREEELLEMVEKLKIE 469
Query: 475 LETERRKNF 483
LETE+ K
Sbjct: 470 LETEKLKTL 478
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297800792|ref|XP_002868280.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297314116|gb|EFH44539.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1388), Expect = e-150, Method: Compositional matrix adjust.
Identities = 289/491 (58%), Positives = 351/491 (71%), Gaps = 44/491 (8%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRET 77
KI++PLD +Y+I+ +IGVGVSA VYKAICIPM+S VVAIKAIDLDQSR D DS+RRET
Sbjct: 4 NKIEFPLDAEAYEIICKIGVGVSASVYKAICIPMNSMVVAIKAIDLDQSRADFDSLRRET 63
Query: 78 KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
KTMSLLSHPNILNA+CSF+VD LWVVMPFMSCGSL SI+SS FP+GLPE CI++ LKET
Sbjct: 64 KTMSLLSHPNILNAYCSFTVDRCLWVVMPFMSCGSLHSIVSSSFPNGLPENCISVFLKET 123
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM---ITD 194
LSA+SYLH+QGHLHRD+KAGNIL DSDGSVKLADFGVSASIYEP ++ +TD
Sbjct: 124 LSAISYLHDQGHLHRDIKAGNILVDSDGSVKLADFGVSASIYEPVTSSSGTTSSSLRLTD 183
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
+AGTPYWMAPEV+ SHTGY FKADIWSFGITALELAHGRPPLSHLPP KSLLMK+T+RF
Sbjct: 184 IAGTPYWMAPEVVHSHTGYGFKADIWSFGITALELAHGRPPLSHLPPLKSLLMKITKRFH 243
Query: 255 FSDYE--KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFF 312
F+DYE + K NKKFS+AF++MV CL+QDP+KRPSAEKL+KH FFKNC KG++F
Sbjct: 244 FADYEINTSGSSKKGNKKFSKAFREMVGLCLEQDPAKRPSAEKLLKHPFFKNC-KGLDFV 302
Query: 313 VKNVLHGLRSVEERFKESR---NHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFEL 369
VKNVLH L + E+ F ES+ VG + ++EE K RRISGWNF E+ +L
Sbjct: 303 VKNVLHSLSNAEQMFMESQILMKSVGDDEEDEEE----DEKIAKNRRISGWNFREDDLQL 358
Query: 370 DPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRIK-KQSESDTNSEESNLGTQLAVHHQ 428
PVFP DSD+ R D I+ KQ + + S LG L+
Sbjct: 359 SPVFP------ATDSDTSESSPR-------EEDHIQDKQEDDNVTITGSELGLGLSNEEA 405
Query: 429 --------------AAESLMALRRSLDEERQQVSNMIALLGG---EISREDQLMQIVERL 471
E L L++SL+ +R +VS +I L G E SRE++L+ +VE+L
Sbjct: 406 KNQEGEVVGFDKDLVLEKLKVLKKSLEHQRARVSIIIEALSGDKEEKSREEELLDMVEKL 465
Query: 472 KMELETERRKN 482
K+ELE E+ ++
Sbjct: 466 KIELEAEKLRS 476
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137922|ref|XP_002322685.1| predicted protein [Populus trichocarpa] gi|222867315|gb|EEF04446.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1195), Expect = e-128, Method: Compositional matrix adjust.
Identities = 269/504 (53%), Positives = 332/504 (65%), Gaps = 40/504 (7%)
Query: 19 KIQYPLDPSSYKILDEIG-VGVSAIVYKAICI--PMDSTVVAIKAIDLDQSRTDLDSIRR 75
++QYP DP++Y+++DEIG G A V+KAICI ST VAI+ DL+Q D D +RR
Sbjct: 1 QLQYPTDPNAYRLVDEIGGTGARAKVHKAICIHNIWKSTFVAIRIFDLEQYPADFDGLRR 60
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
ETKTMSL SHPN+L +H SF+VDS LWVVMP+M+ GSLQ IIS+ FP+GLPEP IAI+LK
Sbjct: 61 ETKTMSLHSHPNVLASHLSFAVDSYLWVVMPYMAAGSLQPIISTYFPEGLPEPSIAIILK 120
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSASIYE------PSHHHHHG 188
ETL L Y+H+QG LH D+KAGNIL D+ +GS+KLAD G S SIY+ S
Sbjct: 121 ETLQGLCYIHDQGRLHTDIKAGNILIDTENGSIKLADRGKSVSIYDLRSVVGSSPLSPSS 180
Query: 189 SAMITDMAGTPYWMAPEVIRS-HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM 247
+TD+AGTPYWMAPEVI GYS KADIWSFGITALE+A+G PP S LPP KSL+M
Sbjct: 181 RMRLTDVAGTPYWMAPEVIHDLDAGYSLKADIWSFGITALEIAYGGPPFSDLPPSKSLIM 240
Query: 248 KMTQRFRFSDY-EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
K+ +R FS+Y ++ K KNKKFS+ FKDMVASCLDQDPSKRPSA++L+++SFFKNC
Sbjct: 241 KIKKRLGFSNYHDEKHKKDFKNKKFSKEFKDMVASCLDQDPSKRPSADQLLEYSFFKNC- 299
Query: 307 KGVEFFVKNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGS--------SPPVKQRRIS 358
+G+EF K V GL +VEE FKE + G +V P K R IS
Sbjct: 300 RGLEFLFKKVFDGLPNVEETFKELKALQGTPSQITAGTDVEEEEERPESVGPSEKTRWIS 359
Query: 359 GWNFNEEGFELDPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRIKKQSESDTNSE--- 415
GW NE F L P F S ++ DSVVK VRFGGETIIP I S +S+
Sbjct: 360 GWKLNEYEFNLVPEF-----SSDSEDDSVVKLVRFGGETIIPDTNIGFSVSSIGSSDLEG 414
Query: 416 -------ESNLGTQLAVHH----QAAESLMALRRSLDEERQQVSNMIALLGGEISREDQL 464
E+ G + V E +MAL RSLDE+R+QV+ MIALLGGE E+QL
Sbjct: 415 SVEDHTGENMSGIEGIVEEFNQVTVLEGIMALMRSLDEQRRQVARMIALLGGEADGEEQL 474
Query: 465 MQIVERLKMELETERRKNFELEME 488
+Q +E L EL+ E+ KN +LEME
Sbjct: 475 VQRIENLMRELDLEKEKNLKLEME 498
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | ||||||
| TAIR|locus:2129780 | 487 | AT4G14480 [Arabidopsis thalian | 0.920 | 0.956 | 0.602 | 3.6e-144 | |
| TAIR|locus:2185440 | 674 | AT5G14720 [Arabidopsis thalian | 0.760 | 0.571 | 0.462 | 1.1e-93 | |
| TAIR|locus:2132716 | 711 | AT4G10730 [Arabidopsis thalian | 0.802 | 0.571 | 0.421 | 4e-83 | |
| TAIR|locus:2019878 | 687 | AT1G79640 [Arabidopsis thalian | 0.662 | 0.487 | 0.485 | 8.2e-83 | |
| TAIR|locus:2135016 | 709 | AT4G24100 [Arabidopsis thalian | 0.671 | 0.479 | 0.477 | 6e-80 | |
| TAIR|locus:2034888 | 473 | AT1G23700 [Arabidopsis thalian | 0.579 | 0.619 | 0.449 | 3.2e-65 | |
| DICTYBASE|DDB_G0276577 | 1028 | fray2 "FRAY subfamily protein | 0.575 | 0.283 | 0.422 | 8.6e-61 | |
| UNIPROTKB|E1C6W3 | 533 | OXSR1 "Uncharacterized protein | 0.628 | 0.596 | 0.412 | 9e-61 | |
| UNIPROTKB|E2RAI8 | 527 | OXSR1 "Uncharacterized protein | 0.628 | 0.603 | 0.406 | 5.7e-59 | |
| MGI|MGI:1917378 | 527 | Oxsr1 "oxidative-stress respon | 0.628 | 0.603 | 0.403 | 1.2e-58 |
| TAIR|locus:2129780 AT4G14480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1409 (501.1 bits), Expect = 3.6e-144, P = 3.6e-144
Identities = 291/483 (60%), Positives = 354/483 (73%)
Query: 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK 78
K+++PLD +Y+I+ +IGVGVSA VYKAICIPM+S VVAIKAIDLDQSR D DS+RRETK
Sbjct: 5 KLEFPLDAEAYEIICKIGVGVSASVYKAICIPMNSMVVAIKAIDLDQSRADFDSLRRETK 64
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
TMSLLSHPNILNA+CSF+VD LWVVMPFMSCGSL SI+SS FP GLPE CI++ LKETL
Sbjct: 65 TMSLLSHPNILNAYCSFTVDRCLWVVMPFMSCGSLHSIVSSSFPSGLPENCISVFLKETL 124
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP---SHHHHHGSAMITDM 195
+A+SYLH+QGHLHRD+KAGNIL DSDGSVKLADFGVSASIYEP S S +TD+
Sbjct: 125 NAISYLHDQGHLHRDIKAGNILVDSDGSVKLADFGVSASIYEPVTSSSGTTSSSLRLTDI 184
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
AGTPYWMAPEV+ SHTGY FKADIWSFGITALELAHGRPPLSHLPP KSLLMK+T+RF F
Sbjct: 185 AGTPYWMAPEVVHSHTGYGFKADIWSFGITALELAHGRPPLSHLPPLKSLLMKITKRFHF 244
Query: 256 SDYEKTLKIKDK--NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
SDYE K NKKFS+AF++MV CL+QDP+KRPSAEKL+KH FFKNC KG++F V
Sbjct: 245 SDYEINTSGSSKKGNKKFSKAFREMVGLCLEQDPTKRPSAEKLLKHPFFKNC-KGLDFVV 303
Query: 314 KNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPVF 373
KNVLH L + E+ F ES+ + + +DEE E VK RRISGWNF E+ +L PVF
Sbjct: 304 KNVLHSLSNAEQMFMESQILIKSVGDDDEEEEEEDEEIVKNRRISGWNFREDDLQLSPVF 363
Query: 374 PFFTTESRADSDSVVKQVRFGGE----TIIPPDR-IKKQSESDTNSEESNLGTQLAVHHQ 428
P ++S S Q + E TI + + +E N E +G +
Sbjct: 364 PATESDSSESSPREEDQSKDKKEDDNVTITGYELGLGLSNEEAKNQEGEVVGFDKDL--- 420
Query: 429 AAESLMALRRSLDEERQQVSNMIALLGG---EISREDQLMQIVERLKMELETERRKNFEL 485
E L L++SL+ +R +VS +I L G E SRE++L+++VE+LK+ELETE+ K
Sbjct: 421 VLEKLKVLKKSLEHQRARVSIIIEALSGDKEEKSREEELLEMVEKLKIELETEKLKTLRA 480
Query: 486 EME 488
+ +
Sbjct: 481 DKD 483
|
|
| TAIR|locus:2185440 AT5G14720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 1.1e-93, Sum P(2) = 1.1e-93
Identities = 185/400 (46%), Positives = 254/400 (63%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM 80
++PL+ YK+ +EIG GVSA V++A+CIP++ VVAIK +DL++ DLD IRRE +TM
Sbjct: 8 KFPLNAKDYKLYEEIGDGVSATVHRALCIPLN-VVVAIKVLDLEKCNNDLDGIRREVQTM 66
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
SL++HPN+L AHCSF+ +LWVVMP+M+ GS II S +PDG EP IA +L+ETL A
Sbjct: 67 SLINHPNVLQAHCSFTTGHQLWVVMPYMAGGSCLHIIKSSYPDGFEEPVIATLLRETLKA 126
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L YLH GH+HRDVKAGNIL DS+G+VKLADFGVSA +++ + + GTP
Sbjct: 127 LVYLHAHGHIHRDVKAGNILLDSNGAVKLADFGVSACMFDTGDRQRSRNTFV----GTPC 182
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
WMAPEV++ GY FKAD+WSFGITALELAHG P S PP K LLM + DYE+
Sbjct: 183 WMAPEVMQQLHGYDFKADVWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGL 320
+K+FS+AFK+MV +CL +DP KRP++EKL+KH FFK+ + ++ VK +L+GL
Sbjct: 243 -------DKRFSKAFKEMVGTCLVKDPKKRPTSEKLLKHPFFKHA-RPADYLVKTILNGL 294
Query: 321 RSVEERFKESRN-HVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPVFPFFTTE 379
+ +R+++ ++ E+E S R IS WNFN E +
Sbjct: 295 PPLGDRYRQIKSKEADLLMQNKSEYEAHLSQQEYIRGISAWNFNLEDLKTQAALISDDDT 354
Query: 380 SRADS-DSVVKQVRFGGETIIPPDRIKKQSESDTNSEESN 418
S A+ D KQ E+ + P+R + + + +E N
Sbjct: 355 SHAEEPDFNQKQCERQDESALSPERASSSATAPSQDDELN 394
|
|
| TAIR|locus:2132716 AT4G10730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 4.0e-83, Sum P(2) = 4.0e-83
Identities = 185/439 (42%), Positives = 257/439 (58%)
Query: 14 GTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSI 73
G +K + ++P YK+++E+G G SA+V++AI +P + VVAIK++DLD+ ++LD I
Sbjct: 32 GDKKKKKGFSVNPKDYKLMEEVGYGASAVVHRAIYLPTNE-VVAIKSLDLDRCNSNLDDI 90
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
RRE +TM+L+ HPN++ + CSF+VD LWVVMPFM+ GS ++ + +PDG E I +
Sbjct: 91 RREAQTMTLIDHPNVIKSFCSFAVDHHLWVVMPFMAQGSCLHLMKAAYPDGFEEAAICSM 150
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
LKETL AL YLH QGH+HRDVKAGNIL D G +KL DFGVSA +++ + +
Sbjct: 151 LKETLKALDYLHRQGHIHRDVKAGNILLDDTGEIKLGDFGVSACLFDNGDRQRARNTFV- 209
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV++ +GY+ KADIWSFGITALELAHG P S PP K LLM +
Sbjct: 210 ---GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAP 266
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
DY D++KKFS++FK++VA CL +D +KRP+AEKL+KHSFFKN K E V
Sbjct: 267 PGLDY-------DRDKKFSKSFKELVALCLVKDQTKRPTAEKLLKHSFFKNV-KPPEICV 318
Query: 314 KNVLHGLRSVEERFKESRNHVGAE---HHEDEEFEVGSSPPVKQRRISGWNFNEEGFELD 370
K + L + R K + A+ + S QR +S WNFN E +
Sbjct: 319 KKLFVDLPPLWTRVKALQAKDAAQLALKGMASADQDAISQSEYQRGVSAWNFNIEDLKEQ 378
Query: 371 PVF---PFFTTESRADSDSVVKQV--------RFGGETIIPPDRIKKQSESDTN------ 413
TESR + +S +Q+ + G ++ + K+ SDT
Sbjct: 379 ASLLDDDDILTESREEEESFGEQLHNKVNDRGQVSGSQLLSENMNGKEKASDTEVVEPIC 438
Query: 414 SEESNLGTQLAVHHQAAES 432
E+S L + + Q A S
Sbjct: 439 EEKSTLNSTTSSVEQPASS 457
|
|
| TAIR|locus:2019878 AT1G79640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 172/354 (48%), Positives = 224/354 (63%)
Query: 14 GTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSI 73
GT+ +K +YP+ P Y + + IG GVSA+V++A+CIP D VVAIK +D ++ DL++I
Sbjct: 2 GTMEKK-KYPIGPEHYTLYEFIGQGVSALVHRALCIPFDE-VVAIKILDFERDNCDLNNI 59
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
RE +TM L+ HPN+L +HCSF D LWV+MP+MS GS I+ + +PDG E IA +
Sbjct: 60 SREAQTMMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATI 119
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L+E L L YLH GH+HRDVKAGNIL + G+VKL DFGVSA +++ + +
Sbjct: 120 LREALKGLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFV- 178
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGIT LELAHG P S PP K LLM +
Sbjct: 179 ---GTPCWMAPEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAP 235
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
DYE+ +KKFSR+FK M+ASCL +DPSKRPSA+KL+KHSFFK ++
Sbjct: 236 PGLDYER-------DKKFSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSS-DYIA 287
Query: 314 KNVLHGLRSVEERF----KESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFN 363
+ +L GL + R ++ + + E D E E S K R ISGWNFN
Sbjct: 288 RKLLDGLPDLVNRVQAIKRKEEDMLAQEKMADGEKEELSQNEYK-RGISGWNFN 340
|
|
| TAIR|locus:2135016 AT4G24100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
Identities = 170/356 (47%), Positives = 227/356 (63%)
Query: 11 SSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL 70
S +G+ Q+ + ++P YK+++EIG G SA+VY+AI +P + VVAIK +DLD+ ++L
Sbjct: 15 SGSGSSKQQRGFSMNPKDYKLMEEIGHGASAVVYRAIYLPTNE-VVAIKCLDLDRCNSNL 73
Query: 71 DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCI 130
D IRRE++TMSL+ HPN++ + CSFSVD LWVVMPFM+ GS ++ + + DG E I
Sbjct: 74 DDIRRESQTMSLIDHPNVIKSFCSFSVDHSLWVVMPFMAQGSCLHLMKTAYSDGFEESAI 133
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190
VLKETL AL YLH QGH+HRDVKAGNIL D +G +KL DFGVSA +++ +
Sbjct: 134 CCVLKETLKALDYLHRQGHIHRDVKAGNILLDDNGEIKLGDFGVSACLFDNGDRQRARNT 193
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
+ GTP WMAPEV++ GY+ KADIWSFGITALELAHG P S PP K LLM +
Sbjct: 194 FV----GTPCWMAPEVLQPGNGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ 249
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVE 310
DY D++KKFS++FK+MVA CL +D +KRP+AEKL+KHS FK+ K E
Sbjct: 250 NAPPGLDY-------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSCFKH-TKPPE 301
Query: 311 FFVKNVLHGLRSVEERFKESRNHVGAE---HHEDEEFEVGSSPPVKQRRISGWNFN 363
VK + L + R K ++ + E S QR +S WNF+
Sbjct: 302 QTVKILFSDLPPLWTRVKSLQDKDAQQLALKRMATADEEAISQSEYQRGVSAWNFD 357
|
|
| TAIR|locus:2034888 AT1G23700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
Identities = 142/316 (44%), Positives = 202/316 (63%)
Query: 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR 74
T + + ++PL Y+IL+EIG GV Y+A CI +D +VAIK +L++ DL++IR
Sbjct: 2 TSSPETRFPLVAKDYEILEEIGDGV----YRARCILLDE-IVAIKIWNLEKCTNDLETIR 56
Query: 75 RETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
+E +SL+ HPN+L HCSF S LW+VMPFMSCGS +I+ S +P+GL EP IAI+L
Sbjct: 57 KEVHRLSLIDHPNLLRVHCSFIDSSSLWIVMPFMSCGSSLNIMKSVYPNGLEEPVIAILL 116
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
+E L AL YLH GH+HR+VKAGN+L DS+G+VKL DF VSAS+++ S
Sbjct: 117 REILKALVYLHGLGHIHRNVKAGNVLVDSEGTVKLGDFEVSASMFDSVERMRTSSE--NT 174
Query: 195 MAGTPYWMAPEV-IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
G P MAPE ++ GY FK DIWSFG+TALELAHG P + LP + + Q
Sbjct: 175 FVGNPRRMAPEKDMQQVDGYDFKVDIWSFGMTALELAHGHSPTTVLP------LNL-QNS 227
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
F +YE+ + KFS++F+++VA+CL +DP KRP+A +L+++ F + E+
Sbjct: 228 PFPNYEE-------DTKFSKSFRELVAACLIEDPEKRPTASQLLEYPFLQQ-TLSTEYLA 279
Query: 314 KNVLHGLRSVEERFKE 329
L GL + ER+++
Sbjct: 280 STFLDGLSPLGERYRK 295
|
|
| DICTYBASE|DDB_G0276577 fray2 "FRAY subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 8.6e-61, P = 8.6e-61
Identities = 130/308 (42%), Positives = 185/308 (60%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-DLDSIRRETKTM 80
YP Y++ + IG G S +V +AIC+P V AIK IDL+ + L+ IR+E + M
Sbjct: 64 YPNSADQYELKETIGKGGSGLVQRAICLPFQENV-AIKIIDLEHCKNVSLEEIRKEIQAM 122
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
SL HPN++ H SF + LWV+M F+S GS I+ FP G E IA +LKE L A
Sbjct: 123 SLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEALKA 182
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ Y H G +HRD+K+GNIL DS+G+++L+DFGVSA++ + G GTP
Sbjct: 183 ICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDT------GETSRNTFVGTPC 236
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
WMAPE++ Y + DIWSFGITALELA G+ P + PP K LL+ + +
Sbjct: 237 WMAPEIMEQ-VNYDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTL------QNPPP 289
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGL 320
+L+ D K+S +FKD+V CL +DPSKRP KL++H FFK K ++ V+++L L
Sbjct: 290 SLE-GDGESKWSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKP-DYLVQHILAKL 347
Query: 321 RSVEERFK 328
+ +R++
Sbjct: 348 PPLGQRYQ 355
|
|
| UNIPROTKB|E1C6W3 OXSR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 622 (224.0 bits), Expect = 9.0e-61, P = 9.0e-61
Identities = 137/332 (41%), Positives = 195/332 (58%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C+P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINKDDYELQEVIGSGATAVVQAAFCVPKKEKV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L EPCIA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKTGVLDEPCIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
LKE L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + +
Sbjct: 127 LKEVLEGLDYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN--KVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L++ + Q
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QND 243
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
S E ++ K+ KK+ ++F+ M++SCL +DP KRP+A +L++H FF K EF
Sbjct: 244 PPS-LETGVQDKEMLKKYGKSFRKMISSCLQKDPEKRPTAAELLRHKFFTKA-KNKEFLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGAEH--HEDEE 343
+ +L ++ ER K+ R G+ H+ E+
Sbjct: 302 EKMLQRAPTITERSKKVRRVPGSSGRLHKTED 333
|
|
| UNIPROTKB|E2RAI8 OXSR1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 5.7e-59, P = 5.7e-59
Identities = 135/332 (40%), Positives = 193/332 (58%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L EP IA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
LKE L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + +
Sbjct: 127 LKEVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN--KVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L++ + Q
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QND 243
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
S E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K EF
Sbjct: 244 PPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKEFLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGAEH--HEDEE 343
+ +L ++ ER K+ R G+ H+ E+
Sbjct: 302 EKILQRAPTISERAKKVRRVPGSSGRLHKTED 333
|
|
| MGI|MGI:1917378 Oxsr1 "oxidative-stress responsive 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 1.2e-58, P = 1.2e-58
Identities = 134/332 (40%), Positives = 193/332 (58%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ Y++ + IG G +A+V A C P V AIK I+L++ +T +D + +E +
Sbjct: 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKERV-AIKRINLEKCQTSMDELLKEIQA 66
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCIAIV 133
MS HPNI++ + SF V LW+VM +S GS+ II G L EP IA +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATI 126
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L+E L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN--KVRK 184
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L++ + Q
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QND 243
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
S E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K EF
Sbjct: 244 PPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKEFLQ 301
Query: 314 KNVLHGLRSVEERFKESRNHVGAEH--HEDEE 343
+ +L ++ ER K+ R G+ H+ E+
Sbjct: 302 EKILQRAPTISERSKKVRRVPGSSGRLHKTED 333
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 506 | |||
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-139 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-92 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-88 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-83 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-79 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-76 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-76 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-69 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-69 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-68 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-66 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-61 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-57 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-57 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-56 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-56 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-55 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-54 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-52 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-52 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-52 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-51 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-50 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-48 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-47 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-46 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-46 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-45 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-45 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-44 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-44 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-43 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-43 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-42 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-42 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-42 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-41 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-41 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-40 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-40 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-40 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-40 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-39 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-38 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-37 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-37 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-36 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-36 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-36 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-35 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-35 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-33 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-33 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-33 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-32 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-31 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-30 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-30 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-29 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-29 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-26 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-25 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-24 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-24 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-23 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-20 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-20 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-16 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-16 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-12 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-05 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 400 bits (1031), Expect = e-139
Identities = 134/277 (48%), Positives = 183/277 (66%), Gaps = 11/277 (3%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
Y++++ IGVG +A+VY AIC+P ++ VAIK IDL++ +T +D +R+E + MS +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLH 145
N++ + SF V LW+VMP++S GSL I+ S +P GL E IA VLKE L L YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+ G +HRD+KAGNIL DGSVK+ADFGVSAS+ + + GTP WMAPE
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK---VRKTFVGTPCWMAPE 176
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
V+ GY FKADIWSFGITA+ELA G P S PP K L++ + +L+
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP------PSLETG 230
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
KK+S++F+ M++ CL +DPSKRP+AE+L+KH FF
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 280 bits (719), Expect = 4e-92
Identities = 119/273 (43%), Positives = 155/273 (56%), Gaps = 21/273 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
++IL++IG G VYKA VAIK I L +S+ + I E + + HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKL-ESKEKKEKIINEIQILKKCKHPNI 59
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + S+ LW+VM F S GSL+ ++ S L E IA V KE L L YLH+ G
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR 208
+HRD+KA NIL SDG VKL DFG+SA + + + M GTPYWMAPEVI
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNT-------MVGTPYWMAPEVIN 170
Query: 209 SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268
Y +KADIWS GITA+ELA G+PP S LPP K+L T L+
Sbjct: 171 G-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP------PGLR---NP 220
Query: 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+K+S FKD + CL ++P KRP+AE+L+KH F
Sbjct: 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 3e-88
Identities = 118/289 (40%), Positives = 159/289 (55%), Gaps = 38/289 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+ +L+ IG G VYKAI + VVAIK IDL+++ +++ I++E + +S P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
I + SF S+LW++M + GS ++ L E IA +L+E L L YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE 116
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI--TDMAGTPYWMAP 204
+G +HRD+KA NIL +G VKLADFGVS + S M GTP+WMAP
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQL---------TSTMSKRNTFVGTPFWMAP 167
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264
EVI+ +GY KADIWS GITA+ELA G PPLS L P + L I
Sbjct: 168 EVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL----------------FLI 210
Query: 265 KDKN------KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
N KFS+ FKD V+ CL++DP +RPSA++L+KH F K K
Sbjct: 211 PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 258 bits (663), Expect = 1e-83
Identities = 93/274 (33%), Positives = 134/274 (48%), Gaps = 20/274 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y+IL+++G G VY A +VAIK I + + D + I RE K + L HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK-TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + F + +L++VM + G L ++ L E L++ LSAL YLH++G
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSKG 117
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR 208
+HRD+K NIL D DG VKLADFG++ + +T GTP +MAPEV+
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--------DPGEKLTTFVGTPEYMAPEVLL 169
Query: 209 SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268
GY DIWS G+ EL G+PP L K+ +
Sbjct: 170 GK-GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG--------KPKPPFPPPE 220
Query: 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
S KD++ L +DP KR +AE+ ++H FF
Sbjct: 221 WDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 3e-79
Identities = 120/295 (40%), Positives = 158/295 (53%), Gaps = 22/295 (7%)
Query: 18 QKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+ I DP YK L++IG G S VYKA VAIK + L + + I E
Sbjct: 9 KDIVSEGDPRELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQN--KELIINE 65
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
M HPNI++ + S+ V LWVVM +M GSL II+ F + EP IA V +E
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCRE 124
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L L YLH+Q +HRD+K+ NIL DGSVKLADFG +A + + + +
Sbjct: 125 VLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-------SVV 177
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTPYWMAPEVI+ Y K DIWS GI +E+A G PP PP ++L + T
Sbjct: 178 GTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------ 230
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEF 311
+ +K+ K+S FKD + CL +DP KRPSAE+L++H F K EF
Sbjct: 231 --KGIPPLKNPE-KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 3e-76
Identities = 114/276 (41%), Positives = 151/276 (54%), Gaps = 21/276 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y+++ IG G VYKA I +VAIK I L+ D + I++E + HPNI
Sbjct: 5 YELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNI 62
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIIS-SCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
+ S+ +LW+VM + GSLQ I + P L E IA V +ETL L+YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLHET 120
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
G +HRD+K NIL DG VKLADFGVSA + A GTPYWMAPEV
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLT-------ATIAKRKSFIGTPYWMAPEVA 173
Query: 208 --RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
GY K DIW+ GITA+ELA +PP+ L P ++L + +++ K+K
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKS-----NFPPPKLK 227
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
DK K+S F D + CL +DP KRP+A KL++H F
Sbjct: 228 DKE-KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 4e-76
Identities = 106/275 (38%), Positives = 150/275 (54%), Gaps = 22/275 (8%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
+ IL+++G G VYKAI VVAIK + ++ DL I +E + P
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPY 59
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ + S+ ++ LW+VM + GS+ I+ L E IA +L +TL L YLH+
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
+HRD+KAGNIL + +G KLADFGVS + A + GTP+WMAPEVI
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQL-------TDTMAKRNTVIGTPFWMAPEVI 171
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
GY+ KADIWS GITA+E+A G+PP S + P +++ M + TL
Sbjct: 172 -QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP------PPTLS---D 221
Query: 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+K+S F D V CL +DP +RPSA +L++H F
Sbjct: 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 3e-69
Identities = 95/271 (35%), Positives = 143/271 (52%), Gaps = 21/271 (7%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPNILNA-H 92
+G G VY A+ ++A+K+++L S +L+++ RE + +S L HPNI+
Sbjct: 8 LGRGSFGSVYLAL-DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 93 CSFSVDSRLW-VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLH 151
+ + + ++S GSL S++ LPEP I ++ L L+YLH+ G +H
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 152 RDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT 211
RD+K NIL DSDG VKLADFG + + + + GTPYWMAPEVIR
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDI-----ETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 212 GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271
Y ADIWS G T +E+A G+PP S L + L K+ + + + +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG---------SSGEPPEIPEHL 229
Query: 272 SRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
S KD + CL +DP KRP+A++L++H F
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 5e-69
Identities = 103/281 (36%), Positives = 157/281 (55%), Gaps = 26/281 (9%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH- 85
S Y+ L+ IG G VY+ +P VVA+K I+LD D+ I+RE +S L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGR-VVALKIINLDTPDDDVSDIQREVALLSQLRQS 59
Query: 86 --PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
PNI + S+ RLW++M + GS+++++ + E I+++++E L AL Y
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKY 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+H G +HRD+KA NIL + G+VKL DFGV+A + + S+ + GTPYWMA
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-------NQNSSKRSTFVGTPYWMA 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL-LMKMTQRFRFSDYEKTL 262
PEVI Y KADIWS GIT E+A G PP S + +++ L+ ++ R D
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG--- 226
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+S+ ++ VA+CLD++P +R SAE+L+K + K
Sbjct: 227 --------YSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 3e-68
Identities = 91/278 (32%), Positives = 140/278 (50%), Gaps = 22/278 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPN 87
Y++L ++G G VYKA +VA+K + + + RRE + + LSHPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKG-TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ +F L++VM + G L +S P L E + + L L YLH+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN 117
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
G +HRD+K NIL D +G VK+ADFG++ + + S T GTP++MAPEV+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-------TTFVGTPWYMAPEVL 170
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM---KMTQRFRFSDYEKTLKI 264
GY K D+WS G+ EL G+PP S L + + F + + +
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG- 229
Query: 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
S KD++ CL++DPSKRP+AE++++H +F
Sbjct: 230 -------SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 102/279 (36%), Positives = 142/279 (50%), Gaps = 31/279 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPN 87
Y++ D IG G +VYK + + VAIK I L L SI +E + L HPN
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ S L++++ + GSL+ II F PE +A+ + + L L+YLH Q
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKK-F-GPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
G +HRD+KA NIL+ DG VKLADFGV+ + + S + GTPYWMAPEVI
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA-------SVVGTPYWMAPEVI 171
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
+G S +DIWS G T +EL G PP L P M FR +D
Sbjct: 172 EM-SGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRIV--------QDD 215
Query: 268 N----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ + S KD + C +DP+ RP+A++L+KH +
Sbjct: 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 9e-61
Identities = 109/290 (37%), Positives = 154/290 (53%), Gaps = 32/290 (11%)
Query: 24 LDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL 82
++P+ ++I+ E+G G VYKA A K I + +S +L+ E +S
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQH-KETGLFAAAKIIQI-ESEEELEDFMVEIDILSE 58
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
HPNI+ + ++ +++LW+++ F G+L SI+ GL EP I V ++ L AL+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALN 117
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH+ +HRD+KAGNIL DG VKLADFGVSA GTPYWM
Sbjct: 118 FLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD-------TFIGTPYWM 170
Query: 203 APEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
APEV+ T Y +KADIWS GIT +ELA PP L P + LL
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL------------ 218
Query: 259 EKTLKIK----DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
K LK + D+ K+S +F D + SCL +DP RP+A +L+KH F +
Sbjct: 219 -KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 111/304 (36%), Positives = 161/304 (52%), Gaps = 35/304 (11%)
Query: 34 EIGVGVS--AIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPNILN 90
IG IV+ A P + T+VA+K I+LD S+ DL +++E T L HPNIL
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTN-TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHL 150
SF VDS L+VV P M+ GS + ++ + FP+GLPE IA +LK+ L+AL Y+H++G +
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM----AGTPYWMAPEV 206
HR VKA +IL DG V L+ S S+ + H ++ D W++PEV
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIK----HGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 207 IRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT-------QRFRFSDY 258
++ + GY+ K+DI+S GITA ELA+G P +P + LL K+ + + Y
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239
Query: 259 EKTLKIKDK---------------NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
E ++ + FS F V CL +DP RPSA +L+ HSFFK
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299
Query: 304 NCNK 307
C +
Sbjct: 300 QCKR 303
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-57
Identities = 81/266 (30%), Positives = 123/266 (46%), Gaps = 53/266 (19%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCS 94
+G G VY A VAIK I + S + L+ + RE + + L+HPNI+ +
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDV 154
F ++ L++VM + GSL+ ++ L E I +L + L L YLH+ G +HRD+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 155 KAGNIL-SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGY 213
K NIL +G VKLADFG+S + +++ + GTP +MAPEV+ Y
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL-------TSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 214 SFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSR 273
S K+DIWS G+ EL
Sbjct: 172 SEKSDIWSLGVILYELPE------------------------------------------ 189
Query: 274 AFKDMVASCLDQDPSKRPSAEKLMKH 299
KD++ L +DP KRPSA+++++H
Sbjct: 190 -LKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 3e-57
Identities = 89/286 (31%), Positives = 143/286 (50%), Gaps = 27/286 (9%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
S + + +G G S +VYK P + A+K I +D + RE KT+ P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
++ + +F + + +V+ +M GSL ++ +PEP +A + ++ L L YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT 117
Query: 147 QGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA----GTPYW 201
+ H+ HRD+K N+L +S G VK+ADFG+S + D GT +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-----------ENTLDQCNTFVGTVTY 166
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
M+PE I+ + YS+ ADIWS G+T LE A G+ P PP + ++ Q
Sbjct: 167 MSPERIQGES-YSYAADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAICDGP---- 219
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
++FS F+D +++CL +DP KRPSA +L++H F K +
Sbjct: 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-56
Identities = 101/292 (34%), Positives = 150/292 (51%), Gaps = 35/292 (11%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP+ +++++ IG G VYKA +VAIK +D+ + + I+ E +
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQ-LVAIKIMDIIEDEEE--EIKEEYNILRKY 59
Query: 84 S-HPNILNAHCSF------SVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVL 134
S HPNI + +F D +LW+VM GS+ ++ G L E IA +L
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
+ETL L+YLH +HRD+K NIL + VKL DFGVSA + +
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF------ 173
Query: 195 MAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
GTPYWMAPEVI Y ++D+WS GITA+ELA G+PPL + P ++L
Sbjct: 174 -IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----- 227
Query: 251 QRFRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
F+ + TLK + +S+ F D ++ CL ++ +RP E+L++H F
Sbjct: 228 --FKIPRNPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 4e-56
Identities = 108/291 (37%), Positives = 160/291 (54%), Gaps = 24/291 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP + L+ IG G VYK I VVAIK IDL+++ +++ I++E +S
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
P I + S+ ++LW++M ++ GS ++ P L E IA +L+E L L Y
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDY 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH++ +HRD+KA N+L G VKLADFGV+ + + + GTP+WMA
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEVI+ + Y FKADIWS GITA+ELA G PP S L P + L + + TL+
Sbjct: 170 PEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP------KNSPPTLE 222
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVK 314
++S+ FK+ V +CL++DP RP+A++L+KH F K F +
Sbjct: 223 -----GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTE 268
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 7e-55
Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 25/271 (9%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLD----QSRTDLDSIRRETKTMSLLSHPNILN 90
+G G VY+ + + D A+K + L + + + +E +S L HPNI+
Sbjct: 8 LGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHL 150
+ + L++ + + GSL ++ PEP I + ++ L L YLH++ +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH 210
HRD+K NIL D++G VKLADFG++ + E + G+PYWMAPEVI
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVE--------FSFAKSFKGSPYWMAPEVIAQQ 176
Query: 211 TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270
GY ADIWS G T LE+A G+PP S L ++ F+ ++ I D
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-------FKIGRSKELPPIPD---H 226
Query: 271 FSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
S KD + CL +DPS RP+A +L++H F
Sbjct: 227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 4e-54
Identities = 109/281 (38%), Positives = 150/281 (53%), Gaps = 25/281 (8%)
Query: 25 DPS-SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSL 82
DP Y ++IG G S VY AI + V AIK ++L Q + +L I E M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEV-AIKQMNLQQQPKKEL--IINEILVMRE 72
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
HPNI+N S+ V LWVVM +++ GSL +++ D E IA V +E L AL
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALE 129
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH+ +HRD+K+ NIL DGSVKL DFG A I P + M GTPYWM
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR------STMVGTPYWM 182
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
APEV+ + Y K DIWS GI A+E+ G PP + P ++L + T T
Sbjct: 183 APEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------GTP 233
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
++++ K S F+D + CL+ D KR SA++L++H F K
Sbjct: 234 ELQNPE-KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 105/285 (36%), Positives = 156/285 (54%), Gaps = 25/285 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP + L+ IG G V+K I VVAIK IDL+++ +++ I++E +S
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQ-VVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
P + + S+ ++LW++M ++ GS ++ + D E IA +LKE L L Y
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD---EFQIATMLKEILKGLDY 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH++ +HRD+KA N+L G VKLADFGV+ + + + GTP+WMA
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEVI+ + Y KADIWS GITA+ELA G PP S + P + L F
Sbjct: 170 PEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNNPPTL 221
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF-KNCNK 307
+ FS+ FK+ + +CL++DPS RP+A++L+KH F KN K
Sbjct: 222 TGE----FSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 6e-52
Identities = 105/285 (36%), Positives = 159/285 (55%), Gaps = 25/285 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP + L++IG G V+K I VVAIK IDL+++ +++ I++E +S
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
P + + S+ D++LW++M ++ GS ++ P L E IA +L+E L L Y
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDY 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH++ +HRD+KA N+L G VKLADFGV+ + + + GTP+WMA
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEVI+ + Y KADIWS GITA+ELA G PP S L P K L + + TL+
Sbjct: 170 PEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNPPTLE 222
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF-FKNCNK 307
+S+ K+ V +CL+++PS RP+A++L+KH F + K
Sbjct: 223 -----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 6e-52
Identities = 110/278 (39%), Positives = 149/278 (53%), Gaps = 26/278 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
++++ IG G VYKA + + AIK I L+ D +++E M H NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNT-GELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNI 68
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ S+ +LW+ M F GSLQ I P L E IA V +ETL L YLH++G
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKG 126
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT---DMAGTPYWMAPE 205
+HRD+K NIL +G VKLADFGVSA I +A I GTPYWMAPE
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQI----------TATIAKRKSFIGTPYWMAPE 176
Query: 206 V--IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
V + GY+ DIW+ GITA+ELA +PP+ L P ++L + F + K
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF------QPPK 230
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+KDK K+S +F V L ++P KRP+AEKL++H F
Sbjct: 231 LKDK-MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 6e-51
Identities = 92/283 (32%), Positives = 138/283 (48%), Gaps = 38/283 (13%)
Query: 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNA 91
L E+G G S +V K + P ++A+K I L+ + I RE + + P I+
Sbjct: 6 LGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH-L 150
+ +F + + + M +M GSL I+ +PE + + L L+YLH + +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA----GTPYWMAPEV 206
HRDVK NIL +S G +KL DFGVS ++ +A GT +MAPE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQ-------------LVNSLAKTFVGTSSYMAPER 170
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
I+ YS K+DIWS G++ +ELA GR P PPE +E I +
Sbjct: 171 IQG-NDYSVKSDIWSLGLSLIELATGRFPY---PPENDPPD--------GIFELLQYIVN 218
Query: 267 K------NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ + KFS F+D V CL +DP +RPS ++L++H F K
Sbjct: 219 EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 105/275 (38%), Positives = 148/275 (53%), Gaps = 20/275 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y+++ +G G VYKA + + A+K I L+ D I++E + H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHT-GELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNI 68
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ S+ +LW+ M + GSLQ I P L E IA V +ETL L+YLH++G
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKG 126
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV-- 206
+HRD+K NIL +G VKLADFGV+A I A GTPYWMAPEV
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITAT-------IAKRKSFIGTPYWMAPEVAA 179
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
+ + GY+ DIW+ GITA+ELA +PP+ L P ++L + F + K+KD
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF------QPPKLKD 233
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
K K+S F + V L ++P KRP+AE+L+ H F
Sbjct: 234 KT-KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 1e-49
Identities = 108/292 (36%), Positives = 149/292 (51%), Gaps = 39/292 (13%)
Query: 23 PLDPSSYKILD---EIGVGVSAIVYKAICIPMDST---VVAIKAIDL-DQSRTDLDSIRR 75
P DP SY LD +IG G + IV CI D + VA+K +DL Q R +L +
Sbjct: 14 PGDPRSY--LDNFVKIGEGSTGIV----CIATDKSTGRQVAVKKMDLRKQQRREL--LFN 65
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E M HPNI+ + S+ V LWVVM F+ G+L I++ + E IA V
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCL 122
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE--PSHHHHHGSAMIT 193
L ALS+LH QG +HRD+K+ +IL SDG VKL+DFG A + + P
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK--------- 173
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
+ GTPYWMAPEVI S Y + DIWS GI +E+ G PP + PP ++ MK +
Sbjct: 174 SLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--MKRIRD- 229
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305
K+K+ K S + + L +DP++R +A +L+ H F
Sbjct: 230 -----NLPPKLKN-LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 23/273 (8%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPN 87
Y+I+ +IG G VY D + +K IDL + S + + E K + L+HPN
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSYLH 145
I+ + SF +L +VM + G L I +G PE I + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
++ LHRD+K NI S+G VKL DFG+S + + + + GTPY+++PE
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGIS-KVLSST------VDLAKTVVGTPYYLSPE 173
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
+ + + Y++K+DIWS G EL + P L +K+ + +
Sbjct: 174 LCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKG----------QYP 221
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
++S +++V+S L +DP +RPS ++++
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 9e-47
Identities = 105/282 (37%), Positives = 141/282 (50%), Gaps = 29/282 (10%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMS 81
DP + L EIG G VY A + + VVAIK + QS I +E + +
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
L HPN + + + W+VM + C S I L E IA + L L
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEY--CLGSASDILEVHKKPLQEVEIAAICHGALQGL 128
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+YLH+ +HRD+KAGNIL G+VKLADFG SAS+ P++ GTPYW
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPAN----------SFVGTPYW 177
Query: 202 MAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
MAPEVI + Y K D+WS GIT +ELA +PPL ++ S L + Q +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ-----NDS 231
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
TL D +S F++ V SCL + P RPS+E+L+KH F
Sbjct: 232 PTLSSND----WSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 106/281 (37%), Positives = 152/281 (54%), Gaps = 25/281 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP Y ++IG G S VY A+ + V AI+ ++L Q + + I E M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEV-AIRQMNL-QQQPKKELIINEILVMREN 74
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIIS-SCFPDGLPEPCIAIVLKETLSALS 142
+PNI+N S+ V LWVVM +++ GSL +++ +C +G IA V +E L AL
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRECLQALE 130
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH+ +HRD+K+ NIL DGSVKL DFG A I P + M GTPYWM
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR------STMVGTPYWM 183
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
APEV+ + Y K DIWS GI A+E+ G PP + P ++L + T T
Sbjct: 184 APEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--------GTP 234
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
++++ +K S F+D + CLD D KR SA++L++H F K
Sbjct: 235 ELQNP-EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 8e-46
Identities = 106/281 (37%), Positives = 152/281 (54%), Gaps = 25/281 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP Y ++IG G S VY AI I V AIK ++L Q + + I E M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEV-AIKQMNL-QQQPKKELIINEILVMREN 73
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIIS-SCFPDGLPEPCIAIVLKETLSALS 142
+PNI+N S+ V LWVVM +++ GSL +++ +C +G IA V +E L AL
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRECLQALD 129
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH+ +HRD+K+ NIL DGSVKL DFG A I P + M GTPYWM
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR------STMVGTPYWM 182
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
APEV+ + Y K DIWS GI A+E+ G PP + P ++L + T T
Sbjct: 183 APEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------GTP 233
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
++++ ++ S F+D + CL+ D +R SA++L++H F K
Sbjct: 234 ELQNP-ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-45
Identities = 101/294 (34%), Positives = 157/294 (53%), Gaps = 24/294 (8%)
Query: 18 QKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+ ++ LDP+ ++I+ E+G G VYKA ++ +A + +S +L+ E
Sbjct: 2 EHVRRDLDPNEVWEIIGELGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYMVE 59
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+ ++ +HP I+ +F D +LW+++ F G++ +I+ GL EP I ++ ++
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQ 118
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L AL YLH+ +HRD+KAGN+L DG +KLADFGVSA +
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR-------DSFI 171
Query: 197 GTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
GTPYWMAPEV+ T Y +KADIWS GIT +E+A PP L P + LL +
Sbjct: 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-----K 226
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
S+ TL + K+S F+D + + LD+ P RPSA +L++H F +
Sbjct: 227 IAKSE-PPTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 87/252 (34%), Positives = 131/252 (51%), Gaps = 18/252 (7%)
Query: 55 VVAIKAIDLDQSRTD-----LDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109
++A+K ++LD S + ++ E + L H NI+ + D+ + + M F+
Sbjct: 26 LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85
Query: 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169
GS+ SI++ P LPEP K+ L ++YLHN +HRD+K N++ +G +KL
Sbjct: 86 GGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKL 143
Query: 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL 229
DFG + + H H S M+ M GTPYWMAPEVI +GY K+DIWS G T E+
Sbjct: 144 IDFGCARRLAWVGLHGTH-SNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEM 201
Query: 230 AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK 289
A G+PPL+ + + F + + FS A D V SCL +D +
Sbjct: 202 ATGKPPLASMDR-------LAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHE 252
Query: 290 RPSAEKLMKHSF 301
RPSA +L++H F
Sbjct: 253 RPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-45
Identities = 76/274 (27%), Positives = 123/274 (44%), Gaps = 30/274 (10%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAH 92
+G G V + A+K + + R +++ E +S ++HP I+ H
Sbjct: 1 LGKGSFGKVLLVR-KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHR 152
+F + +L++V+ + G L S +S E E + AL YLH+ G ++R
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG 212
D+K NIL D+DG +KL DFG++ + GTP ++APEV+ G
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSR-------TNTFCGTPEYLAPEVLLG-KG 169
Query: 213 YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK-NKKF 271
Y D WS G+ E+ G+PP E + YEK LK + +
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYA---EDRKEI----------YEKILKDPLRFPEFL 216
Query: 272 SRAFKDMVASCLDQDPSKR---PSAEKLMKHSFF 302
S +D+++ L +DP+KR AE++ H FF
Sbjct: 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 2e-44
Identities = 98/289 (33%), Positives = 153/289 (52%), Gaps = 32/289 (11%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP+ +++++ +G G VYK + + AIK +D+ + + + I++E +
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKT-GQLAAIKVMDV--TGDEEEEIKQEINMLKKY 59
Query: 84 SH-PNILNAHCSF------SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
SH NI + +F +D +LW+VM F GS+ +I + + L E IA + +E
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L LS+LH +HRD+K N+L + VKL DFGVSA + +
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-------TFI 172
Query: 197 GTPYWMAPEVI----RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
GTPYWMAPEVI Y FK+D+WS GITA+E+A G PPL + P ++L +
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----- 227
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ + K+KK+S+ F+ + SCL ++ S+RP+ E+LMKH F
Sbjct: 228 -----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-44
Identities = 107/280 (38%), Positives = 150/280 (53%), Gaps = 23/280 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP Y ++IG G S V+ AI + V AIK I+L Q + + I E M L
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEV-AIKQINL-QKQPKKELIINEILVMKEL 73
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+PNI+N SF V L+VVM +++ GSL +++ D E IA V +E L AL +
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD---EAQIAAVCRECLQALEF 130
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH +HRD+K+ N+L DGSVKL DFG A I P + M GTPYWMA
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKR------STMVGTPYWMA 183
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEV+ + Y K DIWS GI A+E+ G PP + P ++L + T T +
Sbjct: 184 PEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------GTPE 234
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+++ +K S F+D + CL+ D KR SA++L++H F K
Sbjct: 235 LQNP-EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 103/290 (35%), Positives = 152/290 (52%), Gaps = 25/290 (8%)
Query: 24 LDPSSY-KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL 82
L+P + +I+ E+G G VYKA + A K ID +S +L+ E ++
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQN-KETGVLAAAKVID-TKSEEELEDYMVEIDILAS 58
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
HPNI+ +F ++ LW+++ F + G++ +++ L EP I +V K+TL AL+
Sbjct: 59 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALN 117
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
YLH +HRD+KAGNIL DG +KLADFGVSA GTPYWM
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-------DSFIGTPYWM 170
Query: 203 APEVIRSHTG----YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
APEV+ T Y +KAD+WS GIT +E+A PP L P + LL + S+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL-----KIAKSE- 224
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK-NCNK 307
TL + ++S FKD + CL+++ R + +L++H F N NK
Sbjct: 225 PPTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 4e-43
Identities = 95/289 (32%), Positives = 147/289 (50%), Gaps = 32/289 (11%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP+ +++++ +G G VYK + + AIK +D+ + + I+ E +
Sbjct: 13 DPAGIFELVEVVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTEDEEE--EIKLEINMLKKY 69
Query: 84 SH-PNILNAHCSF------SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
SH NI + +F D +LW+VM F GS+ ++ + + L E IA + +E
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L L++LH +HRD+K N+L + VKL DFGVSA + +
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-------TFI 182
Query: 197 GTPYWMAPEVI----RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
GTPYWMAPEVI Y +++DIWS GITA+E+A G PPL + P ++L +
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----- 237
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ K K+KK+S+ F D + CL ++ RPS E+L+KH F
Sbjct: 238 -----IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 19/274 (6%)
Query: 32 LDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLDQSRTD-LDSIRRETKTMSLLSHPNIL 89
++IG G VY + +D+ ++A+K I + + + I E K + LL HPN++
Sbjct: 5 GNKIGGGTFGKVYT--AVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH 149
+ ++++ M + S G+L+ ++ L E I + + L L+YLH+ G
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 150 LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR- 208
+HRD+K NI D +G +KL DFG + + + + +AGTP +MAPEVI
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG---EEVQSLAGTPAYMAPEVITG 177
Query: 209 -SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
G+ ADIWS G LE+A G+ P S L E ++ + I D
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-------HKPPIPDS 230
Query: 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ S KD + CL+ DP KRP+A +L++H F
Sbjct: 231 LQL-SPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 107/290 (36%), Positives = 149/290 (51%), Gaps = 31/290 (10%)
Query: 18 QKIQYPLDPSSYKILD---EIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSI 73
Q + P DP +Y LD +IG G + IV A + +VA+K +DL Q R +L +
Sbjct: 10 QMVVDPGDPRTY--LDNFIKIGEGSTGIVCIAT-VKSSGKLVAVKKMDLRKQQRREL--L 64
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
E M H N++ + S+ V LWVVM F+ G+L I++ + E IA V
Sbjct: 65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAV 121
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L ALS LH QG +HRD+K+ +IL DG VKL+DFG A + +
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-------K 174
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
+ GTPYWMAPE+I S Y + DIWS GI +E+ G PP + PP K+ MKM +
Sbjct: 175 SLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIR-- 229
Query: 254 RFSDYEKTLKIKDKN-KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
L K KN K S + K + L +DP++R +A +L+KH F
Sbjct: 230 ------DNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-42
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 38/297 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-----SRTDLDSIRRETKTMSLL 83
Y+ L+++G G +VYKA +VA+K I LD T L RE + L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDNEEEGIPSTAL----REISLLKEL 55
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HPNI+ + +L++V + L+ + L I ++ + L L+Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAY 113
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
H+ LHRD+K NIL + DG +KLADFG++ + P + H T ++ A
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-------TLWYRA 166
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF---------- 253
PE++ YS DIWS G E+ G+ PL E L K+ Q
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGK-PLFPGDSEIDQLFKIFQILGTPTEESWPG 225
Query: 254 --RFSDYEKTLKI---KDKNKKFSRAFKDMV---ASCLDQDPSKRPSAEKLMKHSFF 302
+ DY+ T KD K R + + + L +P+KR SA++ +KH +F
Sbjct: 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 8e-42
Identities = 107/293 (36%), Positives = 153/293 (52%), Gaps = 35/293 (11%)
Query: 18 QKIQYPLDPSSYKILD---EIGVGVSAIVYKAICIPMDSTV---VAIKAIDL-DQSRTDL 70
Q + P DP Y LD +IG G + IV CI + VA+K +DL Q R +L
Sbjct: 12 QLVVSPGDPREY--LDSFIKIGEGSTGIV----CIATEKHTGKQVAVKKMDLRKQQRREL 65
Query: 71 DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCI 130
+ E M H N+++ + S+ V LWVVM F+ G+L I++ + E I
Sbjct: 66 --LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQI 120
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190
A V L ALSYLHNQG +HRD+K+ +IL SDG +KL+DFG A + +
Sbjct: 121 ATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR----- 175
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
+ GTPYWMAPEVI S Y + DIWS GI +E+ G PP + PP ++
Sbjct: 176 --KSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAM 227
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+R R + +K K R F D++ L ++PS+R +A++L++H F K
Sbjct: 228 RRIR-DNLPPRVKDSHKVSSVLRGFLDLM---LVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 153 bits (386), Expect = 9e-42
Identities = 96/368 (26%), Positives = 146/368 (39%), Gaps = 17/368 (4%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI--DLDQSRTDLDSIRRETKTMSLLSH 85
SY+IL ++G G VY A D +VA+K + L+ +++ RE + ++ L+H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR----DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 86 P-NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALSY 143
P NI+ + F + L++VM ++ GSL+ ++ G L E +L + LSAL Y
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGS-VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
LH++G +HRD+K NIL D DG VKL DFG A + A+ + GTP +M
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFG-LAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 203 APEVIRSHTG--YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
APEV+ + S +DIWS GIT EL G PP S + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-FEGEKNSSATSQTLKIILELPTPS 234
Query: 261 TLK--IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLH 318
+ S+A D++ L +DP R S+ + H + +
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 319 GLRSVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPVFPFFTT 378
+ A + S G P
Sbjct: 295 --DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLL 352
Query: 379 ESRADSDS 386
S A S
Sbjct: 353 LSTASSKR 360
|
Length = 384 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 100/293 (34%), Positives = 151/293 (51%), Gaps = 34/293 (11%)
Query: 25 DPS-SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDS-IRRETKTM-S 81
DP+ +++I++ IG G VYK + D ++ A+K +D +D+D I E + S
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILD---PISDVDEEIEAEYNILQS 74
Query: 82 LLSHPNILNAHCSF-----SVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVL 134
L +HPN++ + F V +LW+V+ + GS+ ++ G L E I+ +L
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
L L +LHN +HRDVK NIL ++G VKL DFGVSA + +
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS------ 188
Query: 195 MAGTPYWMAPEVIRSHTGYSF----KADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
GTP+WMAPEVI Y + + D+WS GITA+EL G PPL + P K+L K+
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIP 246
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ + TL +K+ R+F ++ CL +D RPS L++H F K
Sbjct: 247 R-----NPPPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y++L+ IG G V K D ++ K ID + + + E + L HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 88 ILNAHCSFSVD---SRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALS 142
I+ + +D L++VM + G L +I C + + E I +L + L AL
Sbjct: 61 IV-RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 143 YLHNQGH-----LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
HN+ LHRD+K NI D++ +VKL DFG++ + H S+ G
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-------GHDSSFAKTYVG 172
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257
TPY+M+PE + + Y K+DIWS G EL PP F +
Sbjct: 173 TPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPP-----------------FTARN 214
Query: 258 Y-EKTLKIKDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ KIK+ ++S +++ S L+ DP KRPS E+L++
Sbjct: 215 QLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 4e-41
Identities = 87/296 (29%), Positives = 136/296 (45%), Gaps = 24/296 (8%)
Query: 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNA 91
L +G G V K + + A+K I D + I RE + P I+
Sbjct: 6 LSRLGEGAGGSVTKCR-LKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 92 HCSF--SVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSYLHNQ 147
+ +F S + + M + GSL SI G + E + + + L LSYLH++
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
+HRD+K NIL G VKL DFGVS + +++ GT ++MAPE I
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---------VNSLAGTFTGTSFYMAPERI 175
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
+ YS +D+WS G+T LE+A R P PPE + + + ++KD+
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFP---FPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 268 ---NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK---GVEFFVKNVL 317
K+S FKD + CL++DP++RP+ +++H + K K + FV V
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVAQVW 287
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 91/290 (31%), Positives = 139/290 (47%), Gaps = 48/290 (16%)
Query: 56 VAIKAIDLDQSRTDLDS-IRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
V ++ I+L+ ++ + ++ E L +HPNI+ +F D+ LWVV FM+ GS +
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87
Query: 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174
+I + F DG+ E IA +L+ L AL Y+H+ G++HR VKA +IL DG V L+
Sbjct: 88 DLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 147
Query: 175 SASIYEPSHHHHHGSAMITDM----AGTPYWMAPEVIRSH-TGYSFKADIWSFGITALEL 229
+ S+ +H ++ D W++PEV++ + GY K+DI+S GITA EL
Sbjct: 148 NLSMI----NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203
Query: 230 AHGRPPLSHLPPEKSLLMKM------------------------------------TQRF 253
A+G P +P + LL K+
Sbjct: 204 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP 263
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
R S+ E + N+ FS F V CL ++P RPSA L+ HSFFK
Sbjct: 264 RPSNGESSS--HPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 97/291 (33%), Positives = 148/291 (50%), Gaps = 34/291 (11%)
Query: 25 DPS-SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDS-IRRETKTMSL 82
DPS +++I++ IG G V+K + + + A+K +D D+D I E +
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLN-KKNGSKAAVKILD---PIHDIDEEIEAEYNILKA 70
Query: 83 LS-HPNILNAHCSF-----SVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVL 134
LS HPN++ + + +LW+V+ + GS+ ++ G + EP IA +L
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
E L L +LH +HRDVK NIL ++G VKL DFGVSA + +
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS------ 184
Query: 195 MAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
GTP+WMAPEVI + Y + D+WS GITA+EL G PPL+ L P ++L K+
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIP 242
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ + TL + + +S F D + CL +D KRP+ L++H F
Sbjct: 243 R-----NPPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 76/260 (29%), Positives = 115/260 (44%), Gaps = 23/260 (8%)
Query: 55 VVAIKAIDLDQSRTD--LDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
+ AIK I +D + E +S P ++ + SF L++VM ++ G
Sbjct: 20 IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79
Query: 113 LQSIISS--CFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
L S++ + E I + E + AL YLH+ G +HRD+K NIL DS+G +KL
Sbjct: 80 LASLLENVGSLD----EDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLT 135
Query: 171 DFGVS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL 229
DFG+S + + + + GTP ++APEVI G+S D WS G E
Sbjct: 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEF 194
Query: 230 AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK 289
G PP PE+ + + E +D S D+++ L DP K
Sbjct: 195 LVGIPPFHGETPEE-IFQNILNG----KIE---WPEDVE--VSDEAIDLISKLLVPDPEK 244
Query: 290 RP---SAEKLMKHSFFKNCN 306
R S E++ H FFK +
Sbjct: 245 RLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 5e-40
Identities = 99/309 (32%), Positives = 144/309 (46%), Gaps = 40/309 (12%)
Query: 34 EIGVGVSAI--VYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILN 90
EIG G + VY A P T+V ++ DL+ + L +++ E HPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPT-GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMT 63
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHL 150
+ F+ S LWV+ PFM+ GS S++ + FP+G+ E I +L L L+YLH G++
Sbjct: 64 SWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH 210
HR++KA +IL DG V L+ S+ W++PE++R
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183
Query: 211 -TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT-------QRFRFSDYEKTL 262
GY+ K+DI+S GITA ELA GR P + + LL K+ F E +
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243
Query: 263 KIKDK----------------------------NKKFSRAFKDMVASCLDQDPSKRPSAE 294
K +K FS AF+++V CL QDP KRPSA
Sbjct: 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS 303
Query: 295 KLMKHSFFK 303
L+ H+FFK
Sbjct: 304 SLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 9e-40
Identities = 104/291 (35%), Positives = 145/291 (49%), Gaps = 37/291 (12%)
Query: 23 PLDPSSYKILD---EIGVGVSAIVYKAICIPMDS---TVVAIKAIDL-DQSRTDLDSIRR 75
DP S L+ +IG G + IV CI + VA+K +DL Q R +L +
Sbjct: 16 QGDPRSL--LENYIKIGEGSTGIV----CIAREKHSGRQVAVKMMDLRKQQRREL--LFN 67
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E M H N++ + S+ V LWV+M F+ G+L I+S L E IA V +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCE 124
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
L AL YLH+QG +HRD+K+ +IL DG VKL+DFG A I + +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-------SL 177
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
GTPYWMAPEVI S T Y + DIWS GI +E+ G PP P +++ +R R
Sbjct: 178 VGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRD 231
Query: 256 SDYEKTLKIKDKN-KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305
S K KN K S +D + L ++P +R +A++L+ H F
Sbjct: 232 SPPPKL-----KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 76/300 (25%), Positives = 124/300 (41%), Gaps = 48/300 (16%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLS-H 85
+K IG G + V A + AIK +D Q + ++ E + ++ L+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
P I+ + +F + L+ V+ + G L I L E C E L AL YLH
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA--------- 196
++G +HRD+K NIL D D +K+ DFG +A + +P+ T++
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFG-TAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 197 -----GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
GT +++PE++ + +D+W+ G ++ G+PP
Sbjct: 179 FASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPP---------------- 221
Query: 252 RFR-FSDYEKTLKIKDKNKKFSRAF----KDMVASCLDQDPSKRP----SAEKLMKHSFF 302
FR ++Y KI F F KD++ L DP R ++L H FF
Sbjct: 222 -FRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 94/292 (32%), Positives = 135/292 (46%), Gaps = 32/292 (10%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM 80
+YP D + + L EIG G VYK V+A+K + ++ + I + +
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVV 67
Query: 81 SLLSH--PNILNAHCSFSVDSRLWVVMPFMS--CGSLQSIISSCFP-DGLPEPCIAIVLK 135
L SH P I+ + F DS +++ M MS L I P D L + +AIV
Sbjct: 68 -LKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIV-- 124
Query: 136 ETLSALSYL-HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
AL YL G +HRDVK NIL D+ G+VKL DFG+S + + T
Sbjct: 125 ---KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--------TR 173
Query: 195 MAGTPYWMAPEVI---RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
AG +MAPE I + Y +AD+WS GI+ +ELA G+ P + E +L K+ Q
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ N+ FS F V CL +D KRP +L++H F +
Sbjct: 234 --------EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 24/272 (8%)
Query: 30 KILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
++ ++G G VYK T VA+K + S + + E M LSHP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ + L++V +M G L + + L + + + + YL +
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLES 120
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPE 205
+ +HRD+ A N L + VK++DFG+S IYE ++ G + P WMAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL------PIKWMAPE 174
Query: 206 VIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264
++ ++ K+D+WSFG+ E+ G P + E+ +L + +R
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRL--------- 223
Query: 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
+ + +++ C DP RP+ +L
Sbjct: 224 -PRPENCPDELYELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 34/282 (12%)
Query: 35 IGVGVSAIVYKAICIPMDS-TVVAIKAIDL--------DQSRTDL-DSIRRETKTMSLLS 84
IG G VY + + + + ++A+K ++L D + D+ ++R E +T+ L
Sbjct: 9 IGKGTYGRVY--LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
H NI+ + + L + + ++ GS+ S + + E + ++ L L+YL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGV---SASIYEPSHHHHHGSAMITDMAGTPYW 201
H++G LHRD+KA N+L D+DG K++DFG+ S IY + M G+ +W
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY--------DNDQNMSMQGSVFW 176
Query: 202 MAPEVIRS-HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
MAPEVI S GYS K DIWS G LE+ GR P S E M F+ +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE--EAIAAM-----FKLGNKRS 229
Query: 261 TLKI-KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
I D + S D + +C +P RP+A +L++H F
Sbjct: 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 102/283 (36%), Positives = 138/283 (48%), Gaps = 29/283 (10%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMS 81
DP + L EIG G VY A + +S VVAIK + QS I +E + +
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
L HPN + + + W+VM + C S + L E IA V L L
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEY--CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+YLH+ +HRDVKAGNIL G VKL DFG SASI P++ GTPYW
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPAN----------XFVGTPYW 177
Query: 202 MAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
MAPEVI + Y K D+WS GIT +ELA +PPL ++ M+ + + E
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNE 230
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
++ +S F++ V SCL + P RP++E L+KH F
Sbjct: 231 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 31/276 (11%)
Query: 33 DEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90
++G G VYK D +T VA+K + D S + +E + M L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 91 -AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS-------ALS 142
+ L++V+ +M G L + P + LK+ LS +
Sbjct: 61 LLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP-YW 201
YL ++ +HRD+ A N L D VK++DFG+S +Y+ ++ + P W
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL------PIRW 173
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
MAPE ++ ++ K+D+WSFG+ E+ G P L E+ +L + + +R
Sbjct: 174 MAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRL----- 226
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
K + +++ SC DP RP+ +L
Sbjct: 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 36/298 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMD-STVVAIKAIDLDQSRTDLD---SIRRETKTMSLLS 84
Y++L +G G +V K C +VAIK +S D D + RE K + L
Sbjct: 3 YEVLGVVGEGAYGVVLK--CRNKATGEIVAIK--KFKESEDDEDVKKTALREVKVLRQLR 58
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
H NI+N +F RL++V ++ L+ + P GLP + + + L A++Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
H+ +HRD+K NIL G +KL DFG + ++ +TD T ++ AP
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP------LTDYVATRWYRAP 170
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRP--P--------------LSHLPPEKSLLMK 248
E++ T Y D+W+ G EL G P P L LPP L
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 249 MTQRF---RFSDYEKTLKIKDK-NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
RF F + + ++ + K S D + +CL DP +R + ++L++H +F
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 30 KILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+ ++G G VYK VA+K + D S ++ RE + M L HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 87 NILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
NI+ C+ + L +VM +M G L + P L + + + YL
Sbjct: 62 NIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMA 203
++ +HRD+ A N L + VK++DFG+S +Y+ ++ G + P WMA
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-------PIRWMA 172
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
PE ++ ++ K+D+WSFG+ E+ G P + + +L + + +R
Sbjct: 173 PESLKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYR-------- 222
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
K ++ C +DP RP+ +L++
Sbjct: 223 --LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 90/297 (30%), Positives = 128/297 (43%), Gaps = 37/297 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPN 87
Y+ L +IG G +VYKA + +VAIK I L +S + RE K + L+HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN 59
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ F L++V FM + I LPE I L + L L++ H+
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSH 117
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
G LHRD+K N+L +++G +KLADFG++ S P T T ++ APE++
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-------PYTHYVVTRWYRAPELL 170
Query: 208 RSHTGYSFKADIWSFGITALELAHGRP--P-------LSHL-----PPEKSLLMKMTQRF 253
GYS DIWS G EL RP P L + P+ + K T
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 254 RFSDYEKTLKIKDKNK-KFSRAFKDMVASCLD-------QDPSKRPSAEKLMKHSFF 302
R K + F + LD DP KR +AE+ + H +F
Sbjct: 231 RNY----KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 24/282 (8%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLDQSRTDL----DSIRRETKTM 80
P++++ +G G VY +C +D+ +A+K + D + +++ E + +
Sbjct: 1 PTNWRRGKLLGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
L H I+ + D L + M +M GS++ + + L E ++ L
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEG 116
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YLH+ +HRD+K NIL DS G+VKL DFG S + G+ M + + GTPY
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKS-VTGTPY 172
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
WM+PEVI GY KAD+WS G T +E+ +PP + M F+ +
Sbjct: 173 WMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPT 224
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
++ +R F + ++ KRPSAE+L++H F
Sbjct: 225 NPQLPSHVSPDARNF---LRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 55/308 (17%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLD--SIRRETKTMSLLSHP 86
Y+ + +IG G VYKA +VA+K I ++ + +IR E K + L HP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHP 58
Query: 87 NILNAHC---SFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALS 142
NI+ S S +++V +M L ++ S P+ E I +K+ L L
Sbjct: 59 NIVRLKEIVTSKGKGS-IYMVFEYMD-HDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQ 114
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
YLH+ G LHRD+K NIL ++DG +KLADFG+ A Y + + + +IT W
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVIT------LWY 167
Query: 203 -APEVIRSHTGYSFKADIWSFGITALELAHGRPPL------------------------- 236
PE++ T Y + D+WS G EL G+P
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 237 --SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
S LP ++L K + R ++ K + D++ L DP KR SA+
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFK--------HLIDPSALDLLDKLLTLDPKKRISAD 279
Query: 295 KLMKHSFF 302
+ ++H +F
Sbjct: 280 QALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 102/283 (36%), Positives = 142/283 (50%), Gaps = 31/283 (10%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMS 81
DP + L EIG G VY A + + VVAIK + QS I +E K +
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
+ HPN + + + W+VM + C S + L E IA + L L
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEY--CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+YLH+ +HRD+KAGNIL G VKLADFG SASI P++ GTPYW
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPAN----------SFVGTPYW 187
Query: 202 MAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
MAPEVI + Y K D+WS GIT +ELA +PPL ++ M+ + + E
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNE 240
Query: 260 K-TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
TL ++ ++S F++ V SCL + P RP++E+L+KH F
Sbjct: 241 SPTL----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-36
Identities = 98/287 (34%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 22 YPLDPSSYKI-LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETK 78
Y DP + L EIG G VY A + VVA+K + Q+ I +E K
Sbjct: 15 YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNE-VVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
+ L HPN + + + W+VM + C S + L E IA + L
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEY--CLGSASDLLEVHKKPLQEVEIAAITHGAL 131
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
L+YLH+ +HRD+KAGNIL G VKLADFG SAS P++ GT
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASKSSPAN----------SFVGT 180
Query: 199 PYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
PYWMAPEVI + Y K D+WS GIT +ELA +PPL ++ S L + Q
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ----- 234
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ TL ++ +++ +F+ V CL + P +RP++ +L++H F +
Sbjct: 235 NDSPTL----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 81/271 (29%), Positives = 131/271 (48%), Gaps = 23/271 (8%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI---DLDQSRTDLDSIRRETKTMSLLSH 85
+KI +IG G ++VYKAIC+ D VVA+K + ++ ++ D ++ E + L H
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSY 143
PN++ SF ++ L +V+ G L +I +PE I + SAL +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+H++ +HRD+K N+ + G VKL D G+ + H + GTPY+M+
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-------SLVGTPYYMS 174
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PE I GY+FK+DIWS G E+A + P +K L + ++ DY
Sbjct: 175 PERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCKKIEKCDYPPL-- 228
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
+S +D+V+ C++ DP KRP
Sbjct: 229 ---PADHYSEELRDLVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 29/276 (10%)
Query: 30 KILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+ ++G G VYK VA+K + D S ++ RE + M L HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 87 NILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
N++ C+ + L++VM +M G L S + L + + + YL
Sbjct: 62 NVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYL 118
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMA 203
++ +HRD+ A N L + VK++DFG+S +Y+ ++ + P WMA
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKL------PIRWMA 171
Query: 204 PEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
PE ++ ++ K+D+WSFG+ E+ G P + E+ +L + +R
Sbjct: 172 PESLKEGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLEYLKNGYR-------- 221
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ D++ C +DP RP+ +L++
Sbjct: 222 --LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 78/296 (26%), Positives = 125/296 (42%), Gaps = 51/296 (17%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKA------IDLDQSRTDLDSIRRETKTM 80
++ + +G G V A+K + L Q ++ + E + +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK-YYALKILSKAKIVKLKQ----VEHVLNEKRIL 55
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
+ HP ++N + SF DS L++VM ++ G L S + PEP + + A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLA 113
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG----VSASIYEPSHHHHHGSAMITDMA 196
L YLH+ ++RD+K N+L DSDG +K+ DFG V Y +
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT--------------LC 159
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP ++APE+I S GY D W+ GI E+ G PP P +++
Sbjct: 160 GTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQI------- 206
Query: 257 DYEKTLKIKDK-NKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
YEK L+ K + FS KD++ + L D +KR + H +F +
Sbjct: 207 -YEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 35/291 (12%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L + + ++G G V K IP TV+A K + + + I RE + M
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
P I++ + +F ++ + + M FM CGSL I P +P + + + L+Y
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTY 118
Query: 144 LHNQGH-LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
L+N +HRD+K NIL +S G +KL DFGVS + +++ GT +M
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---------NSIADTFVGTSTYM 169
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS-----------LLMKMTQ 251
+PE I+ Y+ K+D+WS GI+ +ELA G+ P + LL ++ Q
Sbjct: 170 SPERIQGG-KYTVKSDVWSLGISIIELALGKFPFA-FSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
E ++ + F +D V +CL +DP++RP+ ++L F
Sbjct: 228 -------EPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 93/313 (29%), Positives = 141/313 (45%), Gaps = 39/313 (12%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRET 77
Q IQY + +G G VYKA + ++A+K I LD + I E
Sbjct: 1 QDIQY---------QEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDITVELQKQIMSEL 50
Query: 78 KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
+ + P I+ + +F V++R+ + FM GSL +PE + +
Sbjct: 51 EILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVAV 104
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
+ L+YL + LHRDVK N+L ++ G VKL DFGVS + +++ G
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---------NSIAKTYVG 155
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257
T +MAPE I S Y +D+WS GI+ +ELA GR P + + LM + Q +
Sbjct: 156 TNAYMAPERI-SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-QLLQCIV 213
Query: 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG----VEFFV 313
E + +FS F + C+ + P +RP+ E LM H F N G V +V
Sbjct: 214 DEDPPVLPV--GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWV 271
Query: 314 KNVLHGLRSVEER 326
R++EER
Sbjct: 272 ------CRALEER 278
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 70/273 (25%), Positives = 134/273 (49%), Gaps = 21/273 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPN 87
++IL++IG G +V+K + D V A+K IDL +R + + E + ++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVV-RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ + SF +L +VM + G L ++ LPE + + L L++LH++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K+ N+ D+ +VK+ D GV A + + + + GTPY+++PE+
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGV-AKLLSDN------TNFANTIVGTPYYLSPELC 173
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
Y+ K+D+W+ G+ E G+ P + +L++K+ R F
Sbjct: 174 EDKP-YNEKSDVWALGVVLYECCTGKHPFD-ANNQGALILKII-RGVF---------PPV 221
Query: 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
++ +S+ ++ CL +D +RP +L+++
Sbjct: 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 32/297 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR----RETKTMSLLS 84
Y+ ++G G A+VYKA +VAIK I L + + D I RE K + L
Sbjct: 2 YEKGKKLGEGTYAVVYKA-RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
HPNI+ F S + +V FM L+ +I L I + TL L YL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV-LTPADIKSYMLMTLRGLEYL 118
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
H+ LHRD+K N+L SDG +KLADFG++ S P+ +T T ++ AP
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-------MTHQVVTRWYRAP 171
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL--------PPEKSLLMKMT 250
E++ Y D+WS G EL P + L P + +T
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMV---ASCLDQDPSKRPSAEKLMKHSFFKN 304
+ +++ + F A D + L +P+KR +A + ++H +F N
Sbjct: 232 SLPDYVEFKPFPPT-PLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 85/302 (28%), Positives = 150/302 (49%), Gaps = 38/302 (12%)
Query: 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90
+LDE+G G VYK + P T+ A+K I L+ + + I E + P I++
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTM-AMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIIS-SCFPDGLPEPCIAIVLKETLSALSYLHNQGH 149
+ +F ++ +++ M +M GSL + + +G+PE + + + L +L + +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 150 L-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR 208
+ HRDVK N+L + +G VKL DFGVS ++ S T++ G +MAPE I+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--------ASLAKTNI-GCQSYMAPERIK 174
Query: 209 SHTG-----YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
S Y+ ++D+WS G++ LE+A GR P PPE + + +
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYA----------NIFAQLSA 221
Query: 264 IKDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF---FKNCNKGVEFFVKN 315
I D + +S +D VA CL++ P++RP+ +L++H + +KN + + +V
Sbjct: 222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTG 281
Query: 316 VL 317
L
Sbjct: 282 AL 283
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 38/241 (15%)
Query: 72 SIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIA 131
++ E + + L+HP ++N SF + +++V+ + G L+ +S E +
Sbjct: 46 NVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVK 103
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191
+ E + AL YLH++G +HRD+K NIL D G V + DF ++ +
Sbjct: 104 FWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT--------KVTPDTL 155
Query: 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
T +GTP +MAPEV+ GYS D WS G+TA E G+ P
Sbjct: 156 TTSTSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRP---------------- 198
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFK--------DMVASCLDQDPSKRPS--AEKLMKHSF 301
+R +I+ K + + D + L++DP KR + L H +
Sbjct: 199 -YRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257
Query: 302 F 302
F
Sbjct: 258 F 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 29/277 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD---LDSIRRETKTMSLLSH 85
+K+L ++G G VYK + D+ A+K +DL S + D++ E + ++ ++H
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDL-GSMSQKEREDAVN-EIRILASVNH 58
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSY 143
PNI++ +F ++L +VM + G L IS +PE I + + L L
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH Q LHRD+K+ NIL ++ VK+ D G+S + M GTP++MA
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL---------KKNMAKTQIGTPHYMA 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEV + YS+K+DIWS G E+A PP E + + + + Y
Sbjct: 170 PEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF-----EARSMQDLRYKVQRGKYPPIPP 223
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
I +S+ ++ + S L P RP+ +K++
Sbjct: 224 I------YSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 88/294 (29%), Positives = 136/294 (46%), Gaps = 54/294 (18%)
Query: 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-----DLDQSR--TDLDSIRRETKTMSLL 83
+++E+G G +V K +P T++A+K I +Q R DLD R
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTG-TIMAVKRIRATVNSQEQKRLLMDLDISMR-------- 55
Query: 84 SHPNILNAHCSFSV--------DSRLWVVMPFMSCGSLQSIISSCFPDGL--PEPCIAIV 133
+ C ++V + +W+ M M SL + GL PE + +
Sbjct: 56 ------SVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKI 108
Query: 134 LKETLSALSYLHNQGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192
+ AL YLH++ + HRDVK N+L + +G VKL DFG+S + + S
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--------SVAK 160
Query: 193 TDMAGTPYWMAPEVI---RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249
T AG +MAPE I + GY K+D+WS GIT +ELA GR P K+ ++
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW---KTPFQQL 217
Query: 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
Q + L +KFS F+D V CL ++ +RP+ +L++H FF+
Sbjct: 218 KQVVE--EPSPQL----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 70/245 (28%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 57 AIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSI 116
++ A D+ R+ LD++ RE + L H NI+ S L + + ++ GS+ ++
Sbjct: 37 SVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAAL 96
Query: 117 ISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176
+++ E + +++ L L+YLHN+G +HRD+K NIL D+ G +K++DFG+S
Sbjct: 97 LNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154
Query: 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236
+ S A + G+ +WMAPEV++ T Y+ KADIWS G +E+ G+ P
Sbjct: 155 KLEANSLSTKTNGAR-PSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPF 212
Query: 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
++ F+ + + S D + + D +KRP+A +L
Sbjct: 213 PDCT-------QLQAIFKIGENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
Query: 297 MKHSF 301
+KH F
Sbjct: 262 LKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 79/270 (29%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI---DLDQSRTDLDSIRRETKTMSLL 83
++++I +IG G + VY+A C+ +D VA+K + DL ++ D I+ E + L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL 59
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSAL 141
+HPN++ + SF D+ L +V+ G L +I +PE + + SAL
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
++H++ +HRD+K N+ + G VKL D G+ + H + GTPY+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
M+PE I + GY+FK+DIWS G E+A + P +K L + ++ DY
Sbjct: 173 MSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCKKIEQCDYPPL 228
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
+ +S + +V C++ DP KRP
Sbjct: 229 -----PSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 81/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR-----RETKT-MSL 82
YK++ ++G G VY A +VAIK + + S RE K+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKE-TGELVAIK-----KMKKKFYSWEECMNLREVKSLRKL 54
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
HPNI+ F + L+ V +M +L ++ E I ++ + L L+
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE-PSHHHHHGSAMITDMAGTPYW 201
++H G HRD+K N+L VK+ADFG++ I P + TD T ++
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---------TDYVSTRWY 164
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRP--------------------PLSHLPP 241
APE++ T YS DIW+ G EL RP P P
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224
Query: 242 EKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
E L FRF + T + S D++ L DP KRP+A + ++H +
Sbjct: 225 EGYKLASKLG-FRFPQFAPT-SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
Query: 302 F 302
F
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 81/260 (31%), Positives = 122/260 (46%), Gaps = 44/260 (16%)
Query: 52 DSTVVAIKAIDLDQSRTDLDSIRR-----ETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106
D ++V K ++L T L R E +SLL HPNI+ + F D+ L + M
Sbjct: 24 DDSLVVWKEVNL----TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79
Query: 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166
+ + G+L I E + L + +SA+SY+H G LHRD+K NI G
Sbjct: 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL 139
Query: 167 VKLADFGVSASIYEPSHHHHHGS--AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGI 224
+KL DFG+S + GS +M + GTPY+M+PE+ + Y+FK+DIW+ G
Sbjct: 140 IKLGDFGISKIL---------GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGC 189
Query: 225 TALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK-TLKIKDKN-----KKFSRAFKDM 278
EL L +K T F ++ +KI N +S +
Sbjct: 190 VLYEL---------------LTLKRT--FDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232
Query: 279 VASCLDQDPSKRPSAEKLMK 298
V S L QDP KRP+A++++
Sbjct: 233 VHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 89/291 (30%), Positives = 137/291 (47%), Gaps = 33/291 (11%)
Query: 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTV-VAIKAIDLDQSRTDLDSIRRET 77
+ +Y D + +++ +G G IVY A + + V +AIK I SR + + E
Sbjct: 2 EYEYEYDENGERVV--LGKGTYGIVYAAR--DLSTQVRIAIKEIPERDSR-YVQPLHEEI 56
Query: 78 KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKE 136
S L H NI+ S S + + M + GSL +++ S + P E I K+
Sbjct: 57 ALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVS---ASIYEPSHHHHHGSAMI 192
L L YLH+ +HRD+K N+L ++ G VK++DFG S A I +
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI----------NPCT 166
Query: 193 TDMAGTPYWMAPEVI-RSHTGYSFKADIWSFGITALELAHGRPPLSHL-PPEKSLLMKMT 250
GT +MAPEVI + GY ADIWS G T +E+A G+PP L P+ ++
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----- 221
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
F+ ++ +I + S K+ + C + DP KR SA L++ F
Sbjct: 222 --FKVGMFKIHPEIPE---SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 87/314 (27%), Positives = 133/314 (42%), Gaps = 48/314 (15%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR--RETKTMSLLS 84
Y+IL ++G G VYKA I VVA+K I L + D I RE K + L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKI-LMHNEKDGFPITALREIKILKKLK 65
Query: 85 HPNILN------AHCSFSVDSR--LWVVMPFMS---CGSLQSIISSCFPD-GLPEPCIAI 132
HPN++ S R +++V P+M G L++ P L E I
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN------PSVKLTESQIKC 119
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM- 191
+ + L ++YLH LHRD+KA NIL D+ G +K+ADFG++ P + G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 192 ---ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP-------------- 234
T++ T ++ PE++ Y+ DIW G E+ RP
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 235 ------PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPS 288
P P L F++Y +TL +++ K D+++ L DP
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL--EERFGKLGPEGLDLLSKLLSLDPY 297
Query: 289 KRPSAEKLMKHSFF 302
KR +A ++H +F
Sbjct: 298 KRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 79/284 (27%), Positives = 123/284 (43%), Gaps = 37/284 (13%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDS-IRRETKTMSLLSHPNILNAH 92
+GVG V + T A+K + T I E + + +HP I+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTF-ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 93 CSFSVDSRLWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLKETLSALSYLHNQGHL 150
+F ++++M + G L +I+ F + IA V+ A YLHN+G +
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV----LAFEYLHNRGII 115
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH 210
+RD+K N+L DS+G VKL DFG + + G T GTP ++APE+I +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKS-------GQKTWT-FCGTPEYVAPEIILNK 167
Query: 211 TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK--- 267
GY F D WS GI EL GRPP + M++ Y LK K
Sbjct: 168 -GYDFSVDYWSLGILLYELLTGRPPFGE---DDEDPMEI--------YNDILKGNGKLEF 215
Query: 268 NKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
+A KD++ L ++P +R + + KH +F +
Sbjct: 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 87/302 (28%), Positives = 136/302 (45%), Gaps = 44/302 (14%)
Query: 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNA 91
L E+G G +V K + P ++A K I L+ + I RE K + + P I+
Sbjct: 6 LGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH-L 150
+ +F D + + M M GSL ++ +PE + + L L+YL + +
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIM 122
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH 210
HRDVK NIL +S G +KL DFGVS + + +M GT +M+PE ++
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SMANSFVGTRSYMSPERLQG- 172
Query: 211 TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF---------------RF 255
T Y+ ++DIWS G++ +E+A GR P+ PP+ L M R
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIP--PPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 256 SDYEKTLKI-------------KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
D + + I K + FS F+D V CL ++P +R ++L KH F
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
Query: 303 KN 304
K
Sbjct: 291 KR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 39/244 (15%)
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQS--IISSCFPDGLPEPCIAIVLKETLSALSY 143
P I+ + SF + L++VM +M G L + I FP+ IA E + AL
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA----ELVLALDS 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI------------------YEPSHHH 185
+H G +HRD+K NIL D+DG +KLADFG+ + +
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 186 HHGSAMITDMA----GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP 241
A GTP ++APEV+R Y + D WS G+ E+ +G PP
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFY---- 231
Query: 242 EKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-PSAEKLMKHS 300
+L + +++++L+ S D++ L DP R S E++ H
Sbjct: 232 SDTL---QETYNKIINWKESLRFPPD-PPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHP 286
Query: 301 FFKN 304
FFK
Sbjct: 287 FFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 33/284 (11%)
Query: 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAI-------DLDQSRTDLDSIRRETKTMSLLS 84
L EIG G V K + P T++A+K I + + DLD + R +
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSG-TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC----- 62
Query: 85 HPNILNAHCSFSVDSRLWVVMPFM--SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
P I+ + + + W+ M M S + +PE + + T+ AL+
Sbjct: 63 -PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 143 YLHNQGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YL + + HRDVK NIL D +G++KL DFG+S + + S T AG +
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--------SIAKTRDAGCRPY 173
Query: 202 MAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
MAPE I GY ++D+WS GIT E+A G+ P P S+ ++TQ +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP---YPKWNSVFDQLTQ---VVKGD 227
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ + ++FS +F + + CL +D SKRP ++L++H F K
Sbjct: 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 75/270 (27%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI---DLDQSRTDLDSIRRETKTMSLL 83
++++I +IG G + VY+A C+ +D VA+K + ++ ++ D ++ E + L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQL 59
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSAL 141
+HPN++ SF D+ L +V+ G L +I +PE + + SA+
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
++H++ +HRD+K N+ + G VKL D G+ + H + GTPY+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
M+PE I + GY+FK+DIWS G E+A + P +K L + Q+ DY
Sbjct: 173 MSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLFSLCQKIEQCDYPPL 228
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
+ +S +++V+ C+ DP +RP
Sbjct: 229 PT-----EHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 84/306 (27%), Positives = 133/306 (43%), Gaps = 45/306 (14%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
Y++L IG G +V A+ D VAIK I ++ D I RE K + L
Sbjct: 2 YELLKPIGSGAYGVVCSAV----DKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR 57
Query: 85 HPNILNAHCSFSVDSR-----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
H NI+ S +++V M L +I S P L + I L + L
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILR 114
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L YLH+ +HRD+K NIL +S+ +K+ DFG++ + + T+ T
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD---PDEDEKGFL-TEYVVTR 170
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL---SHL------------PPEKS 244
++ APE++ S + Y+ DIWS G EL +P ++ P E+
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKLM 297
L +++ R +Y K+L K K K S+ F D++ L DP KR +A++ +
Sbjct: 231 LKFITSEKAR--NYLKSLPKKPK-KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287
Query: 298 KHSFFK 303
H +
Sbjct: 288 AHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 88/302 (29%), Positives = 134/302 (44%), Gaps = 46/302 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLDQSRTDLDSIR----RETKTMSLL 83
Y+ L +IG G +V+K C ++ +VAIK +S D I+ RE + + L
Sbjct: 3 YEKLSKIGEGSYGVVFK--CRNRETGQIVAIK--KFVESEDDP-VIKKIALREIRMLKQL 57
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HPN++N F +L +V + L + + P G+PE I ++ +TL A+++
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNF 115
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
H +HRDVK NIL G +KL DFG A I TD T ++ A
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGF-ARILTG------PGDDYTDYVATRWYRA 168
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS--------------LLMKM 249
PE++ T Y D+W+ G EL G+P L P KS L+ +
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQP----LWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 250 TQRFRFSDYEKTLKI---------KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
Q F + + K L I + K S + CL DP++R S E+L++H
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284
Query: 301 FF 302
+F
Sbjct: 285 YF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 92/310 (29%), Positives = 146/310 (47%), Gaps = 49/310 (15%)
Query: 9 QCSSTGTIAQKIQYPLDPSSYKILDE---IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ 65
SS+ + + P S L+ IG G VYK I P + A+K I +
Sbjct: 53 SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPT-GRLYALKVIYGNH 111
Query: 66 SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSI-ISSCFPDG 124
T I RE + + ++HPN++ H F + + V++ FM GSL+ I+
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----- 166
Query: 125 LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS---ASIYEP 181
E +A V ++ LS ++YLH + +HRD+K N+L +S +VK+ADFGVS A +P
Sbjct: 167 --EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 182 SHHHHHGSAMITDMAGTPYWMAPEVIRS------HTGYSFKADIWSFGITALELAHGRPP 235
+ GT +M+PE I + + GY+ DIWS G++ LE GR P
Sbjct: 225 CN----------SSVGTIAYMSPERINTDLNHGAYDGYA--GDIWSLGVSILEFYLGRFP 272
Query: 236 --LSHLPPEKSLL--MKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
+ SL+ + M+Q + SR F+ ++ CL ++P+KR
Sbjct: 273 FGVGRQGDWASLMCAICMSQP------------PEAPATASREFRHFISCCLQREPAKRW 320
Query: 292 SAEKLMKHSF 301
SA +L++H F
Sbjct: 321 SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 82/309 (26%), Positives = 122/309 (39%), Gaps = 60/309 (19%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR----RETKTMSLLS 84
YKIL IG G IV+KA TV A+K + L R I RE K +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETV-ALKKVAL---RRLEGGIPNQALREIKALQACQ 57
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
HP ++ F S +VM +M L ++ LPE + ++ L ++Y+
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYM 115
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
H G +HRD+K N+L +DG +K+ADFG++ E + + T ++ AP
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE------EPRLYSHQVATRWYRAP 169
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRP--------------------PLSHLPPEKS 244
E++ Y D+W+ G EL +G P P P +
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSR-----------AFKDMVASCLDQDPSKRPSA 293
L DY KI K A D++ L DPSKR SA
Sbjct: 230 SL---------PDYN---KITFPESKPIPLEEIFPDASPEAL-DLLKGLLVYDPSKRLSA 276
Query: 294 EKLMKHSFF 302
+ ++H +F
Sbjct: 277 AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 46/288 (15%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD-----LDSIRRETKTMSLLSHPNIL 89
+G G + Y+A + T++A+K + ++ + ++++R+E + M+ L+HP+I+
Sbjct: 8 LGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH 149
+ DS + + +M+ GS+ ++S E I ++ L LSYLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQI 124
Query: 150 LHRDVKAGNILSDSDGS-VKLADFGVSASIYEPSHHHHHGSAMIT-------DMAGTPYW 201
+HRDVK N+L DS G +++ADFG +A + +A T + GT +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARL----------AAKGTGAGEFQGQLLGTIAF 174
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL------SHLPPEKSLLMKMTQRFRF 255
MAPEV+R Y D+WS G +E+A +PP +HL +L+ K+
Sbjct: 175 MAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----ALIFKIASATTA 229
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ L S +D+ CL+ P RP + +L+KH F+
Sbjct: 230 PSIPEHL---------SPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 82/303 (27%), Positives = 140/303 (46%), Gaps = 47/303 (15%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR-RETKTMSLLSHP 86
+++ +++IG G +VYKA + VVA+K I LD + S RE + L+HP
Sbjct: 1 NFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 59
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ +++L++V F+ L+ + + G+P P I L + L L++ H+
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
LHRD+K N+L +++G++KLADFG++ + P + H T ++ APE+
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRAPEI 171
Query: 207 IRSHTGYSFKADIWSFGITALELAHGR---------------------------PPLSHL 239
+ YS DIWS G E+ R P ++ L
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
P K K ++ D+ K + D++ +D+++ L DP+KR SA+ + H
Sbjct: 232 PDYKPSFPKWARQ----DFSKVVPPLDEDG------RDLLSQMLHYDPNKRISAKAALAH 281
Query: 300 SFF 302
FF
Sbjct: 282 PFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 30/257 (11%)
Query: 57 AIKAI---DLDQSRTDLDSIRRE-TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
AIK + D+ ++ + +++ E M P + + SF L++VM +++ G
Sbjct: 25 AIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD 83
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
S+I + GLPE + E + + LH +G +HRD+K N+L D G +KL DF
Sbjct: 84 CASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDF 141
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
G+S + E GTP ++APE I G +D WS G E G
Sbjct: 142 GLSRNGLENK-----------KFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFG 189
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
PP P+ +++R + ++ + S D++ L DP+KR
Sbjct: 190 YPPFHAETPDAVFDNILSRRINWP--------EEVKEFCSPEAVDLINRLLCMDPAKRLG 241
Query: 293 A---EKLMKHSFFKNCN 306
A +++ H FFK+ N
Sbjct: 242 ANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 83/284 (29%), Positives = 139/284 (48%), Gaps = 29/284 (10%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLD----QSRTDLDSIRRETKTM 80
P+++++ +G G VY +C D+ +A+K + D ++ +++++ E + +
Sbjct: 1 PTNWRLGKLLGQGAFGRVY--LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLL 58
Query: 81 SLLSHPNILNAHCSF--SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
L H I+ + ++ L + M M GS++ + S L E ++ L
Sbjct: 59 KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQIL 116
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+SYLH+ +HRD+K NIL DS G+VKL DFG S + G+ M + + GT
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC---LSGTGMKS-VTGT 172
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
PYWM+PEVI S GY KADIWS G T +E+ +PP + ++ TQ ++
Sbjct: 173 PYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP---TNP 228
Query: 259 EKTLKIKDKNKKF-SRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ D + F R F + RPSA++L++H+F
Sbjct: 229 VLPPHVSDHCRDFLKRIFVEA---------KLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 82/276 (29%), Positives = 136/276 (49%), Gaps = 29/276 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPM-DSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHP 86
Y+ + +G G IV+ +C D +V IK I ++Q ++ + + + E + + LLSHP
Sbjct: 2 YEKIRVVGRGAFGIVH--LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ + +F D L +VM + G+L I L E I + L AL ++H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 147 QGHLHRDVKAGNILSDSDGSV-KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+ LHRD+K NIL D V K+ DFG+S + S + + GTP +++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY--------TVVGTPCYISPE 171
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQRFRFSDYEKTLK 263
+ Y+ K+DIW+ G ELA + ++LP +L++K+ F+
Sbjct: 172 LCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIM-SGTFA------P 220
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
I D ++S + ++ S L+ DPSKRP ++M
Sbjct: 221 ISD---RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 87/320 (27%), Positives = 140/320 (43%), Gaps = 56/320 (17%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L ++ + E+G G +V+K P ++A K I L+ + I RE + +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ P I+ + +F D + + M M GSL ++ +PE + V + L+Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 118
Query: 144 LHNQGH-LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
L + +HRDVK NIL +S G +KL DFGVS + + +M GT +M
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SMANSFVGTRSYM 169
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM------------- 249
+PE ++ T YS ++DIWS G++ +E+A GR P+ PP+ L M
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIP--PPDAKELELMFGCPVEGDPAESE 226
Query: 250 ----------------------TQRFRFSDY---EKTLKIKDKNKKFSRAFKDMVASCLD 284
F DY E K+ + F F+D V CL
Sbjct: 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLI 284
Query: 285 QDPSKRPSAEKLMKHSFFKN 304
++P++R ++LM H+F K
Sbjct: 285 KNPAERADLKQLMVHAFIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 68/266 (25%), Positives = 115/266 (43%), Gaps = 42/266 (15%)
Query: 55 VVAIKAI--DLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCG 111
+ A+K + D+ D++ E + ++L HP + H F RL+ VM +++ G
Sbjct: 22 LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81
Query: 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
L I EP E + L +LH +G ++RD+K N+L DS+G +K+AD
Sbjct: 82 DLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIAD 139
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
FG+ G + GTP ++APE++ S+ Y D W+ G+ E+
Sbjct: 140 FGM-------CKEGILGGVTTSTFCGTPDYIAPEIL-SYQPYGPAVDWWALGVLLYEMLA 191
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL--KIKDKNKKFSRAF----KDMVASCLDQ 285
G+ P D E L I + ++ R K ++ S L +
Sbjct: 192 GQSPFE------------------GDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTK 233
Query: 286 DPSKR----PSAEK-LMKHSFFKNCN 306
+P KR P+ E+ + H FF+ +
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFFREID 259
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 88/308 (28%), Positives = 143/308 (46%), Gaps = 50/308 (16%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTM---SLLS 84
Y+IL ++G G IV+KAI VVA+K I D ++ TD RE M L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREI--MFLQELGD 65
Query: 85 HPNI---LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
HPNI LN + + D +++V +M L ++I + + L + ++ + L AL
Sbjct: 66 HPNIVKLLNVIKAEN-DKDIYLVFEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKAL 120
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
Y+H+ +HRD+K NIL +SD VKLADFG++ S+ E + + ++TD T ++
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE--LEENPENPVLTDYVATRWY 178
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRP-------------------PLS----- 237
APE++ T Y+ D+WS G E+ G+P P S
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 238 --HLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK 295
P ++L + R R + + K S D++ L +P+KR +AE+
Sbjct: 239 SIKSPFAATMLDSLPSRPRKP-------LDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291
Query: 296 LMKHSFFK 303
++H +
Sbjct: 292 ALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 35 IGVGVSAIVYKAICIPMDS-TVVAIKAIDLD----QSRTDLDSIRRETKTMSLLSHPNIL 89
+G G VY +C +D+ +A K + D ++ ++ ++ E + + L H I+
Sbjct: 10 LGQGAFGRVY--LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 90 NAHCSFS--VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
+ + L + M +M GS++ + + L E ++ L +SYLH+
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN 125
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
+HRD+K NIL DS G+VKL DFG S + G+ + + GTPYWM+PEVI
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC---MSGTGI-RSVTGTPYWMSPEVI 181
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
S GY KAD+WS G T +E+ +PP + M F+ + ++
Sbjct: 182 -SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-------AMAAIFKIATQPTNPQLPSH 233
Query: 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ +R F C+ + RPSAE+L++H F
Sbjct: 234 ISEHARDF----LGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 85/296 (28%), Positives = 140/296 (47%), Gaps = 35/296 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR-RETKTMSLLSHPN 87
Y+ +++IG G +VYKA + +VA+K I L+ + S RE + L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKA-RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPN 59
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ +++L++V F+ L+ + S GL P I L + L ++Y H+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L D +G++KLADFG++ + P + H T ++ APE++
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-------TLWYRAPEIL 171
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR------------- 254
YS DIWS G E+ + RP L P S + ++ + FR
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRP----LFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 255 --FSDYEKTL---KIKDKNK---KFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
DY+ T +D +K D+++ L DP+KR SA+ ++H +F
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 32/295 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDS-TVVAIKA-IDLDQSRTDLDSIRRETKTMSLLSHP 86
Y+ L +G G +V K C ++ +VAIK ++ + + RE + + L H
Sbjct: 3 YENLGLVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
N++N F RL++V F+ L + +P+GL E + L + L + + H+
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+HRD+K NIL G VKL DFG + ++ P + TD T ++ APE+
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-------TDYVATRWYRAPEL 171
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRP---------PLSH--------LPPEKSLLMK- 248
+ T Y DIW+ G E+ G P L H +P + + K
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 249 -MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ R + ++ ++ + K S D+ CL DP RPS+ +L+ H FF
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 87/309 (28%), Positives = 124/309 (40%), Gaps = 57/309 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIK--AIDLDQSRTDLDSIRRET--KTMSLLS 84
Y+ L EIG G VYKA VA+K + L + L ++R K +
Sbjct: 1 YEELAEIGEGAYGTVYKARD-LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 85 HPNI--LNAHCSFSVDSR---LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
HPNI L C R L +V + L + +S C GLP I ++++ L
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+ +LH+ +HRD+K NIL SDG VK+ADFG+ A IY +MA T
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL-ARIYS------------FEMALTS 165
Query: 200 -----YWMAPEVIRSHTGYSFKADIWSFGITALELAH---------------------GR 233
++ APEV+ + Y+ D+WS G EL G
Sbjct: 166 VVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293
P P SL R F Y K + D++ L +P KR SA
Sbjct: 225 PSEEEWPRNVSLP-----RSSFPSYTPR-SFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
Query: 294 EKLMKHSFF 302
+ ++H +F
Sbjct: 279 FEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 79/307 (25%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSL 82
Y+ L+ I G +VY+A +VA+K + +++ + T L RE +
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTG-EIVALKKLKMEKEKEGFPITSL----REINILLK 60
Query: 83 LSHPNILNAHCSFSVDSRL---WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
L HPNI+ V S L ++VM ++ L+S++ + + + ++ + LS
Sbjct: 61 LQHPNIVTVK-EVVVGSNLDKIYMVMEYVE-HDLKSLMET-MKQPFLQSEVKCLMLQLLS 117
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+++LH+ LHRD+K N+L ++ G +K+ DFG++ P + T + T
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-------TQLVVTL 170
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----- 254
++ APE++ YS D+WS G EL +P L P KS + ++ + F+
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP----LFPGKSEIDQLNKIFKLLGTP 226
Query: 255 ----FSDYEKTLKIKDKN----------KKFSRAFK-----DMVASCLDQDPSKRPSAEK 295
+ + + K K KKF D++ L DP+KR SAE
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286
Query: 296 LMKHSFF 302
+KH +F
Sbjct: 287 ALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 27/283 (9%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLD----QSRTDLDSIRRETKTM 80
P ++++ +G G VY +C D+ +A+K + D ++ +++++ E + +
Sbjct: 1 PVNWRLGKLLGRGAFGEVY--LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58
Query: 81 SLLSHPNILNAHCSFS--VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
L H I+ + + +L + + +M GS++ + + L E ++ L
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQIL 116
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+SYLH+ +HRD+K NIL DS G+VKL DFG S I I + GT
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI----QTICMSGTGIKSVTGT 172
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
PYWM+PEVI S GY KAD+WS T +E+ +PP + M F+ +
Sbjct: 173 PYWMSPEVI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQ 224
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ D S A +D + ++ +RP+AE L++H F
Sbjct: 225 PTKPMLPD---GVSDACRDFLKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 89/321 (27%), Positives = 140/321 (43%), Gaps = 58/321 (18%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L ++ + E+G G +V K P ++A K I L+ + I RE + +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ P I+ + +F D + + M M GSL ++ +PE + V L L+Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAY 118
Query: 144 LHNQGH-LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
L + +HRDVK NIL +S G +KL DFGVS + + +M GT +M
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SMANSFVGTRSYM 169
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR---------- 252
+PE ++ T YS ++DIWS G++ +ELA GR P+ PP+ L + R
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVDGEEGEP 226
Query: 253 ---------------------------FRFSDY---EKTLKIKDKNKKFSRAFKDMVASC 282
F DY E K+ N F+ F++ V C
Sbjct: 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKC 284
Query: 283 LDQDPSKRPSAEKLMKHSFFK 303
L ++P++R + LM H+F K
Sbjct: 285 LIKNPAERADLKMLMNHTFIK 305
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 83/297 (27%), Positives = 131/297 (44%), Gaps = 36/297 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR-RETKTMSLLSHPN 87
Y +++IG G +VYK +VA+K I L+ + S RE + L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRN-KKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALSYLHN 146
I+ +SRL+++ F+S L+ + S + + L + L + + H+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ LHRD+K N+L D+ G +KLADFG++ + P + H T ++ APEV
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-------TLWYRAPEV 172
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR------------ 254
+ YS DIWS G E+A + PL H E L ++ FR
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRI---FRILGTPTEDVWPG 228
Query: 255 ---FSDYEKTL------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
DY+ T ++ K D++ L DP+KR SA+K + H +F
Sbjct: 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 40/246 (16%)
Query: 71 DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSC--FPDGLPE- 127
+ +E + LSHP I+N CSF ++R++ ++ F+ G L + + FP+ + +
Sbjct: 63 QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF 122
Query: 128 PCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187
+VL A YLH++ ++RD+K N+L D+ G VK+ DFG + + + +
Sbjct: 123 YHAELVL-----AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF---- 173
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM 247
+ GTP ++APEVI+S G+ D W+ G+ E G PP P
Sbjct: 174 ------TLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------ 220
Query: 248 KMTQRFRFSDYEKTL--KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK-----LMKHS 300
F YEK L ++K N RA +D+V L D +KR K + H
Sbjct: 221 -------FRIYEKILAGRLKFPNWFDGRA-RDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272
Query: 301 FFKNCN 306
+F N
Sbjct: 273 YFHGAN 278
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 21/232 (9%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E +S+ + P I +F L++VM + G L S+++ + D E L
Sbjct: 51 ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR-YEDQFDEDMAQFYLA 109
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E + A+ +H G++HRD+K N+L D G +KLADFG +A +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM------VNSKLP 163
Query: 196 AGTPYWMAPEVIRSHTG-----YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
GTP ++APEV+ + G Y + D WS G+ A E+ +GR P K+ M
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM- 222
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
++++ LK + + K S F D++ S L +R E L H FF
Sbjct: 223 ------NFQRFLKFPE-DPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
+F D L++ M ++ G ++++++ L E + E A+ LH G++HRD
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGY 213
+K N L D+ G +KL DFG+S I ++ + G+P +MAPEV+R GY
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVTYAN----------SVVGSPDYMAPEVLRG-KGY 175
Query: 214 SFKADIWSFGITALELAHGRPPLSHLPPEKSL--LMKMTQRFRFSDYEKTLKIKDKNKKF 271
F D WS G E G PP S P ++ L + + Y+ D
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD------DPRFNL 229
Query: 272 SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
S D++ ++ + S E + H FFK +
Sbjct: 230 SDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-24
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 19/244 (7%)
Query: 57 AIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSI 116
A+K I L +S + ++ R+E ++ + HPNI+ SF D L++VM + G L
Sbjct: 29 AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQK 88
Query: 117 ISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176
I PE I + + ++H + LHRD+K+ NI +G VKL DFG +
Sbjct: 89 IKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
Query: 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236
+ P A GTPY++ PE I + Y+ K+DIWS G EL + P
Sbjct: 149 LLTSP-------GAYACTYVGTPYYVPPE-IWENMPYNNKSDIWSLGCILYELCTLKHPF 200
Query: 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
K+L++K+ Q K +S + ++ ++P RPSA +
Sbjct: 201 -QANSWKNLILKVCQG----------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249
Query: 297 MKHS 300
+
Sbjct: 250 LSRG 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 30/240 (12%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E K + +S I++ +F L +VM M+ G L+ I + G PE
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ + L +LH + ++RD+K N+L D G+V+++D G++ G I
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV--------ELKGGKKIKGR 154
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL----LMKMTQ 251
AGTP +MAPEV++ Y F D ++ G T E+ GR P + +
Sbjct: 155 AGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
+ D KFS KD+ + L +DP KR SA+++ +H FK+ N
Sbjct: 214 AVEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 69/259 (26%), Positives = 116/259 (44%), Gaps = 34/259 (13%)
Query: 55 VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGS 112
VA+K+++ RE + + L H NI C L ++M ++ GS
Sbjct: 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLS-------ALSYLHNQGHLHRDVKAGNILSDSDG 165
L+ D L I LK L + YL +Q ++HRD+ A NIL +S+
Sbjct: 95 LR--------DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED 146
Query: 166 SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP-YWMAPEVIRSHTGYSFKADIWSFGI 224
VK++DFG++ + E + + +P +W APE +R+ +S +D+WSFG+
Sbjct: 147 LVKISDFGLAKVLPE-----DKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGV 200
Query: 225 TALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK------D 277
T EL +G P S PP + L M + + + L++ + ++ R D
Sbjct: 201 TLYELFTYGDPSQS--PPAEFLRMIGIAQGQMI-VTRLLELLKEGERLPRPPSCPDEVYD 257
Query: 278 MVASCLDQDPSKRPSAEKL 296
++ C + +P RPS L
Sbjct: 258 LMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 40/264 (15%)
Query: 54 TVVAIKAIDLDQSRTD---LDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110
+ KA + +RT+ L+++RR P ++ H +F D++L +++ +++
Sbjct: 39 ATIVQKAKTAEHTRTERQVLEAVRRC---------PFLVTLHYAFQTDTKLHLILDYVNG 89
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
G L + + + E + + + E + AL +LH G ++RD+K NIL DS+G V L
Sbjct: 90 GELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLT 147
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALEL 229
DFG+S + GT +MAPEVIR + G+ D WS G+ EL
Sbjct: 148 DFGLSKEFLAEEEERAY------SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 230 AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN----KKFSRAFKDMVASCLDQ 285
G P + + S E + +I K S +D + L++
Sbjct: 202 LTGASPFT------------VDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEK 249
Query: 286 DPSKR---PSAEKLMKHSFFKNCN 306
DP KR A+++ H FF+ +
Sbjct: 250 DPKKRLGANGADEIKNHPFFQGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 68/260 (26%), Positives = 117/260 (45%), Gaps = 41/260 (15%)
Query: 53 STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
+T VA+K L ++ +E + M L H ++ + S + +++V +MS GS
Sbjct: 30 TTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87
Query: 113 LQSIISSCFPDG--LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
L + S +G L P + + + ++YL ++ ++HRD+ A NIL + K+A
Sbjct: 88 LLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIA 145
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL 229
DFG++ I + + G+ P W APE ++ K+D+WSFGI E+
Sbjct: 146 DFGLARLIEDDEYTAREGAKF-------PIKWTAPEAANYGR-FTIKSDVWSFGILLTEI 197
Query: 230 -AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSR------AFKDMVASC 282
+GR P MT R + L+ ++ + R D++ C
Sbjct: 198 VTYGRVPYP----------GMTNR-------EVLEQVERGYRMPRPPNCPEELYDLMLQC 240
Query: 283 LDQDPSKRPSAEKLMKHSFF 302
D+DP +RP+ E L SF
Sbjct: 241 WDKDPEERPTFEYL--QSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+ + ++G G V++ + + VAIK + D ++E + + L H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLW--KNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHK 62
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSYL 144
++++ SV ++++ M GSL + + S P+G LP + + + ++YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYL 120
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMA 203
Q +HRD+ A NIL D K+ADFG++ I E + ++ PY W A
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--------LSSDKKIPYKWTA 172
Query: 204 PEVIRSHTGYSFKADIWSFGITALEL-AHGRPP 235
PE SH +S K+D+WSFGI E+ +G+ P
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 74/317 (23%), Positives = 122/317 (38%), Gaps = 62/317 (19%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR-------------RETKTMS 81
+G G V KA + +VAIK + + + D+ R RE K M+
Sbjct: 17 LGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
+ H NI+ + + +VM M+ L+ ++ L E + +L + L+ L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGL 132
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS----IYEPSHHHHHGSAMITDMAG 197
+ LH +HRD+ NI +S G K+ADFG++ Y + +M
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192
Query: 198 ---TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP-------------------- 234
T ++ APE++ Y F D+WS G EL G+P
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252
Query: 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLD-------QDP 287
P P+ L T+ F+ K K F + +D +P
Sbjct: 253 PNEDNWPQAKKLPLYTE---FT--------PRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301
Query: 288 SKRPSAEKLMKHSFFKN 304
+R SA++ +KH +FK+
Sbjct: 302 LERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+D +S ++L ++G G V++ + ++T VA+K L D E + M L
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLW--NNTTPVAVKT--LKPGTMDPKDFLAEAQIMKKL 58
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HP ++ + +++ +++V M GSL + L P + + + S ++Y
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WM 202
L Q ++HRD+ A N+L + K+ADFG++ I E + G A P W
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG-------AKFPIKWT 171
Query: 203 APEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
APE + +S K+D+WSFGI E+ +GR P + +L ++ Q +R
Sbjct: 172 APEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRMPCPPGC 229
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
K D++ C +DP RP+ E L
Sbjct: 230 PK----------ELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 23/248 (9%)
Query: 67 RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLP 126
R + + E ++ +P +++ CSF L +VM ++ G +++ + LP
Sbjct: 42 RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LP 99
Query: 127 EPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS--------ASI 178
+ ET+ AL YLHN G +HRD+K N+L S G +KL DFG+S ++
Sbjct: 100 VDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH 238
YE + + GTP ++APEVI GY D W+ GI E G P
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFG 218
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR---PSAEK 295
PE+ ++ + + ++ L +D+++ L Q+P +R A +
Sbjct: 219 DTPEELFGQVISDDIEWPEGDEALPADA---------QDLISRLLRQNPLERLGTGGAFE 269
Query: 296 LMKHSFFK 303
+ +H FF
Sbjct: 270 VKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 38/246 (15%)
Query: 69 DLDSIRRETKTMSLLSHPNILNA-HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPE 127
D++ E + ++L P L H F RL+ VM +++ G L I E
Sbjct: 43 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKE 100
Query: 128 PCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187
P E L +LH++G ++RD+K N++ D++G +K+ADFG+ +
Sbjct: 101 PHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM-------CKENIF 153
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM 247
G GTP ++APE+I ++ Y D W+FG+ E+ G+PP
Sbjct: 154 GGKTTRTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPP------------ 200
Query: 248 KMTQRFRFSDYEKTLK-IKDKNKKFSRAF-KDMVASC---LDQDPSKR----PSAEKLMK 298
F D ++ + I + N + ++ K+ V+ C L + P+KR P+ E+ ++
Sbjct: 201 -----FDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIR 255
Query: 299 -HSFFK 303
H+FF+
Sbjct: 256 EHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 76/305 (24%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
+Y L+++G G A V+K + +VA+K I L+ + RE + L H N
Sbjct: 7 TYIKLEKLGEGTYATVFKGRS-KLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 88 ILNAHCSFSVDSRLWVVMPFMS---------CGSLQSIISSCFPDGLPEPCIAIVLKETL 138
I+ H D L +V ++ CG++ S+ + + I L + L
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN-----------VKIFLYQIL 114
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
L+Y H + LHRD+K N+L + G +KLADFG++ + P+ + ++ T
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-------SNEVVT 167
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP--PLSHLPPEKSLLMKMT------ 250
++ P+V+ + YS + D+W G E+A GRP P S + E L+ ++
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227
Query: 251 -----------QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ + F Y+ I + + +++ L + KR SAE+ MKH
Sbjct: 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGI-ELLTKFLQYESKKRISAEEAMKH 286
Query: 300 SFFKN 304
++F++
Sbjct: 287 AYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI---------DLDQSRTDLDSIRRETK 78
Y +L+ +G G VYK ++A+K I D + + I E
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 79 TM-SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLK 135
+ L HPNI+ + +F + RL++VM + L +S E I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 136 ETLSALSYLHNQGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
+ + AL YLH + + HRD+ NI+ D V + DFG++ S +T
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--------LTS 172
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
+ GT + PE++++ Y KAD+W+FG ++ +PP + SL K+ +
Sbjct: 173 VVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLATKIVE--- 227
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
+ YE +S D++ SCL D RP
Sbjct: 228 -AVYEPL-----PEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 74/256 (28%), Positives = 122/256 (47%), Gaps = 30/256 (11%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
AIKA+ D+ D++ E + +SL HP + + +C+F L+ VM +++ G L
Sbjct: 24 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL 83
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
I SC LP E + L +LH++G ++RD+K NIL D+DG +K+ADFG
Sbjct: 84 MFHIQSCHKFDLPRA--TFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFG 141
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233
+ + G A GTP ++APE++ Y+ D WSFG+ E+ G+
Sbjct: 142 M-------CKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQ 193
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSD--YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
P H E+ L Q R + Y + L +R KD++ ++P +R
Sbjct: 194 SPF-HGHDEEELF----QSIRMDNPCYPRWL---------TREAKDILVKLFVREPERRL 239
Query: 292 SAE-KLMKHSFFKNCN 306
+ + +H FF+ +
Sbjct: 240 GVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 27/255 (10%)
Query: 52 DSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS-VDSRLWVVMPFMS 109
D IK ++L + SR + + +E + +S L HPNI+ S+ D L++VM F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169
G L + LPE + + AL YLH + LHRD+K N+ +K+
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKV 143
Query: 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL 229
D G+ A + E + S +I GTPY+M+PE+ S+ Y++K+D+W+ G E+
Sbjct: 144 GDLGI-ARVLE--NQCDMASTLI----GTPYYMSPELF-SNKPYNYKSDVWALGCCVYEM 195
Query: 230 AHGRPPLSHLPPEK---SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
A L H K SL+ ++ + K+ K +S +++A+ L +
Sbjct: 196 A----TLKHAFNAKDMNSLVYRIIEG----------KLPPMPKDYSPELGELIATMLSKR 241
Query: 287 PSKRPSAEKLMKHSF 301
P KRPS + +++ +
Sbjct: 242 PEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 64/258 (24%), Positives = 123/258 (47%), Gaps = 32/258 (12%)
Query: 55 VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGS 112
+VA+K + + + + ++E + L H NI+ CS L ++M ++ GS
Sbjct: 35 MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 113 LQSIISSCFPDGLPEPCIA-----IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167
L+ D LP+ + + ++ ++YLH+Q ++HRD+ A N+L D+D V
Sbjct: 95 LR--------DYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLV 146
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTP-YWMAPEVIRSHTGYSFKADIWSFGITA 226
K+ DFG++ ++ P H ++ + + +P +W A E ++ + +S+ +D+WSFG+T
Sbjct: 147 KIGDFGLAKAV--PEGHEYY---RVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTL 200
Query: 227 LE-LAHGRPPLSHLPPEKSLLM------KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMV 279
E L H S PP+K M +MT E+ +++ + M
Sbjct: 201 YELLTHCDSKQS--PPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILM- 257
Query: 280 ASCLDQDPSKRPSAEKLM 297
+C + + RP+ L+
Sbjct: 258 KNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 76/306 (24%), Positives = 124/306 (40%), Gaps = 45/306 (14%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLS 84
P Y+ L +G G V A V AIK + QS RE + + +
Sbjct: 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKV-AIKKLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 85 HPNILNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H N++ F+ S L ++V M L +I+ L + I ++ + L
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKC---QKLSDDHIQFLVYQIL 128
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
L Y+H+ G +HRD+K NI + D +K+ DFG++ H +T T
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA----------RHTDDEMTGYVAT 178
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL--------PPEKS 244
++ APE++ + Y+ DIWS G EL G+ + L P++
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKLM 297
LL K++ +Y ++L K K F F D++ L DP KR +A + +
Sbjct: 239 LLQKISSE-SARNYIQSLPQMPK-KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296
Query: 298 KHSFFK 303
H +
Sbjct: 297 AHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 48/307 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL---- 83
Y+++ E+G G IV A + VAIK I S+ L +R + + LL
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHFR 59
Query: 84 SHPNILNAHCSFSVD-------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
H NI C + +D + L++ M L II S P L + + +
Sbjct: 60 GHKNIT---CLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQP--LTDAHFQSFIYQ 113
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L L Y+H+ LHRD+K GN+L ++D +K+ DFG++ S + + +T+
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF---SENPGENAGFMTEYV 170
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP---------PLSHL------PP 241
T ++ APE++ S Y+ D+WS G EL +P L+ + P
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 242 EKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAE 294
E++L + + + +Y ++L K K F F D++ L DP+KR S E
Sbjct: 231 EETLSRIGSPKAQ--NYIRSLPNIPK-KPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287
Query: 295 KLMKHSF 301
+ ++H +
Sbjct: 288 EALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 81/304 (26%), Positives = 134/304 (44%), Gaps = 43/304 (14%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLD-SIRRETKTMSLLSH 85
+ ++ L+ IG G IVY+A +VA+K + +D R + S RE + L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGE-IVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 86 PNILNAH---CSFSVDSRLWVVMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
PNI+ +DS +++VM + C L S++ + P E + ++ + L L
Sbjct: 66 PNIVELKEVVVGKHLDS-IFLVMEY--CEQDLASLLDN-MPTPFSESQVKCLMLQLLRGL 121
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YLH +HRD+K N+L G +K+ADFG++ + P+ +T T ++
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-------MTPKVVTLWY 174
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRP--------------------PLSHLPP 241
APE++ T Y+ D+W+ G EL +P P + P
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234
Query: 242 EKSLLMKMTQRFRFSD--YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
S L + +F Y +K K S A ++ L DP KR +AE+ ++
Sbjct: 235 GFSDL-PLVGKFTLPKQPYN---NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290
Query: 300 SFFK 303
S+FK
Sbjct: 291 SYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 26/254 (10%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
AIKA+ D+ D++ E + ++L HP + + C+F L+ VM +++ G L
Sbjct: 24 AIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL 83
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
I S E E + L +LH +G ++RD+K N+L D DG +K+ADFG
Sbjct: 84 MFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233
+ + +G + GTP ++APE+++ Y+ D WSFG+ E+ G+
Sbjct: 142 MCKE-------NMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQ 193
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-PS 292
P H E L + + + + S+ KD ++ ++DP+KR
Sbjct: 194 SPF-HGEDEDELFDSILNDRPH--FPRWI---------SKEAKDCLSKLFERDPTKRLGV 241
Query: 293 AEKLMKHSFFKNCN 306
+ +H FF+ +
Sbjct: 242 DGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 24/259 (9%)
Query: 53 STVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110
V A+K + + R+D E M+ + I+ H +F D L++VM +M
Sbjct: 68 KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
G L +++S+ +PE E + AL +H+ G +HRDVK N+L D G +KLA
Sbjct: 128 GDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 184
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG---YSFKADIWSFGITAL 227
DFG + +G GTP +++PEV++S G Y + D WS G+
Sbjct: 185 DFGTCMKMDA------NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 228 ELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDP 287
E+ G P SL+ + + D++ +L D + +A KD++ + L
Sbjct: 239 EMLVGDTPFY----ADSLVGTYS---KIMDHKNSLTFPDDIEISKQA-KDLICAFLTDRE 290
Query: 288 SK--RPSAEKLMKHSFFKN 304
+ R +++ H FFKN
Sbjct: 291 VRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 32/266 (12%)
Query: 55 VVAIKAI--DLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCG 111
+ A+K + +L D+D ++ E S HP ++ H F +SRL+ V+ +++ G
Sbjct: 22 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81
Query: 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
L + LPE E AL+YLH +G ++RD+K N+L DS+G +KL D
Sbjct: 82 DLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 139
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
+G+ P + GTP ++APE++R Y F D W+ G+ E+
Sbjct: 140 YGMCKEGLRPGD-------TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMA 191
Query: 232 GRPPL----SHLPPEKSLLMKMTQRFRFS-DYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
GR P S P+++ T+ + F EK ++I + S ++ S L++D
Sbjct: 192 GRSPFDIVGSSDNPDQN-----TEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKD 243
Query: 287 PSKR----PSA--EKLMKHSFFKNCN 306
P +R P + H FF+N +
Sbjct: 244 PKERLGCHPQTGFADIQGHPFFRNVD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 80/297 (26%), Positives = 130/297 (43%), Gaps = 31/297 (10%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+SY L+++G G A VYK I ++ +VA+K I + + RE + L H
Sbjct: 5 TSYLNLEKLGEGSYATVYKGIS-RINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ H L V +M Q +I P GL + + + + L L+Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
Q LHRD+K N+L G +KLADFG++ + PS + S+ + T ++ P+V
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY---SSEVV----TLWYRPPDV 174
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF------------R 254
+ T YS DIW G +E+ G+P + L K+ +
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234
Query: 255 FSDYE-------KTLKIKDKNKKFSRAFK--DMVASCLDQDPSKRPSAEKLMKHSFF 302
+Y+ K +++ K+ SR K D+ + L P R SA+ + H +F
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 31/295 (10%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
++K L+++G G A VYK +VA+K I LD + RE M L H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRN-RTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN 59
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ H +++L +V +M + + + L + + L +++ H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L + G +KLADFG++ + P + ++ T ++ AP+V+
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-------TFSNEVVTLWYRAPDVL 172
Query: 208 RSHTGYSFKADIWSFGITALELAHGRP--------------------PLSHLPPEKSLLM 247
YS DIWS G E+ GRP P P S L
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ F ++ D++ L +P R SA ++H +F
Sbjct: 233 EYKPTFPRY---PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 88/298 (29%), Positives = 131/298 (43%), Gaps = 35/298 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLD-SIRRET---KTMSLLS 84
Y+ + EIGVG VYKA P VA+K++ + + L S RE K +
Sbjct: 2 YEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 85 HPNI---LNAHCSFSVDSRLWVVMPFMSCGS-LQSIISSCFPDGLPEPCIAIVLKETLSA 140
HPNI ++ + D V + F L++ + P GLP I ++++ L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L +LH +HRD+K NIL S G VKLADFG+ A IY S +T + T +
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGL-ARIY--SCQ-----MALTPVVVTLW 172
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRP---------------PLSHLPPEKSL 245
+ APEV+ T Y+ D+WS G E+ +P L LPPE
Sbjct: 173 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231
Query: 246 LMKMT-QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+T R FS ++ + + ++ L +P KR SA + ++H FF
Sbjct: 232 PRDVTLPRGAFSP-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 81/304 (26%), Positives = 133/304 (43%), Gaps = 43/304 (14%)
Query: 77 TKT-MSLLSH----PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIA 131
T+T ++L H P ++ H +F +++L +++ ++S G + + + D E +
Sbjct: 51 TRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVR 108
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191
E + AL +LH G ++RD+K NIL DS+G V L DFG+S +
Sbjct: 109 FYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---- 164
Query: 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
GT +MAPE+IR G+ D WS GI EL G P + L E++ ++++
Sbjct: 165 --SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSR 221
Query: 252 RFRFSDYEKTLKIKDKNKKF-SRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNC 305
R LK F +D++ L +DP KR A ++ +H FFK
Sbjct: 222 RI--------LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
Query: 306 NKGVEFFVKNVLHGLRSVEERFKES-RNHVGAEHHEDE------EFEVGSSPPVKQRRIS 358
+ LR V F+ S RN + + +E + +PP R
Sbjct: 274 DW--------EALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARVFQ 325
Query: 359 GWNF 362
G++F
Sbjct: 326 GYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 72/286 (25%), Positives = 114/286 (39%), Gaps = 55/286 (19%)
Query: 57 AIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
A+K +D + R + + E + ++ L HP + + SF ++ L +VM + G L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 115 SIISSCFPDG-LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
++ P L E E L AL YLH G ++RD+K NIL G + L+DF
Sbjct: 90 RLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFD 148
Query: 174 VS-------------ASIYEPSHHHHH---------GSAMITDMAGTPYWMAPEVIRSHT 211
+S + S GT ++APEVI
Sbjct: 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD- 207
Query: 212 GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKK 270
G+ D W+ GI E+ +G P F+ S+ ++T I K
Sbjct: 208 GHGSAVDWWTLGILLYEMLYGTTP-----------------FKGSNRDETFSNILKKEVT 250
Query: 271 F------SRAFKDMVASCLDQDPSKR----PSAEKLMKHSFFKNCN 306
F S + +D++ L +DPSKR A ++ +H FF+ N
Sbjct: 251 FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 30/232 (12%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIV 133
E + +S L HP I+ H SF ++ + L + G L E +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA-MI 192
+ L + Y+H + LHRD+KA NI ++ +K+ DFGVS + GS +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM--------GSCDLA 162
Query: 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE---LAHGRPPLSHLPPEKSLLMKM 249
T GTPY+M+PE + H GY K+DIWS G E LAH + L S+++++
Sbjct: 163 TTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----SVVLRI 217
Query: 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
+ T + + +SR ++ S L++DPS RPSA +++++ F
Sbjct: 218 VE-------GPTPSLPE---TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 33/298 (11%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+YK LD++G G A VYK +VA+K I L+ + RE + L H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQ-LVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ H L +V ++ L+ + C GL + + L + L L+Y H
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ LHRD+K N+L G +KLADFG++ + PS + + T ++ P+V
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-------TLWYRPPDV 174
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRP--PLSHLPPEK--------------------S 244
+ T YS D+W G E+A GRP P S ++ S
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
F F + + + ++ L +P KR SA + MKH +F
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGE-ELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 48/303 (15%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
+Y LD++G G A V+K + +VA+K I L+ + RE + L H N
Sbjct: 6 TYVKLDKLGEGTYATVFKGRS-KLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 88 ILNAHCSFSVDSRLWVVMPFM---------SCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
I+ H + L +V ++ +CG+L S+ + + I + + L
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN-----------VKIFMFQLL 113
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
LSY H + LHRD+K N+L + G +KLADFG++ + P+ + ++ T
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-------SNEVVT 166
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP--PLSHLPPEKSLLMKM------- 249
++ P+V+ T YS D+W G E+A GRP P S + E L+ ++
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226
Query: 250 -------TQRFR---FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ FR F Y + + + + D+++S L + R SAE ++H
Sbjct: 227 TWPGITSNEEFRSYLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285
Query: 300 SFF 302
S+F
Sbjct: 286 SYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 90/314 (28%), Positives = 139/314 (44%), Gaps = 52/314 (16%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
YKI + IG G Y +C +D+ VAIK I D+ + +D I RE K + LL
Sbjct: 2 YKIQEVIGKGS----YGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR 57
Query: 85 HPNILN-AHCSFSVDSR----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
HP+I+ H R ++VV M Q I ++ D L L + L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN---DDLTPEHHQFFLYQLLR 114
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
AL Y+H HRD+K NIL+++D +K+ DFG++ + + + TD T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----RVAFNDTPTAIFWTDYVATR 170
Query: 200 YWMAPEVIRS-HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL------------ 246
++ APE+ S + Y+ DIWS G E+ G+P L P K+++
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKNVVHQLDLITDLLGT 226
Query: 247 --MKMTQRFRFSD---YEKTLKIKDK---NKKFSRAFKDMVASCLDQ-----DPSKRPSA 293
+ R R Y +++ K ++KF A D +A L + DP RP+A
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNA--DPLALRLLERLLAFDPKDRPTA 284
Query: 294 EKLMKHSFFKNCNK 307
E+ + +FK K
Sbjct: 285 EEALADPYFKGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 43/265 (16%)
Query: 57 AIKAIDLDQ--SRTDLDSIRRETK---TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCG 111
AIKA+ +R +++S+ E + T + HP ++N F + + VM + + G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
L I + D EP + L YLH ++RD+K N+L D++G VK+AD
Sbjct: 88 DLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIAD 144
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
FG+ G T GTP ++APEV+ + T Y+ D W G+ E+
Sbjct: 145 FGLC------KEGMGFGDRTST-FCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLV 196
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKFSRAF-KDMVA---SCLDQD 286
G P F D E+ I + ++ R ++ ++ L ++
Sbjct: 197 GESP-----------------FPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN 239
Query: 287 PSKR-----PSAEKLMKHSFFKNCN 306
P +R AE + K FF++ N
Sbjct: 240 PERRLGSGEKDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 76/263 (28%), Positives = 130/263 (49%), Gaps = 35/263 (13%)
Query: 53 STVVAIKAIDLDQSRTD---LDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109
+T+V KA + +RT+ L+ IR+ P ++ H +F D++L +++ +++
Sbjct: 39 ATIVQ-KAKTTEHTRTERQVLEHIRQS---------PFLVTLHYAFQTDTKLHLILDYIN 88
Query: 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169
G L + +S + E + I E + AL +LH G ++RD+K NIL DS+G V L
Sbjct: 89 GGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 146
Query: 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR-SHTGYSFKADIWSFGITALE 228
DFG+S +E + GT +MAP+++R G+ D WS G+ E
Sbjct: 147 TDFGLSKEFHEDEVERAY------SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPS 288
L G P + + EK+ ++++R S+ ++ S KD++ L +DP
Sbjct: 201 LLTGASPFT-VDGEKNSQAEISRRILKSE-------PPYPQEMSALAKDIIQRLLMKDPK 252
Query: 289 KR----PS-AEKLMKHSFFKNCN 306
KR PS A+++ KH FF+ N
Sbjct: 253 KRLGCGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 73/252 (28%), Positives = 105/252 (41%), Gaps = 57/252 (22%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQS--IISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLH 151
SF L+ VM ++ G + S I F + L IA E A+ +H G +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA----ELTCAIESVHKMGFIH 124
Query: 152 RDVKAGNILSDSDGSVKLADFGVSASI--------YEPSHHHHHGSAMITD--------- 194
RD+K NIL D DG +KL DFG+ Y+ HH S ++
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 195 -------------------MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP 235
+ GTP ++APEV+ TGY+ D WS G+ E+ G+PP
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 236 -LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR---P 291
L+ P E TQ + ++E TL I + K SR D++ L R
Sbjct: 244 FLADTPAE-------TQ-LKVINWETTLHIPSQ-AKLSREASDLILR-LCCGAEDRLGKN 293
Query: 292 SAEKLMKHSFFK 303
A+++ H FFK
Sbjct: 294 GADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAI---CIPMDS-TVVAIKAIDLDQSRTDLDSIRRET 77
+ L ++ E+G G +VY+ + + + T VAIK ++ + S + E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60
Query: 78 KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD-----GLPEPCIAI 132
M + +++ S VVM M+ G L+S + S P+ GL P +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 133 VLK---ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189
++ E ++YL + +HRD+ A N + D +VK+ DFG++ IYE ++ G
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 190 AMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA 230
++ P WMAPE ++ ++ K+D+WSFG+ E+A
Sbjct: 181 GLL------PVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 69/243 (28%), Positives = 116/243 (47%), Gaps = 22/243 (9%)
Query: 67 RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLP 126
R+D E M+ + P ++ C+F D L++VM +M G L +++S+ +P
Sbjct: 84 RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVP 140
Query: 127 EPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186
E E + AL +H+ G +HRDVK N+L D G +KLADFG + E
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET----- 195
Query: 187 HGSAMITDMAGTPYWMAPEVIRSHTG---YSFKADIWSFGITALELAHGRPPLSHLPPEK 243
G GTP +++PEV++S G Y + D WS G+ E+ G P
Sbjct: 196 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY----AD 250
Query: 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSF 301
SL+ + + D++ +L + + + S+ K+++ + L + R E++ +H F
Sbjct: 251 SLVGTYS---KIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306
Query: 302 FKN 304
FKN
Sbjct: 307 FKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 25/243 (10%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQS 115
VA+K + D T + E M+ L HPN++ + L++V +M+ GSL
Sbjct: 32 VAVKCLKDDS--TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89
Query: 116 IISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
+ S + + + YL + +HRD+ A N+L D K++DFG++
Sbjct: 90 YLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
Query: 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRP 234
E S G + W APE +R +S K+D+WSFGI E+ + GR
Sbjct: 150 K---EASQGQDSGKLPVK-------WTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRV 198
Query: 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
P + P K ++ + + +R E ++ C + DP+KRP+ +
Sbjct: 199 PYPRI-PLKDVVPHVEKGYRMEAPEGCPP----------EVYKVMKDCWELDPAKRPTFK 247
Query: 295 KLM 297
+L
Sbjct: 248 QLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 83/310 (26%), Positives = 132/310 (42%), Gaps = 49/310 (15%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRR---ETKTM 80
S YK ++ IG G +V C +D+ VAIK I + +R E K +
Sbjct: 5 SRYKPIENIGSGAYGVV----CSAIDTRSGKKVAIKKIP--HAFDVPTLAKRTLRELKIL 58
Query: 81 SLLSHPN------ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
H N IL + D ++VVM M L II S P L E I L
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKD--VYVVMDLMES-DLHHIIHSDQP--LTEEHIRYFL 113
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
+ L L Y+H+ +HRD+K N+L + D +++ DFG++ + H +T+
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH---KYFMTE 170
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFG------ITALELAHGRPPLSHL--------- 239
T ++ APE++ S Y+ D+WS G + +L G+ + L
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDK---NKKFSRAFK---DMVASCLDQDPSKRPSA 293
P E+ L + R R Y + L K +K F +A D+++ L DP +R +
Sbjct: 231 PSEEVLNRIGSDRVR--KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288
Query: 294 EKLMKHSFFK 303
E+ ++H F
Sbjct: 289 EQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 83/302 (27%), Positives = 124/302 (41%), Gaps = 48/302 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR--RETKTMSLLS-H 85
YKIL +IG G + V KA AIK + + L+ + RE + + LS H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKC--MKKHFKSLEQVNNLREIQALRRLSPH 57
Query: 86 PNILNAHCSFSVDS---RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
PNIL D RL +V M + I P LPE + + + L +L
Sbjct: 58 PNILRL-IEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLD 114
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
++H G HRD+K NIL D +KLADFG IY S + T+ T ++
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIY--SKPPY------TEYISTRWYR 165
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRP--PLSH-------------LPPEKSLLM 247
APE + + Y K DIW+ G E+ P P ++ P + L
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225
Query: 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLD-------QDPSKRPSAEKLMKHS 300
++ R +Y K K + + A LD DP +R +A++ ++H
Sbjct: 226 F--RKSRHMNYNFPSK---KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 301 FF 302
+F
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 64/226 (28%), Positives = 109/226 (48%), Gaps = 23/226 (10%)
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD--GLPEPCIAIVLKETLSALSYLH 145
I++ +F + L +VM M+ G L+ I + + G PEP + +S L +LH
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+ ++RD+K N+L D+DG+V+++D G++ + + G + AGTP +MAPE
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD-------GQSKTKGYAGTPGFMAPE 167
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
+++ Y F D ++ G+T E+ R P EK ++ QR ++
Sbjct: 168 LLQGEE-YDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRI----LNDSVTYP 221
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
D KFS A K + L +DP KR + + L H F++ N
Sbjct: 222 D---KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 36/242 (14%)
Query: 73 IRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII--SSCFPDGLPEPCI 130
+ E + + +SHP I+ + L+++M ++ G L S + S F +
Sbjct: 48 VHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL--- 104
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190
E + AL YLH++ ++RD+K NIL D +G +KL DFG + + + +
Sbjct: 105 -FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW------- 156
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
+ GTP ++APEVI+S G++ D W+ GI E+ G PP P
Sbjct: 157 ---TLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------- 203
Query: 251 QRFRFSDYEKTLKIK-DKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKN 304
F YEK L K + + KD++ L D ++R A+ + H +FK+
Sbjct: 204 ----FGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259
Query: 305 CN 306
+
Sbjct: 260 VD 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 22/276 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-DLDSIRRETKTMSLLSHPN 87
Y+I+ +IG G +Y A DS IK IDL + + ++ ++E ++ + HPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ SF + RL++VM + G L I+ E I + L ++H++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 148 GHLHRDVKAGNILSDSDGSV-KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
LHRD+K+ NI +G V KL DFG++ + + + GTPY+++PE+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSMELAYTCVGTPYYLSPEI 173
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
++ Y+ K DIWS G EL + P + L++K+ Q +
Sbjct: 174 CQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-LVLKICQGY----------FAP 221
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ FSR + +++ P RPS ++K F
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 79/308 (25%), Positives = 130/308 (42%), Gaps = 48/308 (15%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDST---VVAIKAIDLDQSRTDLDSIR-RETKTMSLL 83
+Y+ L++IG G VYKA D +VA+K L+ + RE + +L
Sbjct: 2 AYEKLEKIGEGTYGKVYKA----RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML 57
Query: 84 SH-PNILNAHCSFSVDSR-----LWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLK 135
S I+ V+ + L++V ++ + + S+ LP I +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSV-KLADFGVSASIYEPSHHHHHGSAMITD 194
+ L +++ H G +HRD+K N+L D + K+AD G+ + P + H
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---- 173
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
T ++ APEV+ T YS DIWS G E++ +P L P S L ++ F+
Sbjct: 174 ---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP----LFPGDSELQQLLHIFK 226
Query: 255 F------SDYEKTLKIKD-------KNKKFSRAFKDMVASCLD-------QDPSKRPSAE 294
+ K++D K + SRA D+ LD DP+KR SA+
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 295 KLMKHSFF 302
+ H +F
Sbjct: 287 AALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 26/254 (10%)
Query: 52 DSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110
D IK I++ + S + + R+E +S + HPNI+ SF + L++VM +
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
G L I++ PE I + AL ++H++ LHRD+K+ NI DG++KL
Sbjct: 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLG 143
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA 230
DFG++ + + + GTPY+++PE+ + Y+ K+DIW+ G E+
Sbjct: 144 DFGIARVL-------NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMC 195
Query: 231 HGRPPLSHLPPE---KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDP 287
L H K+L++K+ + Y + +S +++V+ ++P
Sbjct: 196 ----TLKHAFEAGNMKNLVLKIIR----GSYPPV------SSHYSYDLRNLVSQLFKRNP 241
Query: 288 SKRPSAEKLMKHSF 301
RPS +++ +F
Sbjct: 242 RDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 27/236 (11%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E++ + HP + SF RL VM + + G L +S E
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGA 102
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E +SAL YLH+ ++RD+K N++ D DG +K+ DFG+ G+ M T
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------DGATMKT-F 155
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
GTP ++APEV+ + Y D W G+ E+ GR P + EK + + + RF
Sbjct: 156 CGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 214
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
+ S K ++A L +DP +R A+++M+H FF + N
Sbjct: 215 P------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 35 IGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNA 91
+G G VYK + IP V VAIK + + S I E M+ + HP+++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS-------ALSYL 144
+ S++ ++ M G L D + I + L+ +SYL
Sbjct: 75 LG-ICLSSQVQLITQLMPLGCLL--------DYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMA 203
+ +HRD+ A N+L + VK+ DFG+ A + + +H P WMA
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGL-AKLLDVDEKEYHAEG-----GKVPIKWMA 179
Query: 204 PEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLP 240
E I H Y+ K+D+WS+G+T EL G P +P
Sbjct: 180 LESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 82/300 (27%), Positives = 137/300 (45%), Gaps = 41/300 (13%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL-DSIRRETKTMSLLSHP 86
Y+ L++IG G V+KA +VA+K + LD + S RE + L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 59
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGS-LQSIISSCFPDGLPEPCIA-IVLKETLSALSYL 144
NI+ + D +L +V F C L+ SC +G +P I + + L L++
Sbjct: 60 NIVRLYDVLHSDKKLTLV--FEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFC 115
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
H+ LHRD+K N+L + +G +KLADFG++ + P + SA + T ++ P
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY---SAEVV----TLWYRPP 168
Query: 205 EVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR--------- 254
+V+ YS D+WS G ELA+ GRP L P + ++ + FR
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRP----LFPGNDVDDQLKRIFRLLGTPTEES 224
Query: 255 ------------FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ Y T + + K + +D++ + L +P +R SAE+ ++H +F
Sbjct: 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 13/184 (7%)
Query: 55 VVAIKAIDLDQ--SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCG 111
V AIK + D D+D E + ++L + HP + HC F RL+ VM +++ G
Sbjct: 22 VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81
Query: 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
L I EP E AL +LH G ++RD+K NIL D++G KLAD
Sbjct: 82 DLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLAD 139
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
FG+ T GTP ++APE+++ Y D W+ G+ E+
Sbjct: 140 FGMCKEGILN-------GVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMA 191
Query: 232 GRPP 235
G+PP
Sbjct: 192 GQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 72/293 (24%), Positives = 133/293 (45%), Gaps = 28/293 (9%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
+Y LD++G G A VYK + +VA+K I L+ + RE + L H N
Sbjct: 7 TYIKLDKLGEGTYATVYKGRS-KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ H + L +V ++ L+ + C + + + + L + L L+Y H +
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L + G +KLADFG++ + P+ + ++ T ++ P+++
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-------SNEVVTLWYRPPDIL 176
Query: 208 RSHTGYSFKADIWSFGITALELAHGRP--PLSHLPPEKSLLMKM--------------TQ 251
T YS + D+W G E++ GRP P S + + + ++ +
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236
Query: 252 RFRFSDYEKTLK--IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
F+ +Y K + + + ++++ L + KR SAE+ MKH +F
Sbjct: 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 37/301 (12%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
SY+ L+++G G A VYK ++ +VA+K I L + + RE + L H N
Sbjct: 6 SYEKLEKLGEGSYATVYKGKS-KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ H L +V ++ Q + P GL + + L + L LSY+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L G +KLADFG++ + PSH + ++ T ++ P+V+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-------SNEVVTLWYRPPDVL 175
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF-------------- 253
T YS D+W G +E+ G ++ P K + ++ + F
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG---VAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 254 ---------RFSDY-EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
RF+ Y K L+ + +D+ + L P R SA+ + H +F
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 304 N 304
+
Sbjct: 293 D 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 86/302 (28%), Positives = 135/302 (44%), Gaps = 37/302 (12%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH 85
Y+ L IG G +V A P VAIK I + +T RE K + H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 86 PNILNAH---CSFSVDS--RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
NI+ S +S +++V M L +I + L I L + L
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRG 118
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L Y+H+ LHRD+K N+L +++ +K+ DFG+ A I +P H H + +T+ T +
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL-ARIADPEHDH---TGFLTEYVATRW 174
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRP--P-------LSHL------PPEKSL 245
+ APE++ + GY+ DIWS G E+ RP P L+ + P ++ L
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234
Query: 246 LMKMTQRFRFSDYEKTLKIKDK---NKKFSRAFK---DMVASCLDQDPSKRPSAEKLMKH 299
++ R R +Y K+L K K NK F A D++ L +P KR + E+ + H
Sbjct: 235 NCIISLRAR--NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292
Query: 300 SF 301
+
Sbjct: 293 PY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 68/255 (26%), Positives = 121/255 (47%), Gaps = 28/255 (10%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+KA+ D+ D++ E + ++L +P + + +C+F L+ VM F++ G L
Sbjct: 24 AVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL 83
Query: 114 QSIISSCFPDGLPEPCIAIVL-KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
I G + A E + L +LH++G ++RD+K N++ D DG +K+ADF
Sbjct: 84 MFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADF 140
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
G+ + G + GTP ++APE+++ Y+F D WSFG+ E+ G
Sbjct: 141 GM-------CKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIG 192
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
+ P H E L + R Y + + ++ KD++ ++DP++R
Sbjct: 193 QSPF-HGDDEDELFESI--RVDTPHYPRWI---------TKESKDILEKLFERDPTRRLG 240
Query: 293 AEKLMK-HSFFKNCN 306
++ H FFK N
Sbjct: 241 VVGNIRGHPFFKTIN 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 67/263 (25%), Positives = 121/263 (46%), Gaps = 26/263 (9%)
Query: 52 DSTVVAIKAI--DLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFM 108
+ + A+K + +L D+D ++ E S +P ++ H F SRL++V+ ++
Sbjct: 19 NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78
Query: 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVK 168
+ G L + LPE E AL++LH +G ++RD+K N+L D+DG +K
Sbjct: 79 NGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIK 136
Query: 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE 228
L D+G+ P + GTP ++APE++R Y F D W+ G+ E
Sbjct: 137 LTDYGMCKEGLGPGD-------TTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFE 188
Query: 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFS-DYEKTLKIKDKNKKFSRAFKDMVASCLDQDP 287
+ GR P + + T+ + F EK ++I + S ++ L++DP
Sbjct: 189 MMAGRSPFDIITDNPDM---NTEDYLFQVILEKPIRIP---RFLSVKASHVLKGFLNKDP 242
Query: 288 SKRPSAE------KLMKHSFFKN 304
+R + + H+FF++
Sbjct: 243 KERLGCQPQTGFSDIKSHTFFRS 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 38/300 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR-RETKTMSLLSHPN 87
Y+ +++IG G +VYKA + T+ A+K I L+Q + S RE + + H N
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETI-ALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEP-CIAIVLKETLSALSYLHN 146
I+ + RL++V ++ L+ + S PD P I L + L ++Y H+
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 147 QGHLHRDVKAGNILSD-SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
LHRD+K N+L D ++KLADFG++ + P H T ++ APE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-------TLWYRAPE 173
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----------- 254
++ YS DIWS G E+ + +P L P S + ++ + FR
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKP----LFPGDSEIDELFKIFRILGTPNEETWP 229
Query: 255 ----FSDYEKTL-KIKDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
DY+ K K+ A D+++ L DPSKR +A ++H +FK+
Sbjct: 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
|
Length = 294 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I N H +F ++ L++VM + G L +++S F D LPE L E + A+ +H
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
G++HRD+K N+L D +G ++LADFG + G+ GTP +++PE++
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA------DGTVQSNVAVGTPDYISPEIL 175
Query: 208 RSHTG----YSFKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQRFRFSDYEKT 261
++ Y + D WS G+ E+ +G P L +M + F+F
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235
Query: 262 LKIKDKNKKFSRAFKDMVAS--CLDQDPSKRPSAEKLMKHSFF 302
+ S KD++ C + R + H FF
Sbjct: 236 V---------SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 26/245 (10%)
Query: 67 RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLP 126
R+D E M+ + P ++ +F D L++VM +M G L +++S+ +P
Sbjct: 84 RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVP 140
Query: 127 EPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186
E E + AL +H+ G +HRDVK N+L D G +KLADFG + +
Sbjct: 141 EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM------NK 194
Query: 187 HGSAMITDMAGTPYWMAPEVIRSHTG---YSFKADIWSFGITALELAHGRPPL--SHLPP 241
G GTP +++PEV++S G Y + D WS G+ E+ G P L
Sbjct: 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254
Query: 242 EKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKH 299
S +M F D + S+ K+++ + L + R E++ +H
Sbjct: 255 TYSKIMNHKNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304
Query: 300 SFFKN 304
FFKN
Sbjct: 305 LFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 78/309 (25%), Positives = 129/309 (41%), Gaps = 52/309 (16%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLD-SIRRETKTMSLLSHPN 87
+ I+ +IG G VYKA +VA+K + LD + + RE K + L+H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGE-LVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 88 ILNAH---------CSFSVDSR-LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
I+N F D ++V +M L ++ S E I +K+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLESGLVH-FSEDHIKSFMKQL 125
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
L L+Y H + LHRD+K NIL ++ G +KLADFG+ A +Y + + +I
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNKVI----- 179
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP--------------------PLS 237
T ++ PE++ Y D+WS G EL +P P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 238 HLPPEKSLL-----MKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
+ P+ L MK +++R +++++ D++ L DPSKR +
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYR-------RRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292
Query: 293 AEKLMKHSF 301
AE+ + +
Sbjct: 293 AEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 70/270 (25%), Positives = 113/270 (41%), Gaps = 33/270 (12%)
Query: 35 IGVGVSAIVYKAICI-PMDSTV-VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI--LN 90
IG G VY+ + + P + + VA+K S + + +E M HP+I L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHL 150
+ ++ +W+VM G L+S + L + + + +AL+YL ++ +
Sbjct: 74 GVIT---ENPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKRFV 129
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVI-- 207
HRD+ A N+L S VKL DFG+S + + S++ A + P WMAPE I
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK----ASKGKL---PIKWMAPESINF 182
Query: 208 RSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
R T S D+W FG+ E L G P + ++ ++ R
Sbjct: 183 RRFTSAS---DVWMFGVCMWEILMLGVKPFQGV-KNNDVIGRIENGERLP---------- 228
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
++ C DPSKRP +L
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 48/287 (16%)
Query: 24 LDPSSYKILDEIGVGVSAIV-YKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL 82
+DP L E+G G +V Y D VAIK I + D E K M
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYD---VAIKMIK--EGSMSEDEFIEEAKVMMK 55
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF----PDGLPEPCIAIVLKETL 138
LSH ++ + + +++V +MS G L + + P L E C K+
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC-----KDVC 110
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
++YL ++ +HRD+ A N L D G VK++DFG+S + + + T G+
Sbjct: 111 EGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---------TSSVGS 161
Query: 199 PY---WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
+ W PEV+ ++ +S K+D+W+FG+ E+ L +P E RF
Sbjct: 162 KFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVY----SLGKMPYE-----------RF 205
Query: 256 SDYEKTLKIKDKNKKF-----SRAFKDMVASCLDQDPSKRPSAEKLM 297
++ E K+ + + S ++ SC + +RP+ ++L+
Sbjct: 206 NNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 20/242 (8%)
Query: 67 RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLP 126
R + R E + + I H +F ++ L++VM + G L +++S F D LP
Sbjct: 42 RAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLP 100
Query: 127 EPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186
E L E + A+ +H ++HRD+K NIL D +G ++LADFG + E
Sbjct: 101 EDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME------ 154
Query: 187 HGSAMITDMAGTPYWMAPEVIRSHTG----YSFKADIWSFGITALELAHGRPPL--SHLP 240
G+ + GTP +++PE++++ Y + D WS G+ E+ +G P L
Sbjct: 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
+M +RF+F ++ D ++ + ++ C + + E +H
Sbjct: 215 ETYGKIMNHKERFQFP-----AQVTDVSEDAKDLIRRLI--CSREHRLGQNGIEDFKQHP 267
Query: 301 FF 302
FF
Sbjct: 268 FF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 37/272 (13%)
Query: 33 DEIGVGVSAIVYKAICIPMDSTV--VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90
++G G +V + V VA+K + D+ +D +E M L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS--------ALS 142
+ + L +V GSL D L + + L TL +
Sbjct: 61 LY-GVVLTHPLMMVTELAPLGSLL--------DRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-W 201
YL ++ +HRD+ A NIL SD VK+ DFG+ ++ P + H+ + P+ W
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL--PQNEDHYVMEEHLKV---PFAW 166
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
APE +R+ T +S +D+W FG+T E+ +G P + L + +L K+ + E+
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDKE-----GER 219
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
+ + + +++ C +P+ RP+
Sbjct: 220 LERPEACPQDIY----NVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 27/236 (11%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E++ + HP + + SF RL VM +++ G L +S E
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGA 102
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E +SAL YLH+ ++RD+K N++ D DG +K+ DFG+ +A +
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-------DAATMKTF 155
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
GTP ++APEV+ + Y D W G+ E+ GR P + EK + + + +F
Sbjct: 156 CGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF 214
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
+ S K +++ L +DP+KR A+++M+HSFF N
Sbjct: 215 P------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 31 ILDEIGVGVSAIVYKAIC---IPMDS-TVVAIKAID---LDQSRTDLDSIRRETKTMSLL 83
+ E+G G V+ C P + +VA+K + + +R D + RE + ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE---REAELLTNF 65
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD-----GLPEPCIAIVLKETL 138
H NI+ + + +V +M G L + S PD P + L + L
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 139 -------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191
S + YL +Q +HRD+ N L D VK+ DFG+S +Y ++ G M
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 192 ITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPP 235
+ P WM PE I ++ ++D+WSFG+ E+ +G+ P
Sbjct: 186 L------PIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 72/268 (26%), Positives = 125/268 (46%), Gaps = 39/268 (14%)
Query: 50 PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFM 108
P T VA+K + D + DL + E + M ++ H NI+N + + D L+V++ +
Sbjct: 47 PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 109 SCGSLQSIISS--------CF-PDGLPEPCIAIVLKETLS-------ALSYLHNQGHLHR 152
S G+L+ + + C+ P +PE ++ K+ +S + YL ++ +HR
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF--KDLVSCAYQVARGMEYLASKKCIHR 164
Query: 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG 212
D+ A N+L D +K+ADFG++ I HH T+ WMAPE +
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRI- 218
Query: 213 YSFKADIWSFGITALEL-AHGRPPLSHLPPEKSL-LMKMTQRFRFSDYEKTLKIKDKNKK 270
Y+ ++D+WSFG+ E+ G P +P E+ L+K R DK
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM------------DKPSN 266
Query: 271 FSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ M+ C PS+RP+ ++L++
Sbjct: 267 CTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 32/264 (12%)
Query: 55 VVAIKAI--DLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCG 111
+ A+K I +L D+D ++ E S HP ++ H F +SRL+ V+ F+S G
Sbjct: 22 IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81
Query: 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
L + LPE E AL++LH +G ++RD+K N+L D++G +KL D
Sbjct: 82 DLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTD 139
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
+G+ P + GTP ++APE++R Y F D W+ G+ E+
Sbjct: 140 YGMCKEGIRPGD-------TTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMA 191
Query: 232 GRPPL----SHLPPEKSLLMKMTQRFRFS-DYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
GR P P+++ T+ + F EK ++I + S ++ L++D
Sbjct: 192 GRSPFDIVGMSDNPDQN-----TEDYLFQVILEKQIRIP---RSLSVKASSVLKGFLNKD 243
Query: 287 PSKRPSAEK------LMKHSFFKN 304
P +R + H FF+N
Sbjct: 244 PKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 82/295 (27%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLSHPNILNA-- 91
IG G +V+ ++ P D VA+K + ++ Q+ + RE K + H N+L+A
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 92 -----HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
H ++VV M L II S P L + + L + L L YLH+
Sbjct: 67 ILQPPHIDPF--EEIYVVTELMQS-DLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
G LHRD+K GN+L +S+ +K+ DFG+ A + EP H +T T Y+ APE+
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDESKH-----MTQEVVTQYYRAPEI 175
Query: 207 IRSHTGYSFKADIWSFGITALELAHGR------PPLSHLPPEKSLLMKMTQRFRFSDYEK 260
+ Y+ DIWS G EL R P+ L LL + S E
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235
Query: 261 T----LKIKDKNKKFSRAFK----------DMVASCLDQDPSKRPSAEKLMKHSF 301
L+ K + ++ L DP KR SA + H +
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 30/279 (10%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+DPS L E+G G +V+ VAIK I + + ++ D I E K M L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKID--VAIKMIR-EGAMSEDDFIE-EAKVMMKL 56
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
SHPN++ + + +++V +M+ G L + + L + + + A+ Y
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEY 115
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY--- 200
L + G +HRD+ A N L D VK++DFG++ + + + T GT +
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---------TSSQGTKFPVK 166
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
W PEV ++ +S K+D+WSFG+ E+ + G+ P ++ ++ +R
Sbjct: 167 WAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL---- 220
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ K ++ SC + P RP+ +KL+
Sbjct: 221 ------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I H +F ++ L++VM + G L +++S F D LPE + E + A+ +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
++HRD+K N+L D +G ++LADFG + + G+ + GTP +++PE++
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ------DGTVQSSVAVGTPDYISPEIL 175
Query: 208 RSHTG----YSFKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQRFRFSDYEKT 261
++ Y + D WS G+ E+ +G P L +M +RF+F +
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH--- 232
Query: 262 LKIKDKNKKFSRAFKDMVAS--CLDQDPSKRPSAEKLMKHSFFKNCN 306
I D S KD++ C + + E KH+FF+ +
Sbjct: 233 --ITD----VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 31/267 (11%)
Query: 53 STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSC 110
+VA+K + D S + +E K +S LS PNI L C+ VD L ++M +M
Sbjct: 46 PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT--VDPPLCMIMEYMEN 103
Query: 111 GSLQSIISSC--FPDG-------LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS 161
G L + G L + + + S + YL + +HRD+ N L
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 162 DSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIW 220
+ ++K+ADFG+S ++Y ++ G A + P WMA E + ++ K+D+W
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPL------PIRWMAWESVLL-GKFTTKSDVW 216
Query: 221 SFGITALE---LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKD 277
+FG+T E L P HL ++ ++ FR + L + + +
Sbjct: 217 AFGVTLWEILTLCR-EQPYEHL-TDQQVIENAGHFFRDDGRQIYL---PRPPNCPKDIYE 271
Query: 278 MVASCLDQDPSKRPSAEKLMKHSFFKN 304
++ C +D RP+ ++ H F +
Sbjct: 272 LMLECWRRDEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 35 IGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN-- 90
IG G VY I D A+K+++ +++ +E M SHPN+L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHL 150
C S S L VV+P+M G L++ I S + + I L + + YL ++ +
Sbjct: 63 GICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLASKKFV 120
Query: 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEP---SHHHHHGSAMITDMAGTPYWMAPEVI 207
HRD+ A N + D +VK+ADFG++ IY+ S H+H G+ + WMA E +
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK------WMALESL 174
Query: 208 RSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPP 241
++ ++ K+D+WSFG+ EL G PP +
Sbjct: 175 QTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 69/258 (26%), Positives = 119/258 (46%), Gaps = 49/258 (18%)
Query: 65 QSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL------QSII- 117
+++ D + E + + HP I++ +F +L++++ ++S G L + I
Sbjct: 39 RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFM 98
Query: 118 --SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV- 174
++CF L E AL +LH QG ++RD+K NIL D+ G VKL DFG+
Sbjct: 99 EDTACF-----------YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC 147
Query: 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP 234
SI+E + H GT +MAPE++ +G+ D WS G ++ G P
Sbjct: 148 KESIHEGTVTH--------TFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAP 198
Query: 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF-SRAFKDMVASCLDQDPSKR--- 290
P + +K++ +K LK K + + +D++ L ++PS R
Sbjct: 199 PFTAENRKKTI-------------DKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGA 245
Query: 291 -PS-AEKLMKHSFFKNCN 306
P A ++ H FF++ N
Sbjct: 246 GPGDAAEVQSHPFFRHVN 263
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 79/308 (25%), Positives = 133/308 (43%), Gaps = 49/308 (15%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLD-QSRTDLDSIRRETKTMS 81
P Y+ L ++G G Y +C +D VAIK + QS RE + +
Sbjct: 14 PDRYRDLKQVGSGA----YGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69
Query: 82 LLSHPNILNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ H N++ F+ D L ++VMPFM L ++ + L E I ++
Sbjct: 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKH---EKLSEDRIQFLVY 125
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ L L Y+H G +HRD+K GN+ + D +K+ DFG++ + +T
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RQTDSEMTGY 175
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLS---HLPPEKSLLMKMT-- 250
T ++ APEVI + Y+ DIWS G E+ G+P HL +MK+T
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME-IMKVTGT 234
Query: 251 ------QRFRFSD---YEKTL-KIKDKN-KKFSRAFKDMVASCLDQ----DPSKRPSAEK 295
Q+ + D Y K L + + K+ + + + L++ D R +A +
Sbjct: 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294
Query: 296 LMKHSFFK 303
+ H +F+
Sbjct: 295 ALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 55/172 (31%), Positives = 89/172 (51%), Gaps = 15/172 (8%)
Query: 64 DQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD 123
D+ RT + E ++ ++HP I+ H +F + +L++++ F+ G L + +S
Sbjct: 41 DRVRTKM-----ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM- 94
Query: 124 GLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183
E + L E AL +LH+ G ++RD+K NIL D +G +KL DFG+S E
Sbjct: 95 -FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESID 150
Query: 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP 235
H + GT +MAPEV+ + G++ AD WSFG+ E+ G P
Sbjct: 151 HEKKAYS----FCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 85/326 (26%), Positives = 140/326 (42%), Gaps = 57/326 (17%)
Query: 18 QKIQYPL--DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDL 70
+ ++P + S Y+ L +IG G V+KA +VA+K + ++ + T L
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQ-IVALKKVLMENEKEGFPITAL 59
Query: 71 DSIRRETKTMSLLSHPNILN----AHCSFSVDSR----LWVVMPFMSC----GSLQSIIS 118
RE K + LL H N++N + +R ++V F C L S +
Sbjct: 60 ----REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF--CEHDLAGLLSNKN 113
Query: 119 SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178
F L E I V+K L+ L Y+H LHRD+KA NIL DG +KLADFG++ +
Sbjct: 114 VKF--TLSE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169
Query: 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH 238
+ + T+ T ++ PE++ Y D+W G E+ R P+
Sbjct: 170 SLSKNSKPN---RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM-WTRSPIMQ 225
Query: 239 LPPEKSLLMKMTQ-----------------RFRFSDYEKTLK--IKDKNKKFSR---AFK 276
E+ L ++Q F+ + + K +K++ K + + A
Sbjct: 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHAL- 284
Query: 277 DMVASCLDQDPSKRPSAEKLMKHSFF 302
D++ L DP+KR A+ + H FF
Sbjct: 285 DLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 83/319 (26%), Positives = 125/319 (39%), Gaps = 59/319 (18%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLD-QSRTDLDSIRRETKTMS 81
Y+ L IG G IV C D+ VAIK + Q+ T RE M
Sbjct: 15 LKRYQNLKPIGSGAQGIV----CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70
Query: 82 LLSHPNI---LNAHC---SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
L++H NI LN S +++VM M Q I L ++ +L
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----LDHERMSYLLY 125
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ L + +LH+ G +HRD+K NI+ SD ++K+ DFG++ + S M+T
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--------GTSFMMTPY 177
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR---PPLSHL-----------PP 241
T Y+ APEVI GY DIWS G E+ G P H+ P
Sbjct: 178 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236
Query: 242 EKSLLMKMTQRFR-----------------FSDYEKTLKIKDKNKKFSRAFKDMVASCLD 284
+ ++ R F D + NK + +D+++ L
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 285 QDPSKRPSAEKLMKHSFFK 303
DP KR S + ++H +
Sbjct: 297 IDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 74/304 (24%), Positives = 139/304 (45%), Gaps = 47/304 (15%)
Query: 23 PLDP------SSYKILDEIGVGVSAIVYKAICIPMDS----TVVAIKAIDLDQSRTDLDS 72
PLDP + +G G V KA + +D+ + VA+K + D + DL
Sbjct: 2 PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD 61
Query: 73 IRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPE-PCI 130
+ E + M ++ H NI+N + + L+VV+ + + G+L+ + + P G P
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 131 AIVLKETLS-------------ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177
+ETL+ + +L ++ +HRD+ A N+L D +K+ADFG++
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 178 IYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPP 235
I+ ++ + + P WMAPE + Y+ ++D+WSFG+ E+ G P
Sbjct: 182 IHHIDYYRKTTNGRL------PVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP 234
Query: 236 LSHLPPEKSL-LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
+P E+ L+K R +K + ++ ++ C + PS+RP+ +
Sbjct: 235 YPGIPVEELFKLLKEGYRM------------EKPQNCTQELYHLMRDCWHEVPSQRPTFK 282
Query: 295 KLMK 298
+L++
Sbjct: 283 QLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 44/270 (16%)
Query: 54 TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
T VA+K + + S ++L + E + ++HP+++ + + S D L +++ + GSL
Sbjct: 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90
Query: 114 QSII-------------------SSCFPDGLPEPCIAIVLK---ETLSALSYLHNQGHLH 151
+S + S + ++ + + YL +H
Sbjct: 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVH 150
Query: 152 RDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSH 210
RD+ A N+L +K++DFG+S +YE + I P WMA E + H
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI------PVKWMAIESLFDH 204
Query: 211 TGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL-LMKMTQRFRFSDYEKTLKIKDKN 268
Y+ ++D+WSFG+ E+ G P + PE+ L+K R ++
Sbjct: 205 I-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM------------ERP 251
Query: 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ S +++ +C Q+P KRP+ + K
Sbjct: 252 ENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 35/266 (13%)
Query: 50 PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFM 108
P ++ VA+K + D + DL + E + M ++ H NI+N + + D L+V++ +
Sbjct: 44 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 109 SCGSLQSIISSCFPDGLPE-------PCIAIVLKETLS-------ALSYLHNQGHLHRDV 154
S G+L+ + + P G+ P + K+ +S + YL +Q +HRD+
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163
Query: 155 KAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYS 214
A N+L + +K+ADFG++ + ++ + + WMAPE + Y+
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL-----PVKWMAPEALFDRV-YT 217
Query: 215 FKADIWSFGITALEL-AHGRPPLSHLPPEKSL-LMKMTQRFRFSDYEKTLKIKDKNKKFS 272
++D+WSFG+ E+ G P +P E+ L+K R DK +
Sbjct: 218 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM------------DKPANCT 265
Query: 273 RAFKDMVASCLDQDPSKRPSAEKLMK 298
M+ C PS RP+ ++L++
Sbjct: 266 NELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 56 VAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPNILN-AHCSFSVDSRL-----WVVMPFM 108
VA+K + LD + ++++ E M HPN++ F S V++PFM
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 109 SCGSLQSIISSCFPDGLPE--PCIAIVL--KETLSALSYLHNQGHLHRDVKAGNILSDSD 164
G L S + GLPE P ++ + + YL N+ +HRD+ A N + D
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED 149
Query: 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFG 223
+V +ADFG+S IY ++ +A P W+A E + Y+ K+D+W+FG
Sbjct: 150 MTVCVADFGLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRV-YTSKSDVWAFG 202
Query: 224 ITALELA 230
+T E+A
Sbjct: 203 VTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E++ + HP + +F RL VM + + G L +S E
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGA 102
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E +SAL YLH++ ++RD+K N++ D DG +K+ DFG+ G+ M T
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------DGATMKT-F 155
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
GTP ++APEV+ + Y D W G+ E+ GR P + E+ + + + RF
Sbjct: 156 CGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 214
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR----PS-AEKLMKHSFFKNCN 306
+ S K ++A L +DP +R PS A+++M+H FF + N
Sbjct: 215 P------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 77/324 (23%), Positives = 127/324 (39%), Gaps = 59/324 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICI-PMDSTVVAIKAIDLDQSRTDLDSIR--RETKTMSLLSH 85
Y+I IG G VYKA D AIK D+ + S RE + L H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 86 PNILNAHCSF--SVDSRLWVVMPFMSCGSLQSII---SSCFPDGLPEPCIAIVLKETLSA 140
N+++ F D ++++ + Q II +P + +L + L+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ-IIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 141 LSYLHNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
+ YLH+ LHRD+K NIL G VK+ D G++ P ++
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV--- 177
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFG------ITALELAHGR----------------- 233
T ++ APE++ Y+ DIW+ G +T + GR
Sbjct: 178 -TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 234 -------------PPLSHLPPEKSLLMKMTQR--FRFSDYEKTLKIKDKNKKFSRAFKDM 278
P + + PE LMK + + + K ++ K S+ F D+
Sbjct: 237 IFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD--SQGF-DL 292
Query: 279 VASCLDQDPSKRPSAEKLMKHSFF 302
+ L+ DP+KR +AE+ ++H +F
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E + + ++ P I+N +F + L +VM M+ G L+ I + GL +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ + +LH+ ++RD+K N+L D G+ +L+D G++ + IT
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL--------KDGKTITQR 154
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
AGT +MAPE+++ YS+ D ++ G + E+ GR P EK ++ +R
Sbjct: 155 AGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDH-KEKVAKEELKRR--- 209
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR----PSAEKLMKHSFFKNCN 306
E +K + +N F+ KD+ L + P R + KH FFK N
Sbjct: 210 -TLEDEVKFEHQN--FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 67/246 (27%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 69 DLDSIRRETKTMSLLSHPNILNA-HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPE 127
D++ E + ++L P L H F RL+ VM +++ G L I E
Sbjct: 43 DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKE 100
Query: 128 PCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187
P E L +LH +G ++RD+K N++ DS+G +K+ADFG+ H
Sbjct: 101 PQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC------KEHMVD 154
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM 247
G T GTP ++APE+I ++ Y D W++G+ E+ G+PP
Sbjct: 155 GVTTRT-FCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPP------------ 200
Query: 248 KMTQRFRFSDYEKTLK-IKDKNKKFSRAF-KDMVASC---LDQDPSKR----PSAEK-LM 297
F D ++ + I + N + ++ K+ V+ C + + PSKR P E+ +
Sbjct: 201 -----FDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIR 255
Query: 298 KHSFFK 303
+H+FF+
Sbjct: 256 EHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 13/188 (6%)
Query: 52 DSTVVAIKAI--DLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFM 108
+ A+K + D+ D++ E + +SL +HP + +C F RL+ VM F+
Sbjct: 19 SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78
Query: 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVK 168
+ G L I E E SAL +LH++G ++RD+K N+L D +G K
Sbjct: 79 NGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCK 136
Query: 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE 228
LADFG+ +G T GTP ++APE+++ Y D W+ G+ E
Sbjct: 137 LADFGMC------KEGIFNGKTTST-FCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYE 188
Query: 229 LAHGRPPL 236
+ G P
Sbjct: 189 MLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLKETLSA 140
L HP ++ H SF +L+ V+ +++ G L + CF EP E SA
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----EPRARFYAAEVASA 108
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YLH+ ++RD+K NIL DS G V L DFG+ EP + GTP
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-------EETTSTFCGTPE 161
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236
++APEV+R Y D W G E+ +G PP
Sbjct: 162 YLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-17
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 34 EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHC 93
++G G VY+ + TV A+K + D ++ +E M + HPN++
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTV-AVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
+ + +++ FM+ G+L + C + + + + SA+ YL + +HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTG 212
+ A N L + VK+ADFG+S + ++ H G A P W APE + +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-------AKFPIKWTAPESLAYNK- 181
Query: 213 YSFKADIWSFGITALELA-HGRPP 235
+S K+D+W+FG+ E+A +G P
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 66/276 (23%), Positives = 121/276 (43%), Gaps = 24/276 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+ PS ++ EIG G +V+ ++ VAIK I + + E + M L
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYW--LEKRKVAIKTIR--EGAMSEEDFIEEAQVMMKL 56
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
SHP ++ + + S + +V FM G L + + E + + L + ++Y
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL-DVCEGMAY 115
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
L + +HRD+ A N L + VK++DFG++ + + + G+ W +
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSS 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
PEV S + YS K+D+WSFG+ E+ + G+ P + ++ + FR
Sbjct: 170 PEVF-SFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY------ 221
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
K + S++ +++ C + P RPS L+
Sbjct: 222 ----KPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKA-ICIPMDSTV-VAIKAIDLDQSRTDLDSIRRETKTMS 81
+DPS I IG G V + + +P + VAIK + S E M
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMG 60
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL--- 138
HPNI+ + + ++ +M GSL + DG L L
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTV---GQLVGMLRGI 115
Query: 139 -SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
S + YL ++HRD+ A NIL +S+ K++DFG+S + + A T G
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-------EATYTTKGG 168
Query: 198 -TPY-WMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPP 235
P W APE I ++ ++ +D+WSFGI E +++G P
Sbjct: 169 KIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-17
Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLP--EPCIA 131
R E ++ H I+ F D +L ++M + S G L I + LP E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191
++ + + AL +H++ +HRD+K+ NI G +KL DFG S Y S S+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASS- 230
Query: 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
GTPY++APE+ YS KAD+WS G+ EL P P ++ ++ Q
Sbjct: 231 ---FCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKG-PSQREIM----Q 281
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ + Y+ S K ++ L ++P+ RP+ ++L+ F K
Sbjct: 282 QVLYGKYDPF------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 53/154 (34%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
+ HP ++ H SF +L+ V+ F++ G L + PEP E SAL
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALG 110
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
YLH+ ++RD+K NIL DS G V L DFG+ S T GTP ++
Sbjct: 111 YLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-------TTTTFCGTPEYL 163
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236
APEVIR Y D W G E+ +G PP
Sbjct: 164 APEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 56/310 (18%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLD-QSRTDLDSIRRETKTMS 81
P Y L ++G G Y ++C +D VAIK + QS RE +
Sbjct: 14 PERYTSLKQVGSGA----YGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 82 LLSHPNILN------AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ H N++ + S ++VMP+M LQ I+ E + ++
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLS----EDKVQYLVY 124
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ L L Y+H+ G +HRD+K GN+ + D +K+ DFG++ H A +T
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RHADAEMTGY 174
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
T ++ APEVI + Y+ DIWS G E+ G+ L K L ++TQ +
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKGKDYLDQLTQILKV 230
Query: 256 SDY---EKTLKIKDK-------------NKKFSRAFK-------DMVASCLDQDPSKRPS 292
+ E K++DK K FS F D++ L+ D KR +
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT 290
Query: 293 AEKLMKHSFF 302
A + ++H +F
Sbjct: 291 ATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 56/292 (19%)
Query: 24 LDPSSYKILDEIGVGVSAIV----YKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT 79
++PS + E+G G +V ++A VAIKAI+ + + E K
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRA------QIKVAIKAIN--EGAMSEEDFIEEAKV 52
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-------QSIISSCFPDGLPEPCIAI 132
M LSHP ++ + + L++V FM G L Q +S D L C
Sbjct: 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLS---KDMLLSMC--- 106
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192
++ + YL +HRD+ A N L S G VK++DFG++ + + + G+
Sbjct: 107 --QDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQ 251
W PEV + + YS K+D+WSFG+ E+ G+ P
Sbjct: 165 VK------WSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFE-------------- 203
Query: 252 RFRFSDYEKTLKIKDKNKKF-----SRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ S+YE I + + S +++ SC + P RP+ +L++
Sbjct: 204 --KKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLKETLSA 140
+ HP ++ H SF +L+ V+ +++ G L + CF EP E SA
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL----EPRARFYAAEIASA 108
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L YLH+ ++RD+K NIL DS G + L DFG+ E + + GTP
Sbjct: 109 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-------NGTTSTFCGTPE 161
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
++APEV+ Y D W G E+ +G PP + T + K
Sbjct: 162 YLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPP---------FYSRNTAEMYDNILNK 211
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE----KLMKHSFFKNCN 306
L++K + + + ++ L +D +KR A+ ++ H FF N
Sbjct: 212 PLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 26/231 (11%)
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLS 139
L P I+ SF DS L++V +MS G L + +G E + E +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVL 107
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
AL +LH ++RD+K NIL D+ G + L DFG+S + + + GT
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-------NLTDNKTTNTFCGTT 160
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
++APEV+ GY+ D WS G+ E+ G P Q +R +
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--------YAEDTQQMYRNIAFG 212
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKR----PSAEKLMKHSFFKNCN 306
K K+ R F V L+++P R A +L +H FF + +
Sbjct: 213 KVRFPKNVLSDEGRQF---VKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 30/246 (12%)
Query: 74 RRETKTMSL--------LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGL 125
+R+ + M+L ++ +++ ++ L +V+ M+ G L+ I + G
Sbjct: 40 KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF 99
Query: 126 PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185
E E L LH + ++RD+K NIL D G ++++D G++ I E
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE----- 154
Query: 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL 245
I GT +MAPEV+++ Y+F D W G E+ G+ P EK
Sbjct: 155 ---GETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQR-KEKVK 209
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHS 300
++ +R + D E+ ++KFS A + + L +DP R AE++ H
Sbjct: 210 REEVERRVK-EDQEEY------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262
Query: 301 FFKNCN 306
FF+ N
Sbjct: 263 FFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 41/269 (15%)
Query: 50 PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFM 108
P VA+K + D + DL + E + M ++ H NI+N + + D L+V++ +
Sbjct: 41 PNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 109 SCGSLQSIISSCFPDG---------LPEPCIAIVLKETLS-------ALSYLHNQGHLHR 152
S G+L+ + + P G LPE + K+ +S + YL +Q +HR
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEE--QLTFKDLVSCAYQVARGMEYLASQKCIHR 158
Query: 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHT 211
D+ A N+L D +K+ADFG++ ++ ++ T P WMAPE +
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK------TTNGRLPVKWMAPEALFDRV 212
Query: 212 GYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSL-LMKMTQRFRFSDYEKTLKIKDKNK 269
Y+ ++D+WSFG+ E+ G P +P E+ L+K R DK
Sbjct: 213 -YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM------------DKPA 259
Query: 270 KFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ ++ C PS+RP+ ++L++
Sbjct: 260 NCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 36/281 (12%)
Query: 34 EIGVGVSAIVYKAICIPMDSTV--VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNA 91
E+G G V K + + VA+K + + RE M+ L HP I+
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV-LKETLSALS----YLHN 146
L +VM G L + I + LKE ++ YL +
Sbjct: 62 -IGVCKGEPLMLVMELAPLGPLLKYL-------KKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPE 205
+ +HRD+ A N+L + K++DFG+S ++ S ++ +A P W APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA-----GRWPLKWYAPE 168
Query: 206 VIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264
I +S K+D+WS+G+T E ++G P MK + + + L
Sbjct: 169 CINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGE--------MKGAEVIAMLESGERL-- 217
Query: 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305
+ ++ + ++ SC P RP+ +L S F+
Sbjct: 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSEL--ESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 55/199 (27%), Positives = 75/199 (37%), Gaps = 30/199 (15%)
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
SL I+ L E I V + L AL LH Q K+GNIL DG +KL
Sbjct: 1 VSLADILE-VRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL- 52
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA 230
G S + P PY+MAPEVI Y+ KADI+S GIT E
Sbjct: 53 -DG-SVAFKTPEQSR-----------PDPYFMAPEVI-QGQSYTEKADIYSLGITLYEAL 98
Query: 231 HGRPPLSH---LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDP 287
P + L +L+ D + +R+F+D + C + P
Sbjct: 99 DYELPYNEERELSAILEILLNGMPADDPRDRSNLEGVSA-----ARSFEDFMRLCASRLP 153
Query: 288 SKRPSAEKLMKHSFFKNCN 306
+R +A + H
Sbjct: 154 QRREAANHYLAHCRALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 52/155 (33%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIIS--SCFPDGLPEPCIAIVLKETLSA 140
+ HP ++ H SF +L+ V+ +++ G L + FP EP E SA
Sbjct: 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASA 108
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L YLH+ ++RD+K NIL DS G V L DFG+ E S + GTP
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-------SKTTSTFCGTPE 161
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP 235
++APEV+R Y D W G E+ +G PP
Sbjct: 162 YLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 40/247 (16%)
Query: 69 DLDSIRRETKTMSLLSHPNILNA-HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPE 127
D++ E + ++L P L H F RL+ VM +++ G L I E
Sbjct: 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKE 100
Query: 128 PCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV-SASIYEPSHHHH 186
P E L +LH++G ++RD+K N++ DS+G +K+ADFG+ ++++
Sbjct: 101 PHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------ 154
Query: 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL 246
GTP ++APE+I + Y D W+FG+ E+ G+ P
Sbjct: 155 --GVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAP----------- 200
Query: 247 MKMTQRFRFSDYEKTLK-IKDKNKKFSRAF-KDMVASC---LDQDPSKR----PSAEKLM 297
F D ++ + I + N + ++ K+ VA C + + P KR P E+ +
Sbjct: 201 ------FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 254
Query: 298 K-HSFFK 303
K H+FF+
Sbjct: 255 KEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 71/261 (27%), Positives = 121/261 (46%), Gaps = 26/261 (9%)
Query: 55 VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL- 113
+VA+K + D ++T + +E K MS L +PNI+ D L ++ +M G L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 114 ----QSIISSCFPDGLPEPCIAI-----VLKETLSALSYLHNQGHLHRDVKAGNILSDSD 164
Q I S F P ++I + + S + YL + +HRD+ N L +
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFG 223
++K+ADFG+S ++Y ++ G A++ P WMA E I ++ +D+W+FG
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVL------PIRWMAWESILLGK-FTTASDVWAFG 218
Query: 224 ITALELAH--GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVAS 281
+T E+ P S L E+ +++ T F F + + + + S FK M+
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQ--VIENTGEF-FRNQGRQIYLSQTPLCPSPVFKLMM-R 274
Query: 282 CLDQDPSKRPSAEKLMKHSFF 302
C +D RP+ K+ H F
Sbjct: 275 CWSRDIKDRPTFNKI--HHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 69/271 (25%), Positives = 113/271 (41%), Gaps = 37/271 (13%)
Query: 53 STVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110
+ A+K I SR+++ E ++ ++ P I+ SF +L++V+ F++
Sbjct: 18 QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77
Query: 111 GSLQSIIS--SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVK 168
G L + F A E L AL LH ++RD+K NIL D G +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENILLDYQGHIA 133
Query: 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE 228
L DFG+ + GTP ++APE++ H GY+ D W+ G+ E
Sbjct: 134 LCDFGLCKL-------NMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYE 185
Query: 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPS 288
+ G PP + + + RF D F R KD++ L +DP+
Sbjct: 186 MLTGLPPFYDENVNEMYRKILQEPLRFPD------------GFDRDAKDLLIGLLSRDPT 233
Query: 289 KR---PSAEKLMKHSFF------KNCNKGVE 310
+R A+++ H FF K KG++
Sbjct: 234 RRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQ 264
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 59/282 (20%)
Query: 66 SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII--SSCFPD 123
+R + ++ E ++ + ++ + SF L+ VM ++ G + S++ FP+
Sbjct: 41 NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE 100
Query: 124 GLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV--------S 175
L IA E A+ +H G +HRD+K NIL D DG +KL DFG+ +
Sbjct: 101 VLARFYIA----ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156
Query: 176 ASIYEPSHH--------------------------------HHHGSAMITDMAGTPYWMA 203
+ Y+ H H + + GTP ++A
Sbjct: 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPP-LSHLPPEKSLLMKMTQRFRFSDYEKTL 262
PEV+ GY+ D WS G+ E+ G+PP L+ P E L + ++E TL
Sbjct: 217 PEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL--------KVINWENTL 267
Query: 263 KIKDKNKKFSRAFKDMVAS--CLDQDPSKRPSAEKLMKHSFF 302
I + K S D++ C ++ R A+ + H FF
Sbjct: 268 HIPPQ-VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 40/263 (15%)
Query: 52 DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS--HPNILNAHCSFSV-DSR-------L 101
D A+K +D+ + ++ D R + + LL+ +I+ H F+ D R +
Sbjct: 56 DGEPFAVKVVDM-EGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114
Query: 102 WVVMPFMSCGSLQSIISSCFPDGLP--EPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159
+V+ + + G L+ I S E ++ + L A+ ++H++ +HRD+K+ NI
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANI 174
Query: 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD-----MAGTPYWMAPEVIRSHTGYS 214
L S+G VKL DFG S +A ++D GTPY++APE+ R YS
Sbjct: 175 LLCSNGLVKLGDFGFS----------KMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YS 223
Query: 215 FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRA 274
KAD++S G+ EL + P E+ +M T R+ ++ S
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDGENMEE--VMHKTLAGRYDPLPPSI---------SPE 272
Query: 275 FKDMVASCLDQDPSKRPSAEKLM 297
+++V + L DP +RPS+ KL+
Sbjct: 273 MQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 44/265 (16%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGSL 113
VA+K++ + + +++E + + L H NI+ C+ + + ++M F+ GSL
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLS-------ALSYLHNQGHLHRDVKAGNILSDSDGS 166
+ LP I LK+ L + YL ++ ++HRD+ A N+L +S+
Sbjct: 96 KEY--------LPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 147
Query: 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITA 226
VK+ DFG++ +I ++ + D+ +W APE + + + +D+WSFG+T
Sbjct: 148 VKIGDFGLTKAIETDKEYY----TVKDDLDSPVFWYAPECL-IQSKFYIASDVWSFGVTL 202
Query: 227 LELAHGRPPLSHLPPEKSLL-------------MKMTQRFRFSDYEKTLKIKDKNKKFSR 273
EL L++ E S + M +T+ R + K L
Sbjct: 203 YEL------LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP---NCPE 253
Query: 274 AFKDMVASCLDQDPSKRPSAEKLMK 298
++ C + PSKR + + L++
Sbjct: 254 EVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
++N ++ L +V+ M+ G L+ I + G E E L L LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
++RD+K NIL D G ++++D G++ I E I GT +MAPEV+
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--------GESIRGRVGTVGYMAPEVL 173
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
+ Y+ D W G E+ G+ P ++ + + ++ + ++
Sbjct: 174 NNQR-YTLSPDYWGLGCLIYEMIEGQSPFR----------GRKEKVKREEVDRRVLETEE 222
Query: 268 --NKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
+ KFS K + L +DP +R A ++ +H FF+N N
Sbjct: 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 20/193 (10%)
Query: 56 VAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILN--AHCSFSVDSRLW----VVMPFM 108
VA+K + + +R++++ E M HPN++ C +V+S + V++PFM
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 109 SCGSLQSII-----SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS 163
G L S + C P LP + + + S + YL ++ +HRD+ A N + +
Sbjct: 89 KHGDLHSFLLYSRLGDC-PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147
Query: 164 DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFG 223
+ +V +ADFG+S IY ++ I M W+A E + Y+ K+D+WSFG
Sbjct: 148 NMNVCVADFGLSKKIYNGDYYRQ---GRIAKMPVK--WIAIESLADRV-YTTKSDVWSFG 201
Query: 224 ITALELA-HGRPP 235
+T E+A G+ P
Sbjct: 202 VTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 31/241 (12%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTV----VAIKAIDLDQSRTDLDSIRRETKTMS 81
S +L +G G VY+ + D VA+K + S D E MS
Sbjct: 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64
Query: 82 LLSHPNILNAHC---SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
+H NI+ SF R +++ M+ G L+S + P PE ++ +K+ L
Sbjct: 65 KFNHQNIV--RLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPR--PERPSSLTMKDLL 119
Query: 139 -------SALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSASIYEPSHHHHHG 188
YL +HRD+ A N L G K+ADFG++ IY S++ G
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 189 SAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLL 246
AM+ P WM PE ++ K D+WSFG+ E+ + G P ++ +
Sbjct: 180 RAML------PIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
Query: 247 M 247
Sbjct: 233 F 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 80/324 (24%), Positives = 144/324 (44%), Gaps = 44/324 (13%)
Query: 4 HEQEDQCSSTGTIAQ-KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID 62
H+++D S+ + K++Y + + +G G V A D VAIK +
Sbjct: 10 HKKKDSDSTKEPKRKNKMKY----EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 63 LDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII--S 118
+ + +D + E K ++ ++HP +N + SF +S L++V+ F+ G + + +
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN 125
Query: 119 SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178
FP+ + + + YL + ++RD+K N+L D DG +K+ DFG + +
Sbjct: 126 KRFPNDVG----CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181
Query: 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH 238
++ + GTP ++APE++ + G+ AD W+ GI E+ G PP
Sbjct: 182 DTRTY----------TLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYA 230
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF-SRAFKDMVASCLDQDPSKR-----PS 292
P LL+ Y+K L+ KF K ++ L D +KR
Sbjct: 231 NEP---LLI----------YQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKG 277
Query: 293 AEKLMKHSFFKNCNKGVEFFVKNV 316
A+ + +H +F N + V KNV
Sbjct: 278 AQNVKEHPWFGNID-WVSLLHKNV 300
|
Length = 340 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 70/240 (29%), Positives = 105/240 (43%), Gaps = 23/240 (9%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTM 80
L + + L +G GV V+K I IP ++ VAIK I R I M
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII----SSCFPDGLPEPCIAIVLKE 136
L H I+ + L +V GSL + S P L C+ I
Sbjct: 64 GSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA--- 119
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
+ YL +HR++ A NIL SD V++ADFGV+ +Y P + S T +
Sbjct: 120 --KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIK 176
Query: 197 GTPYWMAPEVIRSHTG-YSFKADIWSFGITALEL-AHGRPPLSHL-PPEKSLLMKMTQRF 253
WMA E I G Y+ ++D+WS+G+T E+ ++G P + + P E L++ +R
Sbjct: 177 ----WMALESI--LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL 230
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 22/245 (8%)
Query: 53 STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
+T VAIK L ++ +E + M L H ++ + S + +++V +MS GS
Sbjct: 30 TTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L + L P + + + S ++Y+ ++HRD++A NIL + K+ADF
Sbjct: 87 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 146
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA-H 231
G++ I + + G+ W APE + ++ K+D+WSFGI EL
Sbjct: 147 GLARLIEDNEYTARQGAKFPIK------WTAPEAAL-YGRFTIKSDVWSFGILLTELTTK 199
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
GR P M R E+ ++ + + D++ C ++P +RP
Sbjct: 200 GRVPYP----------GMVNREVLDQVERGYRMPCPP-ECPESLHDLMCQCWRKEPEERP 248
Query: 292 SAEKL 296
+ E L
Sbjct: 249 TFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 34 EIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL 89
E+G G V+ A C + D +VA+KA+ D +RE + +++L H +I+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTVLQHQHIV 70
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD------GLPEPCIAIVLKETL----- 138
+ + L +V +M G L + S PD G + L + L
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 139 --SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
S + YL + +HRD+ N L VK+ DFG+S IY ++ G M+
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML---- 186
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHL 239
WM PE I + ++ ++DIWSFG+ E+ +G+ P L
Sbjct: 187 -PIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 81/302 (26%), Positives = 130/302 (43%), Gaps = 44/302 (14%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIR--RETKTMS 81
+ Y L +G+G +V C D VAIK I + T + + R RE K +
Sbjct: 10 NRYVDLQPVGMGAFGLV----CSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLK 64
Query: 82 LLSHPNILNAHCSF-SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
L H NI++ F S ++ V + L +++S L + I L + L
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTS---RPLEKQFIQYFLYQILRG 120
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L Y+H+ G +HRD+K NIL + + +K+ DFG+ A I +P +T T Y
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQ---------MTGYVSTRY 170
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRP---------------PLSHLPPEK-- 243
+ APE++ + Y + DIWS G E+ G+P L PP+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 244 -SLLMKMTQRFRFS-DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
++ + T RF S + + +K K + D++ L DP KR SA + + H +
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
Query: 302 FK 303
Sbjct: 291 LA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 57/282 (20%)
Query: 67 RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII--SSCFPDG 124
R + ++ E ++ + ++ + SF L+ VM ++ G + S++ FP+
Sbjct: 42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED 101
Query: 125 LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV--------SA 176
L IA E A+ +H G +HRD+K NIL D DG +KL DFG+ +
Sbjct: 102 LARFYIA----ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 177 SIYEPSHH--------------------------------HHHGSAMITDMAGTPYWMAP 204
Y+ H H + + GTP ++AP
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPP-LSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
EV+ TGY+ D WS G+ E+ G+PP L+ P E MK+ ++ +L
Sbjct: 218 EVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ--MKVIN------WQTSLH 268
Query: 264 IKDKNKKFSRAFKDMVASCLD-QDPSKRPSAEKLMKHSFFKN 304
I + K A ++ C +D + A+++ H FFK
Sbjct: 269 IPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
++ L +V+ M+ G L+ I G E E L LH + ++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGY 213
+K NIL D G ++++D G++ + E I GT +MAPEV+++ Y
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPE--------GQTIKGRVGTVGYMAPEVVKNER-Y 178
Query: 214 SFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK--IKDKNKKF 271
+F D W+ G E+ G+ P + ++ + + E+ +K ++ ++KF
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQ----------QRKKKIKREEVERLVKEVQEEYSEKF 228
Query: 272 SRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
S + + L +DP +R A ++ +H FK N
Sbjct: 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 28/233 (12%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E + + HP + SF RL VM + + G L +S E
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGA 102
Query: 136 ETLSALSYLHNQGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
E +SAL YLH++ ++ +RD+K N++ D DG +K+ DFG+ + G+ M T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK------DGATMKT- 155
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
GTP ++APEV+ + Y D W G+ E+ GR P + EK + + + R
Sbjct: 156 FCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFF 302
F + S K +++ L +DP +R A+++M+H FF
Sbjct: 215 FP------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN-AHCSFSVDSRLWVVMPFMSCGSLQ 114
V +K + S + + +E+ + LSH NIL H +V+ P+M+ G+L+
Sbjct: 38 VFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK 97
Query: 115 SIISSCFPDGLPEPCIAIVLKETL-------SALSYLHNQGHLHRDVKAGNILSDSDGSV 167
+ C G A+ ++ + +SYLH +G +H+D+ A N + D + V
Sbjct: 98 LFLQQC-RLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV 156
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITA 226
K+ D +S ++ P +H G D P WMA E + + YS +D+WSFG+
Sbjct: 157 KITDNALSRDLF-PMDYHCLG-----DNENRPVKWMALESL-VNKEYSSASDVWSFGVLL 209
Query: 227 LELA 230
EL
Sbjct: 210 WELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
SF L+++M F+ G + +++ D L E + ET+ A+ +H G +HRD
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 154 VKAGNILSDSDGSVKLADFGVSASI--------YEPSHHHHHGSAMITDM---------- 195
+K N+L DS G VKL+DFG+ + Y +H +M
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 196 ----------AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL 245
GTP ++APEV TGY+ D WS G+ E+ G PP P+++
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
M + + + I +K K F C + P E++ + FF+
Sbjct: 246 KKVMNWKETLI-FPPEVPISEKAKDLILRF-----CCEWEHRIGAPGVEEIKTNPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 31 ILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
+L E+G G +VY+ + T VA+K ++ S + E M +
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD-----GLPEPCIAIVLK---ETL 138
+++ S VVM M+ G L+S + S P+ G P P + +++ E
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
++YL+ + +HRD+ A N + D +VK+ DFG++ IYE ++ G ++
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-----P 184
Query: 199 PYWMAPEVIR--SHTGYSFKADIWSFGITALELA 230
WMAPE ++ T S D+WSFG+ E+
Sbjct: 185 VRWMAPESLKDGVFTTSS---DMWSFGVVLWEIT 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 66/244 (27%), Positives = 103/244 (42%), Gaps = 29/244 (11%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-SRLWVVMPFMSCGSLQ 114
VA+K I D + + E M+ L H N++ + L++V +M+ GSL
Sbjct: 32 VAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174
+ S L C+ + A+ YL +HRD+ A N+L D K++DFG+
Sbjct: 89 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148
Query: 175 SASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHG 232
+ ++ D P W APE +R +S K+D+WSFGI E+ + G
Sbjct: 149 TKE-----------ASSTQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFG 196
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
R P +P L + R EK K+ D D++ C D + RPS
Sbjct: 197 RVPYPRIP-----LKDVVPRV-----EKGYKM-DAPDGCPPVVYDVMKQCWHLDAATRPS 245
Query: 293 AEKL 296
+L
Sbjct: 246 FLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 29/243 (11%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQS 115
VA+K I D + + ET M+ L H N++ + + L++VM MS G+L +
Sbjct: 32 VAVKNIKCDVTA---QAFLEETAVMTKLHHKNLVRL-LGVILHNGLYIVMELMSKGNLVN 87
Query: 116 IISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
+ + + + + + YL ++ +HRD+ A NIL DG K++DFG++
Sbjct: 88 FLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA 147
Query: 176 ASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGR 233
+M D + P W APE ++ H +S K+D+WS+G+ E+ ++GR
Sbjct: 148 RV-----------GSMGVDNSKLPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGR 195
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293
P KM+ + EK +++ + + M SC + +P KRPS
Sbjct: 196 APYP----------KMSLKEVKECVEKGYRMEPPEGCPADVYVLM-TSCWETEPKKRPSF 244
Query: 294 EKL 296
KL
Sbjct: 245 HKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 65/268 (24%), Positives = 116/268 (43%), Gaps = 46/268 (17%)
Query: 73 IRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI 132
+R E ++ +P ++ + SF ++ L+++M ++ G + +++ D E
Sbjct: 48 VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRF 105
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV--------SASIYEPSHH 184
+ ET+ A+ +H G++HRD+K N+L D+ G +KL+DFG+ Y H
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 185 HHHGSAMITD-------------------MA----GTPYWMAPEVIRSHTGYSFKADIWS 221
+ + +A GTP ++APEV TGY+ + D WS
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWS 224
Query: 222 FGITALELAHGRPP-LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVA 280
G+ E+ G PP S P E T R + ++++TL+ D S KD++
Sbjct: 225 LGVIMYEMLVGYPPFCSDNPQE-------TYR-KIINWKETLQFPD-EVPLSPEAKDLIK 275
Query: 281 S--CLDQDPSKRPSAEKLMKHSFFKNCN 306
C + ++ H FFK +
Sbjct: 276 RLCCEAERRLGNNGVNEIKSHPFFKGVD 303
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 29/264 (10%)
Query: 45 KAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104
K I T+V +KA+ + RRE LSH N++ +++
Sbjct: 27 KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86
Query: 105 MPFMSCGSLQS---IISSCFPDGLPEP-----CIAIVLKETLSALSYLHNQGHLHRDVKA 156
+ + G L+ S P P +A+ + L + +L N +HRD+ A
Sbjct: 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL-GMDHLSNARFVHRDLAA 145
Query: 157 GNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSF 215
N L S VK++ +S +Y S ++ +A+I P W+APE ++ +S
Sbjct: 146 RNCLVSSQREVKVSLLSLSKDVYN-SEYYKLRNALI------PLRWLAPEAVQEDD-FST 197
Query: 216 KADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRA 274
K+D+WSFG+ E+ G P L E ++ R + L++ SR
Sbjct: 198 KSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQ----AGKLELPVPEGCPSRL 248
Query: 275 FKDMVASCLDQDPSKRPSAEKLMK 298
+K M C +P RPS +L+
Sbjct: 249 YKLM-TRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 60/242 (24%), Positives = 103/242 (42%), Gaps = 39/242 (16%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
SF L+++M F+ G + +++ D L E + ET+ A+ +H G +HRD
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 154 VKAGNILSDSDGSVKLADFGVSASI--------YEPSHHHHHGSAMITDM---------- 195
+K N+L D+ G VKL+DFG+ + Y H+ +M
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 196 ----------AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL 245
GTP ++APEV TGY+ D WS G+ E+ G PP P+++
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLD-QDPSKRPSAEKLMKHSFFKN 304
M ++++TL + +A ++ C D ++ E++ H FF+
Sbjct: 246 RKVM-------NWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEG 298
Query: 305 CN 306
+
Sbjct: 299 VD 300
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 35/236 (14%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQS 115
VAIK + + ++ D + RE + M L +P I+ ++ L +VM S G L
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNK 83
Query: 116 IISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
+S D + + ++ + + YL + +HRD+ A N+L + K++DFG+S
Sbjct: 84 FLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLS 142
Query: 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRP 234
++ ++ SA + W APE I +S ++D+WS+GIT E ++G+
Sbjct: 143 KALGADDSYYKARSAGKWPLK----WYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQK 197
Query: 235 PLSHL---------------------PPEKSLLM------KMTQRFRFSDYEKTLK 263
P + PPE LM K R F+ E+ ++
Sbjct: 198 PYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 71/310 (22%), Positives = 126/310 (40%), Gaps = 43/310 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
S Y L +G G + +V+ A+ D V A+K I L ++ + RE K + L H
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRV-AVKKIVLTDPQS-VKHALREIKIIRRLDHD 62
Query: 87 NILNA-HCSFSVDSRL-------------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAI 132
NI+ S L ++V +M L +++ L E +
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ---GPLSEEHARL 118
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV-KLADFGVSASIYEPSHHHHHGSAM 191
+ + L L Y+H+ LHRD+K N+ +++ V K+ DFG+ A I +P H+ H G
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL-ARIVDP-HYSHKG--Y 174
Query: 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP----------------- 234
+++ T ++ +P ++ S Y+ D+W+ G E+ G+P
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 235 -PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293
P+ LL + R E ++D + D + L +P R +A
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
Query: 294 EKLMKHSFFK 303
E+ + H +
Sbjct: 295 EEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 64/284 (22%), Positives = 127/284 (44%), Gaps = 37/284 (13%)
Query: 34 EIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL 89
E+G G V+ A C + D +VA+KA+ D + +RE + ++ L H +I+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIV 70
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGL----PEPCIAI----------VLK 135
+ L +V +M G L + + PD + +P A +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ S + YL +Q +HRD+ N L ++ VK+ DFG+S +Y ++ G M+
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML--- 187
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFR 254
WM PE I + ++ ++D+WSFG+ E+ +G+ P L + +++ + R
Sbjct: 188 --PIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIECITQGR 242
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ ++ + + D++ C ++P +R + +++ K
Sbjct: 243 ---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 52/188 (27%), Positives = 92/188 (48%), Gaps = 21/188 (11%)
Query: 54 TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
T VAIK+ L Q ++ E M L HP ++ + + + ++++ +M GSL
Sbjct: 31 TKVAIKS--LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSL 87
Query: 114 QSIISSCFPDG--LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
+ + P+G L + + + ++++ + ++HRD++A NIL K+AD
Sbjct: 88 VDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIAD 145
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPY---WMAPEVIRSHTGYSFKADIWSFGITALE 228
FG+ A + E + + T G + W APE I T ++ K+D+WSFGI E
Sbjct: 146 FGL-ARLIEDNEY--------TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTE 195
Query: 229 L-AHGRPP 235
+ +GR P
Sbjct: 196 IVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 39/268 (14%)
Query: 50 PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFM 108
P + VA+K + + + DL + E + M L+ H NI+N + + L+V++ +
Sbjct: 41 PDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 109 SCGSLQSIISSCFPDGLPE--PCIAIVLKETLS-------------ALSYLHNQGHLHRD 153
+ G+L+ + + P G P+ I V +E LS + YL ++ +HRD
Sbjct: 101 AKGNLREFLRARRPPG-PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159
Query: 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTG 212
+ A N+L D +K+ADFG++ +++ ++ T P WMAPE +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEALFDRV- 212
Query: 213 YSFKADIWSFGITALEL-AHGRPPLSHLPPEKSL-LMKMTQRFRFSDYEKTLKIKDKNKK 270
Y+ ++D+WSFGI E+ G P +P E+ L++ R DK
Sbjct: 213 YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM------------DKPSN 260
Query: 271 FSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ ++ C P++RP+ ++L++
Sbjct: 261 CTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/298 (22%), Positives = 131/298 (43%), Gaps = 33/298 (11%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDST-VVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
+ +++L +G G +V K C ++ +VAIK D +++ ++ RE K + L
Sbjct: 1 NKFEVLGVVGEGAYGVVLK--CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
NI+ +F +L++V ++ L+ + P+G+P + + + + A+ +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
H +HRD+K N+L + +KL DFG + ++ E S +A T+ T ++ +P
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS------NANYTEYVATRWYRSP 170
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRP----------------PLSHLPPEKSLLMK 248
E++ Y D+WS G EL+ G+P L LP E+ L
Sbjct: 171 ELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229
Query: 249 MTQRFRFSDYEKTLKIKDKNKKF----SRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
RF + + +++ S D++ + L +P+ R E+ + H F
Sbjct: 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 28/271 (10%)
Query: 34 EIGVGVSAIVY----KAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL 89
E+G G +VY K + T VAIK ++ S + E M + +++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD-----GLPEPCIAIVLK---ETLSAL 141
S V+M M+ G L+S + S P+ P + +++ E +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+YL+ +HRD+ A N + D +VK+ DFG++ IYE ++ G ++ W
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-----PVRW 187
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
M+PE ++ ++ +D+WSFG+ E+A L+ P + M Q RF
Sbjct: 188 MSPESLKDGV-FTTYSDVWSFGVVLWEIA----TLAEQPYQG---MSNEQVLRFVMEGGL 239
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
L DK +++ C +P RPS
Sbjct: 240 L---DKPDNCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 24 LDPSSYKILDEIGVG-VSAIVYKAICIPMDSTV-VAIKAIDLDQSRTDLDSIRRETKTMS 81
+D S KI IG G + + +P + VAIK + + E M
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV--LKETLS 139
HPNI++ + + +V +M GSL + + DG I +V L+ S
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK--HDG-QFTVIQLVGMLRGIAS 117
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+ YL + G++HRD+ A NIL +S+ K++DFG+S + + +A T P
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIP 172
Query: 200 Y-WMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPP 235
W APE I ++ ++ +D+WS+GI E +++G P
Sbjct: 173 IRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 56 VAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL-------WVVMPF 107
VA+K + D S +D++ RE M HPN++ S+ SR V++PF
Sbjct: 30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL-IGVSLRSRAKGRLPIPMVILPF 88
Query: 108 MSCGSLQSIISSCF----PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS 163
M G L + + P LP + + + S + YL ++ +HRD+ A N + +
Sbjct: 89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE 148
Query: 164 DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSF 222
+ +V +ADFG+S IY ++ G A + P W+A E + + Y+ +D+W+F
Sbjct: 149 NMTVCVADFGLSKKIYS-GDYYRQGCA-----SKLPVKWLALESLADNV-YTTHSDVWAF 201
Query: 223 GITALELA-HGRPP 235
G+T E+ G+ P
Sbjct: 202 GVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 36/299 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRET--KTMSLLS 84
Y+ + EIG G V+KA + VA+K + + L +IR + +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 85 HPNILNAH--CSFSV---DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
HPN++ C+ S +++L +V + L + + G+P I ++ + L
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L +LH+ +HRD+K NIL S G +KLADFG+ A IY +T + T
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYS-------FQMALTSVVVTL 173
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP---------------PLSHLPPEKS 244
++ APEV+ + Y+ D+WS G E+ +P + LP E+
Sbjct: 174 WYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 245 LLMKMT-QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ R F + I+ KD++ CL +P+KR SA + H +F
Sbjct: 233 WPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 60/253 (23%), Positives = 113/253 (44%), Gaps = 24/253 (9%)
Query: 53 STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
+T VAIK L ++ +E + M L H ++ + S + +++V FM GS
Sbjct: 30 TTKVAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L + L P + + + ++Y+ ++HRD++A NIL + K+ADF
Sbjct: 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADF 146
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AH 231
G++ I + + G+ W APE + ++ K+D+WSFGI EL
Sbjct: 147 GLARLIEDNEYTARQGAKFPIK------WTAPEAAL-YGRFTIKSDVWSFGILLTELVTK 199
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
GR P + + +L ++ + +R + + +++ C +DP +RP
Sbjct: 200 GRVPYPGM-VNREVLEQVERGYRMPCPQGC----------PESLHELMKLCWKKDPDERP 248
Query: 292 SAEKLMKHSFFKN 304
+ E + SF ++
Sbjct: 249 TFEYI--QSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 53/244 (21%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 54 TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
T VA+K + +++ E M L H ++ H + + ++++ FM+ GSL
Sbjct: 31 TKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSL 87
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
+ S P P + + ++++ + ++HRD++A NIL + K+ADFG
Sbjct: 88 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 147
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHG 232
++ I + + G+ W APE I + ++ K+D+WSFGI +E+ +G
Sbjct: 148 LARVIEDNEYTAREGAKFPIK------WTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYG 200
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
R P + ++ + + +R + + +++ C P +RP+
Sbjct: 201 RIPYPGM-SNPEVIRALERGYRMP----------RPENCPEELYNIMMRCWKNRPEERPT 249
Query: 293 AEKL 296
E +
Sbjct: 250 FEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 60/253 (23%), Positives = 113/253 (44%), Gaps = 24/253 (9%)
Query: 53 STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
+T VA+K L +S E + M L H ++ + S + +++V +MS GS
Sbjct: 30 NTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L + L P + + + + ++Y+ ++HRD+++ NIL K+ADF
Sbjct: 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADF 146
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AH 231
G++ I + + G+ W APE + ++ K+D+WSFGI EL
Sbjct: 147 GLARLIEDNEYTARQGAKFPIK------WTAPEAAL-YGRFTIKSDVWSFGILLTELVTK 199
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
GR P + + +L ++ + +R + + +++ C +DP +RP
Sbjct: 200 GRVPYPGM-NNREVLEQVERGYRMPCPQDC----------PISLHELMLQCWKKDPEERP 248
Query: 292 SAEKLMKHSFFKN 304
+ E L SF ++
Sbjct: 249 TFEYL--QSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 64/266 (24%), Positives = 116/266 (43%), Gaps = 22/266 (8%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
S K++ ++G G V+ +ST VA+K L + + E M L H
Sbjct: 7 SIKLVKKLGAGQFGEVWMGYY--NNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDK 62
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
++ + + + ++++ +M+ GSL + S + P + + ++Y+ +
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
++HRD++A N+L K+ADFG++ I + + G+ W APE I
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAI 176
Query: 208 RSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQR-FRFSDYE------ 259
+ ++ K+D+WSFGI E+ +G+ P + S +M QR +R E
Sbjct: 177 -NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQRGYRMPRMENCPDEL 233
Query: 260 -KTLKIKDKNKKFSRAFKDMVASCLD 284
+K K K R D + S LD
Sbjct: 234 YDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y+ L IG G IV A +D V K Q++T RE M ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 89 LNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
++ F+ L ++VM M Q I L ++ +L + L +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIK 133
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH+ G +HRD+K NI+ SD ++K+ DFG++ + S M+T T Y+
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--------GTSFMMTPYVVTRYYR 185
Query: 203 APEVIRSHTGYSFKADIWSFGITALEL 229
APEVI GY DIWS G E+
Sbjct: 186 APEVILG-MGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 51/308 (16%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLD-QSRTDLDSIRRETKTMS 81
P Y+ L +G G Y ++C D+ VA+K + QS RE + +
Sbjct: 16 PERYQNLSPVGSGA----YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 82 LLSHPNILNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ H N++ F+ L ++V M L +I+ L + + ++
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC---QKLTDDHVQFLIY 127
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ L L Y+H+ +HRD+K N+ + D +K+ DFG++ H +T
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTDDEMTGY 177
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR---PPLSHL-----------PP 241
T ++ APE++ + Y+ DIWS G EL GR P H+ P
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 242 EKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAF-------KDMVASCLDQDPSKRPSAE 294
LL K++ +Y ++L K F+ F D++ L D KR +A
Sbjct: 238 GAELLKKISSE-SARNYIQSLTQMPK-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295
Query: 295 KLMKHSFF 302
+ + H++F
Sbjct: 296 QALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
++ L +V+ M+ G L+ I + G E E L L + ++RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGY 213
+K NIL D G ++++D G++ I E + GT +MAPEVI + Y
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPE--------GETVRGRVGTVGYMAPEVINNEK-Y 178
Query: 214 SFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK--IKDKNKKF 271
+F D W G E+ G+ P K +R + + ++ +K ++ ++KF
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFR----------KRKERVKREEVDRRVKEDQEEYSEKF 228
Query: 272 SRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
S K + L ++P +R A + +H FKN N
Sbjct: 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 58/313 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLD-QSRTDLDSIRRETKTMSLLS 84
Y+ L IG G IV C D+ + VAIK + Q++T RE M ++
Sbjct: 26 YQNLKPIGSGAQGIV----CAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 85 HPNILNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H NI+ F+ L ++VM M Q I L ++ +L + L
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----LDHERMSYLLYQML 136
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ +LH+ G +HRD+K NI+ SD ++K+ DFG++ + S M+T T
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--------GTSFMMTPYVVT 188
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR---PPLSHLPPEKSLL--------- 246
Y+ APEVI GY DIWS G E+ G P H+ ++
Sbjct: 189 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247
Query: 247 -MKMTQ---------RFRFSDY--EKTL------KIKDKNKKFSRAFKDMVASCLDQDPS 288
MK Q R +++ Y EK + NK + +D+++ L D S
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 289 KRPSAEKLMKHSF 301
KR S ++ ++H +
Sbjct: 308 KRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 61/260 (23%), Positives = 115/260 (44%), Gaps = 23/260 (8%)
Query: 49 IPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108
+VA+K + D ++ + +E K MS L PNI+ L ++ +M
Sbjct: 42 SGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYM 101
Query: 109 SCGSLQSIISSCFPDGLPEPCIAIVLK---------ETLSALSYLHNQGHLHRDVKAGNI 159
G L +S P E + + + S + YL + +HRD+ N
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161
Query: 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKAD 218
L + ++K+ADFG+S ++Y ++ G A++ P WM+ E I ++ +D
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVL------PIRWMSWESILLGK-FTTASD 214
Query: 219 IWSFGITALELAH--GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK 276
+W+FG+T E+ P S L E+ +++ T F F D + + + K +
Sbjct: 215 VWAFGVTLWEILTLCKEQPYSQLSDEQ--VIENTGEF-FRDQGRQVYLP-KPALCPDSLY 270
Query: 277 DMVASCLDQDPSKRPSAEKL 296
++ SC ++ +RPS +++
Sbjct: 271 KLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKA-ICIP-MDSTVVAIKAID---LDQSRTDLDSIRRETK 78
+D S KI + IG G V + + +P VAIK + ++ R D S E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS---EAS 57
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV--LKE 136
M HPNI++ + + ++ FM G+L S + DG I +V L+
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTV-IQLVGMLRG 114
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
+ + YL ++HRD+ A NIL +S+ K++DFG+S + + + + S++ +
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI- 173
Query: 197 GTPY-WMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPP 235
P W APE I ++ ++ +D+WS+GI E +++G P
Sbjct: 174 --PIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 70/307 (22%), Positives = 124/307 (40%), Gaps = 62/307 (20%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRE 76
+YP + Y + +IG G V++A + T+VA+K + + S +RE
Sbjct: 1 EYPRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 58
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP-------------- 122
M+ HPNI+ +V + ++ +M+ G L + P
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 123 -DGLPEP--------CIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
GL CIA K+ + ++YL + +HRD+ N L + VK+ADFG
Sbjct: 119 KCGLNPLPLSCTEQLCIA---KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AH 231
+S +IY ++ + I P WM PE I + Y+ ++D+W++G+ E+ ++
Sbjct: 176 LSRNIYSADYYKASENDAI------PIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSY 228
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN-----KKFSRAFKDMVASCLDQD 286
G P + + E ++D N +++ C +
Sbjct: 229 GMQPY----------------YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKL 272
Query: 287 PSKRPSA 293
PS RPS
Sbjct: 273 PSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 79/311 (25%), Positives = 131/311 (42%), Gaps = 54/311 (17%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAI-DLDQSRTDLDSIRRETKTMS 81
+ Y + IG G IV C +S VAIK I + +R D RE K +
Sbjct: 4 DTKYVPIKPIGRGAYGIV----CSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR 59
Query: 82 LLSHPNIL--------NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
L H N++ +F+ +++V M L II S L +
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFN---DVYIVYELMDT-DLHQIIRS--SQTLSDDHCQYF 113
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L + L L Y+H+ LHRD+K N+L +++ +K+ DFG++ + E +T
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD-------FMT 166
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL----SHL---------- 239
+ T ++ APE++ + + Y+ D+WS G EL GR PL ++
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELL 225
Query: 240 --PPEKSLLMKMTQRFRFSDYEKTLKIKDK---NKKFSRAFK---DMVASCLDQDPSKRP 291
P E+ L ++ R Y ++L + + F A D++ L DPSKR
Sbjct: 226 GSPSEEDLGFIRNEKAR--RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283
Query: 292 SAEKLMKHSFF 302
+ E+ + H +
Sbjct: 284 TVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 60/244 (24%), Positives = 115/244 (47%), Gaps = 20/244 (8%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
VA+K + ++ +++ E K MS L +H NI+N + ++ + V+ + G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174
+ + L + + +++L ++ +HRD+ A N+L VK+ DFG+
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187
Query: 175 SASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHG 232
+ I S++ G+A + P WMAPE I + Y+F++D+WS+GI E+ + G
Sbjct: 188 ARDIMNDSNYVVKGNARL------PVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLG 240
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
P +P + + + +R + E D++ +C D DP KRP+
Sbjct: 241 SNPYPGMPVDSKFYKLIKEGYRMAQPEHA----------PAEIYDIMKTCWDADPLKRPT 290
Query: 293 AEKL 296
+++
Sbjct: 291 FKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 67/292 (22%)
Query: 67 RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLP 126
+ L ++ E ++ P +++ + SF L+++M F+ G L +++ D
Sbjct: 42 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFS 99
Query: 127 EPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186
E + E + A+ +H G +HRD+K NIL D G +KL+DFG+S H
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF-----HKQ 154
Query: 187 HGSA--------------------MITD---------------------MA----GTPYW 201
H SA + D MA GTP +
Sbjct: 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDY 214
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
+APE+ GY + D WS G E G PP + T R + ++ +T
Sbjct: 215 IAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHE------TYR-KIINWRET 266
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCNKGVEF 311
L D + S +D++ + ++ R A ++ H FF +GV++
Sbjct: 267 LYFPD-DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF----RGVDW 313
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 4e-13
Identities = 71/258 (27%), Positives = 111/258 (43%), Gaps = 48/258 (18%)
Query: 76 ETKTMSLLSHPNILNAHCSF--SVDSRLWVVMPFMSCGSLQSIISSCFP--DGLPEPCIA 131
E M L H NI+ F + +L+++M F G L I C+ + E I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 132 IVLKETLSALSYLHN-------QGHLHRDVKAGNIL---------------SDSDGS--V 167
+ ++ L AL+Y HN + LHRD+K NI ++ +G
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITA 226
K+ DFG+S +I S H GTPY+ +PE++ T Y K+D+W+ G
Sbjct: 182 KIGDFGLSKNIGIESMAH--------SCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 227 LELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
EL G+ P H S L+ +R L IK K+K+ + K++ L+
Sbjct: 234 YELCSGKTPF-HKANNFSQLISELKR------GPDLPIKGKSKELNILIKNL----LNLS 282
Query: 287 PSKRPSAEKLMKHSFFKN 304
+RPSA + + + KN
Sbjct: 283 AKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 23/222 (10%)
Query: 34 EIGVGVSAIVYKA----ICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL 89
E+G G V+ A +C D +VA+K + D S RE + ++ L H +I+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIV 70
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-----------LPEPCIAIVLKETL 138
+ L +V +M G L + + PD L + + + ++
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ + YL +Q +HRD+ N L + VK+ DFG+S +Y ++ G M+
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-----P 185
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHL 239
WM PE I + ++ ++D+WS G+ E+ +G+ P L
Sbjct: 186 IRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 25/195 (12%)
Query: 53 STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
+VA+K + D ++ + +E K +S L PNI+ + L ++ +M G
Sbjct: 46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 113 LQSIISS-------------CFPDG-LPEPCIAIVLK---ETLSALSYLHNQGHLHRDVK 155
L +SS P LP + +L + S + YL + +HRD+
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 156 AGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYS 214
N L + ++K+ADFG+S ++Y ++ G A++ P WMA E I ++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL------PIRWMAWECILMGK-FT 218
Query: 215 FKADIWSFGITALEL 229
+D+W+FG+T E+
Sbjct: 219 TASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLD-QSRTDLDSIRRETKTMSLLS 84
Y+ L IG G IV C D+ + VA+K + Q++T RE + ++
Sbjct: 23 YQQLKPIGSGAQGIV----CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78
Query: 85 HPNILNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H NI++ F+ L ++VM M Q I L ++ +L + L
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LDHERMSYLLYQML 133
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ +LH+ G +HRD+K NI+ SD ++K+ DFG++ + + M+T T
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--------NFMMTPYVVT 185
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
Y+ APEVI GY DIWS G EL G
Sbjct: 186 RYYRAPEVILG-MGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 76 ETKTMSLLSH---PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI 132
E +SL+S P I+ +F +L ++ M+ G L +S E +
Sbjct: 44 ERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRF 101
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192
E + L ++HN+ ++RD+K NIL D G V+++D G++ S H S
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHAS--- 155
Query: 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL-SHLPPEKSLLMKMTQ 251
GT +MAPEV++ T Y AD +S G +L G P H +K + +MT
Sbjct: 156 ---VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFK 303
+++ D FS K ++ L +D SKR A+++ +H FFK
Sbjct: 213 TV-------NVELPD---SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 27 SSYKILDEIGVGVSAIVYKAICI---PMDS-TVVAIKAIDLDQSRTDLDSIRRETKTMSL 82
S+ + L+E+G G VYK S T VAIK + + R+E + MS
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSD 64
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEP 128
L HPNI+ + + ++ +++ G L + P L
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 129 CIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188
+ + + + YL + +HRD+ A N L +VK++DFG+S IY ++
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 189 SAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL 229
+++ P WM PE I ++ ++DIWSFG+ E+
Sbjct: 185 KSLL------PVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 34/176 (19%)
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNIL----SDSDGS---VKLADFGVSASIYEPSHH 184
V ++ SALSYL ++ +H +V A NIL ++G+ +KL+D GVS +
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPL-SHLPPE 242
+ P W+APE + S AD WSFG T LE+ G PL P E
Sbjct: 181 ----------VERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
K +RF YEK ++ + + K +++ CL +P++RPS +++
Sbjct: 230 K-------ERF----YEKKHRLPEPSCK---ELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 75 RETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
RE + +SH I+N ++ S + +VMP C L + + P LP +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGP--LPLEQAITIQ 191
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS----ASIYEPSHHHHHGSA 190
+ L AL+YLH +G +HRDVK NI D + L DFG + A P +
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY------ 245
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236
+GT +PE++ Y K DIWS G+ E++ L
Sbjct: 246 ---GWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 29/165 (17%)
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+S+L ++ +HRD+ A NIL K+ DFG++ I S++ G+A + P
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL------PV 280
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
WMAPE I + Y+F++D+WS+GI E+ + G P +P + S KM
Sbjct: 281 KWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKM--------- 329
Query: 259 EKTLKIKDKNKKFSRAFK-----DMVASCLDQDPSKRPSAEKLMK 298
IK+ + S D++ SC D DP KRP+ +++++
Sbjct: 330 -----IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 33 DEIGVGVSAIVYKA-ICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN- 90
DEIG G V M V +K + + + +E + L+HPN+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 91 -AHCSFSVDSRLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLK-ETLSALSYLHN 146
C S+ +V+ F G L++ + S + + + + E S L +LH
Sbjct: 61 LGQCIESIP--YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPE 205
+H D+ N +D SVK+ D+G++ Y ++ + D P W+APE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY------ITKDCHAVPLRWLAPE 172
Query: 206 VIRS---------HTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255
++ T S +IWS G+T EL P L E+ L K R
Sbjct: 173 LVEIRGQDLLPKDQTKKS---NIWSLGVTMWELFTAADQPYPDLSDEQVL--KQVVR--- 224
Query: 256 SDYEKTLKIKDKN--KKFSRAFKDMVASCLDQDPSKRPSAEKL 296
E+ +K+ K+S + +++ C DP RP+AE++
Sbjct: 225 ---EQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 23/163 (14%)
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ +L ++ +HRD+ A NIL + VK+ DFG++ IY+ + G A + P
Sbjct: 192 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL------PL 245
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALE---LAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
WMAPE I Y+ ++D+WSFG+ E L P + E +K R R
Sbjct: 246 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
DY ++ M+ C +PS+RP+ +L++H
Sbjct: 305 DYTT-----------PEMYQTML-DCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 23/197 (11%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCS 94
IG G VYK + +T VA+K +E + + HPNI+
Sbjct: 3 IGKGNFGDVYKGVL--KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-IG 59
Query: 95 FSVDSR-LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
V + +++VM + GSL + + + L + + + + + YL ++ +HRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 154 VKAGNILSDSDGSVKLADFGVS----ASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIR 208
+ A N L + +K++DFG+S IY S + P W APE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVS----------DGLKQIPIKWTAPEALN 168
Query: 209 SHTG-YSFKADIWSFGI 224
G Y+ ++D+WS+GI
Sbjct: 169 --YGRYTSESDVWSYGI 183
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 25/175 (14%)
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
E + L ++HN+ ++RD+K NIL D G V+++D G++ S H S
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHAS------ 155
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL-SHLPPEKSLLMKMTQRFR 254
GT +MAPEV++ Y AD +S G +L G P H +K + +MT
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--- 212
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKN 304
T+ ++ + FS + ++ L +D ++R A+++ +H FF++
Sbjct: 213 ------TMAVELPD-SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 62/256 (24%), Positives = 95/256 (37%), Gaps = 47/256 (18%)
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
++HP+++ + + +V+P S + P LP I+ K+ L L
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP--LPIDQALIIEKQILEGLR 171
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA-SIYEPSHHHHHGSAMITDMAGTPYW 201
YLH Q +HRDVK NI + V + D G + + P +AGT
Sbjct: 172 YLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---------AFLGLAGTVET 222
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
APEV+ + Y+ KADIWS GI E+ + PP + T
Sbjct: 223 NAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281
Query: 262 LKI------KDKNKKFSRAFKDMVASCLDQ---------------------------DPS 288
LK+ +D + R F + AS Q D +
Sbjct: 282 LKVHPEEFPRDPGSRLVRGFIEY-ASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340
Query: 289 KRPSAEKLMKHSFFKN 304
RPSAE+++ + F
Sbjct: 341 MRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 55/240 (22%), Positives = 90/240 (37%), Gaps = 35/240 (14%)
Query: 62 DLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF 121
L D + MS LSH +++ + V +V ++ G L +
Sbjct: 37 VLGSDHRDSLAFFETASLMSQLSHKHLVKLY-GVCVRDENIMVEEYVKFGPLDVFLHR-E 94
Query: 122 PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS-------VKLADFGV 174
+ + V K+ SAL YL ++ +H +V NIL G +KL+D G+
Sbjct: 95 KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154
Query: 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGY-SFKADIWSFGITALELAHGR 233
++ + P W+APE IR+ + AD WSFG T LE+
Sbjct: 155 PITVLSREER----------VERIP-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203
Query: 234 P-PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
PLS L + + ++ + +++ C DP+KRPS
Sbjct: 204 EEPLSTLSSS-----EKERFYQDQHRLPMPDCAE--------LANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 51/184 (27%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 52 DST--VVAIKAIDLDQSRTD-LDSIRRETKTMSLLSHPNILNAH-CSFSVDSR-LWVVMP 106
D+T VVA+K L S + L RE + + L H NI+ +S R L +VM
Sbjct: 30 DNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87
Query: 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166
++ GSL+ + + L + + + + YL ++ ++HRD+ NIL +S+
Sbjct: 88 YLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR 146
Query: 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTP-YWMAPEVIRSHTGYSFKADIWSFGIT 225
VK+ DFG++ + + ++ + + +P +W APE + + + +S +D+WSFG+
Sbjct: 147 VKIGDFGLTKVLPQDKEYY-----KVREPGESPIFWYAPESL-TESKFSVASDVWSFGVV 200
Query: 226 ALEL 229
EL
Sbjct: 201 LYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 63/281 (22%)
Query: 75 RETKTMSLLSHPNILNAHCSF--SVDSRLWVVMPFMSCGSLQSII-------SSCFPDGL 125
RE + L HPN+++ F D ++W++ + L II ++ P L
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQL 105
Query: 126 PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD----GSVKLADFGVSASIYEP 181
P + +L + L + YLH LHRD+K NIL + G VK+AD G + P
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------- 234
A + + T ++ APE++ Y+ DIW+ G EL P
Sbjct: 166 L----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
Query: 235 ------PLSH-----------LP-----------PEKSLLMKMTQRFRFSD-----YEKT 261
P H P PE S LMK +R +++ Y +
Sbjct: 222 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 281
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
K+K +K F ++ L DP KR ++E+ M+ +F
Sbjct: 282 HKVKPDSKAFH-----LLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 32/250 (12%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQS 115
VA+K + + + +E MS +HPNI+ ++ +++M M G L S
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88
Query: 116 IISSCFPDGLPEPCIAIVLKETLS-------ALSYLHNQGHLHRDVKAGNIL-SDSDGS- 166
+ + P + LKE L YL +HRD+ A N L S+
Sbjct: 89 YLRDARVERFGPPLLT--LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDA 146
Query: 167 ---VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFG 223
VK+ DFG++ IY+ ++ G ++ WMAPE + ++ ++D+WSFG
Sbjct: 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLL-----PVRWMAPESLLDGK-FTTQSDVWSFG 200
Query: 224 ITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASC 282
+ E L G+ P L + +L +T R +K DK ++ +C
Sbjct: 201 VLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL---QKPENCPDK-------IYQLMTNC 249
Query: 283 LDQDPSKRPS 292
QDPS+RP+
Sbjct: 250 WAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 23/197 (11%)
Query: 51 MDSTVVAIKAIDLDQSRTD--LDSIRRETKTMSLLSHPNIL----NAHCSFSVDSRLWVV 104
M VAIK + D + RRET + L HPNI+ + L+ V
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP---PGLLFAV 57
Query: 105 MPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI-LSD 162
++ +L+ ++++ DG LP ++ + L AL+ HNQG +HRD+K NI +S
Sbjct: 58 FEYVPGRTLREVLAA---DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 163 SDGS--VKLADFGVSASIYEPSHHHHHGSAMIT---DMAGTPYWMAPEVIRSHTGYSFKA 217
+ K+ DFG+ + A +T ++ GTP + APE +R + +
Sbjct: 115 TGVRPHAKVLDFGIGTLL---PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNS 170
Query: 218 DIWSFGITALELAHGRP 234
D++++G+ LE G+
Sbjct: 171 DLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTM 80
L + +K + +G G VYK + IP V VAIK + S I E M
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 81 SLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSL-------QSIISSCFPDGLPEPCIA 131
+ + +P++ L C S + +MPF G L + I S + L C+
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPF---GCLLDYVREHKDNIGSQY---LLNWCVQ 117
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY--EPSHHHHHGS 189
I ++YL + +HRD+ A N+L + VK+ DFG++ + E +H G
Sbjct: 118 IA-----KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLP 240
I WMA E I H Y+ ++D+WS+G+T EL G P +P
Sbjct: 173 VPIK-------WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 79/310 (25%), Positives = 128/310 (41%), Gaps = 57/310 (18%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
SYK+ + IG G +VY+AICI S VAIK + D + RE M L+H N
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDT-SEKVAIKKVLQDPQYKN-----RELLIMKNLNHIN 120
Query: 88 ILNAHCSFSVDSR--------LWVVMPFMSCGSLQSIIS-----SCFPDGLPEPCIAIVL 134
I+ + + L VVM F+ Q++ + LP + +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIP----QTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYEPSHHHHHGSAMIT 193
+ AL+Y+H++ HRD+K N+L D + ++KL DFG + ++
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--------AGQRSV 228
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP------------- 240
+ ++ APE++ T Y+ D+WS G E+ G P S
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288
Query: 241 -PEKSLLMKMTQRF---RFSDYEKTLKIKDKNKKFSRAFKD----MVASCLDQDPSKRPS 292
P + L +M + +F D +K KD K F + D ++ L +P KR +
Sbjct: 289 TPTEDQLKEMNPNYADIKFPD----VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344
Query: 293 AEKLMKHSFF 302
+ + FF
Sbjct: 345 PIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 13/217 (5%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAIC-IPMDSTV-VAIKAIDLDQSRTDLDSIRRETKTMS 81
+ PS IG G V++ I +P V VAIK + + E M
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI-VLKETLSA 140
SH NI+ + ++ +M G+L + DG + +L+ +
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAG 119
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YL + ++HRD+ A NIL +S+ K++DFG+S + + T P
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE-----GTYTTSGGKIPI 174
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPP 235
W APE I ++ ++ +D+WSFGI E ++ G P
Sbjct: 175 RWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 59/244 (24%), Positives = 111/244 (45%), Gaps = 23/244 (9%)
Query: 52 DSTVVAIKAIDLDQSRTDL-DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110
D+T VA+K+ + DL +E + + SHPNI+ + +++VM +
Sbjct: 19 DNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
G + + + P L + +++ + + YL ++ +HRD+ A N L +K++
Sbjct: 78 GDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKIS 136
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALE- 228
DFG+S + + G M P W APE + ++ YS ++D+WSFGI E
Sbjct: 137 DFGMSREEEDGVYASTGG------MKQIPVKWTAPEAL-NYGRYSSESDVWSFGILLWEA 189
Query: 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPS 288
+ G P ++L ++ T+ E+ +++ ++ M C + DP
Sbjct: 190 FSLGAVPYANLSNQQ------TREA----IEQGVRLPCPELCPDAVYRLME-RCWEYDPG 238
Query: 289 KRPS 292
+RPS
Sbjct: 239 QRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 66/232 (28%), Positives = 97/232 (41%), Gaps = 34/232 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTM 80
L + K + +G G VYK I IP V VAIK + + S I E M
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 81 SLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
+ + P + L C S + +MP+ C D + E I ++ L
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQLVTQLMPY-----------GCLLDYVRENKDRIGSQDLL 112
Query: 139 S-------ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA--SIYEPSHHHHHGS 189
+ +SYL +HRD+ A N+L S VK+ DFG++ I E +H G
Sbjct: 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLP 240
I WMA E I H ++ ++D+WS+G+T EL G P +P
Sbjct: 173 VPIK-------WMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 10/161 (6%)
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E + ++HP+I+ +F+ + +++P L +++ + I + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAA--KRNIAICDILAIER 189
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
L A+ YLH +HRD+KA NI + G V L DFG + + + + ++G
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG------W 243
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236
AGT APE++ + Y DIWS GI E+A L
Sbjct: 244 AGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
+PN + + S + ++M ++ G L ++ L E + ++++ + AL+ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDL 125
Query: 145 HNQGHLHRDVKAGNILSD-SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
H +H D+K N+L D + + L D+G+ I PS + D GT + +
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---------D--GTLDYFS 174
Query: 204 PEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
PE I+ H SF D W+ G+ EL G+ P E+ L + +R +K L
Sbjct: 175 PEKIKGHNYDVSF--DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-----QQKKL 227
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK-LMKHSFFKN 304
K S+ D V S L + + R + ++KH F K
Sbjct: 228 P---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 29 YKILDEIGVGVSAIVYKA---ICIPMDSTVVAIKAIDLDQSRTDLDSIR--RETKTMSLL 83
Y I+ IG G VY A +C S VA+K I D S L R RE K + L
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVC----SRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP-DGLPEPC---------IAIV 133
HP I+ + S ++ MP++ +L+S++ S + + L + ++I
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI-----------YEPS 182
K + + Y+H++G LHRD+K NIL G V + D+G + +
Sbjct: 120 HK-ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGI 224
+ + + + GTP +MAPE + S DI++ G+
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGV 219
|
Length = 932 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 33/279 (11%)
Query: 34 EIGVG-VSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN-- 90
EIG G ++ + V +K + + S + E + L H N+L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGL--PEPCIAIVLK-ETLSALSYLHNQ 147
C+ L VM F G L+ + SC L P+P + E L +LH
Sbjct: 62 GQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEV 206
+H D+ N L +D +VK+ D+G+S + Y+ ++ + D P W+APE+
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY------VTPDQLWVPLRWIAPEL 173
Query: 207 IRSHTGYSFKAD------IWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
+ G D +WS G+T EL G P HL E+ L ++ E
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--------TYTVRE 225
Query: 260 KTLKIKDKNKKFSRA--FKDMVASCLDQDPSKRPSAEKL 296
+ LK+ K + + +++ C Q P +RPSAE++
Sbjct: 226 QQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 16/163 (9%)
Query: 72 SIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIA 131
S E + + LSHP +L V +V+P + + P GL + +
Sbjct: 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQ--VT 263
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG----VSASIYEPSHHHHH 187
V ++ LSA+ Y+H +G +HRD+K N+L + + L DFG S P H+
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY--- 320
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA 230
+AGT APEV+ Y+ DIWS G+ E A
Sbjct: 321 ------GIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 68/306 (22%), Positives = 127/306 (41%), Gaps = 47/306 (15%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLD-QSRTDLDSIRRETKTMS 81
P Y+ L +G G Y ++C D+ + VA+K + QS RE + +
Sbjct: 14 PERYQNLTPVGSGA----YGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 82 LLSHPNILNAHCSFSVD------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ H N++ F+ + +++V M L +I+ L + + ++
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG-ADLNNIVKC---QKLSDEHVQFLIY 125
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ L L Y+H+ G +HRD+K N+ + D +++ DFG++ + +T
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----------MTGY 175
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR---PPLSHL-----------PP 241
T ++ APE++ + Y+ DIWS G EL G+ P ++ P
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235
Query: 242 EKSLLMKMTQRF--RFSDYEKTLKIKDKNKKFSRAFK---DMVASCLDQDPSKRPSAEKL 296
+L K++ ++ + +D K F A D++ L D KR SA +
Sbjct: 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295
Query: 297 MKHSFF 302
+ H +F
Sbjct: 296 LAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 23/163 (14%)
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ +L ++ +HRD+ A NIL + VK+ DFG++ IY+ + G A + P
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL------PL 239
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQ--RFRFS 256
WMAPE I Y+ ++D+WSFG+ E+ + G P + ++ ++ + R R
Sbjct: 240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+Y T +I + M+ C +P RP+ +L++
Sbjct: 299 EY-ATPEI----------YSIML-DCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 44/183 (24%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
+++++S +GL + + + +L ++ +HRD+ A N+L VK+
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL- 229
DFG++ I S++ GS + WMAPE I + Y+ +D+WS+GI E+
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFL-----PVKWMAPESIFDNL-YTTLSDVWSYGILLWEIF 333
Query: 230 AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK 289
+ G P + + + K+ +R + K ++ D++ C + +P K
Sbjct: 334 SLGGTPYPGMIVDSTFYNKIKSGYRMA----------KPDHATQEVYDIMVKCWNSEPEK 383
Query: 290 RPS 292
RPS
Sbjct: 384 RPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 17/218 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST---VVAIKAIDLDQSRTDLDSIRRETKTM 80
LD S KI +G G + + C+ + S VAI + S E T+
Sbjct: 2 LDNKSIKIERILGTGRFGELCRG-CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
H NI+ + + + +V +MS G+L S + L + +L S
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASG 119
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP- 199
+ YL G++H+ + A +L +SD K++ F A+ T M+G
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSP 171
Query: 200 -YWMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPP 235
W APE I+ H +S +D+WSFGI E +++G P
Sbjct: 172 VLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 23/162 (14%)
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ +L ++ +HRD+ A NIL + VK+ DFG++ IY+ + GSA + P
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL------PL 240
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQ--RFRFS 256
WMAPE I Y+ ++D+WSFG+ E+ + G P + + ++ R R
Sbjct: 241 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ + ++ +C DP +RP+ L++
Sbjct: 300 ENA------------TPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKA-ICIP-MD-STVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
S+ + ++E+G +YK + +P MD + +VAIK + + ++E M+ L
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP----------DGLPEPC---- 129
HPNI+ + + + ++ +++ G L + P DG +
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 130 ----IAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185
IAI + + + YL + +H+D+ A NIL VK++D G+S IY ++
Sbjct: 125 DFLHIAI---QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL 229
+++ WM PE I + +S +DIWSFG+ E+
Sbjct: 182 VQPKSLL-----PIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 52/301 (17%)
Query: 22 YP-LDPSSYKILDEIGVGVSAIVYKAIC----IPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
YP L+ + K D IG G V KA + MD+ AIK + S+ D E
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGE 57
Query: 77 TKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII-SSCFPDGLPEPCIAIVL 134
+ + L HPNI+N + L++ + + G+L + S + P IA
Sbjct: 58 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117
Query: 135 KETLSA-------------LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS--ASIY 179
TLS+ + YL + +HRD+ A NIL + K+ADFG+S +Y
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177
Query: 180 EPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELAH--GRPPL 236
+ M P WMA E + +++ Y+ +D+WS+G+ E+ G P
Sbjct: 178 -----------VKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225
Query: 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
E L K+ Q +R EK L D+ D++ C + P +RPS ++
Sbjct: 226 GMTCAE--LYEKLPQGYRL---EKPLNCDDE-------VYDLMRQCWREKPYERPSFAQI 273
Query: 297 M 297
+
Sbjct: 274 L 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 14/222 (6%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTM 80
L + K + +G G VYK I +P TV VAIK ++ E M
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
+ + HP+++ + + +V M G L + D + + +
Sbjct: 64 ASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKG 121
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YL + +HRD+ A N+L S VK+ DFG+ A + E ++ D P
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL-ARLLEGDEKEYNA-----DGGKMPI 175
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLP 240
WMA E I + ++ ++D+WS+G+T EL G P +P
Sbjct: 176 KWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 70/277 (25%), Positives = 111/277 (40%), Gaps = 55/277 (19%)
Query: 75 RETKTMSLLSHPNILNAHCSF--SVDSRLWVVMPFMSCGSLQSII-------SSCFPDGL 125
RE + L HPN++ F D ++W++ + L II ++ P L
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQL 105
Query: 126 PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD----GSVKLADFGVSASIYEP 181
P + +L + L + YLH LHRD+K NIL + G VK+AD G + P
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------- 234
A + + T ++ APE++ Y+ DIW+ G EL P
Sbjct: 166 L----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
Query: 235 ------PLSH-----------LPPEKSL--LMKMTQ------RFRFSDYEKTLKI----K 265
P H P +K + KM + FR + Y + I K
Sbjct: 222 DIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEK 281
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
K K S+ F ++ L DP+KR ++E+ ++ +F
Sbjct: 282 HKVKPDSKVFL-LLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 55 VVAIKAIDLDQSRTDL-DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
VA+K + D + L D + RE M L +P I+ +S +VM G L
Sbjct: 24 TVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES-WMLVMELAELGPL 82
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
+ + E I ++ + + YL +HRD+ A N+L + K++DFG
Sbjct: 83 NKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFG 140
Query: 174 VSASIYEPSHHHH---HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE-L 229
+S ++ +++ HG + W APE + + +S K+D+WSFG+ E
Sbjct: 141 LSKALGADENYYKAKTHGKWPVK-------WYAPECMNYYK-FSSKSDVWSFGVLMWEAF 192
Query: 230 AHGRPP 235
++G+ P
Sbjct: 193 SYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 49/255 (19%)
Query: 54 TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAH--CSFSVDSRLWVVMPFMSCG 111
T V +K +D R +S MS LSH +++ + C +S + V ++ G
Sbjct: 28 TEVLLKVLD-KSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM--VQEYVKFG 84
Query: 112 SLQSIISSCFPDGLPEPCIAI-----VLKETLSALSYLHNQGHLHRDVKAGNIL-----S 161
SL + + + I I V K+ AL +L ++G H +V A N+L
Sbjct: 85 SLDTYLKK------NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREED 138
Query: 162 DSDGS---VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKAD 218
G+ +KL+D G+S ++ ++ + P W+ PE I + S AD
Sbjct: 139 RKTGNPPFIKLSDPGISITVLPKE--------ILLER--IP-WVPPECIENPQNLSLAAD 187
Query: 219 IWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKD 277
WSFG T E+ + G PLS L +K L YE ++ K++ +
Sbjct: 188 KWSFGTTLWEIFSGGDKPLSALDSQKKLQF----------YEDRHQL--PAPKWTE-LAN 234
Query: 278 MVASCLDQDPSKRPS 292
++ C+D +P RPS
Sbjct: 235 LINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 51/229 (22%), Positives = 100/229 (43%), Gaps = 27/229 (11%)
Query: 27 SSYKILDEIGVGVSAIVYKAICI---PMDST-VVAIKAIDLDQSRTDL-DSIRRETKTMS 81
S+ + ++E+G VYK P + T VAIK + D++ L + + E S
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRS 63
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPE 127
L HPNI+ + + L ++ + S L + P L
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 128 PCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187
++ + + + +L + +H+D+ N+L +VK++D G+ +Y ++
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPP 235
G++++ WM+PE I + +S +DIWS+G+ E+ ++G P
Sbjct: 184 GNSLL-----PIRWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ + +L ++ +HRD+ A N+L VK+ DFG++ I S++ GS +
Sbjct: 250 NGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL------ 303
Query: 199 PY-WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFS 256
P WMAPE I + Y+ +D+WSFGI E+ G P LP + + + +R +
Sbjct: 304 PLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297
K S +++ C ++ RP +L+
Sbjct: 363 ----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192
++K+ L A+ Y+H++ +HRD+K NI + DG + L DFG + + +G
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG---- 327
Query: 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALEL 229
GT +PE++ + GY DIWS G+ L++
Sbjct: 328 --WVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 63/266 (23%), Positives = 107/266 (40%), Gaps = 24/266 (9%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCS 94
+G G V+K D T VA+K D + E + + HPNI+
Sbjct: 3 LGKGNFGEVFKGTL--KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDV 154
+ +++VM + G S + + + + L + + ++YL ++ +HRD+
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCIHRDL 119
Query: 155 KAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGY 213
A N L + +K++DFG+ S G + + P W APE + ++ Y
Sbjct: 120 AARNCLVGENNVLKISDFGM-------SRQEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171
Query: 214 SFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFS 272
S ++D+WS+GI E + G P MT + EK ++ K
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYP----------GMTNQQAREQVEKGYRMSCPQKCPD 221
Query: 273 RAFKDMVASCLDQDPSKRPSAEKLMK 298
+K M C D P RP +L K
Sbjct: 222 DVYKVM-QRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 43/284 (15%)
Query: 33 DEIGVGVSAIVYKAICIPMD-------STVVAIKAI--DLDQSRTDLDSIRRETKTM-SL 82
+ +G G +Y I D S IK I LD S D+ ET +M
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
+SH +I+ + D +V F+ G L + D L P V K+ SALS
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALS 119
Query: 143 YLHNQGHLHRDVKAGNILSDSDG-------SVKLADFGVSASIYEPSHHHHHGSAMITDM 195
YL ++ +H +V NIL +G +KL+D G+ ++ +
Sbjct: 120 YLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC----------V 169
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR 254
P W+APE + S AD WSFG T E+ + G PL +K+L K +RF
Sbjct: 170 ERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK----DKTLAEK--ERF- 221
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
YE + + K D++ C++ DP++RP +M+
Sbjct: 222 ---YEGQCMLVTPSCK---ELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ +L ++ +HRDV A N+L K+ DFG++ I S++ G+A + P
Sbjct: 225 MDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL------PV 278
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPP 235
WMAPE I Y+ ++D+WS+GI E+ + G+ P
Sbjct: 279 KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 73 IRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSI--ISSCFPDGLPEPCI 130
++ E ++L P I++ + S + +++VM ++ G ++S+ I F E
Sbjct: 51 VQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD----EEMA 106
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
+ E AL YLH G +HRD+K N+L ++G +KL DFG+S
Sbjct: 107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 17/161 (10%)
Query: 75 RETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
RE T+ PN++ H + +++V+ G L S IS +PE C+
Sbjct: 34 RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWA 91
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
E + AL LH +G + RD+ NIL D G ++L F S E S M
Sbjct: 92 AEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM--- 147
Query: 195 MAGTPYWMAPEV--IRSHTGYSFKADIWSFGITALELAHGR 233
+ APEV I T D WS G EL G+
Sbjct: 148 ------YCAPEVGGISEETE---ACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 47/281 (16%)
Query: 33 DEIGVGVSAIVYKAICIPMDSTVV--AIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNIL 89
D IG G V +A+ I D + AIK + S D E + + L HPNI+
Sbjct: 8 DVIGEGNFGQVIRAM-IKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 90 NAHCSFSVDSRLWVVMPFMSCGSL-----QSIISSCFPDGLPEPCIAIVLK--------- 135
N + L++ + + G+L +S + P E A L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS--ASIYEPSHHHHHGSAMIT 193
+ + + YL + +HRD+ A N+L + + K+ADFG+S +Y +
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----------VKK 175
Query: 194 DMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELAH--GRPPLSHLPPEKSLLMKMT 250
M P WMA E + +++ Y+ K+D+WSFG+ E+ G P E L K+
Sbjct: 176 TMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEKLP 232
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
Q +R +K + +++ C P +RP
Sbjct: 233 QGYRM----------EKPRNCDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSL 113
V +K + + S + + ++ +L HPNIL C ++ L V + G L
Sbjct: 25 VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL--VFEYCELGDL 82
Query: 114 QSIISSCFPDGLPEPCIAIVLK----ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169
+S +S ++L+ E + ++++H LH D+ N SD +VK+
Sbjct: 83 KSYLSQ--EQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKV 140
Query: 170 ADFGVSASIYEPSHHHHHGSAMITD--MAGTPYWMAPEVIRSHTGYSFKAD------IWS 221
D+G+ S Y+ + + T+ W+APE++ G A+ +W+
Sbjct: 141 GDYGIGPSRYKEDY-------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193
Query: 222 FGITALEL-AHGRPPLSHL 239
G+T EL + P SHL
Sbjct: 194 LGVTLWELFENAAQPYSHL 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 30/191 (15%)
Query: 57 AIKAIDLDQSRTDLDSIRRETKTMSLLSH-PNILNAHCSFSVDSRLWVVMPFMSCGSL-- 113
AIK + S+ D E + + L H PNI+N + L++ + + G+L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 114 ---QSIISSCFPDGLPEPCIAIVLK---------ETLSALSYLHNQGHLHRDVKAGNILS 161
+S + P A L + + YL + +HRD+ A NIL
Sbjct: 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 145
Query: 162 DSDGSVKLADFGVS--ASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKAD 218
+ K+ADFG+S +Y + M P WMA E + +++ Y+ +D
Sbjct: 146 GENYVAKIADFGLSRGQEVY-----------VKKTMGRLPVRWMAIESL-NYSVYTTNSD 193
Query: 219 IWSFGITALEL 229
+WS+G+ E+
Sbjct: 194 VWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 106 PFMSCGSLQSIISSCFPDGLPEP-----CIAIVLKETLSALSYLHNQGHLHRDVKAGNIL 160
PF C + PD +P+ I V+++ L+ L LH G +HRD+K N+L
Sbjct: 282 PFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLL 341
Query: 161 SDSDGSVKLADFGVSASI 178
DG VK+ DFG + +
Sbjct: 342 VTVDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 1/48 (2%)
Query: 130 IAIVLKETLSALSYLHNQGHLHRDVKAGNIL-SDSDGSVKLADFGVSA 176
I ++++ L AL LH+ G +HRDVK NI+ S+ GS K+ D G +A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 35/146 (23%), Positives = 63/146 (43%), Gaps = 5/146 (3%)
Query: 126 PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185
+ I ++K+ L+ L Y+H G H D+K NI+ D + + D+G+++ H
Sbjct: 124 NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 186 HHGSAMITDMAGTPYWMAPEVIRSHTG--YSFKADIWSFGITALELAHGRPPLSHLPPEK 243
+ GT Y+ + +H G + + D+ S G L+ A + P
Sbjct: 184 EYSKEQKDLHRGTLYYAG---LDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240
Query: 244 SLLMKMTQRFRFSDYEKTLKIKDKNK 269
+L+ F +E +KIK+ NK
Sbjct: 241 NLIHAAKCDFIKRLHEGKIKIKNANK 266
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.03 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.49 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.27 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.8 | |
| PLN02236 | 344 | choline kinase | 96.54 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.48 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.26 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.18 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.0 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.99 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.69 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.56 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.31 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.11 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.51 |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-59 Score=466.78 Aligned_cols=347 Identities=50% Similarity=0.873 Sum_probs=293.5
Q ss_pred cccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeee
Q 010624 14 GTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHC 93 (506)
Q Consensus 14 ~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 93 (506)
.....+..++++.+.|++.++||.|..++||+|++++.+ ..||||+++.++...+++.+++|+..|+.++||||+++++
T Consensus 13 ~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~-e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~ 91 (516)
T KOG0582|consen 13 SASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTN-EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHC 91 (516)
T ss_pred ccccccccCCCCccceeEEEEEeccceeEeeeeeecccC-CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEE
Confidence 344567889999999999999999999999999998665 9999999999998888999999999999999999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
.|..+..+|+||.||.+||+.++++..++.+++|..|+.|++++++||.|||.+|.||||||+.||||+.+|.|||+|||
T Consensus 92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred EEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhh-hhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV-IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~-l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
.+....... ...........|||+|||||+ .....+|+.|+|||||||+..||++|..||...++.+.+...+.+.
T Consensus 172 vsa~l~~~G---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 172 VSASLFDSG---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred eeeeecccC---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 987655432 111111156789999999999 5556679999999999999999999999999999999999888776
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccchhhHHHhhhhcchhHHHHHHHhhh
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESRN 332 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 332 (506)
..... ......+....++..++.+|..||++||.+|||+.++|+|+||++. +..++..+.+++.++++..+++....
T Consensus 249 pp~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~-k~~~~~~~~~l~~l~~l~~r~~~~q~ 325 (516)
T KOG0582|consen 249 PPTLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA-KSKEYLVKKLLQSLPPLGTRFKKSQS 325 (516)
T ss_pred CCCcc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc-cchhhcchhhhccCCcHHHHHHHHHh
Confidence 54322 2222233456788899999999999999999999999999999998 78889999999999999999998775
Q ss_pred ccCCCCCCCcccccCCCcccccCCCCCccCCCCCCccCCcc
Q 010624 333 HVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPVF 373 (506)
Q Consensus 333 ~~~~~~~~~~e~~~~~~~~v~~~~~~g~~~~~~~~~~~~~~ 373 (506)
.....-. ...+. +...-...+|+|+.+.+.....+
T Consensus 326 ~~~~~~~----~~~~~--~~~e~~~~~W~f~~~~~~~~~~~ 360 (516)
T KOG0582|consen 326 KEESQIS----GLSGN--PLSEYQKGEWNFDYEDLDEEASL 360 (516)
T ss_pred hhccccc----cccCC--chhhhcCCCccccccchhccccc
Confidence 4321000 01111 12222334899988877666554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-56 Score=437.54 Aligned_cols=264 Identities=31% Similarity=0.479 Sum_probs=223.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh------hhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR------TDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
-.+.|.+.+.||+|+||.|-+|+.+ .+|+.||||++.+.... .....+.+|+++|++|+|||||+++++|+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3456999999999999999999996 67899999999765422 2334578999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC---CCeEEeecccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD---GSVKLADFGVS 175 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~---g~vKL~DFGls 175 (506)
...|+||||++||+|.+.+-. ++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999987 5788999999999999999999999999999999999999866 78999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hhc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM-TQR 252 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~-~~~ 252 (506)
.... .........|||.|.|||++.+.. .|..++|+||+||+||-+++|.+||.......+....+ ..+
T Consensus 327 K~~g--------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 327 KVSG--------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred hccc--------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 6432 223445678999999999997532 34558899999999999999999998766655444433 334
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
+.+. +..+..+++++.+||.+||..||++|||++++|+||||+..+.
T Consensus 399 y~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 399 YAFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred cccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 4332 2256789999999999999999999999999999999998753
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=417.34 Aligned_cols=262 Identities=34% Similarity=0.565 Sum_probs=225.2
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-EE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS-RL 101 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~ 101 (506)
.+..++.+.++.||+|..|+||+|.++ .+++.+|+|.+.....+....++.+|+++++.++|||||++|++|..++ .+
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 345568899999999999999999996 6789999999987777888899999999999999999999999999998 59
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+||||+||||.+++.. .+.++|.....++.++++||.|||+ ++|+||||||+||||+..|.|||||||.|.....
T Consensus 154 sI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999999999988 4789999999999999999999996 8999999999999999999999999999765432
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhccccc
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP----EKSLLMKMTQRFRFS 256 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~----~~~~~~~~~~~~~~~ 256 (506)
. ......||..|||||.+.+.. |+.++||||||++++|+++|+.||..... .-.++..+....
T Consensus 232 S---------~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p--- 298 (364)
T KOG0581|consen 232 S---------IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP--- 298 (364)
T ss_pred h---------hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---
Confidence 1 345667999999999999876 99999999999999999999999976411 111122221111
Q ss_pred chhhhhhhhccch-hhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 257 DYEKTLKIKDKNK-KFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 257 ~~~~~~~~~~~~~-~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
++..+. .+|+++++||..||++||.+|||+.|+++|||+++...
T Consensus 299 -------pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 299 -------PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -------CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 122333 49999999999999999999999999999999997644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-53 Score=435.65 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=226.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.+|+..+.||+|||+.||.+.+. .+|..||+|++++.. .....+.+.+||+|.++|+|||||+++.+|++.+++|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 77999999999999999999996 678999999998754 455678899999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
.|+|..++|-.+++. .+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|......
T Consensus 97 LELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--- 171 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--- 171 (592)
T ss_pred EEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc---
Confidence 999999999999986 578999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........|||.|.|||++.. .+++..+||||+||+||.|++|+|||....-.+....+....+.
T Consensus 172 ----~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~---------- 236 (592)
T KOG0575|consen 172 ----GERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS---------- 236 (592)
T ss_pred ----ccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc----------
Confidence 233456679999999999984 56999999999999999999999999877666666555554443
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.+..+|.++++||.+||+.||.+|||+++||.|+||+
T Consensus 237 --~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 237 --MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred --cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 3347899999999999999999999999999999995
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=412.00 Aligned_cols=263 Identities=28% Similarity=0.492 Sum_probs=230.1
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
...+++|+++++||+|+||+||.+..+ .+++.+|+|++.+... ....+..+.|..+|..++||+||+++..|++...
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 567899999999999999999999886 7789999999987653 3456788999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+|+||+.||.|+.+|.+ .+.+++..++.|+.+|+.||.|||++||+||||||+|||+|.+|+++|+|||++.....
T Consensus 100 LylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999999997 58899999999999999999999999999999999999999999999999999764332
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........||+.|||||++.+. +|+.++|+|||||++|+|++|.+||...+.......+...+..
T Consensus 178 ~-------~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~------ 243 (357)
T KOG0598|consen 178 D-------GDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP------ 243 (357)
T ss_pred C-------CCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC------
Confidence 2 1223346899999999999876 5999999999999999999999999987766655554444311
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCC----CHHHHHcCcccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRP----SAEKLMKHSFFKNCNK 307 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp----t~~eiL~hp~f~~~~~ 307 (506)
..+..++.++++|+.++|..||++|. ++.+|-+||||+.+++
T Consensus 244 -----~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 244 -----LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred -----CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 13344889999999999999999996 6899999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=396.81 Aligned_cols=270 Identities=27% Similarity=0.446 Sum_probs=223.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++.|+.+.++|+|+||+||+|.++ .+|+.||||++..... +.-.+-..|||++|++++|||+|.+++.|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccC-CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 467999999999999999999996 7899999999865543 44455668999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
+|||+..-|..+=+. +.+++...++.|++|++.|+.|||+++++||||||+||||+.+|.+||||||+|.....
T Consensus 80 FE~~dhTvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~---- 153 (396)
T KOG0593|consen 80 FEYCDHTVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA---- 153 (396)
T ss_pred eeecchHHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC----
Confidence 999985555444433 78899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc------------
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR------------ 252 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~------------ 252 (506)
..........|.||.|||++.|..+|+.++||||+||++.||++|.+.|.+.+.-+.+..+...-
T Consensus 154 ---pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 154 ---PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ---CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 12233445579999999999998889999999999999999999999998877766655443211
Q ss_pred -------ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 253 -------FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 253 -------~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
++++............+.++..+.+|+++||..||++|++.+++|.||||.++
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 11222222222223445677889999999999999999999999999999654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=414.14 Aligned_cols=271 Identities=27% Similarity=0.482 Sum_probs=231.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.+..++|+++..||+||||.||.|..+ .+|..+|+|++++.. .....+.++.|-.+|...++|+||++|++|++..+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk-~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKK-DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEc-cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 567899999999999999999999885 789999999998765 34567889999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+||||||++||++..+|.. .+.|++..++.++.+++.|++.||..|++||||||+|+|||..|++||+|||+|.....
T Consensus 216 LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999999988 58899999999999999999999999999999999999999999999999999854332
Q ss_pred CCCCC-------------------CC---------------------CCcccccCCCCCccCChhhhhccCCCCccccHH
Q 010624 181 PSHHH-------------------HH---------------------GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIW 220 (506)
Q Consensus 181 ~~~~~-------------------~~---------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIw 220 (506)
..... .. .........|||-|||||++.+.. |+..+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHH
Confidence 11000 00 001123456999999999999765 99999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC---CHHH
Q 010624 221 SFGITALELAHGRPPLSHLPPEKSLLMKMTQR--FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP---SAEK 295 (506)
Q Consensus 221 SlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---t~~e 295 (506)
|||||+|||+.|.|||+...+.+....++.-+ +.++ ....++++++|||.+||. ||++|. ++.|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP----------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP----------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC----------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 99999999999999999988887766555432 2222 334577999999999999 999998 5999
Q ss_pred HHcCccccccccc
Q 010624 296 LMKHSFFKNCNKG 308 (506)
Q Consensus 296 iL~hp~f~~~~~~ 308 (506)
|.+||||+.+++.
T Consensus 442 IK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 442 IKKHPFFKGVDWD 454 (550)
T ss_pred HhcCCccccCCcc
Confidence 9999999998653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=415.57 Aligned_cols=269 Identities=25% Similarity=0.453 Sum_probs=230.9
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (506)
...+.+|++++.||.|+|++|++|..+ .+++.||||++.+.-. ....+.+.+|-.+|.+| +||.|++||..|+++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 466789999999999999999999997 5789999999876542 23345677899999999 7999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|+||+++|+|.++|.+ -+.|++.+++.++.||+.||+|||++|||||||||+|||+|.+|++||+|||.|....
T Consensus 148 sLYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999999998 4889999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCCCC----C--CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 180 EPSHHHH----H--GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 180 ~~~~~~~----~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
....... . .........||..|.+||++.... .+..+|+|+||||+|.|+.|.+||...+.--.+..++.-.+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 3322210 0 111124567999999999998755 78999999999999999999999998877666666665544
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
. .+..+++.+++||+++|..||.+|+|+.+|..||||..+++
T Consensus 305 ~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 305 E------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred c------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 4 34568899999999999999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=384.32 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=232.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+...++|++++.||.|+||.|..+..+ .+|..+|+|++++... -...+...+|..+|+.+.||+++++++.|.+.+.
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEc-cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 366688999999999999999999996 6789999999976552 3456788899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+||||++||.|+.++++ .+++++..++.++.||+.||+|||+.+|++|||||+|||+|.+|.+||+|||+|....
T Consensus 119 lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 9999999999999999998 5789999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.......|||.|+|||++.... |+.++|+|||||++|||+.|.+||...++......++...+.++
T Consensus 196 ---------~rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP---- 261 (355)
T KOG0616|consen 196 ---------GRTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP---- 261 (355)
T ss_pred ---------CcEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC----
Confidence 2245667999999999998754 99999999999999999999999999998888888877777655
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCC-----CCHHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R-----pt~~eiL~hp~f~~~~ 306 (506)
..+++++++||.++|+.|-.+| ....+|..||||+.+.
T Consensus 262 --------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 262 --------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred --------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 4578899999999999999999 3678999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=396.71 Aligned_cols=259 Identities=31% Similarity=0.505 Sum_probs=223.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..+|.+.+.||+|+||+||+|.++ .++..||||.+.+.. ..+..+.+..|+.+|+.++|||||++++++..++.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEec-cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 467999999999999999999997 556999999998776 566778889999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC------CCeEEeeccccccc
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD------GSVKLADFGVSASI 178 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~------g~vKL~DFGls~~~ 178 (506)
||||+||+|.++|+. .+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+|...
T Consensus 88 MEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999998 4689999999999999999999999999999999999999864 35899999997654
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
. .........|+|.|||||++.... |+.|+|+||+|+|+|++++|++||......+.....-...-.
T Consensus 166 ~--------~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---- 232 (429)
T KOG0595|consen 166 Q--------PGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---- 232 (429)
T ss_pred C--------chhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc----
Confidence 3 233455678999999999997654 999999999999999999999999988777765532222111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
++..+..++....+|+...|..+|..|.++.+-+.|++....
T Consensus 233 -----~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 233 -----VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred -----cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 222344566777899999999999999999999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=406.40 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=224.9
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh----hhHHHHHHHHHHHhhCC-CCCceeeeeEEEe
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR----TDLDSIRRETKTMSLLS-HPNILNAHCSFSV 97 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (506)
....+.|++.+.||+|+||+|+.|.+. .++..||+|+++..... ...+.+.+|+.+++.++ ||||++++.++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 355678999999999999999999986 56799999988764221 33457779999999999 9999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-CCeEEeeccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSA 176 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-g~vKL~DFGls~ 176 (506)
...+|+|||||.||+|++++.+ .+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||+|.
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999999998 6889999999999999999999999999999999999999999 999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
... ..........|||.|+|||++.+.. +-+.++||||+||+||.|++|..||.+.........+....+.+
T Consensus 170 ~~~-------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~ 242 (370)
T KOG0583|consen 170 ISP-------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI 242 (370)
T ss_pred ccC-------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC
Confidence 432 1223455678999999999999866 34689999999999999999999999866665555544444433
Q ss_pred cchhhhhhhhccchhh-hHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 256 SDYEKTLKIKDKNKKF-SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~-s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
+ ..+ |+++++|+.+||..||.+|+|+.+|+.||||+.
T Consensus 243 p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 243 P------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred C------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 3 344 999999999999999999999999999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=411.32 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=229.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.-|++++.||.|+.|.|..|.+. .+|+.+|||++.+.. .......+.+||-||+.+.||||+++|+.+++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcc-cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45999999999999999999995 789999999997653 345567888999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
.||++||.|++++.. .+++++.+++++++||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.....
T Consensus 91 lEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---- 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---- 164 (786)
T ss_pred EEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC----
Confidence 999999999999988 68999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........|+|.|.|||++.|.++-+.++||||+|||||.|++|+.||.+.+....+.+.....|.
T Consensus 165 ----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~---------- 230 (786)
T KOG0588|consen 165 ----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE---------- 230 (786)
T ss_pred ----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc----------
Confidence 234456779999999999999887789999999999999999999999976665555554444443
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
.+..+++++++||.+||..||++|+|.++|++|||+..+..
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 44678999999999999999999999999999999987643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=402.66 Aligned_cols=261 Identities=42% Similarity=0.697 Sum_probs=228.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
......|+.++.||+|.||.||+|.+. .+++.||||+++.+......+.+.+|+.+|.+++++||.++|+.|..+..+|
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred CCcccccccchhccccccceeeeeeec-cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 344567999999999999999999996 6789999999999998888999999999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
++||||.||++.+++.. ...+++..+..++++++.||.|||+++.+|||||+.|||+..+|.|||+|||++......
T Consensus 88 iiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred HHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech-
Confidence 99999999999999987 455699999999999999999999999999999999999999999999999997654332
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........|||.|||||++.+ .+|+.++|||||||+.+||++|.+||....+....+.+-..
T Consensus 165 ------~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~----------- 226 (467)
T KOG0201|consen 165 ------VKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS----------- 226 (467)
T ss_pred ------hhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC-----------
Confidence 222356789999999999995 45999999999999999999999999988775433221111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.++.....+++.+++|+..||++||+.||||.++|+|+|++..
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 1222345899999999999999999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=400.77 Aligned_cols=272 Identities=26% Similarity=0.400 Sum_probs=226.3
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCC-E
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDS-R 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~ 100 (506)
.+.+++|.++++||.|.||.||+|..+ .+|..||||.+......-.--.=.||+..|++++ |||||++++.+.+.. .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 355789999999999999999999996 6778899999876554322223358999999999 999999999998877 9
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+|||||+ ..|+++|+.+ ...|++..++.|++||++||+|+|.+|+.|||+||+|||+..+..|||+|||+|.....
T Consensus 85 L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 999999997 8999999987 78899999999999999999999999999999999999999899999999999764432
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---------
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ--------- 251 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~--------- 251 (506)
.........|.||.|||++.....|+.+.|+|++|||++|+.+-++.|.+.+..+.+.+++.-
T Consensus 163 --------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 163 --------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred --------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 223445567999999999998888999999999999999999999999988777766655421
Q ss_pred ----------cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 252 ----------RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 252 ----------~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.++++.... ..+....+.++.++.+||.+||.+||.+||||.++|+||||+...
T Consensus 235 ~eg~~La~~mnf~~P~~~~-~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKP-SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred hhHHHHHHHhccCCCcCCC-CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 111111111 112223345889999999999999999999999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=404.28 Aligned_cols=257 Identities=40% Similarity=0.647 Sum_probs=224.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
..|....+||+|+.|.||.|..+ .+++.||||.+++... ...+-+.+|+.+|+..+|+|||++++.|..++.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~-~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKI-STKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeec-cCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46999999999999999999986 5678899999987653 335778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|++||+|.+++.. ..++|.+|+.+++++++||+|||.+||+|||||.+|||++.+|.+||+|||++......
T Consensus 351 ym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~----- 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE----- 422 (550)
T ss_pred ecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc-----
Confidence 9999999999987 45999999999999999999999999999999999999999999999999997643322
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........|||+|||||++.... |++++||||||+++.||+-|.+||....+...++.+...... ...
T Consensus 423 --~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P---------~lk 490 (550)
T KOG0578|consen 423 --QSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP---------KLK 490 (550)
T ss_pred --cCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC---------CcC
Confidence 22455678999999999998655 999999999999999999999999987776666554443211 112
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+|+.+++|+.+||+.||.+|++|.+||+||||+..
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 456799999999999999999999999999999999755
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=391.34 Aligned_cols=263 Identities=35% Similarity=0.562 Sum_probs=218.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC--EEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--RLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~l 103 (506)
..+|...+.||+|+||+||++.++ .+|...|||.+....... .+.+.+|+.+|+.++|||||++++...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~-~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNK-KTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEec-CCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 567999999999999999999996 458999999998765444 778999999999999999999999855444 6999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccccccccCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls~~~~~~~ 182 (506)
+|||+++|+|.+++..... .+++..++.+.+||++||+|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999998644 7999999999999999999999999999999999999999 79999999998765432
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH-LPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
............|||.|||||++........++|||||||++.||+||++||.. .............. .
T Consensus 171 --~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~------- 240 (313)
T KOG0198|consen 171 --KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-S------- 240 (313)
T ss_pred --ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-C-------
Confidence 111222344577999999999998522123499999999999999999999986 33333333332222 1
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+..+|.++++||.+|+..||++||||.++|+|||.+..
T Consensus 241 --~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 241 --LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred --CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 123556799999999999999999999999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=402.41 Aligned_cols=256 Identities=32% Similarity=0.554 Sum_probs=224.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
+++|-+.+.||+|+||.||||..+ .+.+.||||.+++.. ..+....+++|++|++.++|||||.++++|+...++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 367999999999999999999885 778999999998754 456788899999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
+|||.| +|+.++.. .+.+++..++.++++++.||.|||+++|+|||+||+|||++.+|.+|+||||+|.....
T Consensus 80 te~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---- 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---- 152 (808)
T ss_pred ehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc----
Confidence 999986 99999988 68899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.........|||.|||||+..+.+ |+..+|+||+|||+||+.+|+|||...........+..+...
T Consensus 153 ---~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~---------- 218 (808)
T KOG0597|consen 153 ---NTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK---------- 218 (808)
T ss_pred ---CceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----------
Confidence 233455668999999999999766 999999999999999999999999865444443333333222
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+...+..+++|++.+|.+||.+|.|..+++.|||++..
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 334789999999999999999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=366.35 Aligned_cols=271 Identities=30% Similarity=0.411 Sum_probs=222.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhH-HHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL-DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.+|..+++||+|.||.||+|.+. .+|+.||||.+......... ....|||+.|+.++||||+.+.+.|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57999999999999999999996 67899999999876543322 35679999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||++ .+|..+|+.. ...++...++.|+.++++||+|||++.|+||||||.|+|++++|.+||+|||+|........
T Consensus 81 Efm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred Eecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 9997 9999999875 46799999999999999999999999999999999999999999999999999765443211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--c---------c
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR--F---------R 254 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~--~---------~ 254 (506)
......-|.||.|||++.|...|+..+|+||.|||+.||+.|.|.|.+.++.+.+..+..-- . .
T Consensus 157 -----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 157 -----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred -----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 11222569999999999999999999999999999999999999888776666554443210 0 1
Q ss_pred ccchhhhhhhh-----ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 255 FSDYEKTLKIK-----DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 255 ~~~~~~~~~~~-----~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
.+++......+ ...+..+.++.+|+.+||.+||.+|+|+.|+++|+||++.+.
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 11111111011 123456788899999999999999999999999999997643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=379.63 Aligned_cols=248 Identities=30% Similarity=0.529 Sum_probs=206.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeee-EEEeCCE-EEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHC-SFSVDSR-LWV 103 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~-~~l 103 (506)
.+|+|+++||+|+||.||++.++ .+|..+|.|.+.... ..+..+.+..|+.+|++|+|||||++++ .|..+.. ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46999999999999999999997 678999999987544 3556778899999999999999999987 5655555 999
Q ss_pred EeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 104 VMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHN--QG--HLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs--~g--ivHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
|||||.+|+|..+|+... ...+++..++.++.|++.||.++|+ .. |+||||||.||+++.+|.|||+|||++..
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999997543 3469999999999999999999999 44 89999999999999999999999999654
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... .........|||+||+||++.+.+ |+.++||||+||++|||+.-++||.+.+-.+. ...+.+. .++.
T Consensus 178 l~s-------~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L-~~KI~qg-d~~~ 247 (375)
T KOG0591|consen 178 LSS-------KTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL-CKKIEQG-DYPP 247 (375)
T ss_pred hcc-------hhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHH-HHHHHcC-CCCC
Confidence 322 233455678999999999999765 99999999999999999999999987633332 2222221 1111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~ 293 (506)
.+...+|.++..||..|+..||+.||+.
T Consensus 248 --------~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 --------LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 1236789999999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=403.86 Aligned_cols=290 Identities=25% Similarity=0.423 Sum_probs=241.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (506)
-++..++|+++++||+|.||+|++|..+ .+++.+|||+++++. ...+.+..+.|.+|+...+ ||.++++++.|+..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 4678899999999999999999999996 567899999998776 4566788999999999886 99999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
.++|+||||+.||++..+++ .+.+++..++.|+.+++.||.|||++||||||||.+|||+|..|++||+|||++...
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999999655554 378999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .........|||.|||||++.+.. |+.++|+|||||+||||+.|.+||.+.+..+..-.++.....
T Consensus 519 m~-------~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~---- 586 (694)
T KOG0694|consen 519 MG-------QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR---- 586 (694)
T ss_pred CC-------CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----
Confidence 32 223455678999999999999866 999999999999999999999999988777777666665544
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccccchhhHHHhhhhcchhHHHHHHHhhhc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESRNH 333 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 333 (506)
.+..+|.++.++++++|..||++|.. +.+|..||||+.++ ..+...+.+.....+....-.+..++
T Consensus 587 --------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~-w~~L~~r~i~PPf~P~i~~~~D~snF 657 (694)
T KOG0694|consen 587 --------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID-WDDLLNRRIKPPFVPTIKGPEDVSNF 657 (694)
T ss_pred --------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC-HHHHhhccCCCCCCcccCChhhhccc
Confidence 34568999999999999999999985 58999999999996 33344444433333333333333444
Q ss_pred cCC
Q 010624 334 VGA 336 (506)
Q Consensus 334 ~~~ 336 (506)
...
T Consensus 658 d~e 660 (694)
T KOG0694|consen 658 DEE 660 (694)
T ss_pred chh
Confidence 333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=391.90 Aligned_cols=278 Identities=28% Similarity=0.418 Sum_probs=226.4
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..-.+...+.|+.+++||+|.||.||+|.+. .+|+.||+|.+..+.. ........|||.||++|+||||+++.+...+
T Consensus 109 ~~w~~r~~~~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 109 HGWGPRRADSFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred ccccccchHHHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 3445667788999999999999999999996 6789999999987763 3334556799999999999999999999887
Q ss_pred C--CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 98 D--SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 98 ~--~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
. +.+|+|+|||+ .+|.-++... .-.|++.+|+.|++||+.||+|||++||+|||||.+|||||.+|.+||+|||+|
T Consensus 188 ~~~~siYlVFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred cCCceEEEEEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 6 78999999997 8888888763 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
........ .......-|.||.|||++.|...|+.++|+||.||||.||+.|++.|......+.+..+..-.-..
T Consensus 266 r~y~~~~~------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 266 RFYTPSGS------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred eeccCCCC------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 74433211 112334458999999999999999999999999999999999999998877666555444321110
Q ss_pred --cchh---------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 256 --SDYE---------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 256 --~~~~---------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..|. ....+.+....+++...+|+..||..||.+|.||.++|+|+||...
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 0011 0011122345678889999999999999999999999999999543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=369.88 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=226.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.+.|.+.++||+|.|+.||++.+. .+|+.+|+|+++... +....+.+.+|+.|-+.|+||||++++..+...+..|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 467999999999999999999986 678999999997654 344678899999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~~~~~~ 181 (506)
+|++.|++|..-|-.. --+++..+..+++||+.+|.|+|.+||+|||+||+|+|+-+ ..-|||+|||++....
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999999998766553 45889999999999999999999999999999999999863 3469999999976543
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
.........|||.|||||+++..+ |+.++|||+.|+|||.|+.|.+||++.+.......++...+.++..
T Consensus 165 ------~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~--- 234 (355)
T KOG0033|consen 165 ------DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP--- 234 (355)
T ss_pred ------CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc---
Confidence 223445667999999999998765 9999999999999999999999999877777766666666665432
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.++.+++++++|+++||..||++|+|+.|+|+|||+++-
T Consensus 235 -----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 235 -----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 457899999999999999999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=385.67 Aligned_cols=266 Identities=27% Similarity=0.443 Sum_probs=220.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-------------hhhHHHHHHHHHHHhhCCCCCcee
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-------------RTDLDSIRRETKTMSLLSHPNILN 90 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-------------~~~~~~~~~Ei~il~~l~HpnIv~ 90 (506)
.-.++|++.+.||+|.||.|-+|++. .+++.||||++++... ....+.+++||.+|++|+|||||+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44578999999999999999999995 7789999999975431 122478999999999999999999
Q ss_pred eeeEEEeC--CEEEEEeccCCCCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCe
Q 010624 91 AHCSFSVD--SRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 91 l~~~~~~~--~~~~lV~Ey~~ggsL~~~i~~~~~~~-l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~v 167 (506)
+++...+. ..+|+|+|||..|.+...-. .+. +++.+++.|+++++.||+|||.+||+||||||+|+|++++|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999764 68999999999988753322 234 8999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhc---cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q 010624 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS---HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS 244 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~ 244 (506)
||+|||.|...... .............|||.|+|||...+ ....+.+.||||+||+||-|+.|+.||.+....+.
T Consensus 250 KIsDFGVs~~~~~~--~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 250 KISDFGVSNEFPQG--SDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred EeeccceeeecccC--CccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999998754332 11122223344789999999999987 33346789999999999999999999987766666
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+++...+.++. .+.+.+.+++||.+||.+||++|.+..+|..|||....
T Consensus 328 ~~KIvn~pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 328 FDKIVNDPLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHhcCcccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 6666666555543 34678899999999999999999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=385.45 Aligned_cols=267 Identities=24% Similarity=0.381 Sum_probs=224.1
Q ss_pred ccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeee
Q 010624 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAH 92 (506)
Q Consensus 15 ~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~ 92 (506)
....+....+..++|++.+.||+|+||.||+|.+...++..||+|.+.... .....+.+.+|+.+++.++||||++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 97 (340)
T PTZ00426 18 TKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97 (340)
T ss_pred ccccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence 334456677888999999999999999999998865555789999986432 233456788999999999999999999
Q ss_pred eEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
+++.+++.+|+||||+.||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+||
T Consensus 98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 98 GSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecC
Confidence 999999999999999999999999987 467999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
|++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||................
T Consensus 176 G~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 176 GFAKVVDT----------RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred CCCeecCC----------CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 98754211 112346899999999997654 8999999999999999999999998765543333322221
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.. .+..+++.++++|.+||+.||++|+ |+.++++||||++.+
T Consensus 245 ~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 245 IY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred CC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 11 2345788899999999999999995 899999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=373.79 Aligned_cols=266 Identities=26% Similarity=0.429 Sum_probs=213.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||.|+||+||+|.+. .++..||+|.+...........+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 467999999999999999999985 5688999999876544444456789999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~---- 156 (288)
T cd07871 83 EYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP---- 156 (288)
T ss_pred eCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC----
Confidence 9998 5899988753 345899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch-------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY------- 258 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 258 (506)
........||+.|+|||++.+...++.++||||+||++|+|++|++||......+........ ...+..
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (288)
T cd07871 157 ---TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL-LGTPTEETWPGIT 232 (288)
T ss_pred ---CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChHHhhccc
Confidence 111233457899999999976556899999999999999999999999876554443322211 100000
Q ss_pred -----hhh-------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 259 -----EKT-------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 259 -----~~~-------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
... .........++.++++||.+||+.||.+|||+.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 00001123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=383.85 Aligned_cols=259 Identities=32% Similarity=0.488 Sum_probs=218.6
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeE-EEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTV-VAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~-vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
...+.++.....+.+.||+|+||+||+|.+. |+. ||||++.... .....+.|++|+.+|+.++|||||++++++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3567888888999999999999999999983 455 9999997543 2233679999999999999999999999999
Q ss_pred eCC-EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCCCCEEeCCCC-CeEEeecc
Q 010624 97 VDS-RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG-HLHRDVKAGNILSDSDG-SVKLADFG 173 (506)
Q Consensus 97 ~~~-~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g-ivHrDIKp~NILld~~g-~vKL~DFG 173 (506)
... .+.+||||+++|+|..++.......+++..+..|+.||++||.|||+++ ||||||||+|||++.++ ++||||||
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 887 7999999999999999998754678999999999999999999999999 99999999999999998 99999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhc-cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
+|....... .......||+.|||||++.+ ...|+.++|||||||++|||+||..||....+...........
T Consensus 190 lsr~~~~~~-------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~ 262 (362)
T KOG0192|consen 190 LSREKVISK-------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG 262 (362)
T ss_pred cceeecccc-------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence 986543321 22233679999999999985 2459999999999999999999999999988744443333332
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.+. ..+..+++.+..|+..||..||..||++.+|+
T Consensus 263 ~Rp----------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 263 LRP----------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCC----------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 221 13344889999999999999999999999885
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=376.96 Aligned_cols=271 Identities=26% Similarity=0.407 Sum_probs=213.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||+|+||.||+|.++ .+++.||+|++...........+.+|+.+++.++||||+++++++.++...|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 478999999999999999999985 5688999999876544344456778999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+. ++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 156 (303)
T cd07869 83 EYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP---- 156 (303)
T ss_pred ECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC----
Confidence 9996 6788777653 456899999999999999999999999999999999999999999999999987532211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh---h--
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE---K-- 260 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~-- 260 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||............+......+... .
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 ---SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred ---CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 11122345799999999997666688999999999999999999999987554333322221111100000 0
Q ss_pred ----------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 ----------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ----------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.....-....+++.+++|+.+||+.||.+|||+.++++||||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000001112457889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=382.65 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=218.8
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
......++|++.+.||+|+||.||+|.++ .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..+
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 34445688999999999999999999985 568899999986532 223456788999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||+.||+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 999999999999999999987 467899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 169 ~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---- 233 (329)
T PTZ00263 169 PD----------RTFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK---- 233 (329)
T ss_pred CC----------CcceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC----
Confidence 21 112346899999999998654 799999999999999999999999876554433332222211
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..++..+++||.+||+.||.+||+ +.+++.||||++.+
T Consensus 234 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 234 --------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 23447888999999999999999997 79999999998753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=376.91 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=215.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999985 5688999999865331 23456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---- 153 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---- 153 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC----
Confidence 999999999999987 46799999999999999999999999999999999999999999999999998653321
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 154 ------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------- 216 (291)
T cd05612 154 ------RTWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE---------- 216 (291)
T ss_pred ------CcccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC----------
Confidence 112345899999999997654 899999999999999999999999876554443333322221
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..++..+++||.+||+.||.+||+ +.++++||||+..+
T Consensus 217 --~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 217 --FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred --CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 23456889999999999999999995 99999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=374.90 Aligned_cols=275 Identities=29% Similarity=0.424 Sum_probs=237.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..+..+.|++++.||.|.-|+||+|..+ .++..+|+|++++... ...+.++..|-.||+.++||.++.+|..|+.+.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEec-CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 4566778999999999999999999986 4568999999987653 344567778999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|++||||+||+|..+........+++..++.++.+++.||+|||-.|||+|||||+||||-++|+|.|+||.+|....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999977543
Q ss_pred CCCCCCC-------------------------------------------------CCCcccccCCCCCccCChhhhhcc
Q 010624 180 EPSHHHH-------------------------------------------------HGSAMITDMAGTPYWMAPEVIRSH 210 (506)
Q Consensus 180 ~~~~~~~-------------------------------------------------~~~~~~~~~~Gt~~y~APE~l~~~ 210 (506)
....... ..........||-.|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 2111000 000112344689999999999975
Q ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCC
Q 010624 211 TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR 290 (506)
Q Consensus 211 ~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R 290 (506)
. .+.++|+|+|||.+|||+.|..||.+.+..+.+..++.+...++.. +.++..++|||+++|.+||.+|
T Consensus 311 G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 311 G-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------PEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred C-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------CcchhHHHHHHHHHhccChhhh
Confidence 4 8999999999999999999999999999999998888887776642 3678899999999999999999
Q ss_pred CC----HHHHHcCccccccccc
Q 010624 291 PS----AEKLMKHSFFKNCNKG 308 (506)
Q Consensus 291 pt----~~eiL~hp~f~~~~~~ 308 (506)
.. |.+|.+||||+.+++.
T Consensus 380 lg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred hccccchHHhhcCccccCCChh
Confidence 98 9999999999998754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=385.41 Aligned_cols=267 Identities=23% Similarity=0.440 Sum_probs=215.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++++.||+|+||+||+|.+. .+++.||||++.... .......+.+|+.+++.++||||++++++|.++..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999985 568899999986532 223456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||.||+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+|||++.+|.+||+|||++.........
T Consensus 80 ~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999999987 467999999999999999999999999999999999999999999999999987543211100
Q ss_pred CCC-------------------------------CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCC
Q 010624 185 HHH-------------------------------GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233 (506)
Q Consensus 185 ~~~-------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~ 233 (506)
... .........||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCC
Confidence 000 00011124699999999999764 4899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHcCccccccc
Q 010624 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS---AEKLMKHSFFKNCN 306 (506)
Q Consensus 234 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt---~~eiL~hp~f~~~~ 306 (506)
+||.................... . .....+++.+++||.+||. +|.+|++ +.+++.||||+..+
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~-------~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQ-------F-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccC-------C-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99987665544333222111100 0 1223578899999999996 8999998 99999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=363.25 Aligned_cols=279 Identities=24% Similarity=0.343 Sum_probs=221.6
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh-hHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-DLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
.+-.-..+.|+.+..|++|.||.||+|.++ .+++.||+|.++.+.... ..-.-.|||.+|.+++|||||.+-.+....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccC-CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 344455677999999999999999999996 667999999998765322 122456999999999999999998777543
Q ss_pred --CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 99 --SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 99 --~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
+.+|+|||||+ .+|..++... ..++...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|.
T Consensus 148 ~~d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 148 NMDKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred ccceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 46999999997 8999999886 4689999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR---- 252 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~---- 252 (506)
...... .......-|.||.|||++.+...|+.+.|+||+|||+.||+++++.|.+....+.+..+..--
T Consensus 226 ~ygsp~-------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 226 EYGSPL-------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred hhcCCc-------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 544321 112233348999999999998889999999999999999999999998776666554443210
Q ss_pred ---------------ccccchhhhhhhhccc-hhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 253 ---------------FRFSDYEKTLKIKDKN-KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 253 ---------------~~~~~~~~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
+.++..+....-.... ..+++...+|+..+|..||.+|.||.+.|+|+||...+..
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 0111110000000011 1156889999999999999999999999999999986543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=361.79 Aligned_cols=259 Identities=29% Similarity=0.512 Sum_probs=226.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-------hhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-------RTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDS 99 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (506)
.|.-.+.||.|..++|.+++.+ .+|..+|+|++..... ..-.+.-++|+.||+++. ||||+++.++|+.+.
T Consensus 18 ~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 5777889999999999999886 5677889998865331 122456678999999985 999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+++|+|.|+.|.|+|++.+ .-.+++...+.|++|++.|++|||.++|+||||||+|||+|.+-++||+|||+|....
T Consensus 97 F~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999998 5679999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhh-----ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIR-----SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
.........|||+|+|||.+. ++++|+..+|+|++|+|||.|+.|.+||++....-.+..++..++.
T Consensus 175 --------~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 175 --------PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred --------CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 223345667999999999985 4677999999999999999999999999987766677777778887
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
|.++ .+.+++...++||.+||+.||++|.|+.++|.||||..+
T Consensus 247 F~sp--------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 247 FRSP--------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cCCc--------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 7654 456789999999999999999999999999999999654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=377.39 Aligned_cols=248 Identities=26% Similarity=0.428 Sum_probs=208.6
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++..++.+|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999985 567899999986432 23445678899999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... ....
T Consensus 80 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------~~~~ 150 (312)
T cd05585 80 LFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-------DDKT 150 (312)
T ss_pred HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-------CCcc
Confidence 9999976 467999999999999999999999999999999999999999999999999986532111 1112
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFS 272 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 272 (506)
....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||................. ..+..++
T Consensus 151 ~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~------------~~~~~~~ 217 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL------------RFPDGFD 217 (312)
T ss_pred ccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------------CCCCcCC
Confidence 3346899999999998654 89999999999999999999999987655544333322211 1334678
Q ss_pred HHHHHHHHhhcccCCCCCC---CHHHHHcCcccccc
Q 010624 273 RAFKDMVASCLDQDPSKRP---SAEKLMKHSFFKNC 305 (506)
Q Consensus 273 ~~l~~Li~~~L~~dP~~Rp---t~~eiL~hp~f~~~ 305 (506)
+.+++||.+||..||.+|| ++.++++||||...
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 8999999999999999997 58999999999976
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=367.95 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=210.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||+||+|.++ .++..||+|++..... ....+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999985 5678999999875432 334567889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.++++..+... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 99998877665543 4679999999999999999999999999999999999999999999999999876432110
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc--------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD-------- 257 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 257 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|++||...................+.
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 155 ---NANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ---cccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 11122345899999999997654 899999999999999999999999876544332221110000000
Q ss_pred -----------hhhhh-hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 258 -----------YEKTL-KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 258 -----------~~~~~-~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..... ........++.++++||.+||+.||++|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000 0000112468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=368.85 Aligned_cols=273 Identities=25% Similarity=0.374 Sum_probs=220.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-----
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV----- 97 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 97 (506)
.....|..++.||.|+||.|+.|.++ .+|+.||||.+... ......++..||+.+|+.++|+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34556777899999999999999996 56799999998633 345667788899999999999999999998865
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
-+.+|+|+|+| +.+|..+|+. ...+++..+..+++||++||.|+||.+|+||||||.|+|++.++.+||||||+|..
T Consensus 98 f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 35799999999 5999999998 45699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ...........|.||.|||++.....|+.+.||||+|||+.||++|++.|.+.+.-..+..++.- ...+.
T Consensus 175 ~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~-lGtP~ 248 (359)
T KOG0660|consen 175 LDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL-LGTPS 248 (359)
T ss_pred cccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh-cCCCC
Confidence 5322 11222344556999999999987777999999999999999999999999765544433322211 11000
Q ss_pred hh--------------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 258 YE--------------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 258 ~~--------------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. +...+....+..++.+.+|+.+||..||.+|+|++|+|.|||+....
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00 00111223457789999999999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=369.68 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=213.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|++.+.||+|+||.||+|.+. .+++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+++.+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 4899999999999999999986 5789999999865432 223346778999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+|+|.+++.......+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---- 155 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---- 155 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC----
Confidence 9999999999887654557999999999999999999999999999999999999999999999999997542211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........... +...... ...
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~-------~~~ 222 (285)
T cd05631 156 ----ETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-VDRRVKE-------DQE 222 (285)
T ss_pred ----CeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-HHHHhhc-------ccc
Confidence 1112346899999999998654 89999999999999999999999986443221111 1110000 011
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
..+..++..+.+|+.+||+.||.+||| ++++++||||...+
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 234568899999999999999999997 89999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.03 Aligned_cols=273 Identities=29% Similarity=0.448 Sum_probs=222.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCC-ceeeeeEEEeCC----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPN-ILNAHCSFSVDS---- 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~---- 99 (506)
...|..+++||+|+||+||+|+.+ .+|+.||+|.+..... +.......+|+.+|+.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 566899999999999999999997 6679999999987754 333456679999999999999 999999998877
Q ss_pred --EEEEEeccCCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 100 --RLWVVMPFMSCGSLQSIISSCFP--DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 100 --~~~lV~Ey~~ggsL~~~i~~~~~--~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.+++|+||+. .+|.+++..... .+++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999996 899999988643 47888999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc--
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF-- 253 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~-- 253 (506)
...... ........+|.+|.|||++.+...|+...||||+|||++||+++++.|......+....+..---
T Consensus 168 ra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 743322 12244556799999999999988899999999999999999999999988776555444332110
Q ss_pred ---------cccchhh-------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 254 ---------RFSDYEK-------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 254 ---------~~~~~~~-------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
..+.+.. ........+..++...+++.+||+.+|.+|.|+..+|.||||.....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0111110 11111112233458899999999999999999999999999998743
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=378.05 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=211.0
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
+.||+|+||.||+|.++ .+|+.||+|++.... .......+.+|+.+++.++||||+++++++..++.+|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999985 578899999987543 233456778999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-------~~ 150 (323)
T cd05571 80 GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-------GA 150 (323)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------CC
Confidence 999999986 467999999999999999999999999999999999999999999999999986532111 11
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................. .+..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------------~p~~ 217 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------------FPRT 217 (323)
T ss_pred cccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC------------CCCC
Confidence 122345899999999997654 899999999999999999999999876554433333222211 2346
Q ss_pred hhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 271 FSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 271 ~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
+++++.+||.+||+.||++|| ++.++++||||...+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 788999999999999999999 899999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=377.36 Aligned_cols=260 Identities=25% Similarity=0.434 Sum_probs=211.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCC---ChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQ---SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 101 (506)
+|++++.||+|+||+||+|.+.. .++..||+|++.... .....+.+.+|+.+++.++ ||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 59999999999999999987642 357899999986432 2233467789999999994 99999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999976 467999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhcccccch
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE---KSLLMKMTQRFRFSDY 258 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~ 258 (506)
.........||+.|+|||++.+...++.++|||||||++|+|++|..||...... ......+.. .
T Consensus 159 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~----- 226 (332)
T cd05614 159 ------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-C----- 226 (332)
T ss_pred ------CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-C-----
Confidence 1111223468999999999987655789999999999999999999999643221 111111111 0
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
....+..+++.+++|+.+||+.||++|| ++.++++||||+...
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 227 -----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0113345788999999999999999999 888999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=376.67 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=216.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.++||||+++++++..+...|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999985 5678999999865431 23456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999999976 46799999999999999999999999999999999999999999999999998653321
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+............... ..
T Consensus 154 ------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~ 222 (333)
T cd05600 154 ------YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP----VY 222 (333)
T ss_pred ------ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCC----CC
Confidence 22345689999999999876 48999999999999999999999998766544332222111000000 01
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
......+++++.+||.+||..+|.+|||+.++++||||+..+
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 111235789999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=379.50 Aligned_cols=261 Identities=30% Similarity=0.478 Sum_probs=229.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--hhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 100 (506)
-....|++.+.||+|.||.||+|..+ .+|+.+|+|.+.+.... ...+.+.+|+.+|+++. |||||.+++.|++...
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34557999999999999999999996 56899999999876543 34578999999999999 9999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC----CCeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD----GSVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~----g~vKL~DFGls~ 176 (506)
+++|||+|.||.|++.|... .+++..+..+++|++.++.|||+.|++||||||+|+|+... +.+|++|||+|.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999875 49999999999999999999999999999999999998743 479999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.... ........|||+|+|||++.... |+..+||||+|+++|.|++|.+||...........+....+.+.
T Consensus 188 ~~~~--------~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 188 FIKP--------GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT 258 (382)
T ss_pred EccC--------CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC
Confidence 4332 23456678999999999997644 99999999999999999999999998887777777666666544
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ..+..++..++++|.+||..||.+|+|+.++|+|||++..
T Consensus 259 ~--------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 259 S--------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred C--------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 3 2567789999999999999999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=403.63 Aligned_cols=269 Identities=28% Similarity=0.436 Sum_probs=229.9
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
....++..++|+|+++||+|+||.|..+..+ .+++.||+|++.+-. ......-|+.|-.+|...+.+-|+.++.+|+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3457789999999999999999999999986 668999999986532 2445577999999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
++.++|+||||++||+|-.++.+. ..+++..++.|+.+|+.||.-||+.|+|||||||+|||+|.+|++||+|||.+.
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999999984 389999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ- 251 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~- 251 (506)
.... ..........|||-|.+||++... ..|+..+|+||+||++|||+.|..||+...--+..-.++..
T Consensus 224 km~~------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 224 KMDA------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred hcCC------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 4322 233445677899999999999732 34899999999999999999999999976666655555543
Q ss_pred -cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHcCcccccccc
Q 010624 252 -RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS---AEKLMKHSFFKNCNK 307 (506)
Q Consensus 252 -~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt---~~eiL~hp~f~~~~~ 307 (506)
.+.|| ....+|+++++||.+++.. |+.|.. +.++..||||.+.++
T Consensus 298 ~~l~FP----------~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 298 ESLSFP----------DETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hhcCCC----------cccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCCh
Confidence 33333 2245899999999999865 899998 999999999999865
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=378.56 Aligned_cols=268 Identities=24% Similarity=0.410 Sum_probs=212.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++++.||+|+||+||+|.++ .+++.||+|++.... .......+.+|+.++..++||||+++++.+.++..+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 47999999999999999999985 568899999986532 223446788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||+||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999987 467999999999999999999999999999999999999999999999999997643211000
Q ss_pred CC----------------------------CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCC
Q 010624 185 HH----------------------------HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236 (506)
Q Consensus 185 ~~----------------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf 236 (506)
.. ..........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCC
Confidence 00 0000112346999999999997654 899999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhccc--CCCCCCCHHHHHcCccccccc
Q 010624 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQ--DPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~--dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.................... .+ ....+++++++||.+|+.. ++..||++.+|++||||+..+
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~-------~p-~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 237 CSETPQETYKKVMNWKETLI-------FP-PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CCCCHHHHHHHHHcCcCccc-------CC-CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 87665544433322111100 01 1234788999999987652 333568999999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=380.04 Aligned_cols=268 Identities=26% Similarity=0.432 Sum_probs=219.2
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+..++|++.+.||+|+||.||+|.++ .++..||+|.+.... .......+.+|+.+++.++||||+++++++.++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45677889999999999999999999985 568899999986432 223345677899999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999999999975 46899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccC---CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT---GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
... .........||+.|+|||++.+.. .++.++|||||||++|+|++|.+||...................
T Consensus 193 ~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 193 DAN------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred cCC------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 211 011122346899999999986532 37889999999999999999999998766544433333221111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCccccccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~ 306 (506)
. . .....++.++++||.+||..+|.+ |+|+.++++||||++..
T Consensus 267 ~-------~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 267 T-------F-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred C-------C-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 0 0 122357899999999999999988 99999999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=370.31 Aligned_cols=269 Identities=29% Similarity=0.491 Sum_probs=217.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+..++|++++.||+|+||.||+|.+. .++..+|+|.+.........+.+.+|+.+|+.++||||+++++++..++.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45689999999999999999999985 56889999999766555566789999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred EeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 9999999999999987 45799999999999999999999986 699999999999999999999999998653221
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-c------
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR-F------ 255 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~-~------ 255 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.. ..+..... .
T Consensus 157 -------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 -------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPH 227 (331)
T ss_pred -------cccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCcc
Confidence 1122346899999999998654 899999999999999999999999765443321 11110000 0
Q ss_pred -----------------------c---chhhhh----hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 256 -----------------------S---DYEKTL----KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 256 -----------------------~---~~~~~~----~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ...... ........+++++++||.+||+.||++|||+.+|++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0 000000 0001122478899999999999999999999999999999875
Q ss_pred c
Q 010624 306 N 306 (506)
Q Consensus 306 ~ 306 (506)
.
T Consensus 308 ~ 308 (331)
T cd06649 308 E 308 (331)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=380.11 Aligned_cols=268 Identities=24% Similarity=0.443 Sum_probs=213.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
+.|++++.||+|+||+||+|.++ .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 36999999999999999999985 568899999987543 234456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 80 MDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999999987 467999999999999999999999999999999999999999999999999986432100000
Q ss_pred C----------------------------------------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHH
Q 010624 185 H----------------------------------------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGI 224 (506)
Q Consensus 185 ~----------------------------------------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGi 224 (506)
. ...........||+.|+|||++.+.. ++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhh
Confidence 0 00000112346999999999997654 899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhc--ccCCCCCCCHHHHHcCccc
Q 010624 225 TALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCL--DQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 225 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L--~~dP~~Rpt~~eiL~hp~f 302 (506)
++|+|++|.+||.................... . .....+++++++||.+|+ ..+|..||++.+++.||||
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f 308 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLH-------I-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccC-------C-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence 99999999999987665544333321110000 0 122357899999999854 5566669999999999999
Q ss_pred cccc
Q 010624 303 KNCN 306 (506)
Q Consensus 303 ~~~~ 306 (506)
...+
T Consensus 309 ~~~~ 312 (381)
T cd05626 309 SEVD 312 (381)
T ss_pred CCCC
Confidence 8764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=382.25 Aligned_cols=267 Identities=24% Similarity=0.423 Sum_probs=213.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++++.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+|+.++||||+++++.|.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 47999999999999999999985 568899999986432 123356788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 80 ~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999987 467899999999999999999999999999999999999999999999999986422100000
Q ss_pred C------------------------------------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHH
Q 010624 185 H------------------------------------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE 228 (506)
Q Consensus 185 ~------------------------------------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~e 228 (506)
. ...........||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeee
Confidence 0 00000112346999999999997654 8999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHcCcccccc
Q 010624 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP---SAEKLMKHSFFKNC 305 (506)
Q Consensus 229 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---t~~eiL~hp~f~~~ 305 (506)
|++|+.||.................... ......+++++.+||.+|+ .+|.+|+ |+.++++||||+..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLH--------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCcccc--------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999987665544332221111100 0123457889999999977 5999999 99999999999976
Q ss_pred c
Q 010624 306 N 306 (506)
Q Consensus 306 ~ 306 (506)
+
T Consensus 308 ~ 308 (376)
T cd05598 308 D 308 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=364.94 Aligned_cols=262 Identities=31% Similarity=0.435 Sum_probs=212.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--C---EEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD--S---RLW 102 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~---~~~ 102 (506)
.|+-.+++|+|+||.||+|... .++..||||.+..+....+ +|+.+|+.++|||||++..+|... + ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~-e~~~~vAIKKv~~d~r~kn-----rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLR-ETEEEVAIKKVLQDKRYKN-----RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEc-CCCceeEEEEecCCCCcCc-----HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 5889999999999999999996 4578999999987665443 799999999999999998887542 2 567
Q ss_pred EEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-CCeEEeecccccccc
Q 010624 103 VVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIY 179 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-g~vKL~DFGls~~~~ 179 (506)
+||||++ .+|..+++.. .+..++...++.+.+||++||+|||+.||+||||||+|+|+|.+ |.+||||||.|....
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 8999997 8999988752 24679999999999999999999999999999999999999955 999999999976543
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. ........|.+|.|||++.|...|+.+.||||.||++.||+-|++.|.+.+....+..++ +.+..+...
T Consensus 178 ~~--------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi-k~lG~Pt~e 248 (364)
T KOG0658|consen 178 KG--------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII-KVLGTPTRE 248 (364)
T ss_pred cC--------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH-HHhCCCCHH
Confidence 32 222344568999999999999999999999999999999999999998866555444333 222221111
Q ss_pred hhh--------------h---h-hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 260 KTL--------------K---I-KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 260 ~~~--------------~---~-~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
... + + .-.....++++.+|+.++|.++|.+|.++.+++.||||...
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 100 0 0 01345678999999999999999999999999999999865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=379.79 Aligned_cols=267 Identities=24% Similarity=0.442 Sum_probs=214.4
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
+.|++++.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+++.++||||+++++.|.++..+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 36999999999999999999985 567899999986532 233456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999999976 357899999999999999999999999999999999999999999999999986432100000
Q ss_pred C----------------------------------------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHH
Q 010624 185 H----------------------------------------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGI 224 (506)
Q Consensus 185 ~----------------------------------------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGi 224 (506)
. ...........||+.|+|||++.+.. |+.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechH
Confidence 0 00000112346899999999997654 899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHcCcc
Q 010624 225 TALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS---AEKLMKHSF 301 (506)
Q Consensus 225 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt---~~eiL~hp~ 301 (506)
++|+|++|.+||....+............... ......+++++.++|.+|+ .+|.+|++ +.++++|||
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLH--------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 99999999999987665544433332111110 0123457899999999976 59999997 999999999
Q ss_pred ccccc
Q 010624 302 FKNCN 306 (506)
Q Consensus 302 f~~~~ 306 (506)
|+..+
T Consensus 308 f~~~~ 312 (382)
T cd05625 308 FKTID 312 (382)
T ss_pred cCCcC
Confidence 98864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=376.35 Aligned_cols=265 Identities=28% Similarity=0.501 Sum_probs=217.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||+||+|.+. .+++.||||++.... .......+.+|+.++..++||||+++++++.+++++|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 47999999999999999999985 568899999987543 123456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.+++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999999873 67999999999999999999999999999999999999999999999999987643322100
Q ss_pred ----------------------CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q 010624 185 ----------------------HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242 (506)
Q Consensus 185 ----------------------~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~ 242 (506)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 00001122345689999999999876 4899999999999999999999999876654
Q ss_pred HHHHHHHh--hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-HHHHHcCccccccc
Q 010624 243 KSLLMKMT--QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-AEKLMKHSFFKNCN 306 (506)
Q Consensus 243 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-~~eiL~hp~f~~~~ 306 (506)
........ ....++ ....+++.+.+||.+||. ||.+||+ +.++++||||+...
T Consensus 237 ~~~~~i~~~~~~~~~p----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 237 ETYNKIINWKESLRFP----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHHHHHhccCCcccCC----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 44333322 111111 122378999999999997 9999999 99999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=385.98 Aligned_cols=266 Identities=36% Similarity=0.632 Sum_probs=227.4
Q ss_pred CCCCCC-eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 23 PLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 23 ~~~~~~-Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
.+++.+ |+|+..||.|+||.||+|.++ .++-..|-|++.. .+...++.+.-||.||..++||+||++++.|.-++.+
T Consensus 27 dlnP~d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL 104 (1187)
T KOG0579|consen 27 DLNPRDHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL 104 (1187)
T ss_pred cCCHHHHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce
Confidence 345444 899999999999999999996 5667778888754 3456678899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++.|||.||-+..+|-.. +..|.+..|..+++|+|.||.|||+++|||||||..|||+.-+|.|+|+|||.|.....
T Consensus 105 wiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred EEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-
Confidence 9999999999999988875 57899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.........|||+|||||+... ...|+.++|||||||+|.||..+.||....++...++.+......
T Consensus 183 ------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP--- 253 (1187)
T KOG0579|consen 183 ------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--- 253 (1187)
T ss_pred ------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC---
Confidence 2233456679999999999753 234999999999999999999999999999888877765443211
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
....+...+..+.|++.+||.+||..||++++||+||||.+.+.
T Consensus 254 ------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 254 ------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred ------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 11245678889999999999999999999999999999998754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.04 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=207.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhC---CCCCceeeeeEEE-----e
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLL---SHPNILNAHCSFS-----V 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----~ 97 (506)
.+|++.+.||+|+||.||+|.+...++..||+|.+...... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999986566789999998754322 2234456777777665 6999999999885 3
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...+++||||+. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999997 6999999875556799999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|.+||............... ...+.
T Consensus 160 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~-~~~~~ 229 (290)
T cd07862 160 YSFQ--------MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV-IGLPG 229 (290)
T ss_pred ccCC--------cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH-hCCCC
Confidence 3211 1223446899999999997654 899999999999999999999999876655444333221 11110
Q ss_pred h---hhhh-------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 258 Y---EKTL-------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 258 ~---~~~~-------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
. .... ......+.+++.+++|+.+||+.||++|||+.++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0 0000 0011223578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=378.84 Aligned_cols=267 Identities=23% Similarity=0.413 Sum_probs=212.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++++.||+|+||+||+|.++ .+++.||||++.... .....+.+.+|+.+++.++||||++++++|.++..+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999985 678899999986432 233456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999986 467999999999999999999999999999999999999999999999999997532110000
Q ss_pred ----------CCC------------------------------CCcccccCCCCCccCChhhhhccCCCCccccHHHHHH
Q 010624 185 ----------HHH------------------------------GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGI 224 (506)
Q Consensus 185 ----------~~~------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGi 224 (506)
... .........||+.|+|||++.+.. ++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecch
Confidence 000 000001246999999999997654 899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCC---CCHHHHHcCcc
Q 010624 225 TALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR---PSAEKLMKHSF 301 (506)
Q Consensus 225 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R---pt~~eiL~hp~ 301 (506)
++|+|++|.+||................... .. .....++.++++||.+||. +|.+| +|+.+++.|||
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETL-------YF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCcc-------CC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 9999999999998765544333222111000 00 0123578899999999997 67765 59999999999
Q ss_pred ccccc
Q 010624 302 FKNCN 306 (506)
Q Consensus 302 f~~~~ 306 (506)
|+..+
T Consensus 308 ~~~~~ 312 (377)
T cd05629 308 FRGVD 312 (377)
T ss_pred cCCCC
Confidence 98753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=366.69 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=222.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
..-+|++.+.||+|.||+|-+|... ..|+.||||.++++. ...++-.+++||+||+.|+||||+.+|..|+..+.+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 3458999999999999999999885 678999999998776 4567789999999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
|||||..+|.|+++|.+ .+.|++.+++.+++||+.|+.|||.++++|||||.+|||+|.|+++||+|||+|.....
T Consensus 130 ivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 99999999999999998 47899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........|+|.|.+||+++|.++-++.+|.|||||+||.|+.|..||.+.+.......+....++
T Consensus 206 ------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------- 271 (668)
T KOG0611|consen 206 ------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------- 271 (668)
T ss_pred ------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--------
Confidence 233456679999999999999887789999999999999999999999876554443333222222
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
-+..+.++.-||+.||..||++|.|+.+|-.|=|.+
T Consensus 272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 123456788999999999999999999999998865
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=369.00 Aligned_cols=271 Identities=29% Similarity=0.443 Sum_probs=208.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----CEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-----SRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 101 (506)
+|++.+.||+|+||.||+|.++ .++..||||.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5999999999999999999985 568899999986432 223445788999999999999999999887543 358
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+|||||. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 99999995 789999876 457999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.. .........||+.|+|||++.+. ..++.++|||||||++|+|++|++||........... +......+....
T Consensus 157 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~ 231 (338)
T cd07859 157 TP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL-ITDLLGTPSPET 231 (338)
T ss_pred cC----ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-HHHHhCCCCHHH
Confidence 10 11112345689999999998652 3488999999999999999999999976543322111 111000000000
Q ss_pred --------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 261 --------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 261 --------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
........+.+++.+.++|.+||+.||++|||+.++++||||+....
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00001112346788999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=376.02 Aligned_cols=266 Identities=27% Similarity=0.461 Sum_probs=215.9
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..+..++|++.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 5567789999999999999999999985 567899999986432 2233456789999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999999975 468999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccC---CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT---GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.. .........||+.|+|||++.+.. .++.++|||||||++|+|++|.+||....................
T Consensus 194 ~~------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 267 (370)
T cd05621 194 ET------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267 (370)
T ss_pred cC------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC
Confidence 11 111123456899999999997532 378899999999999999999999987665444333322211110
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCcccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~ 305 (506)
. .....++..+++++.+||..++.+ |+|+.++++||||+..
T Consensus 268 -------~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 268 -------F-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -------C-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0 122357889999999999865543 8899999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=367.90 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=210.1
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHH---hhCCCCCceeeeeEEEeCCEEEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTM---SLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.++ +.++||||+++++++...+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 789999999999999999985 568899999987543 223345677776665 56679999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||++|++|..++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 v~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05589 80 VMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-- 154 (324)
T ss_pred EEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--
Confidence 9999999999988864 57999999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|+|||.+.+.. ++.++|||||||++|+|++|..||..................
T Consensus 155 -----~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------- 219 (324)
T cd05589 155 -----GDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--------- 219 (324)
T ss_pred -----CCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 11123456899999999997654 899999999999999999999999876554443332222111
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..++..+.++|.+||+.||.+|| ++.++++||||++..
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 2345788999999999999999999 799999999998863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=369.94 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=209.7
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999985 668899999987543 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 80 g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-------~~ 150 (328)
T cd05593 80 GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-------AA 150 (328)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-------cc
Confidence 999999876 467999999999999999999999999999999999999999999999999986532111 11
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||................. ..+..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------------~~p~~ 217 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI------------KFPRT 217 (328)
T ss_pred ccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc------------cCCCC
Confidence 122346899999999997654 89999999999999999999999986655443322222211 13346
Q ss_pred hhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 271 FSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 271 ~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
+++++.+||.+||+.||.+|| ++.++++||||...+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 788999999999999999997 899999999998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=369.52 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=210.1
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
+.||+|+||.||+|.++ .+|..||+|++.... .......+.+|+.+++.++||||++++++|.....+|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999985 578899999986542 233456677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
|+|..++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-------~~ 150 (323)
T cd05595 80 GELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-------GA 150 (323)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-------CC
Confidence 999998876 467999999999999999999999999999999999999999999999999986532111 11
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................. .+..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------~p~~ 217 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------------FPRT 217 (323)
T ss_pred ccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC------------CCCC
Confidence 122346899999999997654 899999999999999999999999866554443333222221 2346
Q ss_pred hhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 271 FSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 271 ~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
+++.+.+||.+||+.||.+|| ++.++++||||....
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 788999999999999999998 899999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=366.39 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=212.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCC-CceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP-NILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV 104 (506)
+|++++.||+|+||.||+|.++ .+++.||+|++.... .....+.+..|+.++..++|+ +|+++++++...+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 5999999999999999999985 567899999987543 233456778899999999765 588899999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 ~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05587 80 MEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--- 154 (324)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC---
Confidence 999999999999976 467899999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.................
T Consensus 155 ----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------- 218 (324)
T cd05587 155 ----GKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------- 218 (324)
T ss_pred ----CCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 11223446899999999998655 89999999999999999999999987665444333322211
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCH-----HHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSA-----EKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~-----~eiL~hp~f~~~~ 306 (506)
..+..+++.+.+++.+||..||.+|+++ .++++||||+..+
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 1234578899999999999999999976 8999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=382.49 Aligned_cols=266 Identities=27% Similarity=0.374 Sum_probs=205.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------ 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (506)
...+|++.+.||+|+||+||+|.+. .+++.||||.+.... ....+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4467999999999999999999985 567899999885432 2334799999999999999998877432
Q ss_pred --CEEEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeecc
Q 010624 99 --SRLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFG 173 (506)
Q Consensus 99 --~~~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFG 173 (506)
..+++||||++ ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 25789999998 5777776532 245799999999999999999999999999999999999999665 79999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
+|...... .......||+.|+|||++.+...|+.++|||||||++|+|++|.+||......+.....+....
T Consensus 217 la~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 217 SAKNLLAG--------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred cchhccCC--------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 97643211 1122346799999999987766689999999999999999999999987665544433322110
Q ss_pred -----------------cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 -----------------RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 -----------------~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.++...........+...++++++||.+||..||.+|||+.++++||||...
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0110000000011223467899999999999999999999999999999865
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=370.32 Aligned_cols=263 Identities=27% Similarity=0.421 Sum_probs=215.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||+||+|.++ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 47999999999999999999985 5788999999875432 23456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~--- 155 (330)
T cd05601 80 MEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--- 155 (330)
T ss_pred ECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC---
Confidence 9999999999999874 357999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCcccccCCCCCccCChhhhhc-----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRS-----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.........||+.|+|||++.. ...++.++|||||||++|+|++|..||................ ....
T Consensus 156 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~-- 229 (330)
T cd05601 156 ---KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ-RFLK-- 229 (330)
T ss_pred ---CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC-CccC--
Confidence 1112233468999999999863 2347889999999999999999999998765544433322211 1000
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. .....++..+.+||.+||. +|.+|||+.+++.||||...+
T Consensus 230 ----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 230 ----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 0 1223578899999999998 999999999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=362.64 Aligned_cols=271 Identities=26% Similarity=0.449 Sum_probs=215.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..++|++.+.||+|+||.||+|.++ .++..||+|.+...........+.+|+.+++.++||||+++++++..++..|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 3478999999999999999999985 567899999987655444445677899999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+. ++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 99997 4888887653 345899999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc---hhh-
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD---YEK- 260 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~- 260 (506)
........+|+.|+|||++.+...++.++|||||||++|+|++|++||......+........ ...+. +..
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (309)
T cd07872 158 ----TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL-LGTPTEETWPGI 232 (309)
T ss_pred ----ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhhh
Confidence 111223457899999999876556899999999999999999999999876554433222211 00000 000
Q ss_pred -------hhh--------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 -------TLK--------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 -------~~~--------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
... .......++.++++||.+||..||.+|||+.++++||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 0011235788999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=361.90 Aligned_cols=261 Identities=40% Similarity=0.682 Sum_probs=226.1
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
-|.++++||+|+||.||+|+++ .+|+.+|||.+.. ..+++++.+||.+|++++.|+||++|++|-....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 4889999999999999999996 7799999999875 46688999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
|..|++.++++.. .++|++.++..+++..+.||+|||...-+|||||..|||++.+|+.||+|||.+.....
T Consensus 110 CGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD------- 181 (502)
T KOG0574|consen 110 CGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD------- 181 (502)
T ss_pred cCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-------
Confidence 9999999999875 67899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
.........|||.|||||++.. .+|+.++||||||++..||.-|++||.+..+...++++-.+. ++ ....
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P------PP---TF~K 251 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP------PP---TFKK 251 (502)
T ss_pred hHHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC------CC---CCCC
Confidence 2233456679999999999986 459999999999999999999999999887776655433221 11 1123
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccchhh
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEF 311 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~~~ 311 (506)
+...|.++.+++++||.++|++|-|+.++++|||+++. ++...
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA-~g~~I 294 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA-PGCDI 294 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC-CcccH
Confidence 45678899999999999999999999999999999987 44443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.67 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=227.6
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
........++|++.+.||+|-||.||.|..+ .++..||+|++.+.+. ......+++|++|-+.|+||||+++|++|-
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred ccccccchhhccccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 3334455689999999999999999999986 6778999999876552 122457899999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
+...+|+++||...|+|+..+.......+++...+.+++|++.||.|+|.++|+||||||+|+|++..|.+||+|||.|.
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 99999999999999999999997667889999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
... ........||..|.|||...+.. ++..+|+|++|++.||++.|.+||......+....+..-.+.
T Consensus 173 ~~p---------~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-- 240 (281)
T KOG0580|consen 173 HAP---------SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-- 240 (281)
T ss_pred ecC---------CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--
Confidence 432 23345567999999999998765 899999999999999999999999877755555444433333
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.+..++..++|||.+||..+|.+|.+..+++.|||+..
T Consensus 241 ----------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ----------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 23678999999999999999999999999999999874
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=367.14 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=208.9
Q ss_pred EeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCC---ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 32 LDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQ---SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++.||+|+||.||+|.+.. .+++.||+|++.... .......+.+|+.+|+.++||||+++++.|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 3679999999999998632 357899999986532 22334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.|++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 9999999999977 467899999999999999999999999999999999999999999999999986532111
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||................. .
T Consensus 154 --~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------~ 218 (323)
T cd05584 154 --GTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------N 218 (323)
T ss_pred --CCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------C
Confidence 11122346899999999997654 78999999999999999999999987655443333222211 1
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCcccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNC 305 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~ 305 (506)
.+..+++.+.+||.+||+.+|++|| ++.+++.||||+..
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 2345788999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=367.56 Aligned_cols=262 Identities=21% Similarity=0.378 Sum_probs=208.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSF 95 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (506)
+|++..++|++.+.||+|+||.||+|.+. ..++..||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 47888899999999999999999999752 2345689999987554455567789999999999 899999999988
Q ss_pred EeC-CEEEEEeccCCCCCHHHHHHhhC-----------------------------------------------------
Q 010624 96 SVD-SRLWVVMPFMSCGSLQSIISSCF----------------------------------------------------- 121 (506)
Q Consensus 96 ~~~-~~~~lV~Ey~~ggsL~~~i~~~~----------------------------------------------------- 121 (506)
... ..+|++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 46899999999999999987531
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccccc
Q 010624 122 -------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194 (506)
Q Consensus 122 -------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~ 194 (506)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~ 235 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DYVRKGS 235 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc-----chhcccC
Confidence 1247888999999999999999999999999999999999999999999999875432110 0111123
Q ss_pred CCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhH
Q 010624 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSR 273 (506)
Q Consensus 195 ~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 273 (506)
..+++.|+|||++.+.. ++.++|||||||++|+|++ |..||............+..... ...+..+++
T Consensus 236 ~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~ 304 (338)
T cd05102 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----------MRAPENATP 304 (338)
T ss_pred CCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC----------CCCCCCCCH
Confidence 34568899999997654 8999999999999999997 99999865544333332222111 112345788
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 274 AFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 274 ~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+.+|+.+||+.||.+|||+.++++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=366.29 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=208.0
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||+||+|.++ .+++.||+|++.... .....+.+.+|+.++..+ +||||+++++++...+.+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999985 567899999986532 223455677888888876 69999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-------~ 150 (320)
T cd05590 80 GGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-------G 150 (320)
T ss_pred CchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-------C
Confidence 9999999976 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................. .+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------~~~ 217 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------------YPT 217 (320)
T ss_pred CcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC------------CCC
Confidence 1123346899999999997654 899999999999999999999999876655443333222111 234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH------HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA------EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~------~eiL~hp~f~~~~ 306 (506)
.++.++++||.+||+.||.+||++ .++++||||+...
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 578899999999999999999998 8999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.95 Aligned_cols=268 Identities=24% Similarity=0.427 Sum_probs=214.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++++.||+|+||+||+|.++ .+++.||+|++.... .......+.+|+.++..++||||+++++.+.++..+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999985 568899999986432 233456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||+||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999987 467999999999999999999999999999999999999999999999999987533211000
Q ss_pred CC----------------------------CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCC
Q 010624 185 HH----------------------------HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236 (506)
Q Consensus 185 ~~----------------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf 236 (506)
.. ..........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCC
Confidence 00 0000112346999999999997654 899999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHcCcccccccc
Q 010624 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP---SAEKLMKHSFFKNCNK 307 (506)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~ 307 (506)
.................... .+ ....+++++++||.+|+ .||.+|+ ++.++++||||+..+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~-------~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 237 CSETPQETYRKVMNWKETLV-------FP-PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CCCCHHHHHHHHHcCCCcee-------cC-CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 87665544333222110000 00 12247889999999987 4999998 4899999999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=373.03 Aligned_cols=269 Identities=26% Similarity=0.438 Sum_probs=217.4
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
....+..++|++.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+++.++||||+++++.+..
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 346777899999999999999999999985 678899999986432 22334567899999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
+..+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999999999975 4689999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccC---CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT---GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
.... .........||+.|+|||++.+.. .++.++|||||||++|+|++|.+||...+..............
T Consensus 192 ~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 192 MNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred cCcC------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 3211 111123456899999999997532 3788999999999999999999999876654443333222111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCccccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~ 306 (506)
.. . .....++..+++||.+||..++.+ |+++.++++||||++..
T Consensus 266 ~~-------~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 266 LT-------F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cc-------C-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 10 1 123468899999999999844433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=373.46 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=207.3
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.+...+|++++.||+|+||.||+|.+. .+++.||+|... ...+.+|+.+++.++||||++++++|..+...+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 355678999999999999999999995 668899999743 234678999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+|+|++. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 160 lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred EEEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 9999995 789888876 467899999999999999999999999999999999999999999999999997532111
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhhcccc-
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP------EKSLLMKMTQRFRF- 255 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~------~~~~~~~~~~~~~~- 255 (506)
.........||+.|+|||++.+.. |+.++|||||||++|+|++|..||..... .......+......
T Consensus 236 -----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 236 -----NANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred -----cccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 111123356899999999997654 89999999999999999999988753211 11111111111000
Q ss_pred c-ch--------hhhh----h----------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 256 S-DY--------EKTL----K----------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 256 ~-~~--------~~~~----~----------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
+ .+ .... . .......++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0 00 0000 0 0001123567899999999999999999999999999998764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=363.81 Aligned_cols=276 Identities=33% Similarity=0.544 Sum_probs=212.3
Q ss_pred eEEeeeccc--CCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 30 KILDEIGVG--VSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 30 ~i~~~IG~G--~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+++++||+| +|++||++.++ .+|+.||+|.++.... ....+.+.+|+.+++.++||||++++++|..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 78999999986 6789999999976543 3345677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+++|+|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+...........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999999765556799999999999999999999999999999999999999999999999986433221111011
Q ss_pred CCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc----hh--
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD----YE-- 259 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~-- 259 (506)
..........++..|+|||++.+. ..|+.++|||||||++|+|++|..||..................... ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 111112233567889999999753 34899999999999999999999999865544433332221110000 00
Q ss_pred ----------------------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 ----------------------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 ----------------------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
...........+++.+.+|+.+||+.||++|||++++++||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00000011234578899999999999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=367.39 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=208.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.....+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999985 578899999987542 223456677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
|+|..++.. ...+++..+..++.||+.||.|||+ .|++||||||+|||++.+|.+||+|||++...... .
T Consensus 80 ~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-------~ 150 (325)
T cd05594 80 GELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-------G 150 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-------C
Confidence 999999876 4679999999999999999999998 79999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................. .+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~------------~p~ 217 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------------FPR 217 (325)
T ss_pred cccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC------------CCC
Confidence 1122345899999999997654 899999999999999999999999876554433332222211 234
Q ss_pred hhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCcccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNC 305 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~ 305 (506)
.+++++.+||.+||+.||++|+ ++.++++||||...
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 5788999999999999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=363.34 Aligned_cols=265 Identities=25% Similarity=0.431 Sum_probs=212.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||+|.++ .+++.||+|++.... .....+.+.+|+.+++.++||||++++++|.+++++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 47999999999999999999985 567899999986422 223456688999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.||+|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (331)
T cd05597 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--- 155 (331)
T ss_pred EecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC---
Confidence 9999999999999753 457999999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........||+.|+|||++.. ...++.++|||||||++|+|++|+.||......+...........+.
T Consensus 156 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 228 (331)
T cd05597 156 ---GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---- 228 (331)
T ss_pred ---CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----
Confidence 0111123458999999999963 23478899999999999999999999987655444333222111111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~ 306 (506)
.+.....++..+++||.+||..++.+ |+++.++++||||...+
T Consensus 229 ---~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 229 ---FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred ---CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 11123457899999999988654433 78999999999998763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=363.85 Aligned_cols=269 Identities=29% Similarity=0.504 Sum_probs=215.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+..++|++.+.||.|+||.||+|.+. .++..+|+|.+...........+.+|+.+++.++||||++++++|.+++.+|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 56689999999999999999999985 56889999998766555556788999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999999987 45789999999999999999999985 7999999999999999999999999986532111
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc-------
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF------- 255 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~------- 255 (506)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......... ........
T Consensus 158 --------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 227 (333)
T cd06650 158 --------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL-MFGCPVEGDPAESET 227 (333)
T ss_pred --------ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH-HhcCcccCCcccccc
Confidence 112345899999999997644 8999999999999999999999997544322211 11000000
Q ss_pred ---------------cch---------hhhh-h---hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 256 ---------------SDY---------EKTL-K---IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 256 ---------------~~~---------~~~~-~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
+.. .... . .......++.++++||.+||+.||++|||+.+++.||||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000 0000 0 0001123578899999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=362.61 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=205.1
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhh-CCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+. .+++.||+|.+.... .....+.+..|..++.. .+||||+++++++..+..+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999985 567899999987542 12334455667777765 489999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-------~ 150 (316)
T cd05592 80 GGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-------E 150 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-------C
Confidence 9999999977 467999999999999999999999999999999999999999999999999987542211 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||................ ...+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------~~~~~ 217 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR------------PHFPR 217 (316)
T ss_pred CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------CCCCC
Confidence 1223446899999999998654 8999999999999999999999998765544333222111 11334
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH-HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA-EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~-~eiL~hp~f~~~~ 306 (506)
.++.++.+||.+||+.||.+||++ .++++||||+...
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 578899999999999999999986 5888999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=363.01 Aligned_cols=251 Identities=26% Similarity=0.464 Sum_probs=208.3
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999985 567899999987542 223456677899999887 69999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|..++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-------~ 150 (318)
T cd05570 80 GGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-------G 150 (318)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-------C
Confidence 9999999877 457999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................. .+.
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~------------~~~ 217 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR------------YPR 217 (318)
T ss_pred CcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC------------CCC
Confidence 1122335899999999998654 899999999999999999999999866554433322222111 234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH-----HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA-----EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~-----~eiL~hp~f~~~~ 306 (506)
.++..+.+||.+||+.||.+|||+ .+++.||||+..+
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 578899999999999999999999 9999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=362.52 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=212.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 104 (506)
+|++.+.||+|+||.||+|.+. .++..||+|++..... ......+..|..++..+ +||+|+++++++...+.+|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5899999999999999999985 5678999999875432 23345567788888777 589999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--- 154 (323)
T cd05616 80 MEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--- 154 (323)
T ss_pred EcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC---
Confidence 999999999999976 467999999999999999999999999999999999999999999999999987532111
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..................
T Consensus 155 ----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------- 219 (323)
T cd05616 155 ----GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---------- 219 (323)
T ss_pred ----CCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 11123446899999999998654 899999999999999999999999876655444333322211
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..++.++.+|+.+||+.||.+|++ ..++++||||+..+
T Consensus 220 --~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 220 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred --CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 23457889999999999999999997 48999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=363.76 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=208.5
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.++ .+++.||+|++.... .....+.+..|..++..+ +||||++++++|..++.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 46999999999999985 567899999986542 233455677899988865 79999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
+|+|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-------~ 150 (321)
T cd05591 80 GGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-------G 150 (321)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-------C
Confidence 9999999976 467999999999999999999999999999999999999999999999999987532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.................. .+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~------------~p~ 217 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL------------YPV 217 (321)
T ss_pred ccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------CCC
Confidence 1122345899999999997654 899999999999999999999999876655544333322211 234
Q ss_pred hhhHHHHHHHHhhcccCCCCCC-------CHHHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRP-------SAEKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rp-------t~~eiL~hp~f~~~~ 306 (506)
.++.++.+||.+||+.||++|| ++.++++||||...+
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 5788999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=361.23 Aligned_cols=251 Identities=25% Similarity=0.450 Sum_probs=205.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhh-CCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.++ .++..||+|.+..... ......+..|..++.. ++||||+++++++.+++++|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999985 5688999999875421 2334566778888875 489999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|..++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~ 150 (316)
T cd05620 80 GGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-------D 150 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-------C
Confidence 9999999976 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||................ ...+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~------------~~~~~ 217 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------------PHYPR 217 (316)
T ss_pred CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------CCCCC
Confidence 1123456899999999998654 8999999999999999999999998665443322211111 11234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH-HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA-EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~-~eiL~hp~f~~~~ 306 (506)
.++.++++||.+||+.||++||++ +++++||||+..+
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 578899999999999999999997 5899999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=363.29 Aligned_cols=252 Identities=28% Similarity=0.506 Sum_probs=205.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.+++.+ +||||++++++|...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999985 568899999997543 233456788999999988 69999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-------~ 150 (329)
T cd05588 80 GGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-------G 150 (329)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-------C
Confidence 9999998876 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhhcccccchhhh
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--------KSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--------~~~~~~~~~~~~~~~~~~~ 261 (506)
.......||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...... ......+...
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 220 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------- 220 (329)
T ss_pred CccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---------
Confidence 1122346899999999998654 899999999999999999999999632111 1111111110
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCC------HHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS------AEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt------~~eiL~hp~f~~~~ 306 (506)
....+..++..+.+||.+||+.||.+||| +.++++||||....
T Consensus 221 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 221 --QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 01123457889999999999999999987 78999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.25 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=212.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|++.+.||+|+||+||++.+. .+++.||+|++..... ......+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 4899999999999999999985 5688999999865432 222345678999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+|+|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 155 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---- 155 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC----
Confidence 9999999999887654567999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
.......|++.|+|||++.+.. ++.++||||+||++|+|++|..||......... ..+...+... ..
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~-------~~ 222 (285)
T cd05605 156 ----ETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKED-------QE 222 (285)
T ss_pred ----CccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhhc-------cc
Confidence 1112346899999999997654 899999999999999999999999865432211 1111111000 11
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
..+..++..+.+||.+||+.||.+|| ++.++++||||...+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 12345788999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=367.53 Aligned_cols=262 Identities=30% Similarity=0.460 Sum_probs=209.9
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
.....++|++++.||+|+||.||+|.+. .+++.||||++...........+.+|+.+++.++|+||+++++++..++.+
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 4455678999999999999999999985 568899999987655555567889999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.+++|.+. ...++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999999998643 23567888999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhcc----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
........||+.|+|||.+... ..++.++|||||||++|+|++|+.||..................
T Consensus 222 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 291 (353)
T PLN00034 222 -------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--- 291 (353)
T ss_pred -------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---
Confidence 1112234689999999987432 22456899999999999999999999743322211110000000
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
........++.++++||.+||..||++|||+.++++||||...
T Consensus 292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0112345678899999999999999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.56 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=205.5
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||+|+||+||+|.++ .+++.||+|.+..... ....+.+..|+.+++.++||||+++++++..+...|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999985 5688999999865432 2334677889999999999999999999999999999999999999
Q ss_pred HHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 113 LQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 113 L~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~-------~~ 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-------QS 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-------Cc
Confidence 99888542 2346999999999999999999999999999999999999999999999999987532211 11
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||................... ....+..
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 223 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--------SVTYPDK 223 (280)
T ss_pred cccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--------CCCCccc
Confidence 122346899999999998654 8999999999999999999999997543321111111111100 0112346
Q ss_pred hhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 271 FSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 271 ~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
++..+.+++.+||+.||++|| |++++++||||+..+
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 889999999999999999999 889999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=351.11 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=204.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhC---CCCCceeeeeEEEe-----C
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLL---SHPNILNAHCSFSV-----D 98 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 98 (506)
+|++.+.||+|+||+||+|.++ .+++.||+|.+...... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5999999999999999999985 56889999998754322 1223455677776655 79999999998764 3
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..++++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999998 58999887754556999999999999999999999999999999999999999999999999986533
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc--
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS-- 256 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 256 (506)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||............... ...+
T Consensus 159 ~~~--------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~-~~~~~~ 228 (288)
T cd07863 159 SCQ--------MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPE 228 (288)
T ss_pred cCc--------ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH-hCCCCh
Confidence 211 1122345789999999997654 899999999999999999999999876554433322211 0000
Q ss_pred -chhh-------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 257 -DYEK-------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 257 -~~~~-------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+.. ........+.++..+++||.+||+.||.+|||+.+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 000111224578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=363.23 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=209.2
Q ss_pred EeeecccCCeeEEEEEEe--CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 32 LDEIGVGVSAIVYKAICI--PMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~--~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
++.||+|+||.||++.+. ..+|+.||+|++..... ......+.+|+.++++++||||+++++++..++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999998764 24678999999875432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
.+|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------- 151 (318)
T cd05582 81 RGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------- 151 (318)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-------
Confidence 99999999976 467999999999999999999999999999999999999999999999999986532211
Q ss_pred CcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccc
Q 010624 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (506)
........||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.................. .+
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~------------~p 218 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG------------MP 218 (318)
T ss_pred CCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC------------CC
Confidence 11122346899999999997644 789999999999999999999999876554443333222211 23
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 269 KKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 269 ~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
..+++.+.+||.+||+.||.+||| +.+++.||||....
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 457889999999999999999999 77899999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=361.62 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=205.0
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHH-HHhhCCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETK-TMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||+||+|.++ .+|+.||+|++..... ......+.+|.. +++.++||||+++++.+.....+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999985 6789999999865321 222344555554 5678999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|..++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-------~ 150 (323)
T cd05575 80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-------S 150 (323)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-------C
Confidence 9999999976 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||................. ....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------~~~~ 217 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL------------RLKP 217 (323)
T ss_pred CccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC------------CCCC
Confidence 1223346899999999997654 89999999999999999999999987655443333222211 1234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH----HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA----EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~----~eiL~hp~f~~~~ 306 (506)
.++..+.++|.+||+.||.+||++ .++++||||...+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 568899999999999999999987 6999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.89 Aligned_cols=267 Identities=27% Similarity=0.380 Sum_probs=211.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-----EE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS-----RL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 101 (506)
+|++.+.||+|+||.||+|.+. .+++.||||.+.... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4889999999999999999984 678899999986432 2334567889999999999999999999998776 89
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999996 688888866 467999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh-
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK- 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 260 (506)
. ........+|+.|+|||++.+...++.++|||||||++|+|++|++||............. .....+....
T Consensus 157 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~g~~~~~~~ 229 (372)
T cd07853 157 E------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT-DLLGTPSLEAM 229 (372)
T ss_pred c------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HHcCCCCHHHH
Confidence 1 1112234578999999999876668999999999999999999999998766544332221 1111100000
Q ss_pred --------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 --------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 --------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...........++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000001223457889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=358.75 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=205.7
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhh-CCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+. .+++.||+|++..... ......+..|..+++. ++||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999985 5678999999875421 2334556678888875 589999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~ 150 (316)
T cd05619 80 GGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-------D 150 (316)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-------C
Confidence 9999999986 457899999999999999999999999999999999999999999999999987532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||................ ...+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------------~~~~~ 217 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN------------PCYPR 217 (316)
T ss_pred CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------CCCCc
Confidence 1123346899999999997654 8999999999999999999999998765544332221111 11234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHH-HHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSAE-KLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~~-eiL~hp~f~~~~ 306 (506)
.++.++++||.+||+.||.+||++. +++.||||+..+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 5788999999999999999999996 899999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=352.67 Aligned_cols=270 Identities=26% Similarity=0.444 Sum_probs=215.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..++|++.+.||.|+||.||+|.++ .++..||+|.+...........+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 3467999999999999999999985 567899999987655444455677899999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+. ++|..++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--- 157 (301)
T cd07873 83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 157 (301)
T ss_pred Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC---
Confidence 99997 6898888754 456899999999999999999999999999999999999999999999999987542211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc---cchhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF---SDYEKT 261 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~ 261 (506)
........+++.|+|||.+.+...++.++|||||||++|+|++|++||......+....... .... ..+...
T Consensus 158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (301)
T cd07873 158 ----TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR-ILGTPTEETWPGI 232 (301)
T ss_pred ----CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCChhhchhh
Confidence 11112335688999999987766688999999999999999999999987655433222111 0000 000000
Q ss_pred h----------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 262 L----------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 262 ~----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ........+++.+++||.+||+.||.+|||+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 0011223578899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.22 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=204.8
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHH-HHhhCCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETK-TMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.++ .+|+.||+|++.... .......+.+|.. +++.++||||+++++.+..++.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999985 678999999986532 1223345555554 5778999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|..++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.+|.+||+|||++...... .
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-------~ 150 (325)
T cd05604 80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-------S 150 (325)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-------C
Confidence 9999998876 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||................. ...+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~------------~~~~ 217 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL------------VLRP 217 (325)
T ss_pred CCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc------------cCCC
Confidence 1123446899999999997654 89999999999999999999999987655444333222211 1234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH----HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA----EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~----~eiL~hp~f~~~~ 306 (506)
..+..+.++|.+||..+|.+||++ .++++||||....
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 578889999999999999999976 5999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=368.56 Aligned_cols=257 Identities=32% Similarity=0.522 Sum_probs=215.9
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
-+||+|.||+||.|.++ .+...+|||.+....+ ...+-+..||...++|+|.|||++++++..++++-|+||-++|||
T Consensus 581 vVLGKGTYG~VYA~RD~-~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccc-cceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 35999999999999996 5678899999865433 445778899999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEeeccccccccCCCCCCCCCC
Q 010624 113 LQSIISSCFPDGL--PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 113 L~~~i~~~~~~~l--~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
|.++++... +++ ++..+..+-+||++||.|||.+.|||||||-+|+||+ -.|.+||+|||-|..... ..
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-------in 730 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-------IN 730 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-------CC
Confidence 999998764 456 8999999999999999999999999999999999998 689999999998654332 22
Q ss_pred cccccCCCCCccCChhhhh-ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccc
Q 010624 190 AMITDMAGTPYWMAPEVIR-SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~-~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (506)
.......||..|||||++. |..+|+.++|||||||++.||.||+|||............+- -++ .-+..+
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-myK--------vHP~iP 801 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-MYK--------VHPPIP 801 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-cee--------cCCCCc
Confidence 3445667999999999996 456799999999999999999999999987655443322211 111 012356
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 269 ~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
..++.+++.+|.+|+.+||.+||+|.++|..||++..++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 7889999999999999999999999999999999876443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.82 Aligned_cols=252 Identities=28% Similarity=0.517 Sum_probs=204.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++..+ +||||+++++++..++.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 46999999999999985 567899999987543 233456678899988776 79999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
+|+|..++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-------~ 150 (329)
T cd05618 80 GGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-------G 150 (329)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-------C
Confidence 9999998876 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhhcccccchhhh
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP--------EKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~~~ 261 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+...
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 220 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 220 (329)
T ss_pred CccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---------
Confidence 1122346899999999998654 89999999999999999999999953211 11111111110
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCC------HHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS------AEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt------~~eiL~hp~f~~~~ 306 (506)
....+..++..+++||.+||+.||.+||| +.++++||||++.+
T Consensus 221 --~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 221 --QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 01133567889999999999999999998 58999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=359.41 Aligned_cols=265 Identities=26% Similarity=0.429 Sum_probs=213.4
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||++.++ .+++.+|+|++.... .......+.+|+.++..++|+||+++++.+.+...+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999985 567899999986422 122345578899999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.+|+|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~--- 155 (332)
T cd05623 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--- 155 (332)
T ss_pred EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC---
Confidence 9999999999999763 357899999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||..................+.
T Consensus 156 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 228 (332)
T cd05623 156 ---GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---- 228 (332)
T ss_pred ---CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----
Confidence 1111223468999999999863 33478999999999999999999999987665554443332211111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~ 306 (506)
.+.....+++++++||.+||..++.+ |+++.++++||||...+
T Consensus 229 ---~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 229 ---FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred ---CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 11223457899999999999665444 68999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=356.87 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=211.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 104 (506)
+|++.+.||+|+||.||+|.++ .+++.||+|++.... .....+.+..|+.+++.+. |++|+++++++...+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4889999999999999999985 568899999987543 2233456778999998886 57788899999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--- 154 (323)
T cd05615 80 MEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--- 154 (323)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC---
Confidence 999999999999976 467999999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||..................
T Consensus 155 ----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~---------- 219 (323)
T cd05615 155 ----GVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS---------- 219 (323)
T ss_pred ----CccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 11122345899999999997654 899999999999999999999999876654443333322211
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..++.++.+++.+||+.+|.+|++ ..++++||||+..+
T Consensus 220 --~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 220 --YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred --CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 23457889999999999999999997 47899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=365.45 Aligned_cols=260 Identities=28% Similarity=0.474 Sum_probs=226.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE-EEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR-LWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~l 103 (506)
.+.|..++.||+|+||.++.+.++ .++..+++|.+.... .....+...+|+.+++++.|||||.+.++|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 578999999999999999999886 567899999998766 34445578899999999999999999999999888 999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||+||+||+|.+.|.......+++..+..|+.|++.|+.|||++.|+|||||+.||+++.++.|||+|||+|......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 999999999999999876678999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........|||+||.||++.+.+ |+.++|||||||++|||++-+++|...+.......+....+
T Consensus 160 -----~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~---------- 223 (426)
T KOG0589|consen 160 -----DSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY---------- 223 (426)
T ss_pred -----hhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC----------
Confidence 12445677999999999998766 99999999999999999999999997776665555544331
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...+..++.+++.||..||..+|..||++.++|.+|.....
T Consensus 224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 22456789999999999999999999999999999877643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=356.92 Aligned_cols=265 Identities=24% Similarity=0.414 Sum_probs=213.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||++.++ .+++.||+|++.... .......+.+|+.++..++|+||+++++++.+++..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999985 567899999986422 223345678899999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 155 (331)
T cd05624 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD--- 155 (331)
T ss_pred EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC---
Confidence 9999999999999763 357899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCcccccCCCCCccCChhhhhcc----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.................++.
T Consensus 156 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 228 (331)
T cd05624 156 ---GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---- 228 (331)
T ss_pred ---CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc----
Confidence 01112234689999999998652 2378899999999999999999999987665544333322211111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~ 306 (506)
.+.....+++++++||.+||...+.+ |++++++++||||+..+
T Consensus 229 ---~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 229 ---FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred ---CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 11122457889999999999876544 46899999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=346.21 Aligned_cols=266 Identities=29% Similarity=0.429 Sum_probs=210.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||+|++|.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5999999999999999999985 5688999999865432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|+. ++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 997 688888865432 56899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc----------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF---------- 255 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---------- 255 (506)
........+++.|+|||++.+...++.++|||||||++|+|++|++||...................
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 ---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1112233568899999998766667899999999999999999999998655433322221110000
Q ss_pred -cchhhh------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 256 -SDYEKT------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 256 -~~~~~~------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..+... .........+++++++||.+||+.||.+|||+.+|++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000000 00011233478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.81 Aligned_cols=266 Identities=50% Similarity=0.892 Sum_probs=219.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||.|+||+||+|.+. .++..+|+|.+.........+.+.+|+.+++.++|+||+++++.+..+...|++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999985 57889999998766555567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|+.+++|.+++..... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~- 158 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR- 158 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc-
Confidence 9999999999987544 56899999999999999999999999999999999999999999999999987654332111
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
.........|++.|+|||.+.....++.++|+|||||++|+|++|..||...+............. +.. ...
T Consensus 159 --~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~----~~~ 230 (267)
T cd06610 159 --TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP--PSL----ETG 230 (267)
T ss_pred --cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC--CCc----CCc
Confidence 001223445889999999987664589999999999999999999999987665544433332211 000 011
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.....+++.+.+++.+||..||++|||+.+|++||||
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 1124678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=347.69 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=204.4
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||+|+||.||++.++ .+|+.||+|.+..... ......+..|+.+++.++||||+++++++..+.++|+||||+.|++
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999985 5688999999864322 1223455679999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--------~~~ 151 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--------KTI 151 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--------cee
Confidence 999987654557999999999999999999999999999999999999999999999999986543211 112
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFS 272 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 272 (506)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................. .. .......++
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~ 223 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DE------VKFEHQNFT 223 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-cc------cccccccCC
Confidence 2346899999999997665 899999999999999999999999754322111111111000 00 011223578
Q ss_pred HHHHHHHHhhcccCCCCCCCH----HHHHcCccccccc
Q 010624 273 RAFKDMVASCLDQDPSKRPSA----EKLMKHSFFKNCN 306 (506)
Q Consensus 273 ~~l~~Li~~~L~~dP~~Rpt~----~eiL~hp~f~~~~ 306 (506)
+++++|+.+||+.||.+||++ .+++.||||+.++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 899999999999999999999 6788999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.94 Aligned_cols=261 Identities=24% Similarity=0.395 Sum_probs=214.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
..|.+.+.||+|+||.||+|.....++..||+|.+.... ......+++|+.+++.++||||++++++|..++.+|+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 349999999999999999998864447788999775443 3444677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|++||+|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~-- 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV-- 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc--
Confidence 999999999886532 3468999999999999999999999999999999999999999999999999976432211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................
T Consensus 224 ---~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------- 288 (478)
T PTZ00267 224 ---SLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----------- 288 (478)
T ss_pred ---ccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 111123445899999999997654 89999999999999999999999986655443333222211
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...+..++..+++||.+||..||++|||+.+++.|+|++..
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 11234578899999999999999999999999999999765
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.17 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=213.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC----hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS----RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
+.|++.+.||+|++|.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||+++++++..+..+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 57999999999999999999985 5688999999865432 223467889999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999999987 4568999999999999999999999999999999999999999999999999865322110
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
..........|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||..................
T Consensus 159 ----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------- 225 (263)
T cd06625 159 ----SSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-------- 225 (263)
T ss_pred ----cccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--------
Confidence 0011112345788999999998755 899999999999999999999999866554433322211111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+..++..+.++|.+||..+|.+|||+.++++||||
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 11334678899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.10 Aligned_cols=280 Identities=26% Similarity=0.394 Sum_probs=223.1
Q ss_pred cccccccccc--ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCC
Q 010624 9 QCSSTGTIAQ--KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSH 85 (506)
Q Consensus 9 ~~~~~~~~~~--~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~H 85 (506)
.|...+.... .........+|++.+.||+|+||+||+|.+. .+++.||||.+.... .......+.+|+.++..++|
T Consensus 12 ~~~~~~~~~~~d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h 90 (496)
T PTZ00283 12 VCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF 90 (496)
T ss_pred hccccccccCCCcccccccCCCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCC
Confidence 3444444322 2334456689999999999999999999985 568899999987654 34556678899999999999
Q ss_pred CCceeeeeEEEeCC--------EEEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Q 010624 86 PNILNAHCSFSVDS--------RLWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVK 155 (506)
Q Consensus 86 pnIv~l~~~~~~~~--------~~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIK 155 (506)
+||++++..+.... .+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.||+|||||
T Consensus 91 ~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLK 170 (496)
T PTZ00283 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIK 170 (496)
T ss_pred CcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999987775432 4789999999999999997532 3468999999999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCC
Q 010624 156 AGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP 235 (506)
Q Consensus 156 p~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~P 235 (506)
|+|||++.++.+||+|||++....... .........||+.|+|||++.+.. |+.++|||||||++|+|++|..|
T Consensus 171 P~NILl~~~~~vkL~DFGls~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 171 SANILLCSNGLVKLGDFGFSKMYAATV-----SDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred HHHEEEeCCCCEEEEecccCeeccccc-----cccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999975432111 111123456899999999998654 89999999999999999999999
Q ss_pred CCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 236 LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
|................. ...+..+++++.+|+.+||+.||.+|||+.++++|||++...
T Consensus 245 f~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 245 FDGENMEEVMHKTLAGRY-----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCCCHHHHHHHHhcCCC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 987655443333222211 113456789999999999999999999999999999988653
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=343.35 Aligned_cols=259 Identities=35% Similarity=0.590 Sum_probs=208.9
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhh-HHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD-LDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
|++.+.||+|+||+||+|.+. .+++.||+|.+........ .....+|+.+++.++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 899999999999999999995 6778999999987653332 23446699999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++... ..
T Consensus 80 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-------~~ 150 (260)
T PF00069_consen 80 CPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-------SE 150 (260)
T ss_dssp ETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-------TS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cc
Confidence 999999999984 467899999999999999999999999999999999999999999999999996532 11
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
.........+|+.|+|||++.....++.++||||||+++|+|++|..||........... +...... ... .....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-~~~~~~~-~~~---~~~~~ 225 (260)
T PF00069_consen 151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-IEKILKR-PLP---SSSQQ 225 (260)
T ss_dssp TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-HHHHHHT-HHH---HHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh-hhhcccc-ccc---ccccc
Confidence 222344566799999999997334489999999999999999999999987632222111 1110000 000 00001
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....+..+.++|.+||+.||++|||+.++++||||
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 11224899999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=359.10 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=205.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS---- 99 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (506)
..++|++.+.||+|+||.||+|.+. .+|..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3578999999999999999999985 568899999986543 2344567889999999999999999999986543
Q ss_pred --EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 100 --RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 100 --~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
.+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999975 56666643 488999999999999999999999999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||............... +..+.
T Consensus 173 ~~~--------~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~ 242 (359)
T cd07876 173 ACT--------NFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ-LGTPS 242 (359)
T ss_pred ccc--------CccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCc
Confidence 211 11123346799999999997654 899999999999999999999999866543322211110 00000
Q ss_pred h-----------------------h--hh---h---hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 Y-----------------------E--KT---L---KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~-----------------------~--~~---~---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. . .. . .........++.+++||.+||+.||++|||+.++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0 0 00 0 0000112346789999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.30 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=216.2
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
+..|.+....+++++.||+|.||.||.|.+ .+...||+|.+.... ...+.|.+|+++|++|+|+|||++++.+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~--~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKW--NGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEE--cCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 556888888999999999999999999998 345689999987542 2336788999999999999999999999998
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|||||||+.|+|.+++.......++......++.||++|++||+++++|||||-..||||++++.+||+|||+|...
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 89999999999999999999855678999999999999999999999999999999999999999999999999998732
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ........-..-|.|||.+.... ++.+||||||||+|+||+| |+.||...+..+. +..+.+.++.+
T Consensus 354 ~d~~------Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-~~~le~GyRlp- 424 (468)
T KOG0197|consen 354 GDDE------YTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-LELLERGYRLP- 424 (468)
T ss_pred CCCc------eeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHH-HHHHhccCcCC-
Confidence 2111 11111122234599999998655 8999999999999999999 8999987766554 44455555544
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.+..||+++.+++..||..+|++|||++.+.
T Consensus 425 ---------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ---------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 5577999999999999999999999998663
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=356.87 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=203.7
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHH-HHHhhCCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRET-KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||+||+|.+. .+++.||+|++..... ......+.+|. .+++.++||||+++++++...+.+|+||||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999985 5678999999865321 12223444444 45788999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
|++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-------~ 150 (325)
T cd05602 80 GGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-------N 150 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-------C
Confidence 9999999987 467899999999999999999999999999999999999999999999999987532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||................. ...+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------~~~~ 217 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL------------QLKP 217 (325)
T ss_pred CCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc------------CCCC
Confidence 1123446899999999998654 89999999999999999999999987655443332222111 1334
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHH----HHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSAE----KLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~~----eiL~hp~f~~~~ 306 (506)
.++..+.++|.+||+.||.+||++. ++++|+||...+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 6788999999999999999999875 899999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.89 Aligned_cols=261 Identities=27% Similarity=0.445 Sum_probs=229.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..-|.+.+.||+|.|++|-.|.+. .+|..||||++++.+. ......+.+|++.|+.+.|||||++|........+|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345999999999999999999886 7899999999987663 33456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEeeccccccccCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~DFGls~~~~~~~~ 183 (506)
+|.-.+|+|+++|-+. ..++++..++.|+.||+.|+.|||...+|||||||+|+++- .-|-|||+|||++.....
T Consensus 96 LELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--- 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--- 171 (864)
T ss_pred EEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC---
Confidence 9999999999998765 57899999999999999999999999999999999998765 789999999999764332
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........|+..|-|||++.|..+-.+++||||||||||-|+||++||...+..+.+-+++.-++.
T Consensus 172 -----G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------- 237 (864)
T KOG4717|consen 172 -----GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------- 237 (864)
T ss_pred -----cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---------
Confidence 233455678999999999999875567889999999999999999999999888888877766554
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
.+..++.+.++||..||..||.+|.|.++|..|+|++..+.+
T Consensus 238 ---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 238 ---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ---CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 346789999999999999999999999999999999976543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.72 Aligned_cols=268 Identities=25% Similarity=0.383 Sum_probs=219.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||+||+|.+. .++..||+|.+...... .....+.+|+.+++.++||||+++++.+..+...|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 47999999999999999999985 46889999999765433 3556788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.|++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999999999998654567999999999999999999999999999999999999999999999999987644322110
Q ss_pred CCC----------------------CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q 010624 185 HHH----------------------GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242 (506)
Q Consensus 185 ~~~----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~ 242 (506)
... .........||..|+|||.+.+.. ++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 000 001112346789999999997654 789999999999999999999999876655
Q ss_pred HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC----HHHHHcCccccccc
Q 010624 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS----AEKLMKHSFFKNCN 306 (506)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt----~~eiL~hp~f~~~~ 306 (506)
............++ ....++..++++|.+||+.||++||| +.+++.||||++..
T Consensus 239 ~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 239 ETFSNILKKEVTFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHHhcCCccCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 44433332222211 11237889999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=359.79 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=203.7
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC---CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL---SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
||+|+||+||+|.++ .++..||+|++..... .........|..++..+ +||||+++++.+..+..+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999985 5688999999864321 12233455677777655 69999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
+|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-------~ 150 (330)
T cd05586 80 GGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-------N 150 (330)
T ss_pred CChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-------C
Confidence 9999999876 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+...++.++|||||||++|+|++|..||..................+ ...
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------~~~ 219 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-----------PKN 219 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-----------CCc
Confidence 112234689999999999766568999999999999999999999998765544333222222111 123
Q ss_pred hhhHHHHHHHHhhcccCCCCCC----CHHHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRP----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rp----t~~eiL~hp~f~~~~ 306 (506)
.+++++++||.+||+.||.+|| ++.++++||||+...
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 4688999999999999999998 799999999998763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.50 Aligned_cols=266 Identities=29% Similarity=0.513 Sum_probs=212.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||+|+||.||+|.+. .++..+|+|.+...........+.+|+.+++.++||||++++++|..++.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46999999999999999999985 56789999998765555556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 152 (308)
T cd06615 80 HMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 152 (308)
T ss_pred ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc-----
Confidence 9999999999987 3678999999999999999999998 5999999999999999999999999998643211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch-------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY------- 258 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 258 (506)
.......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......... ............
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 153 ----SMANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ----cccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccc
Confidence 1112346789999999987644 889999999999999999999999754432211 111110000000
Q ss_pred -------hh---------hh----hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 -------EK---------TL----KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 -------~~---------~~----~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. .. .+......++.++++|+.+||..+|++|||+.++++||||.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00 00 00001123678899999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.53 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=211.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|++.+.||+|+||.||+|.+. .+++.||+|.+..... ......+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 4889999999999999999996 5688999999865432 222356778999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.|++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 155 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---- 155 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC----
Confidence 9999999999987654567999999999999999999999999999999999999999999999999987532211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcccccchhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS--LLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||........ .........
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05630 156 ----QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------- 220 (285)
T ss_pred ----ccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----------
Confidence 1112346899999999997654 89999999999999999999999975432111 111110000
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~ 305 (506)
.......+++++++|+.+||+.||++||| +.++++||||+..
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 01123457889999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=354.72 Aligned_cols=252 Identities=27% Similarity=0.503 Sum_probs=205.7
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.++..+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 46999999999999985 5678999999975432 23456788999999888 59999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||+|..++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------~ 150 (327)
T cd05617 80 GGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-------G 150 (327)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-------C
Confidence 9999998876 467999999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhhcccccchhhhhh
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP------EKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+...
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 218 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------- 218 (327)
T ss_pred CceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-----------
Confidence 1123346899999999997654 89999999999999999999999963211 11122111110
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCC------HHHHHcCccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPS------AEKLMKHSFFKNCN 306 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt------~~eiL~hp~f~~~~ 306 (506)
....+..++..+.+++.+||+.||.+|++ +.++++||||+..+
T Consensus 219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 11133457888999999999999999998 57999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=345.97 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=208.1
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||+|+||.||+|.+. .+|..||+|.+..... ......+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 5999999999999999999985 5688999999865432 2223567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+. ++|.+++... ...+++..++.++.||++||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~----- 152 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----- 152 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-----
Confidence 997 5788877653 356999999999999999999999999999999999999999999999999986532211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc----------
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS---------- 256 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 256 (506)
........+++.|+|||.+.+...++.++|||||||++|+|++|..||............+......+
T Consensus 153 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 153 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 11122345688999999997766578999999999999999999888654443332222221111100
Q ss_pred --------chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 257 --------DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 257 --------~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..........+.+++++++||.+||+.||.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000001111234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=357.57 Aligned_cols=264 Identities=23% Similarity=0.374 Sum_probs=207.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------ 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (506)
+++|++++.||+|+||+||+|.+. .++..||||.+..... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 578999999999999999999985 5678999999865432 23345677899999999999999999887543
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 3578999998 7899888864 57999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|..||............... ...+..
T Consensus 169 ~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 237 (343)
T cd07878 169 DD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV-VGTPSP 237 (343)
T ss_pred CC----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-hCCCCH
Confidence 21 1123458999999999977556899999999999999999999999765443332222111 000000
Q ss_pred h-----------hhh---------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 E-----------KTL---------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~-----------~~~---------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ... .........++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 000 0000112356678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.99 Aligned_cols=266 Identities=28% Similarity=0.464 Sum_probs=211.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||.||+|.++ .+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 47999999999999999999985 5688999998865432 233456789999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07847 80 EYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--- 154 (286)
T ss_pred eccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc---
Confidence 99999988888765 4579999999999999999999999999999999999999999999999999876432211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-----------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----------- 254 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~----------- 254 (506)
.......++..|+|||.+.+...++.++|||||||++|+|++|.+||......+...........
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 ----DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred ----ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 01123357889999999876555789999999999999999999999866554433222110000
Q ss_pred --------ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 255 --------FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 255 --------~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..............++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000000000001123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=355.68 Aligned_cols=265 Identities=27% Similarity=0.356 Sum_probs=207.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD----- 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (506)
..++|++.+.||+|+||.||+|.+. ..++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4578999999999999999999985 567899999986543 234456788999999999999999999887543
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
..+|+||||+. ++|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 36799999997 577777753 488999999999999999999999999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||............+.. +..+.
T Consensus 176 ~~~~--------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~ 245 (364)
T cd07875 176 AGTS--------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ-LGTPC 245 (364)
T ss_pred cCCC--------CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCC
Confidence 3211 1122346899999999998654 899999999999999999999999876654443332211 11000
Q ss_pred hhh--h---------------------hh--------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 YEK--T---------------------LK--------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~~~--~---------------------~~--------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
... . .. ........+..+++||.+||+.||.+|||+.++|+||||..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 0 00 000112235678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=353.64 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=203.2
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHH-HHhhCCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETK-TMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|.. +++.++||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999985 6688999999865321 222334555554 6788999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
|++|...+.. ...+++..+..++.||+.||.|||++|++||||||+||+++.+|.+||+|||++...... .
T Consensus 80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-------~ 150 (321)
T cd05603 80 GGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-------E 150 (321)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-------C
Confidence 9999998876 467899999999999999999999999999999999999999999999999986532111 1
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+............. ..+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------~~~~ 217 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL------------QLPG 217 (321)
T ss_pred CccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC------------CCCC
Confidence 1123346899999999997654 89999999999999999999999987654433322222111 1234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCH----HHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSA----EKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~----~eiL~hp~f~~~~ 306 (506)
..+..+.++|.+||+.||.+||++ .++++|+||...+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 567889999999999999999875 5999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.90 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=213.3
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|+..+.||+|+||+||+|.+. .+++.||+|.+..... ......+.+|+.+++.++|+||+++++.+..++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 4888999999999999999985 5688999999865432 222345778999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---- 155 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---- 155 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC----
Confidence 9999999999987654557999999999999999999999999999999999999999999999999987532211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
.......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||............ ....... ..
T Consensus 156 ----~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~-~~~~~~~-------~~ 222 (285)
T cd05632 156 ----ESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV-DRRVLET-------EE 222 (285)
T ss_pred ----CcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhhhcc-------cc
Confidence 1112346899999999997654 899999999999999999999999865443222111 1111100 01
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.....++..+.+|+.+||+.||++||| +.+++.|+||+..+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 123457888999999999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.67 Aligned_cols=265 Identities=38% Similarity=0.622 Sum_probs=218.9
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+.-...+|++.+.||+|+||.||+|.+. .++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+..+
T Consensus 12 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccccCCcccceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 4556666789999999999999999999985 56789999998765433 346788999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
...|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999999999999975 46899999999999999999999999999999999999999999999999986542
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ........|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||....+.............
T Consensus 167 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 234 (296)
T cd06654 167 TPE-------QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---- 234 (296)
T ss_pred ccc-------ccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC----
Confidence 211 11122345889999999987644 789999999999999999999999876554433322211110
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+..++..+.+++.+||..+|++|||+.+++.||||...
T Consensus 235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 235 -----ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -----CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 011234577889999999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=354.98 Aligned_cols=265 Identities=27% Similarity=0.356 Sum_probs=206.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD----- 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (506)
..++|++.+.||+|+||.||+|.+. ..++.||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4578999999999999999999885 567899999986543 234456778999999999999999999988643
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999974 66666643 488999999999999999999999999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||............+... ..+.
T Consensus 169 ~~~~--------~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 238 (355)
T cd07874 169 AGTS--------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL-GTPC 238 (355)
T ss_pred CCCc--------cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCC
Confidence 2211 1123346899999999997654 8999999999999999999999998665443332222110 0000
Q ss_pred hh-------------------------hh---h---hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 YE-------------------------KT---L---KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~~-------------------------~~---~---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.. .. . .........+..+++||.+||+.||++|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 00 0 0000112245678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.09 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=199.5
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC------CCceeeeeEEEeC
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH------PNILNAHCSFSVD 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 98 (506)
...+|++++.||+|+||+||+|.+. .+++.||||++.... .....+..|+.+++.+.| ++|++++++|..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4578999999999999999999985 567899999986421 223445667777777654 4588888888764
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCC-----------
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDG----------- 165 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g----------- 165 (506)
.++|+||+++ |++|.+++.. ...+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 5789999988 6889988876 4679999999999999999999998 5999999999999998765
Q ss_pred -----CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 010624 166 -----SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP 240 (506)
Q Consensus 166 -----~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~ 240 (506)
.+||+|||++.... .......||+.|+|||++.+.. |+.++|||||||++|||++|++||....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred CCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999754211 1122456899999999998754 8999999999999999999999998665
Q ss_pred hHHHHHHHHhhcccccchh-------------------------hhh-hhh----ccchhhhHHHHHHHHhhcccCCCCC
Q 010624 241 PEKSLLMKMTQRFRFSDYE-------------------------KTL-KIK----DKNKKFSRAFKDMVASCLDQDPSKR 290 (506)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~-------------------------~~~-~~~----~~~~~~s~~l~~Li~~~L~~dP~~R 290 (506)
..+...........++... ... ... ......++.+.+||.+||+.||.+|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 4433222111100000000 000 000 0000124568899999999999999
Q ss_pred CCHHHHHcCcccccc
Q 010624 291 PSAEKLMKHSFFKNC 305 (506)
Q Consensus 291 pt~~eiL~hp~f~~~ 305 (506)
||+.|+|+||||.+.
T Consensus 430 ~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 430 LNARQMTTHPYVLKY 444 (467)
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=349.96 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=194.8
Q ss_pred EeeecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEEEEeccC
Q 010624 32 LDEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLWVVMPFM 108 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~ 108 (506)
..+||+|+||+||+|.++. .+++.||+|.+..... ...+.+|+.+++.++||||++++++|.. +..+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 4689999999999998742 3567899999864322 2346789999999999999999998854 56789999998
Q ss_pred CCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe----CCCCCeEEeecccccc
Q 010624 109 SCGSLQSIISSCF-------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS----DSDGSVKLADFGVSAS 177 (506)
Q Consensus 109 ~ggsL~~~i~~~~-------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl----d~~g~vKL~DFGls~~ 177 (506)
. ++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 6 68888876421 2358999999999999999999999999999999999999 4567899999999754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHH
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--------KSLLMKM 249 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--------~~~~~~~ 249 (506)
..... ..........||+.|+|||++.+...++.++||||+||++|+|++|.+||...... ......+
T Consensus 162 ~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 162 FNSPL----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred cCCCC----ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 32111 01112234568999999999987666899999999999999999999999643211 0111111
Q ss_pred hhcccccchhhhh---------------------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 250 TQRFRFSDYEKTL---------------------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 250 ~~~~~~~~~~~~~---------------------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
......+...... .........+..+.+||.+||+.||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111110000000 0000111235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=341.43 Aligned_cols=261 Identities=31% Similarity=0.530 Sum_probs=210.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|.+..+........+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 46899999999999999999985 56789999998766555555678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~------ 147 (279)
T cd06619 80 FMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------ 147 (279)
T ss_pred cCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc------
Confidence 9999999644 2478899999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHhhcccccchhhhhhh
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL--MKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 264 (506)
.......||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.......... ........... ..
T Consensus 148 ---~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~ 218 (279)
T cd06619 148 ---SIAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PP 218 (279)
T ss_pred ---ccccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CC
Confidence 1122346889999999997654 8999999999999999999999996532211100 00000000000 00
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccch
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGV 309 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~ 309 (506)
.......++++++++.+||+.+|++||++.++++||||...+.+.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~ 263 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence 012234678899999999999999999999999999999875544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=334.28 Aligned_cols=255 Identities=26% Similarity=0.471 Sum_probs=211.3
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-CCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV-DSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~ 105 (506)
+|++.+.||.|++|.||++.++ .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999985 567899999987543 33455678899999999999999999988864 45789999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 9999999999998755567999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
........|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+............ ..
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----------~~ 220 (257)
T cd08223 156 ---CDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-----------LP 220 (257)
T ss_pred ---CCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------CC
Confidence 11122345789999999987654 7899999999999999999999997655443322222111 11
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..+..+++.+.+++.+||+.+|.+|||+.++++||||
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1334678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.91 Aligned_cols=254 Identities=37% Similarity=0.609 Sum_probs=218.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|.-++.||.|+||.||-|.|. .+...||||.+.... +......+..|+..|.+++|||+|.+.++|..+...|+||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~-~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeecc-CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4777899999999999999996 677999999987654 3445678999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||- ||-.|++.-. .+++-+.+|+.|..+.+.||+|||+.+.||||||..|||++..|.|||+|||.+...
T Consensus 106 EYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------- 176 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------- 176 (948)
T ss_pred HHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-------
Confidence 9996 7777777543 478999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......|||+|||||++.. ...|+-++|||||||+..||.-++||+.+.+....++.+..+...
T Consensus 177 ----~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP--------- 243 (948)
T KOG0577|consen 177 ----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------- 243 (948)
T ss_pred ----CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC---------
Confidence 22345679999999999863 345999999999999999999999999888777766655443211
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.......|..++.|+..||++-|.+|||.+++|+|+|+...
T Consensus 244 -tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 244 -TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 11346788999999999999999999999999999999865
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=332.95 Aligned_cols=255 Identities=26% Similarity=0.493 Sum_probs=213.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|.+.+.||+|++|.||+|.+. .++..|++|.+.... .....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5899999999999999999985 568899999987543 34556788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 999999999998765567999999999999999999999999999999999999999999999999986533211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........|++.|+|||++.+.. ++.++|+|||||++++|++|..||................. ..
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~ 220 (256)
T cd08529 155 --TNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-----------PP 220 (256)
T ss_pred --cchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------CC
Confidence 11122345788999999997654 88999999999999999999999986654433322221111 11
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....++..+.+++.+||+.+|++||++.++++|||+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 223577899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=339.45 Aligned_cols=258 Identities=43% Similarity=0.742 Sum_probs=216.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||.|+||.||+|.+. .+++.||+|.+...........+.+|+.+++.++||||+++++++.++..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 47999999999999999999985 57899999999766555556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.+++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 152 (274)
T cd06609 80 YCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---- 152 (274)
T ss_pred eeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc----
Confidence 9999999999986 378999999999999999999999999999999999999999999999999865433211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.......|++.|+|||.+.+.. ++.++|||||||++|+|++|.+||....+.......... .. + ..
T Consensus 153 ---~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~-~--------~~ 218 (274)
T cd06609 153 ---SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NP-P--------SL 218 (274)
T ss_pred ---cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CC-C--------CC
Confidence 1223345788999999998655 899999999999999999999999765543322211111 00 0 00
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....++.++.+++.+||..+|++|||+.++++||||.+..
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 1112788999999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.96 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=209.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
++.++|++.+.||+|+||.||+|.++. ..+..||+|.+...........+.+|+.+++.++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 566789999999999999999998642 345789999998765555567788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999999763 357899999999999999999999999999999999999999999999999975432111
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........+++.|+|||.+.+.. ++.++|||||||++|++++ |..||......... ..+......
T Consensus 161 ------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~-~~~~~~~~~----- 227 (266)
T cd05064 161 ------AIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-KAVEDGFRL----- 227 (266)
T ss_pred ------chhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCC-----
Confidence 011122334567899999987654 8999999999999999775 99999876554432 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||+.+|.+|||+.+|++
T Consensus 228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 123557889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=337.05 Aligned_cols=260 Identities=34% Similarity=0.588 Sum_probs=211.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-----hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-----RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
+|++.+.||.|+||.||+|.+ .++..+|+|.+..... ......+.+|+.+++.++|+||+++++++.+...+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 588999999999999999987 4678999999865432 223457889999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+++||+.+++|.+++.+ ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 79 IFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999999976 3578999999999999999999999999999999999999999999999999876432110
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.. ...........|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||..................
T Consensus 157 ~~-~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (265)
T cd06631 157 LH-GTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-------- 226 (265)
T ss_pred cc-ccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC--------
Confidence 00 00111122346899999999997644 789999999999999999999999765544332222111111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..+..++.++.++|.+||..+|.+|||+.++++||||
T Consensus 227 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112345678899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=339.07 Aligned_cols=257 Identities=37% Similarity=0.656 Sum_probs=209.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVD------ 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------ 98 (506)
.+.|++.+.||.|+||.||+|.+. .+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456999999999999999999885 567899999986543 3345788999999998 699999999998753
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|++|||+.+++|.+++.......+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999998755567999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
... ........|++.|+|||++.+ ...++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~- 233 (272)
T cd06637 162 DRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA- 233 (272)
T ss_pred ccc-------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC-
Confidence 211 111234458899999999863 22478899999999999999999999976554433322111100
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.......++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 234 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 ---------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 111234577899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=341.78 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=214.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 47999999999999999999985 567899999986533 233457788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999987 467999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.................
T Consensus 155 -------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 215 (290)
T cd05580 155 -------TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV----------- 215 (290)
T ss_pred -------CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 22345789999999987653 78899999999999999999999987654333322221111
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
..+..++..++++|.+||..||.+|+ ++.++++||||+...
T Consensus 216 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 216 -RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 12344688999999999999999999 999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=341.27 Aligned_cols=267 Identities=28% Similarity=0.455 Sum_probs=208.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||.|++|.||+|.++ .+++.||||.+...........+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 368999999999999999999985 5678999999876543333345678999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+. ++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 156 (291)
T cd07844 83 EYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---- 156 (291)
T ss_pred ecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC----
Confidence 9998 5999988764 347899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh-----
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK----- 260 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 260 (506)
........+++.|+|||.+.+...++.++||||+||++|+|++|.+||............+......+....
T Consensus 157 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 ---SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred ---CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 011122346788999999876555889999999999999999999999765422222221111111000000
Q ss_pred --------------hhhhhccchhhh--HHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 261 --------------TLKIKDKNKKFS--RAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 261 --------------~~~~~~~~~~~s--~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..........++ ..+.+++.+||+.+|++|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000111233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.22 Aligned_cols=266 Identities=24% Similarity=0.401 Sum_probs=212.6
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceee
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNA 91 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 91 (506)
.....+.+..++|++.+.||+|+||.||+|.+. ..++..||+|++.........+.+.+|+.+++.+ +||||+++
T Consensus 25 ~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 25 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred CCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeee
Confidence 345567777889999999999999999999752 2346689999987554445567788999999999 89999999
Q ss_pred eeEEEeCCEEEEEeccCCCCCHHHHHHhhC--------------------------------------------------
Q 010624 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCF-------------------------------------------------- 121 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~-------------------------------------------------- 121 (506)
++++...+..++|||||++|+|.+++....
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 999999999999999999999999986531
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 122 -----------------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 122 -----------------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 124788899999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
..... ........++..|+|||++.+.. ++.++|||||||++|+|++ |..||............+.......
T Consensus 265 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~- 337 (375)
T cd05104 265 RNDSN-----YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML- 337 (375)
T ss_pred cCccc-----ccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-
Confidence 22110 01112233567799999997654 8999999999999999998 8999987655444444333322111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+...+.++++|+.+||+.||++|||+.+|++
T Consensus 338 ---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 338 ---------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 22345778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=339.53 Aligned_cols=266 Identities=27% Similarity=0.440 Sum_probs=212.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5999999999999999999985 5688999999876542 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 99999998764 36799999999999999999999999999999999999999999999999998664322110
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh------
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK------ 260 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------ 260 (506)
.......|+..|+|||.+.+...++.++||||+||++|+|++|.+||.............. .+..+....
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR-TLGTPNEETWPGLTS 230 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH-HcCCCChHHHhhccC
Confidence 1122346889999999987655578999999999999999999888876554433322221 111000000
Q ss_pred -------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 261 -------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 261 -------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
........+..+..+.+||.+||..+|.+|||+.+++.||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000112234678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=338.18 Aligned_cols=259 Identities=39% Similarity=0.654 Sum_probs=209.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 3467999999999999999999985 568899999986443 23345688999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 999999999999976 467899999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........|++.|+|||.+.. ...++.++|+|||||++|+|++|.+||....+...........+..+.
T Consensus 160 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 230 (267)
T cd06646 160 ----IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK----- 230 (267)
T ss_pred ----ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC-----
Confidence 111223457889999999852 233678999999999999999999999755443322111111111110
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~ 301 (506)
......++..+.+||.+||..+|++|||+++|++|+|
T Consensus 231 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 231 --LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0112346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=340.02 Aligned_cols=261 Identities=40% Similarity=0.669 Sum_probs=214.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++++.||.|+||.||+|.+. .++..+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 356999999999999999999985 46789999998654 3445577889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---- 156 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---- 156 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence 999999999998764 356999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........||+.|+|||.+.. ...++.++|+|||||++|+|++|.+||................. +
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~----- 226 (280)
T cd06611 157 ---LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP--P----- 226 (280)
T ss_pred ---ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC--C-----
Confidence 111223457899999999852 22367899999999999999999999987655443322211100 0
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+..++..+.++|.+||+.+|.+|||+.++++||||.+.
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 --TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 011234578899999999999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=336.29 Aligned_cols=267 Identities=29% Similarity=0.440 Sum_probs=219.0
Q ss_pred eeEE-eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEec
Q 010624 29 YKIL-DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 29 Y~i~-~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 106 (506)
|++. +.||+|+|+.|--++.. .+|..||||++++. ....+.++.||++++.++. |+||+.++++|+++..+|+|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i-~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSI-QTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHhHHHHhcCccceeeeeeeee-ccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 5554 45799999999999987 67899999999866 4455678889999999986 9999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEeeccccccccCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLADFGVSASIYEPSH 183 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~DFGls~~~~~~~~ 183 (506)
.|.||+|...|.+ ...+++.++.++.++|+.||.|||.+||.||||||+|||..... -||||||.+.........
T Consensus 157 Km~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999999999988 47899999999999999999999999999999999999986543 499999998665444333
Q ss_pred CCCCCCcccccCCCCCccCChhhhh----ccCCCCccccHHHHHHHHHHHHhCCCCCCCCC----------hHHHHHHH-
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIR----SHTGYSFKADIWSFGITALELAHGRPPLSHLP----------PEKSLLMK- 248 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~----~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~----------~~~~~~~~- 248 (506)
.............|+..|||||+.. ....|+.++|.||||+|+|.|++|.+||.+.- ........
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 3333444556677899999999864 23458999999999999999999999996421 11122222
Q ss_pred ----HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 249 ----MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 249 ----~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
....+.|++ ..+..+|.+.++||..+|..++.+|.++.++++|||++.+..
T Consensus 315 FesIQEGkYeFPd--------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 315 FESIQEGKYEFPD--------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHhccCCcCCh--------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 223333433 245689999999999999999999999999999999997743
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=338.60 Aligned_cols=260 Identities=40% Similarity=0.662 Sum_probs=211.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
...++|++.+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 34468999999999999999999885 5688999999865532 334567899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
+|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 84 CMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred EEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 9999999999999976 467999999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCCcccccCCCCCccCChhhhh--ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIR--SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~--~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........|++.|+|||.+. ....++.++|+|||||++|+|++|..||....+..............+.
T Consensus 160 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 230 (267)
T cd06645 160 -----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK---- 230 (267)
T ss_pred -----ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCc----
Confidence 11123346899999999974 2234788999999999999999999999765544333222221111110
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~ 301 (506)
......++..+.++|.+||..+|++|||+.++++|||
T Consensus 231 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 ---LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0112246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=341.94 Aligned_cols=264 Identities=27% Similarity=0.516 Sum_probs=214.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++++.||+|+||.||+|.+. .++..||+|.+...........+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 47999999999999999999985 56889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999999999887631 2379999999999999999999997 59999999999999999999999999986532111
Q ss_pred CCCCCcccccCCCCCccCChhhhhccC-----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHT-----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~-----~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
......|++.|+|||.+.+.. .++.++|+|||||++|+|++|..||......... ..+......
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~---- 225 (286)
T cd06622 157 ------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDG---- 225 (286)
T ss_pred ------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhc----
Confidence 122335788999999985432 2578999999999999999999999754433221 111110000
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
.....+..+++++.++|.+||+.+|++||++.+++.||||......
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 226 ---DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ---CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 0111334588999999999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.76 Aligned_cols=264 Identities=37% Similarity=0.633 Sum_probs=214.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
...+.|++++.||.|+||.||+|.+. .++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++.+|+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 34467999999999999999999885 56789999998644 34456778899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+++++|..++.+. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred EEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999999999888653 356899999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
........|++.|+|||.+.+ ...++.++|+|||||++|+|++|.+||............... ..+
T Consensus 164 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~--- 233 (292)
T cd06644 164 -----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP--- 233 (292)
T ss_pred -----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc---
Confidence 111223457889999999852 233688999999999999999999999765543332222111 000
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....+..++.++.++|.+||..+|++||++.++++||||...+
T Consensus 234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0112345778899999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.45 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=205.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC---------------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP---------------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~---------------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (506)
+...+|++.+.||+|+||.||+|.+.. .++..||+|.+...........+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 456789999999999999999997631 23457999998766555566789999999999999999
Q ss_pred eeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 010624 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF-----------------PDGLPEPCIAIVLKETLSALSYLHNQGHLH 151 (506)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~-----------------~~~l~e~~i~~i~~qil~gL~yLHs~givH 151 (506)
+++++++.+.+..++||||+.+|+|.+++.... ...+++..+..++.||+.||.|||+.|++|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986531 123678889999999999999999999999
Q ss_pred CCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh
Q 010624 152 RDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231 (506)
Q Consensus 152 rDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt 231 (506)
|||||+|||++.++.+||+|||++....... .........+++.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-----YYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILM 235 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-----eeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHH
Confidence 9999999999999999999999875432110 011122334578899999987654 8999999999999999986
Q ss_pred --CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 232 --GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 232 --G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
+..||........... ....+..... ......+..++..+.+|+.+||+.||.+|||+.+|.
T Consensus 236 ~~~~~p~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 236 LCKEQPYGELTDEQVIEN-AGEFFRDQGR---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred ccCCCCCCcCCHHHHHHH-HHHHhhhccc---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 5678876554433221 1111000000 000112346788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.07 Aligned_cols=263 Identities=38% Similarity=0.620 Sum_probs=217.6
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.+.-...+|++.+.||.|+||.||+|.+. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..+..
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 34445567999999999999999999985 5688999999865433 335678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+|+||+.+++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999999875 4689999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........|++.|+|||.+.+.. ++.++|||||||++|+|++|..||..................
T Consensus 168 ~-------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~------ 233 (296)
T cd06655 168 E-------QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------ 233 (296)
T ss_pred c-------cccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc------
Confidence 1 11122345788999999987644 789999999999999999999999876654443322211110
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+..+++.+.++|.+||..||.+|||+.++++||||+.+
T Consensus 234 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 234 ---ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ---ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 011334678899999999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.38 Aligned_cols=259 Identities=36% Similarity=0.616 Sum_probs=212.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
-|++.+.||.|+||.||+|.+. .++..+|+|.+... .....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3789999999999999999985 56788999998643 344567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.+++|..++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999999987653 357999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 188 GSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|+|||++.. ...++.++|||||||++|+|++|.+||..................
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------- 226 (282)
T cd06643 157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------- 226 (282)
T ss_pred -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC---------
Confidence 111223457899999999842 233678999999999999999999999876554433332221110
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+..++..+++||.+||+.||.+|||+.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 001234578899999999999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.33 Aligned_cols=259 Identities=28% Similarity=0.501 Sum_probs=210.7
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--------hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--------TDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+|.+...||.|+||.||+|.+. .+++.+|+|.+...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 4888999999999999999985 56789999988654321 12357889999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999987 4678999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
...... ..........|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.............. ..
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~------ 228 (267)
T cd06628 158 ANSLST-KTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NA------ 228 (267)
T ss_pred cccccC-CccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cC------
Confidence 211100 0111122345788999999987644 78899999999999999999999986654333222111 00
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..+..++..+.++|.+||+.||.+||++.++++||||
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 111334678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.73 Aligned_cols=263 Identities=29% Similarity=0.500 Sum_probs=207.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHH-HhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT-MSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||.||+|.++ .+|+.||||.+...........+..|+.+ ++.++||||+++++++..++.+|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 47999999999999999999985 56899999998765433333445556654 67789999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
||++ |+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 157 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS- 157 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc-
Confidence 9997 78888876532 34689999999999999999999998 9999999999999999999999999986532111
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhcc---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSH---TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||..................
T Consensus 158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 225 (283)
T cd06617 158 -------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS----- 225 (283)
T ss_pred -------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-----
Confidence 111224578899999998642 33688999999999999999999999753322111111111110
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
.......++.++.++|.+||..+|.+|||+.++++||||.+..+.
T Consensus 226 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 226 ----PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 011123478899999999999999999999999999999987544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=355.31 Aligned_cols=264 Identities=20% Similarity=0.358 Sum_probs=210.4
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeee
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHC 93 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (506)
...|.+..++|++.+.||+|+||.||+|.+.. .++..||+|.+.........+.+.+|+.+++.+ +||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 34566778899999999999999999998642 233579999997665555567888999999999 8999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhC----------------------------------------------------
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCF---------------------------------------------------- 121 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~---------------------------------------------------- 121 (506)
++...+..|+|||||.+|+|.+++....
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999999999999986431
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 122 ----------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 122 ----------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~--- 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--- 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc---
Confidence 1247888999999999999999999999999999999999999999999999975432110
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.........+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...................
T Consensus 267 --~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--------- 334 (374)
T cd05106 267 --NYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--------- 334 (374)
T ss_pred --ceeeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc---------
Confidence 011112233567799999987544 8999999999999999997 999998655443333322222111
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++++++++.+||+.||.+|||+.++++
T Consensus 335 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=340.50 Aligned_cols=266 Identities=28% Similarity=0.460 Sum_probs=210.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999985 56789999987654322 34567889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+++|..+... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 99999999888765 4569999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-----------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----------- 254 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~----------- 254 (506)
.......|+..|+|||.+.+...++.++|||||||++|+|++|.+||......+...........
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 ----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred ----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 11122357889999999876555788999999999999999999999755443322221110000
Q ss_pred --------ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 255 --------FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 255 --------~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+............+.++..+.+|+.+||+.+|++|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000000111234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.79 Aligned_cols=250 Identities=16% Similarity=0.230 Sum_probs=203.5
Q ss_pred CCCCCeeEE--eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--
Q 010624 24 LDPSSYKIL--DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSV-- 97 (506)
Q Consensus 24 ~~~~~Y~i~--~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 97 (506)
++.+++... ..||+|+++.||+|.. +|+.||||.+..... ....+.+.+|+.+|++++||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 344444444 6799999999999987 578999999875432 2235778899999999999999999999876
Q ss_pred --CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 98 --DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 98 --~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
...+++||||+.+|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 4578999999999999999987 46789999999999999999999984 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
+..... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.................
T Consensus 170 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 239 (283)
T PHA02988 170 EKILSS----------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239 (283)
T ss_pred Hhhhcc----------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 653211 11234578999999999752 3589999999999999999999999987765544333322222
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+.+ .+..+++.+++|+.+||+.||++|||+.++++
T Consensus 240 ~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 240 SLK----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCC----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111 22357889999999999999999999999974
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.61 Aligned_cols=258 Identities=38% Similarity=0.688 Sum_probs=215.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
..|+..+.||.|+||.||+|.+. .++..||+|.+...........+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45889999999999999999985 56789999998766555667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.|++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc----
Confidence 9999999999875 568999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.......++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||....+....... .. .. .+.
T Consensus 156 ---~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~-~~---------~~~ 220 (277)
T cd06640 156 ---IKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PK-NN---------PPT 220 (277)
T ss_pred ---cccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hc-CC---------CCC
Confidence 1122345788999999987654 789999999999999999999999865544322211 10 00 111
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
....++..+.+++.+||+.+|++||++.++++||||.+...
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 33457788999999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.94 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=205.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
...+|++++.||.|+||.||+|.... ..+..||+|.+... ....+|+.+++.++||||++++++|......|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34579999999999999999997632 34578999987543 234589999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
+||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 164 v~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~- 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP- 239 (392)
T ss_pred EehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc-
Confidence 999996 788888854 4679999999999999999999999999999999999999999999999999875332211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhccc-----cc
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK--SLLMKMTQRFR-----FS 256 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~-----~~ 256 (506)
.........||+.|+|||++.+.. |+.++|||||||++|+|++|+.||....... ..+..+...+. ++
T Consensus 240 ----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 240 ----DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred ----ccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 111123456899999999997654 8999999999999999999999997543211 11111111110 00
Q ss_pred chh-----h-------h----hhhh--ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 DYE-----K-------T----LKIK--DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~-----~-------~----~~~~--~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
... . . ...+ .....++.++.++|.+||..||.+|||+.++|.||||+..+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 000 0 0 0000 01123567889999999999999999999999999998753
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=330.71 Aligned_cols=259 Identities=42% Similarity=0.714 Sum_probs=213.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||.|+||.||+|.+. .+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++..+..+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 468999999999999999999985 45788999998755433 5678899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 999999999998763 257999999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........|+..|+|||.+.+. ..++.++|+|||||++|+|++|.+||................+....
T Consensus 155 ---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 225 (262)
T cd06613 155 ---IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK------ 225 (262)
T ss_pred ---hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc------
Confidence 0112234578899999998654 24788999999999999999999999876655544333222211111
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~ 301 (506)
......++.++.+++.+||..+|..|||+.+++.|+|
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 -LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0123456788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.05 Aligned_cols=259 Identities=29% Similarity=0.508 Sum_probs=208.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DS 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (506)
+.+|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 357999999999999999999985 567899999886432 22345678899999999999999999998875 46
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 78999999999999999986 3568999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
... ..........|+..|+|||.+.+.. ++.++|||||||++|+|++|..||.................
T Consensus 158 ~~~----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~------ 226 (266)
T cd06651 158 TIC----MSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT------ 226 (266)
T ss_pred ccc----ccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC------
Confidence 110 0011112345788999999997644 78999999999999999999999986654443332221110
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.+..+..+++.+++++ +||..+|++|||+.++++||||+
T Consensus 227 ----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 1112345778899999 68888999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.12 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=213.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||+|+||.||++.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999985 578899999986543 33445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999999998754456899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........|++.|+|||++.+.. ++.++|+|||||++|+|++|..||................. ..
T Consensus 155 --~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----------~~ 220 (256)
T cd08218 155 --VELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-----------PP 220 (256)
T ss_pred --hhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-----------CC
Confidence 11112345788999999987654 78899999999999999999999986655544333322211 11
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..++.++.++|.+||+.+|++||++.++++||||
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.59 Aligned_cols=266 Identities=28% Similarity=0.419 Sum_probs=206.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||+|+||.||+|.+. .++..||+|.+...........+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 67999999999999999999985 56789999998765443334466789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+. ++|.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 156 (291)
T cd07870 84 YMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP----- 156 (291)
T ss_pred ccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-----
Confidence 996 6777766543 356888999999999999999999999999999999999999999999999986532211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc----------
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS---------- 256 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 256 (506)
........+++.|+|||.+.+...++.++|||||||++|+|++|..||...................+
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 --SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred --CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 11122334688999999987655578899999999999999999999976554322222221111100
Q ss_pred --chhhh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 257 --DYEKT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 257 --~~~~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+... ..........+..+.+++.+||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 00000011236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.71 Aligned_cols=263 Identities=38% Similarity=0.632 Sum_probs=215.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+.-...+|++.+.||+|+||.||+|.+. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3344578999999999999999999985 5678999999875443 3346788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999999999975 46899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||................ .+
T Consensus 169 -------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~--~~----- 233 (297)
T cd06656 169 -------QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TP----- 233 (297)
T ss_pred -------ccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC--CC-----
Confidence 11122345789999999997644 7899999999999999999999997654433221111100 00
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....+..++..+++|+.+||..+|++|||+.++++||||+...
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 234 --ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 1112345778899999999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.31 Aligned_cols=255 Identities=40% Similarity=0.704 Sum_probs=211.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||+|+||.||+|.+. .++..+|+|.+.... ..+.+.+|+.+++.++||||+++++++..+..+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 467999999999999999999985 457899999986432 2678999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 999999999999753 357899999999999999999999999999999999999999999999999986643221
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
........|+..|+|||.+.+.. ++.++|||||||++|+|++|++||................. . ..
T Consensus 153 ---~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------~~ 219 (256)
T cd06612 153 ---MAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP--P-------TL 219 (256)
T ss_pred ---ccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC--C-------CC
Confidence 11122344788999999997654 89999999999999999999999986554433222111100 0 01
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..+..++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 1234567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=353.63 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=200.0
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+...+|++++.||+|+||.||+|.+. .++..||+|+.... ....|+.+++.++||||+++++++......++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 44557999999999999999999985 56789999975322 23469999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+. ++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 999996 6888887653 457999999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCC-CCCChH--H------HHHHHHhhccc
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL-SHLPPE--K------SLLMKMTQRFR 254 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf-~~~~~~--~------~~~~~~~~~~~ 254 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|+++..|+ ...+.. . ..+..+.....
T Consensus 211 ------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 211 ------PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred ------cccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 1122345899999999997654 899999999999999999865444 332211 0 00111111110
Q ss_pred cc--chh---------hhhh------------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 255 FS--DYE---------KTLK------------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 255 ~~--~~~---------~~~~------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.. .+. .... .......++.++.+||.+||+.||.+|||+.++|+||||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 000 0000 00011245677889999999999999999999999999986
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.84 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=210.5
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-C-----CCceeeeeEEEeCCEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-H-----PNILNAHCSFSVDSRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~~~ 101 (506)
+|++++.||+|+||.|.+|.+. .+++.||||+++... ....+...|+.+|..|+ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEec-CCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 7999999999999999999996 678999999997543 34456668999999998 4 3999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC--CCCeEEeecccccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS--DGSVKLADFGVSASIY 179 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~--~g~vKL~DFGls~~~~ 179 (506)
|||+|.+. .+|+++++...-.+++...++.++.||+.||.+||+.||||+||||+|||+.. ...|||+|||.|....
T Consensus 264 ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 99999995 99999999987778999999999999999999999999999999999999974 3479999999976543
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc----
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF---- 255 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---- 255 (506)
.. .....-+..|.|||++.|.+ |+.+.||||||||++||++|.+.|.+.+..+.+..++. .+..
T Consensus 343 q~----------vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e-~lG~Pp~~ 410 (586)
T KOG0667|consen 343 QR----------VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE-VLGLPPPK 410 (586)
T ss_pred Cc----------ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH-HhCCCCHH
Confidence 22 11344588999999999876 99999999999999999999888887665555433321 1000
Q ss_pred ------------cc----------hh-----------h-----hhh--hh-cc-------chhhhHHHHHHHHhhcccCC
Q 010624 256 ------------SD----------YE-----------K-----TLK--IK-DK-------NKKFSRAFKDMVASCLDQDP 287 (506)
Q Consensus 256 ------------~~----------~~-----------~-----~~~--~~-~~-------~~~~s~~l~~Li~~~L~~dP 287 (506)
.. .. . ... .+ .. .......+.+||++||..||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 00 00 0 000 00 00 01223567899999999999
Q ss_pred CCCCCHHHHHcCcccccc
Q 010624 288 SKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 288 ~~Rpt~~eiL~hp~f~~~ 305 (506)
.+|+|+.++|+||||...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999854
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=335.37 Aligned_cols=260 Identities=38% Similarity=0.694 Sum_probs=214.3
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC---CCCceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---HPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 104 (506)
.|++.+.||+|+||.||+|.+. .++..||+|.+...........+.+|+.+++.++ ||||+++++++..+...|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 5889999999999999999985 5678999999876655556678889999999997 99999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 81 MEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred EecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence 999999999999875 478999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......|++.|+|||.+.+...++.++|+|||||++|+|++|.+||........... ... ...+
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~-~~~~-------- 220 (277)
T cd06917 156 -----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPK-SKPP-------- 220 (277)
T ss_pred -----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-ccc-CCCC--------
Confidence 1122345888999999987655578999999999999999999999976544332211 110 0000
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
......++.++.+++.+||+.||++|||+.+++.||||++....
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 00112377899999999999999999999999999999876443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.43 Aligned_cols=266 Identities=29% Similarity=0.457 Sum_probs=210.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||.|++|.||+|.+. .++..||||.+..... ......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4899999999999999999985 5678999999865442 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+. ++|..++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 996 68999987755567999999999999999999999999999999999999999999999999986532211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc----------
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS---------- 256 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 256 (506)
........+++.|+|||.+.+...++.++|||||||++|+|++|+.||....................
T Consensus 154 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 154 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 11122334688899999987655568899999999999999999999986655443332221100000
Q ss_pred -chhhh------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 257 -DYEKT------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 257 -~~~~~------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+... .......+.+++.++++|.+||+.||++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00000 00011123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.40 Aligned_cols=261 Identities=39% Similarity=0.710 Sum_probs=215.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+.|++.+.||+|+||.||+|.+. .++..||+|.+.........+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 35888899999999999999985 56789999998766555566788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT----- 154 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-----
Confidence 9999999999864 57899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||....+....... .... ...
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~----------~~~ 220 (277)
T cd06642 155 --QIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNS----------PPT 220 (277)
T ss_pred --chhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCC----------CCC
Confidence 11122345788999999997654 889999999999999999999999765443322211 1100 111
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccchh
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVE 310 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~~ 310 (506)
....++..+.++|.+||+.+|++|||+.++++||||..+.....
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 264 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhHH
Confidence 23356788999999999999999999999999999998754433
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.19 Aligned_cols=261 Identities=24% Similarity=0.426 Sum_probs=218.9
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
..|.+..+...+...||+|.||+||+|.+. | .||||++..+. .....+.|++|+.++++-+|.||+-+.+++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 458899999999999999999999999983 3 59999998765 456789999999999999999999999999988
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+. .||+-||.|-+|+.+++-. ...|.......|++||++|+.|||.++|||||||..||++.+++.|||+|||++...
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 87 8999999999999999864 357999999999999999999999999999999999999999999999999997754
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
... ..........|...|||||+++.. ..|++.+|||||||++|||++|..||. ....+.++..+.+.+..+
T Consensus 539 ~~w-----~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 539 TRW-----SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred eee-----ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCc
Confidence 433 223334556788999999999743 348999999999999999999999998 444444333332222111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+ ......++++++++|+..||.+++++||++.+||.
T Consensus 613 d------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 D------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred c------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1 12245678899999999999999999999999874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=338.52 Aligned_cols=267 Identities=26% Similarity=0.441 Sum_probs=214.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||++.+. ..++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+..++.+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 46999999999999999999985 5678999999865432 23456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999977 357899999999999999999999999999999999999999999999999987532111000
Q ss_pred CC--------CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 185 HH--------HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 185 ~~--------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.. ..........|++.|+|||.+.... ++.++|+|||||++|+|++|..||......+............+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 00 0000112245788999999987644 89999999999999999999999986655443333222211111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS---AEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt---~~eiL~hp~f~~~~ 306 (506)
.....++..+.++|.+||+.+|++||| +.++++||||....
T Consensus 237 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 237 ---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 122357889999999999999999998 79999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=336.94 Aligned_cols=263 Identities=26% Similarity=0.441 Sum_probs=230.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
-.+.+++|..+++||+|.||+|..+..+ .+++.+|||++++... ......-..|-++|+..+||.+..+..+|+...
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeec-ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 4466788999999999999999999886 6789999999976652 334456678999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
++++||||.+||.|+-++.. ...+++...+.+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||++....
T Consensus 242 rlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999887 5789999999999999999999999999999999999999999999999999965432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
. .........|||.|+|||++..+. |+.++|+|.+|+++|||+||+.||++......+-.++...++|+
T Consensus 320 ~-------~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP--- 388 (516)
T KOG0690|consen 320 K-------YGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP--- 388 (516)
T ss_pred c-------ccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC---
Confidence 2 233455678999999999998654 99999999999999999999999998887777766666666543
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCcccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCNK 307 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~~ 307 (506)
..++++++.|+..+|.+||.+|. .+.+|+.|+||..+++
T Consensus 389 ---------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 389 ---------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred ---------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 56899999999999999999996 5889999999999854
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=377.67 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=213.9
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--C
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--D 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 98 (506)
.+....+|++++.||+|+||+||+|.++ .++..||+|.+.... .......+.+|+.+++.++|||||+++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3445578999999999999999999996 567899999987543 33456778899999999999999999998854 4
Q ss_pred CEEEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCccCCCCCCCEEeCC------
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQ-------GHLHRDVKAGNILSDS------ 163 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~-------givHrDIKp~NILld~------ 163 (506)
..+|+||||+.+|+|.++|.... ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 57999999999999999997642 24699999999999999999999985 4999999999999964
Q ss_pred -----------CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHh
Q 010624 164 -----------DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAH 231 (506)
Q Consensus 164 -----------~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLlt 231 (506)
.+.+||+|||++...... .......||+.|+|||++.+. ..++.++||||||||+|+|++
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE--------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc--------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 335999999997543211 112234689999999998643 347899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 232 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
|..||............+..... ......+.++.+||..||..+|.+|||+.++|.||||+...
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~p~-----------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRGPD-----------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcCCC-----------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 99999865554444333322111 11234678999999999999999999999999999998663
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.35 Aligned_cols=276 Identities=38% Similarity=0.605 Sum_probs=210.6
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
|.+.+.+|.|+++ |.+.+. .+++.||+|.+... ......+.+.+|+.+++.++||||++++++|......|++|||
T Consensus 4 ~~i~~~~~~~~~v--~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIV--HLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceE--EEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 4445555555554 444553 46889999998765 3455667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.+++|.+++.......+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+............
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999999998766677999999999999999999999999999999999999999999999999987544322111111
Q ss_pred CCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc-------cchh
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF-------SDYE 259 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~ 259 (506)
.........++..|+|||++... ..|+.++|+|||||++|+|++|..||................... +...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11222344578889999998653 348899999999999999999999998766554433332211100 0000
Q ss_pred ---------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 260 ---------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 260 ---------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
...........++.++.+|+.+||..||++|||+.++++||||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 000001122346778999999999999999999999999999997743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=335.42 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=213.2
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
|.++.++|++.+.||+|+||.||+|.++. ..+..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 56788999999999999999999997642 23568999998765544455678899999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEE
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFP--------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~--------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL 169 (506)
....|+||||+.+|+|.+++..... ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999999975321 23567788999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~ 248 (506)
+|||++....... .........++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||......+.....
T Consensus 161 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETD-----YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CcCCccccccccc-----cccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999865322111 011112233567799999987654 8999999999999999998 78899765554432222
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc------Ccccccc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK------HSFFKNC 305 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~------hp~f~~~ 305 (506)
..... ...+..+++.+++++.+||+.||.+|||+.++++ ||||+.+
T Consensus 235 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 235 MDGGY-----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HcCCC-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 11110 1123456789999999999999999999999986 8999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.27 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=210.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCC----CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~----~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+..++|++.+.||+|+||.||+|.+.... ...||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34568999999999999999999875322 26799999876655556678899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g 165 (506)
..|++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999976421 4588999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 010624 166 SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKS 244 (506)
Q Consensus 166 ~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~ 244 (506)
.+||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSAD-----YYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cEEECCCcceeeccccc-----cccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999875432110 011122334678899999987654 8999999999999999998 9999987665443
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
... +..... ...+..++.++.+|+.+||+.||.+|||+.+|+++
T Consensus 236 ~~~-i~~~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEM-IRSRQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHH-HHcCCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322 222111 11345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=331.76 Aligned_cols=260 Identities=35% Similarity=0.624 Sum_probs=210.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCC---
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDS--- 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~--- 99 (506)
...++|++.+.||.|++|.||+|.++ .+++.+++|.+..... ..+.+.+|+.+++.+ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 34578999999999999999999985 5678999999865432 346788999999998 6999999999997644
Q ss_pred ---EEEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 100 ---RLWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 100 ---~~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
.+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999999987643 46799999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhcc----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
+...... ........|++.|+|||.+... ..++.++|||||||++|+|++|.+||..............
T Consensus 160 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 160 SAQLDST-------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred ceecccc-------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 6533211 1112334588999999998532 3367899999999999999999999976544443332221
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
... . .......++..+++||.+||..||++|||+.++++|||+
T Consensus 233 ~~~--~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 NPP--P-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cCC--C-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 110 0 001123467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=348.23 Aligned_cols=268 Identities=26% Similarity=0.399 Sum_probs=225.0
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+++..+.|+.-++||+||||.||-+..+ .+|+.+|.|.+.+.... .......+|-.||.+++.+.||.+-.+|++.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 5788899999999999999999998885 77899999998765432 22345678999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+++|+..|+||+|.-+|.+..+.++++..+..++.+|+.||++||+.+||+||+||+|||+|++|+|+|+|.|+|....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999999999877899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .......||.+|||||++.... |+...|+|||||++|+|+.|+.||....... ....+.+++. ..
T Consensus 339 ~g--------~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-k~eEvdrr~~-~~-- 405 (591)
T KOG0986|consen 339 EG--------KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-KREEVDRRTL-ED-- 405 (591)
T ss_pred CC--------CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhh-hHHHHHHHHh-cc--
Confidence 22 2233447999999999998776 9999999999999999999999997543221 1111111111 00
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCcccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCNK 307 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~~ 307 (506)
....+.++|+++++|.+.+|..||++|. +++++.+||||++.+.
T Consensus 406 ----~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 406 ----PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred ----hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 1124578999999999999999999997 5679999999999864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=331.82 Aligned_cols=262 Identities=27% Similarity=0.502 Sum_probs=209.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-----hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-----RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.|+..+.||+|+||.||+|.+. .++..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 4888999999999999999985 6688999999865432 123568899999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeeccccccccCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYEP 181 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~~~ 181 (506)
+||||+.|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999986 45789999999999999999999999999999999999998776 5999999986543322
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
.. ..........||..|+|||.+.+.. ++.++|+||+||++|+|++|..||..................
T Consensus 158 ~~---~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (268)
T cd06630 158 GT---GAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA------- 226 (268)
T ss_pred cc---cCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-------
Confidence 10 0011122345788999999987644 789999999999999999999999754332211111100000
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
......+..+++++.+++.+||..+|++|||+.++++||||+
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 001123456788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=333.40 Aligned_cols=266 Identities=27% Similarity=0.411 Sum_probs=211.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
+|++.+.||.|++|.||+|.+. .+|..||||.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5999999999999999999985 678999999997665545556778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 108 MSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 108 ~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
+. ++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||++......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~----- 153 (284)
T cd07836 80 MD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP----- 153 (284)
T ss_pred CC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC-----
Confidence 98 48888886542 246899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc-----------
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF----------- 255 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~----------- 255 (506)
........+++.|+|||.+.+...++.++|||||||++|+|++|.+||......+............
T Consensus 154 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 --VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred --ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 1111233468899999998765557899999999999999999999998765544333222110000
Q ss_pred cchhh------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 256 SDYEK------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 256 ~~~~~------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
+.+.. ........+.++..+++++.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 000011123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=345.62 Aligned_cols=274 Identities=35% Similarity=0.576 Sum_probs=209.5
Q ss_pred Eeeeccc--CCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 32 LDEIGVG--VSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 32 ~~~IG~G--~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
...||.| +||+||+|.+. .+|+.||+|++.... .....+.+.+|+.+++.++||||++++++|..+...|+||||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 3467777 99999999985 678999999987654 3344578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+|++|||.+.............
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999999988666679999999999999999999999999999999999999999999999998643222111111011
Q ss_pred CcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc-------hhh
Q 010624 189 SAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD-------YEK 260 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~ 260 (506)
........++..|+|||++.+. ..++.++|||||||++|+|++|.+||...................+. ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1111223456779999999753 34789999999999999999999999876544433322221100000 000
Q ss_pred ------------------------h----hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 ------------------------T----LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ------------------------~----~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. .........+++.+++|+.+||+.||++|||+.++++||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0 000011234678899999999999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=329.00 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=209.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DS 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (506)
+.+|++.+.||+|+||.||.|.+. .++..||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER 79 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence 468999999999999999999985 568899999886432 12345688899999999999999999998876 35
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 78899999999999999986 3568999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.... .........|+..|+|||.+.+.. ++.++|||||||++|+|++|..||................ .
T Consensus 158 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~----- 226 (265)
T cd06652 158 TICL----SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-T----- 226 (265)
T ss_pred cccc----cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-C-----
Confidence 1100 011122345889999999997644 7899999999999999999999998664444332221111 0
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
....+...+..+.++|.+||. +|.+|||++++++|||++
T Consensus 227 ----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 111344677889999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.23 Aligned_cols=258 Identities=36% Similarity=0.644 Sum_probs=209.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe------
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSV------ 97 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------ 97 (506)
..+.|++.+.||.|+||.||+|.+. .+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 4578999999999999999999985 567899999986542 3345688899999988 69999999998853
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...+|++|||+.+|+|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46889999999999999999876556789999999999999999999999999999999999999999999999998653
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
.... ........|++.|+|||.+.. ...++.++|+|||||++|+|++|.+||....+...........
T Consensus 171 ~~~~-------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~- 242 (282)
T cd06636 171 LDRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP- 242 (282)
T ss_pred hhcc-------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC-
Confidence 3211 111223458899999999852 2347889999999999999999999997655443332211110
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
........++..+.+||.+||+.||.+|||+.+|++||||
T Consensus 243 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ---------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0111234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.13 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=214.3
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++++.||.|+||.||.+.+. .++..+++|.+.... .......+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 5999999999999999999885 567889999987654 34556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987545678999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......+.......... ..
T Consensus 156 ---~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----------~~ 220 (256)
T cd08221 156 ---SMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-----------TP 220 (256)
T ss_pred ---ccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------CC
Confidence 0123345799999999987654 78899999999999999999999986555443333322211 11
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....++.++.+++.+||..+|.+|||+.++++|||+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 224578899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=340.25 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=193.5
Q ss_pred EeeecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEEEEeccC
Q 010624 32 LDEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLWVVMPFM 108 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~ 108 (506)
..+||+|+||+||+|.++. .++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3579999999999998742 2457899998864322 2456789999999999999999998853 56889999998
Q ss_pred CCCCHHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe----CCCCCeEEeecccccc
Q 010624 109 SCGSLQSIISSC-------FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS----DSDGSVKLADFGVSAS 177 (506)
Q Consensus 109 ~ggsL~~~i~~~-------~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl----d~~g~vKL~DFGls~~ 177 (506)
. ++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7 5788877532 12358899999999999999999999999999999999999 5667999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHH
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--------KSLLMKM 249 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--------~~~~~~~ 249 (506)
...... .........||+.|+|||++.+...++.++|||||||++|+|++|.+||...... ......+
T Consensus 162 ~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 162 FNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred cCCCcc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 322110 1111233467999999999977555899999999999999999999999643211 0011111
Q ss_pred hhcccccc---h------------hhh------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 250 TQRFRFSD---Y------------EKT------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 250 ~~~~~~~~---~------------~~~------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
......+. + ... ..........+..+.+|+.+||+.||.+|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11100000 0 000 00001112345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=336.88 Aligned_cols=268 Identities=31% Similarity=0.380 Sum_probs=212.1
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh----hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+|++.+.||.|+||.||+|.+. .+++.||||.+...... .....+..|+.+++.++|+||+++++++.+...+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 4899999999999999999985 56789999998765432 223456789999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+ +++|.+++.... ..+++..+..++.||++||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 156 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN- 156 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-
Confidence 99999 899999997632 379999999999999999999999999999999999999999999999999976432211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh--
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT-- 261 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 261 (506)
.......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||............. ..+..+.....
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (298)
T cd07841 157 ------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF-EALGTPTEENWPG 229 (298)
T ss_pred ------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH-HHcCCCchhhhhh
Confidence 112223467889999998765557899999999999999999988887655433322221 11111100000
Q ss_pred ---------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 ---------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ---------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..........+..+.++|.+||..+|++|||+.+++.||||++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000111244578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=333.27 Aligned_cols=266 Identities=30% Similarity=0.484 Sum_probs=211.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 104 (506)
++|+..+.||.|++|.||+|.+. .+++.+|+|.+...........+.+|+++++.++||||++++++|.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 47999999999999999999985 56899999998766555556788999999999999999999998865 3478999
Q ss_pred eccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 105 MPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
|||+++++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~- 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS- 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc-
Confidence 9999999999987542 2356899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhcccccch
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP----EKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~ 258 (506)
......++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... ........... ..+..
T Consensus 159 --------~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 228 (287)
T cd06621 159 --------LAGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPEL 228 (287)
T ss_pred --------ccccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cchhh
Confidence 112335788899999987654 89999999999999999999999975521 11111111111 00000
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
. .........++.+.++|.+||..+|.+|||+.++++||||++..+
T Consensus 229 ~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 229 K---DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred c---cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 0 001111346788999999999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=327.19 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=210.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
+|++.+.||.|+||.||++.+. .++..+|+|.+.........+.+.+|+.+++.++||||+++++.+..++.+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999985 567899999987665556677888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~------ 153 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------ 153 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc------
Confidence 99999999987654566899999999999999999999999999999999999999999999999986533211
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
........|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.................. ..
T Consensus 154 -~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~ 220 (255)
T cd08219 154 -GAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-----------PL 220 (255)
T ss_pred -ccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------CC
Confidence 11122345889999999987654 889999999999999999999999865544433222211111 12
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
+..++..+.+||.+||+.||++|||+.+++.-
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 34567889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.16 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=209.2
Q ss_pred CCeeEE-eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe----CCE
Q 010624 27 SSYKIL-DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSV----DSR 100 (506)
Q Consensus 27 ~~Y~i~-~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~ 100 (506)
++|.|- ++||-|-.|.|..+.++ .+++.+|+|++.. ....++|++..-.. .|||||.+++.|+. ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k-~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHK-RTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEec-cchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 456664 56899999999999986 6789999998742 24466888875444 59999999988754 467
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeecccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSAS 177 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~~ 177 (506)
+.+|||.++||.|++.|.......+++.++..|++||..|+.|||+.+|.||||||+|+|... |..+||+|||+|..
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 899999999999999999987788999999999999999999999999999999999999874 56799999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhhcc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE----KSLLMKMTQRF 253 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~----~~~~~~~~~~~ 253 (506)
... ........-||+|.|||++.. ..|+..+|+||+||++|.|+||.+||+..... .....+....+
T Consensus 214 t~~--------~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 214 TQE--------PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred cCC--------CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 432 122334456999999999964 45999999999999999999999999864331 12223334445
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.|+.. .+..+|++++++|+++|..+|++|.|+.+++.|||+....
T Consensus 285 ~FP~p--------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 285 EFPEP--------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred cCCCh--------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 55443 4567899999999999999999999999999999998764
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=326.94 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=211.5
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||.|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5999999999999999999985 568899999987653 33456788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-CCeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-g~vKL~DFGls~~~~~~~~~~ 185 (506)
|+++++|.+++.......+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999987655668999999999999999999999999999999999999855 46899999986543211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
.......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||................. .
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-----------~ 219 (256)
T cd08220 156 ----SKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-----------A 219 (256)
T ss_pred ----ccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----------C
Confidence 1122345788999999997644 78899999999999999999999976655443332222111 1
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.....++..+++++.+||..+|.+|||+.+++.||||
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 1234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.92 Aligned_cols=257 Identities=34% Similarity=0.555 Sum_probs=212.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||.|+||.||+|.++ .+++.+|+|.+...........+.+|+.+++.++||||+++++++..+..+|+++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 46899999999999999999985 56789999998776555566788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|+.+++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999998742 678999999999999999999999 99999999999999999999999999986432111
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhcccccchhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP----EKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 261 (506)
......|+..|+|||.+.+. .++.++|||||||++|+|++|..||..... ............
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 220 (265)
T cd06605 155 -----LAKTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-------- 220 (265)
T ss_pred -----HhhcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--------
Confidence 11115678899999999765 489999999999999999999999975421 111111111110
Q ss_pred hhhhccch-hhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 262 LKIKDKNK-KFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 262 ~~~~~~~~-~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+. .++.+++++|.+||..||++|||+.+++.||||+..
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 --PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 001112 278899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=329.37 Aligned_cols=255 Identities=21% Similarity=0.416 Sum_probs=209.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+..++|++.++||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYY--NNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEe--cCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 567889999999999999999999987 356789999875432 2356888999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+.+++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999998755567899999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.......... .+......+
T Consensus 157 ~------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~---- 224 (261)
T cd05072 157 E------YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-ALQRGYRMP---- 224 (261)
T ss_pred c------eeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH-HHHcCCCCC----
Confidence 0 01112234567899999987644 7899999999999999998 999997655444322 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
....++.++.+++.+||..+|++|||++++.+
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 225 ------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 23457889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=343.62 Aligned_cols=271 Identities=24% Similarity=0.365 Sum_probs=209.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----CE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-----SR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 100 (506)
.++|++.+.||+|+||.||+|.+. .+|+.||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 367999999999999999999985 568899999986543344556778899999999999999999876544 35
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+++||+. ++|..++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999997 588888764 5799999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
... .........||+.|+|||.+.+...++.++|||||||++|+|++|++||........... +......+....
T Consensus 159 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~-~~~~~~~~~~~~ 233 (336)
T cd07849 159 EHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL-ILGVLGTPSQED 233 (336)
T ss_pred ccc----ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCCHHH
Confidence 111 111123346899999999986655588999999999999999999999976543222111 111010000000
Q ss_pred --------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 --------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 --------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
........+..++++.++|.+||+.+|++|||+.++++||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000011234578899999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=351.53 Aligned_cols=265 Identities=22% Similarity=0.369 Sum_probs=213.2
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAH 92 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 92 (506)
...+|.+..++|++++.||+|+||.||+|.+.. ..+..||||.+.........+.+.+|+.+++.++ ||||++++
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 345788899999999999999999999998742 2235799999976655555678999999999996 99999999
Q ss_pred eEEEeCCEEEEEeccCCCCCHHHHHHhhC---------------------------------------------------
Q 010624 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCF--------------------------------------------------- 121 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~--------------------------------------------------- 121 (506)
+++...+.+|+|||||++|+|.+++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999886531
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCC
Q 010624 122 -------------------------------------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGN 158 (506)
Q Consensus 122 -------------------------------------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~N 158 (506)
...+++..+..++.|++.||+|||+.+++||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 1247888899999999999999999999999999999
Q ss_pred EEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCC
Q 010624 159 ILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLS 237 (506)
Q Consensus 159 ILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~ 237 (506)
||++.++.+||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDS-----NYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccc-----cccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 999999999999999976432211 111122334678899999997654 8999999999999999997 999997
Q ss_pred CCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 238 HLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...........+...... ..+..++..+.+++.+||+.+|++|||+.++.+
T Consensus 342 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 342 GMIVDSTFYNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ccchhHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 654443333333322211 123457889999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=334.46 Aligned_cols=267 Identities=27% Similarity=0.392 Sum_probs=208.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCE----
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSR---- 100 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~---- 100 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|.+...... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999985 57889999998654322 23456788999999995 6999999999887665
Q ss_pred -EEEEeccCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeecccc
Q 010624 101 -LWVVMPFMSCGSLQSIISSCF---PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVS 175 (506)
Q Consensus 101 -~~lV~Ey~~ggsL~~~i~~~~---~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls 175 (506)
.|++|||+.+ +|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999985 8888886543 235899999999999999999999999999999999999998 899999999986
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
...... ........+++.|+|||.+.+...++.++|||||||++|+|++|.+||............... ...
T Consensus 159 ~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~ 230 (295)
T cd07837 159 RAFSIP-------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL-LGT 230 (295)
T ss_pred eecCCC-------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH-hCC
Confidence 533211 111122346888999999876555789999999999999999999999876554443332211 000
Q ss_pred cc---hh--------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 256 SD---YE--------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 256 ~~---~~--------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
+. +. .........+.++..+.+||.+||..||.+|||+.+++.||||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 00 00001112245788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=332.31 Aligned_cols=261 Identities=24% Similarity=0.374 Sum_probs=208.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
|.+..++|++.+.||+|+||.||+|.+.. ..+..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45677899999999999999999998642 23568999998654444455678899999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEE
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFP--------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~--------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL 169 (506)
+...++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999976321 23678889999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~ 248 (506)
+|||++........ ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||............
T Consensus 161 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99998653321110 01112234577899999997654 8999999999999999999 78899766554333222
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..... ...+..++..+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCc-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21111 11234577889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=328.95 Aligned_cols=256 Identities=22% Similarity=0.443 Sum_probs=210.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+...+|.+.+.||+|+||.||+|.++ .+++.||+|.+..+ ......+.+|+.+++.++||||+++++++..++.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 5677888999999999999999999986 56789999998643 33456788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
+++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999998755567999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+. ...+.....
T Consensus 158 ~------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~------ 223 (263)
T cd05052 158 T------YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYR------ 223 (263)
T ss_pred e------eeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCC------
Confidence 0 11111223466799999987654 8899999999999999998 9999976544332 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..++..+.+++.+||+.+|++|||+.++++
T Consensus 224 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 ----MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1134567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=333.07 Aligned_cols=267 Identities=27% Similarity=0.473 Sum_probs=210.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+.+|+.+++.++|+||+++++++..++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 46999999999999999999985 5678999999865432 334578899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.++.+..+... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 99998777766655 45699999999999999999999999999999999999999999999999998654332211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc------------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF------------ 253 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~------------ 253 (506)
.......|+++|+|||++.+...++.++||||||+++|+|++|.+||.................
T Consensus 156 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 156 ----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 1122345788999999998764589999999999999999999999976544332222111000
Q ss_pred -------cccchhhhhh-hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 254 -------RFSDYEKTLK-IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 254 -------~~~~~~~~~~-~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+........ ....+..++.++++||.+||..+|++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000000000 001123358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=332.43 Aligned_cols=255 Identities=39% Similarity=0.701 Sum_probs=212.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
-|++.+.||.|+||.||+|.+. .++..||+|.+...........+.+|+.+++.++||||+++++++..+...|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3888999999999999999884 567899999987655555567888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.+++|..++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~------ 154 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------ 154 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc------
Confidence 999999999875 46899999999999999999999999999999999999999999999999986533211
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
........|+..|+|||.+.+. .++.++|+|||||++|+|++|..||............... . .+..
T Consensus 155 -~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~---------~~~~ 221 (277)
T cd06641 155 -QIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--N---------PPTL 221 (277)
T ss_pred -hhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--C---------CCCC
Confidence 1112234578899999998754 3788999999999999999999999765443322221111 0 1112
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...++.++.+++.+||..+|.+||++.++++||||.+.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 34578889999999999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=357.04 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=202.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
....|.+.+.||+|+||.||+|.+. ..++.||||... ...+.+|+.+|+.++|||||++++++..++..++|
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3457999999999999999999985 567899999642 22356899999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|+++. ++|..++... ...+++..+..|+.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 239 ~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 99995 7888888653 3469999999999999999999999999999999999999999999999999975432110
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhh-ccccc
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP-------EKSLLMKMTQ-RFRFS 256 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~-------~~~~~~~~~~-~~~~~ 256 (506)
.........||+.|+|||++.+.. ++.++|||||||++|||++|..|+..... .......+.. .....
T Consensus 315 ---~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 315 ---STPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ---ccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 011122346899999999998754 89999999999999999998866543211 1111111111 00000
Q ss_pred chhh--------hh--------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 257 DYEK--------TL--------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 257 ~~~~--------~~--------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.+.. .. ........++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000 00 000011235668999999999999999999999999999974
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=331.09 Aligned_cols=262 Identities=28% Similarity=0.372 Sum_probs=202.7
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeC--CEEEEEe
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVD--SRLWVVM 105 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV~ 105 (506)
|++.+.||+|+||.||+|.+. .++..||+|.+.............+|+.++..+. ||||+++++++.++ +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 789999999999999999985 5678999999875433222233457888888885 99999999999887 8999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+. ++|.+.+... ...+++..+..++.|++.||.|||+.|++||||||+||+++. +.+||+|||++......
T Consensus 80 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---- 152 (282)
T cd07831 80 ELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---- 152 (282)
T ss_pred ecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC----
Confidence 9997 5888877653 356899999999999999999999999999999999999999 99999999987543211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc---------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS--------- 256 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 256 (506)
.......+++.|+|||.+.....++.++|||||||++|+|++|.+||...+..+.............
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 153 ----PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ----CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 1112235788999999876545578899999999999999999999976654433222111000000
Q ss_pred ----ch--h--hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 257 ----DY--E--KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 257 ----~~--~--~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+ . ....+......++..+.++|.+||+.+|++|||+.++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 0 0000111223568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=358.30 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=218.0
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEecc---CCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC--EEEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL---DQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--RLWV 103 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~l 103 (506)
.+...+||+|+|-+||+|.+ ..+|..||+-.+.. .+++...++|..|+.+|+.|+||||+++|.++.+.. .+.+
T Consensus 42 ~k~~evLGrGafKtVYka~D-e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eehhhhcccccceeeeeccc-cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 45567899999999999999 47788998776643 446677899999999999999999999999998754 5889
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCCCCEEeC-CCCCeEEeeccccccccC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ--GHLHRDVKAGNILSD-SDGSVKLADFGVSASIYE 180 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~--givHrDIKp~NILld-~~g~vKL~DFGls~~~~~ 180 (506)
|+|.+..|+|+.|+++ .+.++...++.|++||++||.|||++ .|+|||||.+||+|+ ..|.|||+|+|+|.....
T Consensus 121 iTEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999999998 57899999999999999999999998 599999999999999 568999999999765432
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ......|||.|||||++.. .|++.+||||||++++||+|+..||..+.....+++++....+...
T Consensus 199 s---------~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s--- 264 (632)
T KOG0584|consen 199 S---------HAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA--- 264 (632)
T ss_pred c---------ccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH---
Confidence 2 2233679999999999974 4999999999999999999999999999888888888777654322
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+--.++++++|.+||.. .+.|||+.++|+||||...
T Consensus 265 ------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 ------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2233367899999999999 9999999999999999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=329.79 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=210.3
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC---------hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS---------RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
+|.+.+.||.|+||.||+|.+. .+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 5899999999999999999985 5688999998864321 11235688899999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
...++||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999999873 67999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .........|+..|+|||.+.... .++.++|+||||+++|++++|..||....................
T Consensus 159 ~~~~-----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 232 (272)
T cd06629 159 DDIY-----DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP- 232 (272)
T ss_pred cccc-----cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc-
Confidence 2110 111123345788999999987543 478999999999999999999999975544433322221111100
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
. .......++..++++|.+||..+|.+|||+.++++||||
T Consensus 233 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 I-----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred C-----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 111234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=336.04 Aligned_cols=263 Identities=29% Similarity=0.515 Sum_probs=213.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+..++|++++.||+|+||+||+|.+. .++..||+|++...........+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 34578999999999999999999985 56889999998765555556788999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999999999877 4578999999999999999999997 58999999999999999999999999986432111
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHhhcccc
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS-------LLMKMTQRFRF 255 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~-------~~~~~~~~~~~ 255 (506)
......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||........ ..........
T Consensus 158 --------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 227 (284)
T cd06620 158 --------IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ- 227 (284)
T ss_pred --------ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-
Confidence 11234588999999998754 488999999999999999999999986443210 0011110000
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.. ........++..+.+|+.+||+.||++|||+.++++|+||...
T Consensus 228 ~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 228 EP-----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred cc-----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 0000112377889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.81 Aligned_cols=271 Identities=27% Similarity=0.400 Sum_probs=211.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||.|++|+||+|.++ .+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 57999999999999999999985 5688999999865432 233467889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccccccccCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls~~~~~~~~~ 184 (506)
||++ ++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--- 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--- 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---
Confidence 9996 68888886654445788999999999999999999999999999999999985 567999999987532211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc----------
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR---------- 254 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~---------- 254 (506)
........|++.|+|||.+.+...++.++|||||||++|+|++|.+||..................
T Consensus 157 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 ----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred ----ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 111123356889999999876555789999999999999999999999876554443332211000
Q ss_pred -ccchhhh------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 255 -FSDYEKT------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 -~~~~~~~------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+.+... .......+.+++.+.+++.+||+.+|++||++.++++||||.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0000000 000112345788899999999999999999999999999998763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=337.29 Aligned_cols=271 Identities=27% Similarity=0.411 Sum_probs=211.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh-hHHHHHHHHHHHhhCCCCCceeeeeEEEeC--CEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-DLDSIRRETKTMSLLSHPNILNAHCSFSVD--SRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 101 (506)
..++|++.+.||.|+||.||+|.+. .+|+.||+|.+....... ....+.+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5678999999999999999999985 568899999987543222 223456899999999999999999998765 578
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999997 5888888764 356999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh-
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK- 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 260 (506)
. .......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.............. ....+....
T Consensus 162 ~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (309)
T cd07845 162 A-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ-LLGTPNESIW 233 (309)
T ss_pred c-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hcCCCChhhc
Confidence 1 1112234578899999987655589999999999999999999999987665444332221 111000000
Q ss_pred ----------hh--------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 ----------TL--------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ----------~~--------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. .........++.+.+||.+||+.||++|||+.+++.||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 00 00001123578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.42 Aligned_cols=263 Identities=21% Similarity=0.381 Sum_probs=208.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSF 95 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (506)
+|.+..++|++.+.||.|+||.||+|.+.. .+++.||+|++.........+.+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 377788899999999999999999997532 234789999987655455566788999999999 799999999887
Q ss_pred Ee-CCEEEEEeccCCCCCHHHHHHhhCC----------------------------------------------------
Q 010624 96 SV-DSRLWVVMPFMSCGSLQSIISSCFP---------------------------------------------------- 122 (506)
Q Consensus 96 ~~-~~~~~lV~Ey~~ggsL~~~i~~~~~---------------------------------------------------- 122 (506)
.. +..++++|||+.+++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4678999999999999999865321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccC
Q 010624 123 -------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195 (506)
Q Consensus 123 -------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~ 195 (506)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ........
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-----~~~~~~~~ 235 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DYVRKGDA 235 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-----chhhccCC
Confidence 258899999999999999999999999999999999999999999999999975432110 01112234
Q ss_pred CCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHH
Q 010624 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRA 274 (506)
Q Consensus 196 ~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 274 (506)
.++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+.....+...... ..+..++++
T Consensus 236 ~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~ 304 (337)
T cd05054 236 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM----------RAPEYATPE 304 (337)
T ss_pred CCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC----------CCCccCCHH
Confidence 4567899999987654 8999999999999999998 999997644433333222221111 123456788
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 275 FKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 275 l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
+.+++.+||+.+|++|||+.++++|
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.88 Aligned_cols=258 Identities=33% Similarity=0.571 Sum_probs=215.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||.|++|.||+|.+. .++..||+|.+...........+.+|+.+++.++||||+++++++..+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 46999999999999999999996 46889999998776554556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--- 154 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--- 154 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC---
Confidence 99999999999873 679999999999999999999999 999999999999999999999999999865432211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhcccccchhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP--PEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... ........+....
T Consensus 155 ----~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 219 (264)
T cd06623 155 ----DQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP---------- 219 (264)
T ss_pred ----CcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC----------
Confidence 111234578899999998765 48899999999999999999999997664 2222222222111
Q ss_pred hhccchh-hhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKK-FSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~-~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....... ++..+.++|.+||..+|++|||+.++++||||+.+
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 1112233 78899999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=328.90 Aligned_cols=252 Identities=27% Similarity=0.461 Sum_probs=211.7
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
+|++.+.||.|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++..+..+|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 5999999999999999999985 568899999987543 2244678899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.|++|.+++... ..+++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---- 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---- 153 (258)
T ss_pred eCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC----
Confidence 999999999999873 57999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcccccchhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--KSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ......... .
T Consensus 154 ----~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~ 217 (258)
T cd05578 154 ----TLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----------A 217 (258)
T ss_pred ----ccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----------c
Confidence 1223345788999999997655 899999999999999999999999866532 221111110 0
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCH--HHHHcCccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSA--EKLMKHSFF 302 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~--~eiL~hp~f 302 (506)
....+..++..+.++|.+||..||.+||++ .++++||||
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 112334577899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=347.47 Aligned_cols=269 Identities=27% Similarity=0.429 Sum_probs=210.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEec-cCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-LDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~-~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (506)
+.+....|++++.||+||.+.||++.. .+.+.+|+|.+. ........+-+++|+..|.+|+ |.+||++++|-..++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 446677899999999999999999987 445666666654 3445667889999999999996 999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
++|+||||-+ .+|..++.+.. ..++.-.++.|.+|+|.++.++|.+||||.||||.|+|+ -.|.+||+|||+|....
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ 510 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence 9999999864 79999998753 234434899999999999999999999999999999998 47899999999987543
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccC----------CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT----------GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----------~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
.. ..........||+.||+||.+.... ..+.++||||||||||+|+.|++||......-..+..+
T Consensus 511 ~D-----TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 511 PD-----TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred cc-----ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 32 2233455678999999999986322 15679999999999999999999998655433333333
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
... ...+.++..+. ..++.++++.||..||.+|||+.++|+|||..-..-.
T Consensus 586 ~~P------~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 586 TDP------NHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred cCC------CccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 221 11111111221 1239999999999999999999999999999875433
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.33 Aligned_cols=254 Identities=34% Similarity=0.644 Sum_probs=210.5
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+|+..+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..+..+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 4888899999999999999985 568899999986543 13345678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 80 FLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999987 3568999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
......|++.|+|||.+.....++.++|+|||||++|+|++|.+||............... ..
T Consensus 157 -------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------- 219 (258)
T cd06632 157 -------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-KE--------- 219 (258)
T ss_pred -------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-cc---------
Confidence 1234457899999999865434789999999999999999999999766543332221110 01
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....+..+++.+++++.+||+.+|.+|||+.+++.|||+
T Consensus 220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 111334578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.24 Aligned_cols=264 Identities=22% Similarity=0.344 Sum_probs=215.9
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEE-Ee
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSF-SV 97 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~-~~ 97 (506)
..+.+..-+++|.+.|.+|||+.||.|.+. ..+..||+|.+-.. .....+.+++||.+|++|+ |+|||.+++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~-~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDV-KGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEec-CCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 446677888999999999999999999995 33489999998665 6777899999999999998 99999999832 21
Q ss_pred ---C---CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCCeEE
Q 010624 98 ---D---SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 98 ---~---~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~vKL 169 (506)
. -.++|+||||.||+|-++|..+...+|++.++.+|++|+++|+++||..+ |||||||-+||||+.+|+.||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 25789999999999999998777778999999999999999999999987 999999999999999999999
Q ss_pred eeccccccccCCCCCC--CCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 010624 170 ADFGVSASIYEPSHHH--HHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL 245 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~--~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~ 245 (506)
||||.+.......... ............|+.|+|||.+.- ...+++|+|||+|||+||-|+....||......
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 9999876554432110 111112344567999999999852 334899999999999999999999999865332
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.++...+.++ ..+.++..+++||..||+.||.+||++.+++.+
T Consensus 265 -aIlng~Y~~P----------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 265 -AILNGNYSFP----------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -eEEeccccCC----------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2333444444 336789999999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.50 Aligned_cols=266 Identities=25% Similarity=0.397 Sum_probs=208.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--CEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLLSHPNILNAHCSFSVD--SRLW 102 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (506)
.++|++.+.||.|+||.||+|.+. .+++.+|+|.+...... .....+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 357999999999999999999985 56889999998754422 2334567899999999999999999998877 8999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||||+. ++|.+++... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999997 5999988764 2469999999999999999999999999999999999999999999999999866432211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc---hh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD---YE 259 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~ 259 (506)
.......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||............... ...+. +.
T Consensus 161 -------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (293)
T cd07843 161 -------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL-LGTPTEKIWP 232 (293)
T ss_pred -------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCchHHHH
Confidence 11223456889999999876555788999999999999999999999876554433222111 00000 00
Q ss_pred ----------------hhhhhhccchh--hhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 260 ----------------KTLKIKDKNKK--FSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 260 ----------------~~~~~~~~~~~--~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.........+. +++.+.++|.+||+.+|++|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00000011111 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.96 Aligned_cols=269 Identities=27% Similarity=0.405 Sum_probs=217.4
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
..|...++||+|.||+||+|.++ .+++.||+|.++.+.. ........+||.+++.++|.|||++++....++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~-~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 45788899999999999999996 6788999999987653 333456779999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||. .+|..+..+. ++.++...++.++.|+++||.|+|+++++|||+||+|+||+.+|.+||+|||++......
T Consensus 81 e~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip---- 154 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---- 154 (292)
T ss_pred HHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc----
Confidence 9996 7888888765 678999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc-----------c
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQR-----------F 253 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~-----------~ 253 (506)
........-|.+|.+|.++.+..-|+...|+||.|||+.|+.. |++.|...+..+....+...- .
T Consensus 155 ---vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred ---eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 1122334458999999999998889999999999999999997 666666655554443333210 0
Q ss_pred ccc------chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 RFS------DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 ~~~------~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+ .+.....+....++++...++|++++|..+|..|++++.+++||||.+.
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 111 1122222233345566778999999999999999999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=328.20 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=210.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
|++..++|++.+.||+|+||.||+|.++. ..+..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 56788999999999999999999998853 22478999998765555556778899999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEE
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFP--------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~--------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL 169 (506)
....|+||||+++++|.+++..... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999999975321 23788899999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~ 248 (506)
+|||++....... .........++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||............
T Consensus 161 ~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 161 GDFGMTRDIYETD-----YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCcccchhhccCc-----ccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 9999865432211 011122334678899999987544 8999999999999999998 99999766554433222
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
. .... ...+..++..+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~-~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 235 I-DGGH----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred h-cCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2 1111 1123446889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.41 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=209.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+.+++|++.+.||+|+||+||+|.+... +...||+|.+...........+.+|+.+++.++||||+++++++...+..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3567899999999999999999988532 24589999987665555667888999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999999764 347899999999999999999999999999999999999999999999999997654311
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......... ..+......+
T Consensus 160 ~-----~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~---- 228 (266)
T cd05033 160 E-----ATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDGYRLP---- 228 (266)
T ss_pred c-----cceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHHcCCCCC----
Confidence 0 111112234567899999987644 8999999999999999998 99999766544432 2222211111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....+++.+.+++.+||+.+|++||++.+++++
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234578899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.16 Aligned_cols=262 Identities=34% Similarity=0.619 Sum_probs=207.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEE----
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFS---- 96 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~---- 96 (506)
+....++|++.+.||+|+||.||+|.+. .+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4456689999999999999999999985 567899999875422 2235677899999999 6999999999873
Q ss_pred -eCCEEEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 97 -VDSRLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 97 -~~~~~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
.+..+|+||||++|++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 456799999999999999988642 23568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
++...... ........|++.|+|||++.. ...++.++|||||||++|+|++|..||............
T Consensus 170 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~- 241 (286)
T cd06638 170 VSAQLTST-------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI- 241 (286)
T ss_pred ceeecccC-------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-
Confidence 86543211 111223458999999999853 233788999999999999999999999866543322211
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..... . ....+..++..+.+||.+||+.||++|||+.+|++|+||
T Consensus 242 ~~~~~-~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 242 PRNPP-P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCC-C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11000 0 001223467789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.19 Aligned_cols=265 Identities=23% Similarity=0.415 Sum_probs=214.9
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAH 92 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 92 (506)
.+.++.+..++|.+.+.||+|+||.||+|.+. ...+..||+|.+.........+.+.+|+.+++.+ +||||++++
T Consensus 26 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred ccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 34567788889999999999999999999763 2345689999987654455567889999999999 799999999
Q ss_pred eEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
+++...+..|++|||+.+|+|.+++.......+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999999998644445899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~ 251 (506)
|++........ ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...............
T Consensus 186 g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~ 259 (302)
T cd05055 186 GLARDIMNDSN-----YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259 (302)
T ss_pred cccccccCCCc-----eeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence 98754322110 01112234578899999987654 8999999999999999998 99999876654444333322
Q ss_pred cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.... ..+...++.+.+++.+||+.+|++|||+.++++
T Consensus 260 ~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 GYRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2111 123356789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=334.22 Aligned_cols=265 Identities=30% Similarity=0.484 Sum_probs=208.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 104 (506)
.++|+..+.||+|+||.||++.+. .+++.+|+|.+...........+.+|+.++.++. ||||+++++++..++..|++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 357888899999999999999985 5688999999876554555667889999999996 99999999999999999999
Q ss_pred eccCCCCCHHHHH---HhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 105 MPFMSCGSLQSII---SSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 105 ~Ey~~ggsL~~~i---~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
|||+. ++|.++. .......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99986 4555543 332346799999999999999999999985 999999999999999999999999998653221
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
. .......|++.|+|||.+.+. ..++.++|||||||++|+|++|++||...... ...+.........
T Consensus 161 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~ 229 (288)
T cd06616 161 S--------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---FDQLTQVVKGDPP 229 (288)
T ss_pred C--------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---HHHHhhhcCCCCC
Confidence 1 111233578899999999765 35899999999999999999999999755421 1111111110000
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. ........++.++.+||.+||+.+|++|||+.+|++||||+...
T Consensus 230 --~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 230 --I-LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred --c-CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 0 01112245788999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=332.25 Aligned_cols=276 Identities=26% Similarity=0.364 Sum_probs=207.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
++.-..++|++.+.||+|+||.||+|.+. .+++.||||.+..... ......+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 34455678999999999999999999985 5789999999865432 222345668999999999999999999886543
Q ss_pred --------EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 100 --------RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 100 --------~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
..|+||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 4699999996 5888887653 34689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HH
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM--KM 249 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~--~~ 249 (506)
||++.......... ........++..|+|||.+.+...++.++||||||+++|+|++|.+||........... .+
T Consensus 163 fg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 163 FGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99876443221110 11122345688899999987655578899999999999999999999976554332211 11
Q ss_pred hhccccc-----------------ch-hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 250 TQRFRFS-----------------DY-EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 250 ~~~~~~~-----------------~~-~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+... .. .............+..+++||.+||..||.+|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1110000 00 00000000111245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.05 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=203.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+++++|++.+.||+|+||.||+|.++ ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++......|+
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 35678999999999999999999873 45689999876432 234578899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~-- 153 (256)
T cd05114 77 VTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-- 153 (256)
T ss_pred EEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC--
Confidence 99999999999999753 246899999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........++..|+|||.+.+.. ++.++|+||||+++|+|++ |++||......+..... ......
T Consensus 154 ----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i-~~~~~~------- 220 (256)
T cd05114 154 ----EYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-SRGFRL------- 220 (256)
T ss_pred ----ceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCCC-------
Confidence 011112233566799999987544 8899999999999999999 99999866544433322 221110
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 122345678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.47 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=208.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
...+|.+.+.||+|+||.||+|.+.. .++..||+|.+.........+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 45679999999999999999998742 23578999998765555456789999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeE
Q 010624 101 LWVVMPFMSCGSLQSIISSCF------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVK 168 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vK 168 (506)
.|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 999999999999999997642 23478999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLM 247 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~ 247 (506)
|+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||...........
T Consensus 163 l~d~g~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 163 IGDFGMSRDVYTTD-----YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred ECCcccceecccCc-----ceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999875322110 001112334578899999997655 8999999999999999998 9999987655443322
Q ss_pred HHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..... ....+..++..+++++.+||+.||++|||+.++++
T Consensus 237 ~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGR-----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCC-----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22111 11123457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.21 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=198.8
Q ss_pred eecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--hhHHHHHHHHHHH---hhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 34 EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRETKTM---SLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
.||+|+||.||+|.+. .+++.+|+|.+...... .......+|..++ ...+||||+.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999985 56889999998654322 2122334444443 3457999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~------- 150 (279)
T cd05633 80 NGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------- 150 (279)
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-------
Confidence 99999999876 467999999999999999999999999999999999999999999999999987532211
Q ss_pred CcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcccccchhhhhhhhcc
Q 010624 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS-LLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
......||+.|+|||.+.....++.++||||+||++|+|++|..||........ ......... ....
T Consensus 151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~ 218 (279)
T cd05633 151 --KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV----------NVEL 218 (279)
T ss_pred --CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC----------CcCC
Confidence 112345899999999986544588999999999999999999999975432211 111111000 1113
Q ss_pred chhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
+..++.+++++|.+||..||++|| |+.++++||||+..+
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 456788999999999999999999 699999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.65 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=206.2
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||.|++|.||+|.+. .+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++++.++..+|++|||+++++
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 799999999999985 4678999999876442 2345678999999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 80 L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~--------~~~ 149 (262)
T cd05572 80 LWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--------QKT 149 (262)
T ss_pred HHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc--------ccc
Confidence 9999987 356899999999999999999999999999999999999999999999999986543221 012
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP--PEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
....|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.... .............. ...+..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~ 218 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK----------LEFPNY 218 (262)
T ss_pred ccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC----------CCCCcc
Confidence 2345788999999987544 8899999999999999999999998665 22222221110100 112234
Q ss_pred hhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 271 FSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 271 ~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.++.+.++|.+||+.+|.+||| +.++++||||++..
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 4789999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=322.41 Aligned_cols=261 Identities=31% Similarity=0.559 Sum_probs=211.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|.+.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 5999999999999999999884 5678999999876543 3467789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~-- 155 (264)
T cd06626 80 YCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-- 155 (264)
T ss_pred cCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc--
Confidence 9999999999987 456899999999999999999999999999999999999999999999999986654322110
Q ss_pred CCCcccccCCCCCccCChhhhhccC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.........+++.|+|||.+.+.. .++.++|||||||++|++++|..||.................. +.
T Consensus 156 -~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~------- 226 (264)
T cd06626 156 -MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-PP------- 226 (264)
T ss_pred -ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-CC-------
Confidence 001022345788999999987543 3788999999999999999999999765433222222221110 00
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
......++..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01123458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.80 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=225.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.....|.+.+.||+|.|++|..|.+. .++..||||++++... ...+..+.+|+++|+.++|||||+++.+......+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34457999999999999999999996 6789999999988764 344567899999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||||+.+|.+++++.+ .+.+.+..++.++.|++.|++|||+++|+|||||++|||++.+.++||+|||+|....
T Consensus 132 lV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred EEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999998 5788889999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........|++.|.|||++.+....++.+|+||+|+++|.|++|..||.+..-.......+..+++.
T Consensus 207 -----~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI------- 274 (596)
T KOG0586|consen 207 -----YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI------- 274 (596)
T ss_pred -----ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc-------
Confidence 22344566799999999999998877899999999999999999999998655444433334444432
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+..++.+..+||.++|..+|.+|++++++++|.|....
T Consensus 275 -----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 275 -----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -----cceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 34467789999999999999999999999999998643
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=328.38 Aligned_cols=260 Identities=35% Similarity=0.598 Sum_probs=207.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC-----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVD----- 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----- 98 (506)
..++|.+.+.||+|+||.||+|.+. .+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4578999999999999999999985 568899999986432 2345677899999998 799999999988653
Q ss_pred CEEEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..+|+||||+.+++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 4689999999999999988642 23568999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccC----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
...... .......|++.|+|||.+.... .++.++|||||||++|+|++|++||................
T Consensus 177 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 177 QLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred hccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 432111 1112345788999999985432 25789999999999999999999998665443332221110
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
. .. .......+..+++||.+||+.+|++||++.+|++||||+
T Consensus 250 -~-~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 -P-PT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -C-CC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 00 011234567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.48 Aligned_cols=265 Identities=29% Similarity=0.451 Sum_probs=210.2
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
|++.+.||.|++|.||+|.+. .+|..||+|++...... .....+.+|+.+++.++||||+++++++.+++..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 788999999999999999985 57889999998765432 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
++ ++|.+++.......+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 95 79999987754347999999999999999999999999999999999999999999999999986532111
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc-----------
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS----------- 256 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 256 (506)
........+++.|+|||++.+...++.++|+|||||++|+|++|++||....................
T Consensus 153 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 153 -VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 11112234688899999887655578899999999999999999999987655443333221100000
Q ss_pred chh------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 257 DYE------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 257 ~~~------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+. ...........++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 0001112235577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.67 Aligned_cols=260 Identities=40% Similarity=0.652 Sum_probs=212.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..++|++.+.||+|+||.||++.+. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++......|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 3478999999999999999999885 5678899999864432 3346788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
+||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--- 168 (293)
T cd06647 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 168 (293)
T ss_pred EecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc---
Confidence 999999999999976 46889999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........|++.|+|||.+.... ++.++|+|||||++|++++|..||............... ..+ .
T Consensus 169 ----~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~--~~~-------~ 234 (293)
T cd06647 169 ----QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--GTP-------E 234 (293)
T ss_pred ----ccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC--CCC-------C
Confidence 11122345888999999987644 789999999999999999999999765443322111110 000 0
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
...+..++..++++|.+||+.+|++||++.+++.||||+...
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 112334678899999999999999999999999999999774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.22 Aligned_cols=269 Identities=29% Similarity=0.487 Sum_probs=222.3
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (506)
.-+|..+.++.+++..||+|..|.||++..+ .+|...|||.+..........++.+.+.++...+ .|+||+++++|..
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 4568888899999999999999999999996 5689999999998888888889999999887765 9999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
+...++.||.|. .-+..+++.. ..+++|.-+-.+...+++||.||.. +||+|||+||+|||+|..|++||||||+|.
T Consensus 163 n~dV~IcMelMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 163 NTDVFICMELMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred CchHHHHHHHHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccc
Confidence 999999999984 4444555443 5679999999999999999999976 589999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
.... ........|.+.|||||.+.. ...|+.++|||||||+++||+||+.||......=..+-++.+.-.
T Consensus 241 rlvd--------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 241 RLVD--------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred eeec--------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence 5432 233445678899999999864 345899999999999999999999999876554333333322111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
+. ......+|+.+.+|+..||.+|+.+||...++|+|||++...
T Consensus 313 -P~-------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 313 -PL-------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred -CC-------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 11 012234899999999999999999999999999999998774
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=329.58 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=205.8
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||+|+||+||+|.+. .+|+.||+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999885 5688999999865331 2234566789999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... ....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--------~~~~ 151 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--------GKKI 151 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--------CCcc
Confidence 99999875445799999999999999999999999999999999999999999999999998653221 1112
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFS 272 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 272 (506)
....|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.......... .+...... .....+..++
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~ 222 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRTLE-------MAVEYPDKFS 222 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhcccc-------ccccCCccCC
Confidence 2345788899999987655 8899999999999999999999997544311111 11111100 0111334578
Q ss_pred HHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 273 RAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 273 ~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
+.+.++|.+||+.||.+|| ++.+++.||||+..+
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 8999999999999999999 899999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.87 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=204.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+++++|++.+.||+|+||+||.|.+. ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 35678999999999999999999773 45679999886432 234678899999999999999999999999899999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
+|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||.||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~-- 153 (256)
T cd05113 77 VTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-- 153 (256)
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC--
Confidence 99999999999999764 236899999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||............ ......
T Consensus 154 ----~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~------- 220 (256)
T cd05113 154 ----EYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRL------- 220 (256)
T ss_pred ----ceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-hcCCCC-------
Confidence 111112234567799999997654 8899999999999999998 99999866554432222 221111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
......+..+++++.+||+.+|.+|||+.+|+.+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1223457899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.44 Aligned_cols=255 Identities=28% Similarity=0.491 Sum_probs=210.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||+|+||.||+|.+. .+|..+|+|.+..... ....+.+.+|+.+++.++||||+++++.+..+...|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999995 5678899999866432 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeeccccccccCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~~~~~~~ 185 (506)
|+.+++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---- 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC----
Confidence 99999999999875444689999999999999999999999999999999999999876 4699999986543211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
........|++.|+|||.+.+.. ++.++|+|||||++++|++|..||................. .
T Consensus 156 ---~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~ 220 (257)
T cd08225 156 ---MELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-----------A 220 (257)
T ss_pred ---cccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----------C
Confidence 11122345889999999987554 78999999999999999999999976655443333222111 1
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+.++..++++|.+||..+|++|||+.++++||||
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 1234577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=330.43 Aligned_cols=264 Identities=24% Similarity=0.452 Sum_probs=213.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeee
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHC 93 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (506)
..++.+..++|++.+.||+|+||.||++.++. .....+|+|.+...........+.+|+.+++.+ +||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 56788889999999999999999999998753 234689999987665555567788999999999 7999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCE
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSC--------------FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~--------------~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NI 159 (506)
++..++.+|++|||+.+|+|.+++... ....+++..+..++.|++.||+|||++|++||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999752 134689999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 010624 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSH 238 (506)
Q Consensus 160 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~ 238 (506)
+++.++.+||+|||++....... .........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||..
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHID-----YYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EEcCCCeEEeCcccccccccccc-----ceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999999999999875432111 001112223467899999986544 8999999999999999997 9999986
Q ss_pred CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....+.... +..... ...+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 238 IPVEELFKL-LKEGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCHHHHHHH-HHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 655443322 221111 11234567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.10 Aligned_cols=267 Identities=26% Similarity=0.443 Sum_probs=212.9
Q ss_pred ccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCC------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCC
Q 010624 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPM------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPN 87 (506)
Q Consensus 15 ~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~Hpn 87 (506)
.++....|.+..++|.+.+.||+|+||.||+|.+... +...+|+|.+...........+.+|+.+++.+ +|||
T Consensus 6 ~~~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 6 ELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred cCCCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCC
Confidence 3444567888889999999999999999999986421 23579999987655555567788999999999 7999
Q ss_pred ceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Q 010624 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153 (506)
Q Consensus 88 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrD 153 (506)
|+++++++...+..|+||||+.+|+|.+++..... ..+++..+..++.|++.||+|||++|++|||
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999999999999999999999999999976422 2488999999999999999999999999999
Q ss_pred CCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-C
Q 010624 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-G 232 (506)
Q Consensus 154 IKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G 232 (506)
|||+||+++.++.+||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccc-----hhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999865332110 001111223456899999997654 8999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+||...+... ....+..... ...+..++.++++|+.+||..+|.+|||+.++++
T Consensus 240 ~~p~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 240 GSPYPGVPVEE-LFKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CCCCCcCCHHH-HHHHHHcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 89997655433 2222222111 1133457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=328.03 Aligned_cols=258 Identities=21% Similarity=0.353 Sum_probs=207.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
..++|++.+.||+|+||+||+|.+. ...+..+|+|.+...........+.+|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4578999999999999999999863 1345789999987655555567888999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 102 WVVMPFMSCGSLQSIISSCF---------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~---------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
|++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 99999999999999986321 124788999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~ 245 (506)
+||+|||++....... .........++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.........
T Consensus 163 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 163 VKISDLGLSREIYSAD-----YYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EEeccccccccccCCc-----ceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999875432211 011122334567799999987654 8999999999999999998 99999765543322
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+..... ...+..+++.+++++.+||+.||++||++.+|+++
T Consensus 237 -~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 -EMVRKRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -HHHHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 22222111 11334578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=323.50 Aligned_cols=255 Identities=26% Similarity=0.460 Sum_probs=207.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+..++|++.+.||+|++|.||+|.+ .+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLW--NNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEe--cCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 456778899999999999999999987 356789999986543 2346788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999998754457999999999999999999999999999999999999999999999999987654311
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.......... .+......
T Consensus 157 ~------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~----- 223 (261)
T cd05068 157 I------YEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-QVDQGYRM----- 223 (261)
T ss_pred c------ccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCC-----
Confidence 0 01111122345799999987654 8999999999999999999 999998665443332 22222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.....++..+.+++.+||+.+|.+||++.++++
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 123456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.47 Aligned_cols=256 Identities=22% Similarity=0.369 Sum_probs=205.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+...+|++.+.||+|+||+||+|.+.. ++. .||+|.+.........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 556789999999999999999998753 333 48999987655555667888999999999999999999988765
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..+++++|+.+|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 567999999999999999864 3468899999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........ ..........+
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~-- 231 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLP-- 231 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCC--
Confidence 2111 11112233467899999997654 8999999999999999997 9999986654432 22222211111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus 232 --------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 234567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.95 Aligned_cols=270 Identities=27% Similarity=0.366 Sum_probs=205.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCC-CCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--CEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPM-DSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD--SRLW 102 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~-~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (506)
+|++.+.||+|+||.||+|.+... ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 589999999999999999998632 67899999987633 122345677899999999999999999999988 8899
Q ss_pred EEeccCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC----CCCeEEeecccc
Q 010624 103 VVMPFMSCGSLQSIISSCF---PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS----DGSVKLADFGVS 175 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~---~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~----~g~vKL~DFGls 175 (506)
+||||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+++||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999997 57777765432 236899999999999999999999999999999999999999 899999999987
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--------HHHH
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK--------SLLM 247 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~--------~~~~ 247 (506)
........ .........+|+.|+|||.+.+...++.++|||||||++|+|++|.+||....... ....
T Consensus 160 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLK----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCcc----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 64322111 01122334578899999998776568899999999999999999999997543321 0000
Q ss_pred HHhhcccc------------cchhh--------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcc
Q 010624 248 KMTQRFRF------------SDYEK--------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301 (506)
Q Consensus 248 ~~~~~~~~------------~~~~~--------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~ 301 (506)
.+...+.. +.+.. ...........+..+.+++.+||+.||++|||+.++++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 00000000 00000 00000011256678999999999999999999999999999
Q ss_pred c
Q 010624 302 F 302 (506)
Q Consensus 302 f 302 (506)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=330.81 Aligned_cols=259 Identities=36% Similarity=0.581 Sum_probs=210.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
......|++.+.||+|+||+||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++..+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe
Confidence 344467999999999999999999985 568899999986433 23445678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+. |+|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999999997 6777777543 35699999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.....|++.|+|||++.+ ...++.++||||||+++|+|++|.+||.................
T Consensus 168 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~----- 231 (307)
T cd06607 168 -----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS----- 231 (307)
T ss_pred -----------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----
Confidence 112357889999998742 23478899999999999999999999976655443322211100
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.......++..++++|.+||+.+|++|||+.+++.||||...
T Consensus 232 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 -----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 001123467889999999999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=324.51 Aligned_cols=251 Identities=28% Similarity=0.457 Sum_probs=201.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHH-HhhCCCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKT-MSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||.|+||.||+|.+. .+++.||+|.+..... ......+..|..+ ....+||||+++++++..+..+|+|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 57999999999999985 5678999999865432 1222334455444 445689999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
+++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++.....
T Consensus 81 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--------- 149 (260)
T cd05611 81 GGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--------- 149 (260)
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---------
Confidence 9999999987 46789999999999999999999999999999999999999999999999998653211
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.....|++.|+|||.+.+.. ++.++||||||+++|+|++|.+||..................++ .....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 218 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP--------EEVKE 218 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC--------Ccccc
Confidence 22335788999999998765 89999999999999999999999986655443332222221111 11223
Q ss_pred hhhHHHHHHHHhhcccCCCCCC---CHHHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRP---SAEKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rp---t~~eiL~hp~f~~~~ 306 (506)
.+++.+.+++.+||+.+|++|| ++.+++.||||++.+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 5788999999999999999999 457999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=323.72 Aligned_cols=259 Identities=31% Similarity=0.491 Sum_probs=205.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..+.......||+|+||.||+|.+. .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDL-STQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEec-CCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3344444568999999999999985 567899999886543 33456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGL--PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l--~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls~~~~~~ 181 (506)
+||+.+++|.+++.... ..+ ++..+..++.|++.||+|||++|++||||||+||+++. ++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999998642 334 88899999999999999999999999999999999986 679999999986532211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
........|++.|+|||.+.+. ..++.++|+||||+++|+|++|.+||............... ..
T Consensus 163 -------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~-~~------ 228 (268)
T cd06624 163 -------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM-FK------ 228 (268)
T ss_pred -------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-hc------
Confidence 1112233578999999998643 34788999999999999999999999754332221111100 00
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..+..+..+++++++++.+||+.+|.+|||+.+++.||||
T Consensus 229 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 --IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0111334578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=323.45 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=205.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||.||+|.++ .+++.||||.+.... .......+.+|+.+++.++||||+++++++...+..|++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57999999999999999999985 568899999876432 234456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 105 MPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 99999999999886432 245899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK-SLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 261 (506)
........|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....... .....+.. ..++
T Consensus 160 ------~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~----- 226 (267)
T cd08228 160 ------TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYP----- 226 (267)
T ss_pred ------hHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCC-----
Confidence 11122345888999999997654 7899999999999999999999997543321 12221111 1111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+.....++..+.+++.+||..+|++|||+.++++
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 1123456788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.02 Aligned_cols=272 Identities=26% Similarity=0.384 Sum_probs=211.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe----CCEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSV----DSRL 101 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 101 (506)
.+|++.+.||.|+||.||+|.++ .++..||+|.+..... ......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999986 5688999999875432 2345677889999999999999999988753 4578
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99999996 689998876 456999999999999999999999999999999999999999999999999987543222
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch---
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY--- 258 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 258 (506)
... .........|+..|+|||.+.+...++.++|||||||++|+|++|++||.............. ....+..
T Consensus 161 ~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~-~~g~~~~~~~ 236 (334)
T cd07855 161 PTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS-VLGSPSEEVL 236 (334)
T ss_pred CcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH-HhCCChhHhh
Confidence 111 111122346889999999987655589999999999999999999999976544332211111 0000000
Q ss_pred --------h---------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 --------E---------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 --------~---------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. .........+..++++.++|.+||+.+|.+|||+.+++.||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 00000111234688999999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.50 Aligned_cols=261 Identities=34% Similarity=0.576 Sum_probs=212.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..+.|.....||.|+||.||++.+. .++..||||.+.... ....+.+.+|+.+++.++||||+++++.+..++..|+|
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEEC-CCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 3355777888999999999999885 567899999986433 34456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--- 171 (292)
T cd06658 98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--- 171 (292)
T ss_pred EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc---
Confidence 999999999998865 46899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||........... +...... .
T Consensus 172 ----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~--------~ 237 (292)
T cd06658 172 ----VPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPP--------R 237 (292)
T ss_pred ----cccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCC--------c
Confidence 11112345789999999987544 88999999999999999999999986554433221 1111110 0
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
......++..+.+++.+||..||.+|||+.++++||||+....
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 238 VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0122346788999999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=322.36 Aligned_cols=253 Identities=24% Similarity=0.424 Sum_probs=204.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+..++|++.+.||+|+||.||+|.+ .++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~--~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTW--NGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEe--cCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 456778999999999999999999987 3566799999865433 2457889999999999999999998875 4568
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 89999999999999998754556899999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........++..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||......+.. ..+......
T Consensus 156 ~------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~----- 222 (260)
T cd05070 156 E------YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-EQVERGYRM----- 222 (260)
T ss_pred c------cccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCC-----
Confidence 0 11112223566799999987654 8899999999999999999 89999765544332 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
..+...+..+.+|+.+||..+|.+|||++++.
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 -----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 12345778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=320.18 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=209.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 104 (506)
+|++.+.||.|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.. +...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5999999999999999999985 567899999987543 34556778899999999999999999987754 4578999
Q ss_pred eccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 105 MPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLH-----NQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLH-----s~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
|||+++++|.+++.... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999997642 356899999999999999999999 89999999999999999999999999998664
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
..... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ...+... .
T Consensus 160 ~~~~~-------~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-~--- 226 (265)
T cd08217 160 LGHDS-------SFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQL-ASKIKEG-K--- 226 (265)
T ss_pred ccCCc-------ccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHH-HHHHhcC-C---
Confidence 32211 1122345799999999997654 78999999999999999999999986653322 2222111 1
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....+..++..+.+++.+||+.+|.+|||+.+|++|||+
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 112334678899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.63 Aligned_cols=279 Identities=21% Similarity=0.316 Sum_probs=200.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEecc----------------CCChhhHHHHHHHHHHHhhCCCCCce
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL----------------DQSRTDLDSIRRETKTMSLLSHPNIL 89 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~----------------~~~~~~~~~~~~Ei~il~~l~HpnIv 89 (506)
.++|++++.||+|+||+||+|.++...+..+++|.+.. .........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 36799999999999999999887544443333332110 01122345678999999999999999
Q ss_pred eeeeEEEeCCEEEEEeccCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF---PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~---~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
++++++...+..|++++++. ++|..++.... ........++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 67777665421 123446678899999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCC-CCCCC--hHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP-LSHLP--PEK 243 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~P-f~~~~--~~~ 243 (506)
+||+|||++...... .........||+.|+|||++.+.. |+.++|||||||++|+|++|..| |.... ...
T Consensus 306 vkL~DFGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 306 IVLGDFGTAMPFEKE------REAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EEEEeCCCceecCcc------cccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999997543211 111122346899999999998654 89999999999999999998754 43322 112
Q ss_pred HHHHHHhhccc-----ccchh----hhh---hh---------hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 244 SLLMKMTQRFR-----FSDYE----KTL---KI---------KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 244 ~~~~~~~~~~~-----~~~~~----~~~---~~---------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.....+. .+. ++... ..+ .. ......++.++.++|.+||+.||.+|||+.++|.||||
T Consensus 379 ~~~~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 2222111 111 11000 000 00 00112356778899999999999999999999999999
Q ss_pred cccccchhhHH
Q 010624 303 KNCNKGVEFFV 313 (506)
Q Consensus 303 ~~~~~~~~~~~ 313 (506)
.........+.
T Consensus 458 ~~~~~~~~~~~ 468 (501)
T PHA03210 458 SAEEEEEILFI 468 (501)
T ss_pred hcCCchHHHHH
Confidence 98754433333
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=330.59 Aligned_cols=266 Identities=24% Similarity=0.433 Sum_probs=213.6
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCce
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNIL 89 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 89 (506)
.+...|.+...+|.+.+.||+|+||.||+|.+.. ..+..||+|.+...........+.+|+.+++.+ +||||+
T Consensus 5 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 5 PEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred ccCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCch
Confidence 3456788999999999999999999999997531 234579999987554455567889999999999 799999
Q ss_pred eeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Q 010624 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVK 155 (506)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIK 155 (506)
++++++......|++|||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 999999999999999999999999999976422 347888999999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCC
Q 010624 156 AGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRP 234 (506)
Q Consensus 156 p~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~ 234 (506)
|+||+++.++.+||+|||++........ ........+++.|+|||++.+.. ++.++|||||||++|+|++ |..
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~ 238 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGS 238 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccc-----cccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999998754322110 11122334567899999997654 8999999999999999998 888
Q ss_pred CCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
||...+..+... .+..... ...+..++..+++|+.+||..+|.+|||+.++++.
T Consensus 239 p~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 239 PYPGIPVEELFK-LLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CcccCCHHHHHH-HHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 997665544332 2222111 11234678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=320.72 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=198.9
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
+.||+|+||.||+|.++ .+++.+|+|.+...........+.+|+.+++.++||||+++++++......|+||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999985 56789999988655445556788999999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... .....
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 153 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-----YASTG 153 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc-----ccccC
Confidence 99999753 3468999999999999999999999999999999999999999999999999865422110 00011
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (506)
....++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.......... .+...... ..+..+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-~~~~~~~~----------~~~~~~ 221 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRL----------PCPELC 221 (252)
T ss_pred CCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-HHHcCCCC----------CCcccC
Confidence 1122345799999987654 8899999999999999997 899997655433222 22111111 123456
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 272 SRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 272 s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+..+.+|+.+||+.+|++|||+.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=325.36 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=206.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
..+.|.+.+.||+|+||.||+|.+... .+..||+|.+...........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 446799999999999999999998531 4678999988765555555678899999999999999999999998889
Q ss_pred EEEEeccCCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEeec
Q 010624 101 LWVVMPFMSCGSLQSIISSCFP-----DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLADF 172 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~-----~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~DF 172 (506)
.++||||+.|++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999999977532 2589999999999999999999999999999999999998665 5999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~ 251 (506)
|++....... .........+++.|+|||++.+.. ++.++|||||||++|+|++ |..||........... +..
T Consensus 164 g~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-~~~ 236 (277)
T cd05036 164 GMARDIYRAS-----YYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-VTG 236 (277)
T ss_pred ccccccCCcc-----ceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHc
Confidence 9876431110 000111223356799999997654 8999999999999999997 9999987655443222 221
Q ss_pred cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
... ...+..++..+.+++.+||+.+|++|||+.++++|
T Consensus 237 ~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111 11235578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.80 Aligned_cols=258 Identities=35% Similarity=0.580 Sum_probs=210.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
.|.-.+.||.|++|.||++.+. .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++..++..|+++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 4666789999999999999985 567899999886433 23346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.|++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~------ 168 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------ 168 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC------
Confidence 999999999976 56899999999999999999999999999999999999999999999999975432211
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
........|++.|+|||.+.+.. ++.++|||||||++|+|++|..||....+....... .... .+ ....
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~-~~~~-~~-------~~~~ 237 (285)
T cd06648 169 -VPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNL-PP-------KLKN 237 (285)
T ss_pred -CcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-HhcC-CC-------CCcc
Confidence 11122345889999999997654 889999999999999999999999765544332221 1110 00 0012
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
...++..+.+++.+||+.+|++|||+.++++||||+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 2347789999999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.77 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=214.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||.|+||.||++.+. .++..||+|.+..... ......+.+|+.+++.++|||++++++.+..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 5899999999999999999985 5678999999876543 3556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|+++++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999998753 3679999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......|++.|+|||.+.+.. ++.++|+||+|+++++|++|..||................ .
T Consensus 158 -----~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~ 220 (258)
T cd08215 158 -----DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-----------Y 220 (258)
T ss_pred -----ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------C
Confidence 1223346788999999987654 7899999999999999999999997665444333322211 1
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+..++..+.+++.+||..+|++|||+.++++||||
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 11234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=321.29 Aligned_cols=254 Identities=22% Similarity=0.415 Sum_probs=206.3
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+..++|++.++||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~--~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeec--CCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 567788999999999999999999987 4578899999865432 3467889999999999999999998875 4568
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999999997755567999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||......... ..+......
T Consensus 156 ------~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~----- 222 (260)
T cd05067 156 ------EYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGYRM----- 222 (260)
T ss_pred ------CcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-HHHHcCCCC-----
Confidence 011112234567899999987654 7899999999999999999 99999866544332 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++.++.+++.+||+.+|++|||+.+++.
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 123456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=325.24 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=198.0
Q ss_pred CCeeEEeee--cccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhh-CCCCCceeeeeEEEeCCEEEE
Q 010624 27 SSYKILDEI--GVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 27 ~~Y~i~~~I--G~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~l 103 (506)
+.|++.+.+ |+|+||.||++.++ .++..+|+|.+....... .|+..... .+||||+++++.|..++..|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 457777776 99999999999985 567899999986432211 12222222 279999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeeccccccccCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~~~~ 182 (506)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-- 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-- 162 (267)
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence 99999999999999873 4899999999999999999999999999999999999999988 999999998653321
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.....|++.|+|||++.+.. ++.++|||||||++|+|++|..||...................
T Consensus 163 ---------~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 225 (267)
T PHA03390 163 ---------PSCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------- 225 (267)
T ss_pred ---------CccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------
Confidence 11235789999999997654 8999999999999999999999998544332212222111110
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCC-HHHHHcCccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPS-AEKLMKHSFFKN 304 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-~~eiL~hp~f~~ 304 (506)
.......+++.+++||.+||+.+|.+||+ ++++++||||++
T Consensus 226 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 -KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 11123468899999999999999999996 699999999974
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=325.40 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=201.0
Q ss_pred eEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 30 KILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++.+.||.|+||.||+|... ...+..|+||.+.........+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57899999999999999986 233578999999665555667899999999999999999999999998888999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
||++|+|.+++.......+++..+..|+.|++.||.|||+++++|++|+|.|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~----- 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK----- 156 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 999999999999864568999999999999999999999999999999999999999999999999987654111
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
..........+...|+|||.+.... ++.++||||||+++|||++ |..||........... +..... .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~-~~~~~~----------~ 224 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK-LKQGQR----------L 224 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH-HHTTEE----------T
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc-cccccc----------c
Confidence 0112223334567899999998765 8999999999999999999 7899987755443322 222211 1
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.++|..||..+|.+|||+.+|++
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 134567889999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=325.66 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=213.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (506)
++|.+.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++ ||||+++++.+..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 47999999999999999999985 578899999986533 2333467889999999999 9999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 80 VLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999999987 35799999999999999999999999999999999999999999999999998764432211
Q ss_pred CCC-------------CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 184 HHH-------------HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 184 ~~~-------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
... ..........|+..|+|||.+.+.. ++.++|+|||||+++++++|..||..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 000 0012223445788999999987654 78899999999999999999999986654333222211
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH----HHHHcCccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA----EKLMKHSFF 302 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~----~eiL~hp~f 302 (506)
.. ...+..+++.+.++|.+||+.+|.+|||+ .++++||||
T Consensus 237 ~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11 11334568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=326.61 Aligned_cols=256 Identities=22% Similarity=0.390 Sum_probs=205.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+...+|.+.+.||+|+||+||++.+.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 456789999999999999999998632 33567899988643 2344667899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeE
Q 010624 100 RLWVVMPFMSCGSLQSIISSCF-----------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVK 168 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~-----------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vK 168 (506)
.+|+||||+.+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997532 12489999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLM 247 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~ 247 (506)
|+|||++....... .........+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||...........
T Consensus 161 l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred eccCCccccccCCc-----eeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999875332110 01112233457789999999764 48999999999999999998 9999987655443322
Q ss_pred HHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
...... ...+..++.++.+|+.+||+.||.+|||+.+++
T Consensus 235 i~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 235 ITQGRV-----------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHcCCc-----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 222111 112345778999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=321.77 Aligned_cols=258 Identities=30% Similarity=0.482 Sum_probs=209.1
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||.|+||.||+|.+. .++..+|+|.+..... ....+.+.+|+.+++.++||||+++++.+..+...|++|||+.+++
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999984 5688999999865432 2456788899999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC-CCCCcc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH-HHGSAM 191 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~-~~~~~~ 191 (506)
|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......... ......
T Consensus 80 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 80 LASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99999873 479999999999999999999999999999999999999999999999999866432221100 000112
Q ss_pred cccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhh
Q 010624 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271 (506)
Q Consensus 192 ~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (506)
.....+++.|+|||.+.... ++.++|+||||+++|+|++|..||..................++ ....+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~ 226 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP----------EDVEV 226 (265)
T ss_pred ccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC----------ccccC
Confidence 23445788999999987655 78899999999999999999999987665544333222221111 11124
Q ss_pred hHHHHHHHHhhcccCCCCCCCH---HHHHcCccccccc
Q 010624 272 SRAFKDMVASCLDQDPSKRPSA---EKLMKHSFFKNCN 306 (506)
Q Consensus 272 s~~l~~Li~~~L~~dP~~Rpt~---~eiL~hp~f~~~~ 306 (506)
+..+.+++.+||+.+|.+|||+ .++++||||++++
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 8899999999999999999999 9999999998763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=337.78 Aligned_cols=263 Identities=22% Similarity=0.391 Sum_probs=206.8
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSF 95 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (506)
+|.+..++|++.+.||+|+||+||+|.+. ..+++.||||.+...........+.+|+.++..+ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 47778899999999999999999999753 2456889999997655555567788999999999 689999999887
Q ss_pred Ee-CCEEEEEeccCCCCCHHHHHHhhC-----------------------------------------------------
Q 010624 96 SV-DSRLWVVMPFMSCGSLQSIISSCF----------------------------------------------------- 121 (506)
Q Consensus 96 ~~-~~~~~lV~Ey~~ggsL~~~i~~~~----------------------------------------------------- 121 (506)
.. +..++++||||.+|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 457899999999999999987531
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 122 ------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 122 ------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~ 235 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-----DY 235 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc-----ch
Confidence 1236788889999999999999999999999999999999999999999999875432110 00
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccc
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (506)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||............+...... ..+
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~ 304 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------RAP 304 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC----------CCC
Confidence 1112234567799999987654 8999999999999999997 999997654433333222221111 112
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 269 ~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...++.+.+++..||+.+|.+|||+.+|++|
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3457789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=327.39 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=207.8
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
++..+|++.+.||.|+||.||+|.+.. ..+..||+|.+.........+.+.+|+.+++.++||||+++++++....
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 455679999999999999999998742 2357899999976655555677889999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC
Q 010624 100 RLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g 165 (506)
..++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 9999999999999999986321 13478889999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 010624 166 SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKS 244 (506)
Q Consensus 166 ~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~ 244 (506)
.+||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||........
T Consensus 162 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAAD-----YYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred ceEecccccccccccch-----heeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999865432111 111122334578899999987654 8999999999999999998 8889977655443
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
......... ...+..++..+.+|+.+||+.+|.+||++.+|+.
T Consensus 236 ~~~i~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 236 IEMIRNRQV-----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHHcCCc-----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 322221111 1123568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=331.35 Aligned_cols=258 Identities=34% Similarity=0.567 Sum_probs=210.9
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
.-|.....||.|+||.||+|.+. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...|++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEc-CCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34666778999999999999985 5678999999865432 334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~----- 170 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 170 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-----
Confidence 9999999998865 56899999999999999999999999999999999999999999999999986432111
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........|++.|+|||.+.+.. ++.++|||||||++|+|++|..||........... +... ... ...
T Consensus 171 --~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~-~~~-------~~~ 238 (297)
T cd06659 171 --VPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDS-PPP-------KLK 238 (297)
T ss_pred --cccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhcc-CCC-------Ccc
Confidence 11122345889999999997654 78999999999999999999999976554433221 1111 000 011
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....++..+.++|.+||+.+|.+|||+.++++||||.++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 2345778899999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=337.07 Aligned_cols=265 Identities=27% Similarity=0.384 Sum_probs=206.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD----- 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (506)
..++|++.+.||+|+||.||+|.+. .+++.||||.+.... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3578999999999999999999985 568899999986432 233456777899999999999999999988643
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 35799999996 588888764 289999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||...+......... ..+..+.
T Consensus 168 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~ 237 (353)
T cd07850 168 AGTS--------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII-EQLGTPS 237 (353)
T ss_pred CCCC--------CCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-HhcCCCC
Confidence 3211 1122345788999999997654 8999999999999999999999997655433222211 1111000
Q ss_pred h-------------------------hhh---hh----hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 Y-------------------------EKT---LK----IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~-------------------------~~~---~~----~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ... .. ........++.+++||.+||+.||.+|||+.++|.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0 000 00 000012356778999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.15 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=203.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+...+|++.++||+|+||.||+|.+. +...||+|.+..... ..+.+.+|+.+++.++||||+++++.+. ....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 75 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence 3456678999999999999999999874 345699999865332 3357889999999999999999998875 4568
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.+|+|.+++.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||.+......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999999998754556899999999999999999999999999999999999999999999999987533211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.......... .+......
T Consensus 156 ~------~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~-~~~~~~~~----- 222 (262)
T cd05071 156 E------YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRM----- 222 (262)
T ss_pred c------cccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH-HHhcCCCC-----
Confidence 1 11112334567899999986544 8999999999999999999 888997665443322 22211111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.....++..+.+++.+||+.+|++|||+.+++.
T Consensus 223 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 123457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=324.97 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=199.0
Q ss_pred eecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--hhHHHHHHH---HHHHhhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 34 EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRE---TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
.||+|+||.||+|.+. .+++.||+|.+...... .....+..| +..++..+||||+++++++.....+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999885 56889999998754321 111223333 34455568999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
.|++|..++.. ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 80 ~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~------- 150 (278)
T cd05606 80 NGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------- 150 (278)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-------
Confidence 99999999876 467999999999999999999999999999999999999999999999999986532111
Q ss_pred CcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcccccchhhhhhhhcc
Q 010624 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL-MKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 267 (506)
......|++.|+|||.+.+...++.++||||+||++|+|++|..||.......... ....... ....
T Consensus 151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~ 218 (278)
T cd05606 151 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AVEL 218 (278)
T ss_pred --CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc----------CCCC
Confidence 11234689999999999755458899999999999999999999997653221111 1110000 0112
Q ss_pred chhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
+..++..+.+++.+||..+|.+|| ++.++++||||+...
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 345688999999999999999999 999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.60 Aligned_cols=264 Identities=23% Similarity=0.428 Sum_probs=211.3
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEe------CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCcee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICI------PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILN 90 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~------~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 90 (506)
.+..|.+..++|.+.+.||+|+||.||+|.+. ......+|+|.+...........+.+|+.+++.+ +||||++
T Consensus 3 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred CcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeee
Confidence 35667888899999999999999999999763 1234679999987655555667888999999999 5999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCC
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKA 156 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp 156 (506)
+++++...+.+|++|||+.+|+|.+++.... ...+++..+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999999997642 13488999999999999999999999999999999
Q ss_pred CCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCC
Q 010624 157 GNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPP 235 (506)
Q Consensus 157 ~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~P 235 (506)
+|||++.++.+||+|||++........ ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDY-----YKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred eeEEEcCCCcEEEcccccccccccccc-----ccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCC
Confidence 999999999999999998754321100 01111223456799999997644 8999999999999999999 8999
Q ss_pred CCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 236 LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
|...+....... +..... ...+..++.++++++.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 237 YPGIPVEELFKL-LREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCHHHHHHH-HHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 976655443322 221111 1123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=325.82 Aligned_cols=265 Identities=22% Similarity=0.371 Sum_probs=208.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCC---------------CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD---------------STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~---------------~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (506)
+...+|++.+.||+|+||.||+|.+...+ +..||+|.+.........+.+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 45678999999999999999999875322 256899998876666667889999999999999999
Q ss_pred eeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCE
Q 010624 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF---------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159 (506)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~---------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NI 159 (506)
+++++++..+...+++|||+.+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997642 12689999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh--CCCCCC
Q 010624 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH--GRPPLS 237 (506)
Q Consensus 160 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt--G~~Pf~ 237 (506)
+++.++.++|+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSD-----YYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eecCCCceEEccccceeecccCc-----ceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999999999999875432110 111122334577899999987644 8999999999999999998 778887
Q ss_pred CCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 238 HLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.......... ....+..... ......+..++.++.+++.+||+.||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIEN-AGHFFRDDGR---QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHH-HHhccccccc---cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6554433222 1111110000 0011123456789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=322.76 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=209.3
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
+....+|++.+.||.|+||.||+|.+. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++......|
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 445567999999999999999999984 37899999986543 233567889999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~- 157 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED- 157 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc-
Confidence 9999999999999998765667999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........++..|+|||.+.... ++.++|||||||++|+|++ |..||......+.... +......
T Consensus 158 ------~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~------ 223 (261)
T cd05148 158 ------VYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-ITAGYRM------ 223 (261)
T ss_pred ------cccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HHhCCcC------
Confidence 11112334567899999987644 8899999999999999998 8999976654443332 2222111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.30 Aligned_cols=272 Identities=32% Similarity=0.508 Sum_probs=213.2
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (506)
...+.+..++|++.+.||+|+||.||+|.+. .+++.||||.+...........+.+|+.++..+. ||||+++++++.+
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 3457788899999999999999999999985 4588999999876544444556667777666664 9999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
+...|++|||+. ++|.+++... ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999999985 5788877664 3579999999999999999999997 599999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH---TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
..... .......|++.|+|||.+.+. ..++.++|||||||++|+|++|+.||.................
T Consensus 164 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06618 164 RLVDS--------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235 (296)
T ss_pred hccCC--------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC
Confidence 32211 111233478889999998654 2378899999999999999999999975433222222111110
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccch
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGV 309 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~~ 309 (506)
. . .......++.++.+|+.+||..||.+|||+.+++.||||.......
T Consensus 236 ~-~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 283 (296)
T cd06618 236 P-P-------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283 (296)
T ss_pred C-C-------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence 0 0 0001124688999999999999999999999999999999865443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=330.22 Aligned_cols=274 Identities=27% Similarity=0.410 Sum_probs=205.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------ 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (506)
.++|++.+.||.|+||.||+|.++ .+++.+|+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 478999999999999999999985 5678899999865432 22234567899999999999999999877443
Q ss_pred --CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 99 --SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 99 --~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..+|+||+|+. ++|...+... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999997 5677766542 3579999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCCC----CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 177 SIYEPSHHHHH----GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 177 ~~~~~~~~~~~----~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
........... .........|++.|+|||.+.+...++.++|||||||++|+|++|++||................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 44322111110 11112334568899999998765558899999999999999999999997655543322221110
Q ss_pred c--cccchhhh----------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 253 F--RFSDYEKT----------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 253 ~--~~~~~~~~----------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
. ....+... .........+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 00000000 00001123455788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.82 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=208.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|++..++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 5678899999999999999999999873 45789999986543 2346788999999999999999999999998999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998755567999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........++..|+|||.+.+.. ++.++|+|||||++|+|++ |+.||......... ..+...+..+
T Consensus 157 ------~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~---- 224 (261)
T cd05034 157 ------EYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL-EQVERGYRMP---- 224 (261)
T ss_pred ------hhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCC----
Confidence 011112223456799999997654 8899999999999999998 99999765544332 2222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.+...+..+.+++.+||..+|.+||++.+++
T Consensus 225 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 225 ------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred ------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 2234578899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=322.13 Aligned_cols=278 Identities=27% Similarity=0.382 Sum_probs=209.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCC---eEEEEEEeccCCChh-hHHHHHHHHHHHhhCCCCCceeeeeEEEe-CCE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRT-DLDSIRRETKTMSLLSHPNILNAHCSFSV-DSR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~---~~vAIK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 100 (506)
...|+++..||+|.||.||+|+.+..++ ..+|||.+...+... -.....||+.+++.++||||+.+...|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999997754443 268999987654322 23456699999999999999999888876 889
Q ss_pred EEEEeccCCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC----CCeEEeecc
Q 010624 101 LWVVMPFMSCGSLQSIISSCF---PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD----GSVKLADFG 173 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~---~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~----g~vKL~DFG 173 (506)
+|+++||.+ .+|+.+|+... ...++...++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999996 89999997542 2458999999999999999999999999999999999999877 899999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHH
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP--------EKSL 245 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~--------~~~~ 245 (506)
++.......... .......-|.+|.|||++.|...|+.+.|||++|||+.||++-.+.|..... .-..
T Consensus 182 laR~~~~plkpl----~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 182 LARLFNNPLKPL----ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred HHHHhhcccccc----ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 987654332211 1222334489999999999988899999999999999999998887753211 1111
Q ss_pred HHHHhhcccccc---hhhhhh-----------------------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSD---YEKTLK-----------------------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~---~~~~~~-----------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+......+. |+...+ +-.....-++...+|+.+||..||.+|.|+.++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 122222111111 110000 000111124457899999999999999999999999
Q ss_pred ccccccccc
Q 010624 300 SFFKNCNKG 308 (506)
Q Consensus 300 p~f~~~~~~ 308 (506)
+||......
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 999987433
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.17 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=207.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
++..+|++.+.||+|+||.||+|.++..+ +..+|+|.+...........+.+|+.+++.++||||+++++++..++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35678999999999999999999885332 3479999987655555567889999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999999764 346899999999999999999999999999999999999999999999999987643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.. .........++..|+|||.+.+.. ++.++|+|||||++|++++ |..||......+. ...+......+
T Consensus 160 ~~----~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~---- 229 (267)
T cd05066 160 PE----AAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGYRLP---- 229 (267)
T ss_pred cc----eeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-HHHHhCCCcCC----
Confidence 10 001111223356799999997644 8999999999999999886 9999987654432 22222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
....+++.+.+++.+||+.+|.+|||+.++++
T Consensus 230 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 230 ------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 23456889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.69 Aligned_cols=253 Identities=38% Similarity=0.665 Sum_probs=213.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||+|++|.||+|.+. .++..||+|.+..... ....+.+.+|+.+++.++||||+++++++..+...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 5899999999999999999885 5678899999876542 2456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS---- 153 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc----
Confidence 99999999999873 679999999999999999999999999999999999999999999999999876443221
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.......|+..|+|||...+.. ++.++||||+|+++|+|++|..||................ ...
T Consensus 154 ---~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~ 218 (254)
T cd06627 154 ---KDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-----------HPP 218 (254)
T ss_pred ---ccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-----------CCC
Confidence 1123345788999999987655 7899999999999999999999998665433332222111 111
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 334578899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=329.11 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=203.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCe--EEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 100 (506)
+..++|++.+.||+|+||.||+|.++ .++. .+|+|.+...........+.+|+.++..+ +||||+++++++..++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEc-cCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 44578999999999999999999985 3444 46777765444445567888999999999 89999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 101 LWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
+|+||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999997532 125789999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~ 245 (506)
+||+|||++..... ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+..
T Consensus 163 ~kl~dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred EEeCccccCcccch--------hhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999998642111 01111223456799999987654 8899999999999999998 99999765443322
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
......... ..+..+++.+.+|+.+||+.+|++|||+.+++.+
T Consensus 234 -~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 -EKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -HHHhcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222211111 1233467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=318.40 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=209.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--C
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD--S 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 99 (506)
+.+|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence 357999999999999999999985 568899999875432 234456888999999999999999999998764 5
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 68999999999999999986 3568999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.... .........|+..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.................
T Consensus 158 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 226 (264)
T cd06653 158 TICM----SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT------ 226 (264)
T ss_pred cccc----cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC------
Confidence 1100 011112345889999999997654 78999999999999999999999987654443332221110
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....+..+++.+.+++.+||. +|..|||+.+++.|||.
T Consensus 227 ----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 112345688899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=338.71 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=198.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-EEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS-RLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV 104 (506)
.+.|.--..||+|+||.||+|.. .+++.||||.+....... ..+|.+|+.++..++|||+|++++||.+.+ ..++|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l--~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL--SDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE--CCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 35677778999999999999998 456899999876554432 455999999999999999999999999988 59999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG---HLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g---ivHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
+||+++|+|.+++.......++|.....|+.++++||+|||... |+||||||+|||+|.++++||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998743228999999999999999999999864 999999999999999999999999997432210
Q ss_pred CCCCCCCCcccccC-CCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhhcccccch
Q 010624 182 SHHHHHGSAMITDM-AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP--PEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 182 ~~~~~~~~~~~~~~-~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~ 258 (506)
....... .||.+|+|||.+.... .+.++||||||++|.||++|+.|..... .......+..........
T Consensus 231 -------~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 231 -------DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred -------ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 1111111 7999999999997533 7999999999999999999999887543 111122211111111111
Q ss_pred hhhhhhh---ccch--hhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 259 EKTLKIK---DKNK--KFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 259 ~~~~~~~---~~~~--~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
....... .... ..-..+..+..+|++.+|.+||++.+++
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 1111111 1111 2334466788899999999999998874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=314.11 Aligned_cols=257 Identities=37% Similarity=0.638 Sum_probs=212.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--CEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD--SRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 104 (506)
+|.+.+.||+|++|.||+|.+. .++..|++|.+..... ....+.+.+|+.++++++||||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 5889999999999999999985 4688999999876542 34567889999999999999999999999988 899999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
+||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999999874 48999999999999999999999999999999999999999999999999986654332110
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.................. .
T Consensus 158 -----~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~ 222 (260)
T cd06606 158 -----EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE---------P 222 (260)
T ss_pred -----ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC---------C
Confidence 1123456788999999997654 799999999999999999999999866522222222111000 1
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+..++..++++|.+||+.+|.+||++.+++.||||
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 12334568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.69 Aligned_cols=259 Identities=44% Similarity=0.718 Sum_probs=214.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.+.|++...||.|+||.||+|.+. .++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++..+...|+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 456999999999999999999985 4678899999875433 4567889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~---- 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE---- 169 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc----
Confidence 9999999999998742 37999999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
........|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||....+............. ..
T Consensus 170 ---~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~~ 236 (286)
T cd06614 170 ---KSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP---------PL 236 (286)
T ss_pred ---hhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------CC
Confidence 01122335788999999987654 899999999999999999999999866554433322211110 01
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....++..++++|.+||+.+|.+|||+.++++|+||++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 1223377899999999999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.83 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=203.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
+..+|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 4567999999999999999999873 45689999886432 2335678899999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~--- 153 (256)
T cd05059 78 TEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD--- 153 (256)
T ss_pred EecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc---
Confidence 9999999999999764 246899999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+.. ..+......
T Consensus 154 ---~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~-------- 220 (256)
T cd05059 154 ---QYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAGYRL-------- 220 (256)
T ss_pred ---cccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHcCCcC--------
Confidence 001111223345799999997654 8999999999999999999 89999766554332 222222111
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||..+|++|||+.++++
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=321.90 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=204.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCC---eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~---~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+...+|++.+.||.|+||+||+|.+...+. ..||+|.+...........+.+|+.+++.++||||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 456789999999999999999998753332 248999987665556667888999999999999999999988754 5
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.+++++|+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 77999999999999999763 34689999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
... ........+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||......... ..+.....
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~----- 229 (279)
T cd05109 162 DET-----EYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGER----- 229 (279)
T ss_pred ccc-----eeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCc-----
Confidence 110 11112234567899999997654 8999999999999999998 99999765443322 22221111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
......++..+.+++.+||..||++|||+.++++
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 230 -----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.27 Aligned_cols=266 Identities=22% Similarity=0.350 Sum_probs=213.9
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceee
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNA 91 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l 91 (506)
.....|.+..++|.+.+.||+|+||.||+|.+.. ..+..||+|++.........+.+.+|+.+|..+. ||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 3455688889999999999999999999998632 3456899999976655555567889999999998 9999999
Q ss_pred eeEEEeCCEEEEEeccCCCCCHHHHHHhhCC-------------------------------------------------
Q 010624 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFP------------------------------------------------- 122 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~------------------------------------------------- 122 (506)
++++...+..++|||||.+|+|.+++.....
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 9999999999999999999999999975311
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Q 010624 123 -----------------------------------------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVK 155 (506)
Q Consensus 123 -----------------------------------------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIK 155 (506)
..+++..+..++.|++.||.|||+.+++|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 136777889999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCC
Q 010624 156 AGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRP 234 (506)
Q Consensus 156 p~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~ 234 (506)
|+|||++.++.+||+|||++........ ........+++.|+|||.+.+.. ++.++|||||||++|||++ |..
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~ 340 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSN-----YISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGT 340 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccc-----cccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999754321110 01112234678899999997654 8999999999999999998 899
Q ss_pred CCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
||......+.....+...... ..+..++.++.+|+.+||..+|.+||++.+|++
T Consensus 341 P~~~~~~~~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 341 PYPELPMNEQFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCCCCCchHHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 997665544433333322111 123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=312.49 Aligned_cols=253 Identities=46% Similarity=0.756 Sum_probs=210.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
+|.+.+.||+|++|.||++.+. .++..+++|.+..... .....+.+|+.+++.++||||+++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-CCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 5899999999999999999985 4678999999876543 4567888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 79 CSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred CCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 9999999999874 25799999999999999999999999999999999999999999999999998654322110
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
.....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||............... ..+. ...
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-------~~~ 219 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--GPPG-------LRN 219 (253)
T ss_pred ----ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc--CCCC-------cCc
Confidence 23445788999999997655 789999999999999999999999876444333322211 1110 001
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~ 301 (506)
...++..+.++|.+||+.||++|||+.++++|||
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 2224788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=334.78 Aligned_cols=269 Identities=21% Similarity=0.358 Sum_probs=207.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------- 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------- 98 (506)
..+|++.+.||.|+||.||+|.++ .++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 478999999999999999999985 5688999999865543 4456788999999999999999998766543
Q ss_pred -------CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEe
Q 010624 99 -------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLA 170 (506)
Q Consensus 99 -------~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~ 170 (506)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++ .++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35899999997 689888864 4689999999999999999999999999999999999998 45679999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
|||++........ .........|+..|+|||.+.+...++.++|||||||++|+|++|..||..............
T Consensus 158 dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 158 DFGLARIVDPHYS----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CcccceecCCccc----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9998754321100 011112235788999999886555588999999999999999999999986655443333221
Q ss_pred hcccccch----------hhh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 251 QRFRFSDY----------EKT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 251 ~~~~~~~~----------~~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ...... ... .........++.++++||.+||+.||.+|||+.+++.||||+..
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 234 S-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred h-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 1 100000 000 00001123567889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=334.28 Aligned_cols=270 Identities=27% Similarity=0.400 Sum_probs=214.7
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-----EE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS-----RL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 101 (506)
+|++.+.||.|++|.||+|.+. .++..||||.+..... ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5999999999999999999984 5688999999875432 344567889999999999999999999988765 79
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|+|+. ++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999997 589998876 348999999999999999999999999999999999999999999999999997654332
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh-
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK- 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 260 (506)
... ........+|+.|+|||.+.+...++.++|+|||||++|+|++|.+||......+........ ...+....
T Consensus 157 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 231 (330)
T cd07834 157 EDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV-LGTPSEEDL 231 (330)
T ss_pred ccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh-cCCCChhHh
Confidence 110 011233457899999999987646899999999999999999999999876654433222221 11100000
Q ss_pred -------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 -------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 -------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..........++..+.++|.+||+.+|.+|||+.+++.||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0001112234688899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.83 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=200.0
Q ss_pred CCe-eEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCE
Q 010624 27 SSY-KILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSR 100 (506)
Q Consensus 27 ~~Y-~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 100 (506)
++| ++.+.||+|+||+||.+... ..++..||+|.+...........+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 99999999999999886532 245778999998765544556778899999999999999999998765 346
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 8999999999999999976 4699999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-RFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~ 259 (506)
... .........++..|+|||.+.+.. ++.++|||||||++|+|++|..||......-........ ........
T Consensus 160 ~~~----~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 160 GHE----YYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cch----hhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 100 001112234567799999987644 789999999999999999999998654322110000000 00000000
Q ss_pred hh---hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KT---LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~---~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. ......+..++..+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0001123457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.63 Aligned_cols=267 Identities=26% Similarity=0.392 Sum_probs=211.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS---- 99 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (506)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|+.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4678999999999999999999985 568899999986433 2334457889999999999999999999987654
Q ss_pred --EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 100 --RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 100 --~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
.+++||+|+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999 7899988875 5799999999999999999999999999999999999999999999999998653
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc-
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS- 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~- 256 (506)
... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||............+......+
T Consensus 168 ~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 168 TDS----------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccc----------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 211 112335688999999987644578999999999999999999999986654433322221111000
Q ss_pred ---------chhhh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 ---------DYEKT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ---------~~~~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..... .........+++.+.++|.+||+.||.+|||+.+++.||||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00000 001112245778899999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.76 Aligned_cols=277 Identities=26% Similarity=0.342 Sum_probs=211.3
Q ss_pred CCee-EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhh-------------HHHHHHHHHHHhhCCCCCceeee
Q 010624 27 SSYK-ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD-------------LDSIRRETKTMSLLSHPNILNAH 92 (506)
Q Consensus 27 ~~Y~-i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~-------------~~~~~~Ei~il~~l~HpnIv~l~ 92 (506)
++|. +.+.||.|+||+||+|.+. .+++.||||.+........ ...+.+|+.+++.++||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 4565 5577999999999999985 5688999999865432210 12467899999999999999999
Q ss_pred eEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
+++..+...+++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99999999999999997 689999876 467999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCC-------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 010624 173 GVSASIYEPSHHH-------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL 245 (506)
Q Consensus 173 Gls~~~~~~~~~~-------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~ 245 (506)
|++.......... ...........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9876433110000 000111223346889999999976555789999999999999999999999876654433
Q ss_pred HHHHhhc--ccccchhh--------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 246 LMKMTQR--FRFSDYEK--------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 246 ~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
....... .....+.. ...........+..+.++|.+||+.+|++|||+++++.||||+....
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 2222110 00000000 00011112345788999999999999999999999999999997643
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.98 Aligned_cols=255 Identities=28% Similarity=0.505 Sum_probs=204.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||.|+||.||+|.++ .++..+|||.+.... .......+.+|+.+++.++||||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 57999999999999999999985 568899999876432 233456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 105 MPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
|||+.+++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 9999999999998742 1345899999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..................++
T Consensus 160 ------~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 226 (267)
T cd08229 160 ------TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------ 226 (267)
T ss_pred ------CcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC------
Confidence 11122345789999999997654 78999999999999999999999975433211111111111111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+.....+++.+++++.+||..||.+|||+.+|++
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 1123457889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=312.70 Aligned_cols=269 Identities=22% Similarity=0.323 Sum_probs=212.2
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV- 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 97 (506)
+.++.++.++|+|.+.||.|||+.||.+... .++..+|+|.+.... ..+.+..++|++..++++||||++++++...
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeeccc-Ccccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 6678899999999999999999999999886 567899999987654 5667889999999999999999998876533
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCCeEE
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~vKL 169 (506)
....|++++|...|||.+.+.... +..+++.++..|+.++++||++||+.. ++||||||.|||+...+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 345999999999999999997653 235999999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCCC--CCCCcccccCCCCCccCChhhhhccC--CCCccccHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 010624 170 ADFGVSASIYEPSHHH--HHGSAMITDMAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPP-EKS 244 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~--~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~sDIwSlGiil~eLltG~~Pf~~~~~-~~~ 244 (506)
.|||.+.......... ............|..|.|||++.-.. ..++++|||||||+||.|+.|..||...-. ..+
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 9999865433221111 11111234456789999999986432 368999999999999999999999963211 000
Q ss_pred H-HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 245 L-LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 245 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
. .......+ .++ ....+|+.+.+||++||+.||.+||++.+++.+
T Consensus 251 laLAv~n~q~---------s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQI---------SIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEeeecccc---------ccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 00001111 122 223489999999999999999999999999754
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.35 Aligned_cols=264 Identities=29% Similarity=0.439 Sum_probs=208.1
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--CEEEEEe
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD--SRLWVVM 105 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 105 (506)
|++.+.||.|+||.||+|.+. .+++.+|+|.+.... .......+.+|+.+++.++||||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999985 567899999997654 223345678999999999999999999999888 8999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||++ ++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9997 5898888763 25799999999999999999999999999999999999999999999999998764432210
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh----
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT---- 261 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 261 (506)
.......++..|+|||.+.+...++.++|||||||++|+|++|..||............... ...+.....
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (287)
T cd07840 156 ----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL-CGSPTDENWPGVS 230 (287)
T ss_pred ----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCchhhccccc
Confidence 11223356788999998876555889999999999999999999999876654333222211 100000000
Q ss_pred ---------------hhhhccchh-hhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 262 ---------------LKIKDKNKK-FSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 262 ---------------~~~~~~~~~-~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
......... +++.+.+++.+||..+|.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000011112 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.99 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=208.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----C
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-----S 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (506)
..+|++.+.||+|+||+||+|.+. .++..||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999985 578899999986532 233345677899999999999999999887644 3
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|+++||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 5899999996 789998876 4679999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc---
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS--- 256 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 256 (506)
... .......|+..|+|||.+.....++.++|||||||++|+|++|++||...+......... .....+
T Consensus 160 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 231 (337)
T cd07858 160 EKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT-ELLGSPSEE 231 (337)
T ss_pred CCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH-HHhCCCChH
Confidence 210 112234578899999998754458899999999999999999999997654322111111 000000
Q ss_pred --------chhh---------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 257 --------DYEK---------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 --------~~~~---------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.... ........+.+++++.+||.+||+.+|++|||+.++++||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 000011234578899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=316.26 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=202.3
Q ss_pred eeecccCCeeEEEEEEeCCCCe--EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
+.||+|++|.||+|.+...+++ .||||.+.........+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 4689999999999998543443 6999998776554567789999999999999999999999988 899999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----HYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc----cee
Confidence 9999999875335689999999999999999999999999999999999999999999999998765422111 111
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+........... ...+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER----------LERPE 224 (257)
T ss_pred cccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------CCCCc
Confidence 112345678899999987654 8999999999999999998 99999766555433322211111 11223
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.++..+.+++.+||+.+|++|||+.+++.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 56789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.03 Aligned_cols=261 Identities=24% Similarity=0.409 Sum_probs=218.7
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCC---eEEEEEEecc--CCChhhHHHHHHHHHHHhhCCCCCceeee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDL--DQSRTDLDSIRRETKTMSLLSHPNILNAH 92 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~---~~vAIK~i~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 92 (506)
.+..|.+..++-.+.++||+|+||.||+|..+..++ ..||||.... ......+.++.+|+++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 355588888888889999999999999999975544 2389999875 23566788999999999999999999999
Q ss_pred eEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
|+......+|+|||+|.||+|.+++... +..++..+...++.+.+.||+|||+++++||||-..|||++.++.+||+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999999999984 336999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~ 251 (506)
|+|........ ......-...|+|||.+.... |+.++|||||||++||+.+ |..||......+....+...
T Consensus 307 GLs~~~~~~~~-------~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 307 GLSRAGSQYVM-------KKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN 378 (474)
T ss_pred ccccCCcceee-------ccccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence 99765431110 000112245699999998764 9999999999999999999 89999988877666555455
Q ss_pred cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.++.+ .+...++++..++.+||..+|++|||+.++.
T Consensus 379 ~~r~~----------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 379 GYRMP----------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred CccCC----------CCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 44433 3346788899999999999999999998885
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.16 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=201.4
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCe--EEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 103 (506)
++|++.+.||.|+||.||+|.+.. ++. .+++|.+.........+.+.+|+.++.++ +||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 579999999999999999998853 333 47888876444445567788999999999 79999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEE
Q 010624 104 VMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL 169 (506)
+|||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 999999999999997532 134889999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~ 248 (506)
+|||++...... ........+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...........
T Consensus 161 ~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~- 230 (297)
T cd05089 161 ADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK- 230 (297)
T ss_pred CCcCCCccccce--------eccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence 999986432110 0111122345699999987654 8999999999999999997 9999987655443222
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...... ...+..++..+.+|+.+||+.+|.+|||++++++
T Consensus 231 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 231 LPQGYR----------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred HhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 221111 1123457889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.71 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=205.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
...+|++.+.||+|+||.||+|.++..+ +..||||.+...........+..|+.+++.++||||+++++++..+...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 4567999999999999999999986332 24699999876555566778999999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 82 IITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999764 3568999999999999999999999999999999999999999999999999865332211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
... .........++..|+|||.+.+.. ++.++|||||||++|++++ |..||.......... .+......+
T Consensus 161 ~~~--~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~-~i~~~~~~~----- 231 (269)
T cd05065 161 SDP--TYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN-AIEQDYRLP----- 231 (269)
T ss_pred ccc--ccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH-HHHcCCcCC-----
Confidence 000 000111111245799999997544 8999999999999999886 999998765543322 222211111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+..++..+.+++.+||..+|.+||++.+|+.
T Consensus 232 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 -----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 23456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=317.35 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=202.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEE-EeCCE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSF-SVDSR 100 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~ 100 (506)
|.++.++|++.+.||+|+||.||++.. .+..+|+|.+.... ..+.+.+|+.+++.++|+||+++++++ ..++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 456788999999999999999999976 36789999985432 345788999999999999999999875 45678
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999999999875445689999999999999999999999999999999999999999999999998653221
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
. .....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||......... ..+.....
T Consensus 155 ~----------~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-~~~~~~~~----- 217 (256)
T cd05082 155 T----------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYK----- 217 (256)
T ss_pred c----------CCCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCC-----
Confidence 1 11223456799999987644 8999999999999999997 99999765443322 22211111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
......+++.+.+++.+||+.+|++|||+.++++
T Consensus 218 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1133467889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.11 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=205.9
Q ss_pred eeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
+.||+|+||.||+|.+.. ..+..||+|.+.........+.+.+|+.+++.++|+||+++++++..+..++++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999852 127889999997665555578899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 111 GSLQSIISSCF-------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 111 gsL~~~i~~~~-------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
++|.+++.... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 99999998742 26799999999999999999999999999999999999999999999999998764432211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........+++.|+|||.+.+. .++.++|||||||++|+|++ |..||........... +.....
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~-------- 225 (262)
T cd00192 161 -----YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-LRKGYR-------- 225 (262)
T ss_pred -----cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCC--------
Confidence 1123345578899999998765 48999999999999999999 6999987754433222 222111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 --LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11345568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.60 Aligned_cols=259 Identities=21% Similarity=0.350 Sum_probs=208.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+..++|++...||.|+||.||+|.++.. +...||+|.+.........+.+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3457899999999999999999997532 346799998876544445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFP-------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~-------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
..|+||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999986431 16899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~ 251 (506)
|++...... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||...............
T Consensus 162 ~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNS------EYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234 (275)
T ss_pred ccccccCcc------cccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence 986532211 111122334567799999987654 7889999999999999998 88899765544433222211
Q ss_pred cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+ .....++..+.+++.+||+.+|.+|||+.+++..
T Consensus 235 ~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1111 1234578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=330.59 Aligned_cols=265 Identities=25% Similarity=0.432 Sum_probs=212.2
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCC------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCcee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPM------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILN 90 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 90 (506)
...+|.+...+|++.+.||+|+||.||+|.+... .+..||+|.+.........+.+.+|+.+++++ +||||++
T Consensus 3 ~~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred CCcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3477889999999999999999999999986421 23478999887655555667899999999999 7999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCC
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKA 156 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp 156 (506)
+++++..++.+|++|||+.+|+|.+++.... ...+++..+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999997632 12478889999999999999999999999999999
Q ss_pred CCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCC
Q 010624 157 GNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPP 235 (506)
Q Consensus 157 ~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~P 235 (506)
+|||++.++.+||+|||++....... .........++..|+|||++.+.. ++.++|||||||++|+|++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNID-----YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccc-----ccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999875432110 011112233456799999997654 8899999999999999998 8899
Q ss_pred CCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 236 LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
|...+....... +..... ...+..++..+.+|+.+||+.+|.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 237 YPGIPVEELFKL-LKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCCHHHHHHH-HHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 977655443322 222111 11234567899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=315.35 Aligned_cols=254 Identities=30% Similarity=0.538 Sum_probs=204.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||.|+||.||+|.+. .+|+.||+|.+.... .....+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999995 578899999886432 233467889999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 105 MPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
|||+++++|..++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 99999999999987532 345899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK-SLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 261 (506)
........|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||....... .......... +
T Consensus 160 ------~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~------ 225 (267)
T cd08224 160 ------TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-Y------ 225 (267)
T ss_pred ------CcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-C------
Confidence 11122345788999999987644 8899999999999999999999996543211 1111111110 0
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+.....++..+.++|.+||..+|++|||+.+|++
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01122367789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=321.95 Aligned_cols=263 Identities=33% Similarity=0.495 Sum_probs=209.8
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
|++.+.||.|++|.||+|.+. .+++.+|+|.+...... .....+.+|+.+++.++||||+++++++..+..+++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 778899999999999999984 57899999998754432 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.+ +|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 975 888887763 3579999999999999999999999999999999999999999999999999875443221
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh-------
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK------- 260 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------- 260 (506)
.......++..|+|||.+.+...++.++|+|||||++|+|++|++||...+..+........ ...+....
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT-LGTPDPEVWPKFTSL 229 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCchHhcccchhh
Confidence 11123457889999999977645899999999999999999999999766554433222211 00000000
Q ss_pred ------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 261 ------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 261 ------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..........++.+++++|.+||+.||.+||++.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000011224578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.26 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=206.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
++..+|.+.++||+|+||.||+|.+. ..++..+|+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45678999999999999999999753 124568999987543 3455678999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFP-------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~-------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
..|++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999976422 34889999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~ 245 (506)
+||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.........
T Consensus 161 ~kL~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTD-----YYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred EEECCCCceeEcCCCc-----eeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 9999999875332110 001112233567899999987654 8999999999999999998 99999766554433
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.... .... ...+..+++.+.+++.+||+.||.+||++.+|+.
T Consensus 235 ~~~~-~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECIT-QGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHH-cCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2221 1111 1123457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.39 Aligned_cols=267 Identities=22% Similarity=0.355 Sum_probs=208.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD----- 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (506)
..++|.+.+.||+|+||.||+|.+. .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 4578999999999999999999885 568899999986543 233356788999999999999999999888643
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478888887 7899988865 4699999999999999999999999999999999999999999999999998653
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... ......||+.|+|||.+.+...++.++|||||||++|+|++|.+||.....................
T Consensus 170 ~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 170 TDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred ccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 211 1123457889999999876555889999999999999999999999765543332222111100000
Q ss_pred -h---------hhhhh---------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 258 -Y---------EKTLK---------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 258 -~---------~~~~~---------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. ..... ........++.+++||.+||+.||.+|||+.+++.||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0 00000 0001123577899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=324.16 Aligned_cols=256 Identities=36% Similarity=0.586 Sum_probs=209.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..|...+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.++|||++++++++..+...|+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 45899999999999999999985 567899999986543 233456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+. |+|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 104 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~----- 176 (317)
T cd06635 104 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS----- 176 (317)
T ss_pred EeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-----
Confidence 99997 5777777543 4568999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
......|++.|+|||.+.. ...++.++|||||||++|+|++|.+||..................
T Consensus 177 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------- 242 (317)
T cd06635 177 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------- 242 (317)
T ss_pred ------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--------
Confidence 1123457889999999742 233788999999999999999999999776544433332222110
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
......+++.+++++.+||+.+|.+|||+.++++|+|+....
T Consensus 243 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 243 --TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 112335678899999999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.22 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=204.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.++||+|+||.||+|.+. .+++.||+|++.... .....+++.+|+.+++.++||||+++++++.+++..|++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 68999999999999999999985 568899999987543 233456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 105 MPFMSCGSLQSIISSCF---------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~---------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
|||++|++|.+++.... ...++...+..++.||+.||+|||++|++||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999987531 124567788999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCC-----------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q 010624 176 ASIYEPSHHH-----------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS 244 (506)
Q Consensus 176 ~~~~~~~~~~-----------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~ 244 (506)
.......... ...........||+.|+|||.+.+.. ++.++|||||||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 6541110000 00011112346999999999997655 89999999999999999999999976443322
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.... ... ... .......+++.+.+++.+||+.||++||+..+.+.
T Consensus 240 ~~~~---~i~--~P~----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRD---VIL--SPI----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhh---hcc--Chh----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 000 000 00122467888999999999999999988666554
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=324.27 Aligned_cols=269 Identities=26% Similarity=0.373 Sum_probs=207.7
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC---
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--- 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (506)
...++|++.+.||.|+||.||+|.++ .+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 34578999999999999999999995 5678999999875432 233456778999999999999999999887654
Q ss_pred -------EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 100 -------RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 100 -------~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
.+|+|+||+.+ ++.+.+... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999985 777777653 357999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
|++........ .......+++.|+|||.+.+...++.++|||||||++|+|++|++||............. ..
T Consensus 161 g~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~-~~ 233 (302)
T cd07864 161 GLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS-RL 233 (302)
T ss_pred cccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HH
Confidence 98654322110 111223457789999998765557889999999999999999999998655433322211 11
Q ss_pred ccccc---hhhhh----------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 253 FRFSD---YEKTL----------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 253 ~~~~~---~~~~~----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+. +.... ........++..+.+++.+||..+|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 10000 00000 0001123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=316.48 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=206.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..+.|+..+.||+|+||.||+|.+.... ...+|+|.+.........+.+.+|+.+++.++||||+++++++......
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 45678999999999999999999985322 2379999987665555567889999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999999763 356899999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.. ..........++.|+|||.+.... ++.++|||||||++|+|++ |..||......... ..+......+
T Consensus 161 ~~----~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-~~i~~~~~~~---- 230 (268)
T cd05063 161 PE----GTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-KAINDGFRLP---- 230 (268)
T ss_pred cc----cceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-HHHhcCCCCC----
Confidence 10 011111222345799999987644 8999999999999999997 99999766544322 2222211111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
....++..+.+++.+||..+|++||++.++++
T Consensus 231 ------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 23356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.94 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=201.2
Q ss_pred eeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE-----
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR----- 100 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----- 100 (506)
|.+.+.||+|+||.||+|.+.... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678999999999999999875322 4789999987643 34456788999999999999999999988765443
Q ss_pred -EEEEeccCCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 101 -LWVVMPFMSCGSLQSIISSCF----PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 101 -~~lV~Ey~~ggsL~~~i~~~~----~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.+++|||+.+++|..++.... ...+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999999985532 236899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
........ ........++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+.. ..+.....
T Consensus 161 ~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~~~~~~~~ 233 (273)
T cd05035 161 KKIYSGDY-----YRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-DYLRHGNR 233 (273)
T ss_pred eecccccc-----ccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCC
Confidence 64322111 01112233467799999986544 8999999999999999999 89999766554432 22221111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 234 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11335678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.02 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=207.0
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEecc
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
|.+.+.||+|++|+||+|.+. .++..||||.+.............+|+..++.++ ||||+++++++..++..|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 788999999999999999984 5678999999865443333334557999999999 99999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+ +|+|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~------ 152 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR------ 152 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC------
Confidence 9 789999988754457899999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc---hh-----
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD---YE----- 259 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~----- 259 (506)
.......|+..|+|||.+.+...++.++|+||||+++++|++|++||............... ...+. +.
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 --PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV-LGTPTKQDWPEGYKL 229 (283)
T ss_pred --CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh-cCCCChhhhhhHhhh
Confidence 11123457889999999865555789999999999999999999999766544433222110 00000 00
Q ss_pred -----------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 260 -----------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 260 -----------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
............+..+.++|.+||+.+|++|||+.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000011112236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=316.16 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=203.2
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+..++|++.+.||+|++|.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence 3456678999999999999999999874 34569999876433 23467889999999999999999998875 4568
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 89999999999999998754556899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......... ..+......
T Consensus 156 ~------~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~----- 222 (260)
T cd05069 156 E------YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQVERGYRM----- 222 (260)
T ss_pred c------ccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCC-----
Confidence 0 11112234567899999987654 8899999999999999999 99999876554432 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||..||.+||+++++++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 123457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.09 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=204.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
...+|.+.+.||+|+||.||+|.+.. .++..+++|.+... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 45679999999999999999998632 23467899987533 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 101 LWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
.++||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999997632 134899999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~ 245 (506)
+||+|||++....... .........|++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.........
T Consensus 162 ~~l~dfg~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTD-----YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred EEECCCCcccccCCCc-----eeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999875432211 011122344678899999987654 8899999999999999998 99999776554432
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. +.... .......++..+.+++.+||+.+|.+|||+.++++
T Consensus 236 ~~-~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 236 EC-ITQGR----------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HH-HhCCC----------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 22 21111 11123456788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=320.59 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=201.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+...+|++.+.||.|+||+||+|.+.. ++. .+++|.+...........+..|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 456789999999999999999998853 333 478888765444445567888999999999999999999875 45
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..++++||+.+|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 678999999999999999763 3568999999999999999999999999999999999999999999999999875332
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... .........|+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......... ..+......
T Consensus 161 ~~~-----~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--- 230 (279)
T cd05111 161 PDD-----KKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERL--- 230 (279)
T ss_pred CCC-----cccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcC---
Confidence 110 111122345677899999997654 8999999999999999998 99999765543321 112111110
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||..||++|||+.++++
T Consensus 231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 122346778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=315.35 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=206.7
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.+..++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....|
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999987 368899999875533 5678899999999999999999999999899999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998754447999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
.....++..|+|||.+.... ++.++|||||||++|+|++ |..||...+.... ..........
T Consensus 156 ---------~~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~------ 218 (256)
T cd05039 156 ---------QDSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEKGYRM------ 218 (256)
T ss_pred ---------cccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhcCCCC------
Confidence 11223456799999987544 7889999999999999997 9999976654432 2222222111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.++|.+||..+|++|||+.++++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 ----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.03 Aligned_cols=274 Identities=29% Similarity=0.413 Sum_probs=210.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC--CEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVD--SRL 101 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~ 101 (506)
.++|++.+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++++ +||||+++++++... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467999999999999999999985 567899999885432 233445677899999999 999999999988653 468
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+. ++|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999997 599998876 37889999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch---
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY--- 258 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 258 (506)
.... .........||+.|+|||.+.+...++.++|||||||++|+|++|++||......................
T Consensus 161 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 161 EENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 1110 01122234589999999988665557899999999999999999999997655443322211111000000
Q ss_pred ----------------hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 ----------------EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ----------------~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..........+.++.++.++|.+||+.||++|||+.++++||||+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 000001112233688999999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=318.39 Aligned_cols=262 Identities=29% Similarity=0.402 Sum_probs=204.5
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhC---CCCCceeeeeEEEeCCE----
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLL---SHPNILNAHCSFSVDSR---- 100 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~---- 100 (506)
|++.+.||.|+||.||+|.++ .+++.||+|.+...... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 789999999999999999985 46889999998754332 2234566788777666 59999999999988776
Q ss_pred -EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 101 -LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 101 -~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
++++|||+. ++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999997 589998877544569999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch-
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY- 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 258 (506)
.. .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||......+....... ....+..
T Consensus 159 ~~--------~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (287)
T cd07838 159 FE--------MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD-VIGLPSEE 228 (287)
T ss_pred CC--------cccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH-HcCCCChH
Confidence 11 1112234688899999997654 89999999999999999999999987655443333221 1110000
Q ss_pred -------------h--hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 259 -------------E--KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 259 -------------~--~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
. .........+..++.+.++|.+||+.||.+||++.+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 0000111223467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=342.36 Aligned_cols=247 Identities=26% Similarity=0.441 Sum_probs=207.6
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.|.+..+...-++-||+|+.|.||.|.. .++.||||+++.- -..+|+-|++|+||||+.+.+.|.....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl---~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL---HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec---cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 3666666677788899999999999987 3688999987421 1257888999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
++||||||..|.|..+++. ...+.......|.++|+.|+.|||.++|||||||.-||||..+..|||+|||-|.....
T Consensus 187 yCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999999998 57889999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
........||..|||||+++..+ .++|+|||||||+||||+||..||.+......+...-.+.+..
T Consensus 265 --------~STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L----- 330 (904)
T KOG4721|consen 265 --------KSTKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL----- 330 (904)
T ss_pred --------hhhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc-----
Confidence 13345567999999999998765 8999999999999999999999998765443322211111111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+..+++.++-||++||+..|.+||++.+|+.|
T Consensus 331 -----pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 331 -----PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -----cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1456789999999999999999999999999987
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.00 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=209.1
Q ss_pred CeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCC---hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQS---RTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (506)
.|++.+.||.|+||.||+|.+.. .+|..||+|.+..... ....+.+.+|+.+++.+ +|+||+++++.|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 48999999999999999998742 3678999999865321 23346778999999999 599999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 999999999999999987 467899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...................
T Consensus 159 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----- 227 (290)
T cd05613 159 ------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 227 (290)
T ss_pred ------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----
Confidence 01112234578899999998643 236789999999999999999999996432221111111110000
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
....+..+++.+.+++.+||+.||++|| ++.+++.||||...+
T Consensus 228 ---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 ---EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ---CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0112345788999999999999999997 899999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.99 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=210.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE---
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR--- 100 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--- 100 (506)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEEC-CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3568999999999999999999985 567899999986542 23344667889999999999999999888766554
Q ss_pred ---EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 101 ---LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 101 ---~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
.|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 5799999875 5799999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||............... ...+.
T Consensus 168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~-~~~~~ 236 (343)
T cd07851 168 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL-VGTPD 236 (343)
T ss_pred cccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCC
Confidence 3211 223357889999999876545789999999999999999999999866554333222111 11000
Q ss_pred h-----------hhhhh---------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 258 Y-----------EKTLK---------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 258 ~-----------~~~~~---------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
. ..... .......+++.+.++|.+||+.+|++|||+.+|+.||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 00000 00011235889999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=315.67 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=196.9
Q ss_pred eecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 34 EIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
.||+|+||.||+|.+.. ..+..||+|++.........+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 48999999999998752 3355799999876655555678999999999999999999999886 457899999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........ .....
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~ 155 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS----YYKAR 155 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc----ceecc
Confidence 99998753 35789999999999999999999999999999999999999999999999998753221110 01111
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (506)
....+++.|+|||.+.... ++.++|||||||++|+|++ |..||.......... .+..... ...+..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~----------~~~~~~~ 223 (257)
T cd05115 156 SAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKR----------LDCPAEC 223 (257)
T ss_pred CCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCC----------CCCCCCC
Confidence 2233467899999987644 8899999999999999996 999998766544322 2222111 1134567
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 272 SRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 272 s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
++++.++|.+||..+|++||++.+|.+
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.79 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=205.0
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCC-------------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCcee
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPM-------------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~-------------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 90 (506)
+...+|++.+.||+|+||.||+|.+... ....||+|.+.........+.+.+|+++++.++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 3457899999999999999999877421 123589999876655555678999999999999999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEE
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP----------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL 160 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~----------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NIL 160 (506)
+++++...+..|+||||+.+++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999999999999865311 23688899999999999999999999999999999999
Q ss_pred eCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh--CCCCCCC
Q 010624 161 SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH--GRPPLSH 238 (506)
Q Consensus 161 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt--G~~Pf~~ 238 (506)
++.++.+||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-----YYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCc-----ceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999875432110 011122334567899999987654 8999999999999999988 6678876
Q ss_pred CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
........... ..+.... .......+..+++.+++|+.+||+.||++|||+++|++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTG-EFFRNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHH-Hhhhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55443322211 1000000 00011123457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=314.39 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=198.2
Q ss_pred eeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 110 (506)
++||+|+||.||+|.....+ +..+|+|.+.........+.+.+|+.+++.++||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999875443 26899999876655455678899999999999999999999876 4568999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
++|.+++... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~----~~~ 153 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD----YYR 153 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc----ccc
Confidence 9999999873 4799999999999999999999999999999999999999999999999998764322111 111
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||........ ...+..... ...+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~-~~~~~~~~~----------~~~~~ 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAMLESGER----------LPRPE 221 (257)
T ss_pred cccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHcCCc----------CCCCC
Confidence 112223456799999987654 8999999999999999998 9999987655433 222222111 11345
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.++..++++|.+||..+|.+|||+.++++
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 67889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.92 Aligned_cols=254 Identities=34% Similarity=0.588 Sum_probs=208.0
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
|...+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 777889999999999999884 678899999986543 23344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+. ++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 102 ~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 996 6777777653 3568999999999999999999999999999999999999999999999999864321
Q ss_pred CCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
......|+..|+|||.+.. ...++.++|||||||++|+|++|.+||................. .
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~----------~ 238 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS----------P 238 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------C
Confidence 1123457889999999842 23478899999999999999999999977655443332221111 0
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
......++..+++|+.+||+.+|.+||++.+++.||||+...
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 112234677899999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=320.15 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=206.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+..++|++.+.||.|+||.||+|.+.. .++..||+|.+...........+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 455789999999999999999998742 2567899999876555555677899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCE
Q 010624 100 RLWVVMPFMSCGSLQSIISSCF--------------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~--------------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NI 159 (506)
..|++|||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997531 12478889999999999999999999999999999999
Q ss_pred EeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 010624 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSH 238 (506)
Q Consensus 160 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~ 238 (506)
+++.++.+||+|||++........ ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||..
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred EecCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999998653321110 01111223456799999987654 8999999999999999997 8889876
Q ss_pred CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
....+......... ....+..++..+.+|+.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGN-----------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCC-----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 65544332211111 01123457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=320.37 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=204.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+|++.+.||+|+||.||+|.+... ....+|+|.+...........+.+|+.+++.++||||+++++.+..++..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 588999999999999999987421 2357999988766555566789999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe
Q 010624 104 VMPFMSCGSLQSIISSCF----------------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS 161 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~----------------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl 161 (506)
++||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999999999987531 1347899999999999999999999999999999999999
Q ss_pred CCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 010624 162 DSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLP 240 (506)
Q Consensus 162 d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~ 240 (506)
+.++.+||+|||++........ ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDS-----YVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred cCCCcEEeccccccccccCccc-----hhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999998653321110 01112234567899999986654 8999999999999999998 999997655
Q ss_pred hHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+.... ......... ..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~-~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLF-NLLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHH-HHHhCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 44322 222221111 123457889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.50 Aligned_cols=253 Identities=23% Similarity=0.440 Sum_probs=204.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
|.+..++|++.+.||+|+||.||+|.+ .++..+|+|.+... ....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~--~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATY--NKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEe--cCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 567889999999999999999999986 34567999987643 2335678899999999999999999999887 778
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998754556889999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........++..|+|||.+.... ++.++|+|||||++|++++ |..||......... ..+......
T Consensus 156 ------~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~----- 222 (260)
T cd05073 156 ------EYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRM----- 222 (260)
T ss_pred ------CcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhCCCCC-----
Confidence 011112234567799999997644 8899999999999999998 99999865443322 222222111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
......+.++.+++.+||+.+|++||++.+++
T Consensus 223 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 223 -----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred -----CCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 12345778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=322.14 Aligned_cols=256 Identities=35% Similarity=0.585 Sum_probs=207.7
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
|....+||+|+||.||++.+. .++..||||.+.... ......+.+|+.+++.++||||+++++.+..+...|++|||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 444567999999999999885 578899999986433 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~------- 169 (292)
T cd06657 100 EGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------- 169 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc-------
Confidence 99999998864 46899999999999999999999999999999999999999999999999986532211
Q ss_pred CcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccc
Q 010624 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (506)
........|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||........... +...... .....
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~--------~~~~~ 239 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPP--------KLKNL 239 (292)
T ss_pred cccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhhCCc--------ccCCc
Confidence 11122345789999999986544 78999999999999999999999976544332221 1111100 00022
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 269 ~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..++..+.+++.+||+.+|.+||++.+++.||||....
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 34678899999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=314.20 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=196.0
Q ss_pred eecccCCeeEEEEEEe-CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCC
Q 010624 34 EIGVGVSAIVYKAICI-PMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCG 111 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~-~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 111 (506)
+||+|+||.||+|.+. ..++..+|+|++..... ....+.+.+|+.+++.++||||+++++++. ....++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 34578899999865443 344678899999999999999999999876 44678999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcc
Q 010624 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191 (506)
Q Consensus 112 sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 191 (506)
+|.+++.. ...+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~ 154 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN----YYKA 154 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC----eeee
Confidence 99999976 45789999999999999999999999999999999999999999999999998754322110 0011
Q ss_pred cccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 192 ~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
.....+++.|+|||.+... .++.++|+|||||++|+|++ |.+||.......... .+..... ...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~i~~~~~----------~~~~~~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGER----------MECPQR 222 (257)
T ss_pred cCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCC----------CCCCCC
Confidence 1223346789999998654 37889999999999999998 999998765543322 2222111 113346
Q ss_pred hhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 271 FSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 271 ~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+++++.++|.+||+.||++||++++|.+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 7899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=316.44 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=206.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
|.+...+|.+.+.||.|+||.||+|.+... ....||||...........+.+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred CeechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 456778899999999999999999987533 1346899998766555667789999999999999999999998875 4
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|+||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 578999999999999999764 3468999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ........+++.|+|||.+... .++.++|||||||++|+|++ |..||.......... .+......
T Consensus 159 ~~~------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~--- 227 (270)
T cd05056 159 DES------YYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENGERL--- 227 (270)
T ss_pred ccc------ceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCcC---
Confidence 210 0111122345679999998654 48999999999999999986 999998765544332 22221111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||..+|.+|||+.+++.
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 133567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=317.08 Aligned_cols=259 Identities=23% Similarity=0.396 Sum_probs=208.3
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCC---CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-C
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPM---DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV-D 98 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~---~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~ 98 (506)
.+..++|++.+.||+|+||.||+|.+... ++..||+|.+...........+.+|+.+++.++||||+++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46678999999999999999999998642 2688999998765556667788999999999999999999998765 5
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFP------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
...+++++|+.+++|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 678999999999999999976432 45899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~ 251 (506)
|++....... .........++..|+|||.+.+.. ++.++|||||||++|++++ |++||....+.+. ...+..
T Consensus 162 g~~~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMD-----YHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYLKD 234 (280)
T ss_pred CCcccccCCc-----eEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-HHHHHc
Confidence 9975322110 001112234567799999997654 8999999999999999998 9999987654432 222222
Q ss_pred cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..... ....+++++.+++.+||..||++|||+.++++
T Consensus 235 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 21111 22346789999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=315.69 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=195.3
Q ss_pred eeecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCC
Q 010624 33 DEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCG 111 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 111 (506)
+.||+|+||.||+|.... .....+|+|.+...........+.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997532 2345789998765544455567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 112 SLQSIISSCFP---DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 112 sL~~~i~~~~~---~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
+|.+++..... ...++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~ 155 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED-----Y 155 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch-----h
Confidence 99999976422 235678889999999999999999999999999999999999999999999865322110 0
Q ss_pred CcccccCCCCCccCChhhhhcc------CCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc-ccccchhh
Q 010624 189 SAMITDMAGTPYWMAPEVIRSH------TGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQR-FRFSDYEK 260 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~------~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~ 260 (506)
........+++.|+|||++... ..++.++|||||||++|+|++ |..||....+........... ...+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 231 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP---- 231 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC----
Confidence 0111233456779999998531 236889999999999999999 788997765554433332221 1111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+.....++..+.+++..|| .||++|||+.+|++
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 ---KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 11123467888999999999 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.35 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=198.7
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
+.||+|+||.||+|.. .++..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL--KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe--cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 4689999999999986 45789999998765555555678899999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 79 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~------~~~~~ 151 (250)
T cd05085 79 FLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG------IYSSS 151 (250)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc------ccccC
Confidence 99998754 346899999999999999999999999999999999999999999999999987532211 01111
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (506)
....+++.|+|||.+.+.. ++.++||||||+++|++++ |..||........... +...... ..+..+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~----------~~~~~~ 219 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRM----------SCPQKC 219 (250)
T ss_pred CCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCC----------CCCCCC
Confidence 2223456799999997644 7899999999999999998 9999976654433222 2221111 123457
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 272 SRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 272 s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=325.69 Aligned_cols=271 Identities=26% Similarity=0.368 Sum_probs=206.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCC-hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe----CC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQS-RTDLDSIRRETKTMSLL-SHPNILNAHCSFSV----DS 99 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~ 99 (506)
+|++.+.||+|+||.||+|.+. .. +..||+|.+..... ......+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 5899999999999999999985 34 77899999865332 23345678899999999 59999999886533 24
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|++++|+. ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 6789999986 689998876 4679999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
..... .........||+.|+|||.+.+...++.++|||||||++|+|++|.+||............+. ....+...
T Consensus 157 ~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 232 (332)
T cd07857 157 ENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ-VLGTPDEE 232 (332)
T ss_pred ccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH-HhCCCCHH
Confidence 21111 111122346899999999987655589999999999999999999999976543322211111 10000000
Q ss_pred --------------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 --------------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 --------------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
............+..+.+|+.+||+.||.+|||+.+++.||||+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00001112234578899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.23 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=203.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC---------------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP---------------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL 89 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~---------------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 89 (506)
..++|++.+.||+|+||.||+|.+.. .++..+|+|.+...........+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 35679999999999999999986421 234579999987655555567899999999999999999
Q ss_pred eeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEE
Q 010624 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP---------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL 160 (506)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~---------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NIL 160 (506)
++++++..++..|++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999999976421 23778899999999999999999999999999999999
Q ss_pred eCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh--CCCCCCC
Q 010624 161 SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH--GRPPLSH 238 (506)
Q Consensus 161 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt--G~~Pf~~ 238 (506)
++.++.++|+|||++........ ........+++.|+|||...+.. ++.++|||||||++|+|++ |..||..
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999998754321100 01111223467899999887654 8999999999999999998 7789976
Q ss_pred CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
....+..... ...+.... .......+..+++.+.+|+.+||+.||.+|||+.+|++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENT-GEFFRDQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHH-HHHHhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6554432211 00000000 00011123457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.18 Aligned_cols=257 Identities=36% Similarity=0.584 Sum_probs=209.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
...|...+.||.|+||.||+|.++ .++..+|+|.+.... .......+.+|+.+++.++|||++++++++......|+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 345888999999999999999985 567899999986432 33445678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+. |+|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 999997 6887777543 35689999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
.....|++.|+|||.+.+ ...++.++|||||||++|+|++|..||.................
T Consensus 168 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 231 (308)
T cd06634 168 --------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------- 231 (308)
T ss_pred --------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--------
Confidence 123357889999999853 23378899999999999999999999976544333322221111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.......++..+++||.+||+.+|.+||++.++++|||+....
T Consensus 232 --~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 232 --PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred --CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 1112345788899999999999999999999999999998863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.03 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=210.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++.+.||.|+||.||++.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999885 567899999987543 34456678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 999999999986632 246899999999999999999999999999999999999999999999999986543221
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
......|++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||............... .+
T Consensus 157 ------~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 218 (256)
T cd08530 157 ------MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KY--------- 218 (256)
T ss_pred ------CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CC---------
Confidence 122345788999999997654 788999999999999999999999876554332222111 11
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
......++.++++++.+||..+|.+|||+.++++||++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 11234678899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.74 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=195.0
Q ss_pred eeecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCC
Q 010624 33 DEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCG 111 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 111 (506)
+.||+|+||.||+|.+.. .++..+|+|.+...........+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998642 2346799999876554444557889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 112 SLQSIISSCFP---DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 112 sL~~~i~~~~~---~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
+|.+++..... ...++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-----~ 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-----Y 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc-----e
Confidence 99999975321 246777888999999999999999999999999999999999999999999865322110 0
Q ss_pred CcccccCCCCCccCChhhhhccC------CCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh-cccccchhh
Q 010624 189 SAMITDMAGTPYWMAPEVIRSHT------GYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ-RFRFSDYEK 260 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~~------~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~ 260 (506)
........|++.|+|||++.+.. .++.++|+|||||++|+|++ |..||......+........ .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 231 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP---- 231 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC----
Confidence 11122345678899999986421 25789999999999999996 99999876555433322211 11111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+......++.+.+++.+|| .+|++|||+++|+.
T Consensus 232 ---~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 232 ---KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11122346778999999999 68999999999963
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=341.00 Aligned_cols=267 Identities=35% Similarity=0.632 Sum_probs=226.6
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe-
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSV- 97 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~- 97 (506)
...+...+.|+|.++||.|.+|.||++..+ .+++.+|+|+.+..... -+++..|++|++.. +|||++.++++|..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 345666788999999999999999999996 67899999998765433 35677899998877 59999999998853
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
++.+|+|||||.|||.-|+++...+..+.|..|+.|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 5689999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccC----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
+|...... ........|||+|||||++.... .|+.++|+|||||+..||.-|.+|+.+..+...++.+.
T Consensus 169 vSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip 241 (953)
T KOG0587|consen 169 VSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 241 (953)
T ss_pred eeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence 98754332 23445667999999999986432 37889999999999999999999999988877665433
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.. +++. ...+.+.+..+.++|..||.+|-.+||+..++++|||++.-
T Consensus 242 RN------PPPk---Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 242 RN------PPPK---LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CC------CCcc---ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 22 1111 11356788999999999999999999999999999999943
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=310.49 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=203.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+++.+|++.+.||.|+||.||+|.+. ++..+|+|.+.... .....+.+|+.+++.++||||+++++++......|+
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 35678999999999999999999873 46789999886432 234568899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
+|||+.+++|.+++... ...+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 153 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-- 153 (256)
T ss_pred EEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC--
Confidence 99999999999998763 346899999999999999999999999999999999999999999999999986533211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.......... .+......
T Consensus 154 ----~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~------- 220 (256)
T cd05112 154 ----QYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE-TINAGFRL------- 220 (256)
T ss_pred ----cccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHhCCCCC-------
Confidence 001112233467899999987644 8899999999999999998 999997655433222 22111110
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus 221 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 1123467889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=328.44 Aligned_cols=267 Identities=26% Similarity=0.398 Sum_probs=206.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-- 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 98 (506)
|++ .++|.+.+.||+|+||.||+|.++ .+++.||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 11 WEL-PERYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 444 468999999999999999999985 5688999999865432 23345678999999999999999999988654
Q ss_pred ----CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 99 ----SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 99 ----~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
..+|+|+||+. .+|..++. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 35699999996 57776652 4689999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
+..... ......||+.|+|||.+.+...++.++|||||||++|+|++|+.||............+. ...
T Consensus 164 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~-~~~ 232 (342)
T cd07879 164 ARHADA----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK-VTG 232 (342)
T ss_pred CcCCCC----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hcC
Confidence 653211 112335688999999987644588999999999999999999999986554333222111 111
Q ss_pred ccchh-----------hh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 255 FSDYE-----------KT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 ~~~~~-----------~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+... .. .......+..+..+.+||.+||+.||.+|||+.+++.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000 00 000011234677899999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.11 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=208.2
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
|++.+.||+|++|.||+|.+. .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 778899999999999999985 568899999987654 233346778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+. ++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~------ 151 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP------ 151 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC------
Confidence 98 59999998742 47999999999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---------------
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR--------------- 252 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~--------------- 252 (506)
........++..|+|||.+.+...++.++|||||||++|+|++|.+||................
T Consensus 152 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 152 -LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 1112233457789999998766458999999999999999999999997655433322211100
Q ss_pred ---ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 253 ---FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 253 ---~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
..++.+... ......+..+..+.++|.+||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCcc-chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000000000 0011123457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.39 Aligned_cols=266 Identities=21% Similarity=0.335 Sum_probs=202.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC--CE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD--SR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 100 (506)
..-|++++.||+|+||.||.|... ..++..||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345899999999999999999752 2457889999987665555667899999999999999999999988775 57
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||++|++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 89999999999999999763 34689999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcccccc
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT---QRFRFSD 257 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~---~~~~~~~ 257 (506)
... .........|+..|+|||.+.+.. ++.++|||||||++|+|+++..|+..... ....... .......
T Consensus 162 ~~~----~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 162 DKE----YYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVTR 234 (284)
T ss_pred Ccc----ceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHHH
Confidence 111 011122345677899999987644 88999999999999999998776543211 0000000 0000000
Q ss_pred hhh---hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 258 YEK---TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 258 ~~~---~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
... .......+..++..+.+|+.+||+.+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000 000111234578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.56 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=205.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCC---CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~---~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+...+|++.+.||+|+||.||+|.++..+ ...+|+|.+...........+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 45678999999999999999999985322 236899988766665666788999999999999999999998887 78
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999764 34589999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
... ........++..|+|||.+... .++.++|+|||||++|++++ |..||......+... .+......
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~---- 230 (279)
T cd05057 162 DEK-----EYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-LLEKGERL---- 230 (279)
T ss_pred ccc-----ceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHhCCCCC----
Confidence 110 0111122345679999998654 38899999999999999998 999998765544322 22221111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||..+|..|||+.++++
T Consensus 231 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 123446778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.01 Aligned_cols=263 Identities=26% Similarity=0.445 Sum_probs=206.9
Q ss_pred CeeEEeeecccCCeeEEEEEEe--CCCCeEEEEEEeccCCC---hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICI--PMDSTVVAIKAIDLDQS---RTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~--~~~~~~vAIK~i~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (506)
+|++.+.||.|+||.||+|.+. ..++..||||.+..... ....+.+.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 23568899999864321 23345678999999999 599999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999999999876 357899999999999999999999999999999999999999999999999986542211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........|++.|+|||.+.+.. .++.++|+||||+++|+|++|..||..................
T Consensus 159 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------ 226 (288)
T cd05583 159 ------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK------ 226 (288)
T ss_pred ------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc------
Confidence 111112345788999999986543 3678999999999999999999999643221111110000000
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCC---HHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS---AEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt---~~eiL~hp~f~~~~ 306 (506)
.....+..++..+.+++.+||+.||++||| +.++++||||+...
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 227 --SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 011133457789999999999999999998 56779999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.84 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=197.0
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCC-eEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe------CCE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV------DSR 100 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~-~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~ 100 (506)
|.+.+.||+|+||.||+|.+..... ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999998853222 268999886543 34556788899999999999999999987642 135
Q ss_pred EEEEeccCCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSC----FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~----~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.+++|||+.+|+|.+++... ....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999999987532 12358999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
....... ........+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......... ..+.....
T Consensus 161 ~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~~~~~~- 232 (272)
T cd05075 161 KIYNGDY-----YRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-DYLRQGNR- 232 (272)
T ss_pred ccCcccc-----eecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCC-
Confidence 4322110 01112334577899999987644 8999999999999999999 89999765543322 22221111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
......++..+.++|.+||+.||++|||+.+|+++
T Consensus 233 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 ---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01234577889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=354.93 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=220.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+..+..++.+.||+|+||.||.|......|. .||||.+....+......|.+|..+|+.++|||||++++++-+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 5577899999999999999999998766664 499999988888888899999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCF-----PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~-----~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
..+|++|||+||+|..+|++.. ...++..+...++.||++|+.||+++++|||||...|+|++....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999999999863 23589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
|.............. ..=..-|||||.+.... ++.++|||||||++||++| |..||.+..+.+.........
T Consensus 849 ArDiy~~~yyr~~~~-----a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGE-----AMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCc-----cccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 874332211111111 11134599999998654 8999999999999999999 899999888877766555443
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+.+ .+..|+..+.++|..||..+|++||++..|++
T Consensus 922 RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 322 55779999999999999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.71 Aligned_cols=258 Identities=23% Similarity=0.410 Sum_probs=218.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+...+.+..+.||+|+||+||+|.... .....||||.++.........+|+||+.+|..++|||||++++.+..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34566778889999999999999998742 22467999999887777788999999999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFP------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g 165 (506)
++.+++|+|||..|+|..++....+ ..|+..+...|+.||+.|++||-++.+|||||-..|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 9999999999999999999986532 2288999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 010624 166 SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKS 244 (506)
Q Consensus 166 ~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~ 244 (506)
.|||+|||+|............ ....=...|||||.+.... |+.+||||||||+|+|+++ |.-||....+.+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~-----~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVR-----GNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred EEEecccccchhhhhhhhhccc-----CCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 9999999998765443221111 1111245699999998655 9999999999999999998 9999999888877
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei 296 (506)
+..+...+. ...+..+|.++.+|+..||+.+|.+||++.+|
T Consensus 715 Ie~i~~g~l-----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 715 IECIRAGQL-----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHHcCCc-----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 655444332 23667899999999999999999999999988
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.41 Aligned_cols=148 Identities=26% Similarity=0.439 Sum_probs=134.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.++|.+++.||+|+||+||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++.+....++|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 468999999999999999999985 568899999986543 23345678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
||||+.|++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 82 VmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999976 3578999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.91 Aligned_cols=252 Identities=25% Similarity=0.457 Sum_probs=204.6
Q ss_pred eeEEeeecccCCeeEEEEEEeCCC---CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~---~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
+++.+.||.|+||.||+|.+.... +..||+|.+...........+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357889999999999999985322 38899999976655546778999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-- 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc--
Confidence 999999999999874333399999999999999999999999999999999999999999999999998754432211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......+++.|+|||.+.+. .++.++|+|||||++|+|++ |.+||........... ......
T Consensus 159 ----~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~---------- 222 (258)
T smart00219 159 ----YKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-LKKGYR---------- 222 (258)
T ss_pred ----cccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCC----------
Confidence 011123367899999998653 48999999999999999998 8899876544333322 221111
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
......++.++.+++.+||..+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1123347889999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=368.34 Aligned_cols=262 Identities=31% Similarity=0.519 Sum_probs=220.5
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++.-...||.|.||.||-|++. .+|...|+|.+..... ......+.+|..++..++|||+|++|++-......+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecC-CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3556778999999999999995 7789999998865433 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
||.||+|.+++.. +...++...+.+-.|++.|++|||++|||||||||+||+++.+|.+|++|||.|....... .
T Consensus 1315 yC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~---~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA---Q 1389 (1509)
T ss_pred HhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch---h
Confidence 9999999999987 5668888999999999999999999999999999999999999999999999987655431 1
Q ss_pred CCCcccccCCCCCccCChhhhhccC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
..........|||.|||||++.+.. +..-++|||||||++.||+||+.||...+..-.+...+.-. . .
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-h---------~ 1459 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-H---------K 1459 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-C---------C
Confidence 2223445778999999999998744 45679999999999999999999999876654443333221 1 2
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+..+..+|.+.++||..||..||++|.++.||++|.|-+.+
T Consensus 1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 22455699999999999999999999999999999988765
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=323.06 Aligned_cols=265 Identities=26% Similarity=0.385 Sum_probs=207.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-CCEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSV-DSRLW 102 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 102 (506)
..++|++.+.||.|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4567999999999999999999985 5788999998865332 3345678899999999999999999998865 56789
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+++||+ +++|..++.. ..+++..+..++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 999998 5789888874 4688999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc-----
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD----- 257 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~----- 257 (506)
......+++.|+|||.+.+...++.++|||||||++|+|++|.+||............ ......+.
T Consensus 161 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~ 231 (328)
T cd07856 161 --------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII-TDLLGTPPDDVIN 231 (328)
T ss_pred --------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCCHHHHH
Confidence 1122356888999999866455899999999999999999999999765442221111 10000000
Q ss_pred ---------h------hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 ---------Y------EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ---------~------~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ..........+.++..+.++|.+||+.+|++|||+.+++.||||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 00000111223467899999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=331.17 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=214.6
Q ss_pred eeE--EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 29 YKI--LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 29 Y~i--~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
|+| -++||+|.||+||-|+++ .+|+.||||++++..- ....+.+++|+.||++++||.||.+.+.|+..+.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 444 367999999999999996 7899999999987653 445578999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~DFGls~~~~~~~ 182 (506)
|.+. |+...+|-....++|++...+.++.||+.||.|||-++|+|.||||+|||+.+.. ++||||||+|.....
T Consensus 643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 9997 6666666555578899999999999999999999999999999999999997543 799999999764322
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........|||.|+|||+++.. +|+..-|+||.|+|+|--++|..||.........+. ...+-+
T Consensus 720 ------ksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ--NAaFMy------- 783 (888)
T KOG4236|consen 720 ------KSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ--NAAFMY------- 783 (888)
T ss_pred ------hhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhh--cccccc-------
Confidence 2334566799999999999864 599999999999999999999999975433222211 111222
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
++.++..+++.+.+||..+|+..-.+|.|.++.+.|||+++..
T Consensus 784 -Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 784 -PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred -CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 2346788999999999999999999999999999999999873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.04 Aligned_cols=245 Identities=28% Similarity=0.488 Sum_probs=204.4
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
||.|+||.||++.+. .+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++.+..+...|++|||+.+++
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999985 5678999999876532 2356688899999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~ 150 (250)
T cd05123 80 LFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------SRT 150 (250)
T ss_pred HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-------Ccc
Confidence 9999987 3578999999999999999999999999999999999999999999999999865432211 122
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFS 272 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 272 (506)
....|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||................. ..+...+
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~ 217 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL------------RFPEFLS 217 (250)
T ss_pred cCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------------CCCCCCC
Confidence 3445788999999997654 78899999999999999999999976654332222221111 1334458
Q ss_pred HHHHHHHHhhcccCCCCCCCH---HHHHcCccc
Q 010624 273 RAFKDMVASCLDQDPSKRPSA---EKLMKHSFF 302 (506)
Q Consensus 273 ~~l~~Li~~~L~~dP~~Rpt~---~eiL~hp~f 302 (506)
..+.+++.+||..||++|||+ .++++||||
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=309.14 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=193.3
Q ss_pred eeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE-eCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS-VDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+... .+..+|||.+.........+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4689999999999987432 346799999865444555678889999999999999999999765 4567899999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
+++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~---~~~ 156 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---YSV 156 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc---eee
Confidence 99999999763 34567888899999999999999999999999999999999999999999998753321100 001
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccc
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (506)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.......... .+..... ...+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~-~~~~~~~----------~~~~ 224 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGRR----------LLQP 224 (262)
T ss_pred cccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCC----------CCCC
Confidence 1112334577899999987644 8999999999999999999 566776544433222 1111111 1122
Q ss_pred hhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 269 ~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..++..+.+++.+||..+|++||++.++++
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=310.48 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=200.8
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.+..++|++.+.||+|+||.||++.. ++..||+|.+.... ..+.+.+|+.+++.++||||+++++++..+. .+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~ 74 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LY 74 (254)
T ss_pred cccHHHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cE
Confidence 34567899999999999999999864 56789999986432 3457889999999999999999999987654 78
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999999998754456899999999999999999999999999999999999999999999999986532211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
......+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||......... .........
T Consensus 154 ---------~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~------ 216 (254)
T cd05083 154 ---------VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECVEKGYRM------ 216 (254)
T ss_pred ---------CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHHhCCCCC------
Confidence 11123356799999987544 8899999999999999997 99999866554332 222222111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.....++..+.+++.+||+.+|.+|||+.+++.
T Consensus 217 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 ----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=312.62 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=194.7
Q ss_pred eeecccCCeeEEEEEEeCCCCe--EEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEEeccCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
+.||+|+||.||+|.+.. ++. .+|+|.+.........+.+.+|+.+++.+ +||||+++++++...+.+|++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999853 343 57888876544455567888999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 110 CGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 110 ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 124789999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
...... ........++.|+|||.+.... ++.++|||||||++|+|++ |..||......... ..+.....
T Consensus 160 ~~~~~~--------~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~ 229 (270)
T cd05047 160 RGQEVY--------VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQGYR 229 (270)
T ss_pred cccchh--------hhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HHHhCCCC
Confidence 421110 0111223356799999986544 8999999999999999997 99999765443322 22221111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
. ..+..++.++.+|+.+||..+|.+|||+.+++.
T Consensus 230 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 L----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred C----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 1 123346788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.97 Aligned_cols=272 Identities=25% Similarity=0.438 Sum_probs=223.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..++++.|..++.||-|+||.|.++... .+...||.|.+.+.. .......++.|-.||...+.+-||+||..|+++.
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~Kv-DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKV-DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeec-chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 4578889999999999999999998765 456789999987654 2345567889999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||+|++||++-.++-. .+-|.|..++.++.++.+|+++.|..|+|||||||+|||||.+|++||+|||++....
T Consensus 703 nLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred ceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999998877 4789999999999999999999999999999999999999999999999999977544
Q ss_pred CCCCCC-----------------------------------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHH
Q 010624 180 EPSHHH-----------------------------------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGI 224 (506)
Q Consensus 180 ~~~~~~-----------------------------------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGi 224 (506)
...... ...........||+.|+|||++.. .+|+..||+||.||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGV 859 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhH
Confidence 332110 000122345679999999999975 56999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHcCcc
Q 010624 225 TALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP---SAEKLMKHSF 301 (506)
Q Consensus 225 il~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---t~~eiL~hp~ 301 (506)
|||||+.|++||....+.+.... ...|...+.+. ...++|+++.+||.++. .+++.|. .++++..|||
T Consensus 860 il~em~~g~~pf~~~tp~~tq~k-------v~nw~~~l~~~-~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpf 930 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYK-------VINWRNFLHIP-YQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPF 930 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceee-------eeehhhccccc-cccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcc
Confidence 99999999999988777654332 22333333332 44678999999998865 4588887 4788999999
Q ss_pred ccccc
Q 010624 302 FKNCN 306 (506)
Q Consensus 302 f~~~~ 306 (506)
|+.++
T Consensus 931 FkgID 935 (1034)
T KOG0608|consen 931 FKGID 935 (1034)
T ss_pred ccccc
Confidence 99885
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.55 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=201.7
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+|.+.+.||+|+||.||++.+. ..+..+++|++.... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDK-KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEec-CCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 5999999999999999999885 334556666554311 22334467789999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 104 VMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
||||+.+++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++. +.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999998753 2356999999999999999999999999999999999999975 57999999986543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........|++.|+|||.+.+. .++.++|+||||+++|+|++|..||............... .
T Consensus 159 -------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~------- 221 (260)
T cd08222 159 -------CDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P------- 221 (260)
T ss_pred -------cccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C-------
Confidence 1112234578899999998654 3788999999999999999999999754433322221111 0
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
.+..+..++.++.++|.+||..+|++||++.++++||||
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 111234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.45 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=204.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe---------
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--------- 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------- 97 (506)
.+|+.++.||+||||.||++.++ .+|+.||||.+....+......+.+|+.++.+|+|||||++|.++.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNK-lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNK-LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeec-ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 56888999999999999999996 89999999999887766777889999999999999999998742100
Q ss_pred --------------------------------------------------------------------------------
Q 010624 98 -------------------------------------------------------------------------------- 97 (506)
Q Consensus 98 -------------------------------------------------------------------------------- 97 (506)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CEEEEEeccCCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHH
Q 010624 98 ----------------------D--------SRLWVVMPFMSCGSLQSIISSCFPDGL--PEPCIAIVLKETLSALSYLH 145 (506)
Q Consensus 98 ----------------------~--------~~~~lV~Ey~~ggsL~~~i~~~~~~~l--~e~~i~~i~~qil~gL~yLH 145 (506)
+ ..+||=||||+..+|+++++.. .+ ....++++++||++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1368889999999999999873 33 47789999999999999999
Q ss_pred HCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC-----------CCCCCCCCcccccCCCCCccCChhhhhccC--C
Q 010624 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP-----------SHHHHHGSAMITDMAGTPYWMAPEVIRSHT--G 212 (506)
Q Consensus 146 s~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~-----------~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~ 212 (506)
+.|+|||||||.||++++++.|||+|||++...... ...............||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 999999999999999999999999999998762210 001111222445678999999999998766 5
Q ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC
Q 010624 213 YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292 (506)
Q Consensus 213 ~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt 292 (506)
|+.|+|+||||||++||+. ||...-..-..+..+. ...++.. ......--+.-+.+|++||+.||++|||
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999999999986 5753322222222222 2222211 0112222334578999999999999999
Q ss_pred HHHHHcCcccc
Q 010624 293 AEKLMKHSFFK 303 (506)
Q Consensus 293 ~~eiL~hp~f~ 303 (506)
|.++|++.||-
T Consensus 865 A~eLL~s~llp 875 (1351)
T KOG1035|consen 865 ATELLNSELLP 875 (1351)
T ss_pred HHHHhhccCCC
Confidence 99999999998
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.21 Aligned_cols=240 Identities=26% Similarity=0.379 Sum_probs=189.1
Q ss_pred eecccCCeeEEEEEEeC-----------------------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCcee
Q 010624 34 EIGVGVSAIVYKAICIP-----------------------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~-----------------------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 90 (506)
.||+|+||.||+|.... .....||+|.+.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999997531 112458899886432 233456788999999999999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-----
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG----- 165 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g----- 165 (506)
+++++..+...|+||||+++|+|..++... ...+++..+..++.|++.||+|||++|++||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999998753 35789999999999999999999999999999999999997644
Q ss_pred --CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHH-hCCCCCCCCChH
Q 010624 166 --SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPE 242 (506)
Q Consensus 166 --~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLl-tG~~Pf~~~~~~ 242 (506)
.+|++|||++..... .....+++.|+|||.+.+...++.++|||||||++|+|+ +|..||....+.
T Consensus 160 ~~~~kl~d~g~~~~~~~-----------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 160 SPFIKLSDPGVSFTALS-----------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cceeeecCCcccccccc-----------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 389999998542211 112346788999999876555899999999999999985 699999765443
Q ss_pred HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.... ....... .+...++.+.++|.+||+.+|++|||+.+++++
T Consensus 229 ~~~~-~~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 229 EKER-FYEKKHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHH-HHHhccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3211 1111111 122345679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=313.81 Aligned_cols=240 Identities=26% Similarity=0.383 Sum_probs=190.6
Q ss_pred eeecccCCeeEEEEEEeCCC------CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 33 DEIGVGVSAIVYKAICIPMD------STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~------~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+.||+|+||.||+|.++..+ ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 46999999999999875221 2348888875432 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC--------eEEeeccccccc
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS--------VKLADFGVSASI 178 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~--------vKL~DFGls~~~ 178 (506)
|+.+|+|..++... ...+++..+..++.||+.||+|||++|++||||||+||+++.++. ++++|||++...
T Consensus 80 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 80 YVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred cCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 99999999999764 236899999999999999999999999999999999999987765 699999986432
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG-RPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
. ......+++.|+|||++.+...++.++|||||||++|+|++| .+||.......... ......
T Consensus 159 ~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~---- 222 (258)
T cd05078 159 L-----------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH---- 222 (258)
T ss_pred C-----------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc----
Confidence 1 112245788899999997655578999999999999999998 46665544433211 111111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+...+.++.+|+.+||+.||++|||+.+|++
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 223 --------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred --------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122345678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=311.63 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=198.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CC
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DS 99 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (506)
...+|++.+.||+|+||+||+|... ..++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3468999999999999999999742 245789999998643 33445778899999999999999999987643 45
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+++||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 789999999999999999763 3468999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch-
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY- 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 258 (506)
.... .........++..|+|||.+.+.. ++.++|||||||++|+|++|..|+...... ....+.........
T Consensus 160 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKE----YYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRMMGNDKQGQMIV 232 (284)
T ss_pred CCCc----ceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhhcccccccccch
Confidence 2110 000111223455699999997654 899999999999999999988776433211 11110000000000
Q ss_pred ---hhhh---hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 ---EKTL---KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ---~~~~---~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.... ........++..+.+|+.+||..+|++|||+.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000 001123457889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=310.66 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=189.4
Q ss_pred eeecccCCeeEEEEEEeCC-----------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 33 DEIGVGVSAIVYKAICIPM-----------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~-----------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+.||+|+||.||+|..... ....||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4689999999999985311 12358899875432 33445788899999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC-------eEEeeccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS-------VKLADFGV 174 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~-------vKL~DFGl 174 (506)
+++|||+.+++|..++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++. +|++|||+
T Consensus 80 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999888753 356899999999999999999999999999999999999987664 89999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhhcc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLl-tG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
+.... ......|+..|+|||.+.....++.++|||||||++|+|+ .|..||......+... ......
T Consensus 159 ~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~ 226 (262)
T cd05077 159 PITVL-----------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC 226 (262)
T ss_pred Ccccc-----------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc
Confidence 64321 1122346788999999875455899999999999999998 5888887543322211 111110
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
......++.+.+||.+||+.||.+||++.+|+++
T Consensus 227 ------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 ------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0122345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=305.57 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=199.1
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
++||.|+||.||+|.+. . ++.||+|.+...........+.+|+.+++.++||||+++++++......|+||||+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~-~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEe-C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 46999999999999984 3 789999998766555556789999999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCccc
Q 010624 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192 (506)
Q Consensus 113 L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 192 (506)
|.+++... ...+++..+..++.+++.||.|||+++++||||||+||+++.++.+||+|||++....... .....
T Consensus 79 l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~ 152 (251)
T cd05041 79 LLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI-----YTVSD 152 (251)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc-----ceecc
Confidence 99999764 3468999999999999999999999999999999999999999999999999865432110 00111
Q ss_pred ccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhh
Q 010624 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271 (506)
Q Consensus 193 ~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (506)
....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||........... +...... ..+..+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~----------~~~~~~ 220 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRM----------PAPQLC 220 (251)
T ss_pred ccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCC----------CCCccC
Confidence 1223356799999987654 8999999999999999999 8899976654332222 2111111 123456
Q ss_pred hHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 272 SRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 272 s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+..+.+++.+||..+|.+|||+.++++
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=314.17 Aligned_cols=269 Identities=19% Similarity=0.249 Sum_probs=192.8
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCC---CeEEEEEEeccCCChhhHH----------HHHHHHHHHhhCCCCC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLD----------SIRRETKTMSLLSHPN 87 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~---~~~vAIK~i~~~~~~~~~~----------~~~~Ei~il~~l~Hpn 87 (506)
-..+..++|++.+.||+|+||+||+|.+. .+ +..+|+|+..........+ ....+...+..++|+|
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~-~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCA-SDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEc-CCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34567789999999999999999999985 33 4567788654333211111 1223444566778999
Q ss_pred ceeeeeEEEeCC----EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC
Q 010624 88 ILNAHCSFSVDS----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS 163 (506)
Q Consensus 88 Iv~l~~~~~~~~----~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~ 163 (506)
|+++++.+.... ..+++++++. .++.+++... ...++..+..++.|++.||+|||+.+++||||||+|||++.
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 999998765443 4578888874 5777777652 34678899999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Q 010624 164 DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK 243 (506)
Q Consensus 164 ~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~ 243 (506)
++.+||+|||+|.....................||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999997654321111111111223346999999999997655 8999999999999999999999998764333
Q ss_pred HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.........+. ............+++.+.+++..||..+|++||+++++++
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 241 NLIHAAKCDFI----KRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhHHHHH----HHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22221111100 0000011123456789999999999999999999999864
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.32 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=198.0
Q ss_pred eeecccCCeeEEEEEEeC-----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 33 DEIGVGVSAIVYKAICIP-----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
+.||+|+||.||+|.++. .++..+|||.+...........+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998752 223689999886554445567888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-----CeEEeecccccc
Q 010624 108 MSCGSLQSIISSCF-----PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-----SVKLADFGVSAS 177 (506)
Q Consensus 108 ~~ggsL~~~i~~~~-----~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-----~vKL~DFGls~~ 177 (506)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 99999999997532 23488999999999999999999999999999999999999887 899999998754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
...... ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........... +.....
T Consensus 161 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~-- 231 (269)
T cd05044 161 IYKSDY-----YRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-VTAGGR-- 231 (269)
T ss_pred cccccc-----cccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-HhcCCc--
Confidence 321110 01112234567899999997654 8999999999999999998 9999976554433222 111111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..++..+.++|.+||..+|.+||++.++++
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 --------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1123457889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=315.65 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=202.0
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCC---eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~---~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+...+|++.+.||+|+||.||+|.+...+. ..||+|.+...........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 456789999999999999999998863332 257999887655555556788999999999999999999988754 4
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.+++++|+++|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 67999999999999998763 34689999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........ ...+......
T Consensus 162 ~~-----~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---- 230 (303)
T cd05110 162 DE-----KEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL---- 230 (303)
T ss_pred cc-----cccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC----
Confidence 11 011112234567899999987654 8999999999999999997 9999976544332 2222211111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+++.+||..+|++||++.++++
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122346778999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.33 Aligned_cols=262 Identities=26% Similarity=0.442 Sum_probs=225.2
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (506)
.+...+|..+.+||+|+||+|-+|..+ .+.+.+|||+++++.. ..+.+--+.|-++|.... -|.++.++..|+.-+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 577789999999999999999999875 5668999999977653 234455567888888764 678999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
++|+||||+.||+|-..|.+ -+.+.+..+..++.+|+-||-+||++||++||||.+||++|.+|+|||+|||++....
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999999988 4789999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
. .........|||.|+|||++.-.+ |+.++|+||+|++||||+.|++||...+..+.+..++.....
T Consensus 502 ~-------~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 502 F-------DGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS----- 568 (683)
T ss_pred c-------CCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-----
Confidence 2 233455667999999999997665 999999999999999999999999988777777666665443
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH-----HHHHcCcccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA-----EKLMKHSFFKNCNK 307 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~-----~eiL~hp~f~~~~~ 307 (506)
.++.+|.++.+++...|.+.|.+|..+ .+|-.||||+.+++
T Consensus 569 -------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 569 -------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred -------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 456789999999999999999999754 68899999998854
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.09 Aligned_cols=262 Identities=23% Similarity=0.390 Sum_probs=203.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC---CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CC
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP---MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DS 99 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~---~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (506)
...+|++.+.||+|+||.||+|.... .++..+|+|.+.........+.+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 35679999999999999999998632 24688999998765544456789999999999999999999998877 56
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..+++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 899999999999999999764 2359999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH----------HHHH
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL----------LMKM 249 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~----------~~~~ 249 (506)
.... .........++..|+|||.+.+.. ++.++|||||||++|+|++|..||......... ...+
T Consensus 161 ~~~~----~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 161 EDKD----YYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cCCc----ceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 1110 011111234556799999987654 889999999999999999999998653322100 0000
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
....... .....+..++.++.+++.+||+.+|.+|||+.+|++
T Consensus 236 ~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELLKEG------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHcC------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 001123456788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.25 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=193.6
Q ss_pred eeecccCCeeEEEEEEeCC-CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCC
Q 010624 33 DEIGVGVSAIVYKAICIPM-DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCG 111 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~-~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 111 (506)
+.||+|+||.||+|..... ....+++|.+.........+.+.+|+.+++.++||||+++++.+......|+||||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976322 234567887766555555678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 112 SLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 112 sL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
+|.+++.... ...+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~-----~~~ 155 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-----DYI 155 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-----hhh
Confidence 9999997642 234677788999999999999999999999999999999999999999999986432111 001
Q ss_pred cccccCCCCCccCChhhhhcc------CCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 190 AMITDMAGTPYWMAPEVIRSH------TGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~------~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......|++.|+|||++... ..++.++|||||||++|+|++ |.+||......+.....+.... ...+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~---- 230 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-VKLF---- 230 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc-cccC----
Confidence 111234578899999998531 125779999999999999997 5778876665544433322211 1000
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+.....+++.+.+++..|| .+|++|||+.+|++
T Consensus 231 -~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 231 -KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 01122347788999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=305.83 Aligned_cols=280 Identities=25% Similarity=0.338 Sum_probs=213.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe----
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV---- 97 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---- 97 (506)
....+.|+-+.+||+|.||.||+|.++ .+|+.||+|++..+. ....-....+|+.+|..++|+|++.+++.|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 345567999999999999999999996 567789998875533 22233456689999999999999998766532
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
...+|+||.+|+ .+|..++.+. ...++..+|..++++++.||.|+|++.|+|||+||+|+||+.+|.+||+|||
T Consensus 92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 346999999997 8999998763 4679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hhh
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK--MTQ 251 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~--~~~ 251 (506)
++.......... ........-|.+|.+||.+.|...|+++.|||..|||+.+|++|.+.|........+..+ +..
T Consensus 170 lar~fs~~~n~~---kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVV---KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred cccceecccccC---CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 975433221111 111223344899999999999888999999999999999999999999876655443322 112
Q ss_pred cccccchhh------hhhh-------------h--ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 252 RFRFSDYEK------TLKI-------------K--DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 252 ~~~~~~~~~------~~~~-------------~--~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
.+....|+. ...+ + ..+-.-.+++.+|+.++|..||.+|++++++++|.||..-+-.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 221111110 0000 0 0011124478899999999999999999999999999876443
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.63 Aligned_cols=238 Identities=25% Similarity=0.391 Sum_probs=188.5
Q ss_pred eeecccCCeeEEEEEEeCCCC---------eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 33 DEIGVGVSAIVYKAICIPMDS---------TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~---------~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+.||+|+||.||+|.+...+. ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 469999999999999963321 35788876544322 5788899999999999999999999887 77899
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-------CeEEeeccccc
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-------SVKLADFGVSA 176 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-------~vKL~DFGls~ 176 (506)
||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 78 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999864 23789999999999999999999999999999999999999887 79999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
.... .....++..|+|||.+.+. ..++.++|||||||++|+|++ |..||............. ....
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~ 224 (259)
T cd05037 157 TVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHR 224 (259)
T ss_pred cccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCC
Confidence 3221 1223456789999999765 358899999999999999999 578887654322211111 1000
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+......+.+++.+||..+|.+|||+.++++
T Consensus 225 ------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 ------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11112378999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=328.41 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=225.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..++.+++..||-||||.|-.+... .....+|+|++++.. .....+.+..|-+||..++.|.||++|-.|.+..++
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~-~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVN-SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEec-ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 44567888999999999999888763 222348999887554 345567899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|++||-|-||.|+.+++. .+.+++..++.++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|.....
T Consensus 496 YmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred hhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 999999999999999998 58899999999999999999999999999999999999999999999999999764432
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........|||.|.|||++... +.+.++|.|||||++|||++|.+||...++......++..
T Consensus 573 -------g~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG---------- 634 (732)
T KOG0614|consen 573 -------GRKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG---------- 634 (732)
T ss_pred -------CCceeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh----------
Confidence 2344566799999999999754 4899999999999999999999999999888876665543
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCcccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCNK 307 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~ 307 (506)
+.....+..++..+.+||+++...+|.+|.. +.+|.+|.||..+++
T Consensus 635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 1223355778899999999999999999985 899999999998854
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=304.45 Aligned_cols=252 Identities=25% Similarity=0.443 Sum_probs=202.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC---------ChhhHHHHHHHHHHHhh-CCCCCceeeeeEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ---------SRTDLDSIRRETKTMSL-LSHPNILNAHCSFSV 97 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~---------~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 97 (506)
.|++.+.||+|+||.||+|.+...++..+|+|.+.... .......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999865467899999875422 22344567788888864 799999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
++..|++|||++|++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|.||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999988542 23568999999999999999999996 6899999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
+...... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|.+||..................
T Consensus 161 ~~~~~~~--------~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 161 AKQKQPE--------SKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred eeecccc--------cccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 7543221 0223456788999999998654 799999999999999999999999765443322221111110
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+.....+++.+.++|.+||+.||++|||+.++..
T Consensus 232 ----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 232 ----------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ----------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 1112356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=304.52 Aligned_cols=229 Identities=24% Similarity=0.339 Sum_probs=186.4
Q ss_pred cCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCCHHHHH
Q 010624 38 GVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII 117 (506)
Q Consensus 38 G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i 117 (506)
|.+|.||+|.++ .+++.||+|.+.... ...+|...+....||||+++++++......|++|||+.||+|.+++
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999996 678899999986542 2234555556677999999999999999999999999999999999
Q ss_pred HhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCC
Q 010624 118 SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197 (506)
Q Consensus 118 ~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~G 197 (506)
.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+..... ......+
T Consensus 77 ~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~----------~~~~~~~ 144 (237)
T cd05576 77 SK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----------SCDGEAV 144 (237)
T ss_pred HH--hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----------ccccCCc
Confidence 76 35699999999999999999999999999999999999999999999999997543211 1122345
Q ss_pred CCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHH
Q 010624 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKD 277 (506)
Q Consensus 198 t~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 277 (506)
+..|+|||.+.+.. ++.++|+||+||++|+|++|..||....... .... ....+..+++.+++
T Consensus 145 ~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~----------~~~~~~~~~~~~~~ 207 (237)
T cd05576 145 ENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHT----------TLNIPEWVSEEARS 207 (237)
T ss_pred CccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhc------cccc----------ccCCcccCCHHHHH
Confidence 67799999986544 7899999999999999999998875432110 0000 01123457889999
Q ss_pred HHHhhcccCCCCCCCH-----HHHHcCccc
Q 010624 278 MVASCLDQDPSKRPSA-----EKLMKHSFF 302 (506)
Q Consensus 278 Li~~~L~~dP~~Rpt~-----~eiL~hp~f 302 (506)
+|.+||+.||++|||+ .++++||||
T Consensus 208 li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 9999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=302.52 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=197.6
Q ss_pred eeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC------
Q 010624 29 YKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS------ 99 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 99 (506)
|++.+.||+|+||.||+|.+.. .++..||||.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998753 246889999986543 3445678889999999999999999999886532
Q ss_pred EEEEEeccCCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCF----PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~----~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
..+++++|+.+|+|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478999999999998875422 124789999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
....... .........+++.|++||.+.... ++.++|||||||++|+|++ |.+||........... +.....
T Consensus 161 ~~~~~~~-----~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~ 233 (273)
T cd05074 161 KKIYSGD-----YYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY-LIKGNR 233 (273)
T ss_pred ccccCCc-----ceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH-HHcCCc
Confidence 6432110 011112233567799999987654 7899999999999999999 8999976654332222 111110
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
......++..+.+++.+||+.+|++|||+.+++.
T Consensus 234 ----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 234 ----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.43 Aligned_cols=273 Identities=29% Similarity=0.449 Sum_probs=219.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHH-hhCCCCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM-SLLSHPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~ 97 (506)
.-.+++..++.+-+..||.|+||+|+|-.++ ..|+..|||.++.........+++.|..+. +.-+.||||++|++.-.
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 4457888888899999999999999999986 568999999998877777778888888874 55579999999999988
Q ss_pred CCEEEEEeccCCCCCHHHHH---HhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 98 DSRLWVVMPFMSCGSLQSII---SSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i---~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFG 173 (506)
++..|+.||.|. .||..+. .......++|.-+..|....+.||.||-.. +|+|||+||+|||+|..|.|||||||
T Consensus 135 EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 135 EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence 999999999996 6765543 333356799999999999999999999764 89999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
++..... ........|...|||||.+.... +|+.++|||||||+|||++||+.|+..... .+..+...
T Consensus 214 IcGqLv~--------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~V 282 (361)
T KOG1006|consen 214 ICGQLVD--------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQV 282 (361)
T ss_pred chHhHHH--------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHH
Confidence 9654322 23344566888999999997543 499999999999999999999999976543 22222221
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. ..+ +.+.......+++..++.+|..||.+|-..||.+.+++++||++...
T Consensus 283 v~-gdp-p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 283 VI-GDP-PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred Hc-CCC-CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 11 011 11112223456889999999999999999999999999999998763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.38 Aligned_cols=245 Identities=28% Similarity=0.394 Sum_probs=200.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhh-CCCCCceeeeeEEEeCCEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~l 103 (506)
....|++...+|.|+|+.|-.+.+. .+++..++|++..... ...+|+.++.. -+||||+++++.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeecc-ccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 3578999999999999999999986 5678899999976522 12257755544 469999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe-CCCCCeEEeeccccccccCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS-DSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl-d~~g~vKL~DFGls~~~~~~~ 182 (506)
|||.+.|+.|.+.+.. .+....++..|+++|+.|+.|||++|++||||||+|||+ ++.|+++|+|||.+......
T Consensus 394 v~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999999888876 233337888999999999999999999999999999999 58999999999986543221
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.....-|..|.|||++.. ..|+++|||||||++||+|++|+.||...+........+ ....
T Consensus 470 ---------~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i-~~~~-------- 530 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI-QMPK-------- 530 (612)
T ss_pred ---------hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh-cCCc--------
Confidence 112233778999999985 459999999999999999999999998776662222211 1111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
....+|..+++||.+||+.||.+||++.+++.||||
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 226789999999999999999999999999999999
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=315.11 Aligned_cols=274 Identities=24% Similarity=0.368 Sum_probs=221.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC------hhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS------RTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
-++..++|-++..||+|||+.||+|.+. ...+.||+|+-..+.. ........+|..|.+.|+||.||++|++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 4566789999999999999999999997 5678999999765542 12235677999999999999999999999
Q ss_pred Ee-CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCCCCEEeC---CCCCeEE
Q 010624 96 SV-DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ--GHLHRDVKAGNILSD---SDGSVKL 169 (506)
Q Consensus 96 ~~-~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~--givHrDIKp~NILld---~~g~vKL 169 (506)
.- ...++-|+|||+|.+|.-+++. ...+++.+++.|+.||+.||.||... .|+|-||||.|||+- ..|.+||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 75 4578999999999999999988 57899999999999999999999876 599999999999985 3478999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhc---cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS---HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL 246 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~ 246 (506)
+|||+|.....................||.||++||.+.- .+.++.++||||+|||+|.++.|+.||........++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 9999998766554444444555667789999999999852 3457899999999999999999999998654433322
Q ss_pred HHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 247 MKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
... ..+.... . .....+.++.++++||++||++--+.|....++-.||||..
T Consensus 695 qeN-TIlkAtE----V-qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 695 QEN-TILKATE----V-QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhh-chhccee----c-cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 211 0010000 0 01134568899999999999999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=289.10 Aligned_cols=263 Identities=22% Similarity=0.378 Sum_probs=210.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeC--CEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVD--SRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~ 101 (506)
..++|++.+++|+|.|+.||.|++. .+++.++||++. +.....+.||+.||..|. ||||+++++...+. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLK----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILK----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc-CCCceEEEeeec----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 6789999999999999999999986 567889999985 455678999999999998 99999999998764 568
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~DFGls~~~~~ 180 (506)
.+|+||+++.+...+.. .++...++.++.+++.||.||||.||+|||+||.|++|| ..-.++|+|+|+|.....
T Consensus 111 aLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 89999999988877664 478889999999999999999999999999999999999 456799999999765432
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc------
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR------ 254 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~------ 254 (506)
. ........+.+|.-||++..-..|+..-|+|||||++..|+..+.||.........+..+.....
T Consensus 186 ~--------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 186 G--------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred C--------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 2 22334456888999999988777999999999999999999999998765544333333222111
Q ss_pred ------cc---chhhh-----------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 255 ------FS---DYEKT-----------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 255 ------~~---~~~~~-----------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.. .+... .-..+...-.++++.||+.++|..|-.+||||.|++.||||...
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 10 00000 00111122246899999999999999999999999999999865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=308.43 Aligned_cols=267 Identities=21% Similarity=0.272 Sum_probs=205.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC--C----CceeeeeEEEe
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH--P----NILNAHCSFSV 97 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~~ 97 (506)
....+|++++.+|+|.||.|-++.+... +..||||+++. .....+..+-|++++.++.+ | -+|.+.++|.-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~--V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKN--VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCC-CceehHHHHHH--HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 4478999999999999999999999754 89999999853 24455667789999999952 2 25667788999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC--------------
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-------------- 163 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-------------- 163 (506)
.++.+||+|.+ |-|+++++.+..-.+++...++.+++|++++++|||+.+++|.||||+|||+-+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999998 579999999876778999999999999999999999999999999999999632
Q ss_pred ------CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCC
Q 010624 164 ------DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLS 237 (506)
Q Consensus 164 ------~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~ 237 (506)
+..|||+|||.|...... ......|..|.|||++.+-. ++.++||||+||||+||.+|...|.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~----------hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH----------HSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC----------cceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecc
Confidence 235999999986543222 23445699999999999754 9999999999999999999999998
Q ss_pred CCChHHHHH--HHHhhccc-------------------ccch-------------hhhhhhhccchhhhHHHHHHHHhhc
Q 010624 238 HLPPEKSLL--MKMTQRFR-------------------FSDY-------------EKTLKIKDKNKKFSRAFKDMVASCL 283 (506)
Q Consensus 238 ~~~~~~~~~--~~~~~~~~-------------------~~~~-------------~~~~~~~~~~~~~s~~l~~Li~~~L 283 (506)
..++.+.+. ..+.+.+. ++.- .+...........-.++.|||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 766544321 11111100 0000 0000000011112235789999999
Q ss_pred ccCCCCCCCHHHHHcCcccccc
Q 010624 284 DQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 284 ~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+||++|+|+.|+|.||||+..
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=315.05 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=212.0
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCC-CC--eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPM-DS--TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~-~~--~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.+|.+......+.+.||.|.||.||+|+.... .| --||||..+.+....+.+.|..|..+|+.++|||||++++.+.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 35677777777888999999999999988532 22 3589999888777788899999999999999999999999997
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
+. ..|||||.++-|.|+.++... ...++......+++||+.||+||||..+|||||-..|||+.+..-|||+|||+|.
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 55 589999999999999999875 5679999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
.......... ....=..-|||||-++-.. ++.++|||-||+++||++. |..||....+.+.+.. +.+.-+
T Consensus 540 ~~ed~~yYka------S~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iEnGeR- 610 (974)
T KOG4257|consen 540 YLEDDAYYKA------SRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IENGER- 610 (974)
T ss_pred hccccchhhc------cccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ecCCCC-
Confidence 6543322111 1111234599999987544 8999999999999999887 9999987766553221 111111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
...+++|++.+..|+.+||+++|.+||++.+|.
T Consensus 611 ---------lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 611 ---------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 226788999999999999999999999998874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=325.22 Aligned_cols=272 Identities=19% Similarity=0.245 Sum_probs=179.9
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCC----CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeE--
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCS-- 94 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~----~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-- 94 (506)
......++|++.+.||+|+||.||+|.+. .+ +..||+|.+..... .+....+ .+....+.++..+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence 44567789999999999999999999985 45 68899998753221 1111111 1222223333332221
Q ss_pred ----EEeCCEEEEEeccCCCCCHHHHHHhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 010624 95 ----FSVDSRLWVVMPFMSCGSLQSIISSCFPD------------------GLPEPCIAIVLKETLSALSYLHNQGHLHR 152 (506)
Q Consensus 95 ----~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~------------------~l~e~~i~~i~~qil~gL~yLHs~givHr 152 (506)
...+..+|+|+||+.+++|.+++...... ......+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 23566899999999999999998753100 01234567899999999999999999999
Q ss_pred CCCCCCEEeCC-CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccC--------------------
Q 010624 153 DVKAGNILSDS-DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-------------------- 211 (506)
Q Consensus 153 DIKp~NILld~-~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-------------------- 211 (506)
||||+|||++. ++.+||+|||+|...... .........||+.|+|||.+....
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 99999999985 689999999997533211 111123446789999999764221
Q ss_pred -CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cccccchhhhhhhh---------ccchhhhHHHHHHHH
Q 010624 212 -GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-RFRFSDYEKTLKIK---------DKNKKFSRAFKDMVA 280 (506)
Q Consensus 212 -~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~s~~l~~Li~ 280 (506)
.++.++|||||||++|||+++..|+.. ........+.. ......+....... ......+....+||.
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 244567999999999999997665432 11111111111 01111111000000 001112334669999
Q ss_pred hhcccCCCCCCCHHHHHcCccccccc
Q 010624 281 SCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 281 ~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
+||+.||.+|||+.++|+||||+...
T Consensus 432 ~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHccCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.99 Aligned_cols=205 Identities=30% Similarity=0.490 Sum_probs=176.4
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------CEEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------SRLW 102 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~ 102 (506)
+...+.||+||||.||++.++ .+|+.||||.++........+...+|+++|++++|||||+++++-++. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeeccc-ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 777888999999999999986 789999999998877777788899999999999999999998876543 3567
Q ss_pred EEeccCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC--CCC--CeEEeecccccc
Q 010624 103 VVMPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD--SDG--SVKLADFGVSAS 177 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld--~~g--~vKL~DFGls~~ 177 (506)
+|||||.||||+..+.+-. ..+|++.++..++.++..||.|||.+||+||||||.||++- .+| .-||+|||.|..
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999999997632 34799999999999999999999999999999999999864 334 489999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~ 242 (506)
... ........||+.|++||++.....|+..+|.|||||++|+++||..||......
T Consensus 174 l~d--------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDD--------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCC--------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 332 224556789999999999986566999999999999999999999999765443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=292.66 Aligned_cols=266 Identities=26% Similarity=0.495 Sum_probs=220.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSF 95 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (506)
+..+.+...+|.++++||+|+|++|..+..+ .+.+.+|+|++++.- ...+++-+..|-.+..+. +||.+|.++..|
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 4567788899999999999999999999886 567899999987654 234566777788887766 699999999999
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+.++.+++|.||++||+|--.+.. ...+++..++.+..+|+-||.|||+.||++||||..|+|+|..|++||+|+|++
T Consensus 321 qtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred cccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchh
Confidence 999999999999999999888876 468999999999999999999999999999999999999999999999999996
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHH
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL-------PPEKSLLMK 248 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~-------~~~~~~~~~ 248 (506)
..... .........|||.|.|||++++.. |+..+|+|+||++++||+.|+.||.-. +..+.++..
T Consensus 399 ke~l~-------~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 399 KEGLG-------PGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred hcCCC-------CCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 54322 233445667999999999999876 999999999999999999999999632 222333332
Q ss_pred H-hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC------CHHHHHcCcccccccc
Q 010624 249 M-TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP------SAEKLMKHSFFKNCNK 307 (506)
Q Consensus 249 ~-~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp------t~~eiL~hp~f~~~~~ 307 (506)
+ .+.++ .+..+|-.+..+++..|++||.+|. .+.++..|+||+.+++
T Consensus 471 ilekqir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 471 ILEKQIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred Hhhhccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 2 22232 3345666677889999999999996 5789999999997753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.79 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=210.4
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
++..+...+.++||+|.||.|..+.. .++..||+|+++..........|.+||++|.+|+||||+++++.|..++.++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev--eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV--EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe--cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 45667789999999999999999987 4569999999988777777789999999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+|+||+++|+|.+++.+.....+.-....+|+.||+.|++||.+.++|||||.+.|||++.++++||+|||+|.......
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999987533444555667799999999999999999999999999999999999999999987443321
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH--GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
... ......=...|||||.+.... ++.++|+|+||+++||+++ ...||.........-. ...-+.....
T Consensus 692 yy~-----vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~-- 762 (807)
T KOG1094|consen 692 YYR-----VQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGR-- 762 (807)
T ss_pred cee-----eecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCc--
Confidence 111 111112246799999987655 8999999999999999864 7889987765543221 1111111111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei 296 (506)
-.....+.-|+..+.+||.+||..+-.+|||++++
T Consensus 763 -~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 763 -QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred -ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 11223566789999999999999999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=320.73 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=220.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
-+++++..+|.++||.|.||.||+|..+..+ ...||||.++.....+....|+.|+.||.+++||||+++.+......
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3578888999999999999999999986322 25799999988888888899999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+.||+|||++|+|..+++... +.|+..++..+++-|+.|+.||-+.|+|||||...|||||++-.+|++|||+|....
T Consensus 704 PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999874 569999999999999999999999999999999999999999999999999987443
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... .........=...|.|||.+.-. .++.++||||+||+|+|.++ |..||++..+.+.+ ..+.+.++.+
T Consensus 783 dd~~----~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-kaIe~gyRLP-- 854 (996)
T KOG0196|consen 783 DDPE----AAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-KAIEQGYRLP-- 854 (996)
T ss_pred cCCC----ccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHH-HHHHhccCCC--
Confidence 2211 11111111123569999999754 48999999999999999776 99999988776654 4455556554
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+.+|+..+..|+..||++|-..||.+.+|+.
T Consensus 855 --------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 855 --------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 56789999999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=281.25 Aligned_cols=244 Identities=34% Similarity=0.535 Sum_probs=200.1
Q ss_pred CCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHH
Q 010624 39 VSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIIS 118 (506)
Q Consensus 39 ~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~ 118 (506)
+||.||+|.+. .+++.+|+|++.........+.+.+|+..++.++|+||+++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999985 46789999998765443336789999999999999999999999999999999999999999999998
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCC
Q 010624 119 SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198 (506)
Q Consensus 119 ~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt 198 (506)
.. ..+++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......|+
T Consensus 80 ~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~ 149 (244)
T smart00220 80 KR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFVGT 149 (244)
T ss_pred hc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--------ccccccCC
Confidence 73 348999999999999999999999999999999999999999999999999866433211 23345578
Q ss_pred CccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHH
Q 010624 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDM 278 (506)
Q Consensus 199 ~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~L 278 (506)
..|++||.+.+.. ++.++||||||+++++|++|..||................... .......++..+.++
T Consensus 150 ~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 220 (244)
T smart00220 150 PEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP--------FPPPEWKISPEAKDL 220 (244)
T ss_pred cCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC--------CccccccCCHHHHHH
Confidence 8899999997544 7889999999999999999999997643333333332221110 000111177899999
Q ss_pred HHhhcccCCCCCCCHHHHHcCccc
Q 010624 279 VASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 279 i~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
+.+||..+|++||++.++++||||
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHccCCchhccCHHHHhhCCCC
Confidence 999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.91 Aligned_cols=271 Identities=22% Similarity=0.315 Sum_probs=222.8
Q ss_pred ccccccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCe--EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc
Q 010624 11 SSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88 (506)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (506)
.++.......+--|..++.++.++||+|.||.|++|.++.-+|+ .||||.+..+.....++.|++|+.+|.+|.|||+
T Consensus 94 ~~~~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl 173 (1039)
T KOG0199|consen 94 NSVANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL 173 (1039)
T ss_pred cCCCCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce
Confidence 34444455556667778899999999999999999999765554 5899999887766688999999999999999999
Q ss_pred eeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeE
Q 010624 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVK 168 (506)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vK 168 (506)
+++|+...+ ..+.+|||.+.+|||.+.++......|.-.....|+.||+.|+.||.++++|||||-..|+|+-....||
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVK 252 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVK 252 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceee
Confidence 999999987 6678999999999999999986567788999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLM 247 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~ 247 (506)
|||||+........... .......-...|+|||.++-.. ++.++|||+|||++|||++ |..||-+......+..
T Consensus 253 I~DFGLmRaLg~ned~Y----vm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMY----VMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred eecccceeccCCCCcce----EecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 99999976544332211 1111222245699999998554 8999999999999999998 7899988776655433
Q ss_pred HHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
+- ..-+ ...++.|++++.+++..||..+|++|||+..|..
T Consensus 328 iD-~~er----------LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 328 ID-AGER----------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cc-cccc----------CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 22 2111 1256789999999999999999999999998853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.91 Aligned_cols=256 Identities=23% Similarity=0.458 Sum_probs=216.1
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..|++...+.....+||-|.||.||.|++++. .-.||||.++.+ ....++|..|..+|+.++|||+|++++.|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeecc-ceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 56888899999999999999999999999754 578999998644 345689999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|||+|||..|.|.++++++...-++......++.||..|++||..+++|||||-..|+||.++..||++|||++....
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999999876778888889999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
...... .....-..-|.|||-+.-+. ++.++|||+||++|||+.| |-.||...+... .+..+.+.++.
T Consensus 417 gDTYTA------HAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM--- 485 (1157)
T KOG4278|consen 417 GDTYTA------HAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRM--- 485 (1157)
T ss_pred CCceec------ccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccc---
Confidence 332211 11222245699999986554 8999999999999999998 778887655443 33344444432
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei 296 (506)
+.+..|++.+.+|+..||+.+|.+||++++|
T Consensus 486 -------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 486 -------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred -------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 2457799999999999999999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.39 Aligned_cols=277 Identities=19% Similarity=0.285 Sum_probs=191.5
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeC---------------CCCeEEEEEEeccCCChhh-------------HHH
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIP---------------MDSTVVAIKAIDLDQSRTD-------------LDS 72 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~---------------~~~~~vAIK~i~~~~~~~~-------------~~~ 72 (506)
..+...++|++.++||+|+||+||+|.... ..++.||||.+........ .+.
T Consensus 139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence 345678899999999999999999997521 2346799999865432111 122
Q ss_pred HHHHHHHHhhCCCCCc-----eeeeeEEEe--------CCEEEEEeccCCCCCHHHHHHhhCC-----------------
Q 010624 73 IRRETKTMSLLSHPNI-----LNAHCSFSV--------DSRLWVVMPFMSCGSLQSIISSCFP----------------- 122 (506)
Q Consensus 73 ~~~Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~ggsL~~~i~~~~~----------------- 122 (506)
...|+.++..++|.++ ++++++|.. .+..|+||||+.+++|.+++.....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3347777777776655 455566542 3568999999999999999874211
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCC
Q 010624 123 -----DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197 (506)
Q Consensus 123 -----~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~G 197 (506)
..+++..++.++.|++.||.|||+.+++||||||+|||++.++.+||+|||++...... .........+
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~------~~~~~~~g~~ 372 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG------INFNPLYGML 372 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC------CccCccccCC
Confidence 12467788999999999999999999999999999999999999999999997532211 1111223345
Q ss_pred CCccCChhhhhccCC-------------------C--CccccHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhhccc-
Q 010624 198 TPYWMAPEVIRSHTG-------------------Y--SFKADIWSFGITALELAHGRP-PLSHLPPEKSLLMKMTQRFR- 254 (506)
Q Consensus 198 t~~y~APE~l~~~~~-------------------~--~~~sDIwSlGiil~eLltG~~-Pf~~~~~~~~~~~~~~~~~~- 254 (506)
|+.|+|||.+..... | ..+.||||+||++|+|++|.. ||..................
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 899999999853210 1 234799999999999999875 77543221111111000000
Q ss_pred ccchh-hhhhhhccchhhhHHHHHHHHhhcccCC---CCCCCHHHHHcCccccc
Q 010624 255 FSDYE-KTLKIKDKNKKFSRAFKDMVASCLDQDP---SKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 255 ~~~~~-~~~~~~~~~~~~s~~l~~Li~~~L~~dP---~~Rpt~~eiL~hp~f~~ 304 (506)
+..+. ..... ......++..++|+.+||..+| .+|+|+.++|+||||..
T Consensus 453 ~r~~~~~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 453 WRMYKGQKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHhhcccCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00000 00001 1234578899999999999866 68999999999999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.07 Aligned_cols=265 Identities=39% Similarity=0.659 Sum_probs=228.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
+-..++|+++..+|+|.||.||||.++ .++...|+|++++... .+..-+..|+-+++.++|||||.+++.|.....+|
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred cCCccchhheeeecCCcccchhhhccc-ccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 356788999999999999999999997 6789999999987643 44567789999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+.||||.||+|+++.+- .+++++.++....++.++||+|||+.|-+|||||-.|||++..|.||++|||.+.....
T Consensus 89 icMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred EEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999999999876 68899999999999999999999999999999999999999999999999998764332
Q ss_pred CCCCCCCcccccCCCCCccCChhhhh--ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIR--SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~--~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........|||+|||||+.. ...+|+..+|||++|++..|+.--++|..+..+....+......+..+...
T Consensus 165 -----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk- 238 (829)
T KOG0576|consen 165 -----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK- 238 (829)
T ss_pred -----hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc-
Confidence 233445677999999999964 344699999999999999999999999888877777666555544433221
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....++.+.+|++.+|.++|.+|||+..+|.|||....
T Consensus 239 ------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 239 ------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 234567889999999999999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=287.73 Aligned_cols=149 Identities=21% Similarity=0.343 Sum_probs=129.9
Q ss_pred ccccccccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC----
Q 010624 9 QCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---- 84 (506)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---- 84 (506)
..-..++...++.-.+...+|.+.++||+|.|++||+|.+. .+.+.||+|+++.. ....+....||.+|++++
T Consensus 60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDt-q~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDT-QNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeec-cCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCC
Confidence 34456677777888899999999999999999999999996 67799999998643 444567788999999884
Q ss_pred -C---CCceeeeeEEEe----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCC
Q 010624 85 -H---PNILNAHCSFSV----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVK 155 (506)
Q Consensus 85 -H---pnIv~l~~~~~~----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIK 155 (506)
| .+||++++.|.. +.++++|+|++ |..|..+|......+++...++.|++|+|.||.|||.. ||||.|||
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK 215 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK 215 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence 2 479999999975 45899999999 68999999988889999999999999999999999986 99999999
Q ss_pred CCCEEe
Q 010624 156 AGNILS 161 (506)
Q Consensus 156 p~NILl 161 (506)
|+|||+
T Consensus 216 PENvLl 221 (590)
T KOG1290|consen 216 PENVLL 221 (590)
T ss_pred cceeee
Confidence 999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.89 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=197.7
Q ss_pred eeEEeeecccCCee-EEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEec
Q 010624 29 YKILDEIGVGVSAI-VYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 29 Y~i~~~IG~G~fg~-Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 106 (506)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+- ....+...+||..|+..+ |||||++||.-.+....||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY---EGREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee---CCceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 33345689998875 688876 68999999875 344556779999999886 9999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---C--CCeEEeecccccccc
Q 010624 107 FMSCGSLQSIISSCFP--DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---D--GSVKLADFGVSASIY 179 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~--~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~--g~vKL~DFGls~~~~ 179 (506)
.|. .+|.+++..... ........+.++.|++.||++||+.+|+||||||+||||+. + ..++|+|||++....
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 996 899999987311 11122456889999999999999999999999999999985 3 369999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG-RPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... .........||-+|+|||++.... -..++||||+||++|+.++| .+||.+.-..+.. ++.........
T Consensus 663 ~~~s----S~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKS----SFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHL 735 (903)
T ss_pred CCcc----hhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeee
Confidence 4322 122255678999999999998765 47799999999999999996 8999764333322 22222211110
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
....++ ++++||.+||+++|..||+|.++|.||||-+..+.
T Consensus 736 -------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 736 -------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred -------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 011222 89999999999999999999999999999886443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=283.93 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=204.0
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-----EEEE
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS-----RLWV 103 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~l 103 (506)
+--+.||-|+||.||.+.+ +.+|+.||+|.+..-. +-...+.+.+|+.+|..++|.|++..+++.+-.. .+|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTD-PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTD-PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccC-CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3346799999999999988 5789999999875432 2234467889999999999999999888876543 4688
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
++|.+. .+|..+|.+ +..++...++.+++||++||+|||+.+|+||||||.|+|+++|..+||||||++.......
T Consensus 135 ~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~- 210 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD- 210 (449)
T ss_pred HHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-
Confidence 899885 889999887 7889999999999999999999999999999999999999999999999999976543221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh--
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT-- 261 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 261 (506)
........-|.+|.|||++.|...|+.+.||||.|||+.||+.++..|...++.+.+..+.. -...+..+..
T Consensus 211 -----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd-LLGTPs~EaMr~ 284 (449)
T KOG0664|consen 211 -----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID-LLGTPSQEAMKY 284 (449)
T ss_pred -----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH-HhCCCcHHHHHH
Confidence 11122233478899999999988899999999999999999999998987666555433321 1111111000
Q ss_pred -------------hhhh--------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 262 -------------LKIK--------DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 262 -------------~~~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.+.+ ..+..-..+..+++.++|..||.+|.+..+++.|++..
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 0000 01112334677899999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=280.04 Aligned_cols=263 Identities=29% Similarity=0.405 Sum_probs=204.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC---
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--- 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (506)
..+.+|.-+..+|.|+- .|.-|.+. ..+++||||.+..... .....+..+|..++..++|+||++++.+|....
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~-v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQ-VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchh-hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34578999999999999 77778774 6788999998755432 233456779999999999999999999997543
Q ss_pred ---EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 100 ---RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 100 ---~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..|+|||+|. .+|...+.. .++-..+..++.|++.|+.|||+.||+||||||+||+++.++.+||.|||+|.
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 5899999997 788888863 47788999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... ........|.+|.|||++.+.. |.+.+||||+||++.||++|...|.+....+...+.... ...+
T Consensus 167 ~e~~~--------~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~-lgtp 236 (369)
T KOG0665|consen 167 TEDTD--------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ-LGTP 236 (369)
T ss_pred ccCcc--------cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH-hcCC
Confidence 43322 2233455689999999999876 999999999999999999999988754433332222211 0000
Q ss_pred c--------------------hh--------hhhh---hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 257 D--------------------YE--------KTLK---IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 257 ~--------------------~~--------~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
+ +. +... .....+.-+..+++|+.+||..||++|.|++++|.||||+
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 00 0000 0011223455689999999999999999999999999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.78 Aligned_cols=260 Identities=26% Similarity=0.463 Sum_probs=214.2
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCC------CeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeee
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMD------STVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHC 93 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~------~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~ 93 (506)
.|.+..+...+.+.||+|+||.||+|...... ...||||.+.........+.+..|+.+|+.+. ||||+.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 68888888889999999999999999864211 46799999887666677889999999999985 999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCE
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCF------P--------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~------~--------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NI 159 (506)
++..++.+++|+||+..|+|.++++... . ..++......++.||+.|++||++.+++||||-..||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998864 0 1388999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCC--CCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCC
Q 010624 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG--TPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPL 236 (506)
Q Consensus 160 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~G--t~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf 236 (506)
|+..+..+||+|||+|........ .......| ...|||||.+... .|+.++|||||||+|||+++ |..||
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~------y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDY------YRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred EecCCCEEEEccccceeccCCCCc------eEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCC
Confidence 999999999999999764332211 11111122 2239999999874 49999999999999999998 88999
Q ss_pred CCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
............+....+. ..+..++.++.++++.||+.+|++||++.++.
T Consensus 523 p~~~~~~~l~~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred CCCCcHHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 8755344444444443332 25677899999999999999999999999885
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=328.59 Aligned_cols=248 Identities=20% Similarity=0.266 Sum_probs=186.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
..|...+.||+|+||.||+|.++ .++..||+|.+...... ...|+.++++++|||||++++++.++...|+|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 34667788999999999999985 56789999998643321 1256889999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH---NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH---s~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|+++|+|.++++. +++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ||.+....
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 9999999999963 789999999999999999999 6699999999999999998888876 65432111
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE-KSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 262 (506)
......||+.|+|||++.+.. |+.++|||||||++|||++|+.||...... ....................
T Consensus 834 -------~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 834 -------TDTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred -------cCCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence 111235789999999987654 899999999999999999999998532211 11111111000000000000
Q ss_pred h-----hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 263 K-----IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 263 ~-----~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
. ..........++.+++.+||+.||++|||+.++++
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 0 00112234456789999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.59 Aligned_cols=268 Identities=26% Similarity=0.365 Sum_probs=209.4
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC------CCceeeeeEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH------PNILNAHCSFS 96 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~ 96 (506)
++..++|.+....|+|.|++|..|.+. ..|..||||+|..+. .-...=.+|+.||++|+. -|+++++-.|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 366789999999999999999999996 456799999997542 222344589999999962 37899999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGV 174 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGl 174 (506)
..+++|+|+|-+. ..|..+++... +.+|....++.|+.|++-||..|-..||+|.||||.||||+. ...+||||||.
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 9999999999885 89999998753 346899999999999999999999999999999999999995 56799999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
|....... .....-+..|.|||++.|.+ |+...|+||+||+||||.||+..|.+..+...+...+.-...
T Consensus 584 A~~~~ene---------itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 584 ASFASENE---------ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred cccccccc---------ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 65433221 11122255699999999876 999999999999999999999999887766654433321111
Q ss_pred ccch------------hh----------------------hhh--------------hhccchhhhHHHHHHHHhhcccC
Q 010624 255 FSDY------------EK----------------------TLK--------------IKDKNKKFSRAFKDMVASCLDQD 286 (506)
Q Consensus 255 ~~~~------------~~----------------------~~~--------------~~~~~~~~s~~l~~Li~~~L~~d 286 (506)
++.- .. ..+ .+......-..+++|+.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 1100 00 000 11122334557899999999999
Q ss_pred CCCCCCHHHHHcCccccc
Q 010624 287 PSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 287 P~~Rpt~~eiL~hp~f~~ 304 (506)
|++|.|..++|+||||..
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.52 Aligned_cols=277 Identities=28% Similarity=0.433 Sum_probs=212.0
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (506)
.+...+.|.++++||.|.|++||+|.+... ....||+|.+.....+ .++.+|+++|..+. +.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 556678899999999999999999998632 5688999999765543 45889999999986 89999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEeecccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLADFGVSAS 177 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~DFGls~~ 177 (506)
+...+|+||++..+..++... ++...++.+++.++.||.++|.+|||||||||+|+|.+ ..+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999998888865 67889999999999999999999999999999999998 567889999999871
Q ss_pred ccCCC--------------C------------C-----------CCCCCcccccCCCCCccCChhhhhccCCCCccccHH
Q 010624 178 IYEPS--------------H------------H-----------HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIW 220 (506)
Q Consensus 178 ~~~~~--------------~------------~-----------~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIw 220 (506)
..... . . ............||++|.|||++..-+.-+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10000 0 0 011112234567999999999998766568899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc----------------cc-----ch-------hhh-----------
Q 010624 221 SFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----------------FS-----DY-------EKT----------- 261 (506)
Q Consensus 221 SlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~----------------~~-----~~-------~~~----------- 261 (506)
|.|+|+.-++++..||......-..+..+...+. +. .. ...
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999999765433221111110000 00 00 000
Q ss_pred -hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 -LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 -~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.........++..+.+|+.+||..||.+|.|++++|+||||....
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 000011223455788999999999999999999999999999764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=257.21 Aligned_cols=211 Identities=28% Similarity=0.481 Sum_probs=178.2
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHH-hhCCCCCceeeeeEEEeCCE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM-SLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~ 100 (506)
+.+..++..-+..||+|++|.|-+..+. .+|+..|+|.+...-......++.+|+.+. +....|.+|.+|+.+-.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 6677788888899999999999888885 789999999998766666677888888874 55679999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
+|+.||.|+ .||..+.++.. +..++|..+-+|+..++.||.|||++ .++|||+||+|||+|.+|+||+||||+|..
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999996 88877665442 45699999999999999999999997 899999999999999999999999999765
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhc---cCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS---HTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~ 242 (506)
.... .......|.-.|||||.+.. ..+|+.++||||||+++.||++++.||......
T Consensus 199 L~dS--------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 199 LVDS--------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ehhh--------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 4322 22333567788999999864 336999999999999999999999999865443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=278.60 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=199.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhh--CCCCCceeeeeEEEeC-
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL--LSHPNILNAHCSFSVD- 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~- 98 (506)
.+....+..+.+.||+|.||.||+|.++ |..||||++.. .+.....||.+|.+. |+|+||+.++++-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR---GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc---CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3455678999999999999999999884 78899999852 334556678888775 6899999998876544
Q ss_pred ---CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCccCCCCCCCEEeCCCCCe
Q 010624 99 ---SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN--------QGHLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 99 ---~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs--------~givHrDIKp~NILld~~g~v 167 (506)
..+|+|++|.+.|||+|++.. ..++.....+++..++.||++||- -.|.|||||+.||||.++|.+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 379999999999999999987 679999999999999999999995 249999999999999999999
Q ss_pred EEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCC-----CccccHHHHHHHHHHHHhC----------
Q 010624 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGY-----SFKADIWSFGITALELAHG---------- 232 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~-----~~~sDIwSlGiil~eLltG---------- 232 (506)
-|+|+|+|....... ...........||-.|||||++...-+. -..+||||||.+++|++.+
T Consensus 356 ~IADLGLAv~h~~~t---~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDT---DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EEeeceeeEEecccC---CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999988665432 2233345667899999999999653321 2468999999999999863
Q ss_pred CCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH
Q 010624 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296 (506)
Q Consensus 233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei 296 (506)
++||.+..+.+..+..+.+.+-.....+.+...-.....-..+..|++-||..||..|.|+-.|
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 5799876665544444443322211111111100112233456788999999999999998666
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=280.80 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=192.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC--CCCCceeeeeEEEeCC----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL--SHPNILNAHCSFSVDS---- 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~---- 99 (506)
-....+++.||+|.||.||+|.. +++.||||++. ....+.+..|-.|.+.. .|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc---cCceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 45578899999999999999976 46899999986 45667888888888865 6999999998876554
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---------CCCccCCCCCCCEEeCCCCCeEEe
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN---------QGHLHRDVKAGNILSDSDGSVKLA 170 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs---------~givHrDIKp~NILld~~g~vKL~ 170 (506)
.+|||++|.+.|+|.++++. ..++|....+++..+++||+|||+ ..|+|||||..||||.+|++.-|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 89999999999999999997 579999999999999999999996 359999999999999999999999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCC-----ccccHHHHHHHHHHHHhCCC-----------
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYS-----FKADIWSFGITALELAHGRP----------- 234 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~-----~~sDIwSlGiil~eLltG~~----------- 234 (506)
|||+|...... ..........||..|||||++.+...+. .+.||||+|.+|+||+++..
T Consensus 359 DFGLAl~~~p~-----~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 359 DFGLALRLEPG-----KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred ccceeEEecCC-----CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99998865532 1222334478999999999998765544 36899999999999998643
Q ss_pred -CCCC----CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH
Q 010624 235 -PLSH----LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296 (506)
Q Consensus 235 -Pf~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei 296 (506)
||.. .+..+.....+...-..+.++..+ ........+++.+.-||+.||+.|.|+.=+
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W----~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW----RKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhh----hcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2320 111111111111111111111111 011344568899999999999999997544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=286.21 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=176.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------hhHHHHHHHHHHHhhCC---CCCceeeeeE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------TDLDSIRRETKTMSLLS---HPNILNAHCS 94 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~Ei~il~~l~---HpnIv~l~~~ 94 (506)
...+|..++.+|.|+||.|+.|+++ .+...|+||.+.+.+.- ..+-.+-.||+||..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K-~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHK-ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeec-ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 4567999999999999999999997 45788999998765411 11234557999999998 9999999999
Q ss_pred EEeCCEEEEEeccC-CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 95 FSVDSRLWVVMPFM-SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~-~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
|++++++|++||-. +|.+|+++|.. +..++|.++..|++|++.|+++||+.||+|||||-+|+.++.+|-+||+|||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 99999999999976 56699999987 6889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH 238 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~ 238 (506)
.|.... ........||..|.|||++.|..+.+..-|||++|++||.++....||++
T Consensus 716 saa~~k---------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTK---------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhc---------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 865432 22344567999999999999988778999999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.59 Aligned_cols=271 Identities=25% Similarity=0.341 Sum_probs=216.1
Q ss_pred ccccccccccccccCCCCC-CeeEEeeecccCCeeEEEEEEeCCCC---eEEEEEEeccCCChhhHHHHHHHHHHHhhCC
Q 010624 9 QCSSTGTIAQKIQYPLDPS-SYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRTDLDSIRRETKTMSLLS 84 (506)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~-~Y~i~~~IG~G~fg~Vyka~~~~~~~---~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~ 84 (506)
...+....+....+.+..+ ..+..++||+|+||+||+|.+.+... -+||||++....+.....++..|+-+|.+++
T Consensus 677 plapS~~~~n~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld 756 (1177)
T KOG1025|consen 677 PLAPSGFAANLALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD 756 (1177)
T ss_pred ccccccccchhhheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC
Confidence 3334444444555554443 46778899999999999999986532 3799999988877777889999999999999
Q ss_pred CCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC
Q 010624 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 85 HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~ 164 (506)
|||++++++++.... +-||++|+++|.|.++++.. ..++-......|..||++|+.|||.+.++||||-..|+||.+-
T Consensus 757 Hpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP 834 (1177)
T KOG1025|consen 757 HPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP 834 (1177)
T ss_pred CchHHHHhhhcccch-HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC
Confidence 999999999998665 78999999999999999875 4678889999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHH
Q 010624 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEK 243 (506)
Q Consensus 165 g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~ 243 (506)
.+|||+|||++.......... ......-.+-|||=|.+.-.. |+.++|||||||++||++| |..|+...+..+
T Consensus 835 ~hvkitdfgla~ll~~d~~ey-----~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 835 NHVKITDFGLAKLLAPDEKEY-----SAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred CeEEEEecchhhccCcccccc-----cccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 999999999977544332111 111122245699999887654 9999999999999999998 999998776655
Q ss_pred HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
... .+...-+ ...++.++-++.-++.+||..|+..||++.++..
T Consensus 909 I~d-lle~geR----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 909 IPD-LLEKGER----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred hhH-HHhcccc----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 322 1111111 1245778999999999999999999999988753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=240.85 Aligned_cols=214 Identities=39% Similarity=0.617 Sum_probs=184.5
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCCHH
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 114 (506)
||+|++|.||++.+. .+++.+++|.+.........+.+.+|+..++.+.|++|+++++++......++++||+.|++|.
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999984 4578999999876544334578899999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccccccccCCCCCCCCCCcccc
Q 010624 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSASIYEPSHHHHHGSAMIT 193 (506)
Q Consensus 115 ~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls~~~~~~~~~~~~~~~~~~ 193 (506)
+++.... ..+++..+..++.+++.++.|||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~~~ 151 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------LLK 151 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------hhh
Confidence 9998631 46899999999999999999999999999999999999998 89999999998654322110 123
Q ss_pred cCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhH
Q 010624 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSR 273 (506)
Q Consensus 194 ~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 273 (506)
...+...|++||.+.....++.++|+|++|+++++| .
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~ 188 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------P 188 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------H
Confidence 345678899999997653478999999999999999 4
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHcCc
Q 010624 274 AFKDMVASCLDQDPSKRPSAEKLMKHS 300 (506)
Q Consensus 274 ~l~~Li~~~L~~dP~~Rpt~~eiL~hp 300 (506)
.+.+++.+||+.+|++||++.++++|+
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 678999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-29 Score=236.39 Aligned_cols=210 Identities=34% Similarity=0.531 Sum_probs=175.4
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
|.+.+.||.|++|.||++.+. .++..+|+|.+.........+.+.+|+..++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 678899999999999999985 4578999999876544335678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~-l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
.+++|.+++... .. +++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 80 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 80 EGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred CCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999873 33 8999999999999999999999999999999999999999999999999866543221
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHH
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH-LPPEKSLLM 247 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~-~~~~~~~~~ 247 (506)
........++..|++||.+.....++.++|+||||+++++|++|+.||.. ..+......
T Consensus 153 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 153 -AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred -cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 00123345678899999984334477899999999999999999999976 344433333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=291.35 Aligned_cols=208 Identities=15% Similarity=0.133 Sum_probs=145.7
Q ss_pred hCCC-CCceeeeeEE-------EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Q 010624 82 LLSH-PNILNAHCSF-------SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153 (506)
Q Consensus 82 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrD 153 (506)
.++| +||++++++| .....++.++||+ +++|.+++... ...+++..+..+++||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 4555 5788888877 2234677888887 57999999753 35699999999999999999999999999999
Q ss_pred CCCCCEEeCCCCCeEEeec-------------------cccccccCCCC---------CCCCCCcccccCCCCCccCChh
Q 010624 154 VKAGNILSDSDGSVKLADF-------------------GVSASIYEPSH---------HHHHGSAMITDMAGTPYWMAPE 205 (506)
Q Consensus 154 IKp~NILld~~g~vKL~DF-------------------Gls~~~~~~~~---------~~~~~~~~~~~~~Gt~~y~APE 205 (506)
|||+||||+..|.+|++|| |++........ .............||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999976555555555 44332100000 0000000112245899999999
Q ss_pred hhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhccc
Q 010624 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQ 285 (506)
Q Consensus 206 ~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~ 285 (506)
++.+.. |+.++|||||||+||||++|.+|+..... ....+.... .+. ......+...+++.+||+.
T Consensus 186 ~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 186 EDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV-LPP---------QILLNWPKEASFCLWLLHP 251 (793)
T ss_pred hhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh-cCh---------hhhhcCHHHHHHHHHhCCC
Confidence 998755 89999999999999999999888753211 111111110 000 0011234567899999999
Q ss_pred CCCCCCCHHHHHcCcccccc
Q 010624 286 DPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 286 dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+|.+|||+.++++||||...
T Consensus 252 ~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 252 EPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ChhhCcChHHHhhchhhhhh
Confidence 99999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=238.01 Aligned_cols=243 Identities=24% Similarity=0.314 Sum_probs=186.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeee-eEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAH-CSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~-~~~~~~~~~~l 103 (506)
.+.|.|.+.||+|-||.+-+|.++ .+++.+++|.+... ......|.+|...--.|. |.||+.-| ..|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 467999999999999999999996 56789999998654 344577889988755554 99999866 46788889999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-C-CCCeEEeeccccccccCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-S-DGSVKLADFGVSASIYEP 181 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~-~g~vKL~DFGls~~~~~~ 181 (506)
++||++.|+|..-+.. .++-+...+.++.|++.|+.|+|++++||||||.+||||- . ...|||||||++......
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999988875 6788999999999999999999999999999999999985 2 347999999986543221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccC----CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhhccc
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL---MKMTQRFR 254 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~---~~~~~~~~ 254 (506)
.....-+..|.|||+..... ...+.+|+|.|||++|.+++|++||......+... ....++.
T Consensus 177 ----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk- 245 (378)
T KOG1345|consen 177 ----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK- 245 (378)
T ss_pred ----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-
Confidence 11122245699999875322 24678899999999999999999997433222111 1111111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp 291 (506)
....+.....+++.+..+.++-|..+|.+|-
T Consensus 246 ------~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 246 ------NPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred ------CccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 1123334566888999999999999999983
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=241.21 Aligned_cols=259 Identities=22% Similarity=0.380 Sum_probs=209.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+...++++...+-+|.||.||.|+++.. +.+.|.+|.+....++-....+..|--.+.-++|||++.+.+....
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 345667889999999999999999987532 2245678888777777888899999999999999999998877644
Q ss_pred -CCEEEEEeccCCCCCHHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEe
Q 010624 98 -DSRLWVVMPFMSCGSLQSIISSCF------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170 (506)
Q Consensus 98 -~~~~~lV~Ey~~ggsL~~~i~~~~------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~ 170 (506)
....++++.++.-|.|..++..+. ...++..++..++.|++.|++|||++|++|.||-..|++||+.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 567889999999999999998543 2347778889999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~ 249 (506)
|=.+|......... ..........-||+||.+.... |+.++|+||||++||||+| |+.|+...++.+.....
T Consensus 439 DsaLSRDLFP~DYh-----cLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl- 511 (563)
T KOG1024|consen 439 DSALSRDLFPGDYH-----CLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL- 511 (563)
T ss_pred cchhccccCccccc-----ccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-
Confidence 99887654433211 1122223345699999997654 9999999999999999998 99999988877654332
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.+.++.. .+.+||+++..++.-||...|++||+++|+.
T Consensus 512 kdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 512 KDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred hccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 2333322 4578999999999999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=223.18 Aligned_cols=168 Identities=32% Similarity=0.372 Sum_probs=129.0
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 190 (506)
|+|.+++... ..++++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 7899999863 456999999999999999999999998 999999999999999 998654321
Q ss_pred ccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchh
Q 010624 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKK 270 (506)
Q Consensus 191 ~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (506)
....||+.|||||++.+.. |+.++|||||||++|+|++|..||............+.......... .......
T Consensus 62 --~~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 134 (176)
T smart00750 62 --EQSRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR----DRSNLES 134 (176)
T ss_pred --ccCCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc----ccccHHH
Confidence 1125789999999998755 89999999999999999999999976544333222222211111000 0001223
Q ss_pred hhH--HHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 271 FSR--AFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 271 ~s~--~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
++. .++++|.+||..+|.+|||+.++++|+|+..
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 444 6999999999999999999999999998763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=259.13 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=199.7
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEec----cCCChhhH-HHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAID----LDQSRTDL-DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~----~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.-...+|.|++|.|+.+... .....++.|.+. ........ ..+..|+.+-..++|||++.....+.+....+-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~-~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRR-SDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEec-CCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 56778899999988777664 344445555543 22222222 2267788888899999998876666655555556
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||++ +|+.++.. ...+....+..+++|++.|++|+|+.|+.||||||+|+++..+|.+||+|||.+........
T Consensus 400 mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e- 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE- 475 (601)
T ss_pred hhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc-
Confidence 999998 99999987 35789999999999999999999999999999999999999999999999998765443321
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
..........|+..|+|||++.+...-....||||.|+++..|++|+.||......+..+........+.... ..
T Consensus 476 --~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~---~~ 550 (601)
T KOG0590|consen 476 --KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE---GP 550 (601)
T ss_pred --hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc---Ch
Confidence 1123445667899999999998877445578999999999999999999976554433221111111111110 01
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
......++...+.+|.+||+.||.+|.|+.+|++.+||+.+.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 113455778889999999999999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-25 Score=215.93 Aligned_cols=266 Identities=32% Similarity=0.490 Sum_probs=205.5
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh--hHHHHHHHHHHHhhCCCC-CceeeeeEEEeCCEEEEEe
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT--DLDSIRRETKTMSLLSHP-NILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~--~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 105 (506)
|.+...||.|+||.||++.+. ..+++|.+....... ....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 889999999999999999883 678999987665443 477899999999999988 7999999998888889999
Q ss_pred ccCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeeccccccccCCCC
Q 010624 106 PFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYEPSH 183 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~~~~~ 183 (506)
+|+.++++.+++..... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++........
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977776321 2799999999999999999999999999999999999999888 799999998763222110
Q ss_pred CCCCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhcccccch
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPP---EKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~ 258 (506)
..... .......||+.|+|||.+.+. ..++...|+||+|++++++++|..||..... .......+..... +..
T Consensus 158 ~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (384)
T COG0515 158 TSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT-PSL 235 (384)
T ss_pred ccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC-ccc
Confidence 00000 134566789999999999873 4588999999999999999999999876553 2222222221111 000
Q ss_pred hhhhhhhccc----hhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKTLKIKDKN----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~~~~~~~~----~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..... ......+.+++..|+..+|..|.+......++|....
T Consensus 236 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 236 -----ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred -----ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 00011 1223578999999999999999999998888666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=233.61 Aligned_cols=190 Identities=15% Similarity=0.137 Sum_probs=140.4
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCS 94 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (506)
..+.+...++|.+.+.||+|+||+||+|.++..+++.||||.+.... .......+.+|+.+|+.++|+||+..+..
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 34556677899999999999999999999865578889999875331 12335678999999999999999853322
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC-CCCCEEeCCCCCeEEeecc
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDV-KAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDI-Kp~NILld~~g~vKL~DFG 173 (506)
.+..|+|||||+|++|.. +.. .. ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||
T Consensus 90 ---~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred ---cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 245799999999999973 211 11 1468899999999999999999999 9999999999999999999
Q ss_pred ccccccCCCCCCCC-CCcccccCCCCCccCChhhhhccC-----CCCccccHH
Q 010624 174 VSASIYEPSHHHHH-GSAMITDMAGTPYWMAPEVIRSHT-----GYSFKADIW 220 (506)
Q Consensus 174 ls~~~~~~~~~~~~-~~~~~~~~~Gt~~y~APE~l~~~~-----~~~~~sDIw 220 (506)
+|............ .........|++.|+|||.+.... ..+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 98765432211111 011123556788889999875322 134456666
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=242.04 Aligned_cols=299 Identities=21% Similarity=0.293 Sum_probs=223.8
Q ss_pred HhhCCCCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-ccCCCCCCC
Q 010624 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH-LHRDVKAGN 158 (506)
Q Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~gi-vHrDIKp~N 158 (506)
|+.+.|.|+.++++.+.+++..++|.+||..|+|.+.+... ...+++.....++++|+.||.|||+..| +|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 46789999999999999999999999999999999999873 5679999999999999999999999876 999999999
Q ss_pred EEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCC------CCccccHHHHHHHHHHHHhC
Q 010624 159 ILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG------YSFKADIWSFGITALELAHG 232 (506)
Q Consensus 159 ILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~------~~~~sDIwSlGiil~eLltG 232 (506)
+++|....+||+|||+....... ..........-...|.|||++.+... .+.++||||||++++|+++.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~-----~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEET-----AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ceeeeeEEEEechhhhccccccc-----ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999985543210 00011111112345999999986421 36679999999999999999
Q ss_pred CCCCCCCChHH---HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC--cccccccc
Q 010624 233 RPPLSHLPPEK---SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH--SFFKNCNK 307 (506)
Q Consensus 233 ~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h--p~f~~~~~ 307 (506)
..||....... .....+.+ .....+.+.. . ....+.+++..++..||..+|.+||++.++-.. ..++.. .
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i--~-~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~-~ 229 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSI--E-LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG-S 229 (484)
T ss_pred cCccccccccCChHHHHHHHHh-cCCCCcCcch--h-hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc-c
Confidence 99998633222 22222222 1111111111 1 011456689999999999999999999988542 112211 1
Q ss_pred chhhHHHhhhhcc----hhHHHHHHHhhhccCCCCCCCcccccCCCc-ccccCCCCCccCCCCCCccCCcccccCCCCCC
Q 010624 308 GVEFFVKNVLHGL----RSVEERFKESRNHVGAEHHEDEEFEVGSSP-PVKQRRISGWNFNEEGFELDPVFPFFTTESRA 382 (506)
Q Consensus 308 ~~~~~~~~~~~~l----~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~-~v~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 382 (506)
...++++.+...+ .+++..+.+++.....++...+.+...+.| .|+.++..|-.+.++.|+.+|+|++|..++|.
T Consensus 230 ~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~~vti~fsDiv~fT~ 309 (484)
T KOG1023|consen 230 SKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFDSVTIYFSDIVGFTV 309 (484)
T ss_pred ccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccCceeeeeHHHHHHHH
Confidence 2224555555444 467788888887777777788888888888 89999999999999999999999999999998
Q ss_pred CCCcccc
Q 010624 383 DSDSVVK 389 (506)
Q Consensus 383 ~~~~~~~ 389 (506)
.+...++
T Consensus 310 l~~~~~P 316 (484)
T KOG1023|consen 310 LSSNSTP 316 (484)
T ss_pred HHhcCCC
Confidence 7744444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=219.73 Aligned_cols=258 Identities=19% Similarity=0.193 Sum_probs=192.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC----CCceeeeeEE-EeCCEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH----PNILNAHCSF-SVDSRLW 102 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~~~ 102 (506)
+|++.+.||+|+||.||.|.+.......+|+|........... .+..|+.++..+.. +++..+++.+ ..+...|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999986433468999987654333222 67788888888873 6899999998 5788899
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-----CCeEEeecccccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-----GSVKLADFGVSAS 177 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-----g~vKL~DFGls~~ 177 (506)
+||+.+ |.+|.++........++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||++..
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999998 7999999876655789999999999999999999999999999999999999854 3699999999873
Q ss_pred ccCCCCCC---CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhhc
Q 010624 178 IYEPSHHH---HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM--KMTQR 252 (506)
Q Consensus 178 ~~~~~~~~---~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~--~~~~~ 252 (506)
........ ...........||..|+++....+.. .+.+.|+||++.++.++..|..||........... .....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 22111111 11111123456999999999988765 79999999999999999999999976554322111 11111
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.... ......+..+..+...+-..+...+|....+.
T Consensus 256 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 256 LLTD---------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred hccc---------cccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 1100 01233456677777777777888888877664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=241.14 Aligned_cols=317 Identities=21% Similarity=0.293 Sum_probs=226.1
Q ss_pred eecccCCeeEEEEEEe--CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEeccCC
Q 010624 34 EIGVGVSAIVYKAICI--PMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~--~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 109 (506)
++|.|+||.|+.+... ...+..+|+|+..+... .........|..++..++ ||.+|+++..|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 4799999999976432 23467789998765442 112225557888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 110 CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 110 ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
||.|...+.. ...+.+...+.+...++-+++++|+.+++|||+|++||+++.+|++|+.|||++......
T Consensus 81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~-------- 150 (612)
T KOG0603|consen 81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-------- 150 (612)
T ss_pred cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh--------
Confidence 9999998877 467889999999999999999999999999999999999999999999999997643322
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
....||..|||||++++ ...++|.||||+++++|++|..||.. +....+..... ..+.
T Consensus 151 ---~~~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~------------~~p~ 208 (612)
T KOG0603|consen 151 ---KIACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL------------EMPR 208 (612)
T ss_pred ---hhcccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc------------CCch
Confidence 11278999999999983 57899999999999999999999975 22222222121 2456
Q ss_pred hhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccccchhhHHHhhhhcchhHHHHHHHhhhccCCCCCCCccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESRNHVGAEHHEDEEF 344 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~e~ 344 (506)
..+..+++++..++..+|.+|.. +.++++|+||..+++. +...+.....+.+....-+....+...........
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~-~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~d 287 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN-ELEARSRPPPFKPGSITERDVAQFDPEFTSQVPAD 287 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh-hHhhcCCCCCCCCcccchhhhhhcCchhccCCccc
Confidence 78889999999999999999974 4799999999987432 22233333333333222222222211112222222
Q ss_pred ccCCCcccc-cCCCCCccCCCCCC--ccCCcccccCCCCCCC
Q 010624 345 EVGSSPPVK-QRRISGWNFNEEGF--ELDPVFPFFTTESRAD 383 (506)
Q Consensus 345 ~~~~~~~v~-~~~~~g~~~~~~~~--~~~~~~~~~~~~~~~~ 383 (506)
....+++.. .+.++|.++...+. +.++..+.+....+..
T Consensus 288 sp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~ 329 (612)
T KOG0603|consen 288 SPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREE 329 (612)
T ss_pred CCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccc
Confidence 223333333 37788888876543 3345554444444333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=195.02 Aligned_cols=258 Identities=20% Similarity=0.274 Sum_probs=201.8
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRL 101 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 101 (506)
.+....|+++++||+|+||.+|.|... .+|..||||.-... ..-..+..|..+...|. ...|..+..++.+..+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i-~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISI-TSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeec-cCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 455678999999999999999999997 67899999985432 22235667888888887 46888888888999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSASI 178 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~~~ 178 (506)
.+||+.. |.||.++..-+ ...++..++.-++-|++.-++|+|.++++||||||+|+|+.- ...+.|+|||+|...
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999998 79999998765 578999999999999999999999999999999999999863 346999999999877
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHh-hcccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL--LMKMT-QRFRF 255 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~--~~~~~-~~~~~ 255 (506)
..................||..|.+--...+.. -+.+.|+-|+|.+|.++..|..||.+....... ...+. .+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s- 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS- 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-
Confidence 665555555555667778999999876665443 467889999999999999999999876554322 11221 1111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHH
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ 294 (506)
..+......+|.++.-.+.-|=..--++-|...
T Consensus 243 ------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 ------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred ------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 112234567888899899888777777777654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-22 Score=195.83 Aligned_cols=260 Identities=19% Similarity=0.286 Sum_probs=200.6
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDS 99 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (506)
...+-.-.|++.++||.|.||..+.|.+. .++++||||.-.... ..-+++-|.+..+.|. .++|...|.+..++.
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred CceEecccceeccccccCcceeeeccccc-ccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 34455567999999999999999999997 788999999864432 2345778888888886 789999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-----CeEEeeccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-----SVKLADFGV 174 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-----~vKL~DFGl 174 (506)
+-.+|+|.+ |.||.|+..-+ +..|+...++.++.|++.-++|+|++.+|+|||||+|+||..-+ .|.++|||+
T Consensus 98 ~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999999998 79999999876 67899999999999999999999999999999999999998543 599999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--KSLLMKMTQR 252 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--~~~~~~~~~~ 252 (506)
|.....................||..||+--...|.. -+.+.|+-|||-++.+.+.|..||...... ......+-..
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 9877666555555555667788999999987776665 578899999999999999999999875432 2233333222
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~ 293 (506)
-+... +......+|.++...+.-.=..+-.+-|..
T Consensus 255 Kr~T~------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 255 KRSTP------IEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred cccCC------HHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 11111 222334466666666654444444455554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=191.61 Aligned_cols=138 Identities=20% Similarity=0.175 Sum_probs=109.4
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hh------------------------HHHHHHHHHHHhhCCCC
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TD------------------------LDSIRRETKTMSLLSHP 86 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~------------------------~~~~~~Ei~il~~l~Hp 86 (506)
...||+|+||.||+|.+. +|+.||||+++..... .. .....+|+.++..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 467999999999999883 7899999999754311 01 11234599999999988
Q ss_pred CceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccCCCCCCCEEeCCCC
Q 010624 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL-HNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 87 nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yL-Hs~givHrDIKp~NILld~~g 165 (506)
+|.....+.... .++||||++|+++...+.. ...+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++
T Consensus 80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEecC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 875544333222 3899999999877655433 35789999999999999999999 799999999999999998 57
Q ss_pred CeEEeeccccc
Q 010624 166 SVKLADFGVSA 176 (506)
Q Consensus 166 ~vKL~DFGls~ 176 (506)
.++|+|||+|.
T Consensus 155 ~v~LiDFG~a~ 165 (190)
T cd05147 155 KLYIIDVSQSV 165 (190)
T ss_pred cEEEEEccccc
Confidence 89999999965
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-23 Score=222.77 Aligned_cols=234 Identities=25% Similarity=0.416 Sum_probs=174.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
-..++|..++.|..|+||.||.+.++ .+.+.+|+|+ ++... -+++ ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~-~trqrfa~ki-Nkq~l-----ilRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHK-ETRQRFAMKI-NKQNL-----ILRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeecc-ccccchhhcc-cccch-----hhhc---cccccCCccee--------------
Confidence 34578999999999999999999885 5678899954 22110 1111 33333444444
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|+-.+.++.. +.++-. ++.+++|||+.||+|||+||+|.+|..-|++|++|||++........
T Consensus 136 -------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 5555666552 334332 27899999999999999999999999999999999999765443322
Q ss_pred CCCC--------CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 184 HHHH--------GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 184 ~~~~--------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
.... .........|||.|.|||++... +|+..+|+|++|+|+|+.+-|..||....+.+.+-..+...+.+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 2111 11223455799999999999764 59999999999999999999999999888877766655554443
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC---CHHHHHcCccccccccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP---SAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp---t~~eiL~hp~f~~~~~~ 308 (506)
+ +.....+++++++|.++|+.+|..|. .+-++.+|+||+..++.
T Consensus 278 p---------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 278 P---------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred c---------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 3 24456788999999999999999996 57788999999987544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=194.50 Aligned_cols=235 Identities=22% Similarity=0.319 Sum_probs=151.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCC----------CCceeeeeEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSH----------PNILNAHCSF 95 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~ 95 (506)
.+...+.||.|+++.||.+.+. .+++.+|+|++.... ....++.+++|.-....+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEc-cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3677889999999999999995 678999999986544 23456778777765555432 1222222222
Q ss_pred ---------EeCC--------EEEEEeccCCCCCHHHHHHhh---CCC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Q 010624 96 ---------SVDS--------RLWVVMPFMSCGSLQSIISSC---FPD--GLPEPCIAIVLKETLSALSYLHNQGHLHRD 153 (506)
Q Consensus 96 ---------~~~~--------~~~lV~Ey~~ggsL~~~i~~~---~~~--~l~e~~i~~i~~qil~gL~yLHs~givHrD 153 (506)
.... ..+++|+-+. ++|.+++... ... .+.......+..|+++.+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1111 2367788774 8888876532 111 122333345558999999999999999999
Q ss_pred CCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhcc-------CCCCccccHHHHHHHH
Q 010624 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-------TGYSFKADIWSFGITA 226 (506)
Q Consensus 154 IKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-------~~~~~~sDIwSlGiil 226 (506)
|||+|++++.+|.++|+||+....... . ......+..|.+||..... ..++.+.|.|+||+++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~---------~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT---------R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE---------E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc---------e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999986432211 1 1113445779999987543 2378899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCC
Q 010624 227 LELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR 290 (506)
Q Consensus 227 ~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R 290 (506)
|.|+||..||....+... ....+..+. ++|+.++.||..+|+.||.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~---------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEAD---------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGST---------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccc---------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999975433211 000233345 899999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-23 Score=194.85 Aligned_cols=247 Identities=20% Similarity=0.346 Sum_probs=196.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
++.++..++-+|.....|..|+|.+. |.-++.|++..... ......|..|.-.|+-+.||||+.+++.+.....+.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 55667778889999999999999984 34566777765442 223356888999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCCeEE--eeccccccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGSVKL--ADFGVSASI 178 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~vKL--~DFGls~~~ 178 (506)
++..||+.|||+.+++....--.+..++.+++.++++|++|||+.. |.--.|.+..++||++-+.+| +|-.+|...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999999854445788899999999999999999974 444568889999998877665 344333211
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCC--CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG--YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~--~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
....-.|.||+||.+...+. .-.++|+|||+++++||.|+..||.+.++.+...++.....+..
T Consensus 344 --------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ 409 (448)
T KOG0195|consen 344 --------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH 409 (448)
T ss_pred --------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc
Confidence 11223678999999975432 23478999999999999999999999999887776655544422
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.++.++..+..|+.-|++.||.+||.++.|+
T Consensus 410 ----------ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 410 ----------IPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------CCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 4577889999999999999999999987764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=191.92 Aligned_cols=173 Identities=15% Similarity=0.159 Sum_probs=132.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh--hHHH------HHHHHHHHhhCCCCCceeeeeEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT--DLDS------IRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~--~~~~------~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
+...+|++++.+|.|+||.||.+.. ++..+|||.+....... .... +.+|+..+.++.||+|..+..++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 4578899999999999999998644 35679999987544322 2222 67999999999999999998886
Q ss_pred EeC--------CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCe
Q 010624 96 SVD--------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 96 ~~~--------~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~v 167 (506)
... +..+++|||++|.+|.++.. +++ ..+.+++.+|..+|+.|++|||+||+||+++.+| +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 643 35889999999999988742 222 3466999999999999999999999999999988 9
Q ss_pred EEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHH
Q 010624 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA 230 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLl 230 (506)
+|+|||.+...... .|-+.+.....|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~--------------------~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQR--------------------KAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccch--------------------hhHHHHHHHhHhcccccccceeEeehHHH
Confidence 99999974322100 11112222233778999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=185.36 Aligned_cols=194 Identities=13% Similarity=0.069 Sum_probs=142.2
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEe
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS---RTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 105 (506)
-+...|++|+||+||.+.. .+..++.+.+....- ......+.+|+++|++|. |++|++++++ +..|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3567899999999997643 567788777654332 122336789999999995 5889998876 3468999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC-CCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDV-KAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDI-Kp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
+|+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999999754422 11357889999999999999999999 799999999999999999998743322110
Q ss_pred ------CCCCCcccccCCCCCccCChhhhhccCCCC-ccccHHHHHHHHHHHHhCCCCCCCC
Q 010624 185 ------HHHGSAMITDMAGTPYWMAPEVIRSHTGYS-FKADIWSFGITALELAHGRPPLSHL 239 (506)
Q Consensus 185 ------~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~-~~sDIwSlGiil~eLltG~~Pf~~~ 239 (506)
.............++.|++|+...-....+ .+.++++.|+-+|.++|+..|+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 000001122334788999998765432234 5678899999999999999987643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=192.60 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=148.8
Q ss_pred CCCCceeeeeEEEeC---------------------------CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHH
Q 010624 84 SHPNILNAHCSFSVD---------------------------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136 (506)
Q Consensus 84 ~HpnIv~l~~~~~~~---------------------------~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~q 136 (506)
+|||||+++.+|.+. ..+|+||.... .+|+.++.. ...+....+.++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence 599999998776432 35899998775 788888875 56777888999999
Q ss_pred HHHHHHHHHHCCCccCCCCCCCEEeC--CCC--CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCC
Q 010624 137 TLSALSYLHNQGHLHRDVKAGNILSD--SDG--SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG 212 (506)
Q Consensus 137 il~gL~yLHs~givHrDIKp~NILld--~~g--~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 212 (506)
+++|+.|||.+||.|||+|++|||+. .++ .+.|+|||.+........ ............|.-.-||||+....++
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGl-qlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGL-QLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccc-ccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999999999999999974 444 488999998765443221 2222333455678888999999976544
Q ss_pred C-----CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCC
Q 010624 213 Y-----SFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDP 287 (506)
Q Consensus 213 ~-----~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP 287 (506)
. -.++|.|+.|.+.||++....||+.-...-.... .|.. ...+..+..+++.+++|+..+|+.||
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r---------~Yqe-~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR---------TYQE-SQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechh---------hhhh-hhCCCCcccCChHHHHHHHHHhcCCc
Confidence 2 3589999999999999999999986322111000 1111 11334667899999999999999999
Q ss_pred CCCCCH---HHHHc
Q 010624 288 SKRPSA---EKLMK 298 (506)
Q Consensus 288 ~~Rpt~---~eiL~ 298 (506)
++|+++ +.+++
T Consensus 499 skRvsp~iAANvl~ 512 (598)
T KOG4158|consen 499 SKRVSPNIAANVLN 512 (598)
T ss_pred cccCCccHHHhHHH
Confidence 999985 44554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=181.70 Aligned_cols=138 Identities=20% Similarity=0.192 Sum_probs=110.6
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--------------------h-----hHHHHHHHHHHHhhCCC
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--------------------T-----DLDSIRRETKTMSLLSH 85 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--------------------~-----~~~~~~~Ei~il~~l~H 85 (506)
+.+.||+|+||.||+|.+. +|+.||||+++..... . ....+.+|+..+..+.|
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999999873 7899999998764210 0 01234689999999999
Q ss_pred CCceeeeeEEEeCCEEEEEeccCCCCCHHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCC
Q 010624 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSI-ISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDS 163 (506)
Q Consensus 86 pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~-i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~ 163 (506)
++|.....+.... .|+||||++|+++... +.. ..++...+..++.|++.++.++|+ .|++||||||+||+++
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 9986554443332 4899999998865443 432 568888999999999999999999 9999999999999998
Q ss_pred CCCeEEeeccccc
Q 010624 164 DGSVKLADFGVSA 176 (506)
Q Consensus 164 ~g~vKL~DFGls~ 176 (506)
++.++|+|||++.
T Consensus 153 ~~~~~liDFG~a~ 165 (190)
T cd05145 153 DGKPYIIDVSQAV 165 (190)
T ss_pred CCCEEEEEcccce
Confidence 8899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=217.39 Aligned_cols=254 Identities=25% Similarity=0.284 Sum_probs=180.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhH---HHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL---DSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.|...+.||++.|=+|.+|.+ ..|. |+||++-+....... .+..+|++ ....+|||.+.+.-....+...|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~--~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD--REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC--CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 688999999999999999987 4565 889988654433222 33334555 5677899999988777777888899
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
-+|.. .+|+|.+.- ..-+...+.+-|+.|++.||.-+|..||+|||||.+||||++=+-+.|+||..-.........
T Consensus 100 Rqyvk-hnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHHh-hhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 99985 788888875 345778888999999999999999999999999999999999889999999753322222111
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCC----------CCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcc
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTG----------YSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~----------~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
............--.+|.|||.+....+ .+++.||||+||+++||++ |++||.- ..+...-...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~- 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN- 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-
Confidence 1111112222233458999999865321 4678899999999999998 7888852 1111111110
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.. ..... .. .--+..++.||..|++.||++|.+|++.|+.
T Consensus 252 ~~-~~e~~--Le---~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 AD-DPEQL--LE---KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cc-CHHHH--HH---hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 00000 00 1113368999999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=176.12 Aligned_cols=133 Identities=22% Similarity=0.213 Sum_probs=106.3
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-----CCCCceeeeeEEEeCC---E-E
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-----SHPNILNAHCSFSVDS---R-L 101 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~-~ 101 (506)
-.+.||+|+||.||. + +.++.. +||++..... ...+.+.+|+.+++.+ +||||+++++++.++. . +
T Consensus 6 ~~~~LG~G~~~~Vy~--h-p~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--H-PEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--C-CCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 356799999999995 4 344444 6998866432 2456789999999999 5799999999998873 4 3
Q ss_pred EEEecc--CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCccCCCCCCCEEeCC----CCCeEEeecc
Q 010624 102 WVVMPF--MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL-SYLHNQGHLHRDVKAGNILSDS----DGSVKLADFG 173 (506)
Q Consensus 102 ~lV~Ey--~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL-~yLHs~givHrDIKp~NILld~----~g~vKL~DFG 173 (506)
.+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 478999 558999999976 346665 46788888888 9999999999999999999974 3379999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=174.59 Aligned_cols=142 Identities=21% Similarity=0.162 Sum_probs=111.6
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------------------h----hHHHHHHHHHHHhhCC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------------------T----DLDSIRRETKTMSLLS 84 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------------------~----~~~~~~~Ei~il~~l~ 84 (506)
-|++.+.||.|+||.||+|.+...+|+.||+|++...... . ....+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999999833367899999998754210 0 1123568999999998
Q ss_pred CCC--ceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCCCCEEe
Q 010624 85 HPN--ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG-HLHRDVKAGNILS 161 (506)
Q Consensus 85 Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g-ivHrDIKp~NILl 161 (506)
+.+ +.+++.. . ..|+||||+.|.+|...... ...+....+..++.|++.+|.+||+.| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 643 3344432 2 35899999999888766533 245666778899999999999999999 9999999999999
Q ss_pred CCCCCeEEeeccccc
Q 010624 162 DSDGSVKLADFGVSA 176 (506)
Q Consensus 162 d~~g~vKL~DFGls~ 176 (506)
+ ++.++|+|||.+.
T Consensus 183 ~-~~~i~LiDFg~a~ 196 (237)
T smart00090 183 H-DGKVVIIDVSQSV 196 (237)
T ss_pred E-CCCEEEEEChhhh
Confidence 9 8899999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-21 Score=207.20 Aligned_cols=268 Identities=25% Similarity=0.329 Sum_probs=212.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (506)
....|.+.+.||+|+|+.|-.+.........+|.|.+.... .......+..|..+-+.+. |+|++++++........+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 46779999999999999998887754445567777765543 3444566777888888888 999999999999999999
Q ss_pred EEeccCCCCCHHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCCCCEEeCCCC-CeEEeecccccccc
Q 010624 103 VVMPFMSCGSLQSII-SSCFPDGLPEPCIAIVLKETLSALSYLH-NQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIY 179 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i-~~~~~~~l~e~~i~~i~~qil~gL~yLH-s~givHrDIKp~NILld~~g-~vKL~DFGls~~~~ 179 (506)
++++|..|++++..+ ... ....+...+..++.|+..++.|+| ..++.|+||||+|.+++.++ .+|++|||+|....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999999998 441 236788889999999999999999 99999999999999999999 99999999987654
Q ss_pred CCCCCCCCCCcccccCCC-CCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAG-TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~G-t~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ...........| ++.|+|||...+........|+||.|+++..+++|..||............... .
T Consensus 177 ~~----~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~------~ 246 (601)
T KOG0590|consen 177 NK----NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS------N 246 (601)
T ss_pred cc----CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc------c
Confidence 42 122233344556 999999999987555688999999999999999999999765444321111111 0
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
. .......+..++....+++.++|..+|..|.+..++..+||+..
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00012245678889999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-20 Score=188.52 Aligned_cols=256 Identities=22% Similarity=0.245 Sum_probs=164.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeee------eEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAH------CSFSV 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~------~~~~~ 97 (506)
..+.+.+..+.++++.+....-... ....++-+..+.+........+ +++-.+... .|++.+..- ..+..
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~-r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTF-RQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhh-hhhhheeccccCCcccccCCCCchhhhccc
Confidence 3455666667777777665433211 0122333333333322333333 444444444 455444321 11111
Q ss_pred -----CCEEEEEeccCCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 98 -----DSRLWVVMPFMSCGSLQSIISSC-FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 98 -----~~~~~lV~Ey~~ggsL~~~i~~~-~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
..++||.|++|...+|.++|... .....+...+..++.|+..|++| +|.+|+|+||.||+...++.+||.|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhh
Confidence 23689999999999999999743 23457788899999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~ 250 (506)
||+........ .............||.+||+||.+.+.. |+.++||||||++|+||++ -..+|... .....+
T Consensus 400 Fgl~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~- 472 (516)
T KOG1033|consen 400 FGLVTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERI----ATLTDI- 472 (516)
T ss_pred hhheeecccCC-cccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHH----Hhhhhh-
Confidence 99965443332 1112233456678999999999999765 9999999999999999997 22222211 111111
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
+...+++ ....-.+.-..|+.+||...|.+||++.+.--|+|.
T Consensus 473 ---r~g~ip~------~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 ---RDGIIPP------EFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ---hcCCCCh------HHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111110 011112345689999999999999987776666654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=163.51 Aligned_cols=134 Identities=22% Similarity=0.270 Sum_probs=112.4
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
+.||+|++|.||+|.. .|..+++|........ .....+.+|+.++..+.|++|.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999976 4677899976533211 11246778999999999999988777777777889999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
||++|++|.+++... .. ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+.
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999998752 12 7889999999999999999999999999999999 7899999999753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=193.15 Aligned_cols=203 Identities=19% Similarity=0.275 Sum_probs=157.0
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC---CCCceeeeeE
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---HPNILNAHCS 94 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~ 94 (506)
.....++....|.|-+.||.|+||+||+|.. .+|+.||+|+-.....= +|.=-.+++.+|+ -+.|..+..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~--~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATH--SNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeec--CCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHH
Confidence 3444677888999999999999999999998 45999999986443210 1111222334444 2344555555
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-------CCCe
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-------DGSV 167 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-------~g~v 167 (506)
+.-.+.-++|++|.+.|+|.+++.. .+.+++..+..++.|+|..++.||..+|||+||||+|+||.. +..+
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred HccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence 5555566899999999999999985 678999999999999999999999999999999999999842 3459
Q ss_pred EEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCC
Q 010624 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP 234 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~ 234 (506)
+|+|||.|....... .........+|-.+--+|...|.+ ++..+|.|.|+.+++-|+.|+.
T Consensus 841 ~lIDfG~siDm~lfp-----~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFP-----DGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcC-----CCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 999999877544332 122344556788899999998876 9999999999999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-18 Score=160.06 Aligned_cols=130 Identities=22% Similarity=0.281 Sum_probs=106.2
Q ss_pred eecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 34 EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
.||+|+||.||+|.. ++..+++|........ ....++.+|+.++..+.|+++.....++......+++||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999975 4678999986433211 123567889999999999887665555556667789999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
|++|++|.+++... .. .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++.
T Consensus 78 ~~~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 78 YIEGKPLKDVIEEG--ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred EECCccHHHHHhhc--HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999999988652 11 7899999999999999999999999999999 8899999999854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.7e-18 Score=160.80 Aligned_cols=135 Identities=24% Similarity=0.235 Sum_probs=107.7
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh---------------------hhHHHHHHHHHHHhhCCCC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR---------------------TDLDSIRRETKTMSLLSHP 86 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~---------------------~~~~~~~~Ei~il~~l~Hp 86 (506)
.|.+.+.||+|+||.||+|.. .+|+.||||+++..... .......+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD--PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEc--CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 388899999999999999987 36899999987654310 0112366899999999887
Q ss_pred C--ceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC
Q 010624 87 N--ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 87 n--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~ 164 (506)
+ ++.++. ....+++|||++|++|..+... .....++.+++.++.++|+.|++||||||+||+++.+
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 4 333333 2345899999999999765431 2456788999999999999999999999999999999
Q ss_pred CCeEEeeccccc
Q 010624 165 GSVKLADFGVSA 176 (506)
Q Consensus 165 g~vKL~DFGls~ 176 (506)
+.++|+|||++.
T Consensus 162 ~~~~liDfg~~~ 173 (198)
T cd05144 162 EKIYIIDWPQMV 173 (198)
T ss_pred CcEEEEECCccc
Confidence 999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=179.51 Aligned_cols=135 Identities=19% Similarity=0.215 Sum_probs=109.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccC-CC------hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QS------RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~-~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.|...+.||+|+||+||++... +..+++|..... .. ....+.+.+|+.+++.++|++|+....++.....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeec---CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3456899999999999999773 233444432211 11 1123568899999999999999988777777777
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.++||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999886 246789999999999999999999999999999 67899999999854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.8e-16 Score=149.99 Aligned_cols=133 Identities=17% Similarity=0.196 Sum_probs=102.7
Q ss_pred eeec-ccCCeeEEEEEEeCCCCeEEEEEEeccCC------------ChhhHHHHHHHHHHHhhCCCCCc--eeeeeEEEe
Q 010624 33 DEIG-VGVSAIVYKAICIPMDSTVVAIKAIDLDQ------------SRTDLDSIRRETKTMSLLSHPNI--LNAHCSFSV 97 (506)
Q Consensus 33 ~~IG-~G~fg~Vyka~~~~~~~~~vAIK~i~~~~------------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~ 97 (506)
..|| .||.|+||.+.. ++..+++|.+.... .......+.+|+.++..+.|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 3477 888899998865 36788999875321 01223567899999999998885 566665433
Q ss_pred C-C---EEEEEeccCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 98 D-S---RLWVVMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 98 ~-~---~~~lV~Ey~~g-gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
. . ..++||||++| .+|.+++.. ..+++. .+.+++.+|.+||++||+||||||.|||++.++.++|+||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 2 23599999997 699998865 345554 3678999999999999999999999999999999999999
Q ss_pred ccc
Q 010624 173 GVS 175 (506)
Q Consensus 173 Gls 175 (506)
|.+
T Consensus 187 g~~ 189 (239)
T PRK01723 187 DRG 189 (239)
T ss_pred CCc
Confidence 974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-16 Score=146.00 Aligned_cols=134 Identities=23% Similarity=0.265 Sum_probs=96.9
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHH----------------------HHHHHHHHhhCCCCC-
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDS----------------------IRRETKTMSLLSHPN- 87 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~----------------------~~~Ei~il~~l~Hpn- 87 (506)
.+.||+|+||+||+|.+. +++.||||++...... ..... ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 567999999999999873 6889999998654321 11111 135666666665443
Q ss_pred -ceeeeeEEEeCCEEEEEeccCCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCC
Q 010624 88 -ILNAHCSFSVDSRLWVVMPFMSCGSLQS-IISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 88 -Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~-~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~ 164 (506)
+.++++. ...++||||++|+++.. .+... ... ..+..++.+++.++.++|+ .|++|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 3444432 23589999999854321 12211 011 5678999999999999999 9999999999999999 8
Q ss_pred CCeEEeeccccc
Q 010624 165 GSVKLADFGVSA 176 (506)
Q Consensus 165 g~vKL~DFGls~ 176 (506)
+.++|+|||.+.
T Consensus 151 ~~~~liDfg~a~ 162 (187)
T cd05119 151 GKVYIIDVPQAV 162 (187)
T ss_pred CcEEEEECcccc
Confidence 999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.9e-16 Score=136.71 Aligned_cols=131 Identities=18% Similarity=0.206 Sum_probs=111.0
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC--CCceeeeeEEEeCCEEEEEeccC
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH--PNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
+.+.||.|.++.||++.+. +..+++|....... ...+.+|+.+++.+.| .++++++.++...+..|++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec---CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 4678999999999999873 36899998765433 4578899999999986 58999998888888899999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ---GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~---givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.|+++..+ +......++.+++.+|+++|.. +++|+|++|.||+++..+.++++|||.+.
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 98877654 4556678899999999999985 69999999999999998999999999743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-16 Score=174.79 Aligned_cols=275 Identities=22% Similarity=0.340 Sum_probs=212.9
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
|....+++.+.+-+-+|+++.++.+.-. ..|...++|....... ..+.+.++++-.++-...+|-+++....|....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCcc-ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC
Confidence 7889999999999999999999987653 4566667776543321 223455566666666667788888777777788
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..+++++|..|++|...+++. +..+..-++.++..+.++++|||+..+.|+|++|.|+|+..+|+.+++|||......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 899999999999999999883 467777888999999999999999999999999999999999999999998322111
Q ss_pred CCCCC------------------------CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCC
Q 010624 180 EPSHH------------------------HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP 235 (506)
Q Consensus 180 ~~~~~------------------------~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~P 235 (506)
..... ............||+.|.+||.+.+.. ....+|+|++|+++++.++|.+|
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCC
Confidence 11000 000012245567899999999998765 68899999999999999999999
Q ss_pred CCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHH---HHHcCccccccccch
Q 010624 236 LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE---KLMKHSFFKNCNKGV 309 (506)
Q Consensus 236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~---eiL~hp~f~~~~~~~ 309 (506)
|....+.+.+..+...... ++.-....+..+++++...|..+|.+|..+. ++-.|+||+..+++.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~---------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIP---------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCcchhhhhhccccCCCC---------CCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 9887777665443333222 2334556788999999999999999999876 889999999886543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.6e-15 Score=154.40 Aligned_cols=265 Identities=24% Similarity=0.275 Sum_probs=195.2
Q ss_pred cCCCCCCeeEEeeecc--cCCeeEEEEEE--eCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCC-CCCceeeeeEE
Q 010624 22 YPLDPSSYKILDEIGV--GVSAIVYKAIC--IPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLS-HPNILNAHCSF 95 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~--G~fg~Vyka~~--~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~ 95 (506)
...-...+-+...+|. |.+|.||.+.+ . .++..+|+|.-+.... +.....=.+|+...+.++ |+|.++.+..+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~-~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNS-ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcc-cCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 3344456777888999 99999999988 4 4567888887332221 222223346777767775 99999999999
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCccCCCCCCCEEeCCC-CCeEEe
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS----ALSYLHNQGHLHRDVKAGNILSDSD-GSVKLA 170 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~----gL~yLHs~givHrDIKp~NILld~~-g~vKL~ 170 (506)
...+..|+-+|+|. .+|..+.... ...++...++.++.+... ||.++|+.+++|-|+||.||++..+ ...+++
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence 99999999999995 8888888763 344889999999999999 9999999999999999999999988 899999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
|||+........... .........|..-|++||..++. ++...|+||+|.++.+..++..++........
T Consensus 266 df~~v~~i~~~~~~~--~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W------ 335 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSS--VFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSW------ 335 (524)
T ss_pred CcceeEEccCCcccc--ceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCc------
Confidence 999865443332111 11112333677789999999765 78999999999999999998776543211110
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
...+......+.....+.++...+..|++.+|-.|++++.++.|+++..
T Consensus 336 -----~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 336 -----SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -----cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 0000000111223345566677999999999999999999999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.9e-13 Score=141.73 Aligned_cols=184 Identities=20% Similarity=0.300 Sum_probs=136.5
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccC
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
|.| ...+-++.+..-.|..+ .++.+|.|...+.... ...+.+.+-++.|+.++||||++++..++.++.+|+|+|-+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k-~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRK-ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCccccccccee-ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence 665 44444444433334443 5677888888876554 44567788999999999999999999999999999999998
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 109 ~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
-.|..++.+ +....+...++||+.||.|||. .+++|++|.-..|+|+..|..||++|.++........
T Consensus 92 --~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---- 160 (690)
T KOG1243|consen 92 --RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---- 160 (690)
T ss_pred --ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----
Confidence 577788876 3377888899999999999984 5899999999999999999999999987543322111
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhC
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG 232 (506)
......---.|..|+.+... ....|.|-|||++++++.|
T Consensus 161 ---~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ---PAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---ccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 00011111236677655321 2457999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-13 Score=143.34 Aligned_cols=138 Identities=24% Similarity=0.344 Sum_probs=95.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh---hH------------------------------H------HH
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT---DL------------------------------D------SI 73 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~---~~------------------------------~------~~ 73 (506)
+.||+|++|.||+|.. .+|+.||||+.+..-... +. . .+
T Consensus 123 ~plasaSigQVh~A~l--~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARL--VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEe--cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 5699999999999987 478999999985432100 00 0 23
Q ss_pred HHHHHHHhhCC-----CCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHHC
Q 010624 74 RRETKTMSLLS-----HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS-ALSYLHNQ 147 (506)
Q Consensus 74 ~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~-gL~yLHs~ 147 (506)
.+|...+..+. +++|.-..-+....+..++||||++|++|.++.... ..+.+ ...++..++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-EAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-hcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 44555555542 344332222222234568999999999999887542 12222 3445566655 46889999
Q ss_pred CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 148 GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 148 givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
|++|+|+||.||+++.+|.++++|||++.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~ 305 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVG 305 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCee
Confidence 99999999999999999999999999854
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.3e-13 Score=131.78 Aligned_cols=213 Identities=22% Similarity=0.289 Sum_probs=146.1
Q ss_pred HHHHHHhhCCCCCceeeeeEEEeC-----CEEEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 010624 75 RETKTMSLLSHPNILNAHCSFSVD-----SRLWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQ 147 (506)
Q Consensus 75 ~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~ 147 (506)
.-..-+-++.|.|||+++.|+.+. ....++.||+.-|++..++++.. ...+....-.+|+-||+.||.|||+-
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 334445667799999999988654 45789999999999999998653 34588888899999999999999986
Q ss_pred --CCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHH
Q 010624 148 --GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGIT 225 (506)
Q Consensus 148 --givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGii 225 (506)
-++|+.+....|++..+|-+|+.--- ....................|-++|.|||.=.. .+.+-++|||+||.+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~a---p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVA---PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMC 271 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccC---ccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHH
Confidence 59999999999999999988875321 111111111111222334456788999986432 235678999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 226 ALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 226 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+|..+..--.... .............+. .-..--++++.+||+..|..||++..++.||..-++
T Consensus 272 AlemailEiq~tnse-S~~~~ee~ia~~i~~-------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSE-SKVEVEENIANVIIG-------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HHHHHHheeccCCCc-ceeehhhhhhhheee-------------ccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 999988754321111 110000000000000 001123578999999999999999999999987665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=120.16 Aligned_cols=126 Identities=17% Similarity=0.166 Sum_probs=95.2
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEEEEEeccCCC
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~g 110 (506)
++.|+.|.++.||++.. .+..|++|....... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 46789999999999876 367899998754432 122456899999988766554 4444432 335799999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----ccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH-----LHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~gi-----vHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.++... . .....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+
T Consensus 76 ~~l~~~--~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 76 SELLTE--D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred Cccccc--c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 887643 0 1123467899999999999985 9999999999998 678999999974
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.3e-13 Score=145.89 Aligned_cols=141 Identities=20% Similarity=0.218 Sum_probs=91.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh---------------------------------hhHHHH
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR---------------------------------TDLDSI 73 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~---------------------------------~~~~~~ 73 (506)
..|.. +.||+|++|.||+|..+ .+|+.||||+.+..-.. ...+.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 45666 78999999999999984 34899999998644210 001222
Q ss_pred H------HHHHHHhhCC----CCCceeeeeEEE-eCCEEEEEeccCCCCCHHHHHHhhCCC----CCCHHHHHHHHHHHH
Q 010624 74 R------RETKTMSLLS----HPNILNAHCSFS-VDSRLWVVMPFMSCGSLQSIISSCFPD----GLPEPCIAIVLKETL 138 (506)
Q Consensus 74 ~------~Ei~il~~l~----HpnIv~l~~~~~-~~~~~~lV~Ey~~ggsL~~~i~~~~~~----~l~e~~i~~i~~qil 138 (506)
. +|+..+.++. +.+.+.+-..|. -.+..++||||+.|+++.++-.-...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 3 3333333332 222222222222 134567999999999998753211111 234444455555554
Q ss_pred HHHHHHHHCCCccCCCCCCCEEeCCCC----CeEEeeccccc
Q 010624 139 SALSYLHNQGHLHRDVKAGNILSDSDG----SVKLADFGVSA 176 (506)
Q Consensus 139 ~gL~yLHs~givHrDIKp~NILld~~g----~vKL~DFGls~ 176 (506)
..|++|+|+||.||+++.+| .++++|||++.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg 312 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG 312 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence 58999999999999999888 99999999854
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.5e-12 Score=117.96 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=100.1
Q ss_pred EeeecccCCeeEEEEEEeCC-----CCeEEEEEEeccCCC---------------------hhhHHHHH----HHHHHHh
Q 010624 32 LDEIGVGVSAIVYKAICIPM-----DSTVVAIKAIDLDQS---------------------RTDLDSIR----RETKTMS 81 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~-----~~~~vAIK~i~~~~~---------------------~~~~~~~~----~Ei~il~ 81 (506)
...||.|--+.||.|..... .+..+|||+.+.... ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 45799999999999976311 247899999753210 01123333 8999999
Q ss_pred hCCC--CCceeeeeEEEeCCEEEEEeccCCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccCCCCCC
Q 010624 82 LLSH--PNILNAHCSFSVDSRLWVVMPFMSCGSLQS-IISSCFPDGLPEPCIAIVLKETLSALSYL-HNQGHLHRDVKAG 157 (506)
Q Consensus 82 ~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~-~i~~~~~~~l~e~~i~~i~~qil~gL~yL-Hs~givHrDIKp~ 157 (506)
++.. -++..++++ ..-++||||+.+..+.. .+.. ..++...+..++.+++.+|.++ |..|++|+||+|.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9874 455566654 34579999998654422 2322 2455667788899999999999 8999999999999
Q ss_pred CEEeCCCCCeEEeecccccc
Q 010624 158 NILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 158 NILld~~g~vKL~DFGls~~ 177 (506)
||+++ ++.+.|+|||.|..
T Consensus 155 NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HEEEE-CCcEEEEECCCcee
Confidence 99996 57899999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.8e-13 Score=138.56 Aligned_cols=254 Identities=22% Similarity=0.190 Sum_probs=180.8
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh-hHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-DLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (506)
....+|-++..||.|.|+.|+++.....++..|++|.+....... ....-..|+.+...+ .|.++++.+..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 344678899999999999999987544778899999875443221 111223566565555 488999988888777778
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-CCeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-g~vKL~DFGls~~~~~ 180 (506)
|+=-|||+++++...+.- ...+++...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.....
T Consensus 342 ~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~-- 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL-- 417 (524)
T ss_pred cCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc--
Confidence 899999999988776633 4568888999999999999999999999999999999999876 78899999974321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........++..|-.+|++.....+..++|++|||..+.+.+++.+.-....... .+... .
T Consensus 418 -------~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~-----~--- 479 (524)
T KOG0601|consen 418 -------AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG-----D--- 479 (524)
T ss_pred -------ceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc-----c---
Confidence 11111122223333235666555558899999999999999999865322111110 00000 0
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.. ..+....++..+.+.++..++..||.+.++..|+-|.
T Consensus 480 ---~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 ---TP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---cc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 01 2233447888999999999999999999988776554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.8e-11 Score=110.10 Aligned_cols=144 Identities=22% Similarity=0.254 Sum_probs=112.3
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--C-----hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--S-----RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.+..|-+|+-+.|+++.. .|+.+.||.-.... . .-...+..+|++.+.++.--.|.-..-+|.+...-.+
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 677899999999999976 57888888643322 1 1224567789999999987677666666767666779
Q ss_pred EeccCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEeecccccc
Q 010624 104 VMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLADFGVSAS 177 (506)
Q Consensus 104 V~Ey~~g-gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~DFGls~~ 177 (506)
+|||++| .++.+++...............++++|-+.+.-||.++++|+||..+||++.++| .+.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999987 4788888776444455555588999999999999999999999999999998665 358999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-11 Score=109.63 Aligned_cols=131 Identities=19% Similarity=0.259 Sum_probs=102.0
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--Ch-----hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SR-----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
..+++|+-+.+|.+... |..+++|.-.... .+ -...+-++|..++..+.--.|.-..-++.+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 45889999999998662 4456677543222 11 12356678999999998777776666667777778999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
||++|..|.+++... ...+++.+-.-+.-||..||+|+||.++||++..+ .+.++|||++.
T Consensus 79 e~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~ 139 (204)
T COG3642 79 EYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139 (204)
T ss_pred EEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccc
Confidence 999999999998763 25677888888999999999999999999999765 49999999843
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=7e-11 Score=112.68 Aligned_cols=139 Identities=15% Similarity=0.190 Sum_probs=104.7
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCC--CceeeeeEEEeC---CEEEEEecc
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP--NILNAHCSFSVD---SRLWVVMPF 107 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~---~~~~lV~Ey 107 (506)
+.||.|.++.||++.. .+|..+++|.............+.+|+.+++.+.+. ++.+++.+.... +..|+||||
T Consensus 4 ~~l~~G~~n~~~~v~~--~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTA--GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEe--cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 5689999999999976 345789999876543322345678999999999764 456677666553 367899999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN----------------------------------------- 146 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs----------------------------------------- 146 (506)
++|.++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 999988775532 346666777777777777777773
Q ss_pred ---------------CCCccCCCCCCCEEeCC--CCCeEEeeccccc
Q 010624 147 ---------------QGHLHRDVKAGNILSDS--DGSVKLADFGVSA 176 (506)
Q Consensus 147 ---------------~givHrDIKp~NILld~--~g~vKL~DFGls~ 176 (506)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999998 6678999999743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.6e-09 Score=109.60 Aligned_cols=231 Identities=19% Similarity=0.239 Sum_probs=159.8
Q ss_pred cCCCCCCeeEEeeecc-c--CCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-
Q 010624 22 YPLDPSSYKILDEIGV-G--VSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV- 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~-G--~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 97 (506)
++-....|.-+..+-- + -..+.|++... .+|..|++|.++-++.. .......-+++++++.|+|||++.+.|..
T Consensus 268 ~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~-~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~ 345 (655)
T KOG3741|consen 268 IPSLVESFVNLYPLELLNDLFSITTYKATSN-VDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTY 345 (655)
T ss_pred CCcchhhhhceeecccccccccceeEeeeec-cCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhh
Confidence 3444444444444321 2 45788999884 78899999998433321 11122356778999999999999888863
Q ss_pred ---CCEEEEEeccCCC-CCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEE
Q 010624 98 ---DSRLWVVMPFMSC-GSLQSIISSCF-------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL 160 (506)
Q Consensus 98 ---~~~~~lV~Ey~~g-gsL~~~i~~~~-------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NIL 160 (506)
+..+++|++|.++ ++|.++.-... +...++..+|.++.|+..||.++|+.|+..+-|.|.+||
T Consensus 346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIl 425 (655)
T KOG3741|consen 346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKIL 425 (655)
T ss_pred ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeE
Confidence 4578999999875 57877654321 224788999999999999999999999999999999999
Q ss_pred eCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCCh-hhhhccCCCCccccHHHHHHHHHHHHhCCCC-CCC
Q 010624 161 SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP-EVIRSHTGYSFKADIWSFGITALELAHGRPP-LSH 238 (506)
Q Consensus 161 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~AP-E~l~~~~~~~~~sDIwSlGiil~eLltG~~P-f~~ 238 (506)
++.+-+++|...|+...... .| +.+.++ .+-|.-.||.+++.|.||..- +..
T Consensus 426 v~G~~RIriS~C~i~Dvl~~----------------------d~~~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~ 479 (655)
T KOG3741|consen 426 VTGKMRIRISGCGIMDVLQE----------------------DPTEPLESQ----QQNDLRDLGLLLLALATGTENSNRT 479 (655)
T ss_pred eeCcceEEEecccceeeecC----------------------CCCcchhHH----hhhhHHHHHHHHHHHhhcccccccc
Confidence 99888888887776322110 11 223322 366899999999999998543 111
Q ss_pred CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....+.... .....++.+++++|..+...++.. -++.+++.+
T Consensus 480 d~~~~s~~~------------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 480 DSTQSSHLT------------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred cchHHHHHH------------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 111111111 123457889999999999999876 677788754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.1e-09 Score=105.07 Aligned_cols=132 Identities=11% Similarity=0.028 Sum_probs=95.4
Q ss_pred eeEEEEEEeCCCCeEEEEEEeccCCChhhH----------HHHHHHHHHHhhCCCCCce--eeeeEEEe-----CCEEEE
Q 010624 41 AIVYKAICIPMDSTVVAIKAIDLDQSRTDL----------DSIRRETKTMSLLSHPNIL--NAHCSFSV-----DSRLWV 103 (506)
Q Consensus 41 g~Vyka~~~~~~~~~vAIK~i~~~~~~~~~----------~~~~~Ei~il~~l~HpnIv--~l~~~~~~-----~~~~~l 103 (506)
..|+++.. +|+.|.||........... ..+.+|...+..|..-+|. .+.+++.. ....++
T Consensus 36 rrvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 34556543 5778999976322211111 1367899888888644443 34445543 235789
Q ss_pred EeccCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-------CCCeEEeecccc
Q 010624 104 VMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-------DGSVKLADFGVS 175 (506)
Q Consensus 104 V~Ey~~gg-sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-------~g~vKL~DFGls 175 (506)
|||++++. +|.+++........+......++.+++..+.-||..|++|+|+++.|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999986 8999986533345667788899999999999999999999999999999975 467999999963
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.7e-11 Score=124.97 Aligned_cols=161 Identities=17% Similarity=0.295 Sum_probs=112.6
Q ss_pred HHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC--CCCCcccccCCCCCccCChhhhhccCC
Q 010624 136 ETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH--HHGSAMITDMAGTPYWMAPEVIRSHTG 212 (506)
Q Consensus 136 qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~--~~~~~~~~~~~Gt~~y~APE~l~~~~~ 212 (506)
+++.|+.|+|.. ++||+.|.|++|.++.+|..||+.|+++.......... ...........-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~- 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT- 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence 344999999976 89999999999999999999999999876544321110 11111112222345799999998744
Q ss_pred CCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC
Q 010624 213 YSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291 (506)
Q Consensus 213 ~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp 291 (506)
.+.++|+||+||++|.+.. |+.-+......... ....... ..........++.++++-+.++|..++..||
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~-------~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLL-------NAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhccc-------ccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 6889999999999999995 55444432221111 1111100 0111223467899999999999999999999
Q ss_pred CHHHHHcCcccccc
Q 010624 292 SAEKLMKHSFFKNC 305 (506)
Q Consensus 292 t~~eiL~hp~f~~~ 305 (506)
++..++..|||.+.
T Consensus 258 ~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 258 TLDLLLSIPFFSDP 271 (700)
T ss_pred chhhhhcccccCCc
Confidence 99999999999865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-09 Score=99.43 Aligned_cols=124 Identities=24% Similarity=0.249 Sum_probs=83.6
Q ss_pred eEEEEEEeCCCCeEEEEEEeccCC-------------C------------hhhHHHHHHHHHHHhhCCCC--CceeeeeE
Q 010624 42 IVYKAICIPMDSTVVAIKAIDLDQ-------------S------------RTDLDSIRRETKTMSLLSHP--NILNAHCS 94 (506)
Q Consensus 42 ~Vyka~~~~~~~~~vAIK~i~~~~-------------~------------~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~ 94 (506)
.||.|.. .+|..+|+|+..... . ........+|...|..+..- ++.+++.+
T Consensus 1 ~Vy~~~~--~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAID--PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEE--CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEEC--CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 3899987 578899999975321 0 01134677899999999866 45556544
Q ss_pred EEeCCEEEEEeccCC--CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 95 FSVDSRLWVVMPFMS--CGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY-LHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~--ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~y-LHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
. . -++||||+. |..+..+.... ++......++.+++..+.. +|..|++|+||.+.||+++.+ .+.|+|
T Consensus 79 ~--~--~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 N--R--NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp E--T--TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--
T ss_pred e--C--CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEe
Confidence 2 2 259999998 66665554431 2234567788888886655 589999999999999999877 999999
Q ss_pred ccccc
Q 010624 172 FGVSA 176 (506)
Q Consensus 172 FGls~ 176 (506)
||.+.
T Consensus 150 f~qav 154 (188)
T PF01163_consen 150 FGQAV 154 (188)
T ss_dssp GTTEE
T ss_pred cCcce
Confidence 99854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.2e-08 Score=101.52 Aligned_cols=247 Identities=17% Similarity=0.185 Sum_probs=153.3
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCcee--------eeeEEEeCCEE
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN--------AHCSFSVDSRL 101 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~--------l~~~~~~~~~~ 101 (506)
...+.||+|+-+.+|-.-. -+.. +-|++......... .... .+.+.-.||-+-. +++. .....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~-VAKIYh~Pppa~~a-qk~a--~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQ-VAKIYHAPPPAAQA-QKVA--ELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecch---hhch-hheeecCCCchHHH-HHHH--HhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 3467799999999996532 1223 34666543322211 1111 1223445775433 1111 112337
Q ss_pred EEEeccCCCCC-HHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 102 WVVMPFMSCGS-LQSIISSC----FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 102 ~lV~Ey~~ggs-L~~~i~~~----~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.++|+.+.|.. +..+.... ......|..+.+.++.++.+.+.||..|.+-+|+.++|+|++.++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78999988763 22222211 12347899999999999999999999999999999999999999999999855311
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc----CCCCccccHHHHHHHHHHHHhC-CCCCCCCC-------hHHH
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHG-RPPLSHLP-------PEKS 244 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~sDIwSlGiil~eLltG-~~Pf~~~~-------~~~~ 244 (506)
............|.+.|.+||.-+-. -.-+...|.|.||+++++++.| ++||.... +.+.
T Consensus 166 --------i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 166 --------INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred --------eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 11223344566789999999986511 1246788999999999999997 99997532 1121
Q ss_pred HHHHHhhcccccch-hhhh---hhhccchhhhHHHHHHHHhhcccC--CCCCCCHH
Q 010624 245 LLMKMTQRFRFSDY-EKTL---KIKDKNKKFSRAFKDMVASCLDQD--PSKRPSAE 294 (506)
Q Consensus 245 ~~~~~~~~~~~~~~-~~~~---~~~~~~~~~s~~l~~Li~~~L~~d--P~~Rpt~~ 294 (506)
. +....+.+..- .... .......-+++++..|..+|+... +.-|||+.
T Consensus 238 ~--Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 238 D--IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred h--hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1 11111111100 0000 011123456788999999998763 56899874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-08 Score=98.83 Aligned_cols=133 Identities=25% Similarity=0.254 Sum_probs=101.8
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC---------------------hhhHHHHHHHHHHHhhCCCC-
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS---------------------RTDLDSIRRETKTMSLLSHP- 86 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~---------------------~~~~~~~~~Ei~il~~l~Hp- 86 (506)
+.+...||-|--|.||.|.+ ..|.++|||.-+.... ........+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~--~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID--PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEEC--CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 56788999999999999988 4688999997543210 11134567899999999755
Q ss_pred -CceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC
Q 010624 87 -NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 87 -nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g 165 (506)
.|.+.+++ +...+||||++|..|...- ++...+..++..|+.-+..+-..|++|+|+++-||+++.+|
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 66666543 3456999999987775433 23345566777777777777789999999999999999999
Q ss_pred CeEEeeccc
Q 010624 166 SVKLADFGV 174 (506)
Q Consensus 166 ~vKL~DFGl 174 (506)
.+.++||--
T Consensus 240 ~~~vIDwPQ 248 (304)
T COG0478 240 DIVVIDWPQ 248 (304)
T ss_pred CEEEEeCcc
Confidence 999999965
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.4e-07 Score=89.77 Aligned_cols=102 Identities=20% Similarity=0.285 Sum_probs=81.7
Q ss_pred HHHHHHHHHHhhCCCCCc--eeeeeEEEeC----CEEEEEeccCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 010624 71 DSIRRETKTMSLLSHPNI--LNAHCSFSVD----SRLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143 (506)
Q Consensus 71 ~~~~~Ei~il~~l~HpnI--v~l~~~~~~~----~~~~lV~Ey~~gg-sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~y 143 (506)
....+|...+..|..-+| .+++++.... ...++|+|++++. +|.+++... ...+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHHHH
Confidence 456788888877764443 4455555542 2468999999875 899999863 236777889999999999999
Q ss_pred HHHCCCccCCCCCCCEEeCCCC---CeEEeeccc
Q 010624 144 LHNQGHLHRDVKAGNILSDSDG---SVKLADFGV 174 (506)
Q Consensus 144 LHs~givHrDIKp~NILld~~g---~vKL~DFGl 174 (506)
||.+|++|+|++|.|||++.++ .+.++||+-
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~ 167 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDR 167 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence 9999999999999999999887 899999985
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.8e-10 Score=116.52 Aligned_cols=250 Identities=23% Similarity=0.272 Sum_probs=169.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC-ceeeeeEEEeCCEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN-ILNAHCSFSVDSRLWV 103 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~l 103 (506)
...-|.....+++|+++++||.... ..+....+.+... ...+-++++|.+++||| .+..++.++.+.+.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRpt--aeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCC--hhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 3345777888999999999998663 2233335555322 44567899999999999 7777788888899999
Q ss_pred EeccCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 104 VMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 104 V~Ey~~gg-sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
.++++.++ +....+... ...+.+.....+.+.-+++++|+|+.--+|+| ||+..+ +.+|..||+........
T Consensus 312 ~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~- 384 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT- 384 (829)
T ss_pred hhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc-
Confidence 99999988 322222110 12345556677778888999999999889999 777654 78999999975432221
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......+|+.|+|||+..... +....|+|++|.-..++.-|.+|-....... +.........
T Consensus 385 -------~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~---------~~~g~~p~s~ 447 (829)
T KOG0576|consen 385 -------MKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL---------PMIGNGPNSP 447 (829)
T ss_pred -------cccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcccc---------CCCCCCCCcc
Confidence 1345667899999999987765 8889999999998888888888765421100 0000000000
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
........-+..-.++...|+..-|..|+....++.|.+|..|.
T Consensus 448 ~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 448 MLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred ccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 00000000011112577889999999999999999999998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.1e-07 Score=86.07 Aligned_cols=135 Identities=15% Similarity=0.078 Sum_probs=99.3
Q ss_pred cccCCeeEEEEEEeCCCCeEEEEEEeccC--CC---hhhHHHHHHHHHHHhhCCCCC--ceeeeeEEE-e----CCEEEE
Q 010624 36 GVGVSAIVYKAICIPMDSTVVAIKAIDLD--QS---RTDLDSIRRETKTMSLLSHPN--ILNAHCSFS-V----DSRLWV 103 (506)
Q Consensus 36 G~G~fg~Vyka~~~~~~~~~vAIK~i~~~--~~---~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~-~----~~~~~l 103 (506)
|+||-+-|+.... .|..+-+|.-... .+ +-....|.+|+..+..|..-+ +.++. ++. . .-..+|
T Consensus 27 ~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEe---CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 5688888988654 3456777764311 11 234568889999999886433 44444 222 1 124689
Q ss_pred EeccCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC--eEEeeccc
Q 010624 104 VMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS--VKLADFGV 174 (506)
Q Consensus 104 V~Ey~~g-gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~--vKL~DFGl 174 (506)
|+|-+.| .+|.+++.+..-...+......++.+++..+.-||+.|+.|+|+-+.||+++.+|. |+++||.-
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 9997754 48998886643345677788899999999999999999999999999999987777 99999975
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-06 Score=82.74 Aligned_cols=137 Identities=17% Similarity=0.230 Sum_probs=90.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhH--------HHHHHHHHHHhhC---CCCCceeee
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL--------DSIRRETKTMSLL---SHPNILNAH 92 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~--------~~~~~Ei~il~~l---~HpnIv~l~ 92 (506)
+....|++.+.+-......|.+.. .+|..+++|........... ....+.+..+..+ .--....++
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe---i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE---IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE---ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 456789999999888887776653 46788999987543322111 1122333333333 222333333
Q ss_pred eEEE-----eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCe
Q 010624 93 CSFS-----VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 93 ~~~~-----~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~v 167 (506)
.+.. -....+++|||++|..|.++.. +++ .+...+.+++.-||+.|++|+|..|.|++++.+ .+
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cE
Confidence 2222 2235678999999988876542 222 244667788999999999999999999999855 59
Q ss_pred EEeeccc
Q 010624 168 KLADFGV 174 (506)
Q Consensus 168 KL~DFGl 174 (506)
+++||+.
T Consensus 174 ~iID~~~ 180 (229)
T PF06176_consen 174 RIIDTQG 180 (229)
T ss_pred EEEECcc
Confidence 9999985
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=98.83 Aligned_cols=203 Identities=24% Similarity=0.306 Sum_probs=140.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeEEEeCCE----EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 010624 70 LDSIRRETKTMSLLSHPNILNAHCSFSVDSR----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145 (506)
Q Consensus 70 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH 145 (506)
+....-|+..+..+.|+|++.++.+-...-. ..+..++|...++...+.. -...+....+.+..+++.||+|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHH
Confidence 3444567778888899999998877654332 3355778999999999987 467889999999999999999999
Q ss_pred HCCCccCCCCCC---CEEeCCCCCeEEe--eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCC-CCccccH
Q 010624 146 NQGHLHRDVKAG---NILSDSDGSVKLA--DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG-YSFKADI 219 (506)
Q Consensus 146 s~givHrDIKp~---NILld~~g~vKL~--DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~~sDI 219 (506)
+....|.-+... +--++..+.+.++ ||+.+...... .......-+..|.+||....... .....|+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--------~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--------EKSFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCc--------ccchhhcCccccccccccccccchhhhhhHH
Confidence 997666666555 4445566677777 88875543222 11122223455788887764331 1233699
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 220 WSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 220 wSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
|++|..+..+..|..+-........+ ....+.....++..+|+..++++|+++.+++.|
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~~~---------------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPVSL---------------------LDVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchhhh---------------------hccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999999999876543211000000 111122267888999999999999999999999
Q ss_pred cccc
Q 010624 300 SFFK 303 (506)
Q Consensus 300 p~f~ 303 (506)
+|.+
T Consensus 435 ~f~~ 438 (1351)
T KOG1035|consen 435 PFLR 438 (1351)
T ss_pred hhcc
Confidence 9976
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.1e-06 Score=83.04 Aligned_cols=134 Identities=17% Similarity=0.180 Sum_probs=83.3
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc--eeeeeEEEeCCEEEEEeccCCC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~~~~lV~Ey~~g 110 (506)
..||.|..+.||+. . +..+++|...... ....+.+|.++++.+..-++ .+++.+....+..++||++++|
T Consensus 7 ~~i~~G~t~~~y~~----~-~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----K-TGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----c-CCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 56899999999973 2 3457788875432 33457899999999875444 5677777777888999999998
Q ss_pred CC-HHHH---------------------HHhhCCCCCCHHH-HHHHHHH----------HHHH-HHHHHH----CCCccC
Q 010624 111 GS-LQSI---------------------ISSCFPDGLPEPC-IAIVLKE----------TLSA-LSYLHN----QGHLHR 152 (506)
Q Consensus 111 gs-L~~~---------------------i~~~~~~~l~e~~-i~~i~~q----------il~g-L~yLHs----~givHr 152 (506)
.+ +... ++.......+... ...+..+ +... ..+|.+ ..++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 2111 1110001111111 0111111 1111 122221 236899
Q ss_pred CCCCCCEEeCCCCCeEEeecccc
Q 010624 153 DVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 153 DIKp~NILld~~g~vKL~DFGls 175 (506)
|+.|.||+++.++ +.++||+.+
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhc
Confidence 9999999999888 999999964
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.7e-06 Score=92.70 Aligned_cols=138 Identities=25% Similarity=0.341 Sum_probs=90.6
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh---hh------------------------------HH------HH
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR---TD------------------------------LD------SI 73 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~---~~------------------------------~~------~~ 73 (506)
..|+.++-|.||+|.. .+|+.||||+.+.+-.. .+ .+ .+
T Consensus 131 ~PiAsASIaQVH~A~L--~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVL--KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEe--cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 5689999999999999 45899999997432210 00 01 23
Q ss_pred HHHHHHHhhCC-----CCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHHHC
Q 010624 74 RRETKTMSLLS-----HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA-LSYLHNQ 147 (506)
Q Consensus 74 ~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~g-L~yLHs~ 147 (506)
++|...+.++. .|+|.-..-+++-.+.-.++|||+.|..+.++..-. ..+++...+.. .++++ +.-+=..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-~~g~d~k~ia~---~~~~~f~~q~~~d 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-SAGIDRKELAE---LLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-hcCCCHHHHHH---HHHHHHHHHHHhc
Confidence 44555555442 344433333333345567999999999999885332 24555433333 33322 2223348
Q ss_pred CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 148 GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 148 givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
|++|.|..|.||+++.+|.+.+.|||+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCccee
Confidence 99999999999999999999999999843
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.3e-06 Score=81.22 Aligned_cols=135 Identities=20% Similarity=0.197 Sum_probs=93.1
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh------------------hh-----HHHHHHHHHHHhhCCC--C
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR------------------TD-----LDSIRRETKTMSLLSH--P 86 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~------------------~~-----~~~~~~Ei~il~~l~H--p 86 (506)
...|..|--+.||+|.. .++..+|+|++...... .+ ..-.++|+.-|+++.. -
T Consensus 53 ~g~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 53 VGCISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred EeeecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 34677888899999976 56789999998543210 01 1224568888887753 3
Q ss_pred CceeeeeEEEeCCEEEEEeccCCCCC-HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCC
Q 010624 87 NILNAHCSFSVDSRLWVVMPFMSCGS-LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 87 nIv~l~~~~~~~~~~~lV~Ey~~ggs-L~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~ 164 (506)
.+.+.+.++. -.+||||+.... -.-.++. -++....+..+..++++.+.-|-. .++||+||+.-|||+. +
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 4445555443 359999986431 1111111 123333688888999999988866 8999999999999998 8
Q ss_pred CCeEEeeccccc
Q 010624 165 GSVKLADFGVSA 176 (506)
Q Consensus 165 g~vKL~DFGls~ 176 (506)
+.+.|+|||-|.
T Consensus 203 ~~p~iID~~QaV 214 (268)
T COG1718 203 GEPYIIDVSQAV 214 (268)
T ss_pred CeEEEEECcccc
Confidence 899999999754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.6e-06 Score=79.73 Aligned_cols=78 Identities=15% Similarity=0.235 Sum_probs=56.6
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeeeEEE---eCCEEEEEec
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHCSFS---VDSRLWVVMP 106 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~---~~~~~~lV~E 106 (506)
++.|+.|..+.||++.. .+ ..+++|..... .....+.+|..+++.+.... +.+++.+.. .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~--~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT--DD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEE--TT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEE--CC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 56799999999999877 33 58999986432 34567788999988886443 455665443 3346899999
Q ss_pred cCCCCCHHH
Q 010624 107 FMSCGSLQS 115 (506)
Q Consensus 107 y~~ggsL~~ 115 (506)
|++|.++..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 999998877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.1e-06 Score=79.96 Aligned_cols=75 Identities=17% Similarity=0.185 Sum_probs=52.3
Q ss_pred ecccCC-eeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEeccCCCCC
Q 010624 35 IGVGVS-AIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 35 IG~G~f-g~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
|-.|.+ +.||++.. ++..+.+|+..... ...+.+|+.+++.+. +--+.+++++...++..++||++++|.+
T Consensus 6 ~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 6 VTEGQSGATVYRLDG---KNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred cCCCCCcCeEEEEcC---CCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 444555 88998854 34678888864332 235668999988875 3345567777777677899999999987
Q ss_pred HHHH
Q 010624 113 LQSI 116 (506)
Q Consensus 113 L~~~ 116 (506)
|...
T Consensus 79 l~~~ 82 (244)
T cd05150 79 AAAL 82 (244)
T ss_pred HhHh
Confidence 7643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.6e-05 Score=89.29 Aligned_cols=80 Identities=11% Similarity=0.192 Sum_probs=57.0
Q ss_pred EeeecccCCeeEEEEEEeCCCC--eEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCc--eeeeeEEEeC---CEEEE
Q 010624 32 LDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNI--LNAHCSFSVD---SRLWV 103 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~--~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~~l 103 (506)
++.++.|.+..+|+.... .++ ..+++|+............+.+|+.+|+.+. |++| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~-~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVG-NGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEEC-CCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 677899999999997652 221 4677777644332223356789999999996 6765 6677777654 46789
Q ss_pred EeccCCCCC
Q 010624 104 VMPFMSCGS 112 (506)
Q Consensus 104 V~Ey~~ggs 112 (506)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00011 Score=69.22 Aligned_cols=128 Identities=23% Similarity=0.316 Sum_probs=90.9
Q ss_pred CCCCeeEEeeecccCC-eeEEEEEEeCCCCeEEEEEEecc---CC--------C--h-------hhHHHHHHHHHHHhhC
Q 010624 25 DPSSYKILDEIGVGVS-AIVYKAICIPMDSTVVAIKAIDL---DQ--------S--R-------TDLDSIRRETKTMSLL 83 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~f-g~Vyka~~~~~~~~~vAIK~i~~---~~--------~--~-------~~~~~~~~Ei~il~~l 83 (506)
...+++.++.||.|.- |.||++.. +|..+|+|++.. .. . . ...+.|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 3489999999999999 99999976 678999999321 11 0 0 1234566777776655
Q ss_pred C---CCCc--eeeeeEEEeC------------------CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q 010624 84 S---HPNI--LNAHCSFSVD------------------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140 (506)
Q Consensus 84 ~---HpnI--v~l~~~~~~~------------------~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~g 140 (506)
+ +.++ |+++++..-. ....||.||+.... .+ ...-+.+|++-
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~d 176 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRD 176 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHH
Confidence 4 5566 8898887322 12457777765333 12 23345678888
Q ss_pred HHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 141 L~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+..+|..||+-+|+++.|.. .=||+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 89999999999999999988 2389999863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.7e-05 Score=70.10 Aligned_cols=128 Identities=23% Similarity=0.294 Sum_probs=93.0
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCC---------------ChhhHHHHHHHHHHHhhCC------CCCceee
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ---------------SRTDLDSIRRETKTMSLLS------HPNILNA 91 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~---------------~~~~~~~~~~Ei~il~~l~------HpnIv~l 91 (506)
..||+|+.-.||.- + ......||+..... ........++|+.....+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~H---P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEEC---C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 46999999999953 2 34567899887654 1122456667777766666 7889999
Q ss_pred eeEEEeCCEEEEEeccCCC------CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-
Q 010624 92 HCSFSVDSRLWVVMPFMSC------GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD- 164 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~g------gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~- 164 (506)
+++.+++-.+.+|+|.+.. .+|.+++.. ..++. . +...+-+-..||-+++|+.+|++|.||++..+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 9999999888999997632 378888865 45665 3 33333455578889999999999999998743
Q ss_pred -C--CeEEee
Q 010624 165 -G--SVKLAD 171 (506)
Q Consensus 165 -g--~vKL~D 171 (506)
+ .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.8e-05 Score=68.24 Aligned_cols=133 Identities=18% Similarity=0.251 Sum_probs=92.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..-.-+..+.||+|.+|.||++.+. |..+|+|+-..+. ....+..|+++|..+...++-.=...+.. .++.
T Consensus 20 ~~~~~~v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~ 90 (201)
T COG2112 20 GKYELRVEKELAKGTTSVVYLGEWR---GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIR 90 (201)
T ss_pred cchhhhhhhhhhcccccEEEEeecc---CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEech---hhhh
Confidence 3334556788999999999999873 5589999865443 34567799999999988777653323322 2356
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCC--CCEEeCCCCCeEEeeccccc
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKA--GNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp--~NILld~~g~vKL~DFGls~ 176 (506)
|||+.|-+|.++-... + +.-+..+++.---|-..||-|+.|.- .||++ .++.+.|+||..|.
T Consensus 91 me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-cCCcEEEEEccchh
Confidence 9999988887766431 1 33444556665556778999999974 45555 55599999998743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.82 E-value=9.6e-05 Score=79.29 Aligned_cols=136 Identities=21% Similarity=0.251 Sum_probs=84.9
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh---h---------------------------HHH------HHHH
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT---D---------------------------LDS------IRRE 76 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~---~---------------------------~~~------~~~E 76 (506)
+.||.-+.|.||+|..+ +|+.||||+-+..-... + .+. |.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 56999999999999984 58999999854221100 0 011 2223
Q ss_pred HHHHhh----CCCCC------ceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHH
Q 010624 77 TKTMSL----LSHPN------ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL-SYLH 145 (506)
Q Consensus 77 i~il~~----l~Hpn------Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL-~yLH 145 (506)
.+-..+ +.|-+ |.++|..+. ....++||||+|..+.|+-.- ...+++...+.. .+.++. .-|=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~---~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAI-DKRGISPHDILN---KLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHH-HHcCCCHHHHHH---HHHHHHHHHHH
Confidence 322222 23444 444443333 346799999999977665321 124566654443 333332 2233
Q ss_pred HCCCccCCCCCCCEEeCC----CCCeEEeeccccc
Q 010624 146 NQGHLHRDVKAGNILSDS----DGSVKLADFGVSA 176 (506)
Q Consensus 146 s~givHrDIKp~NILld~----~g~vKL~DFGls~ 176 (506)
..|++|.|=.|.||++.. ++.+.+-|||+..
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 568999999999999994 6689999999843
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0001 Score=71.47 Aligned_cols=73 Identities=8% Similarity=0.161 Sum_probs=45.0
Q ss_pred eeecccCCe-eEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCC---CceeeeeEEEeC---CEEEEEe
Q 010624 33 DEIGVGVSA-IVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP---NILNAHCSFSVD---SRLWVVM 105 (506)
Q Consensus 33 ~~IG~G~fg-~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lV~ 105 (506)
+.|+.|+.. .||+. + ..+++|..... .....+.+|..++..+... -+.++++..... ...|++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~-~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----G-DDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----C-CceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 457777776 58875 1 24667864432 2235788999999888632 233444433322 2458999
Q ss_pred ccCCCCCHH
Q 010624 106 PFMSCGSLQ 114 (506)
Q Consensus 106 Ey~~ggsL~ 114 (506)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00032 Score=67.72 Aligned_cols=76 Identities=14% Similarity=0.212 Sum_probs=48.1
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEEEEEeccCCC
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~g 110 (506)
++.|..|-...+|++......+..|++|+...... . .-...+|+.+++.+...+++ ++++.+. + .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-L-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-c-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence 45688899999999865210246788997653321 1 12234788888888644443 4444332 2 379999998
Q ss_pred CCH
Q 010624 111 GSL 113 (506)
Q Consensus 111 gsL 113 (506)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00018 Score=70.64 Aligned_cols=134 Identities=16% Similarity=0.189 Sum_probs=76.9
Q ss_pred eecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEEEEEeccCCCCC
Q 010624 34 EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRLWVVMPFMSCGS 112 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~ggs 112 (506)
.+..|-...+|+... ++..+++|........-.. ...+|..+++.+...++. +++... . -++||||++|..
T Consensus 3 ~~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEEe---CCccEEEeeCCcccccccC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 356788899998753 4667888875433211111 246788999988754443 333332 2 268999999876
Q ss_pred HHH--------------HH---HhhC--CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCccCCCC
Q 010624 113 LQS--------------II---SSCF--PDGLPE-PCIAIVLKET---------LSALSYLHN--------QGHLHRDVK 155 (506)
Q Consensus 113 L~~--------------~i---~~~~--~~~l~e-~~i~~i~~qi---------l~gL~yLHs--------~givHrDIK 155 (506)
+.. .+ +... ..+++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 531 11 1110 111221 1222222222 111222222 247999999
Q ss_pred CCCEEeCCCCCeEEeeccccc
Q 010624 156 AGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 156 p~NILld~~g~vKL~DFGls~ 176 (506)
|.||+++.++ +.|+||..|.
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCcEEEeCCC-CEEEeccccC
Confidence 9999999877 7899998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=1.1e-05 Score=93.21 Aligned_cols=162 Identities=11% Similarity=0.096 Sum_probs=118.8
Q ss_pred hhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEEEEeccCCCCCHHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHH
Q 010624 68 TDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLWVVMPFMSCGSLQSIISSCFPD--GLPEPCIAIVLKETLSALSY 143 (506)
Q Consensus 68 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~~i~~~~~~--~l~e~~i~~i~~qil~gL~y 143 (506)
...+....|..-++...|+++...+.-... ....|..++|+.+|.++++|.+.... .++...+.....+.+.+..-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 334455566666777889998876544432 34578999999999999999764322 24444455555555777777
Q ss_pred HHHC-C----CccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCcccc
Q 010624 144 LHNQ-G----HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKAD 218 (506)
Q Consensus 144 LHs~-g----ivHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sD 218 (506)
+|+. + .+|+++|+.|.+|..+-.||++++|+... ............+++.|++|++.+.-. ++.++|
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKI-------knp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsd 1422 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKI-------KNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSD 1422 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCcccccccccccc-------cCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHH
Confidence 7764 2 58999999999999999999999999541 112223345566788999999987544 788899
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q 010624 219 IWSFGITALELAHGRPPLS 237 (506)
Q Consensus 219 IwSlGiil~eLltG~~Pf~ 237 (506)
+|+.|+.+|....|.++|-
T Consensus 1423 ilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1423 ILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHHHhcccHHHH
Confidence 9999999999999988874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00019 Score=67.26 Aligned_cols=96 Identities=24% Similarity=0.197 Sum_probs=77.7
Q ss_pred HHHHHHhhCCC-CCceeeeeEEEeCCEEEEEeccCCCCCHHHH---HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 010624 75 RETKTMSLLSH-PNILNAHCSFSVDSRLWVVMPFMSCGSLQSI---ISSCFPDGLPEPCIAIVLKETLSALSYLHN---Q 147 (506)
Q Consensus 75 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~---i~~~~~~~l~e~~i~~i~~qil~gL~yLHs---~ 147 (506)
.|.-+|+.+.+ +++++++|++- .+++.||...+++... +.. -...+|..+..|+.++++.+.+++. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888898886 69999999983 2578999987776532 111 1236899999999999999999987 3
Q ss_pred CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 148 GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 148 givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.+.-.|++|+|+-++.+|.+|++|.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 47889999999999999999999998643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=67.10 Aligned_cols=142 Identities=18% Similarity=0.175 Sum_probs=82.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeeeE------EEeCC
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHCS------FSVDS 99 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~ 99 (506)
....++.++.|....+|++.. .++ .+++|+...... .+.+..|+.++..|...+ +.+++.. ....+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t--~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT--DVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred CceeccccCCccccceEEEEe--CCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 355577788888899998754 344 577887654322 234556777777764222 3343321 12356
Q ss_pred EEEEEeccCCCCCHH--------H---H---HHhh---CCCC------CC-HHH--HH----------HHHHHHHHHHHH
Q 010624 100 RLWVVMPFMSCGSLQ--------S---I---ISSC---FPDG------LP-EPC--IA----------IVLKETLSALSY 143 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~--------~---~---i~~~---~~~~------l~-e~~--i~----------~i~~qil~gL~y 143 (506)
..+++++|++|.++. . . ++.. +... ++ +.. .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 789999999985431 1 1 1111 1000 00 000 00 011123334555
Q ss_pred HHH-------CCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 144 LHN-------QGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 144 LHs-------~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+.. .+++|+|+.+.||+++.++.+.|+||+.+
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 542 57999999999999998887799999973
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=8e-05 Score=74.20 Aligned_cols=133 Identities=19% Similarity=0.211 Sum_probs=97.7
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-----------------hhh----HHHHHHHHHHHhhCC-C
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-----------------RTD----LDSIRRETKTMSLLS-H 85 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-----------------~~~----~~~~~~Ei~il~~l~-H 85 (506)
-|.+.+.||-|--+-||.+.+ ..|++.++|+-++... ... +-...+|+..|+.|. |
T Consensus 93 v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhccccccccccceEEEec--CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 467789999999999999988 5789999997543221 000 123457888888885 3
Q ss_pred CC-ceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC
Q 010624 86 PN-ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 86 pn-Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~ 164 (506)
.. |.+.++ -+..++|||++.|..|..+-+- ..+..+...+..-+.-|..+|+||+|..--||+|+.+
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 22 233332 2456799999999888765432 1234566677777888999999999999999999999
Q ss_pred CCeEEeeccc
Q 010624 165 GSVKLADFGV 174 (506)
Q Consensus 165 g~vKL~DFGl 174 (506)
+.++++||--
T Consensus 239 ~~i~vIDFPQ 248 (465)
T KOG2268|consen 239 DKIVVIDFPQ 248 (465)
T ss_pred CCEEEeechH
Confidence 9999999964
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0016 Score=65.27 Aligned_cols=138 Identities=17% Similarity=0.181 Sum_probs=83.5
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeee------EEEeCCEEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHC------SFSVDSRLW 102 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~ 102 (506)
-.+.|..|....+|++.. ++..+++|+... ...+.+..|+.++..+.+.+ +.+++. +...++..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT---DSGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe---CCCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 366788898899998754 334688898753 22345667888888775433 344432 223456778
Q ss_pred EEeccCCCCCHHH--------H------HHhh---CCCC------CCHHHH----------HHHHHHHHHHHHHHHH---
Q 010624 103 VVMPFMSCGSLQS--------I------ISSC---FPDG------LPEPCI----------AIVLKETLSALSYLHN--- 146 (506)
Q Consensus 103 lV~Ey~~ggsL~~--------~------i~~~---~~~~------l~e~~i----------~~i~~qil~gL~yLHs--- 146 (506)
+|++|++|.++.. + ++.. +... ..+... ......+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 1 1110 0000 011000 0011112334444443
Q ss_pred ----CCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 147 ----QGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 147 ----~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.+++|+|+.|.||+++.++.+.|+||+.+
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 46899999999999998877899999863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.004 Score=63.14 Aligned_cols=137 Identities=17% Similarity=0.235 Sum_probs=75.0
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeee------EEEeCCEEEE
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHC------SFSVDSRLWV 103 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~l 103 (506)
.+.|+.|....+|+... .+| .+++|++. ... .+.+..|+.++..|...+ +.+++. +....+..++
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred cchhccccccceEEEEe--CCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 45677888889998865 334 68889875 212 233444555555553222 233331 2234667899
Q ss_pred EeccCCCCCHH-----------HHH---Hhh---CCC------CCCH-HHH------------HHHHHHHH-HHHHHHH-
Q 010624 104 VMPFMSCGSLQ-----------SII---SSC---FPD------GLPE-PCI------------AIVLKETL-SALSYLH- 145 (506)
Q Consensus 104 V~Ey~~ggsL~-----------~~i---~~~---~~~------~l~e-~~i------------~~i~~qil-~gL~yLH- 145 (506)
+++|++|..+. ..+ +.. +.. .+.+ ... ...+.+.+ ..+..+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999987431 111 110 000 0101 110 01111111 1222332
Q ss_pred ------HCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 146 ------NQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 146 ------s~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
..+++|+|+.|.||+++.+...-|+||+.+
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 237999999999999986655689999974
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0033 Score=65.72 Aligned_cols=77 Identities=19% Similarity=0.144 Sum_probs=54.3
Q ss_pred EeeecccCCeeEEEEEEeCCCC-eEEEEEEeccC-----CC-hhhHHHHHHHHHHHhhCC---CCCceeeeeEEEeCCEE
Q 010624 32 LDEIGVGVSAIVYKAICIPMDS-TVVAIKAIDLD-----QS-RTDLDSIRRETKTMSLLS---HPNILNAHCSFSVDSRL 101 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~-~~vAIK~i~~~-----~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 101 (506)
.+.||.|.+..||++.. .+| +.++||.-... .. +...++...|...|+.+. ..++++++.+ +....
T Consensus 31 ~~elggGn~N~VyrV~~--~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSD--TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEe--CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 56799999999999987 344 57999985321 11 234567788888888763 3456667666 33557
Q ss_pred EEEeccCCCCC
Q 010624 102 WVVMPFMSCGS 112 (506)
Q Consensus 102 ~lV~Ey~~ggs 112 (506)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999998644
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0029 Score=63.72 Aligned_cols=79 Identities=8% Similarity=-0.045 Sum_probs=55.6
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC---CCceeeeeEEEe---CCEEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH---PNILNAHCSFSV---DSRLW 102 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~ 102 (506)
-.-.+.||.|..+.||.... .++ .+.+|..+. ......+.+|...|+.+.. -.|.++++.+.. .+..+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~--~~~-~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD--SQG-NPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hheeeecCCccceeEEEEEc--CCC-CEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34466799999999998754 334 466776432 1123577899999988853 356778877654 36689
Q ss_pred EEeccCCCCCH
Q 010624 103 VVMPFMSCGSL 113 (506)
Q Consensus 103 lV~Ey~~ggsL 113 (506)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0013 Score=66.16 Aligned_cols=77 Identities=19% Similarity=0.195 Sum_probs=49.0
Q ss_pred EeeecccCCeeEEEEEEeC-----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEEEEEe
Q 010624 32 LDEIGVGVSAIVYKAICIP-----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRLWVVM 105 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~-----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~ 105 (506)
++.+..|-...||++.... ..+..+++|+..... .......+|..+++.+...++. ++++++. + .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 4567788888999886521 114688999865432 1223456888888888644443 4555553 2 3689
Q ss_pred ccCCCCCHH
Q 010624 106 PFMSCGSLQ 114 (506)
Q Consensus 106 Ey~~ggsL~ 114 (506)
+|++|.++.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0013 Score=69.25 Aligned_cols=173 Identities=23% Similarity=0.241 Sum_probs=104.9
Q ss_pred HHHHHHHHHHHhhCCCCCceeeeeEEEeC-CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010624 70 LDSIRRETKTMSLLSHPNILNAHCSFSVD-SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148 (506)
Q Consensus 70 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g 148 (506)
...+.-...+++.+.|+|....+++-... .+..+|||++ +.||+++..... +-... +. .++
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s---~~-----------~~~ 87 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDES---LL-----------AHG 87 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhh---hc-----------ccc
Confidence 34566788899999999999887776543 3578999999 589999987632 11111 00 122
Q ss_pred CccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHH
Q 010624 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE 228 (506)
Q Consensus 149 ivHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~e 228 (506)
+.|- +.++.+|- +. |- | |-. .++++||||+|.++.+
T Consensus 88 ~~~~------------~~~~~td~-~~----------------------t~-~--~~~------~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 88 VLHL------------NIIYITDH-FL----------------------TK-Y--PSP------IGPKSDVWSLGFIILE 123 (725)
T ss_pred ccee------------hhhhcccc-cc----------------------cc-C--CCC------CCcchhhhhHHHHHHH
Confidence 2221 12333440 00 00 1 100 2249999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhhcccccchhh-hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK-TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 229 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+.-|..-+......+...... .-+..+.... ..........++..+..+..+|+-..|..||...++.+++-|...
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~-k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILL-KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHH-HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 999877665444333322211 1111111100 000111234467778899999999999999999999999988754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0043 Score=63.13 Aligned_cols=139 Identities=19% Similarity=0.220 Sum_probs=94.8
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-----------------------ChhhHH--HHHHHHHHHhhCC
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-----------------------SRTDLD--SIRRETKTMSLLS 84 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-----------------------~~~~~~--~~~~Ei~il~~l~ 84 (506)
.|-..|..|--+.||.|.. .+|..+|||++..+- .+..+- -...|++-|++++
T Consensus 147 ~inGCiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred ecccccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 3445678899999999976 678889999874210 011111 2336888888888
Q ss_pred CCCceeeeeEEEeCCEEEEEeccCCCCCH-HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCccCCCCCCCEEeC
Q 010624 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYL-HNQGHLHRDVKAGNILSD 162 (506)
Q Consensus 85 HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL-~~~i~~~~~~~l~e~~i~~i~~qil~gL~yL-Hs~givHrDIKp~NILld 162 (506)
...|.-.--+.. .+ ..|||+|+.+-.. .-.++ ...++...+..+-.+++.-+.-| |..++||.||.--|+|+
T Consensus 225 ~aGIP~PePIlL-k~-hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 225 NAGIPCPEPILL-KN-HVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY- 298 (520)
T ss_pred hcCCCCCCceee-ec-ceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-
Confidence 766544332222 22 3599999953221 11122 24577778888888888888777 55689999999999999
Q ss_pred CCCCeEEeeccccc
Q 010624 163 SDGSVKLADFGVSA 176 (506)
Q Consensus 163 ~~g~vKL~DFGls~ 176 (506)
.+|.+.++|-+-|.
T Consensus 299 hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSV 312 (520)
T ss_pred ECCEEEEEEccccc
Confidence 56799999998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0051 Score=61.30 Aligned_cols=29 Identities=31% Similarity=0.472 Sum_probs=23.9
Q ss_pred CCccCCCCCCCEEeCCCCC-eEEeeccccc
Q 010624 148 GHLHRDVKAGNILSDSDGS-VKLADFGVSA 176 (506)
Q Consensus 148 givHrDIKp~NILld~~g~-vKL~DFGls~ 176 (506)
.++|+|++|.||+++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3799999999999997555 5699999743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0043 Score=62.74 Aligned_cols=146 Identities=15% Similarity=0.163 Sum_probs=83.8
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeeeEEEeCC--EEEEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHCSFSVDS--RLWVV 104 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~--~~~lV 104 (506)
-.+++.+-.|..-.+|.... +++.++++.-.............+|+.+++.+.--- +...++.+.++. ..|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~---~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD---TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec---CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 44556665566666666554 367788882211223334456678888888776422 233455665554 77999
Q ss_pred eccCCCCCHHHHHHh------------------h---C---------CCCCCHHHHHHHHHHH--------------HHH
Q 010624 105 MPFMSCGSLQSIISS------------------C---F---------PDGLPEPCIAIVLKET--------------LSA 140 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~------------------~---~---------~~~l~e~~i~~i~~qi--------------l~g 140 (506)
|+|+.|..+.+.... . . +.......+..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999998433221111 0 0 0001111122222222 112
Q ss_pred HHHHHHC--------CCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 141 LSYLHNQ--------GHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 141 L~yLHs~--------givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
..+++.+ .++|+|+.+.|++++..+-+-+.||+++..
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 3344332 379999999999999988899999998654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.016 Score=59.66 Aligned_cols=76 Identities=18% Similarity=0.163 Sum_probs=49.0
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEec----c-C-CChhhHHHHHHHHHHHhhCC--CC-CceeeeeEEEeCCEEEE
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAID----L-D-QSRTDLDSIRRETKTMSLLS--HP-NILNAHCSFSVDSRLWV 103 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~----~-~-~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~l 103 (506)
+.||.|....||++.+ +.+++.|+||.-. . . .-+...++.+-|...|+... -| .+.+++ +| ++....+
T Consensus 1 ~EigdGnlN~VfrV~~-~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~-D~e~~~~ 77 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYD-QEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HF-DTEMAVT 77 (370)
T ss_pred CcCCCCceEEEEEEEc-CCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EE-cccccee
Confidence 3589999999999987 2333679999742 1 1 12344566777888887764 34 344443 33 3444569
Q ss_pred EeccCCCC
Q 010624 104 VMPFMSCG 111 (506)
Q Consensus 104 V~Ey~~gg 111 (506)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.019 Score=59.19 Aligned_cols=145 Identities=18% Similarity=0.199 Sum_probs=83.5
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC---CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP---MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSR 100 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~---~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~ 100 (506)
..+...+ ..|-.|-+-.+|++.... ..+..|++|+..... ....++ .+|..+++.+..-++. ++++.+..+
T Consensus 35 ~~~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 35 DDEALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcCcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 3344444 455569999999986421 123678999875432 222222 5788888888755554 455665432
Q ss_pred EEEEeccCCCCCHHHH-----------------HHhhC-CC---CCCHHHHHHHHHHHH-----------------HHHH
Q 010624 101 LWVVMPFMSCGSLQSI-----------------ISSCF-PD---GLPEPCIAIVLKETL-----------------SALS 142 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~-----------------i~~~~-~~---~l~e~~i~~i~~qil-----------------~gL~ 142 (506)
.|.+|++|.+|... ++... .. ......+..++.++. ..+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 57899887665311 11110 00 111233334432221 1111
Q ss_pred HH----HH----CCCccCCCCCCCEEeCC-CCCeEEeeccccc
Q 010624 143 YL----HN----QGHLHRDVKAGNILSDS-DGSVKLADFGVSA 176 (506)
Q Consensus 143 yL----Hs----~givHrDIKp~NILld~-~g~vKL~DFGls~ 176 (506)
.| .+ ..++|+|+++.||+++. ++.+.++||..+.
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12 21 24699999999999986 5789999998743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.039 Score=55.53 Aligned_cols=27 Identities=33% Similarity=0.469 Sum_probs=24.2
Q ss_pred CCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 147 QGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 147 ~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
.+++|+|+.+.||+++. +.+.|+||+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~ 213 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDY 213 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcc
Confidence 47899999999999987 6789999985
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.03 Score=57.34 Aligned_cols=143 Identities=14% Similarity=0.239 Sum_probs=80.9
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRLWV 103 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~l 103 (506)
+..++ +.|..|-+..+|++.....+ +..|++|+...... ... .-.+|..+++.+..-++- ++++++. .+ +
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 44444 44555899999998653221 23788998754322 111 224788888888765554 4555553 22 5
Q ss_pred EeccCCCCCHHH--------------HHHhhCCCC------C-CHHHHHHHHHHH----------------------HHH
Q 010624 104 VMPFMSCGSLQS--------------IISSCFPDG------L-PEPCIAIVLKET----------------------LSA 140 (506)
Q Consensus 104 V~Ey~~ggsL~~--------------~i~~~~~~~------l-~e~~i~~i~~qi----------------------l~g 140 (506)
|.+|++|.+|.. .+....... . .+..+..++.++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 899998765421 111110000 1 123333333222 111
Q ss_pred HHH----HHHCC----CccCCCCCCCEEeCC-CCCeEEeeccccc
Q 010624 141 LSY----LHNQG----HLHRDVKAGNILSDS-DGSVKLADFGVSA 176 (506)
Q Consensus 141 L~y----LHs~g----ivHrDIKp~NILld~-~g~vKL~DFGls~ 176 (506)
+.. +.+.+ .+|.|+.|.|||++. ++.++++||..|.
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 211 11222 589999999999974 5789999999754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.086 Score=53.30 Aligned_cols=28 Identities=14% Similarity=0.185 Sum_probs=26.0
Q ss_pred CCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 148 GHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 148 givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+++|+|+.++|+|++.++.+.++||..+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 6899999999999999999999999864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.06 Score=56.38 Aligned_cols=75 Identities=13% Similarity=0.067 Sum_probs=51.4
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC---C---hhhHHHHHHHHHHHhhCC---CCCceeeeeEEEeCCEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ---S---RTDLDSIRRETKTMSLLS---HPNILNAHCSFSVDSRL 101 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~---~---~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 101 (506)
-.+.||.|....||+..+ .+..++||.-.... + +...++...|...|+.+. ..++.+++.+..+ ..
T Consensus 36 ~~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CC
Confidence 377899999999999876 23468899854211 1 124555566777777664 2477778777763 35
Q ss_pred EEEeccCCC
Q 010624 102 WVVMPFMSC 110 (506)
Q Consensus 102 ~lV~Ey~~g 110 (506)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 688999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.045 Score=57.06 Aligned_cols=76 Identities=21% Similarity=0.234 Sum_probs=51.0
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEec----cCCC-hhhHHHHHHHHHHHhhCC--CCC-ceeeeeEEEeCCEEEE
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAID----LDQS-RTDLDSIRRETKTMSLLS--HPN-ILNAHCSFSVDSRLWV 103 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~----~~~~-~~~~~~~~~Ei~il~~l~--Hpn-Iv~l~~~~~~~~~~~l 103 (506)
.+.||.|.-..||++.+. .++..|+||.-. ...+ +...++.+-|..+|+... -|. +.+++. | ++....+
T Consensus 34 ~~eigdGnlN~VfrV~~~-~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDE-QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeC-CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhH
Confidence 778999999999999872 234578898742 1111 445677788888888765 343 444443 3 3344568
Q ss_pred EeccCCC
Q 010624 104 VMPFMSC 110 (506)
Q Consensus 104 V~Ey~~g 110 (506)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 9999864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.36 Score=56.85 Aligned_cols=139 Identities=20% Similarity=0.303 Sum_probs=76.9
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-------CCCceee-----eeEEEe-CC
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-------HPNILNA-----HCSFSV-DS 99 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-------HpnIv~l-----~~~~~~-~~ 99 (506)
+.|+ |..-.+|++.. .++..+++|+.+..... ..+..|...|..|. -|.+++- +..... ++
T Consensus 31 ~~L~-s~~d~nf~v~~--~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G 104 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT--DDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG 104 (1013)
T ss_pred eecC-CcCCceEEEEe--CCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence 5565 45688888765 45778999998754322 23334555555442 2333331 111222 22
Q ss_pred --EEEEEeccCCCCCHHHH-----------------HHh---hCCC-----CCCH-----------------HHHHHHHH
Q 010624 100 --RLWVVMPFMSCGSLQSI-----------------ISS---CFPD-----GLPE-----------------PCIAIVLK 135 (506)
Q Consensus 100 --~~~lV~Ey~~ggsL~~~-----------------i~~---~~~~-----~l~e-----------------~~i~~i~~ 135 (506)
+.+.+++|++|..+.+. ++. .+.. .+.| ...+.++.
T Consensus 105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~ 184 (1013)
T PRK06148 105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE 184 (1013)
T ss_pred ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence 57789999999877551 000 0110 0111 11122333
Q ss_pred HHHHHHHH-----HH--HCCCccCCCCCCCEEeCCCC--CeE-Eeecccccc
Q 010624 136 ETLSALSY-----LH--NQGHLHRDVKAGNILSDSDG--SVK-LADFGVSAS 177 (506)
Q Consensus 136 qil~gL~y-----LH--s~givHrDIKp~NILld~~g--~vK-L~DFGls~~ 177 (506)
+++..+.- +. ..++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 185 ~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 185 RFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 33333221 21 14799999999999999775 555 999997543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.25 Score=49.57 Aligned_cols=76 Identities=13% Similarity=0.182 Sum_probs=47.1
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC---CCCceeeeeEEEeCCEEEEEe
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---HPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~ 105 (506)
-+-.+.|+.|....+|+.. .++..+.+|+-. ......+..|..-|+.|. --.+.+++++....+..|+||
T Consensus 19 i~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD---TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp --EEEEE--SSSSEEEEEE---TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeeEecCCCChhheEEEE---CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 4456778999999999865 567789999865 223345677888887773 445777888887777779999
Q ss_pred ccCCCC
Q 010624 106 PFMSCG 111 (506)
Q Consensus 106 Ey~~gg 111 (506)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.092 Score=50.19 Aligned_cols=100 Identities=17% Similarity=0.136 Sum_probs=65.3
Q ss_pred EEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHH
Q 010624 56 VAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135 (506)
Q Consensus 56 vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~ 135 (506)
..+|++......-...-++.+.+++.+++ .|+++..= ....+.++.|+|-.... +. ..++.
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFIT 148 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHH
Confidence 34444443322223445678888988886 47777622 34457789999852111 11 11122
Q ss_pred HHHHHHHHHHHC--CCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 136 ETLSALSYLHNQ--GHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 136 qil~gL~yLHs~--givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
-=+.+|.-.|+. +.+|+|-.|+||+-|+.|.+||.|-+.
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 224677778953 689999999999999999999999885
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.19 Score=52.51 Aligned_cols=81 Identities=15% Similarity=0.209 Sum_probs=48.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCe-----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDST-----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~-----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~ 101 (506)
...-++.|..|-...+|++......+. .|.++..... ..... .-.+|+.+++.+...++- ++++.|..
T Consensus 51 ~~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 51 EFIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred ccEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 334455676799999999865221112 2444442211 11111 224789999999866664 46666642
Q ss_pred EEEeccCCCCCHH
Q 010624 102 WVVMPFMSCGSLQ 114 (506)
Q Consensus 102 ~lV~Ey~~ggsL~ 114 (506)
+++.||++|.+|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5999999987653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.18 Score=51.50 Aligned_cols=134 Identities=19% Similarity=0.187 Sum_probs=78.5
Q ss_pred ecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc------eee----eeEEEeCCEEEEE
Q 010624 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI------LNA----HCSFSVDSRLWVV 104 (506)
Q Consensus 35 IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI------v~l----~~~~~~~~~~~lV 104 (506)
|.+ .-..||+... .+|.. ++|+.... .....+..|+..|..|.-.+| ..+ +.....+.+.+.+
T Consensus 34 l~s-~eN~~f~~~~--~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 34 LNS-EENSNFRVQT--EDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred ccc-ccCceEEEEe--cCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 444 5677888766 44544 89988654 234566678888877753222 111 1122222488899
Q ss_pred eccCCCCCHHH-----H----------HHhh---CC--C-----CCCHH----H---------HHHHHHHHHHHHHHHHH
Q 010624 105 MPFMSCGSLQS-----I----------ISSC---FP--D-----GLPEP----C---------IAIVLKETLSALSYLHN 146 (506)
Q Consensus 105 ~Ey~~ggsL~~-----~----------i~~~---~~--~-----~l~e~----~---------i~~i~~qil~gL~yLHs 146 (506)
++|++|..+.. . ++.. ++ . ...|. . -.....++...+..+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999988772 1 1110 11 0 01111 0 01122334444444443
Q ss_pred --------CC--CccCCCCCCCEEeCCCCC-eEEeecccc
Q 010624 147 --------QG--HLHRDVKAGNILSDSDGS-VKLADFGVS 175 (506)
Q Consensus 147 --------~g--ivHrDIKp~NILld~~g~-vKL~DFGls 175 (506)
-+ +||+|+.|.||+++.+.. +.++|||-+
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 23 899999999999998874 999999963
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.8 Score=46.69 Aligned_cols=71 Identities=13% Similarity=0.017 Sum_probs=44.1
Q ss_pred cCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeee---e--EEEeCCEEEEEeccCCC
Q 010624 38 GVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAH---C--SFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 38 G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~---~--~~~~~~~~~lV~Ey~~g 110 (506)
+.-..||++.. .++..+++|+..... .....+..|+..+..|.... |+... + ....++..+.+++|++|
T Consensus 36 s~eN~vy~v~~--~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD--EDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec--CCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 44567898765 456789999875332 23456777888877664221 22211 1 23345678899999987
Q ss_pred CC
Q 010624 111 GS 112 (506)
Q Consensus 111 gs 112 (506)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.15 Score=52.24 Aligned_cols=72 Identities=25% Similarity=0.282 Sum_probs=53.6
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..+.|++|++. |++|. .+.. -...++..++.+-+..++-+..+ ..-||++...||||+ .|+|-|+||-+|.
T Consensus 298 ~~y~yl~~kdh-gt~is-~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-IIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceee-eeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34677788775 34442 2322 34667888888877777777655 578999999999999 9999999999876
Q ss_pred c
Q 010624 177 S 177 (506)
Q Consensus 177 ~ 177 (506)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.14 Score=53.06 Aligned_cols=61 Identities=25% Similarity=0.279 Sum_probs=46.2
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCccCCCCCCCEEeCCC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY-LHNQGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~y-LHs~givHrDIKp~NILld~~ 164 (506)
..++-+|..|.++..+++. ...++...+.++.-.++|+-- |--.+.+|.|+.|.||++-.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4566778999999999886 456666777777777777643 445689999999999998643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.63 Score=44.88 Aligned_cols=78 Identities=15% Similarity=0.226 Sum_probs=51.8
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC---CCCceeeeeEEEeCCEEEEEec
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---HPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+-.+.+.-|-.-..|... .+..++.+|.-. ......+..|+.-|..+. .-.|.++++.-.+..+.|+|||
T Consensus 19 ~er~~v~gG~inea~~v~---dg~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 19 KEREEVSGGDINEAWRLR---DGTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred hcccccCCccccceeEee---cCCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 334445555555555443 456778888632 233456667776666654 4567788899999999999999
Q ss_pred cCCCCCHH
Q 010624 107 FMSCGSLQ 114 (506)
Q Consensus 107 y~~ggsL~ 114 (506)
|.+-+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99876554
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.75 Score=49.01 Aligned_cols=81 Identities=12% Similarity=0.049 Sum_probs=50.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCC-------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPM-------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSV 97 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~ 97 (506)
.++. -++.|..|-+-.+|++..... .++.|.+++...... .-. .-.+|..+++.+..-+|- ++++.+.
T Consensus 105 ~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~- 180 (442)
T PTZ00296 105 EDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-ELY-NPISEFEVYKTMSKYRIAPQLLNTFS- 180 (442)
T ss_pred cccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-cee-CHHHHHHHHHHHHHCCCCCceEEEeC-
Confidence 3444 677788899999999875311 145788998754321 111 234688888887755554 3555553
Q ss_pred CCEEEEEeccCCCCCH
Q 010624 98 DSRLWVVMPFMSCGSL 113 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL 113 (506)
-+.|.+|++|-+|
T Consensus 181 ---gg~I~efi~g~~l 193 (442)
T PTZ00296 181 ---GGRIEEWLYGDPL 193 (442)
T ss_pred ---CCEEEEeeCCccC
Confidence 2467899987643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 506 | ||||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-60 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-60 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-45 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-44 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-44 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-43 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-43 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-42 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-42 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-42 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-41 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-41 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-41 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-41 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-40 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-39 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-39 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-38 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-38 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-38 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-37 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-36 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-35 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-35 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-35 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-35 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-35 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-35 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-34 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-34 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-34 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-32 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-32 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-27 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-26 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-26 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-25 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-25 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-25 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-24 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-24 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-24 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-24 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-24 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-24 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-24 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-23 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-23 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-22 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-22 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-21 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-20 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 |
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 402 bits (1034), Expect = e-139
Identities = 123/304 (40%), Positives = 175/304 (57%), Gaps = 12/304 (3%)
Query: 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+ + + ++ Y++ + IG G +A+V A C P VAIK I+L++ +T +D + +E
Sbjct: 5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKK-EKVAIKRINLEKCQTSMDELLKE 63
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG------LPEPCI 130
+ MS HPNI++ + SF V LW+VM +S GS+ II G L E I
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190
A +L+E L L YLH G +HRDVKAGNIL DGSV++ADFGVSA + +
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
GTP WMAPEV+ GY FKADIWSFGITA+ELA G P PP K L++ +
Sbjct: 184 --KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVE 310
E ++ K+ KK+ ++F+ M++ CL +DP KRP+A +L++H FF+ K E
Sbjct: 242 N--DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA-KNKE 298
Query: 311 FFVK 314
F +
Sbjct: 299 FLQE 302
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 386 bits (992), Expect = e-131
Identities = 103/400 (25%), Positives = 160/400 (40%), Gaps = 49/400 (12%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVS--AIVYKAICIPMDSTVVAI 58
MAHH + + + Y++L IG G V A P V +
Sbjct: 1 MAHHHHHHMENLY--FQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTG-EYVTV 57
Query: 59 KAIDLD-QSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII 117
+ I+L+ S + ++ E L +HPNI+ +F D+ LWVV FM+ GS + +I
Sbjct: 58 RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117
Query: 118 SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177
+ F DG+ E IA +L+ L AL Y+H+ G++HR VKA +IL DG V L+ + S
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVI-RSHTGYSFKADIWSFGITALELAHGRPPL 236
+ W++PEV+ ++ GY K+DI+S GITA ELA+G P
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 237 SHLPPEKSLLMKMT----------------------------------QRFRFSDYEKTL 262
+P + LL K+
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRS 322
++ FS F V CL ++P RPSA L+ HSFFK + + +L +
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTP 357
Query: 323 VEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNF 362
+ +D G +++ + W F
Sbjct: 358 ITNF--------EGSQSQDHSGIFGLVTNLEELEVDDWEF 389
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-113
Identities = 114/343 (33%), Positives = 173/343 (50%), Gaps = 42/343 (12%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIK 59
MAH + + DP + L++IG G V+K I VVAIK
Sbjct: 1 MAHSPVQSGLPGMQNLKA------DPEELFTKLEKIGKGSFGEVFKGIDNR-TQKVVAIK 53
Query: 60 AIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISS 119
IDL+++ +++ I++E +S P + + S+ D++LW++M ++ GS ++
Sbjct: 54 IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE- 112
Query: 120 CFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179
P L E IA +L+E L L YLH++ +HRD+KA N+L G VKLADFGV+ +
Sbjct: 113 --PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL 239
+ GTP+WMAPEVI+ + Y KADIWS GITA+ELA G PP S L
Sbjct: 171 DTQIKR-------NTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSEL 222
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
P K L + TL+ +S+ K+ V +CL+++PS RP+A++L+KH
Sbjct: 223 HPMKVLFLIPKNN------PPTLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271
Query: 300 SFFKNCNKGVEFFVKNVLHGLRSVEERFKESRNHVGAEHHEDE 342
F K + L + +R+K + AE D+
Sbjct: 272 KFILRNAKKTSY--------LTELIDRYKRWK----AEQSHDD 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 6e-98
Identities = 97/295 (32%), Positives = 154/295 (52%), Gaps = 24/295 (8%)
Query: 18 QKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+ ++ LDP+ ++I+ E+G G VYKA + A K I+ +S +L+ E
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIET-KSEEELEDYIVE 66
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+ ++ HP I+ ++ D +LW+++ F G++ +I+ GL EP I +V ++
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQ 125
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L AL++LH++ +HRD+KAGN+L +G ++LADFGVSA +
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-------SFI 178
Query: 197 GTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
GTPYWMAPEV+ T Y +KADIWS GIT +E+A PP L P + LL
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS- 237
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
+ + K+S F+D + LD++P RPSA +L++H F +
Sbjct: 238 -------DPPTLLTPS-KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 2e-96
Identities = 100/326 (30%), Positives = 159/326 (48%), Gaps = 32/326 (9%)
Query: 18 QKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+ P + +L+++G G VYKAI +VAIK + ++ DL I +E
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVES---DLQEIIKE 74
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
M P+++ + S+ ++ LW+VM + GS+ II L E IA +L+
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQS 133
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
TL L YLH +HRD+KAGNIL +++G KLADFGV+ + + +
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-------NTVI 186
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP+WMAPEVI+ GY+ ADIWS GITA+E+A G+PP + + P +++ M T
Sbjct: 187 GTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------ 239
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNV 316
+ + +S F D V CL + P +R +A +L++H F ++
Sbjct: 240 --NPPPTFRKP-ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG--------- 287
Query: 317 LHGLRSVEERFKESRNHVGAEHHEDE 342
+ LR + + + +E
Sbjct: 288 VSILRDLINEAMDVKLKRQESQQREE 313
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 1e-95
Identities = 103/284 (36%), Positives = 147/284 (51%), Gaps = 23/284 (8%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP Y ++IG G S VY A+ + VAI+ ++L Q + I E M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQ-PKKELIINEILVMREN 74
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+PNI+N S+ V LWVVM +++ GSL +++ + E IA V +E L AL +
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEF 131
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH+ +HRD+K+ NIL DGSVKL DFG A I + M GTPYWMA
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMA 184
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEV+ Y K DIWS GI A+E+ G PP + P ++L + T T +
Sbjct: 185 PEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------NGTPE 235
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
+++ +K S F+D + CL+ D KR SA++L++H F K
Sbjct: 236 LQNP-EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 9e-95
Identities = 97/295 (32%), Positives = 141/295 (47%), Gaps = 29/295 (9%)
Query: 18 QKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIR 74
++ + DP + L EIG G VY A + +S VVAIK + QS I
Sbjct: 44 AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 75 RETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
+E + + L HPN + + + W+VM + GS ++ L E IA V
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVT 160
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
L L+YLH+ +HRDVKAGNIL G VKL DFG ++ + + +
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APANS- 209
Query: 195 MAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
GTPYWMAPEVI + Y K D+WS GIT +ELA +PPL ++ +L + Q
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQN 268
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
++ ++ +S F++ V SCL + P RP++E L+KH F
Sbjct: 269 -------ESPALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 4e-94
Identities = 99/325 (30%), Positives = 142/325 (43%), Gaps = 40/325 (12%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPL-----------------DPSS-YKILDEIGVGVSAI 42
M HH GT Q + DP +IG G + I
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 43 VYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102
V A VA+K +DL + + + E M H N++ + S+ V LW
Sbjct: 61 VCLAREKH-SGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW 118
Query: 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD 162
V+M F+ G+L I+S L E IA V + L AL+YLH QG +HRD+K+ +IL
Sbjct: 119 VLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 163 SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSF 222
DG VKL+DFG A I + + GTPYWMAPEVI + Y+ + DIWS
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKR-------KSLVGTPYWMAPEVIS-RSLYATEVDIWSL 227
Query: 223 GITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASC 282
GI +E+ G PP P +++ K+K+ K S +D +
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQAMKRLRD--------SPPPKLKNS-HKVSPVLRDFLERM 278
Query: 283 LDQDPSKRPSAEKLMKHSFFKNCNK 307
L +DP +R +A++L+ H F
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGL 303
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 6e-94
Identities = 105/330 (31%), Positives = 163/330 (49%), Gaps = 37/330 (11%)
Query: 25 DPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
DP+ +++++ +G G VYK + + AIK +D+ + + I++E +
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTGD--EEEEIKQEINMLKKY 77
Query: 84 S-HPNILNAHCSF------SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
S H NI + +F +D +LW+VM F GS+ +I + + L E IA + +E
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L LS+LH +HRD+K N+L + VKL DFGVSA +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-------NTFI 190
Query: 197 GTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
GTPYWMAPEVI Y FK+D+WS GITA+E+A G PPL + P ++L +
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFF 312
L K+KK+S+ F+ + SCL ++ S+RP+ E+LMKH F ++
Sbjct: 251 A------PRL----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN----- 295
Query: 313 VKNVLHGLRSVEERFKESRNHVGAEHHEDE 342
+ V L+ +R K+ R +E
Sbjct: 296 ERQVRIQLKDHIDRTKKKRGEKDETEYEYS 325
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-91
Identities = 83/316 (26%), Positives = 138/316 (43%), Gaps = 29/316 (9%)
Query: 12 STGTIAQKIQ-YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL 70
TG + Q Y + + + L E+G G V+K V+A+K + ++ +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEEN 67
Query: 71 DSIRRETKT-MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPC 129
I + + P I+ +F ++ +++ M M + + + +PE
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERI 125
Query: 130 IAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188
+ + + AL YL + G +HRDVK NIL D G +KL DFG+S + +
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------- 177
Query: 189 SAMITDMAGTPYWMAPEVI----RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS 244
AG +MAPE I + Y +AD+WS GI+ +ELA G+ P + +
Sbjct: 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+L K+ Q + + + FS F+ V CL +D KRP KL++HSF K
Sbjct: 238 VLTKVLQ--------EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
Query: 305 CNKG---VEFFVKNVL 317
V + K+V+
Sbjct: 290 YETLEVDVASWFKDVM 305
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 4e-91
Identities = 89/334 (26%), Positives = 141/334 (42%), Gaps = 35/334 (10%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT-M 80
+ K L EIG G V K + P ++A+K I + + + M
Sbjct: 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVVM 75
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFM--SCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
P I+ + + + W+ M M S + S D +PE + + T+
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 139 SALSYLHNQGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
AL++L + HRD+K NIL D G++KL DFG+S + S T AG
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--------VDSIAKTRDAG 187
Query: 198 TPYWMAPEVI---RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF- 253
+MAPE I S GY ++D+WS GIT ELA GR P L ++ +
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247
Query: 254 -RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG---V 309
+ S+ E+ ++FS +F + V CL +D SKRP ++L+KH F + V
Sbjct: 248 PQLSNSEE--------REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
Query: 310 EFFVKNVLHGLRSVEERFKESRNHVGAEHHEDEE 343
+V +L ++ + + +HH
Sbjct: 300 ACYVCKIL------DQMPATPSSPMYVDHHHHHH 327
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 5e-82
Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 37/310 (11%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK-TM 80
+ + + E+G G +V K +P ++A+K I + + + + +M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETL 138
+ P + + + + +W+ M M SL G +PE + + +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 139 SALSYLHNQGH-LHRDVKAGNILSDSDGSVKLADFGVSA----SIYEPSHHHHHGSAMIT 193
AL +LH++ +HRDVK N+L ++ G VK+ DFG+S + A
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----------AKDI 168
Query: 194 DMAGTPYWMAPEVIR---SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
D AG +MAPE I + GYS K+DIWS GIT +ELA R P L ++
Sbjct: 169 D-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG-- 308
+ E + ++ KFS F D + CL ++ +RP+ +LM+H FF
Sbjct: 228 E-------EPSPQLPA--DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
Query: 309 -VEFFVKNVL 317
V FVK +L
Sbjct: 279 DVASFVKLIL 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-81
Identities = 69/308 (22%), Positives = 107/308 (34%), Gaps = 28/308 (9%)
Query: 5 EQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST---VVAIKAI 61
+ E + +Y + +G G V++ D A+K +
Sbjct: 36 DNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM----KDKQTGFQCAVKKV 91
Query: 62 DLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF 121
L+ R E + LS P I+ + + + + M + GSL +I
Sbjct: 92 RLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145
Query: 122 PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS-VKLADFGVSASIYE 180
LPE L + L L YLH + LH DVKA N+L SDGS L DFG + +
Sbjct: 146 C--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203
Query: 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP 240
+ + GT MAPEV+ K DIWS L + +G P +
Sbjct: 204 DGLGKSLLTGD--YIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260
Query: 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
L ++ +I + + L ++P R SA +L +
Sbjct: 261 RGPLCLKIASEP------PPIREIPP---SCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311
Query: 301 FFKNCNKG 308
G
Sbjct: 312 GKALQEVG 319
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 2e-78
Identities = 85/349 (24%), Positives = 147/349 (42%), Gaps = 49/349 (14%)
Query: 5 EQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD 64
EQ+ + ++ L ++ + E+G G +V+K P V+A K I L+
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLE 69
Query: 65 QSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG 124
+ I RE + + + P I+ + +F D + + M M GSL ++
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGR 127
Query: 125 LPEPCIAIVLKETLSALSYLHNQGH-LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183
+PE + V + L+YL + +HRDVK NIL +S G +KL DFGVS +
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----- 182
Query: 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL------- 236
+M GT +M+PE ++ T YS ++DIWS G++ +E+A GR P+
Sbjct: 183 ----IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
Query: 237 ------------SHLPPEKSLLMKMTQRFRFSDYEKTLKIKD-------------KNKKF 271
+ P + D + I + + F
Sbjct: 238 LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 297
Query: 272 SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG---VEFFVKNVL 317
S F+D V CL ++P++R ++LM H+F K + ++ + +
Sbjct: 298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTI 346
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 8e-76
Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 35 IGVGVSAIVYKAICIPMDST---VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNA 91
+G G IVY D + +AIK I + + E L H NI+
Sbjct: 30 LGKGTYGIVYAG----RDLSNQVRIAIKEIPE-RDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHL 150
SFS + + + M + GSL +++ S + P E I K+ L L YLH+ +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 151 HRDVKAGNILSDS-DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR- 208
HRD+K N+L ++ G +K++DFG S + + GT +MAPE+I
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG-------INPCTETFTGTLQYMAPEIIDK 197
Query: 209 SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268
GY ADIWS G T +E+A G+PP L ++ + F+ ++ +I +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM------FKVGMFKVHPEIPE-- 249
Query: 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
S K + C + DP KR A L+ F K +K
Sbjct: 250 -SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 5e-73
Identities = 60/309 (19%), Positives = 115/309 (37%), Gaps = 59/309 (19%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMS-LLS 84
+ + L++IG G V+K + +D + AIK D + RE + L
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALS 142
H +++ +++ D + + + + GSL IS + E + +L + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 143 YLHNQGHLHRDVKAGNILSDSDGS-------------------VKLADFGVSASIYEPSH 183
Y+H+ +H D+K NI K+ D G I P
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-- 187
Query: 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK 243
G ++A EV++ + + KADI++ +T + A P
Sbjct: 188 ---------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-------- 230
Query: 244 SLLMKMTQRFRFSDYEKTLKIKDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ ++ +I+ + S+ F +++ + DP +RPSA L+K
Sbjct: 231 -----------PRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
Query: 299 HSFFKNCNK 307
HS + ++
Sbjct: 280 HSVLLSASR 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 8e-73
Identities = 66/293 (22%), Positives = 122/293 (41%), Gaps = 39/293 (13%)
Query: 25 DPSS--YKILDEIGVGVSAIVYKAICIPMDST---VVAIKAIDLD-QSRTDLDSIRRETK 78
K EIG G VYK +D+ VA + ++++ + E +
Sbjct: 22 SNDGRFLKFDIEIGRGSFKTVYKG----LDTETTVEVAWCELQDRKLTKSERQRFKEEAE 77
Query: 79 TMSLLSHPNILNAHCSFSV----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
+ L HPNI+ + S+ + +V M+ G+L++ + + +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWC 135
Query: 135 KETLSALSYLHNQGH--LHRDVKAGNILSDS-DGSVKLADFGVSASIYEPSHHHHHGSAM 191
++ L L +LH + +HRD+K NI GSVK+ D G++ ++
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASF 186
Query: 192 ITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
+ GTP +MAPE+ Y D+++FG+ LE+A P S + ++T
Sbjct: 187 AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+K +K K+++ C+ Q+ +R S + L+ H+FF+
Sbjct: 245 G---------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 9e-70
Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 23/281 (8%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
++I +IG G + VY+A C+ D VA+K + + +E + L+HP
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSYL 144
N++ + SF D+ L +V+ G L +I +PE + + SAL ++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
H++ +HRD+K N+ + G VKL D G+ + + GTPY+M+P
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTAAHSLVGTPYYMSP 205
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPP-LSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
E I GY+FK+DIWS G E+A + P SL K+ Q DY
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ----CDYPPLPS 260
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+S + +V C++ DP KRP + + +
Sbjct: 261 -----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 9e-70
Identities = 66/287 (22%), Positives = 109/287 (37%), Gaps = 42/287 (14%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTM-SLL 83
S++ L +G G V+K D + A+K + D E + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRS-KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
HP + ++ L++ C SLQ + + LPE + L++TL AL+
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTEL--CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALA 171
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH+QG +H DVK NI G KL DFG+ + G P +M
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--------VQEGDPRYM 223
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
APE+++ Y AD++S G+T LE+A E
Sbjct: 224 APELLQG--SYGTAADVFSLGLTILEVACNMEL-------------------PHGGEGWQ 262
Query: 263 KIKDKN------KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+++ S + ++ L+ DP R +AE L+ +
Sbjct: 263 QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-69
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 21/277 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-DQSRTDLDSIRRETKTMSLLSHPN 87
Y L +IG G D IK I++ S + + RRE ++ + HPN
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ SF + L++VM + G L I++ E I + AL ++H++
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K+ NI DG+V+L DFG++ + + + GTPY+++PE+
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-------NSTVELARACIGTPYYLSPEIC 197
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267
+ Y+ K+DIW+ G EL + K+L++K+
Sbjct: 198 E-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVLKIISG----------SFPPV 245
Query: 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ +S + +V+ ++P RPS +++ F
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-68
Identities = 74/316 (23%), Positives = 133/316 (42%), Gaps = 40/316 (12%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
S ++ + +G G V KA +DS AIK I + L +I E ++ L+H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHTEE--KLSTILSEVMLLASLNHQ 62
Query: 87 NILNAHCSF-------------SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
++ + ++ S L++ M + G+L +I S +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRL 121
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI-------YEPSHHHH 186
++ L ALSY+H+QG +HRD+K NI D +VK+ DFG++ ++ S +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL 246
S +T GT ++A EV+ Y+ K D++S GI E+ + E+ +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST----GMERVNI 237
Query: 247 MK--MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+K + F + + K ++ +D DP+KRP A L+ +
Sbjct: 238 LKKLRSVSIEFPPDF--------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 305 CNKGVEFFVKNVLHGL 320
++ + +K L L
Sbjct: 290 KHQ--DEVIKEALKSL 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 6e-68
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 47/295 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+K ++ IG G V+KA +D IK + + + RE K ++ L H NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNI 66
Query: 89 LNAHCSF----------------SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI 132
++ + + S L++ M F G+L+ I + L +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI 192
+ ++ + Y+H++ ++RD+K NI VK+ DFG+ S+
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--------KNDGKR 178
Query: 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
T GT +M+PE I S Y + D+++ G+ EL H E S +
Sbjct: 179 TRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDT----AFETSKFFTDLRD 233
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
SD F + K ++ L + P RP+ ++++ +
Sbjct: 234 GIISDI------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-63
Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 34/318 (10%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQ-YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIK 59
M HH GT Q + Y IL +IG G S+ V++ + + AIK
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIK 58
Query: 60 AIDLDQ-SRTDLDSIRRETKTMSLLSHPN--ILNAHCSFSVDSRLWVVMPFMSCGSLQSI 116
++L++ LDS R E ++ L + I+ + D +++VM + L S
Sbjct: 59 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSW 117
Query: 117 ISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176
+ + K L A+ +H G +H D+K N L DG +KL DFG++
Sbjct: 118 LKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174
Query: 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR----------SHTGYSFKADIWSFGITA 226
+ + S GT +M PE I+ S + S K+D+WS G
Sbjct: 175 QMQPDTTSVVKDS-----QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 227 LELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
+ +G+ P + + S L + ++ + +D++ CL +D
Sbjct: 230 YYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP---------EKDLQDVLKCCLKRD 280
Query: 287 PSKRPSAEKLMKHSFFKN 304
P +R S +L+ H + +
Sbjct: 281 PKQRISIPELLAHPYVQI 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-62
Identities = 72/316 (22%), Positives = 128/316 (40%), Gaps = 33/316 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y IL +IG G S+ V++ + + AIK ++L++ LDS R E ++ L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 88 --ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
I+ + D +++VM + L S + + K L A+ +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 125
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
G +H D+K N L DG +KL DFG++ + + S GT +M PE
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-----QVGTVNYMPPE 179
Query: 206 VIR----------SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
I+ S + S K+D+WS G + +G+ P + + S L +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 235
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKN 315
++E + +D++ CL +DP +R S +L+ H + + V K
Sbjct: 236 PNHEIEF-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
Query: 316 VLHGLRSVEERFKESR 331
++ V +
Sbjct: 291 TTEEMKYVLGQLVGLN 306
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-61
Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 33/296 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
++ + +G G +V++A +D AIK I L + + RE K ++ L HP I
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 89 LNAHCSF------------SVDSRLWVVMPFMSCGSLQSIISS-CFPDGLPEPCIAIVLK 135
+ ++ S L++ M +L+ ++ C + +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH-----HGSA 190
+ A+ +LH++G +HRD+K NI D VK+ DFG+ ++ + A
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
T GT +M+PE I + YS K DI+S G+ EL + P S L +
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV- 240
Query: 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
+ LK + MV L P +RP A +++++ F++ +
Sbjct: 241 ---------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 9e-60
Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y++L IG G K D ++ K +D + + + E + L HPN
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 88 ILNAHCSF--SVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSY 143
I+ + ++ L++VM + G L S+I+ + L E + V+ + AL
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 144 LHNQGH-----LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
H + LHRD+K N+ D +VKL DFG++ + +H ++ GT
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSFAKTFVGT 179
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP---LSHLPPEKSLLMKMTQRFRF 255
PY+M+PE + Y+ K+DIWS G EL PP S K L K+ +
Sbjct: 180 PYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREG--- 231
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
K + ++S +++ L+ RPS E+++++
Sbjct: 232 -------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-59
Identities = 70/311 (22%), Positives = 125/311 (40%), Gaps = 33/311 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y IL +IG G S+ V++ + + AIK ++L++ LDS R E ++ L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 88 --ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
I+ + D +++VM L S + + K L A+ +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH 172
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
G +H D+K N L DG +KL DFG++ + + S G +M PE
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-----QVGAVNYMPPE 226
Query: 206 VIR----------SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
I+ S + S K+D+WS G + +G+ P + + S L +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKN 315
++ + +D++ CL +DP +R S +L+ H + + V K
Sbjct: 287 IEFPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337
Query: 316 VLHGLRSVEER 326
++ V +
Sbjct: 338 TTEEMKYVLGQ 348
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-59
Identities = 70/310 (22%), Positives = 115/310 (37%), Gaps = 25/310 (8%)
Query: 2 AHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI 61
+HH Q +D Y + ++G G + V + D A+K I
Sbjct: 4 SHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRI 62
Query: 62 DLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS----RLWVVMPFMSCGSLQSII 117
+ D + +RE L +HPNIL + W+++PF G+L + I
Sbjct: 63 LC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121
Query: 118 SSCFPDG--LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
G L E I +L L +H +G+ HRD+K NIL +G L D G S
Sbjct: 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG-S 180
Query: 176 ASIYEPSHHHHHGSAMITDMA---GTPYWMAPEVI--RSHTGYSFKADIWSFGITALELA 230
+ + + D A T + APE+ +SH + D+WS G +
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
Query: 231 HGRPP-LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK 289
G P S+ + + + ++ + S A ++ S + DP +
Sbjct: 241 FGEGPYDMVFQKGDSVALAVQNQLSI----------PQSPRHSSALWQLLNSMMTVDPHQ 290
Query: 290 RPSAEKLMKH 299
RP L+
Sbjct: 291 RPHIPLLLSQ 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-56
Identities = 62/296 (20%), Positives = 117/296 (39%), Gaps = 30/296 (10%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HP 86
S+ D +G G + D+ VA+K I + RE + + HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPE----CFSFADREVQLLRESDEHP 78
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
N++ C+ ++ + + +LQ + +L++T S L++LH+
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 147 QGHLHRDVKAGNIL-----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+HRD+K NIL + ++DFG+ + H + + GT W
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR----RSGVPGTEGW 192
Query: 202 MAPEVIRS--HTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
+APE++ ++ DI+S G ++ G P ++ ++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVK 314
EK ++++ + DP KRPSA+ ++KH FF + K ++FF
Sbjct: 253 EKHE---------DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-53
Identities = 63/315 (20%), Positives = 115/315 (36%), Gaps = 40/315 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+ + D +G G +A V++ + AIK + +D RE + + L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 89 LNAHCSFSVDS--RLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
+ + ++M F CGSL + GLPE IVL++ + +++L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 146 NQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
G +HR++K GNI+ D KL DFG + + + ++ + GT +
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-------DEQFVS-LYGTEEY 181
Query: 202 MAPEVIR-------SHTGYSFKADIWSFGITALELAHGRPP-LSHLPPE--KSLLMKMTQ 251
+ P++ Y D+WS G+T A G P P K ++ K+
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAF--------------KDMVASCLDQDPSKRPSAEKLM 297
K ++ +S ++A+ L+ D K ++
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 298 KHSFFKNCNKGVEFF 312
+
Sbjct: 302 AETSDILHRGNSHHH 316
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-52
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 27/292 (9%)
Query: 16 IAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSI 73
I + + P Y +G G A ++ V A K + + +
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKM 62
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
E L+H +++ H F + ++VV+ SL + L EP
Sbjct: 63 SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYY 120
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
L++ + YLH +HRD+K GN+ + D VK+ DFG++ +
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK------V 174
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-R 252
+ GTP ++APEV+ S G+SF+ D+WS G L G+PP K +++ +
Sbjct: 175 -LCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNE 231
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ + + ++ L DP+ RP+ +L+ FF +
Sbjct: 232 YSIPKH------------INPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-52
Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 27/296 (9%)
Query: 11 SSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRT 68
I + + P Y +G G A ++ V A K +
Sbjct: 25 PPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPH 83
Query: 69 DLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEP 128
+ + E L+H +++ H F + ++VV+ SL + L EP
Sbjct: 84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEP 141
Query: 129 CIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188
L++ + YLH +HRD+K GN+ + D VK+ DFG++ +
Sbjct: 142 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK-- 199
Query: 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248
+ GTP ++APEV+ S G+SF+ D+WS G L G+PP K ++
Sbjct: 200 ----V-LCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLR 252
Query: 249 MTQ-RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ + + + + ++ L DP+ RP+ +L+ FF
Sbjct: 253 IKKNEYSIPKH------------INPVAASLIQKMLQTDPTARPTINELLNDEFFT 296
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLL 83
I ++IG G V++A + VA+K + + D ++ RE M L
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 84 SHPNILNAHCSF----SVDSRLWVVMPFMSCGSLQSII-SSCFPDGLPEPCIAIVLKETL 138
HPNI+ F + L +V ++S GSL ++ S + L E + +
Sbjct: 92 RHPNIV----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 139 SALSYLHNQGH--LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
++YLHN+ +HR++K+ N+L D +VK+ DFG+S A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-------KASTFLSSKSAA 200
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP WMAPEV+R + K+D++SFG+ ELA + P +L P + + + R
Sbjct: 201 GTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-- 257
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
L+I + + ++ C +P KRPS
Sbjct: 258 -----LEI---PRNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 74/291 (25%), Positives = 131/291 (45%), Gaps = 38/291 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDL-DSIRRETKTMSLLSHP 86
++I +G G VY A ++A+K + Q + + +RRE + S L HP
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NIL + F +R+++++ + G++ + E A + E +ALSY H+
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS 127
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ +HRD+K N+L S G +K+ADFG S + PS + GT ++ PE+
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRT------D-LCGTLDYLPPEM 178
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR-----FRFSDYEKT 261
I + K D+WS G+ E G+PP E + + +R F F D+
Sbjct: 179 IEGR-MHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDF--- 229
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF-KNCNKGVEF 311
+ +D+++ L +PS+RP ++++H + N +K
Sbjct: 230 ---------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-50
Identities = 76/334 (22%), Positives = 143/334 (42%), Gaps = 44/334 (13%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS 81
+ +D ++ + +G G +V KA + VAIK I+ + + + E + +S
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESES---ERKAFIVELRQLS 56
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSA 140
++HPNI+ + + + +VM + GSL +++ P +
Sbjct: 57 RVNHPNIV--KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 141 LSYLHNQGH---LHRDVKAGNILSDSDGSV-KLADFGVSASIYEPSHHHHHGSAMITDMA 196
++YLH+ +HRD+K N+L + G+V K+ DFG + I +T+
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNK 164
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL-PPEKSLLMKMTQRFRF 255
G+ WMAPEV + YS K D++S+GI E+ R P + P ++ + R
Sbjct: 165 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR- 222
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH-----SFFKNCNKGVE 310
+ K + + ++ C +DPS+RPS E+++K +F ++ ++
Sbjct: 223 ------PPL---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 311 FFVKNVLH----GLRSVEERFKESRNHVGAEHHE 340
+ ++ L G F E +H E
Sbjct: 274 YPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 69/280 (24%), Positives = 128/280 (45%), Gaps = 28/280 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID---LDQSRTDLDSIRRETKTMSLLSH 85
+K+ + +G G A VY+A I VAIK ID + ++ + ++ E K L H
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKH 70
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
P+IL + F + +++V+ G + + + E + + ++ + YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH 129
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+ G LHRD+ N+L + ++K+ADFG++ + P H+ T + GTP +++PE
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY------T-LCGTPNYISPE 182
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-RFRFSDYEKTLKI 264
+ + + + ++D+WS G L GRPP K+ L K+ + +
Sbjct: 183 IA-TRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSF------ 234
Query: 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
S KD++ L ++P+ R S ++ H F
Sbjct: 235 ------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 46/275 (16%), Positives = 93/275 (33%), Gaps = 32/275 (11%)
Query: 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD-LDSIRRETKTMSLL 83
D L ++ S ++K + +K + + T E + +
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 84 SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
SHPN+L C ++ +M GSL +++ + + + +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 142 SYLHNQGH--LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
++LH + + +++ D D + +++ V S P
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------------PGRMYAP 172
Query: 200 YWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257
W+APE ++ AD+WSF + EL P + L + + + R
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--- 229
Query: 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
I S ++ C+++DP+KRP
Sbjct: 230 ----PTIP---PGISPHVSKLMKICMNEDPAKRPK 257
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 63/318 (19%), Positives = 116/318 (36%), Gaps = 40/318 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+ + D +G G +A V++ + AIK + +D RE + + L+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 89 LNAHCSFSVDS--RLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
+ + ++M F CGSL + GLPE IVL++ + +++L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 146 NQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
G +HR++K GNI+ D KL DFG + + + ++ + GT +
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-------DEQFVS-LYGTEEY 181
Query: 202 MAPEVIR-------SHTGYSFKADIWSFGITALELAHGRPP---LSHLPPEKSLLMKMTQ 251
+ P++ Y D+WS G+T A G P K ++ K+
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAF--------------KDMVASCLDQDPSKRPSAEKLM 297
K ++ +S ++A+ L+ D K ++
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 298 KHSFFKNCNKGVEFFVKN 315
+ + F
Sbjct: 302 AETSDILHRMVIHVFSLQ 319
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-49
Identities = 86/509 (16%), Positives = 170/509 (33%), Gaps = 61/509 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+++ + +G G V + I VAIK + S + + E + M L+HPN+
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 89 LNAH------CSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSAL 141
++A + + + M + G L + + GL E I +L + SAL
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
YLH +HRD+K NI+ K+ D G + + + G GT
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------GELCTE-FVGT 186
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF--- 255
++APE++ Y+ D WSFG A E G P K+ ++
Sbjct: 187 LQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 256 ------SDYEKTLKIKDKNKKFSRA---FKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
+ + + N + + L +R + + F+ +
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305
Query: 307 KGVEFFVKNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSSP---------------- 350
+ + +V++ + + + N + + G
Sbjct: 306 SILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSA 365
Query: 351 -PVKQRRISGWNFNEEGFELDPVFPFFTTESRADSDSVVKQVRFGGETIIPPDRIKKQSE 409
P+ Q I + E D +F F ++ + + P +
Sbjct: 366 QPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPA--------HPESVSIVLQD 417
Query: 410 SDTNSEESNLGTQLAVHHQAAESLMAL-RRSLDEERQQVSNMIALLGGEISREDQLMQIV 468
++L Q +L R L +R + N++ +++ +
Sbjct: 418 PKRPLTYTHLRRVWGQIWQTIRALKEDCARLLQGQRTSMVNLLRYNTELSKKKNSMTSEC 477
Query: 469 ERLKMELETERRKNFELEMELEFLKHQIS 497
E+LK +L+ R ++++LE Q+
Sbjct: 478 EQLKAKLDFFRSS---IQIDLEKYSEQME 503
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-49
Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 40/294 (13%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD------LDSIRR 75
L + + +IG G +V+K + +VVAIK++ L S + +R
Sbjct: 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDK-SVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 76 ETKTMSLLSHPNILNAHCSF--SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
E MS L+HPNI+ + + +VM F+ CG L + + +
Sbjct: 73 EVFIMSNLNHPNIV----KLYGLMHNPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRL 127
Query: 134 LKETLSALSYLHNQGH--LHRDVKAGNILSDSDG-----SVKLADFGVSASIYEPSHHHH 186
+ + + Y+ NQ +HRD+++ NI S K+ADFG+S
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH------ 181
Query: 187 HGSAMITDMAGTPYWMAPEVIR-SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL 245
++ + G WMAPE I Y+ KAD +SF + + G P
Sbjct: 182 ----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY---- 233
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
K+ + I + ++++ C DP KRP ++K
Sbjct: 234 -GKIKFINMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 67/322 (20%), Positives = 120/322 (37%), Gaps = 45/322 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID----------------LDQSRTDLDS 72
Y+I+ + G + D+ A+K + ++ D
Sbjct: 33 YRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 73 IRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCF------PDGLP 126
+ E + ++ + + L + ++++ +M S+ F +P
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 127 EPCIAIVLKETLSALSYLHNQGH-LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185
I ++K L++ SY+HN+ + HRDVK NIL D +G VKL+DFG S
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE--------- 200
Query: 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKS 244
+ I GT +M PE + + Y+ K DIWS GI + + P S
Sbjct: 201 YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260
Query: 245 LLMK-MTQRFRF-------SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
L T+ + K N S D + L ++P++R ++E
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 297 MKHSFF-KNCNKGVEFFVKNVL 317
+KH + + + F K +
Sbjct: 321 LKHEWLADTNIEDLREFSKELY 342
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 37/289 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
+ I +G G VY A + ++A+K + Q +RRE + S L HP
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NIL + F R+++++ F G L + E A ++E AL Y H
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHE 132
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ +HRD+K N+L G +K+ADFG S + PS T M GT ++ PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRR------T-MCGTLDYLPPEM 183
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR-----FRFSDYEKT 261
I + K D+W G+ E G PP + + +R +F +
Sbjct: 184 IEGK-THDEKVDLWCAGVLCYEFLVGMPPF-----DSPSHTETHRRIVNVDLKFPPF--- 234
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVE 310
S KD+++ L P +R + +M+H + K ++ V
Sbjct: 235 ---------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 5e-47
Identities = 66/312 (21%), Positives = 127/312 (40%), Gaps = 43/312 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS-LLSHPN 87
+G G S V VA+K + +D D E K ++ HPN
Sbjct: 17 VVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPN 70
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSII-----SSCFPDGLPEPCIAIVLKETLSALS 142
++ +CS + D L++ + + +LQ ++ S E +L++ S ++
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 143 YLHNQGHLHRDVKAGNIL-------------SDSDGSVKLADFGVSASIYEPSHHHHHGS 189
+LH+ +HRD+K NIL + + ++DFG+ +
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-KKLDSGQSSFR-- 186
Query: 190 AMITDMAGTPYWMAPEVIRS------HTGYSFKADIWSFG-ITALELAHGRPPLSHLPPE 242
+ + +GT W APE++ + DI+S G + L+ G+ P
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+S +++ F + + ++ D+++ +D DP KRP+A K+++H F
Sbjct: 247 ESNIIR--GIFSLDEMKC-----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
Query: 303 KNCNKGVEFFVK 314
+K +EF +K
Sbjct: 300 WPKSKKLEFLLK 311
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 24/280 (8%)
Query: 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLL 83
+ IG G VYK VA+K +++ + L + + E +
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 84 SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H NIL + + +L +V + SL + + + + ++T +
Sbjct: 78 RHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGM 133
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YLH + +HRD+K+ NI D +VK+ DFG++ GS ++G+ W
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK-----SRWSGSHQFEQLSGSILW 188
Query: 202 MAPEVIR--SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
MAPEVIR YSF++D+++FGI EL G+ P S++ ++ + +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL----- 243
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ + + K ++A CL + +RPS +++
Sbjct: 244 -SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-47
Identities = 79/314 (25%), Positives = 137/314 (43%), Gaps = 40/314 (12%)
Query: 1 MAHHEQE----DQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVV 56
M HH + GTI + ++G G V+
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDL---------FIFKRKLGSGAFGDVHLVEERSSGLER- 50
Query: 57 AIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QS 115
IK I+ D+S+ ++ I E + + L HPNI+ F +++VM G L +
Sbjct: 51 VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 116 IISSCFPDG-LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLAD 171
I+S+ L E +A ++K+ ++AL+Y H+Q +H+D+K NIL + +K+ D
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
FG++ +++ T+ AGT +MAPEV + +FK DIWS G+ L
Sbjct: 171 FGLAE-LFKSDE-------HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLT 220
Query: 232 GRPPLSHLPPEKSLLMK-MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR 290
G P + + K + ++ + L + D++ L +DP +R
Sbjct: 221 GCLPF-TGTSLEEVQQKATYKEPNYAVECRPL---------TPQAVDLLKQMLTKDPERR 270
Query: 291 PSAEKLMKHSFFKN 304
PSA +++ H +FK
Sbjct: 271 PSAAQVLHHEWFKQ 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 55/285 (19%), Positives = 107/285 (37%), Gaps = 30/285 (10%)
Query: 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90
I+ + K + + S + +D+ + + M S N +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI-VLKETLSALSYLHNQGH 149
S L++ M +L+ ++ E + + + + A+ +LH++G
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 150 LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMI-----TDMAGTPYWMAP 204
+HRD+K NI D VK+ DFG+ ++ + + M T GT +M+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264
E I YS K DI+S G+ EL + E+ ++ +
Sbjct: 246 EQI-HGNNYSHKVDIFSLGLILFELLYSFSTQM----ERVRIIT--------------DV 286
Query: 265 KDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
++ + MV L P++RP A +++++ F+N
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 1/82 (1%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
++ + +G G +V++A +D AIK I L + + RE K ++ L HP I
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 89 LNAHCSFSVDSRLWVVMPFMSC 110
+ ++
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEI 88
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 61/286 (21%), Positives = 106/286 (37%), Gaps = 31/286 (10%)
Query: 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLL 83
+I + IG G VY VAI+ ID+++ + L + +RE
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRW----HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 84 SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H N++ C L ++ +L S++ L + +E + +
Sbjct: 87 RHENVVLFMGACM--SPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGM 143
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YLH +G LH+D+K+ N+ D +G V + DFG+ SI + G
Sbjct: 144 GYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF-SISGVLQAGRREDKL-RIQNGWLCH 200
Query: 202 MAPEVIRSHTG--------YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
+APE+IR + +S +D+++ G EL P P E +
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM----- 255
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+K + D++ C + +RP+ KLM
Sbjct: 256 -----GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-46
Identities = 41/313 (13%), Positives = 92/313 (29%), Gaps = 49/313 (15%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL--DQSRTDLDSIRRETKTMSLL 83
K+++ + VG ++V+ + A+K + + SR++L+ + T + L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 84 SHPNILNA----HCSFSVD----------------------SRLWVVMPFMSCGSLQSII 117
+ A D + ++MP S L+ +
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLF 178
Query: 118 SSC-----FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
S+ F + I+ + + + L ++G +H N+ DG + L D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAH 231
G+ + + E + + ++ + W G++ +
Sbjct: 239 SAL---------WKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
P + P K K ++ L+ D +R
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF---GSCTPLPDFVKTLIGRFLNFDRRRRL 345
Query: 292 SAEKLMKHSFFKN 304
+ M+ F
Sbjct: 346 LPLEAMETPEFLQ 358
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 8e-46
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 28/285 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
YK +G G V A+K I Q +TD +S+ RE + + L HP
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ + F ++V + G L I S E A ++++ LS ++Y+H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK 144
Query: 147 QGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+HRD+K N+L D ++++ DFG+S + +E S + D GT Y++A
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASK-------KMKDKIGTAYYIA 196
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK-MTQRFRFSDYEKTL 262
PEV+ Y K D+WS G+ L G PP + E +L K ++ F
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFEL----- 248
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
+ KK S + KD++ L PS R SA + H + + K
Sbjct: 249 ---PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 69/309 (22%), Positives = 120/309 (38%), Gaps = 60/309 (19%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-------------------------L 63
Y + DEIG G +V A D+T A+K +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 64 DQSRTDLDSIRRETKTMSLLSHPNILNAHC--SFSVDSRLWVVMPFMSCGSLQSIISSCF 121
Q R ++ + +E + L HPN++ + L++V ++ G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-- 131
Query: 122 PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181
L E ++ + + YLH Q +HRD+K N+L DG +K+ADFGVS ++
Sbjct: 132 -KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKG 189
Query: 182 SHHHHHGSAMITDMAGTPYWMAPEVIR-SHTGYS-FKADIWSFGITALELAHGRPPLSHL 239
S + GTP +MAPE + + +S D+W+ G+T G+
Sbjct: 190 SDALLSNT------VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ-----C 238
Query: 240 PPEKSLLMKM-----TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
P +M + +Q F D + KD++ LD++P R
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQP----------DIAEDLKDLITRMLDKNPESRIVVP 288
Query: 295 KLMKHSFFK 303
++ H +
Sbjct: 289 EIKLHPWVT 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 36/292 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM-SLLSHPN 87
++ + G A VY+A + A+K + +I +E M L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 88 ILNAHCSFSVDSR-------LWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLS 139
I+ + S+ ++++ + G L + G L + + +T
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 140 ALSYLHNQGH--LHRDVKAGNILSDSDGSVKLADFGVSA--SIYEPSHHHHHGSAMITDM 195
A+ ++H Q +HRD+K N+L + G++KL DFG + S Y A++ +
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 196 A---GTPYWMAPEVI--RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250
TP + PE+I S+ K DIW+ G L + P E +++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----EDGAKLRIV 262
Query: 251 Q-RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
++ ++ F ++ + L +P +R S +++
Sbjct: 263 NGKYSIPPHD----------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 22/283 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
PS + +G G K V+ +K + + + +E K M L
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGE-VMVMKEL-IRFDEETQRTFLKEVKVMRCL 64
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSALS 142
HPN+L D RL + ++ G+L+ II S D P K+ S ++
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMA 122
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS-------ASIYEPSHHHHHGSAMITDM 195
YLH+ +HRD+ + N L + +V +ADFG++ +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
G PYWMAPE+I Y K D++SFGI E+ P + F
Sbjct: 183 VGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF-- 239
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
++ +F + C D DP KRPS KL
Sbjct: 240 --LDRYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 29/306 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y+ + ++G G V AIK I S + + E + LL HPN
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ + F ++VM G L I E A+++K+ LS ++YLH
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 148 GHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
+HRD+K N+L + D +K+ DFG+S +++E + + GT Y++AP
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQK-------KMKERLGTAYYIAP 207
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK-MTQRFRFSDYEKTLK 263
EV+R Y K D+WS G+ L G PP ++ +L K ++ F
Sbjct: 208 EVLRKK--YDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKYTFDS------ 258
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSV 323
+ K S KD++ L D +R SA++ ++H + K E ++ +
Sbjct: 259 --PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL--ANA 314
Query: 324 EERFKE 329
E ++
Sbjct: 315 IENMRK 320
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-45
Identities = 73/341 (21%), Positives = 135/341 (39%), Gaps = 41/341 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
Y I +++G G IV++ + S+ K + + TD +++E +++ H
Sbjct: 7 YMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHR 61
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
NIL+ H SF L ++ F+S + + I +S F L E I + + AL +LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH 119
Query: 146 NQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+ H D++ NI+ + ++K+ +FG + +P + P + A
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGD-------NFRLLFTAPEYYA 171
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP-----EKSLLMKMTQ-RFRFSD 257
PEV + H S D+WS G L LS + P + ++ + + F +
Sbjct: 172 PEVHQ-HDVVSTATDMWSLGTLVYVL------LSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVL 317
+ K+ S D V L ++ R +A + ++H + K + V V L
Sbjct: 225 --------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276
Query: 318 HGLRSVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRIS 358
R K+ N V + + S V ++
Sbjct: 277 KHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVK 317
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 74/333 (22%), Positives = 138/333 (41%), Gaps = 40/333 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRT----DLDSIRRETKTMSL 82
Y++ + IG G ++V + I T A+K +D+ + + + ++RE +
Sbjct: 26 YELCEVIGKGPFSVVRRCINR---ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIIS-SCFPDGLPEPCIAIVLKETLSA 140
L HP+I+ ++S D L++V FM L I+ + E + +++ L A
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 141 LSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
L Y H+ +HRDVK +L ++ VKL FGV+ + E + G
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-------VAGGRVG 195
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR--FRF 255
TP++MAPEV++ Y D+W G+ L G P K L + + ++
Sbjct: 196 TPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYG---TKERLFEGIIKGKYKM 251
Query: 256 -SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEF-FV 313
+ S + KD+V L DP++R + + + H + K ++ +
Sbjct: 252 NPRQWSHI---------SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHL 302
Query: 314 KNVLHGLR--SVEERFKESRNHVGAEHHEDEEF 344
+ LR + + K + + H + +
Sbjct: 303 PETVEQLRKFNARRKLKGAVLAAVSSHKFNSFY 335
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 74/322 (22%), Positives = 133/322 (41%), Gaps = 59/322 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLS 84
Y + IG G +V AI + AIK ++ ++ + D++ I+ E + M L
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSL------------------------------- 113
HPNI + + + + +VM G L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 114 -------QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL--SDSD 164
E I+ ++++ SAL YLHNQG HRD+K N L ++
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR-SHTGYSFKADIWSFG 223
+KL DFG+S Y+ ++ ++ +T AGTPY++APEV+ ++ Y K D WS G
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYY---GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 224 ITALELAHGRPPLSHLPPEKSLLMKMTQRFRF-SDYEKTLKIKDKNKKFSRAFKDMVASC 282
+ L G P + ++ + ++ F + L S +D++++
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL---------SPLARDLLSNL 314
Query: 283 LDQDPSKRPSAEKLMKHSFFKN 304
L+++ +R A + ++H +
Sbjct: 315 LNRNVDERFDAMRALQHPWISQ 336
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 80/335 (23%), Positives = 131/335 (39%), Gaps = 36/335 (10%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKA 60
M HH Y I+ +G G V K A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGTFA-----ERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKV 54
Query: 61 IDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIIS 118
I+ D +I RE + + L HPNI+ S ++V + G L II
Sbjct: 55 INKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 119 SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVS 175
E A ++K+ S ++Y+H +HRD+K NIL + D +K+ DFG+S
Sbjct: 115 R---KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP 235
+ ++ + + D GT Y++APEV+R Y K D+WS G+ L G PP
Sbjct: 172 -TCFQQNT-------KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPP 221
Query: 236 LSHLPPEKSLLMK-MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
+ E +L + T ++ F + + S KD++ L PS R +A
Sbjct: 222 F-YGKNEYDILKRVETGKYAFDL--------PQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 295 KLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKE 329
+ ++H + + + L S ++
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPS--LESAMTNIRQ 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 44/291 (15%)
Query: 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI---DLDQSRTDLDSIRRETKTMS 81
D + + + IG+G VY+A VA+KA + ++++R+E K +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 82 LLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
+L HPNI L C + L +VM F G L ++S +P + +
Sbjct: 62 MLKHPNIIALRGVCL--KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIAR 116
Query: 140 ALSYLHNQGH---LHRDVKAGNILSD--------SDGSVKLADFGVSASIYEPSHHHHHG 188
++YLH++ +HRD+K+ NIL S+ +K+ DFG++ + +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT------ 170
Query: 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248
AG WMAPEVIR + +S +D+WS+G+ EL G P +
Sbjct: 171 ---KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
Query: 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ L I F ++ C + DP RPS ++
Sbjct: 227 AMNKLA-------LPIP---STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSH 85
Y + +E+G G ++V + + +T A K I+ + S D + RE + L H
Sbjct: 8 YDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
PNI+ H S +S ++V ++ G L + I++ F E + +++ L +++Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 121
Query: 145 HNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
H+ G +HR++K N+L +VKLADFG++ + + A AGTP +
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-------SEAW-HGFAGTPGY 173
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF-SDYEK 260
++PEV++ YS DIW+ G+ L G PP + + + S
Sbjct: 174 LSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
T+ + K ++ S L +P KR +A++ +K + N +
Sbjct: 233 TV---------TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-44
Identities = 41/348 (11%), Positives = 103/348 (29%), Gaps = 41/348 (11%)
Query: 2 AHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTV----VA 57
++ + I K ++ L + +G G A VY+A ++
Sbjct: 40 SYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99
Query: 58 IKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII 117
+K + + + + + + + + + +V S G+L + I
Sbjct: 100 LKVQK-PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 118 ---SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL-----------SDS 163
+ +P+ + L + +H+ +H D+K N + D
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 164 DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFG 223
+ L D G S + G+ T + E++ + ++++ D +
Sbjct: 219 SAGLALIDLGQSIDM----KLFPKGTIFTAK-CETSGFQCVEMLS-NKPWNYQIDYFGVA 272
Query: 224 ITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCL 283
T + G + + E + + + + L
Sbjct: 273 ATVYCMLFGTYM----------------KVKNEGGECKPEGLFRRLPHLDMWNEFFHVML 316
Query: 284 DQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESR 331
+ + L++ K + ++ + + L + K SR
Sbjct: 317 NIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSR 364
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-44
Identities = 75/319 (23%), Positives = 127/319 (39%), Gaps = 50/319 (15%)
Query: 3 HHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKA 60
+DQ + + Y + +G G V A T VAI+
Sbjct: 120 DLTVDDQSVYPKALRDE---------YIMSKTLGSGACGEVKLAFER---KTCKKVAIRI 167
Query: 61 ID-------LDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
I + ++ E + + L+HP I+ F ++V+ M G L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGEL 226
Query: 114 -QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKL 169
++ + L E + + L A+ YLH G +HRD+K N+L + D +K+
Sbjct: 227 FDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITAL 227
DFG S + E S ++ + GTP ++APEV+ S GY+ D WS G+
Sbjct: 284 TDFGHSKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 228 ELAHGRPPLSHLPPEKSLLMKMTQ-RFRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQ 285
G PP S + SL ++T ++ F + + S D+V L
Sbjct: 336 ICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV---------SEKALDLVKKLLVV 386
Query: 286 DPSKRPSAEKLMKHSFFKN 304
DP R + E+ ++H + ++
Sbjct: 387 DPKARFTTEEALRHPWLQD 405
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 71/321 (22%), Positives = 123/321 (38%), Gaps = 57/321 (17%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID-----LDQSRTDLDSIRRETKTMS 81
Y I +E+G G AIV K ST A K I + + I RE +
Sbjct: 14 YDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSA 140
+ H N++ H + + + +++ +S G L + + L E +K+ L
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDG 127
Query: 141 LSYLHNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
++YLH + H D+K NI+ + +KL DFG++ E ++
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGV-------EFKNIF 179
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP ++APE++ + +AD+WS G+ L LS P F
Sbjct: 180 GTPEFVAPEIVN-YEPLGLEADMWSIGVITYIL------LSGASP-----------FLGD 221
Query: 257 DYEKTL-KIKDKNKKF-SRAF-------KDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
++TL I + F F KD + L ++ KR + ++ ++H + +
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281
Query: 308 GVEFFVKNVLHGLRSVEERFK 328
V E F+
Sbjct: 282 Q----QAMVRRESVVNLENFR 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 73/320 (22%), Positives = 118/320 (36%), Gaps = 65/320 (20%)
Query: 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR 74
T+A+ I +L+ +G G V++ VA+K S D S
Sbjct: 5 TVARDIT---------LLECVGKGRYGEVWRGSW---QGENVAVKIF----SSRDEKSWF 48
Query: 75 RETK--TMSLLSHPNILN--AHCSFSVDS--RLWVVMPFMSCGSLQSIISSCFPDGLPEP 128
RET+ +L H NIL A S S +LW++ + GSL + L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTV 105
Query: 129 CIAIVLKETLSALSYLHNQGH--------LHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
++ S L++LH + HRD+K+ NIL +G +AD G++
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH-- 163
Query: 181 PSHHHHHGSAMITDMAGTPYWMAPEVIR-----SHTGYSFKADIWSFGITALELAHG--- 232
S + GT +MAPEV+ + DIW+FG+ E+A
Sbjct: 164 -SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
Query: 233 -------RPPLSHLPPEKSLLMKMT-----QRFRFSDYEKTLKIKDKNKKFS--RAFKDM 278
+PP + P M + R I ++ + +
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR-------PNIPNRWFSDPTLTSLAKL 275
Query: 279 VASCLDQDPSKRPSAEKLMK 298
+ C Q+PS R +A ++ K
Sbjct: 276 MKECWYQNPSARLTALRIKK 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 53/300 (17%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID-----LDQSRTDLDSIRRETKTMS 81
Y++ +E+G G AIV K T A K I + + I RE +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQK---GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSA 140
+ HPNI+ H F + + +++ +S G L + + L E LK+ L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDG 120
Query: 141 LSYLHNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
+ YLH++ H D+K NI+ + + +KL DFG++ E + ++
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-HKIEAGN-------EFKNIF 172
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP ++APE++ + +AD+WS G+ L LS P F
Sbjct: 173 GTPEFVAPEIVN-YEPLGLEADMWSIGVITYIL------LSGASP-----------FLGE 214
Query: 257 DYEKTL-KIKDKNKKFSRAF--------KDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
++TL I N F + KD + L +DP +R + + ++HS+ K +
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 44/312 (14%)
Query: 2 AHHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIK 59
H + GT A++ Y I+ +G G V K T A+K
Sbjct: 6 HHSSGRENLYFQGTFAER---------YNIVCMLGKGSFGEVLKCKDR---ITQQEYAVK 53
Query: 60 AIDLDQSRT-DLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSII 117
I+ ++ D +I RE + + L HPNI+ S ++V + G L II
Sbjct: 54 VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113
Query: 118 SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGV 174
E A ++K+ S ++Y+H +HRD+K NIL + D +K+ DFG+
Sbjct: 114 KRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP 234
S + + M D GT Y++APEV+R Y K D+WS G+ L G P
Sbjct: 171 STCFQQ-------NTKM-KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTP 220
Query: 235 PLSHLPPEKSLLMK-MTQRFRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
P E +L + T ++ F +T+ S KD++ L PS R +
Sbjct: 221 PFYG-KNEYDILKRVETGKYAFDLPQWRTI---------SDDAKDLIRKMLTFHPSLRIT 270
Query: 293 AEKLMKHSFFKN 304
A + ++H + +
Sbjct: 271 ATQCLEHPWIQK 282
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-43
Identities = 79/338 (23%), Positives = 130/338 (38%), Gaps = 44/338 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID-------LDQSRTDLDSIRRETKT 79
Y + +G G V A T VAIK I + ++ E +
Sbjct: 12 YIMSKTLGSGACGEVKLAFER---KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETL 138
+ L+HP I+ F ++V+ M G L ++ + L E + + L
Sbjct: 69 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQML 124
Query: 139 SALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
A+ YLH G +HRD+K N+L + D +K+ DFG S + E S M +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-------TSLM-RTL 176
Query: 196 AGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-R 252
GTP ++APEV+ S GY+ D WS G+ G PP S + SL ++T +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 253 FRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEF 311
+ F + + S D+V L DP R + E+ ++H + ++ + +F
Sbjct: 237 YNFIPEVWAEV---------SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 287
Query: 312 FVKNVLHGLRSVEERFKESRNHVGAEHHEDEEFEVGSS 349
L + + E E +
Sbjct: 288 ---QDLLSEENESTALPQVLAQPSTSRKRPREGEAEGA 322
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 31/282 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y + + IG G V A+ A K I D+D ++E + M L HPNI
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNI 68
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
+ + +F ++ +++VM + G L + ++ E A ++K+ LSA++Y H
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKL 125
Query: 148 GHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
HRD+K N L D +KL DFG++A ++P M+ GTPY+++P
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGK-------MMRTKVGTPYYVSP 177
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK-MTQRFRF-SDYEKTL 262
+V+ Y + D WS G+ L G PP P + +++K F F +
Sbjct: 178 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPEKDWLNV 234
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
S + ++ L + P +R ++ + ++H +F+
Sbjct: 235 ---------SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-43
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 46/290 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP 86
Y IL+E+G G +V++ + +T V K I+ D +++ E M+ L HP
Sbjct: 53 YDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHP 108
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
++N H +F + +++ F+S G L I + + + E + +++ L ++H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH 166
Query: 146 NQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+H D+K NI+ + SVK+ DFG++ P ++ T + A
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDE-------IVKVTTATAEFAA 218
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL- 262
PE++ F D+W+ G+ L LS L P F D +TL
Sbjct: 219 PEIVD-REPVGFYTDMWAIGVLGYVL------LSGLSP-----------FAGEDDLETLQ 260
Query: 263 KIKDKNKKF-SRAF-------KDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+K + +F AF KD + + L ++P KR + ++H + K
Sbjct: 261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 74/326 (22%), Positives = 139/326 (42%), Gaps = 35/326 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSH 85
Y + +E+G G ++V + + +T A K I+ + S D + RE + L H
Sbjct: 31 YDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
PNI+ H S +S ++V ++ G L + I++ F E + +++ L +++Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYC 144
Query: 145 HNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
H+ G +HR++K N+L +VKLADFG++ + + A AGTP +
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-------SEAW-HGFAGTPGY 196
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF-SDYEK 260
++PEV++ YS DIW+ G+ L G PP + + + S
Sbjct: 197 LSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKN-VLHG 319
T+ + K ++ S L +P KR +A++ +K + N + + +
Sbjct: 256 TV---------TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 306
Query: 320 LR--SVEERFKESRNHVGAEHHEDEE 343
L+ + + K +
Sbjct: 307 LKKFNARRKLKGAILTTMIATRNLSN 332
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID--------LDQSRTDLDSIRRETK 78
Y+ + +G GVS++V + I T A+K ID ++ + ++ +E
Sbjct: 19 YEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 79 TMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKE 136
+ +S HPNI+ ++ ++ ++V M G L + L E +++
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRA 132
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L + LH +HRD+K NIL D D ++KL DFG S + G + ++
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-------GEKL-REVC 184
Query: 197 GTPYWMAPEVIR-----SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251
GTP ++APE+I +H GY + D+WS G+ L G PP H L M M+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244
Query: 252 RFRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
++F S S KD+V+ L P KR +AE+ + H FF+
Sbjct: 245 NYQFGSPEWDDY---------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 79/367 (21%), Positives = 137/367 (37%), Gaps = 58/367 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID-----LDQSRTDLDSIRRETKTMS 81
Y I +E+G G AIV K ST A K I + + I RE +
Sbjct: 14 YDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSA 140
+ HPNI+ H + + + +++ +S G L + + L E +K+ L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDG 127
Query: 141 LSYLHNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
++YLH + H D+K NI+ + +KL DFG++ E ++
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGV-------EFKNIF 179
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP ++APE++ + +AD+WS G+ L LS P F
Sbjct: 180 GTPEFVAPEIVN-YEPLGLEADMWSIGVITYIL------LSGASP-----------FLGD 221
Query: 257 DYEKTL-KIKDKNKKF-SRAF-------KDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
++TL I + F F KD + L ++ KR + ++ ++H + +
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281
Query: 308 GVEFFVKNVLHGLR-----SVEERFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNF 362
+ + L V R+K S + V +H + + +
Sbjct: 282 QQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESD 341
Query: 363 NEEGFEL 369
EE
Sbjct: 342 TEENIAR 348
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 38/298 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID------------LDQSRTDLDSIRRE 76
Y + ++G G V + AIK I + I E
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+ L HPNI+ F ++V F G L I + E A ++K+
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQ 154
Query: 137 TLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
LS + YLH +HRD+K NIL +S ++K+ DFG+S S + + +
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDY-------KLR 206
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK-MTQR 252
D GT Y++APEV++ Y+ K D+WS G+ L G PP ++ ++ K +
Sbjct: 207 DRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGK 263
Query: 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVE 310
+ F + K S K+++ L D +KR +AE+ + + K +
Sbjct: 264 YYFDF--------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 66/322 (20%), Positives = 121/322 (37%), Gaps = 42/322 (13%)
Query: 6 QEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ 65
++ Q S +G+ + +++ +IG G V+ VA+K
Sbjct: 16 EQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVF---- 68
Query: 66 SRTDLDSIRRETK--TMSLLSHPNILN--AHC--SFSVDSRLWVVMPFMSCGSLQSIISS 119
T+ S RET+ L+ H NIL A ++L+++ + GSL + S
Sbjct: 69 FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS 128
Query: 120 CFPDGLPEPCIAIVLKETLSALSYLHNQGH--------LHRDVKAGNILSDSDGSVKLAD 171
L + + ++S L +LH + HRD+K+ NIL +G+ +AD
Sbjct: 129 ---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-----HTGYSFKADIWSFGITA 226
G++ ++ GT +M PEV+ H AD++SFG+
Sbjct: 186 LGLAVKFISDTNEVDIPP---NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
Query: 227 LELAHG----------RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK 276
E+A + P L P M + + + + + R
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 277 DMVASCLDQDPSKRPSAEKLMK 298
++ C +P+ R +A ++ K
Sbjct: 303 KLMTECWAHNPASRLTALRVKK 324
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-42
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 53/297 (17%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID-----LDQSRTDLDSIRRETKTMS 81
Y +E+G G A+V K ST A K I + + I RE +
Sbjct: 13 YDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSA 140
+ HPN++ H + + + +++ ++ G L + L E LK+ L+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 141 LSYLHNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
+ YLH+ H D+K NI+ + +K+ DFG++ + + ++
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGN-------EFKNIF 178
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTP ++APE++ + +AD+WS G+ L LS P F
Sbjct: 179 GTPEFVAPEIVN-YEPLGLEADMWSIGVITYIL------LSGASP-----------FLGD 220
Query: 257 DYEKTL-KIKDKNKKFSRAF--------KDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
++TL + N +F + KD + L +DP KR + + ++H + K
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-42
Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 34/300 (11%)
Query: 29 YKILDE-IGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLS- 84
Y++ ++ +G G A V I + T A+K I+ Q + RE + +
Sbjct: 14 YQLQEDVLGEGAHARVQTCINL---ITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQG 69
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIIS-SCFPDGLPEPCIAIVLKETLSALS 142
H N+L F + R ++V M GS+ I F E ++V+++ SAL
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASVVVQDVASALD 125
Query: 143 YLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+LHN+G HRD+K NIL + VK+ DF + + I + + G+
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 200 YWMAPEVIR----SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255
+MAPEV+ + Y + D+WS G+ L G PP +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG---RCGSDCGWDRGEAC 242
Query: 256 SDYEKTL--KIKDKNKKF--------SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305
+ L I++ +F S A KD+++ L +D +R SA ++++H + + C
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 63/327 (19%), Positives = 111/327 (33%), Gaps = 48/327 (14%)
Query: 3 HHEQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID 62
H S + + ++L+ G V+KA + VA+K
Sbjct: 2 GHHHHHHSSGVDLGTENLY--FQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIF- 55
Query: 63 LDQSRTDLDSIRRETK--TMSLLSHPNILN--AHC--SFSVDSRLWVVMPFMSCGSLQSI 116
D S + E + ++ + H NIL SVD LW++ F GSL
Sbjct: 56 ---PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 117 ISSCFPDGLPEPCIAIVLKETLSALSYLHNQGH----------LHRDVKAGNILSDSDGS 166
+ + + + + + + L+YLH HRD+K+ N+L ++ +
Sbjct: 113 LKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSF----KADIWSF 222
+ADFG++ + GT +MAPEV+ + + D+++
Sbjct: 170 ACIADFGLALK-----FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 223 GITALELAHGRPPLSHLPPEKSL-----------LMKMTQRFRFSDYEKTLKIKDKNKKF 271
G+ ELA E L L M + L+ +
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 272 SRAFKDMVASCLDQDPSKRPSAEKLMK 298
+ + C D D R SA + +
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-41
Identities = 69/321 (21%), Positives = 132/321 (41%), Gaps = 42/321 (13%)
Query: 3 HHEQEDQCSSTGTIAQKIQYPLDP--SSYKILD-EIGVGVSAIVYKAICIPMDST--VVA 57
HH ++ + Y + E+G G A+V + I ST A
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK---STGQEYA 58
Query: 58 IKAIDLDQ-SRTDLDSIRRETKTMSLLSH-PNILNAHCSFSVDSRLWVVMPFMSCGSLQS 115
K + + + I E + L P ++N H + S + +++ + + G + S
Sbjct: 59 AKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS 118
Query: 116 IISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADF 172
+ + + E + ++K+ L + YLH +H D+K NIL G +K+ DF
Sbjct: 119 LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
G+S + + ++ GTP ++APE++ + + D+W+ GI A L
Sbjct: 179 GMSR-KIGHAC-------ELREIMGTPEYLAPEILN-YDPITTATDMWNIGIIAYML--- 226
Query: 233 RPPLSHLPP-----EKSLLMKMTQ-RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
L+H P + + ++Q +S+ + S+ D + S L ++
Sbjct: 227 ---LTHTSPFVGEDNQETYLNISQVNVDYSE--------ETFSSVSQLATDFIQSLLVKN 275
Query: 287 PSKRPSAEKLMKHSFFKNCNK 307
P KRP+AE + HS+ + +
Sbjct: 276 PEKRPTAEICLSHSWLQQWDF 296
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y++ +E+G G ++V + + + A I+ + S D + RE + LL HPN
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
I+ H S S + +++ ++ G L + I++ + E + +++ L A+ + H
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQ 128
Query: 147 QGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
G +HR++K N+L +VKLADFG++ + AGTP +++
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-------AWFGFAGTPGYLS 181
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF-SDYEKTL 262
PEV+R Y D+W+ G+ L G PP + + F S T+
Sbjct: 182 PEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ KD++ L +PSKR +A + +KH + +
Sbjct: 241 ---------TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-41
Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLS 84
Y I +E+G G +V++ +T A K + +D +++R+E +TMS+L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMT-PHESDKETVRKEIQTMSVLR 212
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HP ++N H +F D+ + ++ FMS G L + + + E +++ L +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCH 270
Query: 144 LHNQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+H ++H D+K NI+ + +KL DFG++A +P + GT +
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQS-------VKVTTGTAEF 322
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP-----EKSLLMKMTQ-RFRF 255
APEV + D+WS G+ + L LS L P + L + +
Sbjct: 323 AAPEVAE-GKPVGYYTDMWSVGVLSYIL------LSGLSPFGGENDDETLRNVKSCDWNM 375
Query: 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
D S KD + L DP+ R + + ++H + N
Sbjct: 376 DD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-41
Identities = 78/307 (25%), Positives = 134/307 (43%), Gaps = 38/307 (12%)
Query: 11 SSTGTIAQKIQYPLDPSS-------YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL 63
++ GT + Y +D S+ +++ E+G G ++IVY+ A+K +
Sbjct: 30 AAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQ-KPYALKVLK- 87
Query: 64 DQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFP 122
D +R E + LSHPNI+ F + + +V+ ++ G L I+ +
Sbjct: 88 --KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY- 144
Query: 123 DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIY 179
E A +K+ L A++YLH G +HRD+K N+L D +K+ADFG+
Sbjct: 145 --YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGL----- 197
Query: 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL 239
S H M + GTP + APE++R Y + D+WS GI L G P
Sbjct: 198 --SKIVEHQVLM-KTVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDE 253
Query: 240 PPEKSLLMKMTQ-RFRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297
++ + ++ + F S + + S KD+V + DP KR + + +
Sbjct: 254 RGDQFMFRRILNCEYYFISPWWDEV---------SLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 298 KHSFFKN 304
+H +
Sbjct: 305 QHPWVTG 311
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 68/322 (21%), Positives = 122/322 (37%), Gaps = 43/322 (13%)
Query: 7 EDQCSS-TGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ 65
D +S +G+ + + + + IG G V++ VA+K
Sbjct: 21 YDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIF---- 73
Query: 66 SRTDLDSIRRETK--TMSLLSHPNILN--AHCSFSVDS--RLWVVMPFMSCGSLQSIISS 119
S + S RE + +L H NIL A + + +LW+V + GSL ++
Sbjct: 74 SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 133
Query: 120 CFPDGLPEPCIAIVLKETLSALSYLHNQGH--------LHRDVKAGNILSDSDGSVKLAD 171
E I + L T S L++LH + HRD+K+ NIL +G+ +AD
Sbjct: 134 YTVT--VEGMIKLAL-STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR-----SHTGYSFKADIWSFGITA 226
G++ GT +MAPEV+ H +ADI++ G+
Sbjct: 191 LGLAVRH---DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
Query: 227 LELAHG----------RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK 276
E+A + P L P + +M + + + ++ + R
Sbjct: 248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307
Query: 277 DMVASCLDQDPSKRPSAEKLMK 298
++ C + + R +A ++ K
Sbjct: 308 KIMRECWYANGAARLTALRIKK 329
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 80/292 (27%), Positives = 138/292 (47%), Gaps = 40/292 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDL-------DQSRTDLDSIRRETKT 79
Y D IG GVS++V + + +T A+K +++ +Q ++ RRET
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHR---ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 80 MSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKET 137
+ ++ HP+I+ S+ S +++V M G L + L E +++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSL 209
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
L A+S+LH +HRD+K NIL D + ++L+DFG S + G + ++ G
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-------GEKL-RELCG 261
Query: 198 TPYWMAPEVIR-----SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252
TP ++APE+++ +H GY + D+W+ G+ L G PP H L M M +
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321
Query: 253 FRF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
++F S S KD+++ L DP R +AE+ ++H FF+
Sbjct: 322 YQFSSPEWDDR---------SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 65/299 (21%), Positives = 122/299 (40%), Gaps = 41/299 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID---LDQSRTDLDSIRRETKTMSLLSH 85
Y + D +G G V + + A+K + L + ++++E + + L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 86 PNILNAH--CSFSVDSRLWVVMPFMSCGS---LQSIISSCFPDGLPEPCIAIVLKETLSA 140
N++ ++++VM + CG L S+ P + +
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFCQLIDG 121
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L YLH+QG +H+D+K GN+L + G++K++ GV+ ++ H T G+P
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRT-SQGSPA 176
Query: 201 WMAPEVIRSHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR-----FR 254
+ PE+ +S FK DIWS G+T + G P E + K+ + +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG-----LYPFEGDNIYKLFENIGKGSYA 231
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
D++ L+ +P+KR S ++ +HS+F+ + E V
Sbjct: 232 IPGD------------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 40/291 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTM-SLLSH 85
Y++ ++IGVG ++ + I +T A+K ID E + + H
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHK---ATNMEFAVKIID-----KSKRDPTEEIEILLRYGQH 75
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
PNI+ + ++VV M G L I+ F E + VL + YL
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYL 132
Query: 145 HNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
H QG +HRD+K NIL S + S+++ DFG + + + ++ T
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-------LLMTPCYTAN 185
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK---MTQRFRF-S 256
++APEV+ GY DIWS G+ + G P ++ P + + + +F
Sbjct: 186 FVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
Y ++ S KD+V+ L DP +R +A +++H + + ++
Sbjct: 245 GYWNSV---------SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-40
Identities = 61/294 (20%), Positives = 118/294 (40%), Gaps = 42/294 (14%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLS-H 85
+G G +I K + + A+K I + + ++E + L H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHK---KSNQAFAVKIIS----KRMEANTQKEITALKLCEGH 65
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
PNI+ H F ++VM ++ G L + I E + ++++ +SA+S++
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHM 122
Query: 145 HNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
H+ G +HRD+K N+L + + +K+ DFG + + + T ++
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-------PLKTPCFTLHY 175
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
APE++ GY D+WS G+ + G+ P + +
Sbjct: 176 AAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQS-HDRSLTCTSAVEIMK------- 226
Query: 262 LKIKDKNKKF--------SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
KIK + F S+ KD++ L DP+KR L + + ++ ++
Sbjct: 227 -KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 36/323 (11%), Positives = 79/323 (24%), Gaps = 73/323 (22%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL 83
P + +G +A + + + ++ E + LL
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 84 -------------------------SHPNILNAHCSFSVDSRL--WVVMPFMSCGS---L 113
++ L + + P M
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 114 QSIISSCFPDG-LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
+ ++S L + + + L+ LH+ G +H ++ +I+ D G V L F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----------TGYSFKADIWSF 222
G+ + + + PE+ T +F D W+
Sbjct: 251 EHL---------VRDGAR--VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299
Query: 223 GITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKFSRAFKDMVAS 281
G+ + P I K + + ++
Sbjct: 300 GLVIYWIWCADLP-----------------ITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
Query: 282 CLDQDPSKRPSAEKLMKHSFFKN 304
L R + M+ ++
Sbjct: 343 FLRYPKEDRLLPLQAMETPEYEQ 365
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 27 SSYKI--LDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSL 82
S Y + + +G G V+K +T +A K I + D + ++ E M+
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEET---ATGLKLAAKIIKTRGMK-DKEEVKNEISVMNQ 142
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL-QSIISSCFPDGLPEPCIAIVLKETLSAL 141
L H N++ + +F + + +VM ++ G L II + L E + +K+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGI 200
Query: 142 SYLHNQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
++H LH D+K NIL + +K+ DFG++ Y+P + GTP
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPRE-------KLKVNFGTP 252
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP-----EKSLLMKMTQ-RF 253
++APEV+ + SF D+WS G+ A L LS L P + L + R+
Sbjct: 253 EFLAPEVVN-YDFVSFPTDMWSVGVIAYML------LSGLSPFLGDNDAETLNNILACRW 305
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
D ++ + S K+ ++ L ++ S R SA + +KH + +
Sbjct: 306 DLED--------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 36/302 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIR-RETKTMSLLSH 85
Y+ + +IG G +V+K T +VAIK + + I RE + + L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNR---DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
PN++N F RL +V + ++ + G+PE + + +TL A+++ H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCH 119
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+HRDVK NIL +KL DFG + + PS ++ D T ++ +PE
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-------DDEVATRWYRSPE 172
Query: 206 VIRSHTGYSFKADIWSFG-ITALELAHGRPPL---SHL------------PPEKSL---- 245
++ T Y D+W+ G + A EL G P S + +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFA-ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305
+ + D E ++ K S ++ CL DP++R + E+L+ H +F+N
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291
Query: 306 NK 307
+
Sbjct: 292 RE 293
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 39/300 (13%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--TDLDSIRRETKTMSLLSHP 86
Y+ L++IG G V+KA +VA+K + LD ++R E + L H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ H D +L +V F L+ SC L + L + L L + H+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM-APE 205
+ LHRD+K N+L + +G +KLA+FG++ + P + ++T W P+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVT------LWYRPPD 171
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----------- 254
V+ YS D+WS G ELA+ PL L ++ FR
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI---FRLLGTPTEEQWP 228
Query: 255 ----------FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ Y T + + K + +D++ + L +P +R SAE+ ++H +F +
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-39
Identities = 57/277 (20%), Positives = 118/277 (42%), Gaps = 21/277 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+ ++ +G G V A+ VA+K +D+ ++ ++I++E +L+H N+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + + ++ + + S G L I G+PEP + ++ + YLH G
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR 208
HRD+K N+L D ++K++DFG++ +++ ++ M GT ++APE++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLLNKMCGTLPYVAPELL- 179
Query: 209 SHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR-FRFSDYEKTLKIKD 266
+ D+WS GI + G P ++ + +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW-------- 231
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
KK A ++ L ++PS R + + K ++
Sbjct: 232 --KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 38/308 (12%), Positives = 78/308 (25%), Gaps = 62/308 (20%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLS---HPNIL 89
+G +A + + + ++ E + LL +
Sbjct: 86 LGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 90 NAHCSFSV-------------------DSRLWVVMPFM----SCGSLQSIISSCFPDG-- 124
H F + +WV+ F +LQ+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 125 ---LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181
L + + + L+ LH+ G +H ++ +I+ D G V L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLS 237
+ + I P A ++ T +F D W+ G+ + P
Sbjct: 265 A------VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-- 316
Query: 238 HLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
I K + + ++ L R +
Sbjct: 317 ---------------NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361
Query: 297 MKHSFFKN 304
M+ ++
Sbjct: 362 METPEYEQ 369
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-39
Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 36/299 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIR-RETKTMSLLSH 85
Y+ L +G G +V K T +VAIK + I RE K + L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNK---DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
N++N R ++V F+ ++ + P+GL + L + ++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF-PNGLDYQVVQKYLFQIINGIGFCH 141
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+ +HRD+K NIL G VKL DFG + ++ P + D T ++ APE
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-------DDEVATRWYRAPE 194
Query: 206 VIRSHTGYSFKADIWSFG-ITALELAHGRP--P-------LSHL------PPEKS----L 245
++ Y D+W+ G + E+ G P P L H+ +
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ R + ++ ++ + K S D+ CL DP KRP +L+ H FF+
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 69/325 (21%), Positives = 118/325 (36%), Gaps = 41/325 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-------LDQSRTDLDSIRRETKTMS 81
Y + +G G V+ A+ + V +K I L + E +S
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPF-MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
+ H NI+ F +VM S L + I L EP + + ++ +SA
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSA 142
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YL + +HRD+K NI+ D ++KL DFG +A + G T GT
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-------ERGKLFYT-FCGTIE 194
Query: 201 WMAPEVIRSHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
+ APEV+ Y + ++WS G+T L P F + E
Sbjct: 195 YCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENP-------------------FCELE 234
Query: 260 KTLKIK-DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLH 318
+T++ S+ +V+ L P +R + EKL+ + ++ + V
Sbjct: 235 ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294
Query: 319 GLRSVEERFKESRNHVGAEHHEDEE 343
+ + +G D
Sbjct: 295 VNKPESGVLSAASLEMGNRSLSDVA 319
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 34/260 (13%)
Query: 57 AIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
A+K ++ + R ++ ++ +E + M L HP ++N SF + +++V+ + G L+
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 115 SIIS--SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
+ F E + + + E + AL YL NQ +HRD+K NIL D G V + DF
Sbjct: 104 YHLQQNVHFK----EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDF 159
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELA 230
++A + IT MAGT +MAPE+ S GYSF D WS G+TA EL
Sbjct: 160 NIAAML--------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 231 HGRPP---LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDP 287
GR P S ++ + T + +S+ ++ L+ +P
Sbjct: 212 RGRRPYHIRSSTSSKEIVHTFETTVVTYPSA------------WSQEMVSLLKKLLEPNP 259
Query: 288 SKR-PSAEKLMKHSFFKNCN 306
+R + + + N
Sbjct: 260 DQRFSQLSDVQNFPYMNDIN 279
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 86/307 (28%), Positives = 139/307 (45%), Gaps = 40/307 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSR--TDLDSIRRETKTMSL 82
Y+ L+++G G +VYKA DS +VA+K I LD +IR E +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK----DSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKE 75
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
L HPNI++ + L +V FM L+ ++ GL + I I L + L ++
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVA 133
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+ H LHRD+K N+L +SDG++KLADFG++ + P + H ++T W
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VVT------LWY 185
Query: 203 -APEVIRSHTGYSFKADIWSFGITALELAHGRPPL---SHL------------PPEKS-- 244
AP+V+ YS DIWS G E+ G+P + P +
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 245 --LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
+ + ++ F +EK F + D++++ L DP+KR SA M H +F
Sbjct: 246 QVQELPLWKQRTFQVFEKK-PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304
Query: 303 KNCNKGV 309
K+ + +
Sbjct: 305 KDLDPQI 311
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 63/319 (19%), Positives = 106/319 (33%), Gaps = 61/319 (19%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK--TMS 81
LD + K+L+ IG G VYK +D VA+K S + + E +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGS---LDERPVAVKVF----SFANRQNFINEKNIYRVP 62
Query: 82 LLSHPNILN-----AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
L+ H NI + +VM + GSL +S +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHS 119
Query: 137 TLSALSYLHNQGHL---------HRDVKAGNILSDSDGSVKLADFGVS-ASIYEPSHHHH 186
L+YLH + HRD+ + N+L +DG+ ++DFG+S
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 187 HGSAMITDMAGTPYWMAPEVIRSH------TGYSFKADIWSFGITALELAHG-------- 232
GT +MAPEV+ + D+++ G+ E+
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 233 -----RPPLSHLPPEKSLLMKM-----TQRFRFSDYEKTLKIKD---KNKKFSRAFKDMV 279
+ M ++ R K + +N R+ K+ +
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR-------PKFPEAWKENSLAVRSLKETI 292
Query: 280 ASCLDQDPSKRPSAEKLMK 298
C DQD R +A+ +
Sbjct: 293 EDCWDQDAEARLTAQXAEE 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 78/304 (25%), Positives = 135/304 (44%), Gaps = 45/304 (14%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSR--TDLDSIRRETKTMSLLS 84
Y L++IG G +VYKA ++ A+K I L++ +IR E + L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ----NNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 85 HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYL 144
H NI+ + RL +V + L+ ++ C GL L + L+ ++Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYC 116
Query: 145 HNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM-A 203
H++ LHRD+K N+L + +G +K+ADFG++ + P + H ++T W A
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVT------LWYRA 168
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR--------- 254
P+V+ YS DIWS G E+ +G P L P S ++ + FR
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP----LFPGVSEADQLMRIFRILGTPNSKN 224
Query: 255 ------FSDYEKTLK------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
Y+ + K + D+++ L DP++R +A++ ++H++F
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
Query: 303 KNCN 306
K N
Sbjct: 285 KENN 288
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-38
Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 30/279 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y++L IG G A V A I VAIK ID Q + T L + RE + M +L+HPN
Sbjct: 17 YRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ + L+++M + S G + + + + E ++ +SA+ Y H +
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
+HRD+KA N+L D+D ++K+ADFG S G + G P + APE+
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSN-------EFTVGGKLDA-FCGAPPYAAPELF 185
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQ-RFRFSDYEKTLKI 264
+ + D+WS G+ L G P +L L ++ + ++R Y
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVLRGKYRIPFY------ 236
Query: 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
S ++++ L +P KR + E++MK +
Sbjct: 237 ------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 45/296 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT-----DLDSIRRETKTMSLL 83
Y++ +G G V+ + D VAIK I ++ D + E + +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 84 S----HPNILNAHCSFSVDSRLWVVMPF-MSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
HP ++ F +V+ + L I+ L E + +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVV 149
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
+A+ + H++G +HRD+K NIL D G KL DFG A + + D G
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYT--------DFDG 200
Query: 198 TPYWMAPEVIRSHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
T + PE I H Y A +WS GI ++ G P F
Sbjct: 201 TRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIP-------------------FE 240
Query: 257 DYEKTLKIK-DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEF 311
++ L+ + S ++ CL PS RPS E+++ + + + V
Sbjct: 241 RDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
Y + D +GVG V VA+K ++ + S + I+RE + + L HP
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
+I+ + S + ++VM ++S G L I + E + ++ LSA+ Y H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHR 129
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+HRD+K N+L D+ + K+ADFG+S + T G+P + APEV
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLR------T-SCGSPNYAAPEV 181
Query: 207 IRSHTGYS-FKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQ-RFRFSDYEKTL 262
I S Y+ + DIWS G+ L G P H+P +L K+ F +Y
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGGVFYIPEY---- 233
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+R+ ++ L DP KR + + + +H +FK
Sbjct: 234 --------LNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 68/339 (20%), Positives = 136/339 (40%), Gaps = 32/339 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+ ++ +G G V A+ VA+K +D+ ++ ++I++E +L+H N+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + + ++ + + S G L I G+PEP + ++ + YLH G
Sbjct: 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR 208
HRD+K N+L D ++K++DFG++ +++ ++ M GT ++APE++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLLNKMCGTLPYVAPELL- 179
Query: 209 SHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR-FRFSDYEKTLKIKD 266
+ D+WS GI + G P ++ + +
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW-------- 231
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEER 326
KK A ++ L ++PS R + + K ++ K ++ K R
Sbjct: 232 --KKIDSAPLALLHKILVENPSARITIPDIKKDRWYN---KPLKKGAK------RPRVTS 280
Query: 327 FKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEE 365
S + G H + SP R G +++E
Sbjct: 281 GGVSESPSGFSKHIQSNLDF--SPVNSASRTPGSGWSKE 317
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 43/287 (14%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-----SRTDLDSIRRETKTMSLL 83
Y++ +G G VY I + D+ VAIK ++ D+ + + E + +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 84 SH--PNILNAHCSFSVDSRLWVVMPFMS-CGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
S ++ F +++ L I+ L E + L A
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA 161
Query: 141 LSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+ + HN G LHRD+K NIL D + G +KL DFG A + + + + D GT
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYT--------DFDGTR 212
Query: 200 YWMAPEVIRSHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
+ PE IR H Y A +WS GI ++ G P F
Sbjct: 213 VYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIP-------------------FEHD 252
Query: 259 EKTLKIK-DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
E+ ++ + ++ S + ++ CL PS RP+ E++ H + ++
Sbjct: 253 EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 51/312 (16%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSL 82
S +K L+++G G A VYK + VA+K + LD T + RE M
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAI----REISLMKE 59
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSC---GSLQSIISSCFPDGLPEPCIAIVLKETLS 139
L H NI+ + +++L +V FM + S P GL + + L
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L++ H LHRD+K N+L + G +KL DFG++ + P + ++T
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVT------ 171
Query: 200 YWM-APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR---- 254
W AP+V+ YS DIWS G E+ G+P L P + ++ F
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP----LFPGTNDEEQLKLIFDIMGT 227
Query: 255 -----------FSDYEKTLKIKDKN---KKFSRAFK--------DMVASCLDQDPSKRPS 292
Y ++ + + K D + L +P R S
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 293 AEKLMKHSFFKN 304
A++ + H +F
Sbjct: 288 AKQALHHPWFAE 299
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 81/340 (23%), Positives = 142/340 (41%), Gaps = 47/340 (13%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS----RTDLDSIRRETKTMSLL 83
+Y LD++G G A VYK + +VA+K I L+ T + RE + L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDL 57
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
H NI+ H + L +V ++ L+ + C + + + + L + L L+Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAY 115
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM- 202
H Q LHRD+K N+L + G +KLADFG++ + P+ + + ++T W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VVT------LWYR 167
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR-------- 254
P+++ T YS + D+W G E+A GRP L P ++ ++ FR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRP----LFPGSTVEEQLHFIFRILGTPTEE 223
Query: 255 -------FSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKLMKHS 300
+++ K + + D++ L + R SAE MKH
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 301 FFKNCNKGVEFFVKNV-LHGLRSVEERFKESRNHVGAEHH 339
FF + + + + L+ ++ + + S HH
Sbjct: 284 FFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSAHHHHH 323
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-36
Identities = 64/277 (23%), Positives = 110/277 (39%), Gaps = 52/277 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y++ I G +Y A+ ++ V +K + E + ++ + HP+I
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 89 LN-----AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ H D ++VM ++ SL+ P IA +L E L ALSY
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP---VAEAIAYLL-EILPALSY 197
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH+ G ++ D+K NI+ + +KL D G + I + + GTP + A
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGY-----------LYGTPGFQA 245
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPP-----LSHLPPEKSLLMKMTQRFRFSDY 258
PE++R TG + DI++ G T L P + LP + +L
Sbjct: 246 PEIVR--TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVL------------ 291
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-SAE 294
K ++ ++ +D DP +R +AE
Sbjct: 292 -----------KTYDSYGRLLRRAIDPDPRQRFTTAE 317
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 80/359 (22%), Positives = 133/359 (37%), Gaps = 58/359 (16%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDP--SSYKILDE-IGVGVSAIVYKAICIPMDST--V 55
MAHH S + Q + Y++ + +G+GV+ V + T
Sbjct: 1 MAHHHHHHS-SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHR---RTGQK 56
Query: 56 VAIKAIDLDQSRTDLDSIRRETKTM-SLLSHPNILNAHCSF----SVDSRLWVVMPFMSC 110
A+K + D R+E P+I+ + L ++M M
Sbjct: 57 CALKLLY------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110
Query: 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNIL---SDSDGSV 167
G L S I E A ++++ +A+ +LH+ HRDVK N+L + D +
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITAL 227
KL DFG + + + + TPY++APEV+ Y D+WS G+
Sbjct: 171 KLTDFGFAKETTQNA---------LQTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMY 220
Query: 228 ELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF--------SRAFKDMV 279
L G PP + +++ M +R R Y F S K ++
Sbjct: 221 ILLCGFPPF-YSNTGQAISPGMKRRIRLGQYG-----------FPNPEWSEVSEDAKQLI 268
Query: 280 ASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEERFKESRNHVGAEH 338
L DP++R + + M H + + LH R V + K+ + V E
Sbjct: 269 RLLLKTDPTERLTITQFMNHPWINQSMVVPQ----TPLHTAR-VLQEDKDHWDEVKEEM 322
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 89/304 (29%), Positives = 126/304 (41%), Gaps = 42/304 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR----RETKTMSL 82
Y+ LD +G G A VYKA + +VAIK I L D I RE K +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
LSHPNI+ +F S + +V FM L+ II L I + TL L
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLE 126
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
YLH LHRD+K N+L D +G +KLADFG++ S P+ + H ++T W
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVT------RWY 178
Query: 203 -APEVIRSHTGYSFKADIWSFG-ITALELAHGRPPLSHLPPEKSLLMKMTQRFR------ 254
APE++ Y D+W+ G I A EL P P S L ++T+ F
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILA-ELLLRVP----FLPGDSDLDQLTRIFETLGTPT 233
Query: 255 ---------FSDYE-----KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
DY + + D++ +P R +A + +K
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293
Query: 301 FFKN 304
+F N
Sbjct: 294 YFSN 297
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 37/308 (12%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH 85
S +++ +G G +V A P +VAIK I+ RE K + H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 86 PNILNAHCSFSVDSR-----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
NI+ DS ++++ M L +IS+ L + I + +TL A
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST---QMLSDDHIQYFIYQTLRA 124
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG---VSASIYEPSHHHHHGSAMITDMAG 197
+ LH +HRD+K N+L +S+ +K+ DFG + + + + +
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL---------PPE 242
T ++ APEV+ + YS D+WS G EL RP L P
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEK 295
+ L + R +Y K+L + + F D++ L DP+KR +A++
Sbjct: 245 DNDLRCIESP-RAREYIKSLPMYPA-APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 296 LMKHSFFK 303
++H + +
Sbjct: 303 ALEHPYLQ 310
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 76/303 (25%), Positives = 128/303 (42%), Gaps = 43/303 (14%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
SY IG G +VY+A +VAIK + D+ + RE + M L H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKRFKN-----RELQIMRKLDHCN 108
Query: 88 ILN-AHCSFSVDSR-----LWVVMPFMSCGSLQSII--SSCFPDGLPEPCIAIVLKETLS 139
I+ + +S + L +V+ ++ ++ + S LP + + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+L+Y+H+ G HRD+K N+L D D +KL DFG SA G ++ + +
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVR------GEPNVSYIC-S 219
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFG-ITALELAHGRP--P-------LSHL-----PPEK 243
Y+ APE+I T Y+ D+WS G + A EL G+P P L + P +
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278
Query: 244 SLLMKMT---QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
+ +M F+F + K + + + L+ P+ R + + HS
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 301 FFK 303
FF
Sbjct: 339 FFD 341
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 35/292 (11%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL 83
P +K +G G + V A + S AIK ++ + + RE MS L
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII--SSCFPDGLPEPCIAIVLKETLSAL 141
HP + + +F D +L+ + + G L I F E C E +SAL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD----ETCTRFYTAEIVSAL 143
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YLH +G +HRD+K NIL + D +++ DFG + + S S GT +
Sbjct: 144 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-----FVGTAQY 198
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
++PE++ +D+W+ G +L G PP + ++K
Sbjct: 199 VSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLI--------FQKI 244
Query: 262 LKIKDK-NKKFSRAFKDMVASCLDQDPSKRP------SAEKLMKHSFFKNCN 306
+K++ +KF +D+V L D +KR L H FF++
Sbjct: 245 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-35
Identities = 58/257 (22%), Positives = 110/257 (42%), Gaps = 24/257 (9%)
Query: 57 AIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
A K ++ + R E + + ++ +++ ++ L +V+ M+ G L+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174
I G PE E L LH + ++RD+K NIL D G ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP 234
+ + E I GT +MAPEV+++ Y+F D W+ G E+ G+
Sbjct: 333 AVHVPE--------GQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQS 383
Query: 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR---- 290
P +K ++ + + E + + +FS + + + L +DP++R
Sbjct: 384 PFQQ-RKKKIKREEVERLVK----EVPEEYSE---RFSPQARSLCSQLLCKDPAERLGCR 435
Query: 291 -PSAEKLMKHSFFKNCN 306
SA ++ +H FK N
Sbjct: 436 GGSAREVKEHPLFKKLN 452
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-35
Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 24/273 (8%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSI---RRETKTMSLLSH 85
Y++ +G G VY+A + V A+K + S D +RE +T L
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIV-ALKLMSETLSS-DPVFRTRMQREARTAGRLQE 93
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
P+++ H +D +L+V M ++ L +++ P L P ++++ SAL H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAH 151
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
G HRDVK NIL +D L DFG+ AS G+ + GT Y+MAPE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGI-ASATTDEKLTQLGNTV-----GTLYYMAPE 205
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
+++ADI++ E G PP S++ + +
Sbjct: 206 RFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQL--SVMGAHIN-------QAIPRPS 255
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKR-PSAEKLM 297
AF ++A + ++P R + L
Sbjct: 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 76/356 (21%), Positives = 130/356 (36%), Gaps = 59/356 (16%)
Query: 29 YKILDE-IGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLS- 84
YK+ + +G+G++ V + T A+K + D RRE + S
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQ------DCPKARREVELHWRASQ 113
Query: 85 HPNILNAHCSF----SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
P+I+ + + L +VM + G L S I E + ++K A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 141 LSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
+ YLH+ HRDVK N+L + +KL DFG + +++ T
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-------HNSL-TTPCY 225
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP---LSHLPPEKSLLMK-MTQRF 253
TPY++APEV+ Y D+WS G+ L G PP L + + ++
Sbjct: 226 TPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFV 313
F + E + S K ++ + L +P++R + + M H + K V
Sbjct: 285 EFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK-----V 331
Query: 314 KNVLHGLRSVEERFKESRNHVG--------AEHHEDEEFEVGSSPPVK-----QRR 356
V + KE V + E+ ++ +RR
Sbjct: 332 PQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRR 387
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 79/313 (25%), Positives = 135/313 (43%), Gaps = 60/313 (19%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH 85
+Y IG G +V++A + +S VAIK + D+ + RE + M ++ H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKRFKN-----RELQIMRIVKH 91
Query: 86 PNILN-AHCSFSVDSR-----LWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKET 137
PN+++ +S + L +V+ ++ ++ +P I + + +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L +L+Y+H+ G HRD+K N+L D G +KL DFG SA I G ++ +
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIA------GEPNVSYIC 203
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFG-ITALELAHGRP--P-------LSHL-----PP 241
+ Y+ APE+I T Y+ DIWS G + A EL G+P P L + P
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMA-ELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 242 EKSLLMKMT---QRFRFSDYEKTLKIKDKNKKFSRAFK--------DMVASCLDQDPSKR 290
+ + M +F FS+ F+ D+++ L+ PS R
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRP--------HPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 291 PSAEKLMKHSFFK 303
+A + + H FF
Sbjct: 314 LTAIEALCHPFFD 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 54/314 (17%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR--RETKTMSLLS 84
+++ G G V VAIK + D R + + +++L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH 77
Query: 85 HPNILN-AHCSFSVDSR------LWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLK 135
HPNI+ +++ R L VVM ++ +L + + P I + L
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 136 ETLSALSYLHNQGH--LHRDVKAGNILSD-SDGSVKLADFGVSASIYEPSHHHHHGSAMI 192
+ + ++ LH HRD+K N+L + +DG++KL DFG SA PS +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEPN------- 188
Query: 193 TDMAGTPYWMAPEVIRSHTGYSFKADIWSFG-ITALELAHGRP------PLSHL------ 239
+ Y+ APE+I + Y+ DIWS G I A E+ G P L
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 240 --PPEKSLLMKMT-QRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSK 289
P + +L K+ Y K + FS D++++ L P +
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNS--KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305
Query: 290 RPSAEKLMKHSFFK 303
R + + H +F
Sbjct: 306 RMKPYEALCHPYFD 319
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 78/342 (22%), Positives = 131/342 (38%), Gaps = 62/342 (18%)
Query: 3 HHEQEDQCSSTGTIAQKIQYPLDPSS-----YKILDEIGVGVSAIVYKAICIPMDSTVVA 57
HH + + PS+ Y+ + ++G G VYKAI + VA
Sbjct: 5 HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE-TVA 63
Query: 58 IKAIDLDQSR-----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
IK I L+ T + RE + L H NI+ + RL ++ +
Sbjct: 64 IKRIRLEHEEEGVPGTAI----REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-----DGSV 167
L+ + + I L + ++ +++ H++ LHRD+K N+L +
Sbjct: 119 LKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM-APEVIRSHTGYSFKADIWSFG-IT 225
K+ DFG++ + P H +IT W PE++ YS DIWS I
Sbjct: 177 KIGDFGLARAFGIPIRQFTHE--IIT------LWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 226 ALELAHGRPPLSHLPPEKSLLMKMTQRFR---------------FSDYEKTLKIKDKNKK 270
A E+ P L P S + ++ + F D+ K K + K
Sbjct: 229 A-EMLMKTP----LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW-KQSFPKFRGKT 282
Query: 271 FSRAFK--------DMVASCLDQDPSKRPSAEKLMKHSFFKN 304
R D++ + L+ DP KR SA+ ++H +F +
Sbjct: 283 LKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 52/312 (16%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR----RETKTMSL 82
S Y+ + EIGVG VYKA VA+K++ + + RE +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 83 LS---HPNILN-----AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
L HPN++ A + ++ +V + L++ + P GLP I ++
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
++ L L +LH +HRD+K NIL S G+VKLADFG++ ++T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV---VVT- 182
Query: 195 MAGTPYWM-APEVIRSHTGYSFKADIWSFG-ITALELAHGRPPLSHLPP---EKSLLMKM 249
W APEV+ T Y+ D+WS G I A E+ +P L E L K+
Sbjct: 183 -----LWYRAPEVLLQST-YATPVDMWSVGCIFA-EMFRRKP----LFCGNSEADQLGKI 231
Query: 250 TQ-----------------RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
R F ++ + + ++ L +P KR S
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 293 AEKLMKHSFFKN 304
A + ++HS+
Sbjct: 291 AFRALQHSYLHK 302
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 35/303 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSI---RRETKTMSLLSH 85
YKI+D++G G + VY A ++ VAIKAI + +++ RE S LSH
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPRE-KEETLKRFEREVHNSSQLSH 70
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
NI++ D ++VM ++ +L I S P L + L + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAH 128
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+ +HRD+K NIL DS+ ++K+ DFG+ A + + GT + +PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGI-AKALSETSLTQTNHVL-----GTVQYFSPE 182
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
+ DI+S GI E+ G PP + S+ +K Q
Sbjct: 183 QAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV-SIAIKHIQD------SVPNVTT 234
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRP-SAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVE 324
D K ++ +++ ++D + R + +++ + +VLH R+ E
Sbjct: 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD-------------LSSVLHENRANE 281
Query: 325 ERF 327
+ +
Sbjct: 282 DVY 284
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 79/307 (25%), Positives = 125/307 (40%), Gaps = 48/307 (15%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
P +Y +G G V AI VAIK + QS RE + +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 85 HPNILNAHCSFSVDSR------LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H N++ F+ S ++VMPFM LQ I+ E I ++ + L
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL----KFSEEKIQYLVYQML 136
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
L Y+H+ G +HRD+K GN+ + D +K+ DFG++ A +T T
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA----------DAEMTGYVVT 186
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL---------PPEK 243
++ APEVI S Y+ DIWS G E+ G+ L L P +
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKL 296
+ + + Y ++L + K F++ F D++ L+ D KR +A +
Sbjct: 247 FVQKLNDKAAK--SYIQSLPQTPR-KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303
Query: 297 MKHSFFK 303
+ H FF+
Sbjct: 304 LTHPFFE 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 47/307 (15%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
+ Y+ L +G G V A+ VAIK + QS RE + + +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 85 HPNILNAHCSFSVDSR------LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H N++ F+ D ++VMPFM L ++ + L E I ++ + L
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH---EKLGEDRIQFLVYQML 138
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
L Y+H G +HRD+K GN+ + D +K+ DFG++ + +T T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------DSEMTGYVVT 188
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL---------PPEK 243
++ APEVI + Y+ DIWS G E+ G+ L L PP +
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKL 296
+ + + +Y K L +K K F+ +++ L D +R +A +
Sbjct: 249 FVQRLQSDEAK--NYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 305
Query: 297 MKHSFFK 303
+ H +F+
Sbjct: 306 LAHPYFE 312
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 58/265 (21%), Positives = 108/265 (40%), Gaps = 30/265 (11%)
Query: 55 VVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
V A+K ++ R ++ R E + I H +F ++ L++VM + G
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L +++S F + +P L E + A+ +H G++HRD+K NIL D G ++LADF
Sbjct: 148 LLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS------HTGYSFKADIWSFGITA 226
G + G+ GTP +++PE++++ Y + D W+ G+ A
Sbjct: 207 GSCLKL------RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 227 LELAHGRPPLSHLPPEK--SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLD 284
E+ +G+ P + ++ + ++ + +D + L
Sbjct: 261 YEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV---------PEEARDFIQRLL- 310
Query: 285 QDPSKR---PSAEKLMKHSFFKNCN 306
P R A H FF +
Sbjct: 311 CPPETRLGRGGAGDFRTHPFFFGLD 335
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 33/281 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
Y + D +GVG V VA+K ++ + S + IRRE + + L HP
Sbjct: 18 YILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
+I+ + S S +++VM ++S G L I L E + ++ LS + Y H
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR 134
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+HRD+K N+L D+ + K+ADFG+S + T G+P + APEV
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLR------T-SCGSPNYAAPEV 186
Query: 207 IRSHTGYS-FKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQ-RFRFSDYEKTL 262
I S Y+ + DIWS G+ L G P H+P +L K+ F Y
Sbjct: 187 I-SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGIFYTPQY---- 238
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ + ++ L DP KR + + + +H +FK
Sbjct: 239 --------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 57 AIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
A K ++ + R E K ++ + I++ +F + L +VM M+ G ++
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 115 SIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
I + G EP + +S L +LH + ++RD+K N+L D DG+V+++D
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
G++ G AGTP +MAPE++ Y F D ++ G+T E+
Sbjct: 334 GLAV-------ELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAA 385
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-- 290
R P EK ++ QR E+ + D KFS A KD + L +DP KR
Sbjct: 386 RGPFRA-RGEKVENKELKQRVL----EQAVTYPD---KFSPASKDFCEALLQKDPEKRLG 437
Query: 291 ---PSAEKLMKHSFFKNCN 306
S + L H F++ +
Sbjct: 438 FRDGSCDGLRTHPLFRDIS 456
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 15/216 (6%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L+ + ++IG G V+ D+T+VA+K+ +E + +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 84 SHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
SHPNI L C+ +++VM + G + + + L + ++ + + +
Sbjct: 170 SHPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGM 226
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
YL ++ +HRD+ A N L +K++DFG+S + + G + P
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV------PVK 280
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W APE + YS ++D+WSFGI E G P
Sbjct: 281 WTAPEALNYGR-YSSESDVWSFGILLWETFSLGASP 315
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 39/305 (12%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH 85
Y L IG G +V A + VAIK I + +T RE K + H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 86 PNILNAHCSFSVDSR-----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
NI+ + + +++V M L ++ + L I L + L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRG 140
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L Y+H+ LHRD+K N+L ++ +K+ DFG+ A + +P H H + +T+ T +
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL-ARVADPDHDH---TGFLTEYVATRW 196
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL---------PPEKSL 245
+ APE++ + GY+ DIWS G E+ RP L L P ++ L
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKLMK 298
+ + R +Y +L K+K ++R F D++ L +P KR E+ +
Sbjct: 257 NCIINLKAR--NYLLSLPHKNK-VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 299 HSFFK 303
H + +
Sbjct: 314 HPYLE 318
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 66/281 (23%), Positives = 116/281 (41%), Gaps = 34/281 (12%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
Y I + +G G V A VA+K I + RE + LL HP
Sbjct: 11 YIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
+I+ + + + + +V+ + G L I + E ++ + A+ Y H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR 126
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+HRD+K N+L D + +VK+ADFG+S I + T G+P + APEV
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLK------T-SCGSPNYAAPEV 178
Query: 207 IRSHTGYS-FKADIWSFGITALELAHGRPPL--SHLPPEKSLLMKMTQ-RFRFSDYEKTL 262
I + Y+ + D+WS GI + GR P +P +L K+ + D+
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---NLFKKVNSCVYVMPDF---- 230
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
S + ++ + DP +R + +++ + +F
Sbjct: 231 --------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 64/277 (23%), Positives = 127/277 (45%), Gaps = 25/277 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSI---RRETKTMSLLSH 85
Y++ + +G G + V+ A + V A+K + D +R D RRE + + L+H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLAR-DPSFYLRFRREAQNAAALNH 71
Query: 86 PNILNAH----CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
P I+ + ++VM ++ +L+ I+ + P + V+ + AL
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQAL 129
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
++ H G +HRDVK NI+ + +VK+ DFG++ +I + + +A+I GT +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI----GTAQY 185
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
++PE R + ++D++S G E+ G PP + P S+ + + E
Sbjct: 186 LSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVR-------EDP 236
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRP-SAEKLM 297
+ +++ S +V L ++P R +A ++
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 28/263 (10%)
Query: 55 VVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
V A+K ++ + R + R E + I H +F D+ L++VM + G
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L +++S F D LPE L E + A+ +H ++HRD+K NIL D +G ++LADF
Sbjct: 161 LLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 219
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALE 228
G G+ + GTP +++PE++++ Y + D WS G+ E
Sbjct: 220 GSCL------KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 229 LAHGRPPLSHLPPEK--SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQD 286
+ +G P + +M +RF+F S KD++ +
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQV---------TDVSENAKDLIRRLI-CS 323
Query: 287 PSKR---PSAEKLMKHSFFKNCN 306
R E KH FF +
Sbjct: 324 REHRLGQNGIEDFKKHPFFSGID 346
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 86/361 (23%), Positives = 135/361 (37%), Gaps = 32/361 (8%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y + +IG G + +VA+K I+ + ++++RE L HPNI
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNI 78
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + L ++M + S G L I C E ++ LS +SY H+
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 149 HLHRDVKAGNILSDSD--GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
HRD+K N L D +K+ DFG S S S + GTP ++APEV
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKS-TVGTPAYIAPEV 188
Query: 207 IRSHTGYS-FKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
+ Y AD+WS G+T + G P P E K QR Y
Sbjct: 189 L-LRQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIP---- 242
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEE 325
+ + S +++ DP+ R S ++ HS+F N + E+
Sbjct: 243 -DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQ 301
Query: 326 RFKESRNHVGAEHHEDEEFEVGSSPPVKQRRISGWNFNEEGFELDPVFPFFTTESRADSD 385
+ + + P V+ R + F + +LD F +ES D D
Sbjct: 302 PMQSLDTIMQIISEA-------TIPAVRNRCLDD--FMTDNLDLDDDMDDFDSESEIDID 352
Query: 386 S 386
S
Sbjct: 353 S 353
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTM 80
L + +K + +G G VYK + IP VAIK + S I E M
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 81 SLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
+ + +P++ L C S + ++ M G L + D + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIA 127
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
++YL ++ +HRD+ A N+L + VK+ DFG++ + +H +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV------ 181
Query: 199 PY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P WMA E I Y+ ++D+WS+G+T EL G P
Sbjct: 182 PIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 69/315 (21%), Positives = 123/315 (39%), Gaps = 54/315 (17%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMS 81
Y+ + EIG G V+KA + VA+K + + + + RE +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLR 66
Query: 82 LLS---HPNILNAH-----CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
L HPN++ +++L +V + L + + G+P I +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
+ + L L +LH+ +HRD+K NIL S G +KLADFG++ ++T
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVT 182
Query: 194 DMAGTPYWM-APEVIRSHTGYSFKADIWSFG-ITALELAHGRPPLSHLPPEKSLLMKMTQ 251
W APEV+ + Y+ D+WS G I A E+ +P L S + ++ +
Sbjct: 183 ------LWYRAPEVLLQSS-YATPVDLWSVGCIFA-EMFRRKP----LFRGSSDVDQLGK 230
Query: 252 RFR------------FSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPS 292
+ + + D++ CL +P+KR S
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 293 AEKLMKHSFFKNCNK 307
A + H +F++ +
Sbjct: 291 AYSALSHPYFQDLER 305
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 41/263 (15%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
A+K + ++ ++ ++ E++ + HP + +F RL VM + + G L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174
+S E E +SAL YLH++ ++RD+K N++ D DG +K+ DFG+
Sbjct: 94 FHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 175 S-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233
I + G+ M T GTP ++APEV+ Y D W G+ E+ GR
Sbjct: 152 CKEGISD-------GATMKT-FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGR 202
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDPS 288
P F D+E+ I + +F S K ++A L +DP
Sbjct: 203 LP-----------------FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPK 245
Query: 289 KR-----PSAEKLMKHSFFKNCN 306
+R A+++M+H FF + N
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSIN 268
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 63/311 (20%), Positives = 123/311 (39%), Gaps = 44/311 (14%)
Query: 12 STGTIAQKIQYPLD-----PSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLD 64
+ I+ +++ L+ + + +G G V +A D VA+K + D
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 65 Q-SRTDLDSIRRETKTMSLLSHPNILN--AHCS----FSVDSRLWVVMPFMSCGSLQSII 117
+ +D++ RE M HP++ V++PFM G L + +
Sbjct: 63 IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 118 SSCFPDGLPEPCIAIVLKETL-------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170
+ P + L+ + + YL ++ +HRD+ A N + D +V +A
Sbjct: 123 LASRIGENPFN---LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALEL 229
DFG+S IY ++ ++ + P W+A E + + Y+ +D+W+FG+T E+
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKL------PVKWLALESLADNL-YTVHSDVWAFGVTMWEI 232
Query: 230 A-HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPS 288
G+ P + + + + + R + + D++ C DP
Sbjct: 233 MTRGQTPYAGIENAE-IYNYLIGGNRL----------KQPPECMEEVYDLMYQCWSADPK 281
Query: 289 KRPSAEKLMKH 299
+RPS L
Sbjct: 282 QRPSFTCLRME 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 74/320 (23%), Positives = 128/320 (40%), Gaps = 43/320 (13%)
Query: 2 AHHEQEDQCSSTGTIAQKIQYPLD-----PSSYKILDEIGVGVSAIVYKAICIPMD--ST 54
+HH ++++Q L+ + + +G G V + D S
Sbjct: 4 SHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSL 63
Query: 55 VVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILN--AHCSFS---VDSRLWVVMPFM 108
VA+K + LD S+ +++ E M SHPN++ C + V++PFM
Sbjct: 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 109 SCGSLQSIISSCFPDGLPEPCIAIVLKETL-------SALSYLHNQGHLHRDVKAGNILS 161
G L + + + P+ I L+ L + YL N+ LHRD+ A N +
Sbjct: 124 KYGDLHTYLLYSRLETGPKH---IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 162 DSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIW 220
D +V +ADFG+S IY ++ A + P W+A E + Y+ K+D+W
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKM------PVKWIAIESLADRV-YTSKSDVW 233
Query: 221 SFGITALELA-HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMV 279
+FG+T E+A G P + + + + R + + +++
Sbjct: 234 AFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHGHRL----------KQPEDCLDELYEIM 282
Query: 280 ASCLDQDPSKRPSAEKLMKH 299
SC DP RP+ L
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQ 302
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 62/314 (19%), Positives = 119/314 (37%), Gaps = 49/314 (15%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH 85
S Y L +G G + +V+ A+ D VAIK I L + RE K + L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCD-KRVAIKKIVL-TDPQSVKHALREIKIIRRLDH 67
Query: 86 PNILN--------------AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIA 131
NI+ S + + +++V +M L +++ L E
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ---GPLLEEHAR 123
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSASIYEPSHHHHHGSA 190
+ + + L L Y+H+ LHRD+K N+ ++ D +K+ DFG++ + H
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH----KG 179
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL----- 239
+++ T ++ +P ++ S Y+ D+W+ G E+ G+ L +
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 240 ---PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSK 289
+ ++ Y + + K ++ D + L P
Sbjct: 240 SIPVVHEEDRQELLSVIP--VYIRNDMTEPH-KPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 290 RPSAEKLMKHSFFK 303
R +AE+ + H +
Sbjct: 297 RLTAEEALSHPYMS 310
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 62/265 (23%), Positives = 114/265 (43%), Gaps = 38/265 (14%)
Query: 52 DSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109
A+K +D + ++ E + + ++ P ++ SF +S L++VM +++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 110 CGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167
G + S + F + A + + YLH+ ++RD+K N+L D G +
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAA----QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITAL 227
++ DFG + + + T + GTP +APE+I S GY+ D W+ G+
Sbjct: 181 QVTDFGFAKRVKGRTW---------T-LCGTPEALAPEIILSK-GYNKAVDWWALGVLIY 229
Query: 228 ELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK-NKKFSRAFKDMVASCLDQD 286
E+A G PP P +++ YEK + K + FS KD++ + L D
Sbjct: 230 EMAAGYPPFFADQP-----IQI--------YEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 287 PSKR-----PSAEKLMKHSFFKNCN 306
+KR + H +F +
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 73/334 (21%), Positives = 129/334 (38%), Gaps = 49/334 (14%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPL--DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAI 58
MAHH Q++ + P Y+ L +G G V A VA+
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAV 59
Query: 59 KAIDLD-QSRTDLDSIRRETKTMSLLSHPNILN------AHCSFSVDSRLWVVMPFMSCG 111
K + QS RE + + + H N++ S + +++V M
Sbjct: 60 KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118
Query: 112 SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
L +I+ L + + ++ + L L Y+H+ +HRD+K N+ + D +K+ D
Sbjct: 119 DLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
FG++ + +T T ++ APE++ + Y+ DIWS G EL
Sbjct: 176 FGLARHT----------ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 232 GRP------PLSHL---------PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK 276
GR + L P + L ++ R +Y ++L K F+ F
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR--NYIQSLTQMPK-MNFANVFI 282
Query: 277 -------DMVASCLDQDPSKRPSAEKLMKHSFFK 303
D++ L D KR +A + + H++F
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 73/311 (23%), Positives = 126/311 (40%), Gaps = 43/311 (13%)
Query: 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR----RETKTMSL 82
S Y+ L +IG G V+KA VA+K + ++ + + RE K + L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEK---EGFPITALREIKILQL 72
Query: 83 LSHPNILN--------AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
L H N++N A +++V F L ++S+ I V+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVM 130
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITD 194
+ L+ L Y+H LHRD+KA N+L DG +KLADFG+ A + S + T+
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-ARAF--SLAKNSQPNRYTN 187
Query: 195 MAGTPYWMAPEVIRSHTGYSFKADIWSFG-ITALELAHGRPPL------------SHL-- 239
T ++ PE++ Y D+W G I A E+ P + S L
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLALISQLCG 246
Query: 240 -PPEKS----LLMKMTQRFRFSD-YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293
+ ++ ++ ++ +K + K D++ L DP++R +
Sbjct: 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 294 EKLMKHSFFKN 304
+ + H FF +
Sbjct: 307 DDALNHDFFWS 317
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 63/315 (20%), Positives = 112/315 (35%), Gaps = 51/315 (16%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD----------QSRTDLDSIRR 75
S Y + I G V + + VAIK + + R
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVD--SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSR-----LWVVMPFMSCGSLQSIISSCFPDGLPEPCI 130
E + ++ HPNIL F L++V M L +I + I
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVISPQHI 136
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSA 190
+ L L LH G +HRD+ GNIL + + + DF ++ A
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--------DA 188
Query: 191 MITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL----- 239
T ++ APE++ G++ D+WS G E+ + + + L
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 240 ----PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPS 288
P + ++M + R DY + + ++ D++A L+ +P
Sbjct: 249 VVGTPKIEDVVMFSSPSAR--DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306
Query: 289 KRPSAEKLMKHSFFK 303
+R S E+ ++H +F+
Sbjct: 307 RRISTEQALRHPYFE 321
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 24/260 (9%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+K + +L D+D ++ E +HP ++ H F +SRL+ V+ +++ G L
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
+ LPE E AL+YLH +G ++RD+K N+L DS+G +KL D+G
Sbjct: 98 MFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ + G T GTP ++APE++R Y F D W+ G+ E+ G
Sbjct: 156 MCKEGLRP-------GDTTST-FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAG 206
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-- 290
R P + + EK ++I + S ++ S L++DP +R
Sbjct: 207 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLG 263
Query: 291 ----PSAEKLMKHSFFKNCN 306
+ H FF+N +
Sbjct: 264 CHPQTGFADIQGHPFFRNVD 283
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 73/344 (21%), Positives = 123/344 (35%), Gaps = 91/344 (26%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH 85
Y + +G G IV + I A+K + D + RE M +L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDPRYKN-----RELDIMKVLDH 59
Query: 86 PNILNAHCSFSVDSR--------------------------------------LWVVMPF 107
NI+ F L V+M +
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 108 MSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-D 164
+ +L ++ S G +P I+I + + A+ ++H+ G HRD+K N+L +S D
Sbjct: 120 VPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFG- 223
++KL DFG SA P + + + ++ APE++ T Y+ D+WS G
Sbjct: 179 NTLKLCDFG-SAKKLIP------SEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 224 ITALELAHGRP------PLSHL--------PPEKSLLMKMT---QRFRFSDYEKTLKIKD 266
+ EL G+P + L P K +++M RF +
Sbjct: 231 VFG-ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA------ 283
Query: 267 KNKKFSRAFK--------DMVASCLDQDPSKRPSAEKLMKHSFF 302
K + + D++ L +P R + + M H FF
Sbjct: 284 --KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 18/219 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ + L +G GV V+K + IP V IK I+ R ++ +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 81 SLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
L H +I+ C S L +V ++ GSL + L + +
Sbjct: 70 GSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIA 125
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ YL G +HR++ A N+L S V++ADFGV+ + + A
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT------ 179
Query: 199 PY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P WMA E I Y+ ++D+WS+G+T EL G P
Sbjct: 180 PIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-31
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 27/239 (11%)
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIV 133
R +S P I+ +F +L ++ M+ G L +S E +
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFY 297
Query: 134 LKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMIT 193
E + L ++HN+ ++RD+K NIL D G V+++D G++ + H
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--------- 348
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GT +MAPEV++ Y AD +S G +L G P + +
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------ 402
Query: 254 RFSDYEKTLKIKDK-NKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
TL + + FS + ++ L +D ++R A+++ + FF++ +
Sbjct: 403 ----DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 52/221 (23%), Positives = 88/221 (39%), Gaps = 18/221 (8%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETK 78
QY + + +G G VY+ + VA+K D + + + E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 79 TMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
M L HP+I L + W++M G L + L + + +
Sbjct: 66 IMKNLDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQ 121
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
A++YL + +HRD+ NIL S VKL DFG+S I + ++ + +
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL----- 176
Query: 197 GTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P WM+PE I ++ +D+W F + E+ G+ P
Sbjct: 177 --PIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQP 214
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 76/317 (23%), Positives = 125/317 (39%), Gaps = 56/317 (17%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
Y+ L IG G IV A +D VAIK + Q++T RE M ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 85 HPNILN------AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H NI++ + +++VM M +L +I L ++ +L + L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQML 174
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ +LH+ G +HRD+K NI+ SD ++K+ DFG++ + S M+T T
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVT 226
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL--------PPEKS 244
Y+ APEVI GY DIWS G E+ + + P
Sbjct: 227 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 245 LLMKMTQRFRFSDYEKTLKIKDK---NKKFSRAFK---------------DMVASCLDQD 286
+ K+ R +Y + K F + D+++ L D
Sbjct: 286 FMKKLQPTVR--NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 287 PSKRPSAEKLMKHSFFK 303
P+KR S + ++H +
Sbjct: 344 PAKRISVDDALQHPYIN 360
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 24/260 (9%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A++ + +L D+D ++ E +HP ++ H F +SRL+ V+ +++ G L
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
+ LPE E AL+YLH +G ++RD+K N+L DS+G +KL D+G
Sbjct: 141 MFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ + G T GTP ++APE++R Y F D W+ G+ E+ G
Sbjct: 199 MCKEGLRP-------GDTTST-FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAG 249
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR-- 290
R P + + EK ++I + S ++ S L++DP +R
Sbjct: 250 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLG 306
Query: 291 ----PSAEKLMKHSFFKNCN 306
+ H FF+N +
Sbjct: 307 CHPQTGFADIQGHPFFRNVD 326
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 61/264 (23%), Positives = 113/264 (42%), Gaps = 42/264 (15%)
Query: 57 AIKAI---DLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+K + + ++ D + E + + HP I++ +F +L++++ ++S G L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
+ E L E AL +LH +G ++RD+K NI+ + G VKL DFG
Sbjct: 109 FMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ SI++ + GT +MAPE++ G++ D WS G ++ G
Sbjct: 167 LCKESIHD--------GTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTG 217
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDP 287
PP F + +KT+ KI ++ +D++ L ++
Sbjct: 218 APP-----------------FTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNA 260
Query: 288 SKR-----PSAEKLMKHSFFKNCN 306
+ R A ++ H FF++ N
Sbjct: 261 ASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 15/227 (6%)
Query: 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ IG G VY + D A+K+++ ++ E M
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 81 SLLSHPNILNAH-CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
SHPN+L+ + VV+P+M G L++ I + + + +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 139
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH--HHHGSAMITDMAG 197
+ YL ++ +HRD+ A N + D +VK+ADFG++ +Y+ ++ H+ A +
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL----- 194
Query: 198 TPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPE 242
P WMA E +++ ++ K+D+WSFG+ EL G PP +
Sbjct: 195 -PVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 58/318 (18%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
Y+ L IG G IV A ++ VAIK + Q++T RE M ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 85 HPNILNAHCSFSVDSR------LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H NI+ F+ +++VM M +L +I L ++ +L + L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQML 137
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ +LH+ G +HRD+K NI+ SD ++K+ DFG++ + S M+T T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPYVVT 189
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL--------PPEKS 244
Y+ APEVI GY DIWS G E+ G + P
Sbjct: 190 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK-------------------DMVASCLDQ 285
+ K+ R Y + F + F D+++ L
Sbjct: 249 FMKKLQPTVR--TYVENRPKYAG-YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 286 DPSKRPSAEKLMKHSFFK 303
D SKR S ++ ++H +
Sbjct: 306 DASKRISVDEALQHPYIN 323
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 36/265 (13%)
Query: 55 VVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGS 112
V A+K + + R+D E M+ + P ++ +F D L++VM +M G
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L +++S+ +PE E + AL +H+ G +HRDVK N+L D G +KLADF
Sbjct: 156 LVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS---HTGYSFKADIWSFGITALEL 229
G + + G GTP +++PEV++S Y + D WS G+ E+
Sbjct: 213 GTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 230 AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK-----NKKFSRAFKDMVASCLD 284
G P + Y K + K+ + S+ K+++ + L
Sbjct: 267 LVGDTPFYADSLVGT-------------YSKIMNHKNSLTFPDDNDISKEAKNLICAFL- 312
Query: 285 QDPSKR---PSAEKLMKHSFFKNCN 306
D R E++ +H FFKN
Sbjct: 313 TDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 26/293 (8%)
Query: 7 EDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLD 64
D S+ + + P + IG G +VY I AIK++
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 65 QSRTDLDSIRRETKTMSLLSHPNILNAH-CSFSVDSRLWVVMPFMSCGSLQSIISSCFPD 123
+++ RE M L+HPN+L + V++P+M G L I S +
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 124 GLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS- 182
+ + + YL Q +HRD+ A N + D +VK+ADFG++ I +
Sbjct: 121 -PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179
Query: 183 -HHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHL 239
H A + P W A E ++++ ++ K+D+WSFG+ EL G PP H+
Sbjct: 180 YSVQQHRHARL------PVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHI 232
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
P L + Q R + + + ++ C + DP+ RP+
Sbjct: 233 DPFD-LTHFLAQGRRL----------PQPEYCPDSLYQVMQQCWEADPAVRPT 274
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 45/269 (16%), Positives = 75/269 (27%), Gaps = 49/269 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD--LDSIRRETKTMSLLSHP 86
Y++L G ++A+ +D VA+ +D D L T +S + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALD-RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI-VLKETLSALSYLH 145
+ + VV ++ GSLQ + D P P AI ++ +A H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
G + DG V LA M
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPAT---------------------------MPDA 179
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
+ DI G + L R PL L + ++
Sbjct: 180 NPQD--------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-----TAGQPIEPA 226
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAE 294
D ++ + A + D R ++
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRSAST 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 58/216 (26%), Positives = 87/216 (40%), Gaps = 23/216 (10%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L+ K+L IG G V VA+K I D + E M+ L
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGD---YRGNKVAVKCIKNDATAQAF---LAEASVMTQL 71
Query: 84 SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H N++ L++V +M+ GSL + S L C+ + A+
Sbjct: 72 RHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
YL +HRD+ A N+L D K++DFG++ + + P
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKL------PVK 179
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W APE +R +S K+D+WSFGI E+ GR P
Sbjct: 180 WTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 18/219 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTM 80
L + +K + +G G VYK + IP VAIK + S I E M
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 81 SLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
+ + +P++ C S + ++ M G L + D + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIA 127
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
++YL ++ +HRD+ A N+L + VK+ DFG++ + +H +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV------ 181
Query: 199 PY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P WMA E I Y+ ++D+WS+G+T EL G P
Sbjct: 182 PIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 32/290 (11%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + E+G G +VY+ + + T VAIK ++ S + E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL- 138
M + +++ S V+M M+ G L+S + S P P +A +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 139 -------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191
++YL+ +HRD+ A N + D +VK+ DFG++ IYE ++ G +
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 192 ITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKM 249
+ P WM+PE ++ ++ +D+WSFG+ E+A P L E+ +L +
Sbjct: 202 L------PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFV 253
Query: 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ DK +++ C +P RPS +++
Sbjct: 254 MEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 38/265 (14%)
Query: 52 DSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMS 109
+ A+K + + ++ E +S+++HP I+ +F +++++M ++
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 110 CGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167
G L S++ FP P E AL YLH++ ++RD+K NIL D +G +
Sbjct: 90 GGELFSLLRKSQRFP----NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHI 145
Query: 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITAL 227
K+ DFG + + + ++ T + GTP ++APEV+ + Y+ D WSFGI
Sbjct: 146 KITDFGFAKYVPDVTY---------T-LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIY 194
Query: 228 ELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK-NKKFSRAFKDMVASCLDQD 286
E+ G P MK YEK L + + F+ KD+++ + +D
Sbjct: 195 EMLAGYTPFYDSNT-----MKT--------YEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 287 PSKR-----PSAEKLMKHSFFKNCN 306
S+R E + H +FK
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKEVV 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+ + K+++ +G G V+ T VA+K+ L Q D+ E M L
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKS--LKQGSMSPDAFLAEANLMKQL 65
Query: 84 SHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H + L A + ++++ +M GSL + + L + + + +
Sbjct: 66 QHQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
+++ + ++HRD++A NIL S K+ADFG++ I + + G+ P
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-------PIK 175
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W APE I T ++ K+D+WSFGI E+ HGR P
Sbjct: 176 WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 38/260 (14%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
AIKA+ D+ D++ E + +SL HP + + C+F L+ VM +++ G L
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
I SC E + L +LH++G ++RD+K NIL D DG +K+ADFG
Sbjct: 106 MYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ ++ + T GTP ++APE++ Y+ D WSFG+ E+ G
Sbjct: 164 MCKENMLG-------DAKTNT-FCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIG 214
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDP 287
+ P F D E+ I+ N + + KD++ ++P
Sbjct: 215 QSP-----------------FHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 257
Query: 288 SKR-PSAEKLMKHSFFKNCN 306
KR + +H F+ N
Sbjct: 258 EKRLGVRGDIRQHPLFREIN 277
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 65/265 (24%), Positives = 109/265 (41%), Gaps = 43/265 (16%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+K + D+ D++ E + +SL +HP + C F RL+ VM F++ G L
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
I E E +SAL +LH++G ++RD+K N+L D +G KLADFG
Sbjct: 112 MFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ I G T GTP ++APE+++ Y D W+ G+ E+ G
Sbjct: 170 MCKEGICN-------GVTTAT-FCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCG 220
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDP 287
P F + + I + + ++ S + ++P
Sbjct: 221 HAP-----------------FEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNP 263
Query: 288 SKR------PSAEKLMKHSFFKNCN 306
+ R +++H FFK +
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEID 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 34/279 (12%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L+ K+L IG G V VA+K I D + E M+ L
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDATAQAF---LAEASVMTQL 243
Query: 84 SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H N++ L++V +M+ GSL + S L C+ + A+
Sbjct: 244 RHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
YL +HRD+ A N+L D K++DFG++ + + P
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKL------PVK 351
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
W APE +R +S K+D+WSFGI E+ GR P +P + ++ ++ + ++
Sbjct: 352 WTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYKM---- 405
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
D A D++ +C D + RP+ +L +
Sbjct: 406 ------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 40/263 (15%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQ 114
A+K + ++ ++ ++ E + + HP + SF RL VM + + G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 115 SIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFG 173
+S E E +SAL YLH++ ++RD+K N++ D DG +K+ DFG
Sbjct: 237 FHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFG 294
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233
+ G+ M T GTP ++APEV+ Y D W G+ E+ GR
Sbjct: 295 LCKE------GIKDGATMKT-FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGR 346
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDPS 288
P F D+EK I + +F K +++ L +DP
Sbjct: 347 LP-----------------FYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPK 389
Query: 289 KR----PS-AEKLMKHSFFKNCN 306
+R A+++M+H FF
Sbjct: 390 QRLGGGSEDAKEIMQHRFFAGIV 412
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMS 81
+ ++ IG G V++ I + + + VAIK S + + +E TM
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 82 LLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
HP+I L + ++ +W++M + G L+S + L + + + +
Sbjct: 72 QFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 127
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
AL+YL ++ +HRD+ A N+L S+ VKL DFG+S + + +++ + P
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-------P 180
Query: 200 Y-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
WMAPE I ++ +D+W FG+ E+ HG P
Sbjct: 181 IKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 42/264 (15%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+K + D+ D++ E + ++L P + H F RL+ VM +++ G L
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
I EP E L +L ++G ++RD+K N++ DS+G +K+ADFG
Sbjct: 109 MYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ +I++ G T GTP ++APE+I + Y D W+FG+ E+ G
Sbjct: 167 MCKENIWD-------GVTTKT-FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAG 217
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDP 287
+ P F D ++ I + N + S+ + + + P
Sbjct: 218 QAP-----------------FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 260
Query: 288 SKR-----PSAEKLMKHSFFKNCN 306
KR + +H+FF+ +
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRYID 284
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 60/293 (20%), Positives = 132/293 (45%), Gaps = 24/293 (8%)
Query: 6 QEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ 65
+ ++ + G ++ ++ + + ++G G VY+ + S VA+K L +
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKT--LKE 255
Query: 66 SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGL 125
+++ +E M + HPN++ + + +++ FM+ G+L + C +
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315
Query: 126 PEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185
+ + + SA+ YL + +HR++ A N L + VK+ADFG+S + ++
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375
Query: 186 HHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEK 243
H G+ P W APE + + +S K+D+W+FG+ E+A +G P + +
Sbjct: 376 HAGAKF-------PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
+ + + +R ++ + +++ +C +PS RPS ++
Sbjct: 428 -VYELLEKDYRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 15/227 (6%)
Query: 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ IG G VY + D A+K+++ ++ E M
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 81 SLLSHPNILNAH-CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
SHPN+L+ + VV+P+M G L++ I + + + +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 203
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH--HHHGSAMITDMAG 197
+ +L ++ +HRD+ A N + D +VK+ADFG++ +Y+ H+ A +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL----- 258
Query: 198 TPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPE 242
P WMA E +++ ++ K+D+WSFG+ EL G PP +
Sbjct: 259 -PVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 47/248 (18%)
Query: 76 ETKT----MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIIS--SCFPDGLPEPC 129
TK + ++HP I+ H +F + +L++++ F+ G L + +S F E
Sbjct: 72 RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT----EED 127
Query: 130 IAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS-ASIYEPSHHHHHG 188
+ L E AL +LH+ G ++RD+K NIL D +G +KL DFG+S SI H
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI-------DHE 180
Query: 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248
+ GT +MAPEV+ G++ AD WSFG+ E+ G P
Sbjct: 181 KKAYS-FCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLP------------- 225
Query: 249 MTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDPSKR-----PSAEKLMK 298
F+ D ++T+ I S + ++ ++P+ R E++ +
Sbjct: 226 ----FQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281
Query: 299 HSFFKNCN 306
HSFF +
Sbjct: 282 HSFFSTID 289
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 62/310 (20%), Positives = 116/310 (37%), Gaps = 52/310 (16%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS- 84
Y+++ ++G G + V++AI I ++ V +K + I+RE K + L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP----VKKKKIKREIKILENLRG 89
Query: 85 HPNILNAHCSFSVDS--RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
PNI+ +V ++ + + + L + I + E L AL
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALD 144
Query: 143 YLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
Y H+ G +HRDVK N++ D + ++L D+G+ A Y P ++ A + Y+
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVA-------SRYF 196
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL----SHL------------PPEKSL 245
PE++ + Y + D+WS G + + P +
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK------------DMVASCLDQDPSKRPSA 293
+ K + L + K++ R D + L D R +A
Sbjct: 257 IDKYNIE-LDPRFNDILGRHSR-KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314
Query: 294 EKLMKHSFFK 303
+ M+H +F
Sbjct: 315 REAMEHPYFY 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 77/332 (23%), Positives = 120/332 (36%), Gaps = 66/332 (19%)
Query: 27 SSYKILDE-IGVGVSAIVYKAICI-PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS 84
++ +G G VYKA D A+K I+ S RE + L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELK 76
Query: 85 HPNILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSC-------FPDGLPEPCIAIVLK 135
HPN+++ D ++W++ + L II P LP + +L
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 136 ETLSALSYLHNQGHLHRDVKAGNIL----SDSDGSVKLADFGVSASIYEPSHHHHHGSA- 190
+ L + YLH LHRD+K NIL G VK+AD G + P
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 191 MITDMAGTPYWM-APEVIRSHTGYSFKADIWSFG-ITALELAHGRP-------------- 234
++T +W APE++ Y+ DIW+ G I A EL P
Sbjct: 196 VVT------FWYRAPELLLGARHYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNP 248
Query: 235 ---------------P-------LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFS 272
P + + PE S LMK +R +++ ++ K
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKM-PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 273 RAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
++ L DP KR ++E+ M+ +F
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
++ + + ++G G VY+ + S VA+K L + +++ +E M +
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKT--LKEDTMEVEEFLKEAAVMKEI 66
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HPN++ + + +++ FM+ G+L + C + + + + SA+ Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WM 202
L + +HRD+ A N L + VK+ADFG+S + ++ H G+ P W
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-------PIKWT 179
Query: 203 APEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
APE + + +S K+D+W+FG+ E+A +G P
Sbjct: 180 APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRET 77
K + + S ++ ++G G V+ +T VAIK L ++ +E
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKT--LKPGTMSPEAFLQEA 230
Query: 78 KTMSLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ M L H ++ + S + +++V +MS GSL + L P + +
Sbjct: 231 QVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ S ++Y+ ++HRD++A NIL + K+ADFG++ I + + G+
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---- 343
Query: 196 AGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRF 253
P W APE ++ K+D+WSFGI EL GR P + + +L ++ + +
Sbjct: 344 ---PIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGY 398
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
R + + D++ C ++P +RP+
Sbjct: 399 RM----------PCPPECPESLHDLMCQCWRKEPEERPT 427
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+ S K+ ++G G V+ A T VA+K + +++ E M L
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATY--NKHTKVAVKT--MKPGSMSVEAFLAEANVMKTL 240
Query: 84 SHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H + L+A + ++++ FM+ GSL + S P P + + +
Sbjct: 241 QHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
+++ + ++HRD++A NIL + K+ADFG++ I + + G+ P
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-------PIK 350
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W APE I + ++ K+D+WSFGI +E+ +GR P
Sbjct: 351 WTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 20/227 (8%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAI--DLDQSRTDLDSI 73
Q + + ++L+++G G +V + + VA+K + D+ +D
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 74 RRETKTMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIA 131
RE M L H N+ L + +V GSL + ++
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS 124
Query: 132 IVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY-EPSHHHHHGSA 190
+ + YL ++ +HRD+ A N+L + VK+ DFG+ ++ H+
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 191 MITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
+ P+ W APE +++ T +S +D W FG+T E+ +G+ P
Sbjct: 185 KV------PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 5e-29
Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 42/264 (15%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+K + D+ D++ E + ++L P + H F RL+ VM +++ G L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 114 QSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
I EP E L +L ++G ++RD+K N++ DS+G +K+ADFG
Sbjct: 430 MYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 174 VS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG 232
+ +I++ G T GTP ++APE+I + Y D W+FG+ E+ G
Sbjct: 488 MCKENIWD-------GVTTKT-FCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAG 538
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQDP 287
+ P F D ++ I + N + S+ + + + P
Sbjct: 539 QAP-----------------FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 581
Query: 288 SKR-----PSAEKLMKHSFFKNCN 306
KR + +H+FF+ +
Sbjct: 582 GKRLGCGPEGERDIKEHAFFRYID 605
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 67/265 (25%), Positives = 107/265 (40%), Gaps = 45/265 (16%)
Query: 57 AIKAI--DLDQSRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVVMPFMSCGSL 113
A+K + + + I E + + HP ++ H SF +L+ V+ +++ G L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 114 QSIIS--SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
+ CF EP E SAL YLH+ ++RD+K NIL DS G + L D
Sbjct: 127 FYHLQRERCFL----EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTD 182
Query: 172 FGVS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELA 230
FG+ +I H S T GTP ++APEV+ Y D W G E+
Sbjct: 183 FGLCKENI-------EHNSTTST-FCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEML 233
Query: 231 HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL-KIKDKNKKF----SRAFKDMVASCLDQ 285
+G PP F + + I +K + + + + ++ L +
Sbjct: 234 YGLPP-----------------FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276
Query: 286 DPSKR----PSAEKLMKHSFFKNCN 306
D +KR ++ H FF N
Sbjct: 277 DRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 13/217 (5%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMS 81
++ S I IG G S V VAIKA+ + E M
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
HPNI+ + +V +M GSL + + + + +L+ + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGM 164
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS-AMITDMAGTPY 200
YL + G++HRD+ A N+L DS+ K++DFG+S + + + + I P
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI------PI 218
Query: 201 -WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W APE I T +S +D+WSFG+ E+ +G P
Sbjct: 219 RWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERP 254
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 48/212 (22%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM---DSTVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ K + ++G G V P VA+K++ + + +++E + +
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 81 SLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
L H NI+ C+ + + ++M F+ GSL+ + + + +
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQIC 136
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
+ YL ++ ++HRD+ A N+L +S+ VK+ DFG++ +I + D +
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-----DKEYYTVKDDRDS 191
Query: 199 P-YWMAPEVIRSHTGYSFKADIWSFGITALEL 229
P +W APE + + +D+WSFG+T EL
Sbjct: 192 PVFWYAPECLMQSK-FYIASDVWSFGVTLHEL 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 67/301 (22%), Positives = 124/301 (41%), Gaps = 44/301 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ +G G V +A + + VA+K + T+ +++ E K
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 80 MSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+S L +H NI+N C+ + V+ + G L + + + ++++
Sbjct: 80 LSYLGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 137 TLSALS----------------YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
AL +L ++ +HRD+ A NIL K+ DFG++ I
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 181 PSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSH 238
S++ G+A + P WMAPE I + Y+F++D+WS+GI EL G P
Sbjct: 198 DSNYVVKGNARL------PVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+P + + + FR + D++ +C D DP KRP+ +++++
Sbjct: 251 MPVDSKFYKMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 299 H 299
Sbjct: 301 L 301
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 81/332 (24%), Positives = 139/332 (41%), Gaps = 60/332 (18%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
Y+++ ++G G IV+K+I VVA+K I D Q+ TD RE ++ LS
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 85 -HPNILNAHCSFSVDSR--LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
H NI+N D+ +++V +M L ++I + + L V+ + + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA---NILEPVHKQYVVYQLIKVI 122
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFG--------------VSASIYEPSHHHHH 187
YLH+ G LHRD+K NIL +++ VK+ADFG + SI E + +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFG-ITALELAHGRP------PLSHL- 239
++TD T ++ APE++ T Y+ D+WS G I E+ G+P ++ L
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMNQLE 241
Query: 240 --------PPEKSL-----------LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFK---- 276
P + + + + ++ K +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 277 -----DMVASCLDQDPSKRPSAEKLMKHSFFK 303
D++ L +P+KR SA +KH F
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 67/261 (25%), Positives = 124/261 (47%), Gaps = 28/261 (10%)
Query: 57 AIKAI---DLDQSRTDLDSIRRETKTMSLLSH-PNILNAHCSFSVDSRLWVVMPFMSCGS 112
A+K + + Q + R E + + + P ++ H +F +++L +++ +++ G
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L + +S E + I + E + AL +LH G ++RD+K NIL DS+G V L DF
Sbjct: 146 LFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 203
Query: 173 GVS-ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR-SHTGYSFKADIWSFGITALELA 230
G+S + + + D GT +MAP+++R +G+ D WS G+ EL
Sbjct: 204 GLSKEFVADETE-------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
Query: 231 HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR 290
G P + EK+ ++++R + ++ S KD++ L +DP KR
Sbjct: 257 TGASPF-TVDGEKNSQAEISRRIL----KSEPPYP---QEMSALAKDLIQRLLMKDPKKR 308
Query: 291 -----PSAEKLMKHSFFKNCN 306
A+++ +H FF+ N
Sbjct: 309 LGCGPRDADEIKEHLFFQKIN 329
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM 80
++ +DPS + EIG G +V+ ++ VAIK + + + E + M
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKT--IREGAMSEEDFIEEAEVM 57
Query: 81 SLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
LSHP + L C + + +V FM G L + + + + +
Sbjct: 58 MKLSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVC 114
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
++YL +HRD+ A N L + +K++DFG++ + + + G+
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------- 167
Query: 199 PY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P W +PEV + YS K+D+WSFG+ E+ G+ P
Sbjct: 168 PVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRET 77
K + + S ++ ++G G V+ +T VAIK L ++ +E
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKT--LKPGTMSPEAFLQEA 313
Query: 78 KTMSLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ M L H ++ + S + +++V +MS GSL + L P + +
Sbjct: 314 QVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
+ S ++Y+ ++HRD++A NIL + K+ADFG++ I + + G+
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---- 426
Query: 196 AGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRF 253
P W APE ++ K+D+WSFGI EL GR P + + +L ++ + +
Sbjct: 427 ---PIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGY 481
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
R + + D++ C ++P +RP+
Sbjct: 482 RM----------PCPPECPESLHDLMCQCWRKEPEERPT 510
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 62/256 (24%), Positives = 113/256 (44%), Gaps = 25/256 (9%)
Query: 3 HHEQEDQCSSTGTIAQKIQYPLDP-----SSYKILDEIGVGVSAIVYKAICIPM---DST 54
HH G + Q P DP K + ++G G V P
Sbjct: 6 HHHHHHH----GALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE 61
Query: 55 VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGS 112
+VA+KA+ D ++E + L H +I+ C + + L +VM ++ GS
Sbjct: 62 MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 113 LQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172
L+ + + + + ++ ++YLH Q ++HRD+ A N+L D+D VK+ DF
Sbjct: 122 LRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 173 GVSASIYEPSHHHHHGSAMITDMAGTP-YWMAPEVIRSHTGYSFKADIWSFGITALELA- 230
G++ ++ E ++ + + +P +W APE ++ + + + +D+WSFG+T EL
Sbjct: 179 GLAKAVPEGHEYYR-----VREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLT 232
Query: 231 HGRPPLSHLPPEKSLL 246
H S L+
Sbjct: 233 HCDSSQSPPTKFLELI 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L +L E+G G +V VA+K + + D +E +TM L
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKW--KGQYDVAVKM--IKEGSMSEDEFFQEAQTMMKL 60
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
SHP ++ + S + +++V ++S G L + + S L + + + +++
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAF 119
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WM 202
L + +HRD+ A N L D D VK++DFG++ + + + G P W
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-TKF------PVKWS 172
Query: 203 APEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
APEV + YS K+D+W+FGI E+ G+ P
Sbjct: 173 APEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 18/222 (8%)
Query: 21 QYPLDPSSYKILD-EIGVGVSAIVYKAICIPMDSTV-VAIKAIDLDQSRTDLDSIRRETK 78
+ L + I D E+G G V + + + VAIK + + D + + RE +
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 62
Query: 79 TMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
M L +P I L C L +VM G L + + +P +A +L +
Sbjct: 63 IMHQLDNPYIVRLIGVCQ---AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQ 118
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY-EPSHHHHHGSAMITDM 195
+ YL + +HRD+ A N+L + K++DFG+S ++ + S++ +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--- 175
Query: 196 AGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P W APE I +S ++D+WS+G+T E +G+ P
Sbjct: 176 ---PLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 67/326 (20%), Positives = 109/326 (33%), Gaps = 69/326 (21%)
Query: 29 YKILDE-IGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLLS- 84
YK+ + +G+G++ V + T A+K + D RRE + S
Sbjct: 19 YKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQ------DCPKARREVELHWRASQ 69
Query: 85 HPNILNAHCSF----SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
P+I+ + + L +VM + G L S I E + ++K A
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 141 LSYLHNQGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAG 197
+ YLH+ HRDVK N+L + +KL DFG
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------------------------ 165
Query: 198 TPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP---LSHLPPEKSLLMK-MTQRF 253
A E Y D+WS G+ L G PP L + + ++
Sbjct: 166 ----FAKETTG--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219
Query: 254 RF-SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFF 312
F + + S K ++ + L +P++R + + M H + K
Sbjct: 220 EFPNPEWSEV---------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK----- 265
Query: 313 VKNVLHGLRSVEERFKESRNHVGAEH 338
V V + KE V E
Sbjct: 266 VPQTPLHTSRVLKEDKERWEDVKEEM 291
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 35/266 (13%)
Query: 43 VYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR---RETKTMSLLSHPNILNAH-CSFSVD 98
VYK +++T VA+K + T + + +E K M+ H N++ S D
Sbjct: 47 VYKGY---VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEP-------CIAIVLKETLSALSYLHNQGHLH 151
+V +M GSL + P IA + +++LH H+H
Sbjct: 104 DLC-LVYVYMPNGSLLDRL---SCLDGTPPLSWHMRCKIAQ---GAANGINFLHENHHIH 156
Query: 152 RDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT 211
RD+K+ NIL D + K++DFG+ A + + + GT +MAPE +R
Sbjct: 157 RDIKSANILLDEAFTAKISDFGL-ARAS-EKFAQTVMT---SRIVGTTAYMAPEALRGE- 210
Query: 212 GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN-KK 270
+ K+DI+SFG+ LE+ G P + + LL + + + + DK
Sbjct: 211 -ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-DIKEEI-EDEEKTIEDYIDKKMND 267
Query: 271 FS-RAFKDMVA---SCLDQDPSKRPS 292
+ + M + CL + +KRP
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPD 293
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 75/348 (21%), Positives = 121/348 (34%), Gaps = 74/348 (21%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-DLDQSRTDLDSIRRETKTMSLLS 84
P +Y I IG G VY A + VAIK + + + D I RE ++ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTE-KNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 85 HPNILNAHCSFSVDSR-----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
I+ + D L++V+ L+ + + P L E I +L L
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKT--PIFLTEEHIKTILYNLLL 140
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG---------------VSASIYEPSHH 184
+++H G +HRD+K N L + D SVK+ DFG EP H
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFG----------ITALELAHGRP 234
+ + +T T ++ APE+I Y+ DIWS G + + R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 235 PL----SHLPPEKSLLMKMTQRFRFSD---------------------------YEKTLK 263
PL S P K D Y K
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320
Query: 264 IKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ + + +++ S L +P+KR + ++ + H + K+
Sbjct: 321 HRKP-INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 63/296 (21%), Positives = 117/296 (39%), Gaps = 41/296 (13%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKT 79
K+ +G G V +A +D VA+K + + ++ ++ E K
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 80 MSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+ + H N++N C+ L V++ F G+L + + S + +P L +
Sbjct: 84 LIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 137 TL--------------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182
+ +L ++ +HRD+ A NIL VK+ DFG++ IY+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 183 HHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLP 240
+ G A + P WMAPE I Y+ ++D+WSFG+ E+ G P +
Sbjct: 203 DYVRKGDARL------PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
++ ++ + R + + C +PS+RP+ +L
Sbjct: 256 IDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+DP L E+G G +V VAIK + + D E K M L
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNL 76
Query: 84 SHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
SH + L C+ ++++ +M+ G L + + + + K+ A+
Sbjct: 77 SHEKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAM 133
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
YL ++ LHRD+ A N L + G VK++DFG+S + + + G + P
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKF------PVR 186
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W PEV+ ++ +S K+DIW+FG+ E+ G+ P
Sbjct: 187 WSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 72/356 (20%), Positives = 117/356 (32%), Gaps = 82/356 (23%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLS 84
P Y+I IG G V +A + VVAIK I + D I RE ++ L+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 85 HPNILNAH-----CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
H +++ L+VV+ + + + P L E I +L L
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRT--PVYLTELHIKTLLYNLLV 167
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+ Y+H+ G LHRD+K N L + D SVK+ DFG++ ++ P + + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 200 YWM--------------------APEVIRSHTGYSFKADIWSFG----------ITALEL 229
APE+I Y+ D+WS G +
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 230 AHGRPPL----SHLPPEKSLLMKMTQRFRFS----------------------------- 256
R PL S P +F
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 257 -DYEKTLKIKDKNKKFSRAFK-------DMVASCLDQDPSKRPSAEKLMKHSFFKN 304
Y + ++ + F ++ L +P+KR + + + H FFK
Sbjct: 348 KRYIRIFPKREG-TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 68/305 (22%), Positives = 120/305 (39%), Gaps = 48/305 (15%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAI--DLDQSRTDLDSIRRET 77
+ + E+G G V+ A C + D +VA+KA+ + +R D +RE
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREA 94
Query: 78 KTMSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ +++L H +I+ C+ L +V +M G L + S PD V
Sbjct: 95 ELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 136 ETLSAL-------------SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182
L YL +HRD+ N L VK+ DFG+S IY
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 183 HHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLP 240
++ G M+ P WM PE I ++ ++D+WSFG+ E+ +G+ P L
Sbjct: 213 YYRVGGRTML------PIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300
+ + +TQ ++ + ++ C ++P +R S + + H+
Sbjct: 266 NTE-AIDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDV--HA 312
Query: 301 FFKNC 305
+
Sbjct: 313 RLQAL 317
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 20/226 (8%)
Query: 18 QKIQYPLDPSSYKILD-EIGVGVSAIVYKAICIPMDSTV-VAIKAIDLDQ-SRTDLDSIR 74
+ + LD + D E+G G V K VA+K + + D +
Sbjct: 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66
Query: 75 RETKTMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI 132
E M L +P I + C +VM G L + + + I
Sbjct: 67 AEANVMQQLDNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIE 121
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY-EPSHHHHHGSAM 191
++ + + YL +HRD+ A N+L + K++DFG+S ++ + +++
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 192 ITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P W APE I + +S K+D+WSFG+ E +G+ P
Sbjct: 182 W------PVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 16/219 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTM 80
+ PS IG G VYK + VAIK + + E M
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
SH NI+ S + ++ +M G+L + + +L+ +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAG 159
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY--EPSHHHHHGSAMITDMAGT 198
+ YL N ++HRD+ A NIL +S+ K++DFG+S + + + G +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI------- 212
Query: 199 PY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P W APE I S+ ++ +D+WSFGI E+ +G P
Sbjct: 213 PIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM---DSTVVAIKAI--DLDQSRTDLDSIRRETK 78
+ K L ++G G V P+ VVA+K + ++ D RE +
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIE 63
Query: 79 TMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+ L H NI C + L ++M ++ GSL+ D L + I +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR--------DYLQKHKERIDHIK 115
Query: 137 TL-------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189
L + YL + ++HRD+ NIL +++ VK+ DFG++ +
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-----QDKEF 170
Query: 190 AMITDMAGTP-YWMAPEVIRSHTGYSFKADIWSFGITALEL 229
+ + +P +W APE + + +S +D+WSFG+ EL
Sbjct: 171 FKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYEL 210
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETK 78
Y + ++ IG G V++ I + + + VAIK S + + +E
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 79 TMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
TM HP+I L + ++ +W++M + G L+S + L + + +
Sbjct: 444 TMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQ 499
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
+AL+YL ++ +HRD+ A N+L S+ VKL DFG+S + + +++ +
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL----- 554
Query: 197 GTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P WMAPE I ++ +D+W FG+ E+ HG P
Sbjct: 555 --PIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKP 592
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 11/216 (5%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMS 81
LD ++ I +G G V VAIK + + + E M
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
HPNI+ + + +V +M GSL S + + +L+ S +
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGM 160
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY- 200
YL + G++HRD+ A NIL +S+ K++DFG+ + + +A T P
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE-----AAYTTRGGKIPIR 215
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
W +PE I ++ ++ +D+WS+GI E+ +G P
Sbjct: 216 WTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 45/301 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICI------PMDSTVVAIKAIDLDQSRTDLDSIRRET 77
+ +G G V A + P ++ VA+K + D + DL + E
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 78 KTMSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
+ M ++ H NI+N C+ D L+V++ + S G+L+ + + P G+ +
Sbjct: 92 EMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 135 KETL--------------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
E + YL +Q +HRD+ A N+L + +K+ADFG++ I
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 181 PSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSH 238
++ + + P WMAPE + Y+ ++D+WSFG+ E+ G P
Sbjct: 210 IDYYKKTTNGRL------PVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+P E+ L + + R DK + M+ C PS+RP+ ++L++
Sbjct: 263 IPVEE-LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 299 H 299
Sbjct: 312 D 312
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 59/253 (23%), Positives = 95/253 (37%), Gaps = 31/253 (12%)
Query: 3 HHEQED--QCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVV 56
HH + C + T + + + ++ +G G VY+ M V
Sbjct: 4 HHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV 63
Query: 57 AIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQ 114
A+K + S D E +S +H NI+ +++M M+ G L+
Sbjct: 64 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--LQSLPRFILMELMAGGDLK 121
Query: 115 SIISSCFPDGLPEPCIAIVLKETL-------SALSYLHNQGHLHRDVKAGNILSDSDGS- 166
S + P ++ + + L YL +HRD+ A N L G
Sbjct: 122 SFLRETRPRPSQPS--SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179
Query: 167 --VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFG 223
K+ DFG++ IY S++ G AM+ P WM PE ++ K D WSFG
Sbjct: 180 RVAKIGDFGMARDIYRASYYRKGGCAML------PVKWMPPEAFMEGI-FTSKTDTWSFG 232
Query: 224 ITALELA-HGRPP 235
+ E+ G P
Sbjct: 233 VLLWEIFSLGYMP 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/315 (21%), Positives = 121/315 (38%), Gaps = 55/315 (17%)
Query: 21 QYPLDP------SSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDL 70
+Y D + + +G G V A + S VA+K + ++
Sbjct: 33 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 71 DSIRRETKTMSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQS------------ 115
+++ E K M+ L SH NI+N C+ + ++++ + G L +
Sbjct: 93 EALMSELKMMTQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 116 --IISSCFPDGLPEPCIAIVLKETLS-------ALSYLHNQGHLHRDVKAGNILSDSDGS 166
+ E + ++ L + +L + +HRD+ A N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGIT 225
VK+ DFG++ I S++ G+A + P WMAPE + Y+ K+D+WS+GI
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARL------PVKWMAPESLFEGI-YTIKSDVWSYGIL 263
Query: 226 ALELA-HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLD 284
E+ G P +P + + + F+ D+ + ++ SC
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWA 313
Query: 285 QDPSKRPSAEKLMKH 299
D KRPS L
Sbjct: 314 FDSRKRPSFPNLTSF 328
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ K L ++G G V P+ VVA+K + + L RE + +
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEIL 96
Query: 81 SLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
L H NI C + L ++M ++ GSL+ D L + I + L
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR--------DYLQKHKERIDHIKLL 148
Query: 139 -------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAM 191
+ YL + ++HRD+ NIL +++ VK+ DFG++ +
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-----QDKEYYK 203
Query: 192 ITDMAGTP-YWMAPEVIRSHTGYSFKADIWSFGITALEL 229
+ + +P +W APE + + + +S +D+WSFG+ EL
Sbjct: 204 VKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYEL 241
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 18/226 (7%)
Query: 17 AQKIQYPLDPSSYKILD-EIGVGVSAIVYKAICIPMDSTV-VAIKAIDLDQSRTDLDSIR 74
+ + L + I D E+G G V + + + VAIK + + D + +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 75 RETKTMSLLSHPNI--LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAI 132
RE + M L +P I L C L +VM G L + + +P +A
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ---AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAE 440
Query: 133 VLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY-EPSHHHHHGSAM 191
+L + + YL + +HR++ A N+L + K++DFG+S ++ + S++ +
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 192 ITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
P W APE I +S ++D+WS+G+T E +G+ P
Sbjct: 501 W------PLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 47/221 (21%), Positives = 85/221 (38%), Gaps = 26/221 (11%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ S+ + ++E+G VYK + VAIK + + R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE--- 136
+ L HPN++ + D L ++ + S G L + P +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 137 TLSAL-----------SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185
YL + +H+D+ N+L +VK++D G+ +Y ++
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 186 HHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGIT 225
G++++ P WMAPE I +S +DIWS+G+
Sbjct: 186 LLGNSLL------PIRWMAPEAIMYGK-FSIDSDIWSYGVV 219
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAI--DLDQSRTDLDSIRRET 77
+ + E+G G V+ A C + D +VA+KA+ +R D +RE
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREA 68
Query: 78 KTMSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ ++ L H +I+ C L +V +M G L + + PD +
Sbjct: 69 ELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 136 E---TLSAL-----------SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181
+ LS + YL +Q +HRD+ N L ++ VK+ DFG+S +Y
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 182 SHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGIT 225
++ G M+ P WM PE I ++ ++D+WSFG+
Sbjct: 187 DYYRVGGHTML------PIRWMPPESIMYRK-FTTESDVWSFGVI 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 62/294 (21%), Positives = 112/294 (38%), Gaps = 40/294 (13%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM---DSTVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ K + ++G G V P+ +VA+K + D +RE + +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQIL 78
Query: 81 SLLSHPNILNAH--CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
L I+ L +VM ++ G L+ D L + L
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR--------DFLQRHRARLDASRLL 130
Query: 139 -------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI-YEPSHHHHHGSA 190
+ YL ++ +HRD+ A NIL +S+ VK+ADFG++ + + ++
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 191 MITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMK 248
P W APE + +S ++D+WSFG+ EL + S P + L M
Sbjct: 191 QS------PIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCS--PSAEFLRMM 241
Query: 249 MTQRFRFSDYEKTLKIKDKNKKFSR------AFKDMVASCLDQDPSKRPSAEKL 296
+R + L++ ++ ++ +++ C P RPS L
Sbjct: 242 GCERDVPALSR-LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 45/298 (15%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICI------PMDSTVVAIKAIDLDQSRTDLDSIRRET 77
+ +G G V A + P ++ VA+K + D + DL + E
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 78 KTMSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGL-PEPCIAIV 133
+ M ++ H NI+N C+ D L+V++ + S G+L+ + + P G+ I V
Sbjct: 138 EMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 134 LKETLS-------------ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
+E ++ + YL +Q +HRD+ A N+L + +K+ADFG++ I
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 181 PSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSH 238
++ + + P WMAPE + Y+ ++D+WSFG+ E+ G P
Sbjct: 256 IDYYKKTTNGRL------PVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296
+P E+ L + + R DK + M+ C PS+RP+ ++L
Sbjct: 309 IPVEE-LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 30/228 (13%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAIC------IPMDSTVVAIKAIDLDQSRTDLDSIRRET 77
+ + +G G ++K + + T V +K +D
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AA 63
Query: 78 KTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
MS LSH +++ + +V F+ GSL + + + + V K+
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQL 122
Query: 138 LSALSYLHNQGHLHRDVKAGNILSDSDGS--------VKLADFGVSASIYEPSHHHHHGS 189
+A+ +L +H +V A NIL + +KL+D G+S ++
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--------- 173
Query: 190 AMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPP 235
D+ W+ PE I + + D WSFG T E+ G P
Sbjct: 174 ---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 45/301 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICI------PMDSTVVAIKAIDLDQSRTDLDSIRRET 77
L + +G G V A I P T VA+K + D + DL + E
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 78 KTMSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVL 134
+ M ++ H NI+N C+ D L+V++ + S G+L+ + + P GL
Sbjct: 126 EMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 135 KETL--------------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
E + YL ++ +HRD+ A N+L D +K+ADFG++ I+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 181 PSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSH 238
++ + + P WMAPE + Y+ ++D+WSFG+ E+ G P
Sbjct: 244 IDYYKKTTNGRL------PVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+P E+ L + + R DK + M+ C PS+RP+ ++L++
Sbjct: 297 VPVEE-LFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345
Query: 299 H 299
Sbjct: 346 D 346
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 67/306 (21%), Positives = 115/306 (37%), Gaps = 50/306 (16%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + +G G V KA + T VA+K + + S ++L + E
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 80 MSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
+ ++HP+++ CS D L +++ + GSL+ + G +
Sbjct: 80 LKQVNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 138 L----------------------SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
+ YL +HRD+ A NIL +K++DFG+S
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 176 ASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGR 233
+YE + I P WMA E + H Y+ ++D+WSFG+ E+ G
Sbjct: 198 RDVYEEDSYVKRSQGRI------PVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA 293
P +PPE+ L + R ++ S ++ C Q+P KRP
Sbjct: 251 NPYPGIPPER-LFNLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVF 299
Query: 294 EKLMKH 299
+ K
Sbjct: 300 ADISKD 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 40/294 (13%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKT 79
+ + ++ +G G VY+ M VA+K + S D E
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 80 MSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKET 137
+S +H NI+ ++++ M+ G L+S + P ++ + +
Sbjct: 128 ISKFNHQNIVRCIGVS--LQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDL 183
Query: 138 L-------SALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSASIYEPSHHHHH 187
L YL +HRD+ A N L G K+ DFG++ IY ++
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 188 GSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPEKSL 245
G AM+ P WM PE ++ K D WSFG+ E+ G P ++ +
Sbjct: 244 GCAML------PVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-V 295
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
L +T R D K ++ C P RP+ +++
Sbjct: 296 LEFVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 70/271 (25%), Positives = 112/271 (41%), Gaps = 28/271 (10%)
Query: 35 IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI--LNAH 92
IG GV VYK + + D VA+K + S ++ E +T+S HP++ L
Sbjct: 47 IGHGVFGKVYKGV-LR-DGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEP-----CIAIVLKETLSALSYLHNQ 147
C + + ++ +M G+L+ + + I I L YLH +
Sbjct: 104 CD--ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI---GAARGLHYLHTR 158
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
+HRDVK+ NIL D + K+ DFG+S E H + T + GT ++ PE
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH-----LSTVVKGTLGYIDPEYF 213
Query: 208 RSHTGY-SFKADIWSFGITALELAHGRPPLSHLPP--EKSLLMKMTQRFRFSDYEKTL-- 262
G + K+D++SFG+ E+ R + P +L + E+ +
Sbjct: 214 I--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 263 KIKDK-NKKFSRAFKDMVASCLDQDPSKRPS 292
+ DK + R F D CL RPS
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 40/297 (13%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKT 79
++ + +G G V +A + VA+K + + +++ E K
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 80 MSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIA----- 131
MS L H NI+N C+ + V+ + G L + + +P A
Sbjct: 103 MSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 132 IVLKETLS-------ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184
++ L +++L ++ +HRDV A N+L + K+ DFG++ I S++
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 185 HHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGITALELA-HGRPPLSHLPPE 242
G+A + P WMAPE I Y+ ++D+WS+GI E+ G P +
Sbjct: 221 IVKGNARL------PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ ++ + + ++ +C +P+ RP+ +++
Sbjct: 274 SKFYKLVKDGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 72/369 (19%), Positives = 130/369 (35%), Gaps = 74/369 (20%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-----DLDQSRTD---LDSIRRETKT- 79
Y ++ ++G G + V+ A + +++T VA+K + + + + L + T
Sbjct: 21 YILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 80 MSLLSHPNILNAHCSFSVDSRLWV----VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ +IL F+ V V + +L ++I G+P + + K
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISK 138
Query: 136 ETLSALSYLHNQGHL-HRDVKAGNIL------SDSDGSVKLADFGVSASIYEPSHHHHHG 188
+ L L Y+H + + H D+K N+L ++ +K+AD G + H+
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEHY- 192
Query: 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------------PL 236
T+ T + +PEV+ + ADIWS EL G
Sbjct: 193 ----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 237 SHL--------PPEKSLLMKMTQRFRFSD------YEKTLKIKDK----------NKKFS 272
H+ LL F + LK +K +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 273 RAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRS--VEERFKES 330
+ D ++ L DP KR A L+ H + K+ E V + + F+E
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEV 367
Query: 331 RNHVGAEHH 339
R+H + H
Sbjct: 368 RDH---KRH 373
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 37/270 (13%)
Query: 43 VYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAH--CSFSVDSR 100
VYK + D T+VA+K + ++++ + E + +S+ H N+L C R
Sbjct: 46 VYKG-RLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TER 102
Query: 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPC-----IAIVLKETLSALSYLHNQGHL---HR 152
L +V P+M+ GS+ S + P IA+ + L+YLH+ HR
Sbjct: 103 L-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL---GSARGLAYLHDHCDPKIIHR 158
Query: 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG 212
DVKA NIL D + + DFG+ A + + H + T + GT +APE + TG
Sbjct: 159 DVKAANILLDEEFEAVVGDFGL-AKLMDYKDTH-----VTTAVRGTIGHIAPEYLS--TG 210
Query: 213 Y-SFKADIWSFGITALELAHGRPP--LSHLPPEKSLLM-----KMTQRFRFSDY-EKTLK 263
S K D++ +G+ LEL G+ L+ L + +++ + + + + L+
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
Query: 264 IKDKNKKFSRAFKDMVAS-CLDQDPSKRPS 292
K+++ + + VA C P +RP
Sbjct: 271 GNYKDEEVEQLIQ--VALLCTQSSPMERPK 298
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKT 79
++ + + +IG G V++A + T+VA+K + + S +RE
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 80 MSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE- 136
M+ +PNI+ C+ V + ++ +M+ G L + S P + + +
Sbjct: 104 MAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 137 ----------TLSAL-----------SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175
+ + +YL + +HRD+ N L + VK+ADFG+S
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 176 ASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGIT 225
+IY ++ G+ I P WM PE I + Y+ ++D+W++G+
Sbjct: 222 RNIYSADYYKADGNDAI------PIRWMPPESIFYNR-YTTESDVWAYGVV 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 35/223 (15%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKA-ICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS- 81
LD + K D IG G V KA I AIK + S+ D E + +
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 82 LLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQS-IISSCFPDGLPEPCIAIVLKETL 138
L HPNI+N C L++ + + G+L + S + P IA TL
Sbjct: 82 LGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 139 SAL-------------SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS--ASIYEPSH 183
S+ YL + +HRD+ A NIL + K+ADFG+S +Y
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199
Query: 184 HHHHGSAMITDMAGTPY-WMAPEVIRSHTGYSFKADIWSFGIT 225
+ P WMA E + Y+ +D+WS+G+
Sbjct: 200 M-----GRL------PVRWMAIESLNYSV-YTTNSDVWSYGVL 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-23
Identities = 64/374 (17%), Positives = 119/374 (31%), Gaps = 113/374 (30%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y ++ ++G G + V+ + I VA+K + + T+ + E + + + + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSAEHYTE--TALDEIRLLKSVRNSDP 95
Query: 89 LN---AHC-----SFSVDSRLWV----VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
+ F + V + L I GLP PC+ ++++
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 137 TLSALSYLHNQGHL-HRDVKAGNIL----------------------------------- 160
L L YLH + + H D+K NIL
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 161 --------------SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ VK+AD G + H H T + + EV
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNAC----WVHKHFTEDIQ------TRQYRSLEV 264
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLS------------HL--------PPEKSLL 246
+ GY+ ADIWS A ELA G H+ + L+
Sbjct: 265 LIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 247 MKMTQRFRFSD----------------YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR 290
+ F +E ++ + +++ + F D + L+ P KR
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 291 PSAEKLMKHSFFKN 304
+A + ++H + +
Sbjct: 384 ATAAECLRHPWLNS 397
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 67/336 (19%), Positives = 120/336 (35%), Gaps = 75/336 (22%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-----LDQSRTDLDSIRRETKTMSLL 83
Y+I IG G V KA ++ VAIK I L+Q++ ++ + K + +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ I++ F + L +V +S +L ++ + G+ ++ +AL +
Sbjct: 115 KY-YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 144 LHNQ--GHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L +H D+K NIL + ++K+ DFG S+ I +
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSC-----QLGQRIYQYIQ----SR 222
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSHL--------PPEKSL 245
++ +PEV+ Y D+WS G +E+ G P + + P +
Sbjct: 223 FYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 246 LMKMTQRFRF--------------SDYEKTLKIK------------------------DK 267
L + + +F D ++ K
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
FKD++ LD DP R ++HSFFK
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 59/332 (17%), Positives = 118/332 (35%), Gaps = 69/332 (20%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-----LDQSRTDLDSIRRETKTMSLL 83
Y+I+ +G G V + + + VA+K I + +R +++ +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ F+ + + + + + P P + + + AL +
Sbjct: 81 KF-LCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 144 LHNQGHLHRDVKAGNIL-------------------SDSDGSVKLADFGVSASIYEPSHH 184
LH H D+K NIL S + S+++ADFG SA+
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT-----FD 192
Query: 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSH 238
H H + ++ T ++ PEVI G++ D+WS G E G H
Sbjct: 193 HEHHTTIVA----TRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247
Query: 239 L--------PPEKSLLMKMTQRFRF----SDYEKTLKIKDKNKKFSRAFK---------- 276
L P ++ + ++ F +++ K+ + K
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 277 ----DMVASCLDQDPSKRPSAEKLMKHSFFKN 304
D++ L+ DP++R + + + H FF
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 66/337 (19%), Positives = 122/337 (36%), Gaps = 69/337 (20%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-----LDQSRTDLDSIRRETKTMSLL 83
Y+I+D +G G V + I VA+K + + +R+++ + T
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ + F + +V + S I I + + ++++
Sbjct: 76 TF-RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 144 LHNQGHLHRDVKAGNIL-------------------SDSDGSVKLADFGVSASIYEPSHH 184
LH+ H D+K NIL + + +K+ DFG SA+ +
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT-----YD 187
Query: 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRP------PLSH 238
H S +++ T ++ APEVI + G+S D+WS G +E G H
Sbjct: 188 DEHHSTLVS----TRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 239 L--------PPEKSLLMKMTQRFRF----SDYEKTLKIKDKNKKFSR------------- 273
L P K ++ K +R F D+++ + +
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302
Query: 274 -AFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGV 309
D++ L+ DP+KR + + +KH FF K +
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 67/329 (20%), Positives = 114/329 (34%), Gaps = 68/329 (20%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAI-----DLDQSRTDLDSIRRETKTMSLL 83
Y++L IG G V KA VA+K + Q+ ++ + K
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ N+++ +F+ + + + +S +L +I G P + L L
Sbjct: 158 TM-NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 144 LHNQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
LH +H D+K NIL +K+ DFG S+ + H I + ++
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SS-----CYEHQRVYTYIQ----SRFY 265
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPP------LSHL--------PPEKSLLM 247
APEVI Y D+WS G EL G P L P + LL
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 248 KMTQRFRFSDYE---------------------KTLKIKDKNKKFSR------------A 274
+ F + ++ + K + SR
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 275 FKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
F D + CL+ DP+ R + + ++H + +
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 71/344 (20%), Positives = 118/344 (34%), Gaps = 89/344 (25%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-----LDQSRTDLDSIRRETKTMSLL 83
+ ++ ++G G V I + A+K + ++ E + +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNIKKYTRSAKI-------EADILKKI 88
Query: 84 SHPNILNAHC-----SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
+ +I N + F + ++ + SL II+ +G I + E L
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 139 SALSYLHNQGHLHRDVKAGNIL-------------------------SDSDGSVKLADFG 173
AL+YL H D+K NIL +KL DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233
A + + ++I T + APEVI + G+ +D+WSFG EL G
Sbjct: 208 -CA-----TFKSDYHGSIIN----TRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGS 256
Query: 234 P------PLSHL--------PPEKSLLMKMTQR---FRFSDYEKTLKIKDKNKKFS---- 272
+ HL P K++L + T+ + E L + +
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 273 -------------RAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
F D + S L DP+ RPS +L+KH F +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153
S S S +V +S + + D L + + + +L ++ +HRD
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 218
Query: 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY-WMAPEVIRSHTG 212
+ A NIL VK+ DFG++ IY+ + G A + P WMAPE I
Sbjct: 219 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL------PLKWMAPETIFDRV- 271
Query: 213 YSFKADIWSFGITALELA-HGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKF 271
Y+ ++D+WSFG+ E+ G P + ++ ++ + R
Sbjct: 272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------RAPDYT 321
Query: 272 SRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ + C +PS+RP+ +L++H
Sbjct: 322 TPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 31/182 (17%), Positives = 63/182 (34%), Gaps = 15/182 (8%)
Query: 18 QKIQYPLDPSSY-------KILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQS 66
+ P D S + K+ +G G V +A +D VA+K + +
Sbjct: 6 HCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65
Query: 67 RTDLDSIRRETKTMSLL-SHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD 123
++ ++ E K + + H N++N C+ L V++ F G+L + + S +
Sbjct: 66 HSEHRALMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNE 124
Query: 124 GLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183
+P ++ + + D + S S G V+ P
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
Query: 184 HH 185
+
Sbjct: 185 LY 186
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PN 87
YK+ IG G ++++ + +++ VAIK + R+D +R E +T LL+
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTG 67
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
I N + +V+ + G SL+ ++ C +A+ K+ L+ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 147 QGHLHRDVKAGNILSDSDGS-----VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+ ++RD+K N L S + + DFG+ +P H +++GT +
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 202 MAPEVIRSHTGY--SFKADIWSFGITALELAHGRPP 235
M+ I +H G S + D+ + G + G P
Sbjct: 185 MS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 40/215 (18%), Positives = 83/215 (38%), Gaps = 17/215 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PN 87
+++ +IG G + + + VAIK L+ ++ + E + L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNL-YTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I + +V+ + SL+ + C + ++ + +S + Y+H++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 148 GHLHRDVKAGNILSDSDGS-----VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
++RDVK N L G+ + + DF ++ +P H + GT +M
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 203 APEVIRSHTGY--SFKADIWSFGITALELAHGRPP 235
+ I +H G S + D+ + G + G P
Sbjct: 185 S---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 24/236 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPN 87
+++ +IG G +Y I + VAIK ++ L E+K +L
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKHPQL---LYESKIYRILQGGTG 64
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
I N +VM + G SL+ + + C L + ++ + ++ + ++H+
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHS 121
Query: 147 QGHLHRDVKAGNILSDSDGS---VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+ LHRD+K N L V + DFG++ + S H H ++ GT + +
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 204 PEVIRSHTGY--SFKADIWSFGITALELAHGRPPLSHLPP-------EKSLLMKMT 250
+ +H G S + D+ S G + G P L EK K+
Sbjct: 182 ---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 17/214 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PN 87
Y++ +IG G +Y I VAIK + +T + E+K ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVG 66
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
I + +VM + G SL+ + + C + ++ + +S + Y+H+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 123
Query: 147 QGHLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+ +HRDVK N L V + DFG++ + H H ++ GT + +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 204 PEVIRSHTGY--SFKADIWSFGITALELAHGRPP 235
I +H G S + D+ S G + G P
Sbjct: 184 ---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 47/312 (15%), Positives = 94/312 (30%), Gaps = 49/312 (15%)
Query: 1 MAHHEQEDQCSSTGTIAQKIQYPLDPS-------------SYKILDEIGVGVSAIVYKAI 47
M HH SS + + Y + + +IG G ++Y A
Sbjct: 1 MHHHHHH---SSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAF 57
Query: 48 CIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL------ 101
A + ++ + + E K ++ + + L
Sbjct: 58 PT-NKPEKDARHVVKVE--YQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114
Query: 102 -------------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
++VM + LQ I + + + L L Y+H
Sbjct: 115 GSGLTEFKGRSYRFMVMERLGI-DLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENE 171
Query: 149 HLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
++H D+KA N+L + V LAD+G+S +H + GT + +
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS--- 228
Query: 207 IRSHTGY--SFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264
+ +H G S ++D+ G L G+ P + + + +++
Sbjct: 229 LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN-LLDELPQSVLK 287
Query: 265 KDKNKKFSRAFK 276
+
Sbjct: 288 WAPSGSSCCEIA 299
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 51/264 (19%), Positives = 86/264 (32%), Gaps = 42/264 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICI-------PMDSTVVAIK----------AIDLDQSRTDLD 71
+K+ I+Y+A ++K + Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 72 SIRRETKTMSLLSHPNILNAHCSFSVDSRLWV-VMPFMSCGSLQSIISSCFPDGLPEPCI 130
+ + K S I + V+P + SLQS + L E +
Sbjct: 104 QVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSV 161
Query: 131 AIVLKETLSALSYLHNQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHH-HH 187
V L AL +LH ++H +V A NI + V LA +G A Y PS H +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF-AFRYCPSGKHVAY 220
Query: 188 GSAMITDMAGTPYWMAPEVIRSHTGY--SFKADIWSFGITALELAHGRPPLSHLPPEKSL 245
+ G +++ + H G S ++D+ S G L+ +G P ++ P
Sbjct: 221 VEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-- 275
Query: 246 LMKMTQRFRFSDYEKTLKIKDKNK 269
+ K K +K
Sbjct: 276 -----------EDIMKQKQKFVDK 288
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 3e-11
Identities = 60/352 (17%), Positives = 100/352 (28%), Gaps = 74/352 (21%)
Query: 8 DQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR 67
+CS G + L + ++IG GV V++ I D T VAIK I ++
Sbjct: 3 GECSQKG--PVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPD 57
Query: 68 -------TDLDSIRRETKTMSLL---------SHPNI----------------------- 88
+ I E L
Sbjct: 58 LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117
Query: 89 -------LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
N F D +L++V+ F G + +L + ++L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASL 174
Query: 142 SYLHNQGHL-HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG----SAMITDMA 196
+ HRD+ GN+L KL S PS + +
Sbjct: 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234
Query: 197 GTPYWM----APEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQ 251
G + ++ Y F DI+ P S++ L KM +
Sbjct: 235 GIVVFCDVSMDEDLFTGDGDYQF--DIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292
Query: 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ F T +K +K + F + + + + L +HS FK
Sbjct: 293 QMTFKTKCNTPAMKQIKRKI-QEFHRTMLNF-------SSATDLLCQHSLFK 336
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 47/263 (17%), Positives = 81/263 (30%), Gaps = 44/263 (16%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKA-IDLDQSRTDLDSIRRETKTMSLLSHPN 87
+K+ IG G +Y A S V A + +D + E K + P
Sbjct: 37 WKVGLPIGQGGFGCIYLAD--MNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 88 ILNAHCSFSVDSRLWV-------------------VMPFMSCGSLQSIISSCFPDGLPEP 128
+ L V +M LQ I +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN-AKRFSRK 152
Query: 129 CIAIVLKETLSALSYLHNQGHLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHH 186
+ + L L Y+H ++H D+KA N+L + V L D+G++ H
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 187 HGSAMITDMAGTPYWMAPEVIRSHTGY--SFKADIWSFGITALELAHGRPPLSHLPPEKS 244
+ + GT + + I +H G S + D+ G ++ G P +
Sbjct: 213 YAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-- 267
Query: 245 LLMKMTQRFRFSDYEKTLKIKDK 267
Y + KI+ +
Sbjct: 268 -----------PKYVRDSKIRYR 279
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.14 | |
| 1dip_A | 78 | Delta-sleep-inducing peptide immunoreactive peptid | 83.65 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.64 | |
| 2jee_A | 81 | YIIU; FTSZ, septum, coiled-coil, cell division, ce | 80.89 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.38 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-61 Score=484.07 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=226.0
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
..+++|++++.||+|+||+||+|.++ .+|+.||||++.+.. .....+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCccccEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 44578999999999999999999996 678999999997543 223457899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+|||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 108 yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999999987 467999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
. .........||+.|||||++.+.. |+.++|||||||++|+|++|.+||...+.......+....+.
T Consensus 186 ~-----~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~------- 252 (311)
T 4aw0_A 186 S-----KQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD------- 252 (311)
T ss_dssp T-----TCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------
T ss_pred C-----CcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 1 111233457999999999998755 899999999999999999999999877666655555444333
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHH------HHcCcccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK------LMKHSFFKNCNK 307 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~e------iL~hp~f~~~~~ 307 (506)
.+..+|+++++||.+||+.||++|||+.| |++||||+++++
T Consensus 253 -----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 253 -----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp -----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 23467899999999999999999999988 589999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-61 Score=489.28 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=220.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
..++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|++++|||||+++++|.+++.+|+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 4579999999999999999999995 678999999997654 45567889999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||||+||+|.++|.......+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--- 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH---
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC---
Confidence 99999999999999875556789999999999999999999999999999999999999999999999999753211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.........||+.|||||++.+.. |+.++|||||||++|+|++|++||...+.......+....+
T Consensus 178 ----~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------- 242 (350)
T 4b9d_A 178 ----TVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF---------- 242 (350)
T ss_dssp ----HHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----------
T ss_pred ----CcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------
Confidence 011123346999999999998754 99999999999999999999999988776665555444322
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+..+..+|+++++||.+||+.||++|||+.++|+||||++.
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 12345689999999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=483.90 Aligned_cols=258 Identities=35% Similarity=0.570 Sum_probs=220.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
..|+++++||+|+||+||+|.++ .+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999995 6789999999975543 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
||+||+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 152 y~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~----- 223 (346)
T 4fih_A 152 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----- 223 (346)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred CCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-----
Confidence 9999999999986 57999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........||+.|||||++.+.. |+.++|||||||++|||++|.+||...+..+....+... ... ...
T Consensus 224 --~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~--------~~~ 291 (346)
T 4fih_A 224 --VPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPP--------RLK 291 (346)
T ss_dssp --SCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCC--------CCS
T ss_pred --CCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCC--------CCC
Confidence 11233457999999999997654 999999999999999999999999877665544433222 111 011
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+..+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 3456899999999999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-60 Score=466.58 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=207.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++..... ......+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999985 6789999999976542 33456799999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||| +|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 92 mEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--- 165 (275)
T ss_dssp EECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC---
Confidence 9999 6899999987 478999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......||+.|||||++.+...++.++|||||||++|+|++|++||...+............+.
T Consensus 166 -----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~---------- 230 (275)
T 3hyh_A 166 -----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT---------- 230 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------
T ss_pred -----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 12234579999999999988765578999999999999999999999876555444333332222
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.+..+|+++++||.+||+.||++|||+.|+++||||+.
T Consensus 231 --~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 --LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 33568899999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=467.38 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=214.6
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe----CCEEEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV----DSRLWV 103 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l 103 (506)
|++.++||+|+||+||+|.++ .++..||+|.+.... .....+.+.+|+.+|++++|||||+++++|.+ +..+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 588899999999999999995 678899999987544 45566789999999999999999999999875 356899
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeC-CCCCeEEeeccccccccC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSD-SDGSVKLADFGVSASIYE 180 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld-~~g~vKL~DFGls~~~~~ 180 (506)
|||||+||+|.+++.. ...+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|.....
T Consensus 107 vmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999987 467999999999999999999999998 99999999999998 489999999999853221
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.......|||.|||||++.+ .|+.++|||||||++|+|+||++||............+.......
T Consensus 185 ---------~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~---- 249 (290)
T 3fpq_A 185 ---------SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA---- 249 (290)
T ss_dssp ---------TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----
T ss_pred ---------CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC----
Confidence 12234579999999999965 399999999999999999999999987666555555444332211
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
..+..+++++++||.+||+.||++|||+.++|+||||++
T Consensus 250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 133457789999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=476.41 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=218.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...++++|++++.||+|+||+||+|.+.. .+++.||||++..... ......+.+|+.+|++++|||||+++++|.++
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE 98 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 34567899999999999999999998752 3578999999975432 22334678999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred CEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999999999987 467999999999999999999999999999999999999999999999999998643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ........||+.|||||++.+.. |+.++|||||||++|+|++|++||...+..+....+....+.
T Consensus 177 ~~~-------~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---- 244 (304)
T 3ubd_A 177 IDH-------EKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG---- 244 (304)
T ss_dssp -----------CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred cCC-------CccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC----
Confidence 211 11223456999999999998754 999999999999999999999999887766655554443322
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..+|+++++||.+||+.||++||| ++|+++||||++++
T Consensus 245 --------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 245 --------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 33568999999999999999999998 57999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=486.89 Aligned_cols=258 Identities=35% Similarity=0.570 Sum_probs=221.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+.|+++++||+|+||+||+|.++ .+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 46999999999999999999996 6789999999976543 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
||+||+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.|||+|||+|......
T Consensus 229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~----- 300 (423)
T 4fie_A 229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----- 300 (423)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-----
T ss_pred CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-----
Confidence 9999999999976 57999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
........||++|||||++.+.. |+.++|||||||++|||++|.+||...+.......+... ... ...
T Consensus 301 --~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~--------~~~ 368 (423)
T 4fie_A 301 --VPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPP--------RLK 368 (423)
T ss_dssp --CCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCC--------CCS
T ss_pred --CccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCC--------CCc
Confidence 11223456999999999998654 999999999999999999999999877666554433322 111 011
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+..+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 3456899999999999999999999999999999999763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=468.99 Aligned_cols=265 Identities=25% Similarity=0.299 Sum_probs=218.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.+......|++.++||+|+||+||+|.++ .+|+.||||+++..... .+|+.+|+.++|||||+++++|.+++.
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34455678999999999999999999995 67899999999765332 379999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeecccccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIY 179 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~ 179 (506)
+|+|||||+||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999999874 6799999999999999999999999999999999999999988 69999999986532
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.... ...........||+.|||||++.+.. |+.++|||||||++|+|++|++||...........+......
T Consensus 203 ~~~~--~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~----- 274 (336)
T 4g3f_A 203 PDGL--GKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP----- 274 (336)
T ss_dssp -------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----
T ss_pred CCCc--ccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----
Confidence 2110 00111123346999999999998755 999999999999999999999999876655444443332211
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH-------------HcCccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL-------------MKHSFFKNCN 306 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei-------------L~hp~f~~~~ 306 (506)
....++.+++.+++||.+||+.||.+|||+.|+ ++|||+....
T Consensus 275 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 275 ----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp ----GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ----chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 122456789999999999999999999999997 5799998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=450.91 Aligned_cols=266 Identities=24% Similarity=0.398 Sum_probs=202.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-------
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS------- 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 99 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++.........+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 36999999999999999999995 6789999999987766667788999999999999999999999987544
Q ss_pred -----EEEEEeccCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 100 -----RLWVVMPFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 100 -----~~~lV~Ey~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
++|+|||||.||+|.+++..... ...++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 47999999999999999986422 235567789999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCC-----CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010624 174 VSASIYEPSHHHH-----HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 174 ls~~~~~~~~~~~-----~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~ 248 (506)
+|........... ..........||+.|||||++.+.. |+.++|||||||++|||++ ||............
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9865432211100 0011123346999999999998754 9999999999999999996 77532211111111
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
+ ....++ ......++.+++||.+||+.||.+|||+.++++||||++.+.
T Consensus 240 ~-~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 240 V-RNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp H-HTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred H-hcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 1 112221 122345677899999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=448.08 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=215.5
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
.....|++..++|++.++||+|+||+||+|.+. ..||||+++... .....+.|.+|+.+|++++|||||++++++
T Consensus 26 ~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 26 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp ---CCCBCCTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 344568999999999999999999999999752 258999987543 455678899999999999999999999987
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.. +.+|+|||||+||+|.+++... ...+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 64 5689999999999999999763 457999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
....... .........||+.|||||++.+. ..|+.++|||||||++|||+||+.||............+....
T Consensus 180 ~~~~~~~-----~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 180 TVKSRWS-----GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp BC-----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred eecccCC-----cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 6432111 11123345799999999999753 2489999999999999999999999988776665555555443
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+. ....+..+++++.+||.+||+.||++|||+.+|++
T Consensus 255 ~~p~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 255 ASPD------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CCCC------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred CCCC------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3322 12245678999999999999999999999998864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=463.28 Aligned_cols=273 Identities=25% Similarity=0.340 Sum_probs=220.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe------CC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV------DS 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 99 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999995 678999999997654 34456788899999999999999999998764 36
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||. |+|.+++.. ...+++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 7999999996 679999987 5789999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
... ...........||++|||||++.+...|+.++||||+||++|||++|++||...+.......+.......+...
T Consensus 210 ~~~---~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSP---AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp ---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCc---cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 211 11112234567999999999998877689999999999999999999999988776665544443222111100
Q ss_pred ----------hh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 ----------KT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 ----------~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. ..+....+.+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 00 000112245788999999999999999999999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=452.35 Aligned_cols=274 Identities=24% Similarity=0.361 Sum_probs=212.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (506)
..++|++.+.||+|+||+||+|.++. .+++.||||.+.... ....+.+|+.+|+.+ +|||||+++++|.+++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34679999999999999999998852 346889999986543 235678999999988 699999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-CCeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-g~vKL~DFGls~~~~~ 180 (506)
|+|||||+||+|.+++. .+++..++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999984 48999999999999999999999999999999999999876 8999999999864332
Q ss_pred CCCCC---------------------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 010624 181 PSHHH---------------------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL 239 (506)
Q Consensus 181 ~~~~~---------------------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~ 239 (506)
..... ...........||++|||||++.+...|+.++||||+||++|+|++|++||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11100 000111234569999999999988777999999999999999999999999765
Q ss_pred ChHHHHHHHHhhccc--------------------cc--chhh---------------------hhhhhccchhhhHHHH
Q 010624 240 PPEKSLLMKMTQRFR--------------------FS--DYEK---------------------TLKIKDKNKKFSRAFK 276 (506)
Q Consensus 240 ~~~~~~~~~~~~~~~--------------------~~--~~~~---------------------~~~~~~~~~~~s~~l~ 276 (506)
......+..+..... .+ .... ..........+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 544333222211000 00 0000 0000112346789999
Q ss_pred HHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 277 DMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 277 ~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
|||.+||+.||++|||+.|+|+||||++++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=441.04 Aligned_cols=262 Identities=22% Similarity=0.397 Sum_probs=215.3
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
.+..++|.+.+.||+|+||+||+|.+.. .++..||||.+... .....+.|.+|+.+|++++|||||++++++.++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3566789999999999999999998742 35789999998643 445567899999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCe
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCF-----------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~-----------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~v 167 (506)
+.+|+|||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 99999999999999999997632 3469999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 010624 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLL 246 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~ 246 (506)
||+|||+|...... ..........||+.|||||++.+.. |+.++|||||||++|||+| |++||...+..+...
T Consensus 168 Ki~DFGla~~~~~~-----~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 168 KIGDFGMSRDVYST-----DYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp EECCCSCHHHHTGG-----GCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred EECCcccceecCCC-----CceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999998643211 0111122345899999999998765 9999999999999999998 899999877665444
Q ss_pred HHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 247 MKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
...... . ...+..+|+++.+||.+||+.||++|||+.+| |+|+++
T Consensus 242 ~i~~~~-~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 242 CITQGR-V----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHTC-C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHHcCC-C----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 333221 1 12446789999999999999999999999999 455543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=441.01 Aligned_cols=261 Identities=21% Similarity=0.353 Sum_probs=216.0
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+..+++++.++||+|+||+||+|... ..+++.||||.+.........+.|.+|+.+|++++|||||++++++.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3466788999999999999999999863 235689999999766555667889999999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS 163 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~ 163 (506)
++.+|+|||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++|+||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 999999999999999999997532 135899999999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChH
Q 010624 164 DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPE 242 (506)
Q Consensus 164 ~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~ 242 (506)
++.+||+|||+|...... ..........||+.|||||++.+.. |+.++|||||||++|||+| |.+||......
T Consensus 181 ~~~~Ki~DFGlar~~~~~-----~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAA-----DYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GGCEEECCSCCBCGGGGG-----GCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred CCCEEECCcccceeccCC-----CceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999997643211 1111223456899999999998765 9999999999999999998 89999887765
Q ss_pred HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
+..... ..... ...+..+++.+.+|+.+||+.||++|||+.+|+++
T Consensus 255 ~~~~~i-~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMI-RNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHH-HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH-HcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 544332 22211 12346789999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=441.30 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=211.2
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+..++|.+.++||+|+||+||+|.++. .+++.||||++... .....+.|.+|+.+|++++|||||++++++.+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44667889999999999999999998742 35789999999643 45566789999999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCF-------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD 164 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~-------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~ 164 (506)
++.+|+|||||++|+|.+++.... ...+++..+..|+.|++.||+|||+++|+||||||+|||++.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999997642 2459999999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHH
Q 010624 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEK 243 (506)
Q Consensus 165 g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~ 243 (506)
+.+||+|||+|...... ..........||+.|||||++.+.. |+.++|||||||++|||+| |+.||......+
T Consensus 195 ~~~Ki~DFGla~~~~~~-----~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYST-----DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp TEEEECCCC---------------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred CcEEEcccccceeccCC-----CcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999997643221 1111223456899999999998755 9999999999999999999 899998877665
Q ss_pred HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...... ...+ ...+..+++++.+||.+||+.||++|||+.+|+++
T Consensus 269 ~~~~i~-~g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 269 AIDCIT-QGRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHH-HTCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHH-cCCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 443332 2211 12345789999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=442.90 Aligned_cols=264 Identities=23% Similarity=0.392 Sum_probs=221.3
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC-CCceeeeeE
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PNILNAHCS 94 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~ 94 (506)
..|++..++|++.+.||+|+||+||+|.+... .++.||||.+.........+.+.+|+.+|++++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 45788999999999999999999999998632 2468999999877666777889999999999965 999999999
Q ss_pred EEe-CCEEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCE
Q 010624 95 FSV-DSRLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159 (506)
Q Consensus 95 ~~~-~~~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NI 159 (506)
|.. ++.+|+|||||++|+|.++|+... ...+++..+..|+.||+.||+|||+++|+||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 866 457899999999999999997632 23589999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 010624 160 LSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSH 238 (506)
Q Consensus 160 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~ 238 (506)
|++.++.+||+|||+|...... ..........||+.|||||++.+.. |+.++|||||||++|||+| |.+||..
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~-----~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKD-----PDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTC-----TTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred eeCCCCCEEECcchhhhhcccC-----CCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999998643221 1112233456899999999998765 9999999999999999998 9999987
Q ss_pred CChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..........+....+.. .+..+++++.+||.+||+.||++|||+.+|++|
T Consensus 291 ~~~~~~~~~~i~~g~~~~----------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCSHHHHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCC----------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 766555555444433221 345688999999999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=468.23 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=218.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-----ChhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-----SRTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
+.++..++|+++++||+|+||+||+|.++ .+|+.||||++.+.. ........++++.+++.++|||||+++++|
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 45677889999999999999999999995 678999999996532 112223334556777888999999999999
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.+++.+|+|||||+||+|.++|.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|+|||+|||+|
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence 999999999999999999999987 467999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK---SLLMKMTQR 252 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~---~~~~~~~~~ 252 (506)
...... ......|||.|||||++....+|+.++|||||||++|+|++|.+||....... .........
T Consensus 340 ~~~~~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~ 410 (689)
T 3v5w_A 340 CDFSKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410 (689)
T ss_dssp EECSSC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC
T ss_pred eecCCC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Confidence 643221 12345799999999999755569999999999999999999999997533221 111111111
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCcccccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCNK 307 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~~ 307 (506)
+ ..+..+|+++++||.+||+.||.+|++ +.+|++||||+++++
T Consensus 411 ~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 V------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp C------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred C------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 1 134568999999999999999999998 799999999998853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=462.26 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=224.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++++.||+|+||+||+|.++ .+|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.++..+|+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 68999999999999999999996 678999999986543 4456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC--CCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD--GSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~--g~vKL~DFGls~~~~~~~~~ 184 (506)
||+||+|.++|... ...+++..++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+|......
T Consensus 235 ~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--- 310 (573)
T 3uto_A 235 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 310 (573)
T ss_dssp CCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---
T ss_pred ecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC---
Confidence 99999999999653 3579999999999999999999999999999999999999854 89999999997653221
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......||+.|||||++.+.. |+.++|||||||++|+|++|.+||......+....+....+.++.
T Consensus 311 -----~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~------- 377 (573)
T 3uto_A 311 -----QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------- 377 (573)
T ss_dssp -----SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-------
T ss_pred -----CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-------
Confidence 1223456999999999998765 899999999999999999999999987776665555444433322
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
.....+|+++++||.+||+.||.+|||+.|+|+||||+..+.
T Consensus 378 -~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 378 -SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp -GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred -ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 134568999999999999999999999999999999997643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=414.86 Aligned_cols=256 Identities=22% Similarity=0.269 Sum_probs=192.7
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC----EEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS----RLW 102 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 102 (506)
.+|.+.++||+|+||+||+|.+ +|+.||||++.... .......+|+..+..++|||||++++++..++ .+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 5699999999999999999987 47899999986432 11122335666677899999999999997653 689
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ--------GHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~--------givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
+|||||+||+|.+++.. .++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 78 lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999986 5799999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccC-----CCCccccHHHHHHHHHHHHhCCCCCCCCCh--------
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-----GYSFKADIWSFGITALELAHGRPPLSHLPP-------- 241 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-----~~~~~sDIwSlGiil~eLltG~~Pf~~~~~-------- 241 (506)
|......... .........||+.|||||++.+.. .|+.++|||||||++|||+||.+||.....
T Consensus 155 a~~~~~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 155 AVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CEEEETTTTE---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CccccCCCCc---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 7654322110 111122356999999999997542 267799999999999999999876642211
Q ss_pred ------HHHHHHHHh-hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 242 ------EKSLLMKMT-QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 242 ------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.......+. ...+.. .+ .......++..+.+|+.+||+.||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~rp~-~p----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLRPN-IP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCC-CC----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHhcccCCCC-CC----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111111111 111111 00 01122346678999999999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=408.87 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=222.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
..++|++++.||+|+||.||+|.+. .+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3468999999999999999999985 678999999997654 34556788999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||++||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 99999999999999873 67999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+...++.++|||||||++|+|++|.+||................+.
T Consensus 168 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------- 232 (328)
T 3fe3_A 168 ------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--------- 232 (328)
T ss_dssp ------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred ------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 12344569999999999987664468999999999999999999999877665554444333322
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 233 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 233 ---IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred ---CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 234578899999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=409.31 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=222.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.+.|++.+.||+|+||+||+|.++ .+|+.||+|++...... ...+.+.+|+.+|+.++||||++++++|.+...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 467999999999999999999985 67899999999765432 235789999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC----CeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG----SVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g----~vKL~DFGls~ 176 (506)
+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999999976 46799999999999999999999999999999999999998777 79999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... .......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||................+.++
T Consensus 168 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 168 EIEDG--------VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238 (361)
T ss_dssp ECCTT--------CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EcCCC--------CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 43221 1123446899999999997654 89999999999999999999999987766655544444333332
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. ..+..+++.+++||.+||..||.+|||+.++++||||+..+
T Consensus 239 ~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 239 E--------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp H--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred c--------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1 12346788999999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=406.72 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=222.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..++|++++.||+|+||+||+|.++ .+|+.||+|++.... .......+.+|+.+++.++||||++++++|.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 45678999999999999999999985 678999999986532 223456788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999999987 367999999999999999999999999999999999999999999999999997542211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||..................
T Consensus 159 -------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------- 223 (337)
T 1o6l_A 159 -------GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------- 223 (337)
T ss_dssp -------TCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred -------CCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 11223456899999999997654 899999999999999999999999876665544444333222
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..+++++++||.+||+.||.+|| ++.++++||||+..+
T Consensus 224 -----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 2346789999999999999999999 999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=397.92 Aligned_cols=261 Identities=38% Similarity=0.631 Sum_probs=221.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
-..++|++.+.||+|+||+||+|.+. .+++.||||.+..... ...+.+.+|+.+++.++||||++++++|..++.+|+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 34568999999999999999999985 6789999999875443 335678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+.||+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 9999999999999987 46999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|..||...................
T Consensus 170 -----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------- 235 (297)
T 3fxz_A 170 -----QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------- 235 (297)
T ss_dssp -----TCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC--------
T ss_pred -----ccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 11233456899999999998754 8999999999999999999999998776655544433322111
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
...+..+++.+++||.+||+.||.+|||+.++++||||+...
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 236 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 113456889999999999999999999999999999999763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=412.31 Aligned_cols=289 Identities=32% Similarity=0.534 Sum_probs=226.0
Q ss_pred cccccCCCCCCeeEEeeeccc--CCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeE
Q 010624 18 QKIQYPLDPSSYKILDEIGVG--VSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCS 94 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G--~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (506)
....+....++|++++.||+| +||+||+|.++ .+++.||||++.... .....+.+.+|+.+++.++||||++++++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 345577788899999999999 99999999995 578999999997654 34456788899999999999999999999
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
|..++.+|+|||||.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999999999886567899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
+.....................||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.................
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 754322211111112223345789999999999863 3489999999999999999999999987655444333222111
Q ss_pred ccc-------ch---------------------------hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 254 RFS-------DY---------------------------EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 254 ~~~-------~~---------------------------~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
... .. ............+++.+++||.+||+.||++|||+.++|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 00 00000111335578899999999999999999999999999
Q ss_pred cccccccc
Q 010624 300 SFFKNCNK 307 (506)
Q Consensus 300 p~f~~~~~ 307 (506)
|||+....
T Consensus 335 p~f~~~~~ 342 (389)
T 3gni_B 335 SFFKQIKR 342 (389)
T ss_dssp GGGGGC--
T ss_pred HHHHHHhh
Confidence 99998743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=410.57 Aligned_cols=262 Identities=25% Similarity=0.444 Sum_probs=218.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (506)
-.+..++|++++.||+|+||+||+|.++ .+++.||+|++.... .....+.+.+|..+++.+ +||||++++++|.+.
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 4566789999999999999999999985 678999999986532 233456788999999988 699999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999873 67999999999999999999999999999999999999999999999999997532
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...........+......
T Consensus 175 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---- 242 (353)
T 3txo_A 175 IC-------NGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV---- 242 (353)
T ss_dssp CC----------------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred cc-------CCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 21 112233456999999999998765 899999999999999999999999887766655554444332
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH------HHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA------EKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~------~eiL~hp~f~~~~ 306 (506)
.+..+++.+++||.+||+.||.+||++ .+|++||||+..+
T Consensus 243 --------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 243 --------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred --------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 234578899999999999999999998 8999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=408.04 Aligned_cols=264 Identities=27% Similarity=0.457 Sum_probs=220.6
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL-SHPNILNAHCSFSV 97 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (506)
...+..++|++.+.||+|+||+||+|.++ .+++.||||++..... ....+.+.+|..+++.+ +||||++++++|.+
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 34567789999999999999999999985 6789999999865321 23456778899999876 89999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999999873 6799999999999999999999999999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||..................
T Consensus 168 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--- 236 (345)
T 1xjd_A 168 NMLG-------DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--- 236 (345)
T ss_dssp CCCT-------TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---
T ss_pred cccC-------CCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC---
Confidence 2211 11233456899999999998754 899999999999999999999999876665544433332221
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHH-HHHcCcccccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAE-KLMKHSFFKNCNK 307 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~-eiL~hp~f~~~~~ 307 (506)
.+..+++++++||.+||..||.+||++. +|++||||+.++.
T Consensus 237 ---------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 237 ---------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp ---------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ---------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 2345789999999999999999999998 9999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=398.23 Aligned_cols=271 Identities=29% Similarity=0.429 Sum_probs=215.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
..++|++++.||+|+||+||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKD--SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEE--TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEE--CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 457899999999999999999998 4589999999875543 3345678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+. ++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 97 VFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-- 172 (311)
T ss_dssp EEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred EEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence 999998 4888888763 456999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc--cccchhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF--RFSDYEKT 261 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 261 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||................. ....+...
T Consensus 173 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 173 -----VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp -----CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred -----cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 11223456899999999998766689999999999999999999999987665544333222110 00000000
Q ss_pred ----------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 ----------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ----------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.........+++++.+||.+||+.||.+|||+.++++||||++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 001112345778999999999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=390.93 Aligned_cols=269 Identities=28% Similarity=0.408 Sum_probs=215.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++++.||+|+||+||+|.++ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 67999999999999999999985 5689999999976543 344577889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+ +|.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp ECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred ecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence 99986 555555442 467999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh---h--
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE---K-- 260 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~-- 260 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|..||............+......+... .
T Consensus 155 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp ---CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ---cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 11223456899999999998766689999999999999999998888654444443333332211111000 0
Q ss_pred -------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 -------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 -------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..........+++.+++||.+||+.||++|||+.++++||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 000111234578999999999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=398.29 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=222.0
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..++|++++.||+|+||+||+|.++ .+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 34578999999999999999999985 6789999999865321 23456788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 999999999999999987 46799999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||..................
T Consensus 159 ---------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------- 221 (318)
T 1fot_A 159 ---------VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------- 221 (318)
T ss_dssp ---------CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC-------
T ss_pred ---------ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------
Confidence 123456899999999998654 899999999999999999999999877665555444443322
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..+++++++||.+||..||++|| ++.++++||||+..+
T Consensus 222 -----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 222 -----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 2345788999999999999999999 999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=418.89 Aligned_cols=267 Identities=27% Similarity=0.462 Sum_probs=222.8
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
.+.+..++|++++.||+|+||+||+|.++ .+++.||+|++..... ....+.+.+|+.+++.++||||++++++|.++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 35677889999999999999999999985 6688999999864221 11234577999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 999999999999999999976 46999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCC---CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--c
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG---YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR--F 253 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~---~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~--~ 253 (506)
... .........||+.|+|||++.+... |+.++|||||||++|+|++|.+||...........++... +
T Consensus 219 ~~~------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 219 NKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp CTT------SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ccC------CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 211 1112234579999999999976432 6789999999999999999999998776665544443321 1
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCcccccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~ 307 (506)
.++ ....+++++++||.+||..+|.+ ||++.+|++||||++.+.
T Consensus 293 ~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 293 TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp CCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred cCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 111 22468899999999999999988 999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=413.86 Aligned_cols=260 Identities=25% Similarity=0.447 Sum_probs=220.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||+||+|.++ .+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 6789999999976653 345677899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC---CCCCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD---SDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld---~~g~vKL~DFGls~~~~~~~ 182 (506)
|||.||+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 90 DLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp CCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred EeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 99999999999987 46799999999999999999999999999999999999998 4678999999997543221
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||................+.++.
T Consensus 167 ------~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 234 (444)
T 3soa_A 167 ------QQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS----- 234 (444)
T ss_dssp ------CCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred ------CceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc-----
Confidence 11223456999999999997654 899999999999999999999999877666655554444433322
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus 235 ---~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 235 ---PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 1335688999999999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=398.31 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=221.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||+|+||+||+|.+. .++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 478999999999999999999985 67899999998643 344567889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC--CCCeEEeeccccccccCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS--DGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~--~g~vKL~DFGls~~~~~~~~ 183 (506)
|||+||+|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++. ++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-- 157 (321)
T 1tki_A 81 EFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred EeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence 999999999999763 346999999999999999999999999999999999999997 789999999997643211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||..................++.
T Consensus 158 ------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 224 (321)
T 1tki_A 158 ------DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------ 224 (321)
T ss_dssp ------CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH------
T ss_pred ------CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh------
Confidence 1223456899999999998654 799999999999999999999999877666555444444333221
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++++++||.+||..||.+|||+.++++||||++.
T Consensus 225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 1234678999999999999999999999999999999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=398.89 Aligned_cols=261 Identities=28% Similarity=0.531 Sum_probs=218.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (506)
++..++|++++.||+|+||.||+|.++ .+++.||+|++.... .....+.+.+|+.+++.+ +||||++++++|.+.+
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCchhheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 355678999999999999999999985 678999999997653 344567788999999987 8999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999999999873 679999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHH-h
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--------KSLLMKM-T 250 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--------~~~~~~~-~ 250 (506)
.. ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...... ......+ .
T Consensus 162 ~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 162 RP-------GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp CT-------TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred CC-------CCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 11 11233457899999999998754 899999999999999999999999653211 1111111 1
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH------HHHHcCccccccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA------EKLMKHSFFKNCN 306 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~------~eiL~hp~f~~~~ 306 (506)
... ..+..++..+++||.+||+.||.+||++ .++++||||++.+
T Consensus 234 ~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 234 KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CCC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 111 1335688999999999999999999995 8999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=409.00 Aligned_cols=264 Identities=27% Similarity=0.510 Sum_probs=216.5
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL-SHPNILNAHCSFSV 97 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (506)
...+..++|++++.||+|+||+||+|.++ .+++.||+|++..... ....+.+.+|..++.++ +||||++++++|.+
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence 34567789999999999999999999985 6789999999975432 23345678899999876 89999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
++.+|+|||||+||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999999999987 36799999999999999999999999999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHH-
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--------KSLLMK- 248 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--------~~~~~~- 248 (506)
.... ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...... ......
T Consensus 203 ~~~~-------~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 203 GLRP-------GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CCCT-------TCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred cccC-------CCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 2211 12233456899999999998754 899999999999999999999999643211 111111
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH------HHHHcCcccccccc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA------EKLMKHSFFKNCNK 307 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~------~eiL~hp~f~~~~~ 307 (506)
..... ..+..+++++++||.+||+.||.+||++ .+|++||||+++++
T Consensus 275 ~~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 275 LEKQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp HHCCC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred hcccc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 11111 1345688999999999999999999985 79999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=388.40 Aligned_cols=268 Identities=26% Similarity=0.426 Sum_probs=214.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++++.||+|+||+||+|.+ .+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6799999999999999999988 5678999999876543 223467889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+ +|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp ECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 99985 999998764 467999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc--cchhhh--
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF--SDYEKT-- 261 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~-- 261 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||................... ..+...
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 1112334679999999999876568999999999999999999999998776655443332211000 000000
Q ss_pred -------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 262 -------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 262 -------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.........+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00111234578999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=400.29 Aligned_cols=263 Identities=22% Similarity=0.370 Sum_probs=216.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||+|+||+||+|.+. .+++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 468999999999999999999985 5789999999976655555577889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||+|++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 158 (323)
T 3tki_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 158 (323)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC----
Confidence 99999999999976 467999999999999999999999999999999999999999999999999997532211
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
..........||+.|+|||++.+...++.++|||||||++|+|++|..||................... .
T Consensus 159 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------~ 228 (323)
T 3tki_A 159 -NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------L 228 (323)
T ss_dssp -TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------S
T ss_pred -CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------C
Confidence 011112345689999999999876645789999999999999999999998665543333322221111 1
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 1235678999999999999999999999999999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=400.80 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=220.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999985 678999999997654 3455678999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC---CCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD---GSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~---g~vKL~DFGls~~~~~~~ 182 (506)
|||.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 99999999999976 4679999999999999999999999999999999999999865 45999999997543211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||................+.++.
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----- 251 (362)
T 2bdw_A 185 -------EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----- 251 (362)
T ss_dssp -------CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred -------cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 1123456899999999998654 899999999999999999999999877665554444444333321
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+..+++++++||.+||+.||.+|||+.++++||||+..
T Consensus 252 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 252 ---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1235678999999999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=400.99 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=220.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (506)
-.+..++|++++.||+|+||+||+|.++ .+++.||+|++.... .....+.+.+|..++..+ +||||++++++|.+.
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 3466789999999999999999999985 568899999986542 123456788999999987 799999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999999873 57999999999999999999999999999999999999999999999999997642
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||..................
T Consensus 172 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---- 239 (353)
T 2i0e_A 172 IWD-------GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---- 239 (353)
T ss_dssp CCT-------TCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred ccC-------CcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC----
Confidence 211 11233456899999999998654 899999999999999999999999877665554444433322
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..+++++++||.+||..||.+||+ +.+|++||||+.++
T Consensus 240 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 240 --------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 23468899999999999999999994 69999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.40 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=220.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.+.|++.+.||+|+||.||+|.++ .++..||+|++...... ...+.+.+|+.+++.++||||+++++++..+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 356999999999999999999985 67899999998765422 246789999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC----CeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG----SVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g----~vKL~DFGls~ 176 (506)
+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999999976 46799999999999999999999999999999999999999887 89999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||..................++
T Consensus 167 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 167 KIDFG--------NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237 (326)
T ss_dssp ECCTT--------SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred ECCCC--------CccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence 43221 1123346899999999997654 89999999999999999999999987665554443333322222
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. .....+++.+++||.+||+.||.+|||+.++++||||+...
T Consensus 238 ~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 238 D--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp H--------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred c--------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 1 12345788999999999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=393.76 Aligned_cols=272 Identities=26% Similarity=0.410 Sum_probs=206.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++++.||+|+||+||+|.++ .+++.||+|.+.........+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECS-SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 468999999999999999999885 5689999999977655555577889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 106 PFMSCGSLQSIISSCF----PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~----~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 69999987542 245999999999999999999999999999999999999999999999999997643211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc--cchh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF--SDYE 259 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~ 259 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||................... ..+.
T Consensus 162 -------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 162 -------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp -------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred -------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 1112344689999999999875568999999999999999999999998776655443332210000 0000
Q ss_pred h--------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 K--------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 ~--------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. ..........++.++++||.+||+.||.+|||+.++++||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0 0001112235788999999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=388.47 Aligned_cols=271 Identities=26% Similarity=0.407 Sum_probs=216.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.++|++++.||+|+||+||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 368999999999999999999985 5688999999866543 33456788999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--- 155 (311)
T ss_dssp EECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc---
Confidence 999999999999876 467999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc-------
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD------- 257 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~------- 257 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||.....................
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 ----SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ----ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 111234468999999999987666899999999999999999999999877665544332211111000
Q ss_pred ------------hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 258 ------------YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 258 ------------~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
...........+.+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 0000000111246788999999999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=399.43 Aligned_cols=258 Identities=23% Similarity=0.412 Sum_probs=222.3
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
....++|++++.||+|+||.||+|.++ .+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 345678999999999999999999985 578999999986532 12345778899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999999874 5799999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||..................
T Consensus 194 ----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------ 256 (350)
T 1rdq_E 194 ----------RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------ 256 (350)
T ss_dssp ----------CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------
T ss_pred ----------CcccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 122346899999999998654 899999999999999999999999877665544444333222
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..+++.+++||.+||+.||.+||+ +.+|++||||+..+
T Consensus 257 ------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 257 ------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 23467899999999999999999998 99999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=392.24 Aligned_cols=263 Identities=22% Similarity=0.409 Sum_probs=213.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEe--CCCCeEEEEEEeccCCC---hhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICI--PMDSTVVAIKAIDLDQS---RTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~--~~~~~~vAIK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
..+..++|++.+.||+|+||.||+|.+. ..+++.||+|++..... ......+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4566789999999999999999999874 24688999999976432 234566789999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.++.+|+||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999987 3679999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 170 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-- 239 (327)
T 3a62_A 170 ESIHD-------GTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN-- 239 (327)
T ss_dssp ----------------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--
T ss_pred ccccC-------CccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--
Confidence 32211 11223456899999999997654 899999999999999999999999877665544443333222
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..+++.+++||.+||..||.+|| ++.++++||||+..+
T Consensus 240 ----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 240 ----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred ----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 2346789999999999999999999 899999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=390.10 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=209.8
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------------------------hhHHHHHHHHH
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------------------------TDLDSIRRETK 78 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------------------------~~~~~~~~Ei~ 78 (506)
+..++|++.+.||+|+||.||+|.+. .+++.||||++...... ...+.+.+|+.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 44578999999999999999999985 67899999998754321 12356889999
Q ss_pred HHhhCCCCCceeeeeEEEe--CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCC
Q 010624 79 TMSLLSHPNILNAHCSFSV--DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKA 156 (506)
Q Consensus 79 il~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp 156 (506)
+++.++||||+++++++.+ ...+|+||||+++++|.+++.. ..+++..++.++.|++.||+|||++|++||||||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 9999999999999999987 6789999999999999886543 5799999999999999999999999999999999
Q ss_pred CCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCC--CCccccHHHHHHHHHHHHhCCC
Q 010624 157 GNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG--YSFKADIWSFGITALELAHGRP 234 (506)
Q Consensus 157 ~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~--~~~~sDIwSlGiil~eLltG~~ 234 (506)
+|||++.++.+||+|||++...... ........||+.|+|||++.+... ++.++|||||||++|+|++|..
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS-------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS-------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEECCCCCEEEecCCCccccccc-------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999997643221 112234568999999999976432 3778999999999999999999
Q ss_pred CCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
||..................++ ....+++++++||.+||+.||.+|||+.++++||||+
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCccHHHHHHHHhcccCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 9987655443322222222111 2346789999999999999999999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=398.05 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=207.8
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
.......++|++++.||+|+||+||+|.++ .+++.||||++..... ..+.+.+|+.+++.++||||+++++++.+++
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCCCCCTTTEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCCCCCcEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 345567789999999999999999999995 6789999999975432 2356889999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC--eEEeecccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS--VKLADFGVSAS 177 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~--vKL~DFGls~~ 177 (506)
.+|+||||+.||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999999999999999987 367999999999999999999999999999999999999987765 99999998753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hhcc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM----TQRF 253 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~----~~~~ 253 (506)
... ........||+.|+|||++.+....+.++|||||||++|+|++|++||............+ ....
T Consensus 168 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 168 SVL--------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp ---------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred ccc--------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 211 1122344689999999999876533445899999999999999999997644322221111 1111
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.++ ....+++.+++||.+||+.||.+|||+.++++||||...
T Consensus 240 ~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 240 SIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 111 223578999999999999999999999999999999654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=400.56 Aligned_cols=274 Identities=28% Similarity=0.435 Sum_probs=208.9
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCC--EEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDS--RLW 102 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~ 102 (506)
++|++++.||+|+||+||+|.++ .+++.||||++.... .......+.+|+.+++.+. ||||+++++++..++ .+|
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp TTEEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred CceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 67999999999999999999985 678999999986543 3455677889999999997 999999999997644 799
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+|||||. ++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|.......
T Consensus 88 lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999998 689999986 579999999999999999999999999999999999999999999999999986432211
Q ss_pred CCC--------------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010624 183 HHH--------------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 183 ~~~--------------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~ 248 (506)
... ...........||++|+|||++.+...|+.++|||||||++|+|++|.+||............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 000 001112234579999999999987666899999999999999999999999877665544333
Q ss_pred Hhhcccccchhhh------------------------------------hhhhccchhhhHHHHHHHHhhcccCCCCCCC
Q 010624 249 MTQRFRFSDYEKT------------------------------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292 (506)
Q Consensus 249 ~~~~~~~~~~~~~------------------------------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt 292 (506)
+ .....+..... .........+++++.+||.+||+.||.+|||
T Consensus 244 ~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 244 I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp H-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred H-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 3 22222211100 0001112257889999999999999999999
Q ss_pred HHHHHcCccccccc
Q 010624 293 AEKLMKHSFFKNCN 306 (506)
Q Consensus 293 ~~eiL~hp~f~~~~ 306 (506)
+.++|+||||+...
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999998653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=412.40 Aligned_cols=271 Identities=26% Similarity=0.421 Sum_probs=223.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..+..++|+++++||+|+||+||+|.++ .+++.||+|++..... ......+.+|+.+++.++||||++++++|.+++
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 4577789999999999999999999985 6689999999864221 112234789999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 999999999999999999863 4679999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
.. .........||+.|+|||++.. ...|+.++|||||||++|+|++|.+||......+....++.....+
T Consensus 227 ~~------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 227 ED------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TT------SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred cC------CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 21 1112233569999999999972 3348999999999999999999999998776665554443321111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCC--CCCHHHHHcCcccccccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSK--RPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--Rpt~~eiL~hp~f~~~~~ 307 (506)
..+.....+++++++||.+||..+|.+ ||++.++++||||+.+++
T Consensus 301 -------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 301 -------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp -------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred -------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 111223458999999999999888888 999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=401.41 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=221.1
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+..++|++++.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34566789999999999999999999985 668899999986432 123456788999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999999999999987 467999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPE--KSLLMKMTQRFR 254 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~ 254 (506)
.. ........||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||...... ......+...
T Consensus 166 ~~--------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-- 235 (384)
T 4fr4_A 166 PR--------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-- 235 (384)
T ss_dssp CT--------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--
T ss_pred cC--------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--
Confidence 21 1123345699999999999642 34889999999999999999999999753322 1121111111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-HHHHHcCcccccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-AEKLMKHSFFKNCNK 307 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-~~eiL~hp~f~~~~~ 307 (506)
....+..+++.+.+||.+||+.||.+||+ +.++++||||+.++.
T Consensus 236 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 236 ---------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ---------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 11134567899999999999999999998 999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=381.85 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=214.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||+|+||+||+|.++ .++..||+|.+.........+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 57999999999999999999985 56889999999876666667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccccCC
Q 010624 107 FMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 107 y~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~~~~ 181 (506)
|+.+|+|.+++... ....+++..++.++.|++.||+|||++|++||||||+|||+ +.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~- 179 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS- 179 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC-
Confidence 99999999988653 23679999999999999999999999999999999999999 4567899999999753221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||..................+.
T Consensus 180 -------~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----- 245 (285)
T 3is5_A 180 -------DEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA----- 245 (285)
T ss_dssp --------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred -------cccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----
Confidence 112234568999999999864 389999999999999999999999987665554433322221111
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.....+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus 246 ----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ----VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 122346889999999999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=393.13 Aligned_cols=273 Identities=23% Similarity=0.347 Sum_probs=211.3
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
-....++|++++.||+|+||+||+|.+. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++..+..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3455678999999999999999999985 6789999999975543 2334567899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-----CCCCeEEeecccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-----SDGSVKLADFGVS 175 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-----~~g~vKL~DFGls 175 (506)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999998 599999987 46799999999999999999999999999999999999994 4456999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
...... ........||+.|+|||++.+...++.++|||||||++|+|++|.+||................ ..
T Consensus 185 ~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~ 256 (329)
T 3gbz_A 185 RAFGIP-------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GL 256 (329)
T ss_dssp HHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CC
T ss_pred cccCCc-------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-CC
Confidence 643211 1122344679999999999876668999999999999999999999998776655544433221 11
Q ss_pred cchh---hhh----------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 256 SDYE---KTL----------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 256 ~~~~---~~~----------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
+... ... ........+++++++||.+||+.||.+|||+.++++||||++.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1000 000 00001223788999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=407.40 Aligned_cols=270 Identities=24% Similarity=0.386 Sum_probs=221.2
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..+..++|++++.||+|+||+||+|.++ .+++.||+|++.... .....+.+.+|+.++..++||||++++++|.+++
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4577889999999999999999999985 678999999986432 1223345789999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999999999999999864 3479999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhc------cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRS------HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
.. .........||+.|+|||++.. ...|+.++|||||||++|+|++|.+||...........+.....
T Consensus 214 ~~------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 214 AD------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp TT------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred CC------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 21 1111234579999999999973 23489999999999999999999999987766555444332111
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCC---CCHHHHHcCcccccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKR---PSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R---pt~~eiL~hp~f~~~~~ 307 (506)
.. ..+.....+++++++||.+||. +|.+| |++.+|++||||+.+++
T Consensus 288 ~~-------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 288 HL-------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp HC-------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred Cc-------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 00 0111234689999999999999 99998 59999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=395.57 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=215.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+..+.|++.+.||+|+||+||+|.++ .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 33467999999999999999999985 678999999986432 1224678899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC---eEEeeccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGV 174 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~---vKL~DFGl 174 (506)
.+|+|||||.|++|.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999999887653 2345899999999999999999999999999999999999986654 99999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
+...... ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||... ............+.
T Consensus 180 a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGES-------GLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTT-------SCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCC
T ss_pred eeEecCC-------CeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCC
Confidence 7643221 11123446899999999998654 899999999999999999999999764 22222222222222
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
... .....+++.+++||.+||+.||++|||+.++++||||+..
T Consensus 251 ~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 251 MNP--------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CCH--------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCc--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 111 1224678999999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=377.35 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=221.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.++|++.+.||+|+||.||+|.++ .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 578999999999999999999985 668899999987654 445567889999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC---eEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~---vKL~DFGls~~~~~~ 181 (506)
|||+.+++|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998873 67999999999999999999999999999999999999986655 999999997543221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................++.
T Consensus 162 --------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 228 (284)
T 3kk8_A 162 --------EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---- 228 (284)
T ss_dssp --------CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred --------ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence 1123456899999999998654 899999999999999999999999877665554444433333221
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.....+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 229 ----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp ----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred ----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 12346789999999999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=399.62 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=213.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHH-HhhCCCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKT-MSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~ 98 (506)
-.+..++|++++.||+|+||.||+|.++ .+++.||+|++..... ......+.+|..+ ++.++||||++++++|.+.
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 3466789999999999999999999985 6688999999976532 2334566677776 5778999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||+.||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999999999987 367999999999999999999999999999999999999999999999999997642
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...........+......
T Consensus 190 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~---- 257 (373)
T 2r5t_A 190 IEH-------NSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ---- 257 (373)
T ss_dssp BCC-------CCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC----
T ss_pred ccC-------CCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC----
Confidence 211 11233456899999999998654 899999999999999999999999876665554444333222
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH----HHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA----EKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~----~eiL~hp~f~~~~ 306 (506)
.+..++..+++||.+||+.||.+||++ .++++||||+.++
T Consensus 258 --------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 258 --------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 234688999999999999999999986 6999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=408.14 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=213.9
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+..++|++++.||+|+||.||+|.++ .+++.||||++.... .......+.+|+.+++.++||||++++++|...
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 220 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH 220 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence 44566788999999999999999999985 678999999986532 233456778999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
+.+|+||||++||+|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|..
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred CEEEEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999999999987 3679999999999999999999998 9999999999999999999999999999753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ........||+.|+|||++.+.. |+.++|||||||++|+|++|..||..................
T Consensus 299 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--- 367 (446)
T 4ejn_A 299 GIKD-------GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--- 367 (446)
T ss_dssp TCC------------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---
T ss_pred ccCC-------CcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence 2111 11233457899999999997654 899999999999999999999999877665554444433332
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..+++++.+||.+||+.||.+|| |+.++++||||+..+
T Consensus 368 ---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 368 ---------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 2345789999999999999999999 999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=384.95 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=220.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.++|++.+.||+|+||.||+|.++ .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++..+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 356999999999999999999985 57899999998765432 246789999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC----CeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG----SVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g----~vKL~DFGls~ 176 (506)
+|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999999999987 46799999999999999999999999999999999999999888 79999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................++
T Consensus 168 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 168 EIEDG--------VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp ECCTT--------CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred ecCcc--------ccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 43221 1123446899999999997654 89999999999999999999999987665554443333222221
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
. .....+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 239 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 239 E--------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp H--------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred h--------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 1 122457889999999999999999999999999999997743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=404.93 Aligned_cols=277 Identities=26% Similarity=0.357 Sum_probs=200.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-----CC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV-----DS 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~ 99 (506)
.++|++++.||+|+||+||+|.++ .+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999985 578999999986543 34556788999999999999999999999843 35
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 7999999985 799999987 4679999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCC--------------------CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh--------
Q 010624 180 EPSHHHH--------------------HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-------- 231 (506)
Q Consensus 180 ~~~~~~~--------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-------- 231 (506)
....... ..........||++|+|||++.....|+.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2111000 000123445789999999988655669999999999999999999
Q ss_pred ---CCCCCCCCChH-------------------HHHHHHHhhcccccchhh-----------h---------hhhhccch
Q 010624 232 ---GRPPLSHLPPE-------------------KSLLMKMTQRFRFSDYEK-----------T---------LKIKDKNK 269 (506)
Q Consensus 232 ---G~~Pf~~~~~~-------------------~~~~~~~~~~~~~~~~~~-----------~---------~~~~~~~~ 269 (506)
|.+||...... ......+......+.... . .......+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 66777543210 011111111111110000 0 00112234
Q ss_pred hhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 270 KFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 5689999999999999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=378.69 Aligned_cols=269 Identities=24% Similarity=0.405 Sum_probs=221.5
Q ss_pred ccccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceee
Q 010624 13 TGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNA 91 (506)
Q Consensus 13 ~~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l 91 (506)
................|++.+.||+|+||+||+|.+. .++..||+|.+.... .....+.+.+|+.+++.++||||+++
T Consensus 12 ~~l~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (290)
T 1t4h_A 12 EELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp ------CCEECTTSCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred HHHhhhhhhcccCceeEEeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 3333445667777788999999999999999999985 667899999987544 45567789999999999999999999
Q ss_pred eeEEEe----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeC-CC
Q 010624 92 HCSFSV----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSD-SD 164 (506)
Q Consensus 92 ~~~~~~----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld-~~ 164 (506)
++++.. ...+|+||||+++++|.+++... ..+++..++.++.|++.||.|||++| ++||||||+|||++ .+
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 168 (290)
T 1t4h_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT
T ss_pred eeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCC
Confidence 999875 46799999999999999999873 67999999999999999999999999 99999999999998 78
Q ss_pred CCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Q 010624 165 GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS 244 (506)
Q Consensus 165 g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~ 244 (506)
+.+||+|||++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||........
T Consensus 169 ~~~kl~Dfg~~~~~~~---------~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 237 (290)
T 1t4h_A 169 GSVKIGDLGLATLKRA---------SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237 (290)
T ss_dssp SCEEECCTTGGGGCCT---------TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred CCEEEeeCCCcccccc---------cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence 9999999999753221 12234468999999999864 389999999999999999999999987666555
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
............ ......++.+.+||.+||+.||.+|||+.++++||||++
T Consensus 238 ~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 238 IYRRVTSGVKPA---------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHTTTCCCG---------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHhccCCcc---------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 554444332211 123456788999999999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=385.42 Aligned_cols=269 Identities=28% Similarity=0.447 Sum_probs=207.5
Q ss_pred CCCeeEE-eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKIL-DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~-~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 103 (506)
.+.|++. +.||+|+||+||+|.+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+++.+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-SSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEc-CCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3679995 78999999999999985 568899999997543 33457788999999884 79999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC---eEEeeccccccccC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSASIYE 180 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~---vKL~DFGls~~~~~ 180 (506)
||||+.|++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999999874 67999999999999999999999999999999999999998776 99999998754322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhcc----CCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------------
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSH----TGYSFKADIWSFGITALELAHGRPPLSHLPPE-------------- 242 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~-------------- 242 (506)
................||+.|+|||++.+. ..++.++|||||||++|+|++|.+||......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111111111122334589999999999741 23789999999999999999999999764321
Q ss_pred HHHHHHHh-hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 243 KSLLMKMT-QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
......+. ....++. .....+++.+++||.+||+.||.+|||+.++++||||+...
T Consensus 247 ~~~~~~i~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPD--------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHCCCCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHhccCcccCc--------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 11111111 1111111 01235788999999999999999999999999999999763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=383.69 Aligned_cols=271 Identities=27% Similarity=0.385 Sum_probs=210.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC----hhhHHHHHHHHHHHhhCC---CCCceeeeeEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS----RTDLDSIRRETKTMSLLS---HPNILNAHCSFS 96 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~----~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~ 96 (506)
+..++|++.+.||+|+||+||+|.+. .+++.||+|++..... ......+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34678999999999999999999985 6789999999864331 112345667777777664 999999999998
Q ss_pred eCC-----EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 97 VDS-----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 97 ~~~-----~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
... .+++||||+. ++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 6899999997 6999999886555699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~ 251 (506)
||++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...............
T Consensus 164 fg~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 164 FGLARIYSY--------QMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CSCTTTSTT--------CCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CccccccCC--------CcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999753321 11223456899999999998655 899999999999999999999999877665554443321
Q ss_pred ccccc--chhh-------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 252 RFRFS--DYEK-------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 252 ~~~~~--~~~~-------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+ .+.. ........+.+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 11000 0000 000111234678999999999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=399.71 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=212.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.++|++.+.||+|+||+||+|.+. .+++.||+|++..... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 368999999999999999999985 6788999999864321 1223578899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+ +|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 99999 68999988773 67999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+...++.++|||||||++|+|++|..||........ .......
T Consensus 162 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----~~~i~~~------- 223 (336)
T 3h4j_B 162 ------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----FKKVNSC------- 223 (336)
T ss_dssp ------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----BCCCCSS-------
T ss_pred ------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHcC-------
Confidence 1223456899999999998765447899999999999999999999975432211 0111000
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
....+..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11134567899999999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=410.73 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=218.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++++.||+|+||+||+|.++ .+++.||||++.... .......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999985 578999999986432 2234577899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC---CCCCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD---SDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld---~~g~vKL~DFGls~~~~~~~ 182 (506)
|||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999999773 6799999999999999999999999999999999999995 4567999999997543211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......||+.|+|||++.+. |+.++|||||||++|+|++|.+||................+.+..
T Consensus 178 -------~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 243 (486)
T 3mwu_A 178 -------TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----- 243 (486)
T ss_dssp -----------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS-----
T ss_pred -------CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----
Confidence 122345689999999999753 899999999999999999999999877666555444444333221
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..+..+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 244 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 244 ---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ---GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ---cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 13356889999999999999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=391.72 Aligned_cols=270 Identities=27% Similarity=0.429 Sum_probs=211.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++++.||+|+||+||+|.+. .+++.||+|++...........+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 67999999999999999999985 57889999998755433333345579999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+. |+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~----- 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP----- 153 (324)
T ss_dssp CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-----
Confidence 998 5899988764 456999999999999999999999999999999999999999999999999997532211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc--ccchhhhh--
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR--FSDYEKTL-- 262 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~-- 262 (506)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||.................. ...+....
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 --TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred --ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 112234467999999999987666899999999999999999999999877665544333221100 00000000
Q ss_pred --------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 263 --------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 263 --------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
........+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00112345788999999999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=386.10 Aligned_cols=264 Identities=24% Similarity=0.393 Sum_probs=207.9
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-------
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS------- 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 99 (506)
++|++.+.||+|+||.||+|.++ .+++.||||++.........+.+.+|+.+|+.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46999999999999999999985 5789999999987666666788999999999999999999999986543
Q ss_pred --------------------------------------------------EEEEEeccCCCCCHHHHHHhhCC-CCCCHH
Q 010624 100 --------------------------------------------------RLWVVMPFMSCGSLQSIISSCFP-DGLPEP 128 (506)
Q Consensus 100 --------------------------------------------------~~~lV~Ey~~ggsL~~~i~~~~~-~~l~e~ 128 (506)
.+|+|||||.|++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 48999999999999999987422 235677
Q ss_pred HHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC-----CCcccccCCCCCccCC
Q 010624 129 CIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH-----GSAMITDMAGTPYWMA 203 (506)
Q Consensus 129 ~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~-----~~~~~~~~~Gt~~y~A 203 (506)
.+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++............ .........||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 79999999999999999999999999999999999999999999997654332110000 0112234568999999
Q ss_pred hhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhc
Q 010624 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCL 283 (506)
Q Consensus 204 PE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L 283 (506)
||++.+.. ++.++|||||||++|+|++|..|+.. ....... .....++ ......++.+.+||.+||
T Consensus 245 PE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 245 PEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME---RVRIITD-VRNLKFP---------LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp HHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHH-HHTTCCC---------HHHHHHCHHHHHHHHHHH
T ss_pred hHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHH-hhccCCC---------cccccCChhHHHHHHHHc
Confidence 99998754 89999999999999999998776521 1111111 1111111 123456778899999999
Q ss_pred ccCCCCCCCHHHHHcCcccccc
Q 010624 284 DQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 284 ~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+.||.+|||+.++++||||+++
T Consensus 311 ~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 311 SPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CSSGGGSCCHHHHHHSTTCCCC
T ss_pred cCCCCcCCCHHHHhhchhhhcC
Confidence 9999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=386.97 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=213.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-----CCCceeeeeEEEeC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-----HPNILNAHCSFSVD 98 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~~ 98 (506)
+..++|++++.||+|+||+||+|.+. .+++.||||++.. .......+.+|+.+++.+. ||||+++++++...
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred EecCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 44578999999999999999999985 5688999999863 2444567788999999996 99999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---------------
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS--------------- 163 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~--------------- 163 (506)
+..|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999999 899999998865567999999999999999999999999999999999999975
Q ss_pred ----------CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCC
Q 010624 164 ----------DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR 233 (506)
Q Consensus 164 ----------~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~ 233 (506)
++.+||+|||+|..... ......||+.|+|||++.+.. |+.++|||||||++|+|++|+
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD----------YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS----------CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccccccCCCCEEEEeccCceecCC----------CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCC
Confidence 78999999999764221 122456899999999998755 899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhhcccccchhhhhh----------------------------------hhccchhhhHHHHHHH
Q 010624 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLK----------------------------------IKDKNKKFSRAFKDMV 279 (506)
Q Consensus 234 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~s~~l~~Li 279 (506)
+||...................+....... .+......++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999876655443332221111111000000 0000111237788999
Q ss_pred HhhcccCCCCCCCHHHHHcCcccc
Q 010624 280 ASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 280 ~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.+||+.||++|||+.++|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=385.52 Aligned_cols=282 Identities=42% Similarity=0.745 Sum_probs=201.8
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+.+..++|++.+.||+|+||+||+|.+. .+++.||||.+.........+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred ccccccchhhhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3457788999999999999999999999885 567899999987655555567888999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeec
Q 010624 99 SRLWVVMPFMSCGSLQSIISSC------FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADF 172 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~------~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DF 172 (506)
+..|+||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999998742 2356999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 173 GVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 173 Gls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
|++........ ...........||+.|+|||++.+...++.++|||||||++|+|++|..||................
T Consensus 166 g~~~~~~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 166 GVSAFLATGGD--ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp HHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred cchheeccCCC--ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 98754322110 0011122345689999999999764458999999999999999999999998877665544433322
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.. ..............+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 244 ~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 244 PP--SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CC--CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CC--ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 11 1111111122345678999999999999999999999999999999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=382.10 Aligned_cols=257 Identities=35% Similarity=0.553 Sum_probs=216.0
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEecc
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPF 107 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey 107 (506)
.|...+.||+|+||.||+|.++ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 3889999999999999999984 578999999987543 33457788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCC
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHH 187 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~ 187 (506)
+.|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 124 ~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------ 194 (321)
T 2c30_A 124 LQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------ 194 (321)
T ss_dssp CCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred CCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC------
Confidence 999999999875 57999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 188 GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 188 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||............... .. +. ...
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~-~~-------~~~ 263 (321)
T 2c30_A 195 -VPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PP-PK-------LKN 263 (321)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SC-CC-------CTT
T ss_pred -ccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CC-CC-------cCc
Confidence 11123456899999999997654 899999999999999999999999876554433222211 10 00 012
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
...+++.+.+||.+||+.||++|||+.++++||||....
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 345788999999999999999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=398.75 Aligned_cols=291 Identities=25% Similarity=0.330 Sum_probs=217.9
Q ss_pred ccccccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceee
Q 010624 13 TGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNA 91 (506)
Q Consensus 13 ~~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l 91 (506)
.+...+..+--...++|++.+.||+|+||+||+|.++ .+++.||||++.... .....+.+.+|+.+|+.++||||+++
T Consensus 12 ~~~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 90 (432)
T 3n9x_A 12 ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90 (432)
T ss_dssp CCCCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhcCCCcceecCCEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceE
Confidence 3444455555556789999999999999999999995 678999999997543 34556788999999999999999999
Q ss_pred eeEEEeC-----CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 92 HCSFSVD-----SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 92 ~~~~~~~-----~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
++++... ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~ 167 (432)
T 3n9x_A 91 YDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS 167 (432)
T ss_dssp EEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred EEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC
Confidence 9999776 57999999997 699999987 467999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCC---------------CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh
Q 010624 167 VKLADFGVSASIYEPSHHHH---------------HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~---------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt 231 (506)
+||+|||+|........... ..........||++|+|||++.....|+.++|||||||++|+|++
T Consensus 168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 99999999865432211000 000123456789999999998666669999999999999999998
Q ss_pred CCC-----------CCCCCCh----------------HHHHHHHHhhcccccchh-----------hhh---------hh
Q 010624 232 GRP-----------PLSHLPP----------------EKSLLMKMTQRFRFSDYE-----------KTL---------KI 264 (506)
Q Consensus 232 G~~-----------Pf~~~~~----------------~~~~~~~~~~~~~~~~~~-----------~~~---------~~ 264 (506)
|.. +|..... .......+...+..+... ... ..
T Consensus 248 g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (432)
T 3n9x_A 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINL 327 (432)
T ss_dssp TCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred cccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCH
Confidence 544 3432210 011111111111111000 000 00
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
....+.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 328 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 1122457899999999999999999999999999999998743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=396.17 Aligned_cols=260 Identities=23% Similarity=0.420 Sum_probs=218.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++++.||+|+||.||+|.++ .+++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999985 678899999986543 334567889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC--CCCeEEeeccccccccCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS--DGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~--~g~vKL~DFGls~~~~~~~~ 183 (506)
||+.||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp ECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred EcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 999999999999753 347999999999999999999999999999999999999984 578999999997643221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||..................+.
T Consensus 205 ------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------- 270 (387)
T 1kob_A 205 ------EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------- 270 (387)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred ------cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 1123346899999999998654 89999999999999999999999987665554443333222211
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
......+++++++||.+||+.||.+|||+.++++||||+..
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 11335688999999999999999999999999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=407.71 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=223.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
...++|++.+.||+|+||.||+|.++ .+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 33467999999999999999999985 6789999999876542 34567899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASI 178 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~ 178 (506)
|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|...
T Consensus 102 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999987 4679999999999999999999999999999999999999 46789999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... .......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||................+.+..
T Consensus 180 ~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~- 248 (484)
T 3nyv_A 180 EAS--------KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL- 248 (484)
T ss_dssp CCC--------CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-
T ss_pred ccc--------cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 221 12234468999999999976 3899999999999999999999999887766655544444333221
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..+..+++.+++||.+||+.||.+|||+.++|+||||+...
T Consensus 249 -------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 249 -------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp -------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred -------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 13356889999999999999999999999999999998653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=408.42 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=221.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
-.+..++|++.+.||+|+||.||+|.+. .+|+.||||++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4455678999999999999999999985 5789999999865321 223567899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||+.||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999999976 4679999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|..||................+.
T Consensus 168 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----- 234 (476)
T 2y94_A 168 DG--------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY----- 234 (476)
T ss_dssp TT--------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC-----
T ss_pred cc--------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC-----
Confidence 21 11234568999999999987654578999999999999999999999876655444333322211
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 235 -------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 -------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 234578899999999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=376.16 Aligned_cols=263 Identities=22% Similarity=0.369 Sum_probs=219.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|++.........+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46999999999999999999985 56889999999766555566889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
|+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 159 (276)
T 2yex_A 86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (276)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred ecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc----
Confidence 9999999999876 4679999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.........||+.|+|||++.+...++.++|||||||++|+|++|..||................... ..
T Consensus 160 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~ 229 (276)
T 2yex_A 160 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------LN 229 (276)
T ss_dssp -EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---------ST
T ss_pred -chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---------cC
Confidence 01112345689999999999865545789999999999999999999998765443333222221110 11
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 2346788999999999999999999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=389.59 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=205.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
...++|++.+.||+|+||+||+|.+. .+++.||||++.... ..+.+.+|+.+++.++||||+++++++......|+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 33467999999999999999999985 567899999987542 34568899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccccccC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSASIYE 180 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~~~~~ 180 (506)
||||+.+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++. ++.+||+|||++.....
T Consensus 126 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999999976 467999999999999999999999999999999999999975 88999999999754321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-ccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR-FRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~ 259 (506)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||............+... ..+.
T Consensus 204 ~--------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~--- 271 (349)
T 2w4o_A 204 Q--------VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI--- 271 (349)
T ss_dssp -----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC---
T ss_pred c--------cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC---
Confidence 1 1123456899999999998654 8999999999999999999999998766555443333321 1111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
......++..+++||.+||+.||++|||+.++++||||.....
T Consensus 272 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 272 -----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp -----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred -----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 1123567899999999999999999999999999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.33 Aligned_cols=275 Identities=24% Similarity=0.328 Sum_probs=214.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSV------- 97 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 97 (506)
.++|++++.||+|+||+||+|.++ .+++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 357999999999999999999985 6788999999865543 2334567899999999999999999999887
Q ss_pred -CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 -DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 -~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.+.+|+||||+.+ +|.+.+... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4578999999985 777777653 3579999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
....... ..........||+.|+|||++.+...++.++|||||||++|+|++|.+||...................+
T Consensus 173 ~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKN---SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSS---SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccc---ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 5432211 1112234456899999999998766689999999999999999999999987665554433322111111
Q ss_pred c--hhhhhhh------------------hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 D--YEKTLKI------------------KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~--~~~~~~~------------------~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. +...... .......++.+++||.+||+.||++|||+.++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 0 0000000 000011367899999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=385.00 Aligned_cols=274 Identities=26% Similarity=0.403 Sum_probs=220.3
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+-...++|++++.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 4556789999999999999999999985 5688999999865543 3445678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999999999998776 46799999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch--
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY-- 258 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 258 (506)
. ........||+.|+|||++.+...++.++|||||||++|+|++|.+||......................
T Consensus 177 ~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 177 P-------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred C-------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 1 1122345689999999999876568999999999999999999999998776655444333211111000
Q ss_pred -----------------hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 -----------------EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 -----------------~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..........+.+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 00000111224678999999999999999999999999999999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=374.06 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=218.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++.+.||+|+||.||+|.+. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 56999999999999999999985 5678999999865433 345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccccCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~~~~~~ 183 (506)
|+.+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-- 162 (277)
T 3f3z_A 87 LCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-- 162 (277)
T ss_dssp CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--
Confidence 9999999999987 3679999999999999999999999999999999999999 78899999999987543211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||..................++..
T Consensus 163 ------~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 229 (277)
T 3f3z_A 163 ------KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK----- 229 (277)
T ss_dssp ------SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----
T ss_pred ------cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----
Confidence 122344689999999999754 8999999999999999999999998776665544444333322211
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 230 ---DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 123578899999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=389.24 Aligned_cols=277 Identities=27% Similarity=0.422 Sum_probs=221.0
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHHhhCCCCCceeeee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ----SRTDLDSIRRETKTMSLLSHPNILNAHC 93 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 93 (506)
+.....-..++|++.+.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 33444445678999999999999999999985 678899999986432 2345678999999999999999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhC--------------------------------------CCCCCHHHHHHHHH
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCF--------------------------------------PDGLPEPCIAIVLK 135 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~--------------------------------------~~~l~e~~i~~i~~ 135 (506)
++.+.+..|+|||||+||+|.+++.... ...+++..++.++.
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 9999999999999999999999985210 11246788999999
Q ss_pred HHHHHHHHHHHCCCccCCCCCCCEEeCCCC--CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CC
Q 010624 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDG--SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TG 212 (506)
Q Consensus 136 qil~gL~yLHs~givHrDIKp~NILld~~g--~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~ 212 (506)
|++.||+|||++|++||||||+|||++.++ .+||+|||++........ ..........||+.|+|||++.+. ..
T Consensus 176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN---GEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC---C--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc---cccccccccCCCccccCchhhccCCCC
Confidence 999999999999999999999999998776 899999999764322110 111123345689999999999752 45
Q ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC
Q 010624 213 YSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292 (506)
Q Consensus 213 ~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt 292 (506)
++.++|||||||++|+|++|..||..................+... ....+++.+.+||.+||+.||.+|||
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP--------NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG--------GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc--------ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 8899999999999999999999998877766655555444332211 23457899999999999999999999
Q ss_pred HHHHHcCccccccc
Q 010624 293 AEKLMKHSFFKNCN 306 (506)
Q Consensus 293 ~~eiL~hp~f~~~~ 306 (506)
+.++++||||++..
T Consensus 325 ~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 325 AMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSHHHHTTS
T ss_pred HHHHhcChhhccCh
Confidence 99999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=375.92 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=216.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
....++|++.+.||+|+||+||+|.+. .++..||+|++..... ......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 345578999999999999999999985 6678999999864321 2234678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999999874 6799999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................
T Consensus 162 ---------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 224 (279)
T 3fdn_A 162 ---------SRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------- 224 (279)
T ss_dssp ---------------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------
T ss_pred ---------ccccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-------
Confidence 1123446899999999998654 78999999999999999999999987665544333222211
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 225 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 13345788999999999999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=407.31 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=217.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh------------hhHHHHHHHHHHHhhCCCCCceeeee
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR------------TDLDSIRRETKTMSLLSHPNILNAHC 93 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~l~~ 93 (506)
.++|++++.||+|+||+||+|.++ .+++.||+|++...... ...+.+.+|+.+|+.++||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 467999999999999999999985 67889999998754321 33578899999999999999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEe
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLA 170 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~ 170 (506)
++.++..+|+|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999873 6799999999999999999999999999999999999999776 69999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
|||+|...... .......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||..............
T Consensus 192 Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 192 DFGLSSFFSKD--------YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CCTTCEECCTT--------SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ECCCCEEcCCC--------CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99997643221 12234568999999999974 389999999999999999999999988776655544444
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..+.++.. .+..+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 262 ~~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 262 GKYYFDFN--------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCCCCCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCCCcc--------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 33332211 2346789999999999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=385.89 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=211.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCC--CCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSH--PNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~ 99 (506)
.+...+|++++.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+.+|+.++| |||+++++++..+.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC--TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe--CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 45678899999999999999999987 468899999997654 34556789999999999986 99999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||| +.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999999 557899999987 56899999999999999999999999999999999999997 6789999999975432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhc----------cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRS----------HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----------~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
.. ..........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.............
T Consensus 159 ~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 233 (343)
T 3dbq_A 159 PD-----TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233 (343)
T ss_dssp ----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cc-----cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence 11 11112234568999999999964 1348899999999999999999999998654433222222
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..... ....+...+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 234 ~~~~~---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 234 IDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hcCCc---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 21110 0112344577899999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=388.55 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=209.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 104 (506)
.++|++.+.||+|+||+||+|.++ .+++.||+|++...... ..+|+.++..+ +||||++++++|.++..+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 457999999999999999999985 67899999999755432 34688888877 799999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CC---CeEEeeccccccccC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DG---SVKLADFGVSASIYE 180 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g---~vKL~DFGls~~~~~ 180 (506)
||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+.. ++ .+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 95 TELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp ECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999987 467999999999999999999999999999999999999853 33 599999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhhcccccc
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP---PEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~---~~~~~~~~~~~~~~~~~ 257 (506)
. ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.... ............+.+.
T Consensus 173 ~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 243 (342)
T 2qr7_A 173 E-------NGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS- 243 (342)
T ss_dssp T-------TCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-
T ss_pred C-------CCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-
Confidence 1 11223456899999999998654 8899999999999999999999997532 2222222222222211
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...+..+++++++||.+||..||.+|||+.++++||||.+.
T Consensus 244 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 244 -------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 11235689999999999999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=387.07 Aligned_cols=270 Identities=24% Similarity=0.354 Sum_probs=219.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----CE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-----SR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 100 (506)
.++|++++.||+|+||.||+|.+. .++..||||++.........+.+.+|+.+++.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999985 678999999998666666678899999999999999999999999765 47
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+. ++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 899999997 599999976 5799999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.. ..........||+.|+|||++.+...++.++|||||||++|+|++|.+||.................. +....
T Consensus 181 ~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~ 255 (364)
T 3qyz_A 181 DH----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS-PSQED 255 (364)
T ss_dssp GG----CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS-CCHHH
T ss_pred CC----CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC-CCHHH
Confidence 11 11111234578999999999876666899999999999999999999999877665544333221111 00000
Q ss_pred --------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 --------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 --------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..........+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000111224578899999999999999999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=375.84 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=219.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
-....+..++|++.+.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp ----CCCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCccchhhhhceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 3345567789999999999999999999985 5788999999864321 123467889999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
+.+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 999999999999999999999874 579999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 163 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 230 (284)
T 2vgo_A 163 HAPS---------LRRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-- 230 (284)
T ss_dssp ECSS---------SCBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--
T ss_pred cCcc---------cccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--
Confidence 3321 1123446899999999998654 899999999999999999999999876655443333222111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..++..+++||.+||+.||.+|||+.++++||||+..
T Consensus 231 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 231 ----------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ----------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 235578899999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=405.50 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=214.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
+|++++.||+|+||+||+|.++ .++..||+|++..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6999999999999999999985 5788999999976542 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC---CCeEEeeccccccccCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD---GSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~---g~vKL~DFGls~~~~~~~~ 183 (506)
||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|......
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 99999999998773 679999999999999999999999999999999999999764 45999999997643221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||................+.+...
T Consensus 193 ------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 259 (494)
T 3lij_A 193 ------KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----- 259 (494)
T ss_dssp ------BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-----
T ss_pred ------ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-----
Confidence 12234568999999999864 38999999999999999999999998877666555444444333221
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+++.+++||.+||+.||.+|||+.++|+||||+..
T Consensus 260 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 260 ---EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ---GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ---hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 235688999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=388.89 Aligned_cols=266 Identities=25% Similarity=0.358 Sum_probs=211.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS----- 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 99 (506)
.++|++++.||+|+||.||+|.+. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 578999999999999999999985 678999999986543 3445678899999999999999999999997653
Q ss_pred -EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 100 -RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 100 -~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7999999986 57999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ......||++|+|||++.+...|+.++|||||||++|+|++|++||...........+.......+..
T Consensus 179 ~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 179 DS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cc----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 21 12234689999999999875569999999999999999999999998766655443333211111100
Q ss_pred ----------hhh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 ----------EKT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ----------~~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
... .........+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 001112345789999999999999999999999999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=423.17 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=222.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (506)
..+..++|++++.||+|+||.||+|.++ .+++.||||++.... .....+.+.+|..++..+ +||||++++++|.+.
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456789999999999999999999985 578899999986532 123456778899999987 699999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999999999874 67999999999999999999999999999999999999999999999999997642
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ........||+.|+|||++.+.. |+.++|||||||++|||++|.+||......+....+......
T Consensus 493 ~~~-------~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---- 560 (674)
T 3pfq_A 493 IWD-------GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---- 560 (674)
T ss_dssp CCT-------TCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC----
T ss_pred ccC-------CcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC----
Confidence 211 11233456999999999997654 899999999999999999999999887766655555444332
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCH-----HHHHcCcccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA-----EKLMKHSFFKNCNK 307 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~-----~eiL~hp~f~~~~~ 307 (506)
.+..+++++++||.+||+.||++||++ .+|++||||+.+++
T Consensus 561 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 561 --------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp --------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred --------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 234688999999999999999999997 99999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=390.71 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=210.5
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-----
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV----- 97 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 97 (506)
....++|++.+.||+|+||+||+|.+. .+|+.||||++..+.... .+|+.+|+.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~~~-----~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTTSC-----CHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcchH-----HHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456688999999999999999999985 678999999986543322 379999999999999999999843
Q ss_pred ---------------------------------CCEEEEEeccCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHH
Q 010624 98 ---------------------------------DSRLWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLKETLSALS 142 (506)
Q Consensus 98 ---------------------------------~~~~~lV~Ey~~ggsL~~~i~~--~~~~~l~e~~i~~i~~qil~gL~ 142 (506)
..++++||||++ ++|.+.+.. .....+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999998 587777654 22467999999999999999999
Q ss_pred HHHHCCCccCCCCCCCEEeC-CCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHH
Q 010624 143 YLHNQGHLHRDVKAGNILSD-SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWS 221 (506)
Q Consensus 143 yLHs~givHrDIKp~NILld-~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwS 221 (506)
|||++||+||||||+|||++ .++.+||+|||+|...... .......||+.|+|||++.+...|+.++||||
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--------EPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--------CCCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 99999999999999999998 6889999999997643221 12234567999999999987666899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-----------------ccchhhhhhhhccchhhhHHHHHHHHhhcc
Q 010624 222 FGITALELAHGRPPLSHLPPEKSLLMKMTQRFR-----------------FSDYEKTLKIKDKNKKFSRAFKDMVASCLD 284 (506)
Q Consensus 222 lGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~ 284 (506)
|||++|+|++|++||......+.....+..... ++...........+..+++++.+||.+||+
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999999877666554443321110 000000000011234578899999999999
Q ss_pred cCCCCCCCHHHHHcCcccccc
Q 010624 285 QDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 285 ~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.||.+|||+.++++||||+..
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHH
T ss_pred CChhhCCCHHHHhcCHHHHHH
Confidence 999999999999999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=381.20 Aligned_cols=265 Identities=22% Similarity=0.370 Sum_probs=212.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEe--CCEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSV--DSRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~ 101 (506)
..++|++.+.||+|+||+||+|.+. .+++.||+|++.. ...+.+.+|+.+++.++ ||||+++++++.. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4578999999999999999999985 6789999999863 23467889999999997 9999999999988 6789
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~~ 180 (506)
++||||+.+++|.+++.. +++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999998854 88999999999999999999999999999999999999776 899999999754322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. .......||+.|+|||++.+...++.++|||||||++|+|++|..||............+...........
T Consensus 184 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 184 G--------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp T--------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred C--------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 1 12234468999999999987566899999999999999999999999655443332222221111100000
Q ss_pred h--------------------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 261 T--------------------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 261 ~--------------------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
. .........+++++++||.+||+.||.+|||+.++|+||||++..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 0 0001112337899999999999999999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=387.93 Aligned_cols=272 Identities=30% Similarity=0.488 Sum_probs=220.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
..+..++|++.+.||+|+||+||+|.+. .++..||+|++.........+.+.+|+.+++.++||||+++++++..++.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3566789999999999999999999985 578999999998776667778899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
|+||||++|++|.+++... ..+++..+..++.|++.||.|||+. |++||||||+|||++.++.+||+|||++.....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999999874 5799999999999999999999996 999999999999999999999999998643211
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc------
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR------ 254 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~------ 254 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 185 ---------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 185 ---------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp ---------HC----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ---------ccccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 1122346899999999998754 899999999999999999999999876554332211000000
Q ss_pred --------------cc-----ch---hhh----hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 255 --------------FS-----DY---EKT----LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 --------------~~-----~~---~~~----~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. .. ... .........++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00 00 000 000112234788999999999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=398.93 Aligned_cols=264 Identities=28% Similarity=0.376 Sum_probs=207.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------ 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (506)
.++|++++.||+|+||+||+|.+. .+++.||||++.... .......+.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999985 678999999997543 345567888999999999999999999999654
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+||||+.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 4689999999854 666664 35999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ........||++|+|||++.+. .|+.++|||||||++|+|++|++||...........++.. ...+..
T Consensus 215 ~~--------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~-lg~p~~ 284 (464)
T 3ttj_A 215 GT--------SFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ-LGTPCP 284 (464)
T ss_dssp ----------CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCSCCH
T ss_pred CC--------CcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCH
Confidence 21 1122345789999999999875 4999999999999999999999999877655544333321 111100
Q ss_pred hhh----------h-------------hhh--------ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKT----------L-------------KIK--------DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~----------~-------------~~~--------~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
... . ..+ ......++++++||.+||..||.+|||+.++|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000 0 000 0011126789999999999999999999999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=373.66 Aligned_cols=259 Identities=39% Similarity=0.692 Sum_probs=221.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.+.|++++.||+|+||.||+|.+. .+++.||+|++.........+.+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 456999999999999999999985 5688999999987766666788999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---- 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---- 172 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT----
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc----
Confidence 99999999999975 57999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||................ ..
T Consensus 173 ---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~ 237 (303)
T 3a7i_A 173 ---QIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----------PP 237 (303)
T ss_dssp ---BCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------CC
T ss_pred ---ccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-----------CC
Confidence 11223456899999999997654 8899999999999999999999998766554433222111 11
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
.....++..+.+||.+||+.||.+|||+.++++||||.....
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 234567889999999999999999999999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=409.88 Aligned_cols=263 Identities=23% Similarity=0.398 Sum_probs=220.7
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
++..++|++.+.||+|+||.||+|.++ .+|+.||+|++.... .......+.+|+.+|+.++||||++++++|.+.+.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 477789999999999999999999985 578999999986532 12335678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999999999875455699999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhcccccc
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE---KSLLMKMTQRFRFSD 257 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~---~~~~~~~~~~~~~~~ 257 (506)
. .......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...... ......+...
T Consensus 339 ~--------~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----- 404 (576)
T 2acx_A 339 G--------QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----- 404 (576)
T ss_dssp T--------CCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----
T ss_pred C--------ccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----
Confidence 1 1123347999999999998654 899999999999999999999999865321 1111111110
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
....+..+++++++||.+||+.||.+|| ++.+|++||||++.+
T Consensus 405 ------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 405 ------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 1113356889999999999999999999 899999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.95 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=205.2
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhH-HHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL-DSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+.+..++|++.+.||+|+||+||+|.+. .+++.||+|++......... +.+.++...++.++||||+++++++..++.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 4577789999999999999999999985 67899999999765444333 344556666888999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
.|+||||++ |+|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999998 5887777542 246799999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhh---ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIR---SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
.... .......||+.|+|||++. ....++.++|||||||++|+|++|..||..................
T Consensus 160 ~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 160 LVDD--------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred cccc--------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 3211 1223346899999999973 3344889999999999999999999999864443333322222111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.......+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 232 ---------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ---------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 111234678999999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=390.31 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=211.7
Q ss_pred CeeE--EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKI--LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i--~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|.+ .+.||+|+||.||+|.+. .+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEET-TTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEc-CCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4555 678999999999999985 578999999987543 345678999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe--CCCCCeEEeeccccccccCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS--DSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl--d~~g~vKL~DFGls~~~~~~~~ 183 (506)
||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 166 E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-- 242 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-- 242 (373)
T ss_dssp ECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--
T ss_pred eCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--
Confidence 999999999988753 3469999999999999999999999999999999999999 56789999999997643221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................+..
T Consensus 243 ------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------ 309 (373)
T 2x4f_A 243 ------EKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED------ 309 (373)
T ss_dssp ------CBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS------
T ss_pred ------cccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh------
Confidence 1122345899999999997654 899999999999999999999999877666555444443332221
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++++++||.+||+.||.+|||+.++++||||++.
T Consensus 310 --~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 --EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1234678999999999999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=381.66 Aligned_cols=256 Identities=36% Similarity=0.584 Sum_probs=215.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
+.|++++.||+|+||+||+|.+. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35999999999999999999985 6789999999976532 33456789999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+. |+|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~----- 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 205 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-----
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-----
Confidence 99997 6888887653 4679999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||..................
T Consensus 206 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-------- 271 (348)
T 1u5q_A 206 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------- 271 (348)
T ss_dssp ------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred ------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------
Confidence 1123468999999999863 334889999999999999999999999877665544333322111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
......+++.+++||.+||+.||.+|||+.++++||||....
T Consensus 272 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 272 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred --CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 112346788999999999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=382.96 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=192.0
Q ss_pred CeeEE---eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEE
Q 010624 28 SYKIL---DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 28 ~Y~i~---~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (506)
+|++. +.||+|+||+||+|.++ .+++.||||++.. .....+.+|+.+++.+. ||||+++++++.++...|+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHK-KSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEET-TTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEEC-CCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 46665 78999999999999985 6689999999863 33466789999999997 9999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEeeccccccccC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLADFGVSASIYE 180 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~DFGls~~~~~ 180 (506)
||||+.||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 9999999999999987 46799999999999999999999999999999999999998765 899999999754321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh-hcc
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE------KSLLMKMT-QRF 253 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~------~~~~~~~~-~~~ 253 (506)
. ........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...... ......+. ..+
T Consensus 162 ~-------~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 162 D-------NQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp -----------------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred C-------CCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 1 11223445799999999997654 899999999999999999999999754321 11111111 111
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+.. ..+..+++++++||.+||+.||.+|||+.++++||||++.
T Consensus 234 ~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 234 SFEG--------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCCS--------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCc--------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 1111 1224578999999999999999999999999999999865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=383.87 Aligned_cols=273 Identities=29% Similarity=0.375 Sum_probs=211.8
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh----hHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT----DLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
...++|++.+.||+|+||.||+|.+. .+|+.||||++....... ....+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34578999999999999999999985 568899999987543221 1246789999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|+||||+.+ +|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.+|.+||+|||++....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 99999999985 898888763 3568999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc--c
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS--D 257 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--~ 257 (506)
.. ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.................... .
T Consensus 164 ~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 164 SP-------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp SC-------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CC-------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 11 11223456899999999997766689999999999999999999999987766555444332211100 0
Q ss_pred hhhh--------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 258 YEKT--------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 258 ~~~~--------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
+... .........+++++++||.+||+.||.+|||+.++++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 0000 000011245678999999999999999999999999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=406.00 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=219.4
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
++..++|++.+.||+|+||.||+|.++ .+|+.||+|++..... ....+.+.+|+.+++.++||||++++++|.+...
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 466789999999999999999999985 5789999999865431 2335678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999998643 346999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPP----EKSLLMKMTQRFR 254 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~----~~~~~~~~~~~~~ 254 (506)
... ........||+.|+|||++.+. .|+.++|||||||++|+|++|.+||..... ............
T Consensus 340 ~~~-------~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~- 410 (543)
T 3c4z_A 340 KAG-------QTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410 (543)
T ss_dssp CTT-------CCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-
T ss_pred cCC-------CcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-
Confidence 221 1112234789999999999875 489999999999999999999999976432 122211111111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
..+..+++.+++||.+||+.||.+||+ +.+|++||||+.++
T Consensus 411 -----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 411 -----------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred -----------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 134568899999999999999999996 58999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.48 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=208.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.+.||+|+||+||+|.+. .+++.||+|.+..... ......+.+|+.++..+ +||||+++++++.+++..|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999985 5789999999876532 34456788999999999 899999999999999999999
Q ss_pred eccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC------------------
Q 010624 105 MPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD------------------ 164 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~------------------ 164 (506)
|||++|++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999997642 2569999999999999999999999999999999999999844
Q ss_pred -CCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Q 010624 165 -GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK 243 (506)
Q Consensus 165 -g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~ 243 (506)
..+||+|||++..... .....||+.|+|||++.+...++.++|||||||++|+|++|.+|+......
T Consensus 170 ~~~~kl~Dfg~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~- 237 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS-----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW- 237 (289)
T ss_dssp CCCEEECCCTTCEETTC-----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-
T ss_pred ceEEEEcccccccccCC-----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-
Confidence 4799999998764322 122348999999999987655778999999999999999999887543221
Q ss_pred HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. .+... . ....+..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 238 --~-~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 238 --H-EIRQG-R---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp --H-HHHTT-C---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred --H-HHHcC-C---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 1 11111 0 1123456889999999999999999999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=369.72 Aligned_cols=264 Identities=29% Similarity=0.489 Sum_probs=220.7
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--------hhhHHHHHHHHHHHhhCC-CCCceeeeeE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--------RTDLDSIRRETKTMSLLS-HPNILNAHCS 94 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~ 94 (506)
...++|++.+.||+|+||.||+|.++ .+++.||||++..... ....+.+.+|+.+++.+. ||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 34578999999999999999999985 6789999999976531 123467889999999996 9999999999
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
+..++..|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 9999999999999999999999987 36799999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhc-----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
+...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.............
T Consensus 171 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 171 SCQLDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp CEECCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hhhcCCC--------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 7543211 12234568999999999863 3347889999999999999999999998766555444433
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.....+.. .....++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus 243 ~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 243 SGNYQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HTCCCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCCcccCc--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 33332221 12346789999999999999999999999999999999763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=389.61 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=211.2
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCC--CCCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLS--HPNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 99 (506)
.+...+|++++.||+|+||+||+|.+ .+++.||||++.... .....+.+.+|+.+|+.+. ||||+++++++..++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEC--TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEccCCCeEEEEEEc--CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34456699999999999999999987 348899999997654 3455678999999999996 599999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEEEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9999999 567999999987 46799999999999999999999999999999999999995 6899999999975432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhcc----------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----------TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----------~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
... .........||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||............+
T Consensus 206 ~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 206 PDT-----TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp -------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred CCC-----ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 110 11112345699999999999751 248999999999999999999999998654432222222
Q ss_pred hh-cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 250 TQ-RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. ... ...+...+.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 281 ~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 281 IDPNHE----------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HCTTSC----------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hCcccc----------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 21 111 112334578899999999999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=372.46 Aligned_cols=264 Identities=36% Similarity=0.619 Sum_probs=214.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
..++|++.+.||+|+||.||+|.+. .++..||+|++... .....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4467999999999999999999985 56889999998654 234567888999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--- 170 (302)
T ss_dssp EECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---
T ss_pred EEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc---
Confidence 9999999999998764 467999999999999999999999999999999999999999999999999986422110
Q ss_pred CCCCCcccccCCCCCccCChhhhh----ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIR----SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~----~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
........||+.|+|||++. ....++.++|||||||++|+|++|..||...................
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 241 (302)
T 2j7t_A 171 ----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----- 241 (302)
T ss_dssp ----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----
T ss_pred ----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----
Confidence 01122346899999999985 23447899999999999999999999998776655443332221110
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
...+..++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 242 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 242 ----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp ----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 1124567889999999999999999999999999999998743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=383.96 Aligned_cols=259 Identities=30% Similarity=0.532 Sum_probs=216.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------hhHHHHHHHHHHHhhC-CCCCceeeeeEEEeC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------TDLDSIRRETKTMSLL-SHPNILNAHCSFSVD 98 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (506)
++|++.+.||+|+||.||+|.++ .+|+.||||++...... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 46999999999999999999984 56899999998765421 1245778999999999 799999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+..|+||||+.|++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.+|.+||+|||++...
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999999987 367999999999999999999999999999999999999999999999999987643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhcc-----CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-----TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
... .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.................
T Consensus 251 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 251 EPG--------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CTT--------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CCC--------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 221 112345689999999998742 2478899999999999999999999987665544443333333
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.+... .+..++..+.+||.+||+.||.+|||+.++++||||+.
T Consensus 323 ~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSP--------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHH--------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCc--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22211 12457889999999999999999999999999999973
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=371.65 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=221.2
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+...++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence 455678999999999999999999985 568899999987543 34556788999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999999999873 6799999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 168 ~-------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 233 (294)
T 2rku_A 168 D-------GERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 233 (294)
T ss_dssp T-------TCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------
T ss_pred C-------ccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC------
Confidence 1 11223456899999999997654 899999999999999999999999876655544333222211
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+++.+.+||.+||+.||++|||+.++++||||...
T Consensus 234 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 234 ------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 234678899999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=378.07 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=203.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhh-CCCCCceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSL-LSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV 104 (506)
++|++.++||+|+||+||+|.++ .+++.||||++.... .........+|+..+.. .+||||+++++++.+++.+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999985 578999999986543 23334445556655554 4899999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
|||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--- 210 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence 9999 67999988765 457999999999999999999999999999999999999999999999999996543211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+..... .
T Consensus 211 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~~---------~ 270 (311)
T 3p1a_A 211 -----GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYL---------P 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTCC---------C
T ss_pred -----CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccCC---------C
Confidence 12234458999999999976 389999999999999999999776653211 111221111 0
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
......+++++.+||.+||+.||++|||+.++++||||++
T Consensus 271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1123467899999999999999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=393.31 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=202.3
Q ss_pred CCCeeEE-eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHH-hhCCCCCceeeeeEEEe----CC
Q 010624 26 PSSYKIL-DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM-SLLSHPNILNAHCSFSV----DS 99 (506)
Q Consensus 26 ~~~Y~i~-~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~ 99 (506)
.++|.+. +.||+|+||+||+|.++ .+++.||||++... ..+.+|+.++ +..+||||++++++|.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3578887 78999999999999985 67899999998532 3566888887 55689999999999876 56
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSA 176 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~ 176 (506)
.+|+|||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 7999999999999999998754456999999999999999999999999999999999999997 7899999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK----SLLMKMTQR 252 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~----~~~~~~~~~ 252 (506)
..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||....... .........
T Consensus 213 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 213 ETTSH--------NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp ECC-------------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred ccCCC--------CccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 43211 112345689999999999764 48999999999999999999999997643321 111122222
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+.++. .....+++++++||.+||+.||.+|||+.++++||||...
T Consensus 284 ~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 284 YEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 22211 1235688999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=369.91 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=215.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
++|++.+.||+|+||+||+|.+. .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 56999999999999999999985 56889999998754321 2467899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC----CeEEeecccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG----SVKLADFGVSAS 177 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g----~vKL~DFGls~~ 177 (506)
|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999999987 36799999999999999999999999999999999999999877 899999998754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................+..
T Consensus 162 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 162 IEAG--------NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232 (283)
T ss_dssp CC----------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred ccCC--------CcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence 3211 1123345899999999997654 899999999999999999999999876655444333222222111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 233 --------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp --------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 1224578899999999999999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=370.14 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=210.9
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 445678999999999999999999985 578899999986432 12335678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999874 5799999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. .......||+.|+|||++.+...++.++|||||||++|+|++|..||.................
T Consensus 164 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 228 (276)
T 2h6d_A 164 G--------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------- 228 (276)
T ss_dssp ---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred C--------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------
Confidence 1 1123446899999999998765446899999999999999999999987655443322221111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 1234578899999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=373.05 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=194.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 357999999999999999999985 5688999999864321 1234678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-- 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-- 165 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--
Confidence 99999999999999863 357999999999999999999999999999999999999999999999999987643211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||............... .
T Consensus 166 -----~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~------ 228 (278)
T 3cok_A 166 -----HEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-----D------ 228 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-----C------
T ss_pred -----CCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-----c------
Confidence 11122346899999999997654 789999999999999999999999765443322111111 0
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...+..++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 229 -YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 11334578899999999999999999999999999999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=378.78 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=221.4
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+....+|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 445678999999999999999999985 567899999987543 34556788999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999999999873 6799999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 194 ~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 259 (335)
T 2owb_A 194 D-------GERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------ 259 (335)
T ss_dssp T-------TCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------
T ss_pred C-------cccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC------
Confidence 1 11223456899999999998654 899999999999999999999999876655444333222211
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 260 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 260 ------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 234678899999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=374.11 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=214.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 357999999999999999999985 5788999999975432 23456889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~~~~~ 182 (506)
||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 999999999999773 579999999999999999999999999999999999999 7888999999998643211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................+..
T Consensus 162 -------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 228 (304)
T 2jam_A 162 -------GIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES----- 228 (304)
T ss_dssp -------BTTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT-----
T ss_pred -------CccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence 1122345899999999997654 899999999999999999999999876655444333332222211
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 ---PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1235678999999999999999999999999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=384.66 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=212.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------TDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
++|++.+.||+|+||+||+|.++ .+++.||||++...... .....+.+|+.+++.++||||++++++|.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 57999999999999999999985 67899999999765421 13345678999999999999999999999999
Q ss_pred EEEEEeccCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 100 RLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 100 ~~~lV~Ey~~gg-sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
.+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999999766 99999987 467999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..||...... ...
T Consensus 181 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~------- 239 (335)
T 3dls_A 181 ERG--------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEA------- 239 (335)
T ss_dssp CTT--------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTT-------
T ss_pred CCC--------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhh-------
Confidence 221 11223468999999999987664588999999999999999999999752110 000
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....+..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 240 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 240 -----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp -----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred -----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 1113345789999999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=371.21 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=213.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..++|++++.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 44578999999999999999999985 568899999986543 344567899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999999874 57999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||............+..... ..
T Consensus 165 ------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~--- 232 (294)
T 4eqm_A 165 ------SLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP--NV--- 232 (294)
T ss_dssp ----------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC--CH---
T ss_pred ------cccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC--Cc---
Confidence 111223346899999999998755 899999999999999999999999877665554444433221 11
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.......+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 1124466889999999999999999999655655555543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=383.73 Aligned_cols=263 Identities=25% Similarity=0.439 Sum_probs=218.5
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeee
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAH 92 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 92 (506)
..+.+..++|++.+.||+|+||.||+|.+.. .++..||||++.........+.+.+|+.+|+.+ +||||++++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 4466777899999999999999999998742 345689999997766666778899999999999 899999999
Q ss_pred eEEEeCCEEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCC
Q 010624 93 CSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGN 158 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~N 158 (506)
+++..++.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 999999999999999999999999987432 358999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCC
Q 010624 159 ILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLS 237 (506)
Q Consensus 159 ILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~ 237 (506)
||++.++.+||+|||++....... .........||+.|+|||++.+.. |+.++|||||||++|+|++ |..||.
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCC-----TTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEECCCCCEEEccccCCcccCccc-----ceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999976432211 111223445788999999998754 8999999999999999999 999998
Q ss_pred CCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 238 HLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.......... +..... ...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 308 ~~~~~~~~~~-~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 308 GIPVEELFKL-LKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TCCGGGHHHH-HHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHH-HhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7665544332 222111 12345688999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=378.89 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=218.3
Q ss_pred CCCeeEE-eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEE
Q 010624 26 PSSYKIL-DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 26 ~~~Y~i~-~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (506)
.+.|.+. +.||+|+||+||+|.++ .+++.||+|++..... ......+.+|+.+++.+. ||||+++++++...+.+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3568888 89999999999999985 6689999999876442 334678889999999995 699999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeecccccccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSASIY 179 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~~~~ 179 (506)
+||||+.+|+|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999999987655577999999999999999999999999999999999999997 7899999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................+.
T Consensus 186 ~~--------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 253 (327)
T 3lm5_A 186 HA--------CELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS--- 253 (327)
T ss_dssp ----------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred Cc--------cccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC---
Confidence 11 1123346899999999997654 89999999999999999999999987766555444333322221
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
......+++.+.+||.+||+.||.+|||+.++++||||+..+.
T Consensus 254 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 254 -----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred -----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 1133568899999999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=370.77 Aligned_cols=263 Identities=37% Similarity=0.654 Sum_probs=212.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
.....++|++.+.||+|+||.||+|.+. .+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+.+
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3455678999999999999999999985 568999999987543 346788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999999999743 467999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 179 -------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 243 (314)
T 3com_A 179 -------MAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP------- 243 (314)
T ss_dssp -------BSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred -------ccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-------
Confidence 11223446899999999997654 899999999999999999999999876655443322221100
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
....+..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 244 --~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 --TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp --CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred --ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0012345788999999999999999999999999999999763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=380.04 Aligned_cols=265 Identities=22% Similarity=0.366 Sum_probs=213.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC---
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--- 99 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (506)
..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 3578999999999999999999985 678999999997653 3344568899999999999999999999987643
Q ss_pred -EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 100 -RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 100 -~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 459999999999999999873 57999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....................
T Consensus 167 ~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 239 (311)
T 3ork_A 167 ADSG----NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-- 239 (311)
T ss_dssp -------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH--
T ss_pred cccc----cccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc--
Confidence 2211 1111223346899999999998754 89999999999999999999999987766655444443322111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
......+++++.+||.+||+.||.+||++.+++.|+|++..
T Consensus 240 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 ------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11235688999999999999999999999999999998743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=379.19 Aligned_cols=277 Identities=24% Similarity=0.341 Sum_probs=217.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----C
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-----S 99 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (506)
..++|++.+.||+|+||.||+|.+. .+|+.||||.+...........+.+|+.+++.++||||+++++++..+ .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3578999999999999999999985 578999999997655566667888999999999999999999987654 6
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 7999999997 689999986 579999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCCC---CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 180 EPSHHHH---HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 180 ~~~~~~~---~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
....... ..........||+.|+|||++.+...++.++|||||||++|+|++|.+||....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 2211100 0011123356899999999987655689999999999999999999999987665444332221100000
Q ss_pred -----------chhhh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 -----------DYEKT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 -----------~~~~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..... .........+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000 001112346789999999999999999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=374.18 Aligned_cols=267 Identities=36% Similarity=0.633 Sum_probs=215.4
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe--
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSV-- 97 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-- 97 (506)
......++|++.+.||+|+||.||+|.+. .+++.||||++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34556789999999999999999999985 5688999999875432 346788999999998 79999999999987
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
...+|+||||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 5689999999999999999987544679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
++...... ........||+.|+|||++.. ...++.++|||||||++|+|++|..||.............
T Consensus 175 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRT-------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp TTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CceecCcC-------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 86543211 111233468999999999862 2347899999999999999999999998766554433322
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
.... .......+++.+.+||.+||..||.+|||+.++++||||++...
T Consensus 248 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 248 RNPA----------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HSCC----------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred cCcc----------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 2111 11123567899999999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=385.69 Aligned_cols=265 Identities=23% Similarity=0.373 Sum_probs=200.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------ 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (506)
.++|++++.||+|+||.||+|.+. .+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 478999999999999999999985 678999999986543 345567888999999999999999999999754
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 6899999875 57999999999999999999999999999999999999999999999999997542
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ......||++|+|||++.+...|+.++|||||||++|+|++|++||............... ...+..
T Consensus 183 ~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~-~g~p~~ 251 (367)
T 2fst_X 183 AD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGA 251 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCSCCH
T ss_pred cc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCH
Confidence 21 1233568999999999987556899999999999999999999999877655444333221 110000
Q ss_pred h-----------hh---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 E-----------KT---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~-----------~~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. .. .........+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0 00 000111235678999999999999999999999999999999763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=372.27 Aligned_cols=268 Identities=21% Similarity=0.247 Sum_probs=215.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC------ceeeeeEEEeC
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN------ILNAHCSFSVD 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~ 98 (506)
..++|++.+.||+|+||+||+|.+...+++.||+|++... ....+.+.+|+.+++.++|+| |+++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3578999999999999999999985567899999998643 345577889999999987654 99999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---------------
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS--------------- 163 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~--------------- 163 (506)
+.+|+||||+ +++|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 899999998764457999999999999999999999999999999999999987
Q ss_pred ----CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 010624 164 ----DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL 239 (506)
Q Consensus 164 ----~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~ 239 (506)
++.+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE----------HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS----------CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCceEeeCcccccCcc----------ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 67899999998754221 122346899999999998654 899999999999999999999999876
Q ss_pred ChHHHHHHHHhhcccccchh--------------------------------hhhhhhccchhhhHHHHHHHHhhcccCC
Q 010624 240 PPEKSLLMKMTQRFRFSDYE--------------------------------KTLKIKDKNKKFSRAFKDMVASCLDQDP 287 (506)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP 287 (506)
................+... ............++.+.+||.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 65443322211110100000 0000011223457889999999999999
Q ss_pred CCCCCHHHHHcCccccccc
Q 010624 288 SKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 288 ~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+|||+.++++||||+...
T Consensus 318 ~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGG
T ss_pred ccccCHHHHhcCHHHHHHh
Confidence 9999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=372.67 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=208.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
...+.+...+|++.+.||+|+||+||+|.+ ++..||+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 444678889999999999999999999976 47899999987654 34556788999999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~vKL~DFGl 174 (506)
.+.+|+||||+.+|+|.+++..... ..+++..+..++.|++.||+|||++| ++||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999986321 13999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
+...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 186 a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (309)
T 3p86_A 186 SRLKAST-------FLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257 (309)
T ss_dssp -----------------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC
T ss_pred Ccccccc-------ccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 7532211 11223456899999999998755 899999999999999999999999877665544332222111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 258 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 258 ----------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1234568899999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.48 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=212.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC------CCCCceeeeeEEEeC
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL------SHPNILNAHCSFSVD 98 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~ 98 (506)
...+|++++.||+|+||+||+|.+. .+++.||||++... ......+.+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3457999999999999999999985 56899999998643 33446677888888877 578999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC--eEEeeccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS--VKLADFGVSA 176 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~--vKL~DFGls~ 176 (506)
..+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 79999998865567999999999999999999999999999999999999999887 9999999975
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.... ......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||............+.. ...+
T Consensus 251 ~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~-~~~p 318 (429)
T 3kvw_A 251 YEHQ----------RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL-LGMP 318 (429)
T ss_dssp ETTC----------CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCC
T ss_pred ecCC----------cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCC
Confidence 4221 122346899999999998765 899999999999999999999999877665544333221 1111
Q ss_pred chhhhhh------------------------------------------------hhccchhhhHHHHHHHHhhcccCCC
Q 010624 257 DYEKTLK------------------------------------------------IKDKNKKFSRAFKDMVASCLDQDPS 288 (506)
Q Consensus 257 ~~~~~~~------------------------------------------------~~~~~~~~s~~l~~Li~~~L~~dP~ 288 (506)
....... ........++.+.+||.+||+.||+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 0000000 0001112378899999999999999
Q ss_pred CCCCHHHHHcCcccccc
Q 010624 289 KRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 289 ~Rpt~~eiL~hp~f~~~ 305 (506)
+|||+.++|+||||+..
T Consensus 399 ~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 399 VRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TSCCHHHHHTSTTTC--
T ss_pred hCCCHHHHhCChhhccC
Confidence 99999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=394.05 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=204.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-------hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-------RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
.++|++.+.||+|+||+||+|.+. .+++.||||++..... ......+.+|+.+|++++||||+++++++. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 468999999999999999999985 6788999999875421 112235789999999999999999999985 4
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEEeecccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKLADFGVS 175 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL~DFGls 175 (506)
+..|+||||+.+|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 568999999999999998876 46799999999999999999999999999999999999997544 5999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-c
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-R 252 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~-~ 252 (506)
..... ........||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||............+.. .
T Consensus 290 ~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~ 361 (419)
T 3i6u_A 290 KILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred eecCC--------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence 54321 112234568999999999853 344788999999999999999999999765443332222222 1
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+. +.....+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 362 ~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 362 YNFI--------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCCC--------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 1111 11234578999999999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=385.67 Aligned_cols=264 Identities=26% Similarity=0.452 Sum_probs=213.7
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCC---ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQ---SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSV 97 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (506)
+..++|++++.||+|+||+||+|.+.. .+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 445799999999999999999998842 468899999986432 122345567899999999 69999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
+..+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999874 5799999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEK---SLLMKMTQRF 253 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~---~~~~~~~~~~ 253 (506)
.... .........||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... .....+...
T Consensus 209 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~- 281 (355)
T 1vzo_A 209 FVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 281 (355)
T ss_dssp CCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred cccC------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-
Confidence 3211 11112234689999999999753 347899999999999999999999997533221 111111110
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
....+..++..+++||.+||..||.+|| |+.++++||||+..+
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 1123456888999999999999999999 999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=363.51 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=214.6
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..|.+..++|++.+.||+|+||.||+|.+ .++..||+|++..... ..+.+.+|+.++++++||||+++++++.+++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEE--TTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEe--cCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 45888999999999999999999999998 4678899999875432 3467889999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|+||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred ceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999999999763 4569999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.............. ...
T Consensus 158 ~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~---- 225 (269)
T 4hcu_A 158 DD------QYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFR---- 225 (269)
T ss_dssp CH------HHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCC----
T ss_pred cc------ccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-Ccc----
Confidence 11 111223445688899999998655 8999999999999999999 9999987666544333222 111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+++.+.+++.+||+.||.+|||+.++++|
T Consensus 226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11345578899999999999999999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=372.23 Aligned_cols=275 Identities=25% Similarity=0.393 Sum_probs=217.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhC---CCCCceeeeeEEE--
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLL---SHPNILNAHCSFS-- 96 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-- 96 (506)
....++|++.+.||+|+||.||+|.+...+++.||+|++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 334578999999999999999999985467899999998654321 2223455777777665 8999999999987
Q ss_pred ---eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 97 ---VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 97 ---~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
.....++||||+. |+|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 4568999999998 699999987655669999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||............... .
T Consensus 166 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~ 235 (326)
T 1blx_A 166 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV-I 235 (326)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-H
T ss_pred ccccccC--------CCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH-c
Confidence 8653211 11233456899999999998654 899999999999999999999999877665544333221 1
Q ss_pred cccc---hhh-------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 254 RFSD---YEK-------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 254 ~~~~---~~~-------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
..+. +.. ..........++..+++||.+||+.||.+|||+.++++||||++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 1000 000 000112235688999999999999999999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=386.00 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=206.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS------ 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 99 (506)
..+|++.+.||+|+||+||+|.+. .+..||+|.+....... .+|+.+|+.++||||++++++|...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~~~-----~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKRFK-----NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTTSC-----CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcchH-----HHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 457999999999999999999984 34458888876443222 27999999999999999999986543
Q ss_pred EEEEEeccCCCCCHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEeecccccc
Q 010624 100 RLWVVMPFMSCGSLQSIIS-SCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLADFGVSAS 177 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~-~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~DFGls~~ 177 (506)
.+|+||||+.++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|..
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 4899999998765444332 12246799999999999999999999999999999999999999 799999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc---
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR--- 254 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~--- 254 (506)
.... .......||+.|+|||++.+...|+.++|||||||++|+|++|++||............+.....
T Consensus 192 ~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 192 LIAG--------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp CCTT--------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccCC--------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 3221 11234568999999999987666899999999999999999999999877665554443321100
Q ss_pred --------------ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 255 --------------FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 --------------~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
++..............+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0000000000112345788999999999999999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=376.01 Aligned_cols=268 Identities=23% Similarity=0.377 Sum_probs=212.0
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC--EE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--RL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 101 (506)
+..++|++.+.||+|+||+||+|.+. .+++.||||++.........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44578999999999999999999995 5688999999976554555678889999999999999999999998755 88
Q ss_pred EEEeccCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe----CCCCCeEEeeccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS----DSDGSVKLADFGVSA 176 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl----d~~g~vKL~DFGls~ 176 (506)
|+||||+.|++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986432 239999999999999999999999999999999999999 788889999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhc-------cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----HH
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-------HTGYSFKADIWSFGITALELAHGRPPLSHLPPEK----SL 245 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-------~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~----~~ 245 (506)
..... .......||+.|+|||++.. ...++.++|||||||++|+|++|..||....... ..
T Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTT--------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCC--------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 43221 11223468999999999863 2448899999999999999999999997543322 22
Q ss_pred HHHHhhcccc--c----------chhhh-hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCc
Q 010624 246 LMKMTQRFRF--S----------DYEKT-LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300 (506)
Q Consensus 246 ~~~~~~~~~~--~----------~~~~~-~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp 300 (506)
.......... . .+... .........+++.+.+||.+||+.||++|||+.++++||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2222211100 0 00000 001123356788999999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=380.70 Aligned_cols=265 Identities=23% Similarity=0.386 Sum_probs=218.8
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeee
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHC 93 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (506)
...|.+..++|++.+.||+|+||.||+|.+. ..+++.||||++.........+.+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 4567888999999999999999999999853 2456899999998766666678899999999999 7999999999
Q ss_pred EEEeCC-EEEEEeccCCCCCHHHHHHhhCC--------------------------------------------------
Q 010624 94 SFSVDS-RLWVVMPFMSCGSLQSIISSCFP-------------------------------------------------- 122 (506)
Q Consensus 94 ~~~~~~-~~~lV~Ey~~ggsL~~~i~~~~~-------------------------------------------------- 122 (506)
++...+ .+|+|||||.||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998754 58999999999999999986422
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCC
Q 010624 123 --------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188 (506)
Q Consensus 123 --------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~ 188 (506)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~ 248 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----PD 248 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-----TT
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc-----cc
Confidence 12899999999999999999999999999999999999999999999999997643221 11
Q ss_pred CcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhcc
Q 010624 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK 267 (506)
Q Consensus 189 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............+...... ..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------RA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------CC
T ss_pred chhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------CC
Confidence 12233456789999999998654 8999999999999999998 999998766555444443332221 13
Q ss_pred chhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 268 NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 268 ~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 45678899999999999999999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=389.75 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=206.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC------CE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD------SR 100 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~ 100 (506)
.+|++.+.||+|+||+||+|.++ .+++.||||++...... ..+|+.+|+.++||||++++++|... .+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46999999999999999999985 56899999998654322 23799999999999999999888542 24
Q ss_pred EEEEeccCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-CCeEEeecccccc
Q 010624 101 LWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSAS 177 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~--~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-g~vKL~DFGls~~ 177 (506)
+++||||+.+ +|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7899999985 66666543 224679999999999999999999999999999999999999965 5789999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc----
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF---- 253 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~---- 253 (506)
.... .......||++|+|||++.+...|+.++|||||||++|+|++|++||............+....
T Consensus 207 ~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 207 LVRG--------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCTT--------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccC--------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 3211 1123346899999999998765689999999999999999999999987766554444332100
Q ss_pred -------------cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 -------------RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 -------------~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.++......-.......+++++++||.+||..||.+|||+.++++||||+..
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0000000000001234568899999999999999999999999999999865
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.17 Aligned_cols=271 Identities=22% Similarity=0.299 Sum_probs=210.1
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC----------hhhHHHHHHHHHHHhhCCCCCceeee
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS----------RTDLDSIRRETKTMSLLSHPNILNAH 92 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~----------~~~~~~~~~Ei~il~~l~HpnIv~l~ 92 (506)
....++|++.+.||+|+||.||+|.+ .++..||||.+..... ....+.+.+|+.+++.++||||++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVD--SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEEC--TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHhccceEEeEEeccCCCEEEEEEEC--CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34568899999999999999999987 4589999999864332 12247889999999999999999999
Q ss_pred eEEEe-----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCe
Q 010624 93 CSFSV-----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 93 ~~~~~-----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~v 167 (506)
+++.. ...+|+||||+. |+|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence 99854 347899999998 6888888753 4579999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 010624 168 KLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM 247 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~ 247 (506)
||+|||++..... ........||+.|+|||++.+...++.++|||||||++|+|++|++||...........
T Consensus 174 kl~Dfg~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 174 TICDFNLAREDTA--------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp EECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEEecCccccccc--------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999753221 11223456899999999998755689999999999999999999999987665544333
Q ss_pred HHhhcccccchhhh---------------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 248 KMTQRFRFSDYEKT---------------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 248 ~~~~~~~~~~~~~~---------------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..... ..+..... .........+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 246 i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 246 IVEVV-GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHH-CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHc-CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 32211 11110000 001112345688899999999999999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=368.65 Aligned_cols=271 Identities=21% Similarity=0.340 Sum_probs=209.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE---------
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS--------- 96 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--------- 96 (506)
.++|++++.||+|+||.||+|.+. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET-TTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 478999999999999999999985 56899999998654 3455678899999999999999999998873
Q ss_pred -----eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEe
Q 010624 97 -----VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLA 170 (506)
Q Consensus 97 -----~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~ 170 (506)
.....|+||||+. |+|.+++.. ..+++..++.++.|++.||+|||++|++||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4478999999998 699999965 5799999999999999999999999999999999999997 56799999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
|||++....... ..........||+.|+|||++.+...++.++|||||||++|+|++|..||..............
T Consensus 164 Dfg~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 164 DFGLARIMDPHY----SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCccccccCCCc----ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999976432110 0111223445799999999987655689999999999999999999999987766554433332
Q ss_pred hcccccchhh------------h------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 251 QRFRFSDYEK------------T------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 251 ~~~~~~~~~~------------~------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.......... . .........++.++++||.+||+.||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 2111100000 0 000112345789999999999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=379.78 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=205.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS----- 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 99 (506)
.++|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999985 678999999997543 3455677889999999999999999999997665
Q ss_pred -EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 100 -RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 100 -~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
.+|+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 7899999998 578888853 5899999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... .......||+.|+|||++.+.. |+.++|||||||++|+|++|..||............+.. ...+..
T Consensus 178 ~~~--------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 247 (371)
T 2xrw_A 178 GTS--------FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ-LGTPCP 247 (371)
T ss_dssp --------------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC--CCCCCH
T ss_pred ccc--------cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCH
Confidence 211 1223456899999999998754 899999999999999999999999876655443333221 111100
Q ss_pred hhh----------------------------hhhh---ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 259 EKT----------------------------LKIK---DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 259 ~~~----------------------------~~~~---~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
... ...+ ......++++++||.+||+.||.+|||+.++++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 0000 0012247789999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=381.45 Aligned_cols=271 Identities=24% Similarity=0.380 Sum_probs=217.7
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh----------------hhHHHHHHHHHHHhhCCCCC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR----------------TDLDSIRRETKTMSLLSHPN 87 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~----------------~~~~~~~~Ei~il~~l~Hpn 87 (506)
...++|++.+.||+|+||.||+|.+ +++.||+|.+...... ...+.+.+|+.+++.++|||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 3457999999999999999999987 6899999998643211 11278899999999999999
Q ss_pred ceeeeeEEEeCCEEEEEeccCCCCCHHHH------HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEE
Q 010624 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSI------ISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNIL 160 (506)
Q Consensus 88 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~------i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NIL 160 (506)
|+++++++.+.+..|+||||+++++|.++ +.......+++..++.++.|++.||.|||+ +|++||||||+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 655445679999999999999999999999 99999999999999
Q ss_pred eCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCc-cccHHHHHHHHHHHHhCCCCCCCC
Q 010624 161 SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSF-KADIWSFGITALELAHGRPPLSHL 239 (506)
Q Consensus 161 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~-~sDIwSlGiil~eLltG~~Pf~~~ 239 (506)
++.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EcCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999987543211 2344568999999999987644666 999999999999999999999876
Q ss_pred ChHHHHHHHHh-hcccccchhhhh-------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 240 PPEKSLLMKMT-QRFRFSDYEKTL-------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.........+. ....++...... ........+++.+.+||.+||+.||.+|||+.++++||||++.+
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 65333333332 222222100000 00011256789999999999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=368.22 Aligned_cols=267 Identities=23% Similarity=0.394 Sum_probs=222.6
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceee
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNA 91 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 91 (506)
.....|.+..++|++.+.||+|+||.||+|.+. ..++..||+|++.........+.+.+|+.+++.+ +||||+++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 345568888899999999999999999999863 3567899999998766666678899999999999 89999999
Q ss_pred eeEEEeCCEEEEEeccCCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Q 010624 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFP----------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVK 155 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~----------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIK 155 (506)
++++..++..|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||++|++|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 9999999999999999999999999987432 148999999999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCC
Q 010624 156 AGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRP 234 (506)
Q Consensus 156 p~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~ 234 (506)
|+||+++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~ 246 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSS 246 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCT-----TSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccc-----cceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999976433221 111223345688999999998654 8999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
||............+...... ..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 247 p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 247 PYPGMPVDSKFYKMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSTTCCSSHHHHHHHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccchhHHHHHhccCCCC----------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 998766555444433332221 1235678899999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=368.15 Aligned_cols=263 Identities=26% Similarity=0.381 Sum_probs=211.7
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.+..++|++.+.||+|+||+||+|.+. .++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEEC-CCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 356789999999999999999999985 5688999998843 34556778999999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+||||+.+++|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999874 4679999999999999999999999999999999999999999999999999976543221
Q ss_pred CCCCC-------CCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 183 HHHHH-------GSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 183 ~~~~~-------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
..... .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---------~ 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---------F 232 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---------S
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---------H
Confidence 11000 001112457899999999998754 899999999999999999999998754322110 0
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
............+..+++.+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000111112235678889999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=369.99 Aligned_cols=268 Identities=24% Similarity=0.416 Sum_probs=221.6
Q ss_pred ccccccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCcee
Q 010624 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN 90 (506)
Q Consensus 15 ~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 90 (506)
.+.....+.+..++|++.+.||+|+||.||+|.+.. .++..||+|++.........+.+.+|+.+++.++||||++
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp ---CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred eccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceee
Confidence 344566788999999999999999999999998742 3458999999987666677788999999999999999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP----------------------DGLPEPCIAIVLKETLSALSYLHNQG 148 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~----------------------~~l~e~~i~~i~~qil~gL~yLHs~g 148 (506)
+++++..++..|+||||+.+++|.+++..... ..+++..+..++.||+.||.|||++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999987432 23899999999999999999999999
Q ss_pred CccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHH
Q 010624 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE 228 (506)
Q Consensus 149 ivHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~e 228 (506)
++||||||+|||++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWE 244 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTS-----CEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHH
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccc-----cceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHH
Confidence 9999999999999999999999999976432211 111223445788999999998754 8999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 229 LAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 229 Llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
|++ |..||............ ..... ...+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 245 l~t~g~~p~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 245 IVTLGGNPYPGIPPERLFNLL-KTGHR----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHTTSCCSSTTCCGGGHHHHH-HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHh-hcCCc----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999 99999876655433222 21111 12345688999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=373.55 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=215.9
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+..++|++.+.||+|+||.||+|.+... .+..||||.+.........+.+.+|+.+++.++||||+++++++.++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567788999999999999999999998522 34569999998766666778899999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+..|+||||+.|++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999763 457999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ..........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||............. .....
T Consensus 202 ~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~-- 273 (325)
T 3kul_A 202 EDDP----DAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRL-- 273 (325)
T ss_dssp C--------CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCC--
T ss_pred ccCc----cceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCC--
Confidence 3221 1112223445688999999998654 8999999999999999999 999998776655433322 22111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 274 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 --------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 134568899999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=379.75 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=208.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC--------CCCceeeeeEEE-
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS--------HPNILNAHCSFS- 96 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~~- 96 (506)
.++|++.+.||+|+||+||+|.+. .+++.||||++... ....+.+.+|+.+++.+. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 578999999999999999999985 67899999998643 445677889999999985 788999999987
Q ss_pred ---eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCC-------
Q 010624 97 ---VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDG------- 165 (506)
Q Consensus 97 ---~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g------- 165 (506)
....+|+||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 456899999999 56777776654446799999999999999999999999 999999999999999775
Q ss_pred ------------------------------------------CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCC
Q 010624 166 ------------------------------------------SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203 (506)
Q Consensus 166 ------------------------------------------~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~A 203 (506)
.+||+|||++..... ......||+.|+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~----------~~~~~~gt~~y~a 261 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----------HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----------CSCSCCSCGGGCC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----------cCccCCCCCcccC
Confidence 799999999764321 1233468999999
Q ss_pred hhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcccccch--------------------
Q 010624 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE-----KSLLMKMTQRFRFSDY-------------------- 258 (506)
Q Consensus 204 PE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~~-------------------- 258 (506)
||++.+.. |+.++|||||||++|+|++|.+||...... ......+.........
T Consensus 262 PE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99998765 899999999999999999999999754421 1111111110000000
Q ss_pred -----------hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 259 -----------EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 259 -----------~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.............++.+.+||.+||+.||++|||+.++|+||||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000011123556788999999999999999999999999999973
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=374.49 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=207.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-------hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-------RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
++|++.+.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 57999999999999999999985 6789999999865431 122345789999999999999999999997665
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC---eEEeeccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSA 176 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~---vKL~DFGls~ 176 (506)
.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++. +||+|||++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 8999999999999999976 467999999999999999999999999999999999999987664 9999999975
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-RF 253 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~-~~ 253 (506)
.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||............+.. ..
T Consensus 166 ~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 166 ILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237 (322)
T ss_dssp ECCC--------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred eccc--------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence 4321 111223458999999999853 345889999999999999999999999765443222222221 11
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+. +.....+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 238 NFI--------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred ccC--------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 110 11234578899999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=378.42 Aligned_cols=269 Identities=26% Similarity=0.428 Sum_probs=223.4
Q ss_pred cccccccccCCCCCCeeEEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCC
Q 010624 14 GTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHP 86 (506)
Q Consensus 14 ~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~Hp 86 (506)
..+.....+.+..++|++.+.||+|+||+||+|.+.. ..+..||+|++...........+.+|+.+++.+ +||
T Consensus 56 ~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp 135 (382)
T 3tt0_A 56 YELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135 (382)
T ss_dssp CCCCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred cccccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCc
Confidence 3444566788889999999999999999999999753 234689999998776677778899999999999 899
Q ss_pred CceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 010624 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHR 152 (506)
Q Consensus 87 nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHr 152 (506)
||+++++++..++..|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 136 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 999999999999999999999999999999987532 359999999999999999999999999999
Q ss_pred CCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-
Q 010624 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH- 231 (506)
Q Consensus 153 DIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt- 231 (506)
||||+|||++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCC-----TTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred CCCcceEEEcCCCcEEEcccCccccccccc-----ccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999976432211 112233445788999999998654 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 232 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
|..||.......... .+..... ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus 290 g~~p~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 290 GGSPYPGVPVEELFK-LLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp SCCSSTTCCHHHHHH-HHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHH-HHHcCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999998766554332 2222211 11345688999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=377.42 Aligned_cols=264 Identities=28% Similarity=0.388 Sum_probs=212.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE---
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL--- 101 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--- 101 (506)
.++|++.+.||+|+||+||+|.++ .+|+.||||++.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 478999999999999999999985 678999999997543 344567888999999999999999999999877654
Q ss_pred ---EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 102 ---WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 102 ---~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
|+||||+. ++|.+++. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 68887774 45999999999999999999999999999999999999999999999999997532
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|..||................ ..+..
T Consensus 195 ~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~ 263 (371)
T 4exu_A 195 DA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT-GVPGT 263 (371)
T ss_dssp ---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCH
T ss_pred cc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCcH
Confidence 21 12344679999999999875568999999999999999999999998776555443332211 10000
Q ss_pred hh-----------h---------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 EK-----------T---------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~-----------~---------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. . .........+++.+++||.+||+.||.+|||+.++++||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00 0 001112345789999999999999999999999999999998763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=364.09 Aligned_cols=270 Identities=29% Similarity=0.463 Sum_probs=215.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...+.+..+.|.....||+|+||.||+|.+. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEET-TTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEEC-CCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 3445555566777779999999999999985 668899999987543 34457788999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSA 176 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls~ 176 (506)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 99999999999999999998742 235779999999999999999999999999999999999997 8999999999876
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
..... ........||+.|+|||++.+. ..++.++|||||||++|+|++|..||................ .
T Consensus 172 ~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~- 242 (295)
T 2clq_A 172 RLAGI-------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-K- 242 (295)
T ss_dssp ESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-C-
T ss_pred ccCCC-------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-c-
Confidence 43221 1112345689999999999754 237899999999999999999999997544332221111100 0
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.....+..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 243 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 243 -------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred -------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 01123456889999999999999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=368.00 Aligned_cols=261 Identities=22% Similarity=0.376 Sum_probs=212.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHHhhCCCCCceeeeeEEE--eCCE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ---SRTDLDSIRRETKTMSLLSHPNILNAHCSFS--VDSR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~ 100 (506)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 468999999999999999999984 678899999986532 1234578899999999999999999999984 4568
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+.++ |.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999877 88888776567899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.................
T Consensus 162 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------ 230 (305)
T 2wtk_C 162 FA-----ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------ 230 (305)
T ss_dssp TC-----SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------
T ss_pred cc-----cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC------
Confidence 11 112233456899999999997633 247799999999999999999999987655443322222211
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 231 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1334678899999999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=370.73 Aligned_cols=266 Identities=23% Similarity=0.386 Sum_probs=219.0
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAH 92 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 92 (506)
....+.+..++|++.+.||+|+||+||+|.+. ..+++.||||++...........+.+|+.+++.+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34567888999999999999999999999864 2456899999998766666677899999999999 699999999
Q ss_pred eEEEeCC-EEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCC
Q 010624 93 CSFSVDS-RLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAG 157 (506)
Q Consensus 93 ~~~~~~~-~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~ 157 (506)
+++...+ .+|+||||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987754 59999999999999999987432 12899999999999999999999999999999999
Q ss_pred CEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCC
Q 010624 158 NILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPL 236 (506)
Q Consensus 158 NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf 236 (506)
||+++.++.+||+|||++...... ..........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKD-----PDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTC-----TTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eEEECCCCCEEECCCccccccccC-----ccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999997643221 1112233445788999999998755 8999999999999999998 99999
Q ss_pred CCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
............+...... ..+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHHhccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8766544444333332211 1334578899999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=362.33 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=213.7
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...|.+..++|++++.||+|+||.||+|.+ .++..||+|++..... ..+.+.+|+.+++.++||||+++++++.++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEE--TTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEE--cCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 457889999999999999999999999987 4678899999875432 346788999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999764 356999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............. ....
T Consensus 171 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~--- 239 (283)
T 3gen_A 171 LDD------EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLR--- 239 (283)
T ss_dssp CCH------HHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCC---
T ss_pred ccc------ccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccC---
Confidence 211 111223445688899999998655 8999999999999999998 999998776654443322 2111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 -------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 11334568899999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=359.37 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=214.1
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+.+..++|++.+.||+|+||.||+|.+ .++..||+|++.... ...+.+.+|+.+++.++||||+++++++..+...
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKW--KGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred eEechhheeeeeeeccCCCceEEEEEe--cCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 567788999999999999999999987 467789999986543 2346788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999999874 346999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
.........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||................ .
T Consensus 158 ------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~------ 223 (268)
T 3sxs_A 158 ------QYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-R------ 223 (268)
T ss_dssp ------CEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-C------
T ss_pred ------hhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-C------
Confidence 112223445678899999998654 8999999999999999999 999998766655443332221 1
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 224 ----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234568899999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=375.02 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=217.3
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeee
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHC 93 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (506)
...|.+..++|++.+.||+|+||.||+|.+. ..++..||+|++.........+.+.+|+.+++.+ +||||+++++
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3457888899999999999999999999973 2356789999997655555567899999999999 8999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFP---------------------DGLPEPCIAIVLKETLSALSYLHNQGHLHR 152 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~---------------------~~l~e~~i~~i~~qil~gL~yLHs~givHr 152 (506)
++...+..|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++|++||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999987432 238999999999999999999999999999
Q ss_pred CCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-
Q 010624 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH- 231 (506)
Q Consensus 153 DIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt- 231 (506)
||||+|||++.++.+||+|||++...... ..........||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSD-----SNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGC-----TTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccC-----ccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcC
Confidence 99999999999999999999997643221 1112233445788999999998755 8999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCc
Q 010624 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHS 300 (506)
Q Consensus 232 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp 300 (506)
|..||............+...... ..+..+++.+.+||.+||+.||.+|||+.++++|-
T Consensus 271 g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCCcHHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999998776555544444333221 13456789999999999999999999999998753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=363.62 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=204.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe---------
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--------- 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------- 97 (506)
++|++.+.||+|+||.||+|.+. .+++.||||.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 46999999999999999999985 57899999998542 3456788999999999999999999998865
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
....|+||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 45789999999999999999863 3568899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCC-------CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 010624 174 VSASIYEPSHHH-------HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL 246 (506)
Q Consensus 174 ls~~~~~~~~~~-------~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~ 246 (506)
++.......... ...........||+.|+|||++.+...++.++|||||||++|+|++ ||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 876432211000 0001122345689999999999865568999999999999999998 554322222222
Q ss_pred HHHhh-cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 247 MKMTQ-RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 247 ~~~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+.. ...+ ........++.+++||.+||+.||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEF--------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCC--------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred Hhcccccccc--------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 22211 1111 112345677889999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=381.00 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=217.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+..++|++.+.||+|+||+||+|.+. ..++..||||.+...........+.+|+.+++.++||||+++++++..
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3566788999999999999999999853 245678999999766666667788999999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC---CeEE
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFP-----DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG---SVKL 169 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~-----~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g---~vKL 169 (506)
+...|+|||||.||+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999999987532 3599999999999999999999999999999999999999655 5999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~ 248 (506)
+|||++...... ..........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............
T Consensus 226 ~DFG~a~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 226 GDFGMARDIYRA-----GYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp CCCHHHHHHHHH-----SSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCCccccccccc-----cccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999997532111 0111223345789999999998654 8999999999999999998 99999876655443332
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
... .. ...+..++..+.+||.+||+.||.+|||+.+|+++.++.
T Consensus 300 ~~~-~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSG-GR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcC-CC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 221 11 113456788999999999999999999999999887654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=364.33 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=215.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 57999999999999999999985 578899999986543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC---CCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD---GSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~---g~vKL~DFGls~~~~~~~ 182 (506)
||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 999999999998763 579999999999999999999999999999999999999754 47999999987643221
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......||+.|+|||++.+. ++.++|||||||++|+|++|..||..................+..
T Consensus 178 -------~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 243 (287)
T 2wei_A 178 -------TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----- 243 (287)
T ss_dssp -------SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred -------CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence 111223478899999999753 899999999999999999999999876655443333333222111
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 244 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 ---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1224678899999999999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=372.30 Aligned_cols=261 Identities=22% Similarity=0.367 Sum_probs=217.6
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.+.+..++|++.+.||+|+||.||+|.+.. .+++.||+|++.........+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 357778999999999999999999999863 3458999999987666666788999999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFP----------------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDV 154 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~----------------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDI 154 (506)
.++..|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++|++||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999987421 56999999999999999999999999999999
Q ss_pred CCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CC
Q 010624 155 KAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GR 233 (506)
Q Consensus 155 Kp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~ 233 (506)
||+|||++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-----CBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTC
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-----cccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCC
Confidence 9999999999999999999875432110 111223446789999999998655 8999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 234 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.||................. ...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGNI-----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCCCCChHHHHHHHhCCCc-----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99987665544333222211 1134568899999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=362.45 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=205.9
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+.+..++|++.+.||+|+||.||+|.+... .+..||+|.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 45788889999999999999999999998532 356799999876666666788999999999999999999999985
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
++..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 55688999999999999999863 34699999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.... .........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||............... ..
T Consensus 166 ~~~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~-- 235 (281)
T 1mp8_A 166 MEDS------TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ER-- 235 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CC--
T ss_pred cCcc------cccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-CC--
Confidence 3221 111223445688999999998654 8999999999999999996 99999876655443322211 11
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.++|.+||+.||++|||+.++++
T Consensus 236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 236 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1134568899999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=368.94 Aligned_cols=271 Identities=23% Similarity=0.366 Sum_probs=200.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCC--eEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~--~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
-..+.+..++|++.+.||+|+||+||+|.+...++ ..||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34467888999999999999999999998853322 279999987553 344567899999999999999999999999
Q ss_pred EeCCEE------EEEeccCCCCCHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC
Q 010624 96 SVDSRL------WVVMPFMSCGSLQSIISSCFP----DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 96 ~~~~~~------~lV~Ey~~ggsL~~~i~~~~~----~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g 165 (506)
...... ++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 999999999999999975421 2599999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 010624 166 SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKS 244 (506)
Q Consensus 166 ~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~ 244 (506)
.+||+|||++...... ..........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||........
T Consensus 175 ~~kl~Dfg~a~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSG-----DYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp CEEECCCCC----------------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CEEEeecccccccccc-----ccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999997543221 1111223445688999999998755 8999999999999999999 9999987766554
Q ss_pred HHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-------HHHHHcCccccccc
Q 010624 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-------AEKLMKHSFFKNCN 306 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-------~~eiL~hp~f~~~~ 306 (506)
........ . ...+..+++.+.+||.+||+.||.+||| +.+++.|||+....
T Consensus 249 ~~~~~~~~-~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 249 YNYLIGGN-R----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHHTTC-C----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HHHHhcCC-C----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 43333221 1 1134568899999999999999999999 77788899998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=368.95 Aligned_cols=267 Identities=19% Similarity=0.255 Sum_probs=212.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC------ceeeeeEEEeCC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN------ILNAHCSFSVDS 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~ 99 (506)
.++|++.+.||+|+||+||+|.+...++..||+|++... ....+.+.+|+.+++.++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 578999999999999999999986555589999998642 345677889999999998766 899999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe------------------
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS------------------ 161 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl------------------ 161 (506)
..|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999999 6777777776544679999999999999999999999999999999999999
Q ss_pred -CCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 010624 162 -DSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLP 240 (506)
Q Consensus 162 -d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~ 240 (506)
+.++.+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHE----------HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp EESCCCEEECCCTTCEETTS----------CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCcEEEeecCccccccc----------cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5678999999999754221 123346899999999998654 8999999999999999999999998766
Q ss_pred hHHHHHHHHhhcccccchh------------------------h--------hhhhhccchhhhHHHHHHHHhhcccCCC
Q 010624 241 PEKSLLMKMTQRFRFSDYE------------------------K--------TLKIKDKNKKFSRAFKDMVASCLDQDPS 288 (506)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~------------------------~--------~~~~~~~~~~~s~~l~~Li~~~L~~dP~ 288 (506)
...............+... . ...........+.++.+||.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 5443322211111111000 0 0000011233467899999999999999
Q ss_pred CCCCHHHHHcCccccccc
Q 010624 289 KRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 289 ~Rpt~~eiL~hp~f~~~~ 306 (506)
+|||+.++++||||+...
T Consensus 324 ~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 324 QRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TSCCHHHHTTSGGGGGCC
T ss_pred hCcCHHHHhcChhhcCCC
Confidence 999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=374.39 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=201.9
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS- 99 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 99 (506)
......++|++.+.||+|+||+||+|.++ .+++.||||++..... ......+++..++.++||||++++++|...+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEET-TTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 34455678999999999999999999985 5688999999865432 2235567888889999999999999986533
Q ss_pred ------EEEEEeccCCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCCCCEEeCC-CCCeE
Q 010624 100 ------RLWVVMPFMSCGSLQSIISS--CFPDGLPEPCIAIVLKETLSALSYLH--NQGHLHRDVKAGNILSDS-DGSVK 168 (506)
Q Consensus 100 ------~~~lV~Ey~~ggsL~~~i~~--~~~~~l~e~~i~~i~~qil~gL~yLH--s~givHrDIKp~NILld~-~g~vK 168 (506)
.+++||||+.+ +|...+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 38999999986 55444432 12457899999999999999999999 999999999999999996 89999
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~ 248 (506)
|+|||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||............
T Consensus 173 l~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 173 LCDFGSAKKLSPS--------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp ECCCTTCBCCCTT--------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EeeCCCceecCCC--------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 9999997643221 12234468999999999977666899999999999999999999999877665544433
Q ss_pred Hhhcccccchh---------------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 249 MTQRFRFSDYE---------------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 249 ~~~~~~~~~~~---------------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
... ...+... ............++++++||.+||+.||.+|||+.++++||||+...
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 245 VRV-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHH-HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHH-cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 321 1111000 00011122234678999999999999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.25 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=215.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 100 (506)
-..++|++.+.||+|+||.||+|.++ .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 34578999999999999999999985 578999999997654 34566789999999999999999999998754 678
Q ss_pred EEEEeccCCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCCCCEEeCCCCCeEEeecc
Q 010624 101 LWVVMPFMSCGSLQSIISSCF--PDGLPEPCIAIVLKETLSALSYLHNQG-----HLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~--~~~l~e~~i~~i~~qil~gL~yLHs~g-----ivHrDIKp~NILld~~g~vKL~DFG 173 (506)
+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999997632 345999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHD-------TSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp HHHHC----------CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred hheeeccc-------cccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 87543211 11122345899999999998654 89999999999999999999999987665443322222111
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...+..+++.+.++|.+||+.||.+|||+.++++|+|+..-
T Consensus 234 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -----------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11345678999999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=388.89 Aligned_cols=253 Identities=14% Similarity=0.143 Sum_probs=201.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHH---HHHhhCCCCCceeee----
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRET---KTMSLLSHPNILNAH---- 92 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei---~il~~l~HpnIv~l~---- 92 (506)
+....++|++.+.||+|+||.||+|.++ .+|+.||||++.... .....+.+.+|+ .+++.++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3344678999999999999999999985 568999999997542 334567889999 555566899999988
Q ss_pred ---eEEEeCC-----------------EEEEEeccCCCCCHHHHHHhhCCCCCC-------HHHHHHHHHHHHHHHHHHH
Q 010624 93 ---CSFSVDS-----------------RLWVVMPFMSCGSLQSIISSCFPDGLP-------EPCIAIVLKETLSALSYLH 145 (506)
Q Consensus 93 ---~~~~~~~-----------------~~~lV~Ey~~ggsL~~~i~~~~~~~l~-------e~~i~~i~~qil~gL~yLH 145 (506)
+++.+++ ..|+||||+ +|+|.+++... ..++ +..+..|+.||+.||+|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6666553 289999999 58999999863 2233 4788899999999999999
Q ss_pred HCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhcc----------CCCCc
Q 010624 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----------TGYSF 215 (506)
Q Consensus 146 s~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----------~~~~~ 215 (506)
++||+||||||+|||++.++.+||+|||+|.... .......| +.|+|||++.+. ..|+.
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 9999999999999999999999999999976321 12234456 999999999876 24899
Q ss_pred cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHH
Q 010624 216 KADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK 295 (506)
Q Consensus 216 ~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~e 295 (506)
++|||||||++|+|++|..||......... . ........+++++.+||.+||+.||.+|||+.+
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~-------------~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGS-------------E---WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCS-------------G---GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccch-------------h---hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 999999999999999999999653321100 0 011123567899999999999999999999999
Q ss_pred HHcCcccccc
Q 010624 296 LMKHSFFKNC 305 (506)
Q Consensus 296 iL~hp~f~~~ 305 (506)
+++||||+..
T Consensus 357 ~l~hp~f~~~ 366 (377)
T 3byv_A 357 AMETPEYEQL 366 (377)
T ss_dssp HHTSHHHHHH
T ss_pred HhhChHHHHH
Confidence 9999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=383.74 Aligned_cols=272 Identities=26% Similarity=0.367 Sum_probs=194.5
Q ss_pred CCeeE-EeeecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEE
Q 010624 27 SSYKI-LDEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLW 102 (506)
Q Consensus 27 ~~Y~i-~~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 102 (506)
+.|++ .++||+|+||+||+|.++. .++..||||++..... ...+.+|+.+|+.++||||++++++|.. +..+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45777 4579999999999999742 3578899999865432 2467799999999999999999999954 67899
Q ss_pred EEeccCCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe----CCCCCeEEee
Q 010624 103 VVMPFMSCGSLQSIISSCF-------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS----DSDGSVKLAD 171 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~-------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl----d~~g~vKL~D 171 (506)
+||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999997 58888776321 2249999999999999999999999999999999999999 6788999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------H
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--------K 243 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--------~ 243 (506)
||+|....... ..........||+.|+|||++.+...|+.++|||||||++|+|++|.+||...... .
T Consensus 176 fg~a~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 176 MGFARLFNSPL----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp TTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred CCCceecCCCC----cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99976432110 11122334578999999999987556899999999999999999999999754331 1
Q ss_pred HHHHHHhhcccccchhhhhh---------------------------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHH
Q 010624 244 SLLMKMTQRFRFSDYEKTLK---------------------------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL 296 (506)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei 296 (506)
.....+...+..+....+.. ........++.+.+||.+||+.||.+|||+.++
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11111211111111000000 000111236789999999999999999999999
Q ss_pred HcCccccccc
Q 010624 297 MKHSFFKNCN 306 (506)
Q Consensus 297 L~hp~f~~~~ 306 (506)
|+||||....
T Consensus 332 L~hp~f~~~~ 341 (405)
T 3rgf_A 332 MQDPYFLEDP 341 (405)
T ss_dssp HTSGGGTSSS
T ss_pred hcChhhccCC
Confidence 9999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.43 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=216.4
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
+..|.+..++|++.+.||+|+||.||+|.++ .+++.||||.+.........+.+.+|+.+|+.++||||+++++++..+
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 4568889999999999999999999999985 568899999987655555566788999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999999999864 346999999999999999999999999999999999999999999999999997642
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... .........+++.|+|||++.+.. ++.++|||||||++|||++ |..||........... +......
T Consensus 264 ~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~-- 334 (377)
T 3cbl_A 264 ADGV-----YAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRL-- 334 (377)
T ss_dssp TTSE-----EECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-HHTTCCC--
T ss_pred CCCc-----eeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC--
Confidence 2110 001111223467899999998654 8999999999999999998 9999987765543322 2222111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.+||.+||+.||++|||+.++++
T Consensus 335 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 --------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 134567889999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=371.67 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=209.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CC-----CceeeeeEEEeCC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HP-----NILNAHCSFSVDS 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~ 99 (506)
.++|++.+.||+|+||+||+|.+. .+++.||||++... ......+.+|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 478999999999999999999985 67899999998643 344567788999988885 55 4999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCCCCEEeC--CCCCeEEeecccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH--NQGHLHRDVKAGNILSD--SDGSVKLADFGVS 175 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH--s~givHrDIKp~NILld--~~g~vKL~DFGls 175 (506)
.+|+||||+. ++|.+++.......+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999999996 59999998765567999999999999999999999 47999999999999995 5788999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
..... ......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||............... ...
T Consensus 209 ~~~~~----------~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~ 276 (382)
T 2vx3_A 209 CQLGQ----------RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV-LGI 276 (382)
T ss_dssp EETTC----------CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCS
T ss_pred eeccc----------ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCC
Confidence 64321 123456899999999998765 899999999999999999999999877665544333321 111
Q ss_pred cchhhhhh----------hh-------------------------------------------ccchhhhHHHHHHHHhh
Q 010624 256 SDYEKTLK----------IK-------------------------------------------DKNKKFSRAFKDMVASC 282 (506)
Q Consensus 256 ~~~~~~~~----------~~-------------------------------------------~~~~~~s~~l~~Li~~~ 282 (506)
+....... .+ ......++++++||.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 10000000 00 00011235789999999
Q ss_pred cccCCCCCCCHHHHHcCcccccc
Q 010624 283 LDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 283 L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
|+.||++|||+.++|+||||+..
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=355.55 Aligned_cols=253 Identities=17% Similarity=0.299 Sum_probs=212.9
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD- 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 98 (506)
...+..++|++.+.||+|+||+||+|.+ +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 3567778999999999999999999988 37899999997654 345567899999999999999999999999887
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~vKL~DFGls 175 (506)
...++||||+++|+|.+++.......+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78899999999999999998754446999999999999999999999999 999999999999999999999999985
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.................
T Consensus 161 ~~~------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 161 FSF------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228 (271)
T ss_dssp CTT------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC
T ss_pred eee------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC
Confidence 321 112346799999999998643 133479999999999999999999987766655444433322
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. ..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 229 RP----------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 21 134568899999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=371.95 Aligned_cols=272 Identities=23% Similarity=0.348 Sum_probs=212.6
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-----------CCC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-----------HPN 87 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-----------Hpn 87 (506)
....++..++|++.+.||+|+||+||+|.+. .+++.||||++... ....+.+.+|+.+++.++ |||
T Consensus 11 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 11 FKGEPYKDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp CTTCEETTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred ecCCcccCCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3445667789999999999999999999985 67899999998643 344567889999999886 899
Q ss_pred ceeeeeEEEeCC----EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeC
Q 010624 88 ILNAHCSFSVDS----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSD 162 (506)
Q Consensus 88 Iv~l~~~~~~~~----~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld 162 (506)
|+++++++...+ .+++||||+ +++|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999999998654 899999999 89999999886566799999999999999999999998 999999999999994
Q ss_pred ------CCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCC
Q 010624 163 ------SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236 (506)
Q Consensus 163 ------~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf 236 (506)
..+.+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCCcCcceEEEcccccccccCC----------CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence 444899999999754321 122346899999999998765 899999999999999999999999
Q ss_pred CCCChH-----HHHHHHHhhcc-cccch------------------------------hhhhhhhccchhhhHHHHHHHH
Q 010624 237 SHLPPE-----KSLLMKMTQRF-RFSDY------------------------------EKTLKIKDKNKKFSRAFKDMVA 280 (506)
Q Consensus 237 ~~~~~~-----~~~~~~~~~~~-~~~~~------------------------------~~~~~~~~~~~~~s~~l~~Li~ 280 (506)
...... ......+.... ..+.. .........+..+++++.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 754321 11111111100 00000 0000011233567889999999
Q ss_pred hhcccCCCCCCCHHHHHcCcccccc
Q 010624 281 SCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 281 ~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
+||+.||.+|||+.++++||||++.
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHhccCccccCCHHHHhhChhhhcc
Confidence 9999999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=355.14 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=202.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS---RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
.+..++|++.+.||+|+||.||+|.+ .+..||+|++..... ....+.+.+|+.+++.++||||+++++++..++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45678999999999999999999987 378999999865432 234578899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCCCCEEeCC--------CCCeE
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG---HLHRDVKAGNILSDS--------DGSVK 168 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g---ivHrDIKp~NILld~--------~g~vK 168 (506)
..|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++| ++||||||+|||++. ++.+|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred ceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999999999999964 57999999999999999999999999 899999999999986 77899
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~ 248 (506)
|+|||++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||............
T Consensus 157 l~Dfg~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 226 (271)
T 3dtc_A 157 ITDFGLAREWHR---------TTKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226 (271)
T ss_dssp ECCCCC----------------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred EccCCccccccc---------ccccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Confidence 999999753221 1122346899999999998754 899999999999999999999999877665544443
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....... ..+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 227 AMNKLAL----------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HTSCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCC----------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 3332221 1345678999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=369.36 Aligned_cols=264 Identities=27% Similarity=0.384 Sum_probs=211.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR---- 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 100 (506)
.++|++.+.||+|+||.||+|.++ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 468999999999999999999985 678999999987543 34446788899999999999999999999987654
Q ss_pred --EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 101 --LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 101 --~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 599999997 68877764 35999999999999999999999999999999999999999999999999987532
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|..||............... ...+..
T Consensus 177 ~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 245 (353)
T 3coi_A 177 DA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV-TGVPGT 245 (353)
T ss_dssp -----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH-HCBCCH
T ss_pred CC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCH
Confidence 11 1223468999999999987556899999999999999999999999876655443332221 110000
Q ss_pred hh--------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 259 EK--------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~--------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.. ..........+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 0001112346789999999999999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.72 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=212.3
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCC--CCCceeeeeEEE
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLS--HPNILNAHCSFS 96 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~ 96 (506)
....+..++|++++.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEC--TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEc--CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 34567778899999999999999999987 458899999997654 3456678999999999997 599999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.++.+|+||| +.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||++.
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence 9999999999 567899999987 46799999999999999999999999999999999999996 4899999999975
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc----------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH----------TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLL 246 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----------~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~ 246 (506)
...... .........||+.|+|||++.+. ..++.++|||||||++|+|++|..||..........
T Consensus 175 ~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 175 QMQPDT-----TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp C-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccCcc-----ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 432111 11112344689999999999651 247889999999999999999999998654433222
Q ss_pred HHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 247 MKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
........ ....+...+..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 250 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 250 HAIIDPNH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHCTTS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHhccc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 22211110 0112344578899999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.71 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=213.3
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+|.++.++|++.+.||+|+||.||+|.+ .++..||+|++..... ..+.+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEe--cCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4778889999999999999999999998 4678999999875432 34678899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999999999999864 35689999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
. .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||............ .....
T Consensus 157 ~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-~~~~~----- 223 (267)
T 3t9t_A 157 D------QYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFR----- 223 (267)
T ss_dssp H------HHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCC-----
T ss_pred c------cccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-hcCCc-----
Confidence 1 111223445788999999998654 8999999999999999999 89999876655433322 22111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus 224 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 -----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11334578899999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=365.40 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=219.2
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCS 94 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (506)
...+.+..++|++.+.||+|+||.||+|.++. .++..||+|.+...........+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34577888999999999999999999998752 34678999999876666667789999999999999999999999
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCF--------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~--------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
+..++..|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 999999999999999999999997632 145799999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~ 245 (506)
+||+|||++...... ..........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.........
T Consensus 177 ~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 177 VKIGDFGMTRDIYET-----DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp EEECCTTCCCGGGGG-----GCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EEECcCccccccccc-----cccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 999999987533211 1111223445688999999998655 8999999999999999999 89999876655443
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
........ ...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 251 ~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 251 RFVMEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 33222211 12345688999999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=381.15 Aligned_cols=267 Identities=14% Similarity=0.171 Sum_probs=193.7
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhC--CCCCceeee-------
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLL--SHPNILNAH------- 92 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l--~HpnIv~l~------- 92 (506)
.....|++.+.||+|+||+||+|.+. .+++.||||++..... ....+.+++|+.+++.+ +||||++++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCceeeeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 34456999999999999999999985 6789999999987653 34456788885544444 699988754
Q ss_pred eEEEeC-----------------CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHHCCC
Q 010624 93 CSFSVD-----------------SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCI------AIVLKETLSALSYLHNQGH 149 (506)
Q Consensus 93 ~~~~~~-----------------~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i------~~i~~qil~gL~yLHs~gi 149 (506)
+.+... ..+|+|||||. |+|.+++... ...+++..+ ..++.||+.||+|||++||
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 455433 34899999999 8999999864 223444455 5777999999999999999
Q ss_pred ccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhc-cCCCCccccHHHHHHHHHH
Q 010624 150 LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-HTGYSFKADIWSFGITALE 228 (506)
Q Consensus 150 vHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~~sDIwSlGiil~e 228 (506)
+||||||+|||++.+|.+||+|||+|.... .......||+.|+|||++.+ ...|+.++|||||||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVG----------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETT----------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecC----------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999976432 11114456799999999975 1248999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 229 LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 229 LltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
|++|+.||.......... .....................+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 286 lltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGS---WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp HHHSSCSTTBCCTTCTTC---CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred HHhCCCCCCCcCcccccc---hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 999999998653321100 000000000000000112346899999999999999999999999999999998763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=369.57 Aligned_cols=274 Identities=30% Similarity=0.468 Sum_probs=200.0
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHH-HHhhCCCCCceeeeeEE
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK-TMSLLSHPNILNAHCSF 95 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~ 95 (506)
.....+.+..++|++++.||+|+||.||+|.++ .+++.||||++...........+.+|+. +++.++||||+++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 345668899999999999999999999999985 5789999999987655555556666666 77888999999999999
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEee
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISS---CFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~---~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~D 171 (506)
..++..|+||||+.+ +|.+++.. .....+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 91 FREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp ECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECC
T ss_pred EeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEcc
Confidence 999999999999985 88777763 2246799999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhh---ccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR---SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~ 248 (506)
||++...... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.........
T Consensus 170 fg~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 238 (327)
T 3aln_A 170 FGISGQLVDS--------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--- 238 (327)
T ss_dssp CSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------
T ss_pred CCCceecccc--------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---
Confidence 9987533211 1122336899999999984 2234889999999999999999999999764322111
Q ss_pred HhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.......... . ........+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 239 ~~~~~~~~~~--~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 239 LTQVVKGDPP--Q-LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp -CCCCCSCCC--C-CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHhcCCCC--C-CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 1111110000 0 00112345789999999999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=355.82 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=213.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
..++.+..++|++.+.||+|+||+||+|.+...+ +..||+|.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred CccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3567888899999999999999999999875333 45699999987666667788999999999999999999999987
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.+ ..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 54 468999999999999999764 3569999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
..... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............... ..
T Consensus 162 ~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~- 232 (281)
T 3cc6_A 162 YIEDE------DYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DR- 232 (281)
T ss_dssp CC---------------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CC-
T ss_pred ccccc------cccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CC-
Confidence 43221 111223445788999999997654 8999999999999999998 99999866555433222111 11
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 233 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 ---------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 11334578899999999999999999999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=367.81 Aligned_cols=282 Identities=21% Similarity=0.298 Sum_probs=219.5
Q ss_pred ccccccccccccccccccCCCCCCeeEEeeecccCCeeEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHH
Q 010624 5 EQEDQCSSTGTIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICI----PMDSTVVAIKAIDLDQSRTDLDSIRRETKTM 80 (506)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~----~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il 80 (506)
++...|....+-.-..-..+..++|++.+.||+|+||.||+|.+. ..++..||||.+...........+.+|+.++
T Consensus 8 ~~~~~~~~~~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l 87 (327)
T 2yfx_A 8 HNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87 (327)
T ss_dssp -CCCEEETTEEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccCCccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHH
Confidence 333334333333333334577889999999999999999999842 2457789999997666666677899999999
Q ss_pred hhCCCCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Q 010624 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP-----DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVK 155 (506)
Q Consensus 81 ~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~-----~~l~e~~i~~i~~qil~gL~yLHs~givHrDIK 155 (506)
+.++||||+++++++......|+||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|||||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk 167 (327)
T 2yfx_A 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167 (327)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence 999999999999999999999999999999999999987532 358999999999999999999999999999999
Q ss_pred CCCEEeCCC---CCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-
Q 010624 156 AGNILSDSD---GSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH- 231 (506)
Q Consensus 156 p~NILld~~---g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt- 231 (506)
|+|||++.+ +.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 168 p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred HhHEEEecCCCcceEEECcccccccccccc-----ccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcC
Confidence 999999944 469999999876432211 111223345789999999998654 8999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 232 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
|..||............... .. ...+..+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 242 g~~p~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 242 GYMPYPSKSNQEVLEFVTSG-GR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp SCCSSTTCCHHHHHHHHHTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHhcC-CC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999876554433222211 11 113456788999999999999999999999999987764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=366.48 Aligned_cols=267 Identities=24% Similarity=0.439 Sum_probs=219.8
Q ss_pred cccccccCCCCCCeeEEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCc
Q 010624 16 IAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNI 88 (506)
Q Consensus 16 ~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnI 88 (506)
+.....|.+..++|++.+.||+|+||.||+|.+.. .++..||+|++.........+.+.+|+.+++.+ +||||
T Consensus 24 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 24 LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE
Confidence 34566788999999999999999999999998742 346789999998766667778899999999999 89999
Q ss_pred eeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Q 010624 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDV 154 (506)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDI 154 (506)
+++++++..++.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++|++||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 9999999999999999999999999999987432 24899999999999999999999999999999
Q ss_pred CCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CC
Q 010624 155 KAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GR 233 (506)
Q Consensus 155 Kp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~ 233 (506)
||+|||++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~ 257 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGG 257 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTS-----SEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccceEEEcCCCCEEEccccccccccccc-----cccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999976432211 111223445788999999998654 8999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 234 PPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 234 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.||........... +..... ...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 258 ~p~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 258 SPYPGIPVEELFKL-LKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CSSTTCCHHHHHHH-HHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCcCCHHHHHHH-HhcCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99987665443322 222111 11345678999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.75 Aligned_cols=257 Identities=22% Similarity=0.450 Sum_probs=217.6
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.|.+..++|++.+.||+|+||+||+|.+. .++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 57788999999999999999999999985 56889999998654 3345788999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+.|++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999876566799999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
. .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||........... +.....
T Consensus 164 ~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~----- 230 (288)
T 3kfa_A 164 D------TYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYR----- 230 (288)
T ss_dssp S------SSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCC-----
T ss_pred C------ccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCC-----
Confidence 1 112233445688999999998654 8999999999999999999 9999987655443322 222211
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.+|+.+||..||.+|||+.++++
T Consensus 231 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1134567899999999999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=354.92 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=209.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (506)
+..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .+.+.+|+.+++.+ +|+||+++++++..+...|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 45678999999999999999999985 6789999999865432 23577899999999 7999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC-----eEEeecccccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS-----VKLADFGVSAS 177 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~-----vKL~DFGls~~ 177 (506)
+||||+ +++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++. +||+|||++..
T Consensus 83 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999999 99999999864 356999999999999999999999999999999999999987776 99999999875
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE--KSLLMKMTQRFRF 255 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~ 255 (506)
...................||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-
Confidence 4432221111112234567999999999998755 899999999999999999999999874322 111111111100
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..........+++++.+|+.+||+.||.+|||+.+|++
T Consensus 239 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 -----STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp -----HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 00111233468899999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=367.40 Aligned_cols=264 Identities=20% Similarity=0.357 Sum_probs=218.4
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCC----CeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeee
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHC 93 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~----~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (506)
...+.+..++|++.+.||+|+||.||+|.+...+ ...||+|.+.........+.+.+|+.+++.+ +||||+++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3458889999999999999999999999985322 2479999998766666778899999999999 8999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCF------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS 161 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl 161 (506)
++..++.+|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 9999999999999999999999997542 3468999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 010624 162 DSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLP 240 (506)
Q Consensus 162 d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~ 240 (506)
+.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCT-----TSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCeEEECcccccccccccc-----ceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999999976432211 111223345688999999998655 8999999999999999998 999998765
Q ss_pred hHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
............... ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 272 VNSKFYKLVKDGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp SSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 554444433332221 123456889999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.53 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=204.6
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
-.+..++|++.+.||+|+||+||+|.+.. +++ .||+|.+.........+.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 34667889999999999999999999853 343 3688887655555667889999999999999999999999987
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
+. .++|++|+.+|+|.+++... ...+++..+..|+.|++.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 65 77999999999999999874 45799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||........... +.....
T Consensus 167 ~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~-- 237 (327)
T 3poz_A 167 LGAEE-----KEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGER-- 237 (327)
T ss_dssp HTTTC-----C-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCC--
T ss_pred ccCCc-----ccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-HHcCCC--
Confidence 43221 111223445788999999998754 8999999999999999999 9999987665543322 222111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11345678899999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=363.61 Aligned_cols=260 Identities=17% Similarity=0.236 Sum_probs=206.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (506)
+..++|++.+.||+|+||.||+|.+. .+++.||||++..... .+.+.+|+.+++.+ +||||+++++++..+...|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEEC-CCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34578999999999999999999985 6789999999875433 23577999999999 8999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC-----eEEeecccccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS-----VKLADFGVSAS 177 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~-----vKL~DFGls~~ 177 (506)
+||||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999999 99999999864 467999999999999999999999999999999999999998887 99999999875
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-hhccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS--LLMKM-TQRFR 254 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~--~~~~~-~~~~~ 254 (506)
...................||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ....+ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 4332211111111234567999999999998754 89999999999999999999999986543221 11111 11111
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+ .......++ ++.+++.+||+.||.+||++.+|++
T Consensus 239 ~~-------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TP-------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SC-------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CC-------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00 011122345 9999999999999999999998863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.44 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=206.9
Q ss_pred ccccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 17 AQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 17 ~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
+....+.+..++|++.+.||+|+||+||+|.+ .++.||||++... ........+|+.+++.++||||+++++++.
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEE---CCCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 45667788999999999999999999999987 3789999998643 233445667999999999999999999998
Q ss_pred eCC----EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCccCCCCCCCEEeC
Q 010624 97 VDS----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ----------GHLHRDVKAGNILSD 162 (506)
Q Consensus 97 ~~~----~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~----------givHrDIKp~NILld 162 (506)
... .+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. |++||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 743 47999999999999999986 4699999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccC----CCCccccHHHHHHHHHHHHhCCCCCCC
Q 010624 163 SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSH 238 (506)
Q Consensus 163 ~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~~sDIwSlGiil~eLltG~~Pf~~ 238 (506)
.++.+||+|||++....... .........||+.|+|||++.+.. .++.++|||||||++|+|++|.+||..
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGK-----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp TTCCEEECCCTTCEEECTTS-----CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred CCCeEEEccCCccccccccc-----CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999986433221 111223356899999999997632 256788999999999999999999975
Q ss_pred CChH---------------HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 239 LPPE---------------KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 239 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.... .............+.... .......++++.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD----YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG----GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCCCCccc----cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3221 111111111111111000 0012345677999999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=360.09 Aligned_cols=268 Identities=28% Similarity=0.479 Sum_probs=203.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhH-HHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDL-DSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
...|....++|++++.||+|+||.||+|.++ .+++.||||++......... +.+.++..+++.++||||+++++++..
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 4457788899999999999999999999985 56889999999776554433 344555567888999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~-givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
++.+|+||||+ ++.+..+.... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred CCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 99999999999 56676666543 46799999999999999999999995 99999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||............+...
T Consensus 174 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (318)
T 2dyl_A 174 RLVDD--------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245 (318)
T ss_dssp ---------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred hccCC--------ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence 32211 11233468999999999952 3347899999999999999999999998754443333332221
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
... .......+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 246 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 246 EPP--------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCC--------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 110 001223578999999999999999999999999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=356.23 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=214.8
Q ss_pred ccCCCCCCeeEEe-eecccCCeeEEEEEEe-CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILD-EIGVGVSAIVYKAICI-PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~-~IG~G~fg~Vyka~~~-~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
.+.+..++|.+.+ .||+|+||.||+|.+. ..++..||+|++.........+.+.+|+.+++.++||||+++++++ ..
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 4566778899998 9999999999999863 2357889999998776667778899999999999999999999999 45
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 6689999999999999999753 456999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
..... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............... ..
T Consensus 161 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~--- 231 (287)
T 1u59_A 161 GADDS----YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KR--- 231 (287)
T ss_dssp TTCSC----EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CC---
T ss_pred ccCcc----eeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-Cc---
Confidence 32211 111223445789999999997654 8999999999999999998 99999876655433222211 11
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 232 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 232 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12345788999999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=360.02 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=205.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCC------eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDS------TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~------~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.+..++|++.+.||+|+||+||+|.+...+. ..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4567899999999999999999999864332 57999998643 2345678999999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC--------eE
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS--------VK 168 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~--------vK 168 (506)
.++..|+||||+.|++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++. +|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999873 334999999999999999999999999999999999999998887 99
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCC-CCCCCCChHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR-PPLSHLPPEKSLLM 247 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~-~Pf~~~~~~~~~~~ 247 (506)
|+|||++.... ......||+.|+|||++.+...++.++|||||||++|+|++|. +||..... .....
T Consensus 162 l~Dfg~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVL-----------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQ 229 (289)
T ss_dssp ECCCCSCTTTS-----------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHH
T ss_pred eccCccccccc-----------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHH
Confidence 99999864221 1122347889999999987455899999999999999999955 55544333 22222
Q ss_pred HHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...... ..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 230 ~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 230 FYEDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222211 1234457789999999999999999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=367.74 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=184.6
Q ss_pred CCCCCeeEEe-eecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe----C
Q 010624 24 LDPSSYKILD-EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV----D 98 (506)
Q Consensus 24 ~~~~~Y~i~~-~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~ 98 (506)
...++|++.+ .||+|+||+||+|.++ .+++.||||++... . ....+....++.++||||+++++++.. +
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~--~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLLYDS--P---KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESS--H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeEecceeeeeCCCeEEEEEEEC-CCCCEEEEEEecCc--H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 4457899965 6999999999999995 56899999998542 1 122233344677899999999999976 4
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeecccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVS 175 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls 175 (506)
..+|+||||+.||+|.+++.......+++..++.++.|++.||.|||++|++||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998765567999999999999999999999999999999999999986 455999999987
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........... .......
T Consensus 179 ~~~~~---------~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~ 247 (336)
T 3fhr_A 179 KETTQ---------NALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRIRL 247 (336)
T ss_dssp EEC-------------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred eeccc---------cccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhhhc
Confidence 53321 1123446799999999996544 78999999999999999999999975443322110 0111100
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+ .........+++.+++||.+||+.||.+|||+.++++||||++.
T Consensus 248 ~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 GQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 00111235688999999999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.93 Aligned_cols=260 Identities=22% Similarity=0.381 Sum_probs=205.0
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..+..++|++.+.||+|+||.||+|.++. .++..||||.+.........+.+.+|+.++++++||||+++++++..+.
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 45677899999999999999999998741 3467899999977666666788999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999999863 3579999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... .........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||........... +......
T Consensus 199 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-i~~~~~~--- 269 (373)
T 2qol_A 199 DDPE----AAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRL--- 269 (373)
T ss_dssp -------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-HHTTEEC---
T ss_pred cCCc----cceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC---
Confidence 2110 111122334578899999998654 8999999999999999998 9999987765543322 2222111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+||.+||+.||.+|||+.++++
T Consensus 270 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 -------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 133467889999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=355.90 Aligned_cols=264 Identities=25% Similarity=0.434 Sum_probs=204.6
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.+..+.+..++|++.+.||+|+||+||+|.+ ...||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEES----SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEE----cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 4566789999999999999999999999975 2359999987654 355667899999999999999999999865
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.....++||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecc
Confidence 556689999999999999999653 4579999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
..... ..........||+.|+|||++.. ...++.++|||||||++|+|++|..||..................
T Consensus 169 ~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 169 EKSRW-----SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp --------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred ccccc-----cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence 33211 11112234568999999999862 234788999999999999999999999877666555444433222
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+. .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 244 ~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 244 SPD------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CCC------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccc------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 11234568899999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.85 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=211.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCC---CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD---STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~---~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
.....+..++|++.+.||+|+||.||+|.+...+ +..||+|.+...........+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3445788899999999999999999999886333 3469999998666666677899999999999999999999999
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
...+..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999999999763 457999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
........ .........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||........... +.....
T Consensus 195 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~ 268 (333)
T 1mqb_A 195 RVLEDDPE----ATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFR 268 (333)
T ss_dssp --------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCC
T ss_pred hhhccccc----cccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCc
Confidence 64322110 111223345688999999997654 8999999999999999998 9999987665543322 222211
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
. ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 269 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 269 L----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp C----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 133567899999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=368.62 Aligned_cols=274 Identities=22% Similarity=0.298 Sum_probs=212.3
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
...+..++|++.+.||+|+||+||+|.+ .+++.||||++...........+.+|+.+++.++||||+++++++..++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECC--SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEe--cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 3557788999999999999999999975 46889999998765544444468899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFP--DGLPEPCIAIVLKETLSALSYLHNQ---GHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~--~~l~e~~i~~i~~qil~gL~yLHs~---givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.++||||+.+|+|.+++..... ..+++..+..++.|++.||+|||++ |++||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 9999999999999999987432 3499999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhh
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL----PPEKSLLMKMTQ 251 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~----~~~~~~~~~~~~ 251 (506)
...... .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ............
T Consensus 182 ~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 182 KLMDYK------DTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp EECCSS------SSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred cccCcc------cccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 643211 112233445899999999997655 899999999999999999999999521 010111111111
Q ss_pred ccccc---chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 252 RFRFS---DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 252 ~~~~~---~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
..... ...............+..+.+++.+||+.||.+|||+.++++|-.-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11100 00000011123456678899999999999999999999999875433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=366.44 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=207.5
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.-.+..++|++.+.||+|+||+||+|.+.. ++. .||+|.+...........+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345677899999999999999999999863 444 388888765444444456778999999999999999999886
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
++..++||||+.+|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 45688999999999999999763 3578999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
...... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............... ..
T Consensus 164 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~- 235 (325)
T 3kex_A 164 LLPPDD-----KQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ER- 235 (325)
T ss_dssp GSCCCT-----TCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CB-
T ss_pred ccCccc-----ccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CC-
Confidence 543221 111223456788999999998655 8999999999999999999 99999876554433222211 11
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..++.++.++|.+||+.||.+|||+.+++++
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11334577789999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=357.91 Aligned_cols=266 Identities=20% Similarity=0.339 Sum_probs=205.2
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEE---eCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAIC---IPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV-- 97 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~---~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 97 (506)
.+..++|++++.||+|+||+||+|.. ...+++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 45678899999999999999999984 2356899999998643 34556788999999999999999999999854
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...+|+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 35689999999999999999874 34599999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
..... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ........ ....
T Consensus 164 ~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~-~~~~ 235 (295)
T 3ugc_A 164 LPQDK----EFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGND-KQGQ 235 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTT-CCTH
T ss_pred ccCCc----ceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCc-cccc
Confidence 32211 1112223445778899999998765 899999999999999999999998643211 11111100 0000
Q ss_pred hh--------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YE--------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~--------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. ........+..+++++.+||.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 000011234568899999999999999999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=369.25 Aligned_cols=272 Identities=16% Similarity=0.149 Sum_probs=204.8
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhh----------HHHHHHHHHHHhhCCCCCc
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTD----------LDSIRRETKTMSLLSHPNI 88 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~----------~~~~~~Ei~il~~l~HpnI 88 (506)
.+..++|++.+.||+|+||.||+|.+... .++.||||++........ ...+.+|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 45677999999999999999999988532 257899999865432111 1234456677888899999
Q ss_pred eeeeeEEEeC----CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC--
Q 010624 89 LNAHCSFSVD----SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-- 162 (506)
Q Consensus 89 v~l~~~~~~~----~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-- 162 (506)
+++++++... ...|+||||+ |++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 9999998764 5689999999 99999999873 46799999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q 010624 163 SDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242 (506)
Q Consensus 163 ~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~ 242 (506)
.++.+||+|||++.....................||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999998643322111111112223445999999999998765 899999999999999999999999854333
Q ss_pred HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
............. ..............+++++.+++..||..||.+|||+.+|++
T Consensus 268 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRE-NIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHH-CHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhh-hHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3222222111110 011111111122567899999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=379.22 Aligned_cols=257 Identities=23% Similarity=0.436 Sum_probs=214.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...|.+..++|++.+.||+|+||.||+|.+ .++..||||.+.... ...+.+.+|+.+|+.++||||+++++++. .
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATY--NKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEE--TTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEE--CCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 456888999999999999999999999988 457889999987543 34678999999999999999999999986 5
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++...
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 67899999999999999998643346899999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... .........+|+.|+|||++.... ++.++|||||||++|+|++ |..||......+.... +......+
T Consensus 335 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~- 405 (454)
T 1qcf_A 335 EDN------EYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMP- 405 (454)
T ss_dssp CCH------HHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHHTCCCC-
T ss_pred CCC------ceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCC-
Confidence 211 011122344678899999998654 8999999999999999999 9999987766544332 22222211
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+..+++++.+||.+||+.||++|||+.+|++
T Consensus 406 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ---------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 34568899999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=360.87 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=207.1
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.-.+..++|++++.||+|+||+||+|.+.. +++ .||+|.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 344677899999999999999999999863 344 368888766555566788999999999999999999999998
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.+. .++|++|+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred cCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 765 78999999999999999864 4579999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
..... ..........||+.|+|||++.+.. |+.++|||||||++|+|++ |.+||............ .....
T Consensus 166 ~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~- 237 (327)
T 3lzb_A 166 LLGAE-----EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER- 237 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCC-
T ss_pred EccCc-----cccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCC-
Confidence 43221 1112223445788999999998755 8999999999999999999 99999876665543322 22111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..++.++.+||.+||..||.+|||+.++++
T Consensus 238 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 238 ---------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1134568889999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=351.99 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=207.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhh------HHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTD------LDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
-.+..++|++.+.||+|+||+||+|.+. .+++.||+|++........ .+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhccceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 3467789999999999999999999985 5788999999865543221 26788999999999999999999999
Q ss_pred EeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCC-----eE
Q 010624 96 SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGS-----VK 168 (506)
Q Consensus 96 ~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~-----vK 168 (506)
.+.. ++||||+.+++|.+.+... ...+++..+..++.|++.||+|||++| ++||||||+|||++.++. +|
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 7665 6999999999999988764 457999999999999999999999999 999999999999988776 99
Q ss_pred EeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhc-cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 010624 169 LADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLM 247 (506)
Q Consensus 169 L~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~ 247 (506)
|+|||++.... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........
T Consensus 170 l~Dfg~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 239 (287)
T 4f0f_A 170 VADFGLSQQSV----------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239 (287)
T ss_dssp ECCCTTCBCCS----------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred eCCCCcccccc----------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence 99999875321 12334568999999999843 23368899999999999999999999986654443222
Q ss_pred HHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 248 KMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
........ ....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 240 NMIREEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11111111 11234568899999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=365.53 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=212.4
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhCC--CCCceeee
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLLS--HPNILNAH 92 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l~--HpnIv~l~ 92 (506)
.......++|++.+.||+|+||.||+|.+. .+++.||||++...... .....+.+|+.+++.++ ||||++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344566789999999999999999999985 67899999998754321 12245668999999996 59999999
Q ss_pred eEEEeCCEEEEEeccCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEEe
Q 010624 93 CSFSVDSRLWVVMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKLA 170 (506)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~g-gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL~ 170 (506)
+++..++..++||||+.+ ++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999999976 899999987 36799999999999999999999999999999999999999 78999999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
|||++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.... . ...
T Consensus 193 Dfg~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~ 257 (320)
T 3a99_A 193 DFGSGALLKD---------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIR 257 (320)
T ss_dssp CCTTCEECCS---------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH
T ss_pred eCcccccccc---------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhc
Confidence 9998764321 112234689999999999876645788999999999999999999996421 1 111
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
... .....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 258 ~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 GQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 111 12356788999999999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.08 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=198.3
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhh--CCCCCceeeeeEEEe----
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL--LSHPNILNAHCSFSV---- 97 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~---- 97 (506)
...++|++.+.||+|+||+||+|.+ +++.||||++.. .....+.+|..++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 4457899999999999999999987 578999999853 234556667777766 799999999988654
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccCCCCCCCEEeCCCCCeEE
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH--------NQGHLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH--------s~givHrDIKp~NILld~~g~vKL 169 (506)
...+|+||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.|++||||||+|||++.++.+||
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999964 57999999999999999999999 999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCC-----CCccccHHHHHHHHHHHHhC----------CC
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG-----YSFKADIWSFGITALELAHG----------RP 234 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-----~~~~sDIwSlGiil~eLltG----------~~ 234 (506)
+|||++......... .........||+.|+|||++.+... ++.++|||||||++|+|++| ..
T Consensus 155 ~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp CCCTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred eeCCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999997543322111 0111223468999999999976532 34789999999999999999 88
Q ss_pred CCCCCChHH----HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 235 PLSHLPPEK----SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 235 Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
||....... ............+... .......+++.+.+||.+||+.||.+|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 886543221 1111111111111110 01123457789999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.01 Aligned_cols=269 Identities=20% Similarity=0.307 Sum_probs=207.3
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEE---eCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAIC---IPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~---~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
..+....|++++.||+|+||.||+|.. ...+++.||+|++.........+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 345567799999999999999999984 13568999999998666556678899999999999999999999999876
Q ss_pred --CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 99 --SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 99 --~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..+|+||||+.+++|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6789999999999999999664 4569999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
...... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..|+... ...............
T Consensus 175 ~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 175 AIETDK----EYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSP--MALFLKMIGPTHGQM 247 (302)
T ss_dssp ECCTTC----CEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH--HHHHHHHHCSCCGGG
T ss_pred cccCCC----cceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcch--hhHHhhccCCccccc
Confidence 543221 1112233456888999999998754 789999999999999999999987422 111111100000000
Q ss_pred chhh------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 257 DYEK------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 257 ~~~~------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.... .......+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000 00011234578899999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.01 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=206.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
-..+.+..++|++.+.||+|+||.||+|.+... ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 444778889999999999999999999988643 45689999987654 345567899999999999999999999999
Q ss_pred EeCC-----EEEEEeccCCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 96 SVDS-----RLWVVMPFMSCGSLQSIISSC----FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 96 ~~~~-----~~~lV~Ey~~ggsL~~~i~~~----~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
.... ..|+||||+.+++|.+++... ....+++..++.++.|++.||.|||++|++||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7654 459999999999999998542 2356999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~ 245 (506)
+||+|||++....... .........+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.........
T Consensus 186 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 186 VCVADFGLSKKIYSGD-----YYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp EEECSCSCC---------------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EEEeecCcceeccccc-----ccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 9999999875432211 111223445788999999998654 8999999999999999999 89999876655443
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...... .. ...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHG-HR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTT-CC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcC-CC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332221 11 11345678899999999999999999999999753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.19 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=207.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEE-EeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSF-SVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~ 98 (506)
.......|++.+.||+|+||+||+|.+...+ ...+|+|.+.........+.+.+|+.++++++||||+++++++ ..+
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 3344557999999999999999999874322 3468999988766667778899999999999999999999985 456
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+..|+||||+.+|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 7889999999999999999763 456899999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ...........||+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.................
T Consensus 179 ~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---- 250 (298)
T 3f66_A 179 YDKE---YYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---- 250 (298)
T ss_dssp SCGG---GCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC----
T ss_pred cccc---hhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC----
Confidence 2211 11112234456788999999998755 8999999999999999999 6677765554443333222211
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123557889999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.18 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=211.2
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...|.+..++|++.+.||+|+||.||+|.+ .++.||||.+.... ..+.+.+|+.+|++++||||+++++++...
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 345789999999999999999999999987 36899999997543 456788999999999999999999998765
Q ss_pred C-EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 99 S-RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 99 ~-~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
. .+|+||||+.+|+|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4 799999999999999999886445589999999999999999999999999999999999999999999999999763
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+.... +....+.
T Consensus 339 ~~~----------~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~- 405 (450)
T 1k9a_A 339 ASS----------TQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKM- 405 (450)
T ss_dssp CC----------------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCC-
T ss_pred ccc----------cccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC-
Confidence 221 112235688999999998654 8999999999999999998 9999987665544322 2222211
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 406 ---------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 ---------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 134568899999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=360.79 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=207.6
Q ss_pred cC-CCCCCeeEEeeecccCCeeEEEEEEeCCCCeE--EEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEe
Q 010624 22 YP-LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV--VAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~-~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~--vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 97 (506)
|+ +..++|++.+.||+|+||.||+|.++ .++.. +|+|.+.........+.+.+|+.+++.+ +||||+++++++..
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cccccHHHccceeeeecCCCceEEEEEEc-cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 44 55689999999999999999999986 45554 4999987655555667889999999999 89999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS 163 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~ 163 (506)
.+.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 999999999999999999998642 246999999999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChH
Q 010624 164 DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPE 242 (506)
Q Consensus 164 ~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~ 242 (506)
++.+||+|||++..... ........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......
T Consensus 178 ~~~~kL~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GGCEEECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCeEEEcccCcCccccc--------cccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 99999999998753211 11223345688999999997654 8999999999999999998 99999876554
Q ss_pred HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 243 KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
... ..+..... ...+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 249 ~~~-~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 249 ELY-EKLPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHH-HHGGGTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-HHhhcCCC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 432 22222111 11345678999999999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=361.82 Aligned_cols=269 Identities=22% Similarity=0.296 Sum_probs=211.4
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
.....++|++.+.||+|+||+||+|.+ .++..||||.+.... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVL--RDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEEC--TTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEE--CCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 344568999999999999999999986 468899999886543 34567899999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFP--DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~--~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
|+||||+.+|+|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999999865422 358999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH---Hhhccc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL--LMK---MTQRFR 254 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~--~~~---~~~~~~ 254 (506)
... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....+.... ... ......
T Consensus 191 ~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 191 ELD-----QTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp SSS-----CCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred ccc-----ccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 111 111123345799999999998655 899999999999999999999999754332110 000 000000
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
................++..+.+++.+||+.||++|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000000000112345678899999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=382.67 Aligned_cols=258 Identities=22% Similarity=0.438 Sum_probs=217.4
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..|.+...+|++.+.||+|+||.||+|.++ .++..||||.+.... ...+.+.+|+.+|+.++||||+++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 357788899999999999999999999985 457899999986543 34678999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999999987655679999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.......... .+....+.
T Consensus 370 ~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~--- 438 (495)
T 1opk_A 370 GD------TYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM--- 438 (495)
T ss_dssp TC------CEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCC---
T ss_pred CC------ceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCC---
Confidence 21 111223345678899999998654 8999999999999999999 999998766554332 22222221
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus 439 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 -------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 134568899999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=350.20 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=205.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE-EE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL-WV 103 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-~l 103 (506)
-.|++.+.||+|+||+||+|.+... ++..||+|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 3577889999999999999987532 23479999998766666778899999999999999999999999876554 99
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+.+++|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-- 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR-- 177 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG--
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC--
Confidence 99999999999999763 467899999999999999999999999999999999999999999999999997533211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR-PPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
............||+.|+|||.+.+.. ++.++|||||||++|+|++|. +||........ ...+.....
T Consensus 178 -~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~-------- 246 (298)
T 3pls_A 178 -EYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-THFLAQGRR-------- 246 (298)
T ss_dssp -GGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH-HHHHHTTCC--------
T ss_pred -cccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHH-HHHhhcCCC--------
Confidence 111112233456789999999998654 899999999999999999955 55554444332 222222211
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 247 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 --LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1134567889999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=350.55 Aligned_cols=255 Identities=22% Similarity=0.395 Sum_probs=210.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.|.+..++|++.+.||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEE--cCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 5778889999999999999999999987 467889999986543 235678999999999999999999998864 45
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 88999999999999999764333699999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
. .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||........... +.....
T Consensus 162 ~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~----- 228 (279)
T 1qpc_A 162 N------EYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYR----- 228 (279)
T ss_dssp S------CEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCC-----
T ss_pred c------ccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccC-----
Confidence 1 111223445688999999998654 8999999999999999999 9999987665443322 222111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.+|+.+||..||++|||+.++++
T Consensus 229 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1134567899999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.45 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=208.7
Q ss_pred cccCCCCCCeeEEe-eecccCCeeEEEEEEe-CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 20 IQYPLDPSSYKILD-EIGVGVSAIVYKAICI-PMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~-~IG~G~fg~Vyka~~~-~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
..+.++.++|++.+ .||+|+||+||+|.+. ..++..||||++..... ....+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34567788999999 9999999999999653 34568999999876543 33467899999999999999999999999
Q ss_pred eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 97 VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 97 ~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..+..|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 56678999999999999999987 4679999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
....... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||............. ....
T Consensus 166 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~- 238 (291)
T 1xbb_A 166 ALRADEN----YYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGER- 238 (291)
T ss_dssp ECCTTCS----EEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC-
T ss_pred eeccCCC----cccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC-
Confidence 4322211 111123345678999999997654 7899999999999999999 999998766554332222 1111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1134568899999999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=363.29 Aligned_cols=272 Identities=16% Similarity=0.145 Sum_probs=202.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCCChh----------hHHHHHHHHHHHhhCCCCCce
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQSRT----------DLDSIRRETKTMSLLSHPNIL 89 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~~~~----------~~~~~~~Ei~il~~l~HpnIv 89 (506)
..+..++|++.+.||+|+||.||+|.+.. .++..+|+|.+....... ....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 34667899999999999999999999852 156889999987654321 113466889999999999999
Q ss_pred eeeeEEEe----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC
Q 010624 90 NAHCSFSV----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG 165 (506)
Q Consensus 90 ~l~~~~~~----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g 165 (506)
++++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence 99999988 78999999999 99999999873 4799999999999999999999999999999999999999877
Q ss_pred --CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Q 010624 166 --SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK 243 (506)
Q Consensus 166 --~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~ 243 (506)
.+||+|||++.....................||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 9999999997643221111111122234557999999999998754 8999999999999999999999996432222
Q ss_pred HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 244 SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
............. .............+++++.+||.+||..||.+|||+.+|++
T Consensus 268 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 VAVQTAKTNLLDE-LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHHT-TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhccc-ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2222211111100 00111111112268889999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=351.55 Aligned_cols=257 Identities=28% Similarity=0.499 Sum_probs=199.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..++..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4568999999999999999999985 568899999987533 3455678899999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 103 VVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+||||+.+++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999998752 245699999999999999999999999999999999999999999999999998653321
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................++
T Consensus 189 ~-------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 256 (310)
T 2wqm_A 189 K-------TTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP---- 256 (310)
T ss_dssp -----------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC----
T ss_pred C-------CccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC----
Confidence 1 11123346899999999998654 89999999999999999999999975432221111111111111
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
......+++++.+||.+||+.||.+|||+.++++
T Consensus 257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1123567889999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=353.63 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=201.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
.....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 3345678999999999999999999985 578999999987543 2334578899999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999999999873 579999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+......
T Consensus 186 ~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~---- 253 (309)
T 2h34_A 186 DE------KLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPR---- 253 (309)
T ss_dssp -----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCC----
T ss_pred cc------ccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCC----
Confidence 21 111223446899999999997654 899999999999999999999999865433 222222221111
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCC-CHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-SAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-t~~eiL~ 298 (506)
.......+++.+.++|.+||+.||.+|| |+.++++
T Consensus 254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1123456888999999999999999999 7887763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.12 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=197.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 104 (506)
.+.|.+.+.||+|+||+||.+.. .+|+.||||.+... ..+.+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34577789999999999987644 56899999998643 345678999999876 899999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC-------------CC
Q 010624 105 MPFMSCGSLQSIISSCFPDG-----LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD-------------GS 166 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~-----l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~-------------g~ 166 (506)
||||. |+|.+++....... .++..+..++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99996 69999998632111 1333467899999999999999999999999999999754 48
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhc------cCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS------HTGYSFKADIWSFGITALELAH-GRPPLSHL 239 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~ 239 (506)
+||+|||++........ ..........||+.|+|||++.+ ...++.++|||||||++|+|++ |..||...
T Consensus 167 ~kL~DFG~a~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQS---SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEEcccccceecCCCCc---cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999765432111 00111234568999999999975 2348999999999999999999 99999765
Q ss_pred ChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..... .........+.. .......+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 244 ~~~~~--~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 244 YSRES--NIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp TTHHH--HHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred hhhHH--HHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 44332 222222222211 011234678899999999999999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=374.51 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=209.6
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...|.+..++|++.+.||+|+||.||+|.+ .++..||||++.... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEE--TTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEE--CCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 445788899999999999999999999998 346789999987543 235678999999999999999999999876
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+||||+.+|+|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 67899999999999999997643456999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... .........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+.... +....+.
T Consensus 331 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~-- 400 (452)
T 1fmk_A 331 EDN------EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRM-- 400 (452)
T ss_dssp ------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCC--
T ss_pred CCC------ceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC--
Confidence 211 111223345678899999998654 8999999999999999999 9999987765544332 2222221
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++.+.+||.+||+.||++|||+.+|++
T Consensus 401 --------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 401 --------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 134568899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=354.59 Aligned_cols=267 Identities=23% Similarity=0.381 Sum_probs=206.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--C
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--D 98 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 98 (506)
+....|++++.||+|+||+||++... ..+++.||||++.........+.+.+|+.+++.++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 44444599999999999999888642 236789999999877666777889999999999999999999999988 4
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 689999999999999999976 45999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cc---c
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ-RF---R 254 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~-~~---~ 254 (506)
.... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||............... .. .
T Consensus 185 ~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 185 PEGH----EYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CTTC----SEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccc----cccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 3211 1111233456788999999998754 789999999999999999999999643221110000000 00 0
Q ss_pred ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.............+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00000000011234568899999999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=360.26 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=201.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhC----CCCCceee
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLL----SHPNILNA 91 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l----~HpnIv~l 91 (506)
......++|++.+.||+|+||.||+|.+. .+++.||+|++...... .....+.+|+.+++.+ +||||+++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34556788999999999999999999885 56889999998654321 1233456799999998 89999999
Q ss_pred eeEEEeCCEEEEEecc-CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC-CCCCeEE
Q 010624 92 HCSFSVDSRLWVVMPF-MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD-SDGSVKL 169 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey-~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld-~~g~vKL 169 (506)
++++...+..++|||| +.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999999 7899999999873 5799999999999999999999999999999999999999 8899999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.... . ..
T Consensus 182 ~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~ 246 (312)
T 2iwi_A 182 IDFGSGALLHDE---------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----IL 246 (312)
T ss_dssp CCCSSCEECCSS---------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HH
T ss_pred EEcchhhhcccC---------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hh
Confidence 999987643221 12344589999999999876544568999999999999999999996421 1 11
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.... ..+..++..+.+||.+||+.||++|||+.++++||||+..
T Consensus 247 ~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 247 EAEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HTCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred hhcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 1111 1335678899999999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.06 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=203.5
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
.+..|.+..++|++.+.||+|+||+||+|.+ +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 4566889999999999999999999999977 47899999986432 45678899999999999999999998754
Q ss_pred C-CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 D-SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 ~-~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
. +..|+||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence 4 578999999999999999987433348999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||........... +.....
T Consensus 166 ~~~~----------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~- 232 (278)
T 1byg_A 166 EASS----------TQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYK- 232 (278)
T ss_dssp --------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCC-
T ss_pred cccc----------cccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCC-
Confidence 3221 112335788999999998654 8999999999999999998 9999987655443322 222111
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 233 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 ---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 1134568899999999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=346.77 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=204.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeee-EEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHC-SFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~~~lV 104 (506)
.++|++.+.||+|+||.||+|.+. .+++.||+|++...... +.+.+|+.+++.++|++++..+. ++..+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 468999999999999999999985 67899999998654432 35789999999999888766554 44678899999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~~~~ 181 (506)
|||+ +++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||+ +.++.+||+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9999 89999999753 4579999999999999999999999999999999999999 48889999999997654433
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhcccccch
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE---KSLLMKMTQRFRFSDY 258 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~ 258 (506)
...............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .............+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred ccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--
Confidence 221111112234567899999999998755 899999999999999999999999864321 11111111111111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.......+++.+.+|+.+||+.||.+|||+.++++
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11123567899999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=365.31 Aligned_cols=267 Identities=19% Similarity=0.199 Sum_probs=203.9
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCC-------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCcee-----
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPM-------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILN----- 90 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~----- 90 (506)
....++|++.+.||+|+||.||+|.+... +++.||+|.+... +.+.+|+.+++.++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhh
Confidence 44568999999999999999999998632 4789999998644 35779999999999999987
Q ss_pred ----------eeeEEEe-CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCE
Q 010624 91 ----------AHCSFSV-DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNI 159 (506)
Q Consensus 91 ----------l~~~~~~-~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NI 159 (506)
+++++.. +...|+||||+ +++|.+++.......+++..+..++.||+.||.|||++|++||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5667766 78999999999 99999999874346799999999999999999999999999999999999
Q ss_pred EeCCCC--CeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCC
Q 010624 160 LSDSDG--SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLS 237 (506)
Q Consensus 160 Lld~~g--~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~ 237 (506)
|++.++ .+||+|||++.....................||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999998 9999999997643321111111111223457899999999998754 8999999999999999999999998
Q ss_pred CCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 238 HLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...............+.... ............+++.+.+||.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 65422222221111110000 0000000112356899999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=356.02 Aligned_cols=272 Identities=20% Similarity=0.283 Sum_probs=211.7
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSF 95 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 95 (506)
...-.+..++|++.+.||+|+||.||+|... ..++..||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4555678899999999999999999999842 356889999998654 345567789999999999999999999988
Q ss_pred E--eCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecc
Q 010624 96 S--VDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173 (506)
Q Consensus 96 ~--~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFG 173 (506)
. ....+|+||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 6 456799999999999999999864 2469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcc
Q 010624 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
++....... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ........
T Consensus 173 ~~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~ 245 (327)
T 3lxl_A 173 LAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCER 245 (327)
T ss_dssp GCEECCTTC----SEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC---
T ss_pred cceecccCC----ccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhccccc
Confidence 976542211 1111233456889999999998754 7999999999999999999999986432211 11000000
Q ss_pred cccchhh------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 254 RFSDYEK------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 254 ~~~~~~~------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....... .......+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000000 000112345788999999999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.89 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=201.5
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDS 99 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (506)
.+.+...+|.+.+.||+|+||+||.... .+++.||||.+..... ..+.+|+.+|+.+ +||||+++++++.+..
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 3556677899999999999999764433 5688999999864332 2345899999999 7999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-----CCCeEEeeccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-----DGSVKLADFGV 174 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-----~g~vKL~DFGl 174 (506)
..|+|||||. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 9999999997 6999999864 234556677899999999999999999999999999999953 23588999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhc--cCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhh
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--HTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQ 251 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~ 251 (506)
|....... ..........||+.|+|||++.+ ...++.++|||||||++|+|++ |.+||.......... ...
T Consensus 170 a~~~~~~~----~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~ 243 (432)
T 3p23_A 170 CKKLAVGR----HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLG 243 (432)
T ss_dssp EECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTT
T ss_pred eeeccCCC----cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--Hhc
Confidence 76432211 01112234568999999999974 2346789999999999999999 999996544333221 111
Q ss_pred cccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 252 RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..... ........+..+++||.+||+.||.+|||+.++++||||....
T Consensus 244 ~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 244 ACSLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp CCCCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred cCCcc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 11111 1112345677899999999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=352.52 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=204.3
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCe--EEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCS 94 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (506)
.....+..++|++.+.||+|+||+||+|.+...++. .||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp -CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 344566778999999999999999999987544443 68999987543 23456789999999999999999999999
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
+..+. .++||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence 98765 88999999999999999864 35699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRF 253 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 253 (506)
+........ .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.................
T Consensus 168 ~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 168 MRALPQNDD----HYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242 (291)
T ss_dssp CEECCC-CC----EEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred ccccccccc----chhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC
Confidence 765322111 111223445788999999998654 7899999999999999999 9999987766554433322221
Q ss_pred cccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. ..+..++..+.++|.+||..||.+|||+.++++
T Consensus 243 ~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 243 RL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 133568899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=346.71 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=200.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeee-EEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHC-SFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~~~lV 104 (506)
.++|++.+.||+|+||+||+|.+. .+++.||||++...... ..+.+|+.+++.++|++++..+. ++..+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 367999999999999999999985 67899999987654322 34778999999999888776554 44778899999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~~~~ 181 (506)
|||+ +++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||+ +.++.+||+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999 99999999853 4579999999999999999999999999999999999999 78899999999998754433
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhcccccch
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE---KSLLMKMTQRFRFSDY 258 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~ 258 (506)
...............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .............+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence 221111112234567899999999998755 899999999999999999999999764332 11111111111100
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.......+++.+.+||.+||+.||++|||+.++++
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11123557899999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.33 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=200.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCC--eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEE-eCCEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFS-VDSRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~--~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ 101 (506)
....|++.+.||+|+||+||+|.+...++ ..||+|.+.........+.+.+|+.+++.++||||+++++++. .++..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 34458999999999999999998864443 4689999876555666788999999999999999999999864 45688
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999999763 356899999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. ...........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+......... .
T Consensus 246 ~---~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~------ 314 (373)
T 3c1x_A 246 E---FDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R------ 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-C------
T ss_pred c---cccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-C------
Confidence 1 01111223445788999999998654 8999999999999999999 788887655444332222211 1
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 315 ----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 315 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1134567889999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=350.69 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=205.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe---------
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--------- 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------- 97 (506)
.+|++.+.||+|+||.||+|.+. .+++.||+|.+.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 46999999999999999999984 578999999986543 346689999999999999999998864
Q ss_pred -------CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEe
Q 010624 98 -------DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLA 170 (506)
Q Consensus 98 -------~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~ 170 (506)
...+|+||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 4568999999999999999987555679999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 010624 171 DFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT 250 (506)
Q Consensus 171 DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~ 250 (506)
|||++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ......+.
T Consensus 165 Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~ 232 (284)
T 2a19_B 165 DFGLVTSLKND--------GKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLR 232 (284)
T ss_dssp CCTTCEESSCC--------SCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHH
T ss_pred cchhheecccc--------ccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhh
Confidence 99987643221 1123346899999999998654 899999999999999999999887421 11111111
Q ss_pred hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 251 QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
. ...+..++..+++||.+||+.||.+|||+.++++|.+.-.
T Consensus 233 ~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 D-------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp T-------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred c-------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1 1123457889999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.27 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=195.7
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC--CCCCceeeeeEEEeC---
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL--SHPNILNAHCSFSVD--- 98 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~--- 98 (506)
...++|++.+.||+|+||.||+|.+ .++.||||++... ......+|..++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3446899999999999999999987 3789999998532 234445566666554 899999999999887
Q ss_pred -CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCccCCCCCCCEEeCCCCCeEE
Q 010624 99 -SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ--------GHLHRDVKAGNILSDSDGSVKL 169 (506)
Q Consensus 99 -~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~--------givHrDIKp~NILld~~g~vKL 169 (506)
..+|+||||+.+|+|.+++.. ..+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999976 4799999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCc------cccHHHHHHHHHHHHhC----------C
Q 010624 170 ADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSF------KADIWSFGITALELAHG----------R 233 (506)
Q Consensus 170 ~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~------~sDIwSlGiil~eLltG----------~ 233 (506)
+|||++........ ..........||+.|+|||++.+.. +.. ++|||||||++|+|++| .
T Consensus 184 ~Dfg~a~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 184 ADLGLAVKFISDTN---EVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CCCTTCEECC------------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeCCCceeeccccc---cccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999754322111 0111122446899999999997654 344 38999999999999999 6
Q ss_pred CCCCCCChHH----HHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 234 PPLSHLPPEK----SLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 234 ~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.||....... ............+... .......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCcccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7776432211 1111111111001100 011234678899999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=370.55 Aligned_cols=266 Identities=23% Similarity=0.374 Sum_probs=208.2
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC--EE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS--RL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 101 (506)
...++|++.+.||+|+||+||+|.+. .+++.||||++.........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34568999999999999999999995 5689999999976554555678889999999999999999999998755 78
Q ss_pred EEEeccCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe----CCCCCeEEeeccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS----DSDGSVKLADFGVSA 176 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl----d~~g~vKL~DFGls~ 176 (506)
|+|||||.||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999976422 239999999999999999999999999999999999999 778889999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhcc-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHH
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH-------TGYSFKADIWSFGITALELAHGRPPLSHLPP----EKSL 245 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-------~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~----~~~~ 245 (506)
..... .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ....
T Consensus 165 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDD--------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCG--------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCC--------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 43221 122345689999999998652 2378899999999999999999999964322 2222
Q ss_pred HHHHhhccccc------------chhhh-hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 246 LMKMTQRFRFS------------DYEKT-LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 246 ~~~~~~~~~~~------------~~~~~-~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
........... .+... .........++..+.++|.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 22222111000 00000 0011123567889999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=349.85 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=197.5
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.++.++|++.+.||+|+||+||+|.+ .++.||+|.+.. ....+.+.+|+.+++.++||||+++++++.+ ..|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 35678899999999999999999987 368899999853 2345778999999999999999999998873 478
Q ss_pred EEeccCCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCCCCEEeCCCCC-eEEeecccccc
Q 010624 103 VVMPFMSCGSLQSIISSCFP-DGLPEPCIAIVLKETLSALSYLHN---QGHLHRDVKAGNILSDSDGS-VKLADFGVSAS 177 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~-~~l~e~~i~~i~~qil~gL~yLHs---~givHrDIKp~NILld~~g~-vKL~DFGls~~ 177 (506)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||+ +|++||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999986422 247899999999999999999999 89999999999999998886 79999998753
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..................
T Consensus 156 ~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--- 221 (307)
T 2eva_A 156 IQT----------HMTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--- 221 (307)
T ss_dssp -------------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---
T ss_pred ccc----------ccccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---
Confidence 211 112345899999999998654 899999999999999999999999765433222111111111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 222 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 ------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11134567889999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=354.13 Aligned_cols=270 Identities=23% Similarity=0.327 Sum_probs=207.9
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
+...+.+..++|++.+.||+|+||.||+|.+. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 34446778899999999999999999999985 67899999998653 34556788999999999999999999999863
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
....|+||||+.+|+|.+++... ....+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 34789999999999999999763 245699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCC--CCCcccccCCCCCccCChhhhhccC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH-HHH
Q 010624 172 FGVSASIYEPSHHHH--HGSAMITDMAGTPYWMAPEVIRSHT--GYSFKADIWSFGITALELAHGRPPLSHLPPEK-SLL 246 (506)
Q Consensus 172 FGls~~~~~~~~~~~--~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~-~~~ 246 (506)
||++........... ..........||+.|+|||++.+.. .++.++|||||||++|+|++|..||....... ...
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 998653211100000 0000112345799999999986533 26889999999999999999999995311100 011
Q ss_pred HHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 247 MKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
........ ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 258 LAVQNQLS----------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhccCC----------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 11111111 11235678999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=378.40 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=208.6
Q ss_pred ccCCCCCCeeEEe-eecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 21 QYPLDPSSYKILD-EIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 21 ~~~~~~~~Y~i~~-~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
.+.+..++|.+.+ .||+|+||.||+|.++. .++..||||++.........+.+.+|+.+|+.++||||+++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 3456667788777 89999999999998753 34568999999876555667889999999999999999999999976
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+|||||.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5689999999999999999753 456999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.... ..........+|+.|+|||++.+.. ++.++|||||||++|||++ |..||......+..... .....
T Consensus 487 ~~~~----~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-~~~~~--- 557 (613)
T 2ozo_A 487 GADD----SYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKR--- 557 (613)
T ss_dssp C------------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-HTTCC---
T ss_pred cCCC----ceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCC---
Confidence 2111 1111122344678999999998654 8999999999999999998 99999877665543322 22111
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
...+..+++++.+||.+||+.||++|||+.+|+
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 113456889999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=377.08 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=213.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
...|.+..++|++.+.||+|+||.||+|.+ .++..||||++.... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEE--CCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 445888999999999999999999999998 346789999997543 235678999999999999999999999876
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
..+|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 67899999999999999997643456999999999999999999999999999999999999999999999999997532
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
... .........+|+.|+|||++.... ++.++|||||||++|+|++ |..||......+.... +....+.
T Consensus 414 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~-- 483 (535)
T 2h8h_A 414 EDN------EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRM-- 483 (535)
T ss_dssp CCH------HHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCC--
T ss_pred CCC------ceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC--
Confidence 210 011122345678899999998654 8999999999999999999 9999987665544332 2222221
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+||.+||+.||++|||+.+|++
T Consensus 484 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 484 --------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 134568899999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=346.39 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=204.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ---SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.|...+.||+|+||+||+|.+ +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 355668999999999999975 57899999986543 234467899999999999999999999999999999999
Q ss_pred eccCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 105 MPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 187 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA- 187 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS-
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc-
Confidence 99999999999997532 3469999999999999999999999999999999999999999999999999876432211
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcccccchhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL---LMKMTQRFRFSDYEK 260 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~ 260 (506)
.........||+.|+|||++.+. ++.++|||||||++|+|++|.+||......... ........ .....
T Consensus 188 ----~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 259 (307)
T 2nru_A 188 ----QTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE--KTIED 259 (307)
T ss_dssp ----SCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS--CCHHH
T ss_pred ----ccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh--hhhhh
Confidence 11122345689999999999754 789999999999999999999999764432211 11111100 00000
Q ss_pred hh--hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 261 TL--KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 261 ~~--~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.. ........++..+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 1122345678889999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=359.90 Aligned_cols=256 Identities=14% Similarity=0.150 Sum_probs=203.2
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEE----eCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC---CCCcee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAIC----IPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---HPNILN 90 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~----~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~ 90 (506)
....+.+..++|++.+.||+|+||+||+|.+ ...+++.||+|++... ....+.+|+.+++.++ |+||++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhh
Confidence 3445667888999999999999999999942 1256789999998643 3456778888888887 999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC----
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSC---FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---- 163 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~---~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---- 163 (506)
+++++..++..|+|||||+||+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 999999999999999999999999999753 2457999999999999999999999999999999999999998
Q ss_pred -------CCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCC
Q 010624 164 -------DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236 (506)
Q Consensus 164 -------~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf 236 (506)
++.+||+|||+|...... ..........||+.|+|||++.+.. |+.++|||||||++|+|++|+.||
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLF-----PKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGS-----CTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccccccccCCEEEeeCchhhhhhcc-----CCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCcc
Confidence 899999999997543211 1112234556999999999998765 899999999999999999999999
Q ss_pred CCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....... .... ........++.+.+++..||+.+|.+|++..+.+.+
T Consensus 286 ~~~~~~~---------~~~~-------~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 286 VKNEGGE---------CKPE-------GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EEEETTE---------EEEC-------SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ccCCCCc---------eeec-------hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 6432211 0000 000112346788999999999999999765544443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.32 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=192.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHH--HhhCCCCCceeeeeEEEe-
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKT--MSLLSHPNILNAHCSFSV- 97 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~- 97 (506)
...+..++|++.+.||+|+||+||+|.+ +++.||||++... ....+..|..+ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 3456789999999999999999999976 5789999998643 23334444444 456899999999876543
Q ss_pred ----CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccCCCCCCCEEeCCC
Q 010624 98 ----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ---------GHLHRDVKAGNILSDSD 164 (506)
Q Consensus 98 ----~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~---------givHrDIKp~NILld~~ 164 (506)
...+|+||||+++|+|.+++.. ...++..+..++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 3367999999999999999976 4568999999999999999999999 99999999999999999
Q ss_pred CCeEEeeccccccccCCCCCC-CCCCcccccCCCCCccCChhhhhcc------CCCCccccHHHHHHHHHHHHhCCCCCC
Q 010624 165 GSVKLADFGVSASIYEPSHHH-HHGSAMITDMAGTPYWMAPEVIRSH------TGYSFKADIWSFGITALELAHGRPPLS 237 (506)
Q Consensus 165 g~vKL~DFGls~~~~~~~~~~-~~~~~~~~~~~Gt~~y~APE~l~~~------~~~~~~sDIwSlGiil~eLltG~~Pf~ 237 (506)
+.+||+|||++.......... ...........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999986543221100 0111222345689999999999762 225678999999999999999977764
Q ss_pred CCChH-----------------HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 238 HLPPE-----------------KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 238 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..... .............+... ........+++.+.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP---EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC---TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC---cccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 32211 00111111110001000 011123346778999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=351.98 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=207.7
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
...+.+..++|++.+.||+|+||.||+|.+. ..+|+|++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 4568899999999999999999999999873 2489999875432 2334567789999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
.+.+++||||+.|++|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++ ++.+||+|||++..
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999999999999999999763 34699999999999999999999999999999999999998 78999999998654
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhc--------cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS--------HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--------~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~ 249 (506)
...... ...........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.............
T Consensus 179 ~~~~~~--~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 179 SGVLQA--GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp -----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccc--cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 321111 111122334568999999999975 2347889999999999999999999998766554433222
Q ss_pred hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. .. .......++.++.++|.+||..||.+|||+.++++
T Consensus 257 ~~-~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 257 TG-MK---------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TT-CC---------CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cC-CC---------CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 21 11 01122357788999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=344.09 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=190.7
Q ss_pred CCCeeEE-eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHH-hhCCCCCceeeeeEEEe----CC
Q 010624 26 PSSYKIL-DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM-SLLSHPNILNAHCSFSV----DS 99 (506)
Q Consensus 26 ~~~Y~i~-~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~ 99 (506)
.++|.+. +.||+|+||.||+|.++ .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. +.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEc-CCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3568887 78999999999999985 6788999999853 23566888887 67799999999999987 67
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSA 176 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~ 176 (506)
.+|+||||++||+|.+++.......+++..++.++.|++.||.|||++|++||||||+|||++. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 8999999999999999998865557999999999999999999999999999999999999997 7899999999853
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
... ...|+.++|||||||++|+|++|.+||.......... .........
T Consensus 169 ~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~ 217 (299)
T 3m2w_A 169 ETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRMG 217 (299)
T ss_dssp ECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-CSCCSSCTT
T ss_pred ccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-HHHHHHhhc
Confidence 210 1226789999999999999999999997543322110 001111111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
... ........+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 218 ~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 218 QYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000 00111245789999999999999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=383.41 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=209.4
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe------CCE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV------DSR 100 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~ 100 (506)
++|++.+.||+|+||+||+|.+. .+|+.||||++.........+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 68999999999999999999885 56889999998776666777889999999999999999999988755 677
Q ss_pred EEEEeccCCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC---eEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCF-PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS---VKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~-~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~---vKL~DFGls~ 176 (506)
.|+|||||+||+|.+++.... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999998742 236999999999999999999999999999999999999997765 9999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM------- 249 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~------- 249 (506)
..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.............
T Consensus 173 ~~~~~--------~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 173 ELDQG--------ELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp BTTSC--------CCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccc--------cccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 43221 1123456899999999997654 8999999999999999999999997543221110000
Q ss_pred -------hhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 250 -------TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 250 -------~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+... ..........+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 244 ~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000001000 000112345578999999999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=348.66 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=201.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhh--CCCCCceeeeeEEEeCC----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL--LSHPNILNAHCSFSVDS---- 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~---- 99 (506)
.++|++.+.||+|+||.||+|.+ +++.||||++.. .....+.+|+.+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 46899999999999999999987 478999999853 334567789999887 78999999999998876
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH--------NQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH--------s~givHrDIKp~NILld~~g~vKL~D 171 (506)
.+|+||||+.+|+|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+|||++.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 89999999999999999976 46999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCC-----CCccccHHHHHHHHHHHHhC----------CCCC
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTG-----YSFKADIWSFGITALELAHG----------RPPL 236 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-----~~~~sDIwSlGiil~eLltG----------~~Pf 236 (506)
||++......... .........||+.|+|||++.+... ++.++|||||||++|+|++| ..||
T Consensus 191 fg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 191 LGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp CTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9997643322110 0011234468999999999976432 23689999999999999999 7888
Q ss_pred CCCChH----HHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 237 SHLPPE----KSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 237 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...... ......+......+.... .-....++..+.+||.+||+.||++|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 764321 222222211111111100 00224567889999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=376.56 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=211.6
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPM--DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~--~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
..+.+..++|++.+.||+|+||.||+|.+... .+..||||.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 45677788999999999999999999998532 356899999876666666788999999999999999999999985
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
++..|+||||+.+|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 45689999999999999999863 34699999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||............... ..
T Consensus 541 ~~~~------~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~-- 610 (656)
T 2j0j_A 541 MEDS------TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ER-- 610 (656)
T ss_dssp CCC----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CC--
T ss_pred cCCC------cceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CC--
Confidence 3221 111223345688999999998654 8999999999999999997 99999877665543332221 11
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 611 --------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1134568899999999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.79 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=188.9
Q ss_pred cccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEE--
Q 010624 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFS-- 96 (506)
Q Consensus 20 ~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~-- 96 (506)
..+.+...+|++.+.||+|+||.||+|.+. .+++.||+|.+... .......+.+|+.+++.+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 345677789999999999999999999985 57889999998544 3445567889999999996 999999999984
Q ss_pred ------eCCEEEEEeccCCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeCCCCCe
Q 010624 97 ------VDSRLWVVMPFMSCGSLQSIISSC-FPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSDSDGSV 167 (506)
Q Consensus 97 ------~~~~~~lV~Ey~~ggsL~~~i~~~-~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld~~g~v 167 (506)
....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||++| ++||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3446899999996 7898888653 2456999999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCCCCCCC-----CCCcccccCCCCCccCChhhhh--ccCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 010624 168 KLADFGVSASIYEPSHHHH-----HGSAMITDMAGTPYWMAPEVIR--SHTGYSFKADIWSFGITALELAHGRPPLSHLP 240 (506)
Q Consensus 168 KL~DFGls~~~~~~~~~~~-----~~~~~~~~~~Gt~~y~APE~l~--~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~ 240 (506)
||+|||++........... ..........||+.|+|||++. ....++.++|||||||++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999764332211000 0001112445899999999984 23347889999999999999999999997543
Q ss_pred hHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.... ....... ......+..+.+||.+||+.||.+|||+.++++|
T Consensus 258 ~~~~----~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 258 KLRI----VNGKYSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHh----hcCcccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3221 1111111 1234456678999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=375.01 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=204.2
Q ss_pred CCCCCCeeEEe-eecccCCeeEEEEEEe-CCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 23 PLDPSSYKILD-EIGVGVSAIVYKAICI-PMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 23 ~~~~~~Y~i~~-~IG~G~fg~Vyka~~~-~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
.++...+.+.. .||+|+||.||+|.+. ..+++.||||++.... .....+.+.+|+.+|+.++|||||++++++.. +
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 34444555544 7999999999999764 2346889999987543 33456789999999999999999999999965 4
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..++|||||.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred CEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 58899999999999999987 5679999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... .........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+...... ....
T Consensus 521 ~~~~----~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~---- 590 (635)
T 4fl3_A 521 ADEN----YYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGER---- 590 (635)
T ss_dssp C-----------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC----
T ss_pred cCcc----ccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC----
Confidence 2111 111223345688999999998654 8999999999999999998 999998776655433322 2111
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...+..+++++.+||.+||+.||++|||+.+|++
T Consensus 591 ------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 ------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1134568899999999999999999999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=346.36 Aligned_cols=269 Identities=19% Similarity=0.310 Sum_probs=206.8
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEe---CCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICI---PMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~---~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
...+...+|++++.||+|+||.||+|... ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 34566788999999999999999999842 356899999998754 34456789999999999999999999998865
Q ss_pred CC--EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 98 DS--RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 98 ~~--~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.+ .+++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 43 789999999999999999874 356999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
........ .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .............
T Consensus 193 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 193 KVLPQDKE----YYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AEFMRMIGNDKQG 265 (326)
T ss_dssp EECCSSCS----EEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHHHHHCTTCCT
T ss_pred hhcccccc----ccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHHHhhccccch
Confidence 65332111 011123345788899999998754 7899999999999999999999986321 1111111000000
Q ss_pred cc----hhhh---hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 256 SD----YEKT---LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 256 ~~----~~~~---~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.. .... ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0000 0011234568899999999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=358.35 Aligned_cols=260 Identities=19% Similarity=0.293 Sum_probs=205.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC-CCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV 104 (506)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.+.| ++|..+..++......|+|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 478999999999999999999985 66889999988654432 346789999999987 5566666777888999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe---CCCCCeEEeeccccccccCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS---DSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl---d~~g~vKL~DFGls~~~~~~ 181 (506)
|||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 82 me~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9999 89999999854 4679999999999999999999999999999999999999 58899999999998754432
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcccccchh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEK--SLLMKMTQRFRFSDYE 259 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~ 259 (506)
...............||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ..+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-----
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-----
Confidence 221111122233567999999999998755 8999999999999999999999998654321 11111111100
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..........++.++.+||.+||+.+|.+||++.+|++
T Consensus 234 -~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 -ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00011123467899999999999999999999998864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.18 Aligned_cols=252 Identities=21% Similarity=0.252 Sum_probs=195.0
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-------ChhhHHHHHHHHHHHhhCC---------CC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-------SRTDLDSIRRETKTMSLLS---------HP 86 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-------~~~~~~~~~~Ei~il~~l~---------Hp 86 (506)
.+..++|++.+.||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+++.++ ||
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred hcccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 35668899999999999999999987 57999999997653 2334578889999999886 77
Q ss_pred CceeeeeEE-----------------Ee-------------CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHH
Q 010624 87 NILNAHCSF-----------------SV-------------DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136 (506)
Q Consensus 87 nIv~l~~~~-----------------~~-------------~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~q 136 (506)
||+++.+.+ .+ ...+|+|||||.+|++.+.+.. ..+++..++.++.|
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQ 169 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHH
Confidence 776666554 22 6789999999999976666643 56899999999999
Q ss_pred HHHHHHHHH-HCCCccCCCCCCCEEeCCCC--------------------CeEEeeccccccccCCCCCCCCCCcccccC
Q 010624 137 TLSALSYLH-NQGHLHRDVKAGNILSDSDG--------------------SVKLADFGVSASIYEPSHHHHHGSAMITDM 195 (506)
Q Consensus 137 il~gL~yLH-s~givHrDIKp~NILld~~g--------------------~vKL~DFGls~~~~~~~~~~~~~~~~~~~~ 195 (506)
|+.||+||| ++||+||||||+|||++.++ .+||+|||+|..... ...
T Consensus 170 i~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~ 237 (336)
T 2vuw_A 170 LTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEE
T ss_pred HHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcE
Confidence 999999999 99999999999999999887 899999999764321 123
Q ss_pred CCCCccCChhhhhccCCCCccccHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHH
Q 010624 196 AGTPYWMAPEVIRSHTGYSFKADIWSFGIT-ALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRA 274 (506)
Q Consensus 196 ~Gt~~y~APE~l~~~~~~~~~sDIwSlGii-l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 274 (506)
.||+.|+|||++.+.. +.++||||||++ .+++++|..||............+.....+.... .......++++
T Consensus 238 ~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~ 311 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC----NTPAMKQIKRK 311 (336)
T ss_dssp ECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCC----CSHHHHHHHHH
T ss_pred EEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCccc----chhhhhhcCHH
Confidence 6899999999998653 889999998777 7788999999843211111222222111111110 11123568999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHH-cCcccc
Q 010624 275 FKDMVASCLDQDPSKRPSAEKLM-KHSFFK 303 (506)
Q Consensus 275 l~~Li~~~L~~dP~~Rpt~~eiL-~hp~f~ 303 (506)
+++||.+||+.| |+.++| +||||+
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 999999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=374.53 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=201.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE---
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR--- 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--- 100 (506)
+..++|++.+.||+|+||+||+|.+...+++.||||++...........+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34579999999999999999999996547899999998766555666788999999999999999999999987655
Q ss_pred --EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 101 --LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 101 --~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
.|+||||++|++|.+++.. .+++..+..|+.||+.||.|||++||+||||||+|||++.+ .+||+|||++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred ceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988754 69999999999999999999999999999999999999875 9999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...... .. +.
T Consensus 232 ~~-----------~~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~--~~- 286 (681)
T 2pzi_A 232 NS-----------FGYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GL--PE- 286 (681)
T ss_dssp TC-----------CSCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SC--CT-
T ss_pred cc-----------CCccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc---------cc--cc-
Confidence 21 1334689999999999764 589999999999999999999988642110 00 00
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
.......++.+.+||.+||+.||.+||+..+++.|+|+.
T Consensus 287 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 ------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 011234567899999999999999999999999888875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.68 Aligned_cols=252 Identities=15% Similarity=0.130 Sum_probs=192.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCC-CCcee-----------
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSH-PNILN----------- 90 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~H-pnIv~----------- 90 (506)
....|++.+.||+|+||+||+|.+. .+|+.||||++..... ....+.+++|+.+++.+.| +|+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CceeEEEecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3445899999999999999999985 5688999999874432 2346789999999999987 32211
Q ss_pred ----------eeeEEEe-----CCEEEEEeccCCCCCHHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 010624 91 ----------AHCSFSV-----DSRLWVVMPFMSCGSLQSIISSC-----FPDGLPEPCIAIVLKETLSALSYLHNQGHL 150 (506)
Q Consensus 91 ----------l~~~~~~-----~~~~~lV~Ey~~ggsL~~~i~~~-----~~~~l~e~~i~~i~~qil~gL~yLHs~giv 150 (506)
+..++.. ...++++|+++ +++|.+++... ....+++..+..++.|++.||+|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111 22467777776 58999998522 234578889999999999999999999999
Q ss_pred cCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhh---------ccCCCCccccHHH
Q 010624 151 HRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR---------SHTGYSFKADIWS 221 (506)
Q Consensus 151 HrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~---------~~~~~~~~sDIwS 221 (506)
||||||+|||++.++.+||+|||++..... ......| +.|+|||++. ....|+.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999653211 1234456 9999999994 2223788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcc
Q 010624 222 FGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301 (506)
Q Consensus 222 lGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~ 301 (506)
|||++|+|++|+.||......... . ........+++.+.+||.+||+.||.+|||+.++++|||
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~-------------~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGS-------------E---WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCS-------------G---GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhH-------------H---HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 999999999999999754332110 0 011123467899999999999999999999999999999
Q ss_pred cccc
Q 010624 302 FKNC 305 (506)
Q Consensus 302 f~~~ 305 (506)
|+..
T Consensus 367 ~~~~ 370 (413)
T 3dzo_A 367 YEQL 370 (413)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=329.22 Aligned_cols=229 Identities=18% Similarity=0.154 Sum_probs=187.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..++|++.+.||+|+||.||+|.+. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 45578999999999999999999984 5689999999976543 44567889999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+||||++|++|.+++.. +.....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999954 24666789999999999999999999999999999999999999998554
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
|++| ++.++|||||||++|+|++|+.||............ ...... . .
T Consensus 175 -------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~~~~~~-~---~ 222 (286)
T 3uqc_A 175 -------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ERDTAG-Q---P 222 (286)
T ss_dssp -------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-CBCTTS-C---B
T ss_pred -------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-HHHhcc-C---C
Confidence 3333 688999999999999999999999865432210000 000000 0 0
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.........+++++.+||.+||+.||.+| |+.++++
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00112345688999999999999999999 9999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-34 Score=308.97 Aligned_cols=230 Identities=14% Similarity=0.135 Sum_probs=151.7
Q ss_pred eecccCCeeEEEEEEeCCCCeEEEEEEeccCC---------ChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCEEEE
Q 010624 34 EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ---------SRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 34 ~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~---------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 103 (506)
..+.|+.|.+..+... ..|+.+|+|++.... ...+.+.+.+|+.+|+++ +|+||+++++++++++.+||
T Consensus 241 ~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEE-EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccc-cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3566666666655443 457889999997543 123456799999999999 69999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||||+|++|.++|.. .+.+++. .|+.||+.||+|||++||+||||||+|||++.+|.|||+|||+|......
T Consensus 320 VMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp EEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 9999999999999987 4667764 58899999999999999999999999999999999999999997643221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|||||++.+. +..++|+||+|++++.+.++..||. ..+...
T Consensus 393 -----~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~~---------~~l~~~----------- 445 (569)
T 4azs_A 393 -----CSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNWL---------YAVWQE----------- 445 (569)
T ss_dssp ------CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH---------HHHHTS-----------
T ss_pred -----CccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccchhH---------HHhhcC-----------
Confidence 1122334689999999999864 6788999999999988876544331 111000
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
+.....+..+...++..+|..||.......++|..
T Consensus 446 -----~~~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 446 -----PVERWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp -----CGGGCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred -----CCCCCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 00111245566667777787787766555555543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=263.60 Aligned_cols=192 Identities=16% Similarity=0.119 Sum_probs=143.8
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-------hhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-------TDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
..+.||+|+||.||+|. ..+..+|+|........ ...+.+.+|+.+|++++||||+++..++......|+
T Consensus 340 ~~~~LG~G~fg~Vy~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS---YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEE---CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEE---ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 35689999999999994 35678899986543211 123568999999999999999966666667777899
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|........
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999999875 5689999999999999999999999999999998 999999999764322100
Q ss_pred CCCCCCcccccCCCCCccCChhhhhc-cCCCCccccHHHHHHHHHHHHhCCCCCC
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRS-HTGYSFKADIWSFGITALELAHGRPPLS 237 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~~sDIwSlGiil~eLltG~~Pf~ 237 (506)
.............||++|||||++.. ...|+..+|+||..+-..+-+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00000001234568999999999975 1237889999999999888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-25 Score=217.25 Aligned_cols=157 Identities=18% Similarity=0.202 Sum_probs=122.5
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----------------hhHHHHHHHHHHHhhCCCCCceee
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----------------TDLDSIRRETKTMSLLSHPNILNA 91 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----------------~~~~~~~~Ei~il~~l~HpnIv~l 91 (506)
|.+.+.||+|+||.||+|.+ .+|+.||+|++...... .....+.+|+.+|+.++ | +++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 44559999999999999998 57899999998653311 13567889999999999 4 555
Q ss_pred eeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
..++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+.|++||||||+|||++ +|.+||+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 555544 44689999999999988 421 23557999999999999999999999999999999 99999999
Q ss_pred ccccccccCCCCCCCCCCcccccCCCCCccCChhhhhcc---------CCCCccccHHH
Q 010624 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSH---------TGYSFKADIWS 221 (506)
Q Consensus 172 FGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~---------~~~~~~sDIwS 221 (506)
||+|. ++..++|||++... ..|+..+|+|.
T Consensus 236 FG~a~--------------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 236 FPQSV--------------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CTTCE--------------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCCe--------------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99853 24458999998531 12455666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5e-21 Score=187.23 Aligned_cols=139 Identities=17% Similarity=0.176 Sum_probs=107.4
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeE--EEEEEeccCCCh-----------------------hhHHHHHHHHHHHhh
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTV--VAIKAIDLDQSR-----------------------TDLDSIRRETKTMSL 82 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~--vAIK~i~~~~~~-----------------------~~~~~~~~Ei~il~~ 82 (506)
-|++.+.||+|+||.||+|.+. .+|+. ||||++...... .....+.+|+.+|+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3889999999999999999884 45788 999997543211 112367899999999
Q ss_pred CCCCCceeeeeEEEeCCEEEEEeccCCC-C----CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCC
Q 010624 83 LSHPNILNAHCSFSVDSRLWVVMPFMSC-G----SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH-NQGHLHRDVKA 156 (506)
Q Consensus 83 l~HpnIv~l~~~~~~~~~~~lV~Ey~~g-g----sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH-s~givHrDIKp 156 (506)
+.|+||.....+.. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.|++||||||
T Consensus 127 l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 99886532222222 245899999942 3 77776543 234567899999999999999 99999999999
Q ss_pred CCEEeCCCCCeEEeeccccc
Q 010624 157 GNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 157 ~NILld~~g~vKL~DFGls~ 176 (506)
+|||++. .++|+|||+|.
T Consensus 200 ~NILl~~--~~~liDFG~a~ 217 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAV 217 (258)
T ss_dssp TSEEESS--SEEECCCTTCE
T ss_pred HHEEEcC--cEEEEECcccc
Confidence 9999988 99999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.9e-18 Score=174.40 Aligned_cols=136 Identities=17% Similarity=0.165 Sum_probs=100.6
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-------------hhhH--------HHHHHHHHHHhhCCCCC
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-------------RTDL--------DSIRRETKTMSLLSHPN 87 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-------------~~~~--------~~~~~Ei~il~~l~Hpn 87 (506)
|++...||.|+||.||+|.+ .+|+.||||+++.... .... -...+|...|..+.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d--~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD--EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC--TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEEC--CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 99999999999999999987 5689999999754210 0000 11235777777776555
Q ss_pred ceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC-
Q 010624 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS- 166 (506)
Q Consensus 88 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~- 166 (506)
+.-...+.... .++||||+.|++|..+.. . .....++.|++.+|.|||+.|+|||||||.|||++.+|.
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 43322222222 269999999988865432 1 235678899999999999999999999999999998763
Q ss_pred ---------eEEeeccccc
Q 010624 167 ---------VKLADFGVSA 176 (506)
Q Consensus 167 ---------vKL~DFGls~ 176 (506)
+.|+||+-+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 8999999643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=127.17 Aligned_cols=138 Identities=16% Similarity=0.131 Sum_probs=110.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 105 (506)
..|++...+|.|+++.||++.. ++..+++|....... .....+.+|+.+++.+. +..+.++++++...+..|+||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3699999999999999999864 367899999864211 11235789999999885 677888999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN--------------------------------------- 146 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs--------------------------------------- 146 (506)
||++|.+|.+.+.. ......++.++..+|..||+
T Consensus 90 e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999876321 12235788899999999998
Q ss_pred --------------------CCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 147 --------------------QGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 147 --------------------~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
..++|+|++|.||+++.++.+.|+||+.+
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 34789999999999987666779999863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=6.2e-12 Score=121.18 Aligned_cols=133 Identities=18% Similarity=0.154 Sum_probs=99.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeeeEEEeCCEEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV 104 (506)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.+ +.++++++..++..|+|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEec--CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 4577765555677799999854 45678999987543 2245678999999886545 45688888888889999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG------------------------------------ 148 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g------------------------------------ 148 (506)
|||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 94 LGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999998884 21 112 2356677777788887643
Q ss_pred ----------------------CccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 149 ----------------------HLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 149 ----------------------ivHrDIKp~NILld~~g~vKL~DFGls 175 (506)
++|+|++|.||+++.++.+.|+|||.+
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 899999999999987766789999974
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.3e-11 Score=121.83 Aligned_cols=142 Identities=15% Similarity=0.213 Sum_probs=105.8
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEec--cCCChhhHHHHHHHHHHHhhCC--CCCceeeeeEEEeC---CEE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID--LDQSRTDLDSIRRETKTMSLLS--HPNILNAHCSFSVD---SRL 101 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~--~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~ 101 (506)
..-++.|+.|.++.||++.. .+..+++|+.. ..........+.+|+.+++.+. +..+.+++.++.+. +..
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC---SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34577899999999999865 34578888765 3322222356778999999987 45577888888766 458
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN----------------------------------- 146 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs----------------------------------- 146 (506)
|+||||++|.++.+.. ...++......++.+++..|+.||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999998875421 2347888889999999999999997
Q ss_pred -----------------------CCCccCCCCCCCEEeCCCCC--eEEeecccccc
Q 010624 147 -----------------------QGHLHRDVKAGNILSDSDGS--VKLADFGVSAS 177 (506)
Q Consensus 147 -----------------------~givHrDIKp~NILld~~g~--vKL~DFGls~~ 177 (506)
..++|+|++|.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35799999999999997753 69999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=2e-10 Score=114.25 Aligned_cols=187 Identities=17% Similarity=0.178 Sum_probs=120.5
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCc--eeeeeEEEeCC---EEEEEe
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNI--LNAHCSFSVDS---RLWVVM 105 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~~---~~~lV~ 105 (506)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +..| .+++....... ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~------~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN------RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST------TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC------CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3458999999999751 3588887542 234567889999998873 4333 34444433332 358999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN--------------------------------------- 146 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs--------------------------------------- 146 (506)
+|++|.+|...... .++......++.+++..|+.||+
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99999988764432 46777888888899988888886
Q ss_pred -------------------CCCccCCCCCCCEEeCC--CCCeEEeeccccccccCCCCCCCCCCcccccCCCC-------
Q 010624 147 -------------------QGHLHRDVKAGNILSDS--DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT------- 198 (506)
Q Consensus 147 -------------------~givHrDIKp~NILld~--~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt------- 198 (506)
..++|+|++|.||+++. .+.+.|+||+.+................ ...+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~--~~~~~~~~~~~l 249 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD--EEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT--TSCCHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc--cccCHHHHHHHH
Confidence 13599999999999997 5568999999865432211000000000 00000
Q ss_pred --CccCC-hhhhhccCCCCccccHHHHHHHHHHHHhCCCCC
Q 010624 199 --PYWMA-PEVIRSHTGYSFKADIWSFGITALELAHGRPPL 236 (506)
Q Consensus 199 --~~y~A-PE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf 236 (506)
..... |+.... .....+.|++|.++|.+.+|.++|
T Consensus 250 ~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111 222211 122358999999999999998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=4.6e-07 Score=87.80 Aligned_cols=136 Identities=13% Similarity=0.156 Sum_probs=96.4
Q ss_pred eeEEeeecccCCe-eEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEec
Q 010624 29 YKILDEIGVGVSA-IVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 29 Y~i~~~IG~G~fg-~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 106 (506)
|+.. .+..|..+ .||+.... .++..+.+|.-.. .....+.+|...|+.+. +--|.++++++.+++..|+||+
T Consensus 27 ~~~~-~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 27 YRWA-RDNVGQSGATIYRLYGK-PNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp CEEE-EEECSSSSCEEEEEECC-TTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred CeEE-EccCCCcCCeEEEEEec-CCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 4433 34556655 68987653 4567788997642 23456788999998875 3236678888999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ--------------------------------------- 147 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~--------------------------------------- 147 (506)
+++|.++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99999988766431 112344556666666666631
Q ss_pred -------------------CCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 148 -------------------GHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 148 -------------------givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
.++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987777899999743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=5e-07 Score=89.81 Aligned_cols=132 Identities=17% Similarity=0.158 Sum_probs=92.8
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCC---CceeeeeEEE-eCCEEEEEecc
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP---NILNAHCSFS-VDSRLWVVMPF 107 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey 107 (506)
++.++.|....||+. +..+++|+.. .......+.+|..+|+.+.+. .|.+++.+.. ..+..|+||+|
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE------CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456789999999986 3457888742 233456788999999998753 2455666654 45567899999
Q ss_pred CCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 010624 108 MSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ---------------------------------------- 147 (506)
Q Consensus 108 ~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~---------------------------------------- 147 (506)
++|.+|.+..-. .++......++.++...|+.||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 999888764321 244555555566666666555542
Q ss_pred --------------------CCccCCCCCCCEEeCC---CCC-eEEeeccccc
Q 010624 148 --------------------GHLHRDVKAGNILSDS---DGS-VKLADFGVSA 176 (506)
Q Consensus 148 --------------------givHrDIKp~NILld~---~g~-vKL~DFGls~ 176 (506)
.++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3489999999999987 455 4899999754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.1e-05 Score=78.39 Aligned_cols=136 Identities=21% Similarity=0.240 Sum_probs=77.1
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-----CCCceeee-e--EEEeCCEEEE
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-----HPNILNAH-C--SFSVDSRLWV 103 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~~l 103 (506)
++.|+.|.++.||++.. .+ ..+++|+.... . ..+..|+.+++.|. .|.++... + +....+..|+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~-~~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DS-GAVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEECC----CEEEEEEE--TT-EEEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeeccccccCcEEEEEe--CC-CCEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 34567778999999865 33 45899988642 2 33444555555443 24443310 0 2245778899
Q ss_pred EeccCCCCCHH--------------HHHHhh---C--CCC-------CCHHH----------------------------
Q 010624 104 VMPFMSCGSLQ--------------SIISSC---F--PDG-------LPEPC---------------------------- 129 (506)
Q Consensus 104 V~Ey~~ggsL~--------------~~i~~~---~--~~~-------l~e~~---------------------------- 129 (506)
+|+|++|.++. ..++.. . +.. -.+..
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986431 011111 1 100 01110
Q ss_pred ---HHHHHHHHHHHHHHHHH-------------CCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 130 ---IAIVLKETLSALSYLHN-------------QGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 130 ---i~~i~~qil~gL~yLHs-------------~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+..+..++..++.+|+. ..++|+|++|.||+++.++.+.|+||+.+
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11122233445666652 57899999999999988889999999963
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=5e-06 Score=85.38 Aligned_cols=78 Identities=19% Similarity=0.120 Sum_probs=50.1
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC------hhhHHHHHHHHHHHhhCCC--CC-ceeeeeEEEeCCEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS------RTDLDSIRRETKTMSLLSH--PN-ILNAHCSFSVDSRL 101 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~------~~~~~~~~~Ei~il~~l~H--pn-Iv~l~~~~~~~~~~ 101 (506)
-.+.||.|.++.||++... .++..+++|....... ....+.+.+|..+++.+.. |. +.+++.+ +....
T Consensus 34 ~~~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEEECCCCceEEEEEEEEC-CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 4678999999999999653 3457899998653211 1123456789999887742 33 3445543 34456
Q ss_pred EEEeccCCCC
Q 010624 102 WVVMPFMSCG 111 (506)
Q Consensus 102 ~lV~Ey~~gg 111 (506)
++||||++|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=9.4e-06 Score=81.90 Aligned_cols=86 Identities=5% Similarity=-0.009 Sum_probs=55.9
Q ss_pred eeEEeee-cccCCeeEEEEEEeC-C----CCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCC-C--CCceeeeeEEEe
Q 010624 29 YKILDEI-GVGVSAIVYKAICIP-M----DSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLS-H--PNILNAHCSFSV 97 (506)
Q Consensus 29 Y~i~~~I-G~G~fg~Vyka~~~~-~----~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~ 97 (506)
....+.| +.|....+|++.... . ++..+++|+...... ......+.+|+.+++.+. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 899999999876520 0 156788997643220 001134668888888875 2 346677777665
Q ss_pred C---CEEEEEeccCCCCCHH
Q 010624 98 D---SRLWVVMPFMSCGSLQ 114 (506)
Q Consensus 98 ~---~~~~lV~Ey~~ggsL~ 114 (506)
. +..|+||||++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999986643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00019 Score=71.46 Aligned_cols=77 Identities=12% Similarity=0.074 Sum_probs=60.0
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC---CCCceeeeeEEEeCCEEEEEec
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS---HPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E 106 (506)
.-.+.|+.|.+..+|+... ++..+++|+... .....+.+|...|+.|. ...+.+++.+....+..|+|||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CEEEEECCSSSSEEEEEES---SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE---CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 3467789999999999753 466788898653 23567888999988874 3567788888888889999999
Q ss_pred cCCCCCH
Q 010624 107 FMSCGSL 113 (506)
Q Consensus 107 y~~ggsL 113 (506)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00014 Score=75.15 Aligned_cols=75 Identities=16% Similarity=0.123 Sum_probs=44.8
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccC-----CC-h--hhHHHHHHHHHHHh-hCCCCCceeeeeEEEeCCEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-----QS-R--TDLDSIRRETKTMS-LLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~-----~~-~--~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~ 101 (506)
-++.||.|..+.||++.. ++..+++|..... .. . .....+..|+..+. ......+.+++.+. .+..
T Consensus 38 ~i~~l~~G~~n~vyrv~~---~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~ 112 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG---SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA 112 (420)
T ss_dssp EEEECCCSSSCEEEEEEC---SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred EEEEccCCCcEEEEEEEc---CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence 367789999999999843 4678999953211 00 0 12223333433322 22234566666655 5667
Q ss_pred EEEeccC-CC
Q 010624 102 WVVMPFM-SC 110 (506)
Q Consensus 102 ~lV~Ey~-~g 110 (506)
++||||+ +|
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 8999999 76
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00041 Score=64.82 Aligned_cols=136 Identities=21% Similarity=0.144 Sum_probs=92.0
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCC
Q 010624 111 GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH-NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189 (506)
Q Consensus 111 gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLH-s~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 189 (506)
-||.+++... +.++++.++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 4799999865 789999999999999999987762 22222334456899999999998774 2211
Q ss_pred cccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccch
Q 010624 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNK 269 (506)
Q Consensus 190 ~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (506)
.....+.|||... ...+.+.=|||||+++|.-+--..|= ....
T Consensus 98 ------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------------~eE~ 140 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------------NEER 140 (229)
T ss_dssp ---------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------------TEEE
T ss_pred ------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------------ccch
Confidence 0122366888763 23567888999999999988532221 1335
Q ss_pred hhhHHHHHHHHhhccc-------------------------CCCCCCCHHHHHc
Q 010624 270 KFSRAFKDMVASCLDQ-------------------------DPSKRPSAEKLMK 298 (506)
Q Consensus 270 ~~s~~l~~Li~~~L~~-------------------------dP~~Rpt~~eiL~ 298 (506)
.+|+.+..||..|..- .+..|+|+.+|++
T Consensus 141 eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 141 ELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred hhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 6788899999888755 2467888888875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00018 Score=70.80 Aligned_cols=71 Identities=8% Similarity=0.044 Sum_probs=43.6
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCCEEEEEeccC-C
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDSRLWVVMPFM-S 109 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~-~ 109 (506)
++.|+.|....+|++ ..+++|+....... .-...+|+.+++.+...++ .++++++ ...-+++++|+ +
T Consensus 23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee-------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 678999999999987 34788887543111 1112467777777653333 3454433 33346899999 6
Q ss_pred CCCH
Q 010624 110 CGSL 113 (506)
Q Consensus 110 ggsL 113 (506)
|.+|
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0004 Score=69.20 Aligned_cols=138 Identities=10% Similarity=0.060 Sum_probs=70.9
Q ss_pred EeeecccCCee-EEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCC--CceeeeeEEEeCCEEEEEeccC
Q 010624 32 LDEIGVGVSAI-VYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP--NILNAHCSFSVDSRLWVVMPFM 108 (506)
Q Consensus 32 ~~~IG~G~fg~-Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~Ey~ 108 (506)
++.|+.|+... +|+... .++..+++|....... ..+..|+.+++.+... .+.+++.+....+ +++||++
T Consensus 23 ~~~l~gg~s~~~~~r~~~--~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS--PTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp ECC--------CCEEEEC--TTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eeECCCCCCCceEEEEEc--CCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 44566666555 666542 2256677776433211 2344677777766422 3455665533333 6899999
Q ss_pred CCCCHHHHHHhh---------------------CC---CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 010624 109 SCGSLQSIISSC---------------------FP---DGLPEPCIA-------IVL-------------KETLSALSYL 144 (506)
Q Consensus 109 ~ggsL~~~i~~~---------------------~~---~~l~e~~i~-------~i~-------------~qil~gL~yL 144 (506)
.+.++.+.+... .. ..++..... .+. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 877776544321 00 012221110 000 0111222333
Q ss_pred ------HHCCCccCCCCCCCEEeCCC----CCeEEeecccccc
Q 010624 145 ------HNQGHLHRDVKAGNILSDSD----GSVKLADFGVSAS 177 (506)
Q Consensus 145 ------Hs~givHrDIKp~NILld~~----g~vKL~DFGls~~ 177 (506)
+...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 12468999999999999874 6899999997553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0016 Score=63.49 Aligned_cols=78 Identities=17% Similarity=0.105 Sum_probs=54.2
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCC---CceeeeeEEEeCCEEEEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP---NILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~~~~~lV 104 (506)
...-+..+|.|..+.||++.. .+|+.|.+|+..... ......+.+|+..|+.|.-. -+.++++. +. -++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l--~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL--ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE--TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEE
T ss_pred CeEEEEecCCCCCeEEEEEEE--CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEE
Confidence 455678899999999999987 678899999864332 22234577899999888522 23444443 23 3689
Q ss_pred eccCCCCC
Q 010624 105 MPFMSCGS 112 (506)
Q Consensus 105 ~Ey~~ggs 112 (506)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0017 Score=64.10 Aligned_cols=141 Identities=15% Similarity=0.108 Sum_probs=78.2
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeee------EEEeCCE
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHC------SFSVDSR 100 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~ 100 (506)
..-++.|+.|....+|++.. .++ .+++|+..... ..+.+..|+.+++.+...+ +.+++. +....+.
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~--~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT--TKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEE--SSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEe--CCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34466788899999999875 334 68899876421 1234556777777664222 233321 1234567
Q ss_pred EEEEeccCCCCCHH-----H---------HHHhh---CCCC----CC---HHHHH-H-----------HHHHHHHHHHHH
Q 010624 101 LWVVMPFMSCGSLQ-----S---------IISSC---FPDG----LP---EPCIA-I-----------VLKETLSALSYL 144 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~-----~---------~i~~~---~~~~----l~---e~~i~-~-----------i~~qil~gL~yL 144 (506)
.+++|+|++|..+. . .++.. +... .. +.... . +...+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 89999999986431 0 11211 1111 11 11100 0 001133445555
Q ss_pred HH-------CCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 145 HN-------QGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 145 Hs-------~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+. .+++|+|+.|.||+++.++.+.|+||+.+
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 53 35899999999999987766689999863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0016 Score=64.41 Aligned_cols=75 Identities=13% Similarity=0.111 Sum_probs=48.1
Q ss_pred eeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCC--ceeeeeE-----EEeCCEEEEEe
Q 010624 33 DEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN--ILNAHCS-----FSVDSRLWVVM 105 (506)
Q Consensus 33 ~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~ 105 (506)
..++ |....||++.. .+|..+++|...... .....+..|..+++.+...+ +++++.. ...++..+++|
T Consensus 32 ~~l~-g~~n~~y~v~~--~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD--EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC--TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc--CCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3466 88899998754 346678999886332 12345667888887775222 3444332 23456778999
Q ss_pred ccCCCCC
Q 010624 106 PFMSCGS 112 (506)
Q Consensus 106 Ey~~ggs 112 (506)
+|++|.+
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00083 Score=69.76 Aligned_cols=75 Identities=13% Similarity=0.150 Sum_probs=49.9
Q ss_pred EEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCCEEEE
Q 010624 31 ILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDSRLWV 103 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 103 (506)
-++.|+.|....||++.... .++..+++|+...... .+.+.+|..+++.+...++ .++++.+. + .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 35678999999999987621 1246789998743211 2455579999888864444 45666554 2 38
Q ss_pred EeccCCCCC
Q 010624 104 VMPFMSCGS 112 (506)
Q Consensus 104 V~Ey~~ggs 112 (506)
|++|++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0015 Score=66.77 Aligned_cols=143 Identities=18% Similarity=0.255 Sum_probs=83.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDS 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~ 99 (506)
+..+ ++.|..|....+|++.... .++..+++|+.... ......+.+|..+++.+.--++ .++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence 3444 4567889999999986521 12467899985321 1234556689999988763333 456666543
Q ss_pred EEEEEeccCCCCCHH-----------HH---H---Hhh---CCCCC--CHHHHHHHHHHHHH------------------
Q 010624 100 RLWVVMPFMSCGSLQ-----------SI---I---SSC---FPDGL--PEPCIAIVLKETLS------------------ 139 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~-----------~~---i---~~~---~~~~l--~e~~i~~i~~qil~------------------ 139 (506)
.+||||++|.+|. .+ + +.. ..... -+..+..++.++-.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 2899999986542 11 1 111 01112 24566666655432
Q ss_pred -HHHHHH----HC----CCccCCCCCCCEEeCCC----CCeEEeeccccc
Q 010624 140 -ALSYLH----NQ----GHLHRDVKAGNILSDSD----GSVKLADFGVSA 176 (506)
Q Consensus 140 -gL~yLH----s~----givHrDIKp~NILld~~----g~vKL~DFGls~ 176 (506)
.+..|. .. .++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 22 47999999999999876 789999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0012 Score=66.89 Aligned_cols=75 Identities=12% Similarity=0.082 Sum_probs=43.5
Q ss_pred EeeecccCCeeEEEEEEeCC-------CCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCCEEEE
Q 010624 32 LDEIGVGVSAIVYKAICIPM-------DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDSRLWV 103 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~-------~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 103 (506)
...|+.|....+|++..... .+..+++|+..... ........|..+++.+...++ .++++.+ .+ ++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 55788899999999876210 12578899864321 111123578888887753343 4566544 22 68
Q ss_pred EeccCCCCC
Q 010624 104 VMPFMSCGS 112 (506)
Q Consensus 104 V~Ey~~ggs 112 (506)
||+|++|.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.013 Score=58.67 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=26.3
Q ss_pred CCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 147 ~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
..++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 357999999999999988899999998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.025 Score=59.02 Aligned_cols=76 Identities=20% Similarity=0.194 Sum_probs=47.8
Q ss_pred EEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCCEEEEEeccCC
Q 010624 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDSRLWVVMPFMS 109 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~ 109 (506)
-++.|+.|....+|++... ..+..+++|+..... ....+ -.+|..+++.|...++ .++++.+. + .+||+|++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~-~~~~~~vLRi~g~~~-~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDM-SKQAKYLIRLYGPKT-DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEET-TTTEEEEEEEECC-C-CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEEC-CCCceEEEEECCCCh-hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 3567899999999998762 224788899874322 11111 1478999998875555 45666663 2 25999998
Q ss_pred CCCH
Q 010624 110 CGSL 113 (506)
Q Consensus 110 ggsL 113 (506)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.15 E-value=0.021 Score=58.97 Aligned_cols=76 Identities=13% Similarity=0.112 Sum_probs=47.3
Q ss_pred EEeeecccCCeeEEEEEEeCCC------CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCCEEEE
Q 010624 31 ILDEIGVGVSAIVYKAICIPMD------STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDSRLWV 103 (506)
Q Consensus 31 i~~~IG~G~fg~Vyka~~~~~~------~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 103 (506)
-++.|..|....+|++.....+ +..+++|+..... ... -...+|..+++.+...+| .++++.+ .+ ++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKF-YDSKVELDVFRYLSNINIAPNIIADF--PE--GR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chh-cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence 3566788999999998763111 4678999864322 111 112478888887753333 4455543 22 68
Q ss_pred EeccCCCCC
Q 010624 104 VMPFMSCGS 112 (506)
Q Consensus 104 V~Ey~~ggs 112 (506)
||+|++|.+
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.05 E-value=0.26 Score=50.16 Aligned_cols=28 Identities=36% Similarity=0.527 Sum_probs=23.8
Q ss_pred CccCCCCCCCEEe------CCCCCeEEeeccccc
Q 010624 149 HLHRDVKAGNILS------DSDGSVKLADFGVSA 176 (506)
Q Consensus 149 ivHrDIKp~NILl------d~~g~vKL~DFGls~ 176 (506)
++|+|+.+.|||+ +.++.+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.14 E-value=0.83 Score=42.33 Aligned_cols=116 Identities=8% Similarity=0.009 Sum_probs=78.0
Q ss_pred CCCCCceeeeeEEEeCCEEEEEeccCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEe
Q 010624 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILS 161 (506)
Q Consensus 83 l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg-sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILl 161 (506)
..||+.+.. .+-.+++.+.+.++.-..+ ++.. +. .++....++++.+|+....++ ..-+|--|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE
Confidence 468888876 4556666666666654422 3332 33 377888999999998887544 345888999999999
Q ss_pred CCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCC
Q 010624 162 DSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLS 237 (506)
Q Consensus 162 d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~ 237 (506)
+.++.+++.=.|+-. -++|.- ++...=+-.+=|++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~------------------------~l~P~~------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQN------------------------VVDPLP------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETT------------------------TBSCCC------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCcc------------------------CCCCCC------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999888611 122211 1111223347788899999988874
|
| >1dip_A Delta-sleep-inducing peptide immunoreactive peptide; structure, leucine zipper, PIG, acetylation; NMR {Sus scrofa} SCOP: h.1.12.1 | Back alignment and structure |
|---|
Probab=83.65 E-value=0.78 Score=34.23 Aligned_cols=33 Identities=36% Similarity=0.290 Sum_probs=28.1
Q ss_pred HHHHHHHHHHHHHHhhhhhhHHHHHHHHHHhcc
Q 010624 466 QIVERLKMELETERRKNFELEMELEFLKHQISG 498 (506)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 498 (506)
.+||.||..+.+-..+|.+||.||..||...|.
T Consensus 15 EEVevLKe~I~EL~e~~~qLE~EN~~Lk~~asp 47 (78)
T 1dip_A 15 EEVEILKEQIRELVEKNSQLERENTLLKTLASP 47 (78)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCH
Confidence 357888888888899999999999999876653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.64 E-value=1.9 Score=40.00 Aligned_cols=83 Identities=14% Similarity=-0.062 Sum_probs=59.9
Q ss_pred CCCCCceeeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHHHCCCccCCCCCCCEEe
Q 010624 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS-YLHNQGHLHRDVKAGNILS 161 (506)
Q Consensus 83 l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~-yLHs~givHrDIKp~NILl 161 (506)
..||++ -..+-.+++.+.+.++.-+++.=+..+. .++....++++.+|+.... ++ ..-+|--|.|+||++
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f 117 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF 117 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence 458888 3344466777777777664443333443 3678888888888877665 44 455888999999999
Q ss_pred CCCCCeEEeeccc
Q 010624 162 DSDGSVKLADFGV 174 (506)
Q Consensus 162 d~~g~vKL~DFGl 174 (506)
+.++.+++.-.|+
T Consensus 118 ~~~~~p~i~hRGi 130 (219)
T 4ano_A 118 NRALEPFFLHVGV 130 (219)
T ss_dssp CTTCCEEESCCEE
T ss_pred eCCCcEEEEEcCC
Confidence 9999999998886
|
| >2jee_A YIIU; FTSZ, septum, coiled-coil, cell division, cell cycle, hypothetical protein; 2.8A {Escherichia coli} | Back alignment and structure |
|---|
Probab=80.89 E-value=2.2 Score=32.79 Aligned_cols=31 Identities=29% Similarity=0.382 Sum_probs=24.2
Q ss_pred hHHHHHHHHHHHHHHHHHHhhhhhhHHHHHH
Q 010624 461 EDQLMQIVERLKMELETERRKNFELEMELEF 491 (506)
Q Consensus 461 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (506)
-.+++.+|.-|+||+++-|.||..|..|++-
T Consensus 15 Iq~avdtI~lLqmEieELKekN~~L~~e~~e 45 (81)
T 2jee_A 15 VQQAIDTITLLQMEIEELKEKNNSLSQEVQN 45 (81)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3468888999999999999999886554444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.38 E-value=0.13 Score=53.79 Aligned_cols=63 Identities=16% Similarity=0.115 Sum_probs=18.5
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEE------EEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEE
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAI------KAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFS 96 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAI------K~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (506)
.+.+.|| ||.||++... ....+||+ |...... .......+.+|..+++.++|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~-~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAY-KKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC----------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhccccc-ccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556676 9999999884 23457888 6554322 2333456788999999999999999987765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 506 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-61 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-61 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-56 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-53 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-53 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-53 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-47 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-44 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-41 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 6e-70
Identities = 60/281 (21%), Positives = 123/281 (43%), Gaps = 18/281 (6%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
+ ++ +G G V A+ VA+K +D+ ++ ++I++E +L+H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + + ++ + + S G L I G+PEP + ++ + YLH G
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 149 HLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIR 208
HRD+K N+L D ++K++DFG++ +++ ++ M GT ++APE+++
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLLNKMCGTLPYVAPELLK 178
Query: 209 SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKN 268
++ D+WS GI + G P ++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------NPW 229
Query: 269 KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF-KNCNKG 308
KK A ++ L ++PS R + + K ++ K KG
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-69
Identities = 97/290 (33%), Positives = 144/290 (49%), Gaps = 24/290 (8%)
Query: 20 IQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK 78
+ L+P ++I+ E+G G VYKA S + A K ID S +L+ E
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTK-SEEELEDYMVEID 61
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
++ HPNI+ +F ++ LW+++ F + G++ +++ L E I +V K+TL
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTL 120
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
AL+YLH+ +HRD+KAGNIL DG +KLADFGVSA GT
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-------DSFIGT 173
Query: 199 PYWMAPEVIRSHT----GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
PYWMAPEV+ T Y +KAD+WS GIT +E+A PP L P + LL
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
++S FKD + CL+++ R + +L++H F
Sbjct: 234 TLAQ---------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 7e-68
Identities = 87/330 (26%), Positives = 150/330 (45%), Gaps = 49/330 (14%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L ++ + E+G G +V+K P V+A K I L+ + I RE + +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ P I+ + +F D + + M M GSL ++ +PE + V + L+Y
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTY 119
Query: 144 LHNQ-GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
L + +HRDVK NIL +S G +KL DFGVS + + +M GT +M
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------SMANSFVGTRSYM 170
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK-------------- 248
+PE ++ YS ++DIWS G++ +E+A GR P+ ++ LM
Sbjct: 171 SPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 249 ------------MTQRFRFSDYEKTLKIKDK------NKKFSRAFKDMVASCLDQDPSKR 290
M R + +E I ++ + FS F+D V CL ++P++R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 291 PSAEKLMKHSFFKNCN-KGVEF--FVKNVL 317
++LM H+F K + + V+F ++ + +
Sbjct: 290 ADLKQLMVHAFIKRSDAEEVDFAGWLCSTI 319
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 5e-67
Identities = 104/290 (35%), Positives = 143/290 (49%), Gaps = 23/290 (7%)
Query: 18 QKIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRE 76
+ I DP Y ++IG G S VY A+ + VAI+ ++L Q + + I E
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQ-QPKKELIINE 67
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKE 136
M +PNI+N S+ V LWVVM +++ GSL ++ + E IA V +E
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRE 124
Query: 137 TLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMA 196
L AL +LH+ +HRD+K+ NIL DGSVKL DFG A I M
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-------MV 177
Query: 197 GTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256
GTPYWMAPEV+ Y K DIWS GI A+E+ G PP + P ++L + T
Sbjct: 178 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
+K S F+D + CLD D KR SA++L++H F K
Sbjct: 237 QN---------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-66
Identities = 67/279 (24%), Positives = 120/279 (43%), Gaps = 20/279 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSL 82
+ + IG G VYK VA+K +++ + L + + E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGK----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 83 LSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
H NIL +S +L +V + SL + + + ++T +
Sbjct: 61 TRHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMD 118
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
YLH + +HRD+K+ NI D +VK+ DFG++ S H ++G+ WM
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-----QFEQLSGSILWM 173
Query: 203 APEVIR--SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
APEVIR YSF++D+++FGI EL G+ P S++ ++ + + + D
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--- 230
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ +A K ++A CL + +RP +++
Sbjct: 231 ---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 5e-66
Identities = 95/291 (32%), Positives = 133/291 (45%), Gaps = 29/291 (9%)
Query: 19 KIQYPLDPSS-YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRR 75
++ + DP + L EIG G VY A + +S VVAIK + QS I +
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 76 ETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
E + + L HPN + + + W+VM + + + P L E IA V
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTH 122
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
L L+YLH+ +HRDVKAGNIL G VKL DFG ++ +
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----------NSF 171
Query: 196 AGTPYWMAPEVIR--SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
GTPYWMAPEVI Y K D+WS GIT +ELA +PPL ++ +L
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
Query: 254 RFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
++ +S F++ V SCL + P RP++E L+KH F
Sbjct: 232 PA----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-65
Identities = 67/277 (24%), Positives = 121/277 (43%), Gaps = 27/277 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMSLLSHP 86
++I +G G VY A ++A+K + + +RRE + S L HP
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NIL + F +R+++++ + G++ + E A + E +ALSY H+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS 124
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ +HRD+K N+L S G +K+ADFG S + GT ++ PE+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---------LCGTLDYLPPEM 175
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
I + K D+WS G+ E G+PP +++ F F D+
Sbjct: 176 IEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------- 226
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ +D+++ L +PS+RP ++++H +
Sbjct: 227 ----VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 206 bits (526), Expect = 7e-63
Identities = 64/281 (22%), Positives = 119/281 (42%), Gaps = 22/281 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y I +E+G G +V++ A K + +D +++R+E +TMS+L HP +
Sbjct: 28 YDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTL 85
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+N H +F D+ + ++ FMS G L ++ + + E +++ L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 149 HLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
++H D+K NI+ + +KL DFG++A + GT + APEV
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--------TTGTAEFAAPEV 196
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
+ D+WS G+ + L G P +++L + + D
Sbjct: 197 AEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------S 247
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
S KD + L DP+ R + + ++H + N
Sbjct: 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-62
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 30/283 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y++L IG G K D ++ K +D + + + E + L HPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 88 ILNAHCSF--SVDSRLWVVMPFMSCGSLQSIISSCFPDG--LPEPCIAIVLKETLSALSY 143
I+ + ++ L++VM + G L S+I+ + L E + V+ + AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 144 LHNQGH-----LHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
H + LHRD+K N+ D +VKL DFG++ + + GT
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-------KAFVGT 177
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
PY+M+PE + Y+ K+DIWS G EL PP + ++ +FR Y
Sbjct: 178 PYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
++S +++ L+ RPS E+++++
Sbjct: 237 -----------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-62
Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 29/289 (10%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMSLL 83
P +K +G G + V A + S AIK ++ + + RE MS L
Sbjct: 7 PEDFKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HP + + +F D +L+ + + G L I E C E +SAL Y
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEY 123
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
LH +G +HRD+K NIL + D +++ DFG + + S S GT +++
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-----FVGTAQYVS 178
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PE++ +D+W+ G +L G PP + + F +
Sbjct: 179 PELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE------ 231
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK------LMKHSFFKNCN 306
KF +D+V L D +KR E+ L H FF++
Sbjct: 232 ------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 203 bits (518), Expect = 9e-62
Identities = 61/283 (21%), Positives = 118/283 (41%), Gaps = 22/283 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y IL+E+G G +V++ + V K I+ D +++ E M+ L HP +
Sbjct: 31 YDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKL 88
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+N H +F + +++ F+S G L I++ + E + +++ L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 149 HLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+H D+K NI+ + SVK+ DFG++ + T + APE+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--------ATAEFAAPEI 199
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
+ F D+W+ G+ L G P + ++L + F + D
Sbjct: 200 VDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--------D 250
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGV 309
S KD + + L ++P KR + ++H + K + +
Sbjct: 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-61
Identities = 64/283 (22%), Positives = 125/283 (44%), Gaps = 31/283 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
K EIG G VYK + + VA + + ++++ + E + + L HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 88 ILNAHCSFSVDSR----LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
I+ + S+ + + +V M+ G+L++ + + + ++ L L +
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQF 127
Query: 144 LHNQGH--LHRDVKAGNIL-SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
LH + +HRD+K NI + GSVK+ D G++ ++ + GTP
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---------LKRASFAKAVIGTPE 178
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
+MAPE+ Y D+++FG+ LE+A P S + ++T + + +
Sbjct: 179 FMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF-- 234
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+K K+++ C+ Q+ +R S + L+ H+FF+
Sbjct: 235 -------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 200 bits (509), Expect = 3e-61
Identities = 79/289 (27%), Positives = 132/289 (45%), Gaps = 33/289 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL--------DQSRTDLDSIRRETKTM 80
Y+ + +G GVS++V + I P A+K ID+ ++ + ++ +E +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 81 SLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
+S HPNI+ ++ ++ ++V M G L ++ L E +++ L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLE 121
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+ LH +HRD+K NIL D D ++KL DFG S + + ++ GTP
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--------DPGEKLREVCGTP 173
Query: 200 YWMAPEVIRS-----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254
++APE+I H GY + D+WS G+ L G PP H L M M+ ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 255 FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
F E +S KD+V+ L P KR +AE+ + H FF+
Sbjct: 234 FGSPE--------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 2e-60
Identities = 75/316 (23%), Positives = 130/316 (41%), Gaps = 25/316 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y D +G G + V A +VAIK I S+ E + + HPNI
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + L+++M +S G L I E + ++ + L A+ YLH+ G
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG 127
Query: 149 HLHRDVKAGNIL---SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+HRD+K N+L D D + ++DFG+S ++++ GTP ++APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLS--------KMEDPGSVLSTACGTPGYVAPE 179
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
V+ YS D WS G+ A L G PP K + + F
Sbjct: 180 VLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------S 230
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRS--V 323
S + KD + +++DP KR + E+ ++H + + ++V ++
Sbjct: 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFA 290
Query: 324 EERFKESRNHVGAEHH 339
+ ++K++ N H
Sbjct: 291 KSKWKQAFNATAVVRH 306
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-57
Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 22/276 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+DPS + EIG G +V+ + + VAIK I + + E + M L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIR--EGAMSEEDFIEEAEVMMKL 57
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
SHP ++ + + + +V FM G L + + + + + ++Y
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAY 116
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
L +HRD+ A N L + +K++DFG++ + + + G W +
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG------TKFPVKWAS 170
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEV + YS K+D+WSFG+ E+ ++ ++ FR
Sbjct: 171 PEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------ 223
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ S ++ C + P RP+ +L++
Sbjct: 224 ----PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-57
Identities = 67/311 (21%), Positives = 124/311 (39%), Gaps = 23/311 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y I +++G G IV++ + K + + TD +++E +++ H NI
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNI 63
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
L+ H SF L ++ F+S + I++ L E I + + AL +LH+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 149 HLHRDVKAGNIL--SDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
H D++ NI+ + ++K+ +FG + + + + P + APEV
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--------LFTAPEYYAPEV 174
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
+ H S D+WS G L G P ++ + M + F + +
Sbjct: 175 HQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE--------E 225
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKGVEFFVKNVLHGLRSVEER 326
K+ S D V L ++ R +A + ++H + K + V V L R
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTL 285
Query: 327 FKESRNHVGAE 337
K+ N V +
Sbjct: 286 IKKDLNMVVSA 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-57
Identities = 67/278 (24%), Positives = 110/278 (39%), Gaps = 30/278 (10%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
L+ K+L IG G V VA+K I D + + E M+ L
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGD---YRGNKVAVKCIKNDATA---QAFLAEASVMTQL 57
Query: 84 SHPNILNAH-CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
H N++ L++V +M+ GSL + S L C+ + A+
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
YL +HRD+ A N+L D K++DFG S+ W
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFG----------LTKEASSTQDTGKLPVKWT 167
Query: 203 APEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
APE +R +S K+D+WSFGI E + GR P +P + ++ ++ + ++
Sbjct: 168 APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYKM------ 219
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
D A +++ +C D + RPS +L +
Sbjct: 220 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-56
Identities = 62/277 (22%), Positives = 111/277 (40%), Gaps = 24/277 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL 83
+DP L E+G G +V VAIK I D E K M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNL 56
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
SH ++ + + ++++ +M+ G L + + + + K+ A+ Y
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
L ++ LHRD+ A N L + G VK++DFG+S + + + W
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS------VGSKFPVRWSP 169
Query: 204 PEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
PEV+ ++ +S K+DIW+FG+ E+ + G+ P + + Q R
Sbjct: 170 PEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQGLRLYR----- 222
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
S ++ SC + +RP+ + L+ +
Sbjct: 223 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-55
Identities = 78/294 (26%), Positives = 114/294 (38%), Gaps = 30/294 (10%)
Query: 31 ILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIR----RETKTMSLLSHP 86
LD +G G A VYKA + +VAIK I L D I RE K + LSHP
Sbjct: 2 KLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
NI+ +F S + +V FM I + L I + TL L YLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQ 118
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
LHRD+K N+L D +G +KLADFG++ S P+ + H T ++ APE+
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-------QVVTRWYRAPEL 171
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE------- 259
+ Y D+W+ G EL P L L ++ +
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 260 ---------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ + D++ +P R +A + +K +F N
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 1e-55
Identities = 61/279 (21%), Positives = 114/279 (40%), Gaps = 18/279 (6%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMS 81
+D S KI IG G V VAIK + + E M
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
HPN+++ + + + ++ FM GSL S + + +L+ + +
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIAAGM 141
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YL + ++HRD+ A NIL +S+ K++DFG+S + + + + SA+ W
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL--GGKIPIRW 199
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
APE I+ ++ +D+WS+GI E +++G P + + ++ + Q +R
Sbjct: 200 TAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-VINAIEQDYRL----- 252
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
A ++ C +D + RP +++
Sbjct: 253 -----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-55
Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 27/282 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMSL-LSH 85
+ + +G G V+ A + AIKA+ D D++ E + +SL H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 86 PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
P + + C+F L+ VM +++ G L I SC E + L +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH 120
Query: 146 NQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
++G ++RD+K NIL D DG +K+ADFG+ + G A GTP ++APE
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDYIAPE 173
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
++ Y+ D WSFG+ E+ G+ P E+ + +
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW------- 225
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEK-LMKHSFFKNCN 306
+ KD++ ++P KR + +H F+ N
Sbjct: 226 -----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-55
Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 24/288 (8%)
Query: 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK 78
K + + S ++ ++G G V+ +T VAIK + ++ +E +
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM--SPEAFLQEAQ 64
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
M L H ++ + S + +++V +MS GSL + L P + + +
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
S ++Y+ ++HRD++A NIL + K+ADFG++ I + + G
Sbjct: 124 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG------AKFP 177
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
W APE + ++ K+D+WSFGI EL + +L ++ + +R
Sbjct: 178 IKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--- 233
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK--HSFFKN 304
+ + D++ C ++P +RP+ E L +F +
Sbjct: 234 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-55
Identities = 76/326 (23%), Positives = 121/326 (37%), Gaps = 31/326 (9%)
Query: 29 YKILDE-IGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS-LLSHP 86
YK+ + +G+G++ V + A+K + D RRE + P
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKR-TQEKFALKMLQ------DCPKARREVELHWRASQCP 65
Query: 87 NILNAHCSF----SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
+I+ + + L +VM + G L S I E + ++K A+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 143 YLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
YLH+ HRDVK N+L S + +KL DFG + + TP
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--------PCYTP 177
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
Y++APEV+ Y D+WS G+ L G PP ++ M R R YE
Sbjct: 178 YYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYE 235
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK--GVEFFVKNVL 317
+ + S K ++ + L +P++R + + M H + K VL
Sbjct: 236 FP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 292
Query: 318 HGLRSVEERFKESRNHVGAEHHEDEE 343
+ E KE A D E
Sbjct: 293 KEDKERWEDVKEEMTSALATMRVDYE 318
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-55
Identities = 63/307 (20%), Positives = 119/307 (38%), Gaps = 43/307 (14%)
Query: 20 IQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRR 75
+++ + + +G G V A + T VA+K + ++ +++
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 89
Query: 76 ETKTMS-LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSC-------------- 120
E K M+ L SH NI+N + ++ ++++ + G L + + S
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149
Query: 121 -------FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFG 173
+ L + + + +L + +HRD+ A N+L VK+ DFG
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 174 VSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE-LAHG 232
++ I S++ G+A WMAPE + Y+ K+D+WS+GI E + G
Sbjct: 210 LARDIMSDSNYVVRGNAR-----LPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLG 263
Query: 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS 292
P +P + + + F+ D+ + ++ SC D KRPS
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 293 AEKLMKH 299
L
Sbjct: 314 FPNLTSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-54
Identities = 78/359 (21%), Positives = 140/359 (38%), Gaps = 43/359 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMSLLSHP 86
+ L +G G V A+K + + ++ ++ E++ + HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
+ +F RL VM + + G L +S E E +SAL YLH+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS 123
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ ++RD+K N++ D DG +K+ DFG+ GTP ++APEV
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-------FCGTPEYLAPEV 176
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
+ Y D W G+ E+ GR P + E+ + + + RF
Sbjct: 177 LE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---------- 225
Query: 267 KNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCNKGVEFFVKNVLHGLR 321
+ S K ++A L +DP +R A+++M+H FF + N ++V+ +
Sbjct: 226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW------QDVVQ--K 275
Query: 322 SVEERFKESRNHVGAEHHEDEEFE---VGSSPPVKQRRISGWNFNEEGFELDPVFPFFT 377
+ FK + D+EF + +PP + + ++ E +F F
Sbjct: 276 KLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQR--EEQEMFEDFD 332
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-54
Identities = 64/305 (20%), Positives = 114/305 (37%), Gaps = 35/305 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPN 87
Y+ L +IG G V+KA VA+K + ++ + + RE K + LL H N
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 88 ILNAHCSFSV--------DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
++N +++V F + I V++ L+
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLN 128
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L Y+H LHRD+KA N+L DG +KLADFG++ + + + T+ T
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN---RYTNRVVTL 185
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPL--------------------SHL 239
++ PE++ Y D+W G E+ P + +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
P + ++ +K + K D++ L DP++R ++ + H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 300 SFFKN 304
FF +
Sbjct: 306 DFFWS 310
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-54
Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 27/297 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPN 87
++ +++IG G +VYKA VVA+K I LD ++ + RE + L+HPN
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ +++L++V F+ + + +S G+P P I L + L L++ H+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L +++G++KLADFG++ + P + H T ++ APE++
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-------EVVTLWYRAPEIL 174
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL--LMKMTQRFRFSDYEKTLKIK 265
YS DIWS G E+ R L + + + +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 266 DKNKKF---------------SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307
D F + +++ L DP+KR SA+ + H FF++ K
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-54
Identities = 56/286 (19%), Positives = 115/286 (40%), Gaps = 24/286 (8%)
Query: 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETK 78
+ ++ + + K+++ +G G V+ T VA+K++ Q D+ E
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLK--QGSMSPDAFLAEAN 60
Query: 79 TMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
M L H ++ + + ++++ +M GSL + + L + + +
Sbjct: 61 LMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
++++ + ++HRD++A NIL S K+ADFG++ I + + G+
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA------KFP 173
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
W APE I T ++ K+D+WSFGI E+ ++ + + +R
Sbjct: 174 IKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK--HSFF 302
+ ++ C + P RP+ + L FF
Sbjct: 233 D----------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 180 bits (458), Expect = 2e-53
Identities = 67/285 (23%), Positives = 123/285 (43%), Gaps = 33/285 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMSLLSHP 86
++IL +G G V+ + A+K + + ++ E +S+++HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
I+ +F +++++M ++ G L S++ P P E AL YLH+
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLHS 122
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
+ ++RD+K NIL D +G +K+ DFG + + + + + GTP ++APEV
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----------VTYTLCGTPDYIAPEV 172
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
+ + Y+ D WSFGI E+ G P K+ + RF +
Sbjct: 173 VSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-------- 223
Query: 267 KNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
F+ KD+++ + +D S+R E + H +FK
Sbjct: 224 ----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-53
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 23/281 (8%)
Query: 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKT 79
Y + ++ IG G V++ I + ++ VAIK S + + +E T
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
M HP+I+ + ++ +W++M + G L+S + L + + + +
Sbjct: 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLST 119
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
AL+YL ++ +HRD+ A N+L S+ VKL DFG+S + + +++ +
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPI 173
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
WMAPE I ++ +D+W FG+ E L HG P + ++ ++ R
Sbjct: 174 KWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERL--- 228
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
++ C DPS+RP +L
Sbjct: 229 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-53
Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 29/287 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDL-----DQSRTDLDSIRRETKTMSLL 83
Y +E+G G A+V K A K I + + I RE + +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
HPN++ H + + + +++ ++ G L ++ + L E LK+ L+ + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 144 LHNQGHLHRDVKAGNILSDSDGS----VKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
LH+ H D+K NI+ +K+ DFG++ I + + + GTP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--------IFGTP 180
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
++APE++ + +AD+WS G+ L G P +++L + F D
Sbjct: 181 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED-- 237
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306
+ S KD + L +DP KR + + ++H + K +
Sbjct: 238 ------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-53
Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 34/303 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLD-SIRRETKTMSLLS--- 84
Y+ + EIG G V+KA + VA+K + + + S RE + L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 85 HPNILNAHCSFSV-----DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
HPN++ +V +++L +V + + P G+P I ++ + L
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQLLR 127
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L +LH+ +HRD+K NIL S G +KLADFG++ + T
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--------VVVTL 179
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH---------------LPPEKS 244
++ APEV+ Y+ D+WS G E+ +P LP E+
Sbjct: 180 WYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ + + I+ KD++ CL +P+KR SA + H +F++
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
Query: 305 CNK 307
+
Sbjct: 299 LER 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-53
Identities = 71/295 (24%), Positives = 122/295 (41%), Gaps = 29/295 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPN 87
Y+ L++IG G V+KA +VA+K + LD S RE + L H N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ H D +L +V F + L + L + L L + H++
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L + +G +KLA+FG++ + P + T ++ P+V+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-------EVVTLWYRPPDVL 173
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ---------------- 251
YS D+WS G ELA+ PL L ++ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 252 --RFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+ Y T + + K + +D++ + L +P +R SAE+ ++H +F +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 178 bits (452), Expect = 7e-53
Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 29/293 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPN 87
Y L++IG G +VYKA A+K I L+ + + RE + L H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I+ + RL +V + + + GL L + L+ ++Y H++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 148 GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVI 207
LHRD+K N+L + +G +K+ADFG++ + P + H T ++ AP+V+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-------EIVTLWYRAPDVL 172
Query: 208 RSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSL--LMKMTQRFRFSDYEKTLKIK 265
YS DIWS G E+ +G P + L + ++ ++ ++
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 266 DKNKKF---------------SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+ F + D+++ L DP++R +A++ ++H++FK
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-53
Identities = 64/290 (22%), Positives = 119/290 (41%), Gaps = 24/290 (8%)
Query: 24 LDPSSYKILD-EIGVGVSAIVYKAICIPMDS-TVVAIKAIDLDQSRTDLDSIRRETKTMS 81
L + I D E+G G V + + VAIK + + D + + RE + M
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 64
Query: 82 LLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
L +P I+ L +VM G L + + +P +A +L + +
Sbjct: 65 QLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGM 122
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
YL + +HRD+ A N+L + K++DFG+S ++ ++ SA W
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA----GKWPLKW 178
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
APE I +S ++D+WS+G+T E L++G+ P + + ++ + Q R
Sbjct: 179 YAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRM----- 231
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSA---EKLMKHSFFKNCNK 307
+ + +++ C RP E+ M+ ++ +K
Sbjct: 232 -----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (451), Expect = 1e-52
Identities = 56/278 (20%), Positives = 120/278 (43%), Gaps = 20/278 (7%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTM 80
++ ++ + + ++G G VY+ + S VA+K + D +++ +E M
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED--TMEVEEFLKEAAVM 67
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
+ HPN++ + + +++ FM+ G+L + C + + + + SA
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YL + +HRD+ A N L + VK+ADFG+S + ++ H
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH------AGAKFPIK 181
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
W APE + + +S K+D+W+FG+ E+A + + + +R
Sbjct: 182 WTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----- 235
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
++ + +++ +C +PS RPS ++ +
Sbjct: 236 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-52
Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 26/292 (8%)
Query: 24 LDPSSYKILD-EIGVGVSAIVYKAICIPMDS-TVVAIKAIDLD-QSRTDLDSIRRETKTM 80
LD + D E+G G V K VA+K + + D + E M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
L +P I+ +S +VM G L + + + I ++ +
Sbjct: 63 QQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMG 119
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YL +HRD+ A N+L + K++DFG+S ++ +++ T
Sbjct: 120 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVK 175
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
W APE I + +S K+D+WSFG+ E ++G+ P + + + + + R
Sbjct: 176 WYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERM---- 229
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL---MKHSFFKNCNKG 308
R D++ C D RP + +++ ++ N+G
Sbjct: 230 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (455), Expect = 2e-52
Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 31/288 (10%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAID-----LDQSRTDLDSIRRETKTMSLL 83
+ + IG G VY + A+K +D + Q T + R +S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 84 SHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
P I+ +F +L ++ M+ G L +S E + E + L +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEH 122
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+HN+ ++RD+K NIL D G V+++D G++ + H GT +MA
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PEV++ Y AD +S G +L G P + ++ + E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVE---- 227
Query: 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306
FS + ++ L +D ++R A+++ + FF++ +
Sbjct: 228 ---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 176 bits (446), Expect = 4e-52
Identities = 60/281 (21%), Positives = 123/281 (43%), Gaps = 22/281 (7%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD--QSRTDLDSIRRETKTMSLLSHP 86
Y++ + +G G + V+ A + VA+K + D + + RRE + + L+HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 87 NILNAHCSFSVDS----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
I+ + + ++ ++VM ++ +L+ I+ + P + V+ + AL+
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALN 125
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+ H G +HRDVK NI+ + +VK+ DFG++ +I + + +A+I GT ++
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI----GTAQYL 181
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
+PE R ++D++S G E+ G PP + P + +
Sbjct: 182 SPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS----- 235
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303
+++ S +V L ++P R M+ +
Sbjct: 236 ---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-52
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 33/300 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y L IG G +V A + VAIK I + +T RE K + H NI
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68
Query: 89 LNAHCSFSVDS-----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
+ + + +++V M + + L I L + L L Y
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKY 124
Query: 144 LHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMA 203
+H+ LHRD+K N+L ++ +K+ DFG++ H +T+ T ++ A
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG----FLTEYVATRWYRA 180
Query: 204 PEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263
PE++ + GY+ DIWS G E+ RP L + S +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 264 IKDKNKKF-------------------SRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
I K + + D++ L +P KR E+ + H + +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-52
Identities = 55/281 (19%), Positives = 105/281 (37%), Gaps = 22/281 (7%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLD--QSRTDLDSIRRETKT 79
+ ++L+++G G +V + VA+K + D +D RE
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 80 MSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLS 139
M L H N++ + + +V GSL + ++ +
Sbjct: 65 MHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAE 122
Query: 140 ALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
+ YL ++ +HRD+ A N+L + VK+ DFG+ ++ + H+ M
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV----MQEHRKVPF 178
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258
W APE +++ +S +D W FG+T E +G+ P L + L + R
Sbjct: 179 AWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--- 234
Query: 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ + + +++ C P RP+ L
Sbjct: 235 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-51
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 42/292 (14%)
Query: 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-----QSRTDLDSIRRET 77
PL+ S Y++ +G G VY I + D+ VAIK ++ D + + E
Sbjct: 1 PLE-SQYQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 78 KTMSLLS--HPNILNAHCSFSVDSRLWVVMPFMSCGS-LQSIISSCFPDGLPEPCIAIVL 134
+ +S ++ F +++ L I+ L E
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFF 116
Query: 135 KETLSALSYLHNQGHLHRDVKAGNILSDSD-GSVKLADFGVSASIYEPSHHHHHGSAMIT 193
+ L A+ + HN G LHRD+K NIL D + G +KL DFG A + + + T
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---------VYT 167
Query: 194 DMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRF 253
D GT + PE IR H + A +WS GI ++ G P
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------------ 209
Query: 254 RFSDYEKTLKIK-DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
F E+ ++ + ++ S + ++ CL PS RP+ E++ H + ++
Sbjct: 210 -FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-51
Identities = 58/278 (20%), Positives = 102/278 (36%), Gaps = 19/278 (6%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRTDLDSIRRETKTM 80
+ PS IG G VYK + VAIK + + E M
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
SH NI+ S + ++ +M G+L + + + +L+ +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAG 122
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
+ YL N ++HRD+ A NIL +S+ K++DFG+S + + + +
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY----TTSGGKIPIR 178
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260
W APE I ++ +D+WSFGI E+ ++ + FR
Sbjct: 179 WTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----- 232
Query: 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
A ++ C Q+ ++RP ++
Sbjct: 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 4e-51
Identities = 60/307 (19%), Positives = 123/307 (40%), Gaps = 44/307 (14%)
Query: 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSI 73
++YP + + + + +IG G V++A + T+VA+K + + S
Sbjct: 6 LSLEYPRN--NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 74 RRETKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSII---------------- 117
+RE M+ +PNI+ +V + ++ +M+ G L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 118 ------SSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171
SS P L + ++ + ++YL + +HRD+ N L + VK+AD
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 172 FGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH 231
FG+S +IY ++ G+ A WM PE I + Y+ ++D+W++G+ E+
Sbjct: 184 FGLSRNIYSADYYKADGN-----DAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFS 237
Query: 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP 291
+ + ++ + I + +++ C + P+ RP
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDG----------NILACPENCPLELYNLMRLCWSKLPADRP 287
Query: 292 SAEKLMK 298
S + +
Sbjct: 288 SFCSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 2e-50
Identities = 51/282 (18%), Positives = 101/282 (35%), Gaps = 16/282 (5%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI 88
Y++ +IG G +Y I VAIK + + E+K ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVG 64
Query: 89 LNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG 148
+ + V++ + SL+ + + C + ++ + +S + Y+H++
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 149 HLHRDVKAGNILSDSDGS---VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPE 205
+HRDVK N L V + DFG++ + H H ++ GT + +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 206 VIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265
S + D+ S G + G P L K + R S+ + + I+
Sbjct: 184 THLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMSTPIE 238
Query: 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAE---KLMKHSFFKN 304
K + F + C +P +L ++ F +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-50
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 23/280 (8%)
Query: 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV---VAIKAIDLDQSRTDLDSIRRETKTM 80
L + +K + +G G VYK + IP V VAIK + S I E M
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 81 SLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
+ + +P++ + S + ++ M G L + D + + +
Sbjct: 66 ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKG 123
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
++YL ++ +HRD+ A N+L + VK+ DFG++ + +H
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-----AEGGKVPIK 178
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALEL-AHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259
WMA E I H Y+ ++D+WS+G+T EL G P +P + + + + R
Sbjct: 179 WMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL---- 232
Query: 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ + ++ C D RP +L+
Sbjct: 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-49
Identities = 74/290 (25%), Positives = 135/290 (46%), Gaps = 28/290 (9%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDST--VVAIKAID---LDQSRTDLDSIRRETKTMSLL 83
+++L +G G V+ I T + A+K + + Q + R E + + +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 84 SH-PNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALS 142
P ++ H +F +++L +++ +++ G L + +S E + I + E + AL
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALE 143
Query: 143 YLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
+LH G ++RD+K NIL DS+G V L DFG+S + D GT +M
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY------DFCGTIEYM 197
Query: 203 APEVIR-SHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261
AP+++R +G+ D WS G+ EL G P + EK+ ++++R S+
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPP-- 254
Query: 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306
++ S KD++ L +DP KR A+++ +H FF+ N
Sbjct: 255 -----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-49
Identities = 63/309 (20%), Positives = 119/309 (38%), Gaps = 48/309 (15%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPN 87
Y+++ ++G G + V++AI I ++ V +K + I+RE K + L PN
Sbjct: 37 YQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILK----PVKKKKIKREIKILENLRGGPN 91
Query: 88 ILNAHCSF--SVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLH 145
I+ V +V ++ + + + L + I + E L AL Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH 146
Query: 146 NQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAP 204
+ G +HRDVK N++ D + ++L D+G++ + ++ + Y+ P
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--------RVASRYFKGP 198
Query: 205 EVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQ------------- 251
E++ + Y + D+WS G + + P H L+++ +
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 252 -----RFRFSDYEKTLKIKDKNKKF--------SRAFKDMVASCLDQDPSKRPSAEKLMK 298
RF+D K + S D + L D R +A + M+
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 299 HSFFKNCNK 307
H +F K
Sbjct: 319 HPYFYTVVK 327
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-49
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 37/300 (12%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICI------PMDSTVVAIKAIDLDQSRTDLDSIR 74
++ L + +G G V A I P T VA+K + D + DL +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 75 RETKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--------- 124
E + M ++ H NI+N + + D L+V++ + S G+L+ + + P G
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 125 -----LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179
L + + + YL ++ +HRD+ A N+L D +K+ADFG++ I+
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHL 239
++ + WMAPE + Y+ ++D+WSFG+ E+
Sbjct: 187 HIDYYKKTTN-----GRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
P + L + + R DK + M+ C PS+RP+ ++L++
Sbjct: 241 VPVEELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-49
Identities = 59/291 (20%), Positives = 114/291 (39%), Gaps = 28/291 (9%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRE 76
++ + + E+G G +VY+ + + T VAIK ++ S + E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 77 TKTMSLLSHPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDG--------LPEP 128
M + +++ S V+M M+ G L+S + S P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 129 CIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHG 188
+ + E ++YL+ +HRD+ A N + D +VK+ DFG++ IYE ++ G
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 189 SAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMK 248
+ WM+PE ++ ++ +D+WSFG+ E+A + +L
Sbjct: 194 KGL-----LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 249 MTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ + DK +++ C +P RPS +++
Sbjct: 248 VMEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (425), Expect = 8e-49
Identities = 47/276 (17%), Positives = 98/276 (35%), Gaps = 17/276 (6%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PN 87
YK+ IG G ++++ + ++ VAIK R+D +R E +T LL+
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTG 62
Query: 88 ILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQ 147
I N + +V+ + + +A+ K+ L+ + +H +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120
Query: 148 GHLHRDVKAGNILSDS-----DGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWM 202
++RD+K N L + + DFG+ +P H +++GT +M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 203 APEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262
+ S + D+ + G + G P L + R + +++
Sbjct: 181 SINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----NKQKYERIGEKKQST 235
Query: 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+++ F F + + P + L
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-49
Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 39/302 (12%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
SY IG G +VY+A +VAIK + D+ RE + M L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKRF-----KNRELQIMRKLDHCN 74
Query: 88 ILNAHCSFSVDSR------LWVVMPFMSCGSLQSIISSCFPDG-LPEPCIAIVLKETLSA 140
I+ F L +V+ ++ + LP + + + + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSV-KLADFGVSASIYEPSHHHHHGSAMITDMAGTP 199
L+Y+H+ G HRD+K N+L D D +V KL DFG + + + +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSR 186
Query: 200 YWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMT--------- 250
Y+ APE+I T Y+ D+WS G EL G+P L+ +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 251 --------QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302
F+F + K + + + L+ P+ R + + HSFF
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 303 KN 304
Sbjct: 307 DE 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 9e-49
Identities = 60/298 (20%), Positives = 113/298 (37%), Gaps = 38/298 (12%)
Query: 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPN 87
+ + + IG G V++ VA+K + R+ E +L H N
Sbjct: 4 TIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWF--REAEIYQTVMLRHEN 58
Query: 88 ILNAHCSFSVD----SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSY 143
IL + + D ++LW+V + GSL ++ + + + T S L++
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 115
Query: 144 LHNQ--------GHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
LH + HRD+K+ NIL +G+ +AD G++ +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP---NHR 172
Query: 196 AGTPYWMAPEVIRS-----HTGYSFKADIWSFGITALELAHGRP----------PLSHLP 240
GT +MAPEV+ H +ADI++ G+ E+A P L
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 241 PEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
P + +M + + + ++ + R ++ C + + R +A ++ K
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-49
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 38/300 (12%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRE 76
++ + +G G V +A + + VA+K + T+ +++ E
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 77 TKTMSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPD------------ 123
K +S L H NI+N + ++ V+ + G L + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 124 ----GLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179
L + + +++L ++ +HRD+ A NIL K+ DFG++ I
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALE-LAHGRPPLSH 238
S++ + WMAPE I + Y+F++D+WS+GI E + G P
Sbjct: 197 NDSNYVVK-----GNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 239 LPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298
+P + + + FR + D++ +C D DP KRP+ +++++
Sbjct: 251 MPVDSKFYKMIKEGFRMLS----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-48
Identities = 65/295 (22%), Positives = 107/295 (36%), Gaps = 36/295 (12%)
Query: 22 YP-LDPSSYKILDEIGVGVSAIVYKAICIPMDSTV-VAIKAIDLDQSRTDLDSIRRETKT 79
YP LD + K D IG G V KA + AIK + S+ D E +
Sbjct: 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 80 MSLLS-HPNILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DG 124
+ L HPNI+N + L++ + + G+L +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 125 LPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184
L + + + YL + +HRD+ A NIL + K+ADFG+S
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS 244
T WMA E + ++ Y+ +D+WS+G+ E+
Sbjct: 184 --------TMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
L K+ Q +R +K D++ C + P +RPS +++
Sbjct: 235 LYEKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-47
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 21/290 (7%)
Query: 16 IAQKIQYPLDPSSYKIL---DEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDL 70
+ Q +Q+ + S I+ + IG G VY + D A+K+++ ++
Sbjct: 13 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72
Query: 71 DSIRRETKTMSLLSHPNILNAH-CSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPC 129
E M SHPN+L+ + VV+P+M G L++ I
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKD 131
Query: 130 IAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGS 189
+ + + +L ++ +HRD+ A N + D +VK+ADFG++ +Y+ H
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 190 AMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKM 249
T WMA E +++ ++ K+D+WSFG+ EL P + + +
Sbjct: 192 ---TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
Query: 250 TQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
Q R + +++ C RPS +L+
Sbjct: 248 LQGRRLLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 41/307 (13%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLS 84
+ Y+ L +G G V A+ VAIK + QS RE + + +
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 85 HPNILNAHCSFSVDSRL------WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETL 138
H N++ F+ D L ++VMPFM + + + L E I ++ + L
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLVYQML 131
Query: 139 SALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGT 198
L Y+H G +HRD+K GN+ + D +K+ DFG++ + +T T
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RQADSEMTGYVVT 181
Query: 199 PYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSH--------------LPPEKS 244
++ APEVI + Y+ DIWS G E+ G+ P
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 245 LLMKMTQRFRFSDYEKTLKIKDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
+ ++ + + +++ K+ S +++ L D +R +A + + H
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
Query: 300 SFFKNCN 306
+F++ +
Sbjct: 302 PYFESLH 308
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (409), Expect = 6e-46
Identities = 62/285 (21%), Positives = 114/285 (40%), Gaps = 33/285 (11%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHP 86
+ + +G G V A+K +D + ++ E + + ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 87 NILNAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN 146
++ SF +S L++VM +++ G + S + EP + + YLH+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS 159
Query: 147 QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEV 206
++RD+K N+L D G +++ DFG + + + GTP +APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAPEI 209
Query: 207 IRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266
I S GY+ D W+ G+ E+A G PP P + ++ + RF
Sbjct: 210 ILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--------- 259
Query: 267 KNKKFSRAFKDMVASCLDQDPSKR-----PSAEKLMKHSFFKNCN 306
FS KD++ + L D +KR + H +F +
Sbjct: 260 ---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-45
Identities = 60/300 (20%), Positives = 115/300 (38%), Gaps = 37/300 (12%)
Query: 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRE 76
++ K+ +G G V +A +D T VA+K + + ++ ++ E
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 77 TKTMSLLSHPNILN--AHCSFSVDSRLWVVMPFMSCGSLQSIISSC-------------- 120
K + + H + L V++ F G+L + + S
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180
+ D L + + + +L ++ +HRD+ A NIL VK+ DFG++ IY+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG-RPPLSHL 239
+ G A WMAPE I Y+ ++D+WSFG+ E+ P +
Sbjct: 187 DPDYVRKGDAR-----LPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 240 PPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299
++ ++ + R + + C +PS+RP+ +L++H
Sbjct: 241 KIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-44
Identities = 64/302 (21%), Positives = 114/302 (37%), Gaps = 37/302 (12%)
Query: 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLS 84
P Y+ L +G G V A VA+K + QS RE + + +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 85 HPNILNAHCSFSVDSRLW----VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSA 140
H N++ F+ L V + G+ + I C L + + ++ + L
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRG 133
Query: 141 LSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPY 200
L Y+H+ +HRD+K N+ + D +K+ DFG++ + + T +
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----------TRW 183
Query: 201 WMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLS--------------HLPPEKSLL 246
+ APE++ + Y+ DIWS G EL GR P LL
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 247 MKMTQRFRFSDYEKTLKIKDKN-----KKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSF 301
K++ + + ++ N + D++ L D KR +A + + H++
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 302 FK 303
F
Sbjct: 304 FA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 52/313 (16%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD-QSRTDLDSIRRETKTMSLLSHPN 87
Y+ L IG G IV A VAIK + Q++T RE M ++H N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 88 ILNAHCSFSVDS------RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSAL 141
I++ F+ +++VM M Q I ++ +L + L +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGI 132
Query: 142 SYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYW 201
+LH+ G +HRD+K NI+ SD ++K+ DFG++ S M+T T Y+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTSFMMTPYVVTRYY 184
Query: 202 MAPEVIRSHTGYSFKADIWSFGITALELAHGRPP----------------LSHLPPEKSL 245
APEVI GY DIWS G E+ + L PE
Sbjct: 185 RAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 246 LMKMTQRFRFSDYEKTLKIK--------------DKNKKFSRAFKDMVASCLDQDPSKRP 291
++ T R + K + + NK + +D+++ L DP+KR
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 292 SAEKLMKHSFFKN 304
S + ++H +
Sbjct: 304 SVDDALQHPYINV 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 5e-33
Identities = 72/339 (21%), Positives = 122/339 (35%), Gaps = 71/339 (20%)
Query: 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSL 82
P + Y ++ ++G G + V+ A + ++T VA+K + D+ T+ + E K +
Sbjct: 9 PYKDARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDKVYTE--AAEDEIKLLQR 65
Query: 83 LSHPNI-------------LNAHCSFSVDSRLWVVMPFMSCGSLQ-SIISSCFPDGLPEP 128
++ + L H + + + VVM F G ++I G+P
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 129 CIAIVLKETLSALSYLH-NQGHLHRDVKAGNILSDSDG------SVKLADFGVSASIYEP 181
+ + K+ L L Y+H G +H D+K N+L + +K+AD G + E
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPP------ 235
+ T + +PEV+ + ADIWS EL G
Sbjct: 186 YTNSI----------QTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEG 234
Query: 236 ----------------LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDK------------ 267
L LP K T+ F S K K
Sbjct: 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294
Query: 268 --NKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304
+K ++ D ++ L DP KR A L+ H + K+
Sbjct: 295 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 5e-15
Identities = 26/215 (12%), Positives = 53/215 (24%), Gaps = 40/215 (18%)
Query: 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS---------RTDLDSIRRETKT 79
I +G G + V+ +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59
Query: 80 MSLLSHPNILNAHCSFSVD----SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLK 135
+ + V+M + + VL
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK---------ELYRVRVENPDEVLD 110
Query: 136 ETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDM 195
L ++ +++G +H D+ N+L S+ + + DF S + E
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEE-------------G 156
Query: 196 AGTPYWMAPEVIRSHTG--YSFKADIWSFGITALE 228
I ++ Y + DI S L+
Sbjct: 157 WREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.86 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.6 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-60 Score=467.25 Aligned_cols=262 Identities=22% Similarity=0.374 Sum_probs=218.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 57999999999999999999995 67899999999876555556778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 84 y~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~---- 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 157 (271)
T ss_dssp CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred ccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC----
Confidence 9999999999976 4679999999999999999999999999999999999999999999999999976432111
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.........||+.|||||++.+...++.++|||||||++|+|++|++||................... ..
T Consensus 158 -~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------~~ 227 (271)
T d1nvra_ 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------LN 227 (271)
T ss_dssp -EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------ST
T ss_pred -ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------CC
Confidence 11123345799999999999876645788999999999999999999997665544333333322211 11
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
....+|+++++||.+||+.||++|||+.++++||||++.
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 345688999999999999999999999999999999853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=458.58 Aligned_cols=258 Identities=39% Similarity=0.646 Sum_probs=221.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++++.||+|+||+||+|.++ .+|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 357999999999999999999985 6689999999875543 33577899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 97 Ey~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp ECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 99999999999876 57999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIK 265 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||................... .
T Consensus 170 ---~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---------~ 236 (293)
T d1yhwa1 170 ---QSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------L 236 (293)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------C
T ss_pred ---cccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---------C
Confidence 12233456999999999998754 8999999999999999999999998777666554444332110 1
Q ss_pred ccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 266 DKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 266 ~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..+..+++.+++||.+||+.||.+|||+.|+|+||||+..
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1345689999999999999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=454.27 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=219.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.++|++++.||+|+||+||+|.++ .+++.||+|++.... .....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 368999999999999999999995 678999999986432 12345678899999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 84 vmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 9999999999999987 36799999999999999999999999999999999999999999999999999753321
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.......||+.|||||++.+.. |+.++|||||||++|+|++|++||...+............+.
T Consensus 159 ------~~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------- 222 (263)
T d2j4za1 159 ------SRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------- 222 (263)
T ss_dssp ------CCCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------
T ss_pred ------CcccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 1223456999999999998754 899999999999999999999999876665544433332222
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.+..+|+++++||.+||+.||++|||+.|+|+||||..
T Consensus 223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 33468899999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-58 Score=458.85 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=208.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.+.|++.+.||+|+||+||+|.++ .+++.||||++...........+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356999999999999999999985 5789999999987655555567889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC---CCCCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD---SDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld---~~g~vKL~DFGls~~~~~~~ 182 (506)
|||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|......
T Consensus 87 E~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 99999999999987 57899999999999999999999999999999999999995 5789999999997533211
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.......||+.|||||++.+.. |+.++|||||||++|+|++|.+||..................++.
T Consensus 164 -------~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----- 230 (307)
T d1a06a_ 164 -------SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----- 230 (307)
T ss_dssp ----------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-----
T ss_pred -------CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-----
Confidence 1223456999999999998754 899999999999999999999999877666655554444333221
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.....+|+++++||.+||+.||++|||+.|+++||||++.
T Consensus 231 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 ---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1345789999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-58 Score=454.43 Aligned_cols=265 Identities=36% Similarity=0.604 Sum_probs=223.1
Q ss_pred cCCCC-CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 22 YPLDP-SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 22 ~~~~~-~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
..+++ +.|++++.||+|+||+||+|.++ .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++.
T Consensus 6 r~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 6 RDLNPEDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp ESSCGGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcccCeEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 34444 45999999999999999999985 678999999997653 3445778899999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+|||||+||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999999998764 45799999999999999999999999999999999999999999999999999753211
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhc----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRS----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.........||+.|+|||++.. ...|+.++|||||||++|+|++|.+||......+............
T Consensus 163 -------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~- 234 (288)
T d2jfla1 163 -------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT- 234 (288)
T ss_dssp -------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-
T ss_pred -------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 1112234579999999999852 2348899999999999999999999998877766655544432211
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
...+..+|+++++||.+||+.||.+|||+.|+++||||+..
T Consensus 235 --------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 235 --------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp --------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred --------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11345689999999999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-58 Score=455.30 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=220.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
.+++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|++++||||++++++|.+++.+|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 4578999999999999999999995 568999999986532 1234577899999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
+|||||+||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 85 ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999999987 4689999999999999999999999999999999999999999999999999976432111
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||...+.......+....+.
T Consensus 163 -----~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-------- 228 (288)
T d1uu3a_ 163 -----KQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-------- 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred -----cccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence 111223456999999999998765 899999999999999999999999877665554444433222
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHH------HHcCcccccccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEK------LMKHSFFKNCNK 307 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~e------iL~hp~f~~~~~ 307 (506)
.+..+++++++||.+||+.||.+|||++| +++||||++++.
T Consensus 229 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 229 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp ----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 23468899999999999999999999988 578999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=463.56 Aligned_cols=272 Identities=31% Similarity=0.507 Sum_probs=220.6
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEE
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLW 102 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (506)
++..++|++++.||+|+||+||+|.++ .+|+.||+|++.........+.+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999985 6789999999987666666788999999999999999999999999999999
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
+|||||+||+|.+++.+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|.....
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999999999873 679999999999999999999997 5999999999999999999999999999764321
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-------
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR------- 254 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~------- 254 (506)
.......||++|+|||++.+.. |+.++||||+||++|||++|+.||..................
T Consensus 158 --------~~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 158 --------SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp --------HTC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred --------CccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 1122357999999999998755 999999999999999999999999765443221111000000
Q ss_pred -------------------ccchhhh--h----hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 255 -------------------FSDYEKT--L----KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 255 -------------------~~~~~~~--~----~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
....... . ........+|.++++||.+||+.||.+|||+.|+|+||||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0000000 0 000112246889999999999999999999999999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-57 Score=444.54 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=215.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe----CCEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV----DSRL 101 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 101 (506)
.-|++.++||+|+||+||+|.++ .+++.||+|.+.... .....+.+.+|+++|++++|||||+++++|.+ +..+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 34588889999999999999995 568899999987654 45556789999999999999999999999875 4578
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCCCCEEeC-CCCCeEEeeccccccc
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQG--HLHRDVKAGNILSD-SDGSVKLADFGVSASI 178 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~g--ivHrDIKp~NILld-~~g~vKL~DFGls~~~ 178 (506)
|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|...
T Consensus 88 ~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999999873 67999999999999999999999998 99999999999997 5889999999998532
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .......||+.|||||++.+ .|+.++|||||||++|+|++|+.||............+.......
T Consensus 166 ~~---------~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~-- 232 (270)
T d1t4ha_ 166 RA---------SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-- 232 (270)
T ss_dssp CT---------TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--
T ss_pred cC---------CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--
Confidence 21 12234569999999999975 389999999999999999999999987666665555544432211
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
..+..+++++++||.+||+.||++|||+.|+|+||||+
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 13345788999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-57 Score=453.06 Aligned_cols=254 Identities=35% Similarity=0.567 Sum_probs=218.9
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.|++++.||+|+||+||+|.++ .+++.||||++..... ....+.+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4999999999999999999985 6789999999976543 344567899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||.||+|..++.. ..++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 99999999877766 46899999999999999999999999999999999999999999999999999753221
Q ss_pred CCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
.....||+.|||||++.+. ..|+.++|||||||++|+|++|.+||..................
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~--------- 232 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------- 232 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 2345699999999999642 34899999999999999999999999877666555444433221
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
......+|+++++||.+||+.||.+|||++++|+||||...
T Consensus 233 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 233 -ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp -CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 11335678999999999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=445.47 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=207.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--CCEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV--DSRLW 102 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 102 (506)
.++|++++.||+|+||+||+|.++ .+|+.||+|.+.... .....+.+.+|+.+|++++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 467999999999999999999985 678999999997654 45566789999999999999999999999864 56789
Q ss_pred EEeccCCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 103 VVMPFMSCGSLQSIISSC--FPDGLPEPCIAIVLKETLSALSYLHNQG-----HLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~--~~~~l~e~~i~~i~~qil~gL~yLHs~g-----ivHrDIKp~NILld~~g~vKL~DFGls 175 (506)
+|||||+||+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999998653 2467999999999999999999999976 999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc
Q 010624 176 ASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF 255 (506)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 255 (506)
...... ........||+.|||||++.+.. |+.++|||||||++|+|++|++||...+..+.........+
T Consensus 162 ~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-- 231 (269)
T d2java1 162 RILNHD-------TSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 231 (269)
T ss_dssp HHC------------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--
T ss_pred eecccC-------CCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--
Confidence 653221 11223457899999999997654 89999999999999999999999987666554333322211
Q ss_pred cchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccc
Q 010624 256 SDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFF 302 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f 302 (506)
...+..+|+++++||.+||+.||.+|||+.||++|||+
T Consensus 232 ---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 12345689999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-57 Score=456.01 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=224.9
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRL 101 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (506)
+..++|++++.||+|+||+||+|.++ .+|+.||||++++.. .....+.+.+|+.+|+.++||||++++++|.++..+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 45678999999999999999999995 678999999997543 223467788999999999999999999999999999
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEP 181 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~ 181 (506)
|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 81 ~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999999988 467999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhh
Q 010624 182 SHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKT 261 (506)
Q Consensus 182 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|++||...+............+.
T Consensus 159 -------~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~------- 223 (337)
T d1o6la_ 159 -------GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------- 223 (337)
T ss_dssp -------TCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred -------CcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC-------
Confidence 11233456899999999998754 899999999999999999999999987766555444443322
Q ss_pred hhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 262 LKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 262 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
.+..+|+++++||.+||+.||.+||+ +.++++||||++.+
T Consensus 224 -----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 34568999999999999999999994 99999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=444.96 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=221.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-----hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-----RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
.++|++++.||+|+||+||+|.++ .+|+.||||++..... ....+.+.+|+.+|++++|||||+++++|.+++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 367999999999999999999995 6789999999975432 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC----CeEEeeccccc
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG----SVKLADFGVSA 176 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g----~vKL~DFGls~ 176 (506)
+|+|||||+||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999999873 6799999999999999999999999999999999999999776 59999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... .......||+.|+|||++.+.. |+.++|||||||++|+|++|..||...+..+...........++
T Consensus 166 ~~~~~--------~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 166 KIDFG--------NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp ECTTS--------CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred hcCCC--------ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 43221 1233456899999999998654 89999999999999999999999987766665544444333322
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
. ..+..+|+.+++||.+||+.||++|||+.++++||||+..
T Consensus 237 ~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 237 D--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp H--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred c--------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1 1235678999999999999999999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.8e-56 Score=453.01 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=222.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 58999999999999999999995 678999999986543 4456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC--CCCCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD--SDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld--~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||+||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|......
T Consensus 104 ~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--- 179 (350)
T d1koaa2 104 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 179 (350)
T ss_dssp CCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---
T ss_pred cCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---
Confidence 99999999999653 35799999999999999999999999999999999999996 4688999999997643221
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
.......||+.|||||++.+.. |+.++|||||||++|+|++|.+||...+..+....+......++.
T Consensus 180 -----~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------- 246 (350)
T d1koaa2 180 -----QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------- 246 (350)
T ss_dssp -----SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-------
T ss_pred -----cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------
Confidence 2234467899999999998755 899999999999999999999999877666655544443333221
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.....+|+++++||.+||+.||++|||++|+|+||||+..+
T Consensus 247 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 247 -SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp -GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred -ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 13356889999999999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-56 Score=447.63 Aligned_cols=255 Identities=26% Similarity=0.472 Sum_probs=222.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 367999999999999999999985 678999999986532 22346788999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||||.||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 82 vmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 9999999999999987 57789999999999999999999999999999999999999999999999999765322
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
......||+.|||||++.+.. |+.++|||||||++|+|++|+.||...+..............
T Consensus 157 -------~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------- 219 (316)
T d1fota_ 157 -------VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------- 219 (316)
T ss_dssp -------CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---------
T ss_pred -------ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence 123457999999999998754 899999999999999999999999887766655544443322
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..++++++++|.+||+.||.+|+ |+++|++||||++++
T Consensus 220 ---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 220 ---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 3356889999999999999999996 999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-56 Score=452.97 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=222.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEec
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVMP 106 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 106 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++.... ......+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999985 578999999987643 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeC--CCCCeEEeeccccccccCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSD--SDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld--~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||+||+|.+++... ..++++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---- 181 (352)
T d1koba_ 107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---- 181 (352)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT----
T ss_pred cCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC----
Confidence 99999999987653 45699999999999999999999999999999999999998 678999999999764322
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKI 264 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|.+||................+.++
T Consensus 182 ----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------- 248 (352)
T d1koba_ 182 ----DEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------- 248 (352)
T ss_dssp ----TSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred ----CCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 12234457899999999998754 89999999999999999999999987776665554444333322
Q ss_pred hccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 265 KDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 265 ~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
......+|+++++||.+||+.||.+|||+.++|+||||+..
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 12345789999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-55 Score=432.98 Aligned_cols=260 Identities=30% Similarity=0.512 Sum_probs=222.5
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh--------hhHHHHHHHHHHHhhCC-CCCceeeeeEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR--------TDLDSIRRETKTMSLLS-HPNILNAHCSFSV 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~--------~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (506)
++|++.+.||+|+||+||+|.++ .+|+.||||+++..... ...+.+.+|+.+|++++ ||||++++++|.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 68999999999999999999985 67899999999765421 22456889999999997 9999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
++.+|+|||||+||+|.+++.. ..++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999999987 46899999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhc-----cCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRS-----HTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQR 252 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~ 252 (506)
.... .......||+.|+|||++.+ ...++.++||||+||++|+|++|++||...+............
T Consensus 160 ~~~~--------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 160 LDPG--------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCTT--------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccCC--------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 3221 12234568999999999974 2347889999999999999999999999877666555555444
Q ss_pred ccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 253 FRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
..++. .....+|+++++||.+||+.||++|||+.+|++||||+..
T Consensus 232 ~~~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 232 YQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 33221 1345789999999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.1e-55 Score=449.41 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=215.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-----hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-----RTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
+..++|++++.||+|+||+||+|.++ .+|+.||||++..... ........+++.+++.++|||||+++++|.++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 35678999999999999999999985 6789999999864321 11122334457778888999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred CEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999999987 467999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... ......||+.|+|||++.....|+.++|||||||++|+|++|++||.......... ........
T Consensus 158 ~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~--- 224 (364)
T d1omwa3 158 SKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM--- 224 (364)
T ss_dssp SSS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSC---
T ss_pred CCC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccC---
Confidence 221 12345699999999999765568999999999999999999999998654432211 11111110
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCC-----HHHHHcCccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPS-----AEKLMKHSFFKNCN 306 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt-----~~eiL~hp~f~~~~ 306 (506)
....+..+|+++++||.+||+.||.+||| +.+|++||||++++
T Consensus 225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 11134568999999999999999999999 79999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-55 Score=448.53 Aligned_cols=255 Identities=24% Similarity=0.417 Sum_probs=221.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
.++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 478999999999999999999995 678999999986432 22345778999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999999999874 6799999999999999999999999999999999999999999999999999764321
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
......||+.|||||++.+.. |+.++|||||||++|+|++|.+||...........+....+.
T Consensus 194 -------~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------- 256 (350)
T d1rdqe_ 194 -------RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------- 256 (350)
T ss_dssp -------CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred -------ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC---------
Confidence 122456899999999998754 899999999999999999999999877665544444333222
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
.+..+++++.+||.+||+.||.+|+ |+.+|++||||++.+
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 3456889999999999999999995 999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=442.70 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=218.4
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHHh-hCCCCCceeeeeEEEeCCEEEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ--SRTDLDSIRRETKTMS-LLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~--~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~l 103 (506)
++|++++.||+|+||+||+|.++ .+++.||||++.+.. .....+.+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 68999999999999999999996 678999999997543 1233456667777665 7899999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||||+||+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||++......
T Consensus 81 vmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 9999999999999987 467999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|+|||++.+.. |+.++|||||||++|+|++|+.||...+............+.
T Consensus 157 -----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------- 221 (320)
T d1xjda_ 157 -----DAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--------- 221 (320)
T ss_dssp -----TCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred -----cccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 12233457999999999998755 899999999999999999999999877665544433333221
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHH-HHHcCccccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAE-KLMKHSFFKNCN 306 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~-eiL~hp~f~~~~ 306 (506)
.+..+|+++++||.+||+.||++|||+. ++++||||++.+
T Consensus 222 ---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 222 ---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 3356899999999999999999999995 899999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=441.00 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=221.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
.++|++++.||+|+||+||+|.++ .+++.||||+++... .+...+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999995 678999999997643 33456889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCC--CCeEEeeccccccccCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSD--GSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~--g~vKL~DFGls~~~~~~~~ 183 (506)
|||+||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 E~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--- 156 (321)
T d1tkia_ 81 EFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc---
Confidence 999999999999763 3469999999999999999999999999999999999999854 5899999999764321
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
........||+.|+|||.+.+.. |+.++|||||||++|+|++|.+||...........+....+.++..
T Consensus 157 -----~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 225 (321)
T d1tkia_ 157 -----GDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE----- 225 (321)
T ss_dssp -----TCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH-----
T ss_pred -----CCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh-----
Confidence 12234456899999999998654 8999999999999999999999998877666555555444443321
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+..+|+++++||.+||+.||.+|||+.++++||||+..
T Consensus 226 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 234678999999999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=431.55 Aligned_cols=273 Identities=27% Similarity=0.435 Sum_probs=219.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++..... ....+.+.+|+.+|++++|||||+++++|.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 68999999999999999999995 6789999999975543 233578889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||.++ +.+++......++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---- 155 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---- 155 (298)
T ss_dssp ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC----
T ss_pred eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC----
Confidence 999754 555554444677999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc--hhhhh-
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD--YEKTL- 262 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~- 262 (506)
........||+.|+|||++.....++.++|||||||++|+|++|+.||...+................. +....
T Consensus 156 ---~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ---SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 122334568999999999987776789999999999999999999999877665554443322111100 00000
Q ss_pred --------------hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 263 --------------KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 263 --------------~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
........+++++++||.+||+.||++|||+.||++||||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0011224578899999999999999999999999999999988654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=435.05 Aligned_cols=267 Identities=28% Similarity=0.355 Sum_probs=211.9
Q ss_pred eEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChh----hHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRT----DLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
+.+++||+|+||+||+|.++ .+|+.||||++....... ..+.+.+|+.+|++++|||||+++++|.+++++|+||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 35789999999999999985 568999999987554221 1246889999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
|||.|+++..++.. ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 80 E~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~---- 153 (299)
T d1ua2a_ 80 DFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP---- 153 (299)
T ss_dssp ECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC----
T ss_pred hhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC----
Confidence 99998888777654 467999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc--chhh---
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS--DYEK--- 260 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~--- 260 (506)
........||+.|+|||++.+...|+.++|||||||++|+|++|.+||......+....+........ .+..
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ---cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 11223456899999999998766689999999999999999999999987766655444332110000 0000
Q ss_pred -----------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 261 -----------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 261 -----------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..........+++++++||.+||+.||++|||+.|+|+||||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0001112345788999999999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-54 Score=431.10 Aligned_cols=258 Identities=21% Similarity=0.404 Sum_probs=218.9
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
+|+++.++|++.+.||+|+||+||+|.++ .+++.||||++..+. ...+.+.+|+.+|++++|||||+++++|.+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 48899999999999999999999999985 568999999986543 345789999999999999999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEK 260 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 260 (506)
. .........||+.|+|||++.+.. |+.++|||||||++|||++|..||............+......
T Consensus 168 ~------~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~----- 235 (287)
T d1opja_ 168 D------TYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----- 235 (287)
T ss_dssp S------SSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred C------CceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-----
Confidence 1 112233445789999999998765 8999999999999999999777665544444444444433221
Q ss_pred hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 261 TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 261 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++++++||.+||+.||++|||+.+|++
T Consensus 236 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 234568899999999999999999999999965
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=427.30 Aligned_cols=262 Identities=25% Similarity=0.444 Sum_probs=214.7
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
.|++..++|++.+.||+|+||+||+|.. + ..||||+++... .....+.+.+|+.+|++++|||||++++++. ++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~---~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKW---H-GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEES---S-SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEE---C-CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 4788999999999999999999999965 2 359999987554 3556788999999999999999999999865 45
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 689999999999999999763 4569999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhcc--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSH--TGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
.. ..........||+.|||||++.+. ..|+.++|||||||++|||+||+.||............+......+.
T Consensus 156 ~~-----~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 156 RW-----SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp ---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred cc-----CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 21 111122345789999999999753 24899999999999999999999999887766665555544433222
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
....+..+++++++||.+||+.||++|||+.+|+++
T Consensus 231 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 122456789999999999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=435.76 Aligned_cols=265 Identities=23% Similarity=0.384 Sum_probs=218.3
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCC----CeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeee
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD----STVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHC 93 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~----~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (506)
...|++..++|++.+.||+|+||+||+|.+...+ ...||+|.+...........+.+|+.+|+++ +|||||++++
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4567888899999999999999999999986433 2479999987665556667889999999988 8999999999
Q ss_pred EEEeCCEEEEEeccCCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Q 010624 94 SFSVDSRLWVVMPFMSCGSLQSIISSCFP---------------------DGLPEPCIAIVLKETLSALSYLHNQGHLHR 152 (506)
Q Consensus 94 ~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~---------------------~~l~e~~i~~i~~qil~gL~yLHs~givHr 152 (506)
++.+.+.+|+|||||++|+|.+++..... ..+++..++.++.|++.||+|||++||+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999976421 348999999999999999999999999999
Q ss_pred CCCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-
Q 010624 153 DVKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH- 231 (506)
Q Consensus 153 DIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt- 231 (506)
||||+|||++.++.+||+|||+|....... .........||+.|||||++.+.. |+.++|||||||++|||+|
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~ 262 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 262 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-----TSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTT
T ss_pred cCchhccccccCCeEEEeeccccccccCCC-----ceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhC
Confidence 999999999999999999999976432211 111223445799999999998755 8999999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 232 GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 232 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
|.+||...+........+....+.+ .+..+|+++++||.+||+.||++|||+++|++|
T Consensus 263 g~~Pf~~~~~~~~~~~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 263 GVNPYPGIPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999987766665555555443322 345688999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=424.71 Aligned_cols=263 Identities=21% Similarity=0.365 Sum_probs=216.0
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
+..|++..++|++.+.||+|+||+||+|.+ .+++.||||++.... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYY--NGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEE--TTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEE--CCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 456888899999999999999999999998 467899999986543 345679999999999999999999998754
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+|||||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 56789999999999999886654456999999999999999999999999999999999999999999999999998643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... .........||+.|+|||++.+.. |+.++|||||||++|||+||..|+............+....+.
T Consensus 160 ~~~------~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~--- 229 (272)
T d1qpca_ 160 EDN------EYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--- 229 (272)
T ss_dssp SSS------CEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---
T ss_pred cCC------ccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---
Confidence 221 112233456899999999998655 8999999999999999999655544333333333333332221
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc--Ccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK--HSFFK 303 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~--hp~f~ 303 (506)
..+..+++++.+||.+||+.||++|||+.+|++ |+||.
T Consensus 230 -------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 -------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 134568899999999999999999999999987 77775
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=427.96 Aligned_cols=273 Identities=25% Similarity=0.368 Sum_probs=214.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHHhhC---CCCCceeeeeEEEe----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-TDLDSIRRETKTMSLL---SHPNILNAHCSFSV---- 97 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~---- 97 (506)
.++|++++.||+|+||+||+|.+...+++.||||++...... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999996566788999998654322 2223455777776655 79999999999853
Q ss_pred -CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccc
Q 010624 98 -DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSA 176 (506)
Q Consensus 98 -~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~ 176 (506)
...+|++|||+.++++...... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3578999999998776554443 35679999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
... .........||+.|+|||++.+.. |+.++||||+||++|+|++|++||......+.............
T Consensus 165 ~~~--------~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 165 IYS--------FQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CCC--------GGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhc--------ccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 321 122345667999999999998755 99999999999999999999999987766655444332111000
Q ss_pred c--hh-------------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccccc
Q 010624 257 D--YE-------------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNKG 308 (506)
Q Consensus 257 ~--~~-------------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~~ 308 (506)
. +. ...........+++.+++||.+||+.||++|||+.|+|+||||+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 0 00 0000112335678999999999999999999999999999999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=417.66 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=203.4
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+++++|++++.||+|+||+||+|.+ .++..||||++.... ...+.+.+|+.++++++|||||++++++..++.+|+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYW--LNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEE--TTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEE--CCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 5788999999999999999999998 467889999987543 334678999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
|||||++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|......
T Consensus 78 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~-- 154 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-- 154 (263)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC--
Confidence 99999999999998764 456899999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG-RPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........||+.|+|||++.+.. |+.++|||||||++|||+|+ .+||......+ ....+....+.
T Consensus 155 ----~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~~~~------- 221 (263)
T d1sm2a_ 155 ----QYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRL------- 221 (263)
T ss_dssp --------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-HHHHHHHTCCC-------
T ss_pred ----CceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-HHHHHHhcCCC-------
Confidence 111223456899999999998765 89999999999999999995 56665544433 33333332221
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+..+++++.+||.+||+.||++|||+++|++|
T Consensus 222 ---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 ---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1345678999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-53 Score=421.01 Aligned_cols=267 Identities=26% Similarity=0.393 Sum_probs=216.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|+++++||+|+||+||+|.+ .+|+.||||++..... ....+.+.+|+.+|++++|||||+++++|..++..|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEe--CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 6899999999999999999988 4679999999976543 333578899999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
+|+.++.+..+... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|......
T Consensus 80 e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~---- 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (286)
T ss_dssp ECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC----
Confidence 99998877777665 478999999999999999999999999999999999999999999999999997654321
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccc--cchhhh--
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRF--SDYEKT-- 261 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~-- 261 (506)
........||+.|+|||.+.+...++.++|||||||++|+|++|++||......+............ ..+...
T Consensus 154 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 1122344689999999999877768999999999999999999999998776655444332211110 000000
Q ss_pred -------------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccc
Q 010624 262 -------------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKN 304 (506)
Q Consensus 262 -------------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~ 304 (506)
.........+++.+++||.+||+.||++|||+.|+++||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0011223457889999999999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-53 Score=423.86 Aligned_cols=263 Identities=22% Similarity=0.369 Sum_probs=208.5
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
..+..++|++.+.||+|+||+||+|.++..+ ...||||.+.........+.+.+|+.+|++++|||||++++++..++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 3567789999999999999999999985332 23689999877767777788999999999999999999999999999
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999988764 4569999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... ...........||+.|||||.+.+.. |+.++|||||||++|||+| |.+||......+.... +....+.
T Consensus 180 ~~~~--~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~--- 252 (299)
T d1jpaa_ 180 DDTS--DPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRL--- 252 (299)
T ss_dssp ------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCC---
T ss_pred CCCC--cceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCC---
Confidence 2111 11111223345799999999998654 8999999999999999998 8999987766554333 3222221
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+..+++.+.+||.+||+.||++|||+.+|+++
T Consensus 253 -------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 -------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1345688999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=434.67 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=207.8
Q ss_pred CCCeeEEe-eecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHh-hCCCCCceeeeeEEEe----CC
Q 010624 26 PSSYKILD-EIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMS-LLSHPNILNAHCSFSV----DS 99 (506)
Q Consensus 26 ~~~Y~i~~-~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~----~~ 99 (506)
.++|+++. .||+|+||+||+|.++ .+++.||||++.. ...+.+|+.++. .++|||||+++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEEC-CCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46799885 5999999999999996 5689999999853 245678999865 5589999999999976 46
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSA 176 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~ 176 (506)
.+|+|||||+||+|.++|.......+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|.
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 7999999999999999998754567999999999999999999999999999999999999985 5679999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... .......||+.|||||++.+.. |+.++|||||||++|+|+||++||............ ...+...
T Consensus 163 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-~~~i~~~ 232 (335)
T d2ozaa1 163 ETTSH--------NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMG 232 (335)
T ss_dssp ECCCC--------CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSC
T ss_pred eccCC--------CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-HHHHhcC
Confidence 43321 1233456999999999998755 899999999999999999999999754433222111 1111111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.+.. +...+..+|+++++||.+||+.||++|||+.++++||||++.
T Consensus 233 ~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 233 QYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SSSC---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCC---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 1100 011234688999999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=421.23 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=210.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHHhhCC--CCCceeeeeEEEeC
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSR-----TDLDSIRRETKTMSLLS--HPNILNAHCSFSVD 98 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~-----~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~ 98 (506)
.++|++.+.||+|+||+||+|.++ .+|+.||||++...... .....+.+|+.+|++++ |||||+++++|.++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 467999999999999999999995 57899999998754321 12234668999999987 89999999999999
Q ss_pred CEEEEEeccCCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-CCCeEEeeccccc
Q 010624 99 SRLWVVMPFMSC-GSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-DGSVKLADFGVSA 176 (506)
Q Consensus 99 ~~~~lV~Ey~~g-gsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-~g~vKL~DFGls~ 176 (506)
+..|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 999999999976 688888877 467999999999999999999999999999999999999985 4799999999976
Q ss_pred cccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 177 SIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.... . ......
T Consensus 160 ~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~~~~~--- 221 (273)
T d1xwsa_ 160 LLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRGQV--- 221 (273)
T ss_dssp ECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHCCC---
T ss_pred ecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----Hhhccc---
Confidence 43211 12345699999999999877656788999999999999999999996421 1 111111
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
..+..+|+++++||.+||+.||++|||+.|+++||||++..
T Consensus 222 ---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 222 ---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 13456899999999999999999999999999999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=419.85 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=216.4
Q ss_pred cCCCCCCeeEEee-ecccCCeeEEEEEEeC-CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDE-IGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~-IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
+-+..++|.+.+. ||+|+||+||+|.++. .++..||||++.........+.+.+|+.+|++++|||||++++++..+
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 4566778999995 9999999999998753 335689999998777777788999999999999999999999998754
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 588999999999999998653 3579999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... .........||+.|+|||++.+.. |+.++|||||||++|||+| |.+||......+... .+....+
T Consensus 161 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~i~~~~~---- 230 (285)
T d1u59a_ 161 ADDS----YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKR---- 230 (285)
T ss_dssp TCSC----EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCC----
T ss_pred cccc----ccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCC----
Confidence 2211 112223456899999999998654 8999999999999999998 999998776554433 2222211
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH---HcCcccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL---MKHSFFK 303 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei---L~hp~f~ 303 (506)
...+..+|+++.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 231 ------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12446789999999999999999999999888 4556553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=409.30 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=215.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWV 103 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (506)
+++++|+++++||+|+||+||+|.+ .+++.||||++..... ..+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEE--TTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEE--CCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4688999999999999999999998 4678999999976543 34679999999999999999999999999999999
Q ss_pred EeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCC
Q 010624 104 VMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSH 183 (506)
Q Consensus 104 V~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~ 183 (506)
||||+++|+|..++... ...+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 77 v~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-- 153 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-- 153 (258)
T ss_dssp EEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS--
T ss_pred EEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC--
Confidence 99999999999997664 457899999999999999999999999999999999999999999999999997543221
Q ss_pred CCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 184 HHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 184 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
.........||+.|+|||++.+.. |+.++|||||||++|||+| |+.||......+.... +....+.
T Consensus 154 ----~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~------- 220 (258)
T d1k2pa_ 154 ----EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRL------- 220 (258)
T ss_dssp ----SCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCC-------
T ss_pred ----CceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-HHhCCCC-------
Confidence 111233456899999999998765 8999999999999999998 8999988776554433 3332221
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+..+++++.+||.+||+.||++|||+.+|++|
T Consensus 221 ---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1345678899999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=412.02 Aligned_cols=261 Identities=22% Similarity=0.348 Sum_probs=209.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCC---eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDS---TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~---~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
-++.++.|++.+.||+|+||.||+|.++..++ ..||||.+...........+.+|+.+|++++|||||++++++.+.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 35778899999999999999999999864332 479999998776667777899999999999999999999999999
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+++|||||.++++.+++... ...+++..+..++.|++.||+|||+++|+||||||+||||+.++.+||+|||+|...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999999999988764 467999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.... ..........||+.|||||++.+.. |+.++|||||||++|||++|..||............+....+.
T Consensus 161 ~~~~----~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--- 232 (283)
T d1mqba_ 161 EDDP----EATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--- 232 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---
T ss_pred cCCC----ccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---
Confidence 2211 1111233456899999999998654 8999999999999999999665554444444444444433322
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..++..+.+||.+||+.||++|||+.+|++
T Consensus 233 -------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 134568899999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=416.00 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=214.8
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
+..|.++.++|++.+.||+|+||.||+|.+ .++..||||++.... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~--~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW--NGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEE--TTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEE--CCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 566889999999999999999999999988 355789999986543 334779999999999999999999999865
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+|+|||||++|+|..++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 45789999999999999987654567999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccch
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
... .........||+.|+|||++.... ++.++|||||||++|||++|..||............+....+.
T Consensus 164 ~~~------~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~--- 233 (285)
T d1fmka3 164 EDN------EYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--- 233 (285)
T ss_dssp ------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---
T ss_pred cCC------CceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---
Confidence 211 112233456899999999998655 8999999999999999999665555444444444444333221
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc--Ccccccc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK--HSFFKNC 305 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~--hp~f~~~ 305 (506)
..+..+++++++||.+||+.||++|||+.+|++ ++||...
T Consensus 234 -------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 144678899999999999999999999999987 7888754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=415.67 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=205.1
Q ss_pred CeeEE-eeecccCCeeEEEEEEeC-CCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEE
Q 010624 28 SYKIL-DEIGVGVSAIVYKAICIP-MDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 28 ~Y~i~-~~IG~G~fg~Vyka~~~~-~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 104 (506)
.+.+. ++||+|+||+||+|.+.. ..++.||||++.... .....+.+.+|+.+|++++|||||++++++..+ ..|+|
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv 85 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 85 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence 34444 369999999999998752 345789999986543 234467899999999999999999999998654 57899
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCC
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHH 184 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~ 184 (506)
||||++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 86 mE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~-- 161 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-- 161 (277)
T ss_dssp EECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC--
T ss_pred EEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc--
Confidence 999999999999987 5679999999999999999999999999999999999999999999999999976432211
Q ss_pred CCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchhhhhh
Q 010624 185 HHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLK 263 (506)
Q Consensus 185 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (506)
..........||+.|||||++.+.. |+.++|||||||++|||++ |.+||......+... .+....+
T Consensus 162 --~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~--------- 228 (277)
T d1xbba_ 162 --NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGER--------- 228 (277)
T ss_dssp --SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCC---------
T ss_pred --cccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCC---------
Confidence 1112233456899999999998755 8999999999999999997 899998776654333 2222211
Q ss_pred hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH---cCcccc
Q 010624 264 IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM---KHSFFK 303 (506)
Q Consensus 264 ~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL---~hp~f~ 303 (506)
...+..+|+++.+||.+||+.||++|||+++|+ +|+|+.
T Consensus 229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 123456889999999999999999999999984 566554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-52 Score=413.52 Aligned_cols=262 Identities=22% Similarity=0.372 Sum_probs=209.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC----
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS--RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS---- 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (506)
.++|++.+.||+|+||+||+|.++ .+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 467999999999999999999995 6789999999976543 445678999999999999999999999987643
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||+|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 48999999999999999987 3679999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
... ..........||+.|+|||++.+.. |+.++|||||||++|+|+||++||......+.....+......+
T Consensus 163 ~~~----~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 234 (277)
T d1o6ya_ 163 DSG----NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--- 234 (277)
T ss_dssp --------------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred ccc----ccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence 211 1112234557999999999998754 89999999999999999999999988777666555554432211
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccc
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFK 303 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~ 303 (506)
......+|+++++||.+||+.||.+||+..+.+.|+|.+
T Consensus 235 -----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 124467899999999999999999999544444566654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=423.66 Aligned_cols=269 Identities=25% Similarity=0.364 Sum_probs=213.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC-
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS- 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 99 (506)
|.+ .++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 444 578999999999999999999995 578999999997644 3445678899999999999999999999997654
Q ss_pred -----EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 100 -----RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 100 -----~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
++|+||||| +.+|..++.. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 579999999 6788888875 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR 254 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 254 (506)
|..... ......||+.|+|||++.+...++.++||||+||++|+|++|.+||..................
T Consensus 168 a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 168 ARQADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp CEECCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeccCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 764322 1234568999999999987666899999999999999999999999877655444332221111
Q ss_pred ccch----------hh---------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 255 FSDY----------EK---------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 255 ~~~~----------~~---------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
.+.. .. ..........+++++++||.+||..||.+|||+.+||+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1100 00 0001122346789999999999999999999999999999999764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=411.36 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=207.8
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeCCC--CeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIPMD--STVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS 99 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~--~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (506)
|++..++|++.+.||+|+||.||+|.+...+ +..||||.+.........+.+.+|+.+|++++|||||++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 6788899999999999999999999885332 35789999876666666788999999999999999999999996 46
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+|....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 789999999999999987653 4579999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
.. .........||+.|+|||++.+.. |+.++|||||||++|||++ |.+||......+........ ..
T Consensus 160 ~~------~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-~~---- 227 (273)
T d1mp8a_ 160 DS------TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ER---- 227 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CC----
T ss_pred CC------cceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC----
Confidence 21 111233456899999999998755 8999999999999999998 89999887766554433222 11
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+..+|+.+++||.+||+.||++|||+.+|++|
T Consensus 228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12456789999999999999999999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=409.06 Aligned_cols=269 Identities=27% Similarity=0.383 Sum_probs=221.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 105 (506)
++|++++.||+|+||+||+|.++ .+++.||||+++.... ......+.+|+.+|+.++||||++++++|.+....++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999996 6789999999976543 345678999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHH 185 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~ 185 (506)
+++.+++|..++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|......
T Consensus 81 ~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~---- 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp ECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC----
T ss_pred eecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC----
Confidence 99999999988876 578999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc--------
Q 010624 186 HHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD-------- 257 (506)
Q Consensus 186 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 257 (506)
........+++.|+|||++.+...++.++|||||||++|+|++|+.||............+......+.
T Consensus 155 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp ---CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ---CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 122334457899999999987766799999999999999999999997655544433333221111000
Q ss_pred ----------hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 ----------YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ----------~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.............+++.+++||.+||+.||.+||||.|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 000011112335678899999999999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-52 Score=420.65 Aligned_cols=272 Identities=23% Similarity=0.325 Sum_probs=213.6
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC----EEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS----RLW 102 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 102 (506)
++|++++.||+|+||+||+|.++ .+|+.||||++.........+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46999999999999999999985 6789999999987666666778999999999999999999999987643 234
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCC
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~ 182 (506)
++++|+.||+|.+++.. .++++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 45556778999999976 579999999999999999999999999999999999999999999999999976432221
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh---
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE--- 259 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--- 259 (506)
..........||+.|+|||++.....|+.++||||+||++|+|++|.+||.......................
T Consensus 164 ----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 164 ----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp ----CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred ----ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 1112234456899999999997666689999999999999999999999987665444333222111100000
Q ss_pred -------h-h--------hhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 -------K-T--------LKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 -------~-~--------~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. . .........+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 0 000112345788999999999999999999999999999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=413.58 Aligned_cols=273 Identities=24% Similarity=0.310 Sum_probs=210.1
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHHhhCCCCCceeeeeEEEe--------
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-RTDLDSIRRETKTMSLLSHPNILNAHCSFSV-------- 97 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 97 (506)
++|+++++||+|+||+||+|.++ .+|+.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 56999999999999999999995 6789999999876543 3345678899999999999999999988754
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
+..+|+|||||.++.+..+... ...+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 3468999999987776655443 56799999999999999999999999999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
...... ..........||++|+|||++.+...|+.++|||||||++|+|++|++||..................+..
T Consensus 167 ~~~~~~---~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKN---SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccc---cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 332211 11122334568999999999987766899999999999999999999999876655544332221111110
Q ss_pred hh-----------h---------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 258 YE-----------K---------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 258 ~~-----------~---------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
.. . ...........++.+++||.+||+.||++|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 00 0 000000112246788999999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=419.46 Aligned_cols=264 Identities=25% Similarity=0.331 Sum_probs=208.8
Q ss_pred CeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe------CCEE
Q 010624 28 SYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV------DSRL 101 (506)
Q Consensus 28 ~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~ 101 (506)
+|+.+++||+|+||+||+|.++ .+|+.||||++...... ..+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 6999999999999999999995 57899999999765432 2379999999999999999999854 3468
Q ss_pred EEEeccCCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeecccccccc
Q 010624 102 WVVMPFMSCGSLQSIISS-CFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIY 179 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~-~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~ 179 (506)
|+|||||+++.+..+... .....+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999987655444332 2256799999999999999999999999999999999999999775 89999999976432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-----
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----- 254 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~----- 254 (506)
.. .......||+.|+|||.+.+...|+.++||||+||++|+|++|.+||..................
T Consensus 175 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 175 RG--------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp TT--------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CC--------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 21 12234568999999999987667999999999999999999999999877665544433221100
Q ss_pred ------------ccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 255 ------------FSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 255 ------------~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
++..............+++++.+||.+||..||++|||+.|+|+||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000000000111234578999999999999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-51 Score=416.02 Aligned_cols=265 Identities=22% Similarity=0.376 Sum_probs=211.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEe--CCEE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSV--DSRL 101 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~ 101 (506)
..++|+++++||+|+||+||+|.++ .+|+.||||++... ..+.+.+|+.+|+.++ ||||++++++|.. ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 4467999999999999999999995 67899999998643 3467889999999995 9999999999975 4579
Q ss_pred EEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCC-CeEEeeccccccccC
Q 010624 102 WVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDG-SVKLADFGVSASIYE 180 (506)
Q Consensus 102 ~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g-~vKL~DFGls~~~~~ 180 (506)
|+|||||.+++|..+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999987653 4699999999999999999999999999999999999999655 699999999764322
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc------
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR------ 254 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~------ 254 (506)
. .......||+.|+|||.+.+...|+.++||||+||++|+|++|..||............+.....
T Consensus 183 ~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 183 G--------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp T--------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred C--------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 1 12334568999999999988777899999999999999999999999866543322222111100
Q ss_pred ------cc---chh-----------hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccccc
Q 010624 255 ------FS---DYE-----------KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCNK 307 (506)
Q Consensus 255 ------~~---~~~-----------~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~~ 307 (506)
.. .+. ...........+++++++||.+||..||.+|||+.|+|+||||+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 00 000 000011123457889999999999999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=410.16 Aligned_cols=266 Identities=22% Similarity=0.377 Sum_probs=209.5
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPM----DSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAH 92 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~----~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 92 (506)
+...|++..++|++.+.||+|+||.||+|.+... +++.||||++.........+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 4556888899999999999999999999998532 35789999998766666677788888887776 689999999
Q ss_pred eEEEe-CCEEEEEeccCCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCC
Q 010624 93 CSFSV-DSRLWVVMPFMSCGSLQSIISSCF--------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAG 157 (506)
Q Consensus 93 ~~~~~-~~~~~lV~Ey~~ggsL~~~i~~~~--------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~ 157 (506)
+++.. +..+|+|||||++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 88765 457899999999999999997532 235899999999999999999999999999999999
Q ss_pred CEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhC-CCCC
Q 010624 158 NILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG-RPPL 236 (506)
Q Consensus 158 NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG-~~Pf 236 (506)
|||++.++.+||+|||+|....... .........||+.|+|||++.+.. |+.++|||||||++|||++| .+||
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp GEEECGGGCEEECC------CCSCT-----TSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ceeECCCCcEEEccCcchhhccccc-----cccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCC
Confidence 9999999999999999976432211 112233456899999999998755 89999999999999999986 5688
Q ss_pred CCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 237 SHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
............+...... ..+..+++++++||.+||+.||++|||+.+|++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 238 PGVKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TTCCCSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7766555554444443322 1345688999999999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=415.33 Aligned_cols=267 Identities=26% Similarity=0.434 Sum_probs=217.6
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeC--CCCeEEEEEEeccCC---ChhhHHHHHHHHHHHhhCCC-CCceeeeeEEEe
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIP--MDSTVVAIKAIDLDQ---SRTDLDSIRRETKTMSLLSH-PNILNAHCSFSV 97 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~--~~~~~vAIK~i~~~~---~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~ 97 (506)
+..++|++++.||+|+||+||+|.+.. .+|+.||||++.... .....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 345889999999999999999998842 357899999986543 12334668899999999976 899999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccc
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSAS 177 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~ 177 (506)
...+|++|||+.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999874 6788999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCcccccCCCCCccCChhhhhccC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccccc
Q 010624 178 IYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-GYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFS 256 (506)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 256 (506)
.... .........||+.|+|||.+.+.. .++.++|||||||++|+|++|..||...................
T Consensus 179 ~~~~------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~- 251 (322)
T d1vzoa_ 179 FVAD------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 251 (322)
T ss_dssp CCGG------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred hccc------ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence 3211 122234557899999999997643 46889999999999999999999997654433322222111110
Q ss_pred chhhhhhhhccchhhhHHHHHHHHhhcccCCCCCC-----CHHHHHcCccccccc
Q 010624 257 DYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRP-----SAEKLMKHSFFKNCN 306 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rp-----t~~eiL~hp~f~~~~ 306 (506)
....+..+++++++||.+||++||.+|| |++|+++||||+.++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 1123457899999999999999999999 589999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=408.36 Aligned_cols=255 Identities=22% Similarity=0.363 Sum_probs=205.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEEeCCCCe----EEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCCE
Q 010624 25 DPSSYKILDEIGVGVSAIVYKAICIPMDST----VVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDSR 100 (506)
Q Consensus 25 ~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~----~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (506)
..++|++++.||+|+||+||+|.++. +|+ .||+|.+.........+.+.+|+.+|++++|||||++++++.++ .
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 45689999999999999999999853 343 68999887665566678899999999999999999999999865 5
Q ss_pred EEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccC
Q 010624 101 LWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYE 180 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~ 180 (506)
.+++++|+.+|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67889999999999988764 56799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 181 PSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 181 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.. .........||+.|+|||++.+.. |+.++|||||||++|||+| |.+||...+..+.. ..+....+.
T Consensus 164 ~~-----~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~---- 232 (317)
T d1xkka_ 164 EE-----KEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL---- 232 (317)
T ss_dssp TC-----C--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCC----
T ss_pred cc-----ccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCC----
Confidence 21 111223346899999999998765 8999999999999999998 78999876655433 223222221
Q ss_pred hhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 260 KTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 260 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
..+..+++.+.+||.+||+.||.+|||+.+|++|
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1345688999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=414.42 Aligned_cols=267 Identities=21% Similarity=0.318 Sum_probs=213.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC-----C
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD-----S 99 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (506)
+++|++++.||+|+||+||+|.++ .+|+.||||++.... .....+.+.+|+.+|++++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 578999999999999999999985 678999999997654 344566788999999999999999999998643 3
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
..+++|+|+.||+|.+++.. .++++..++.+++||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 44667778889999999965 579999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchh
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYE 259 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 259 (506)
.......||+.|+|||++.+...++.++|||||||++|+|++|.+||.......................
T Consensus 173 ----------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 173 ----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp ----------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ----------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 2234456899999999988776679999999999999999999999987665544443332221111000
Q ss_pred h-------------------hhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCccccccc
Q 010624 260 K-------------------TLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNCN 306 (506)
Q Consensus 260 ~-------------------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~~ 306 (506)
. ..........+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 0000112245788999999999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=401.76 Aligned_cols=258 Identities=21% Similarity=0.352 Sum_probs=204.1
Q ss_pred CCCCCCeeEEeeecccCCeeEEEEEEeCCCC--eEEEEEEeccCC--ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeC
Q 010624 23 PLDPSSYKILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQ--SRTDLDSIRRETKTMSLLSHPNILNAHCSFSVD 98 (506)
Q Consensus 23 ~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~--~~vAIK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (506)
-++.++|++++.||+|+||.||+|.....++ ..||||++.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 3567889999999999999999998764443 478999987543 23446789999999999999999999999975
Q ss_pred CEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccc
Q 010624 99 SRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASI 178 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~ 178 (506)
+.+++|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 4678999999999999988764 456999999999999999999999999999999999999999999999999997754
Q ss_pred cCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccc
Q 010624 179 YEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSD 257 (506)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 257 (506)
..... .........||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+..........+.+
T Consensus 162 ~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~- 235 (273)
T d1u46a_ 162 PQNDD----HYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP- 235 (273)
T ss_dssp CC-CC----EEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC-
T ss_pred ccCCC----cceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC-
Confidence 32211 112223445788999999998755 8999999999999999998 8999988777766554444332221
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
.+..+|+.+++||.+||+.||++|||+.+|+
T Consensus 236 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 236 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3456889999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=397.90 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=205.0
Q ss_pred ccCCCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-CC
Q 010624 21 QYPLDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV-DS 99 (506)
Q Consensus 21 ~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 99 (506)
+|+++.++|++.+.||+|+||.||+|.+ .|+.||||.++.+ ...+.+.+|+.++++++||||+++++++.+ .+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4889999999999999999999999987 3688999998653 334678999999999999999999998854 46
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||+++++||||||+|||++.+|.+||+|||++....
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 68999999999999999976544469999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhcccccch
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPPLSHLPPEKSLLMKMTQRFRFSDY 258 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 258 (506)
. ......+|+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+.... +....+.
T Consensus 155 ~----------~~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~--- 219 (262)
T d1byga_ 155 S----------TQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKM--- 219 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCC---
T ss_pred C----------CCccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCC---
Confidence 1 123345789999999998754 8999999999999999998 7888887665554333 3222221
Q ss_pred hhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 259 EKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 259 ~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
..+..+++++++||.+||+.||.+|||+.++++
T Consensus 220 -------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 220 -------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 234567899999999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-50 Score=400.89 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=214.7
Q ss_pred cCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe
Q 010624 22 YPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV 97 (506)
Q Consensus 22 ~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (506)
+.+..++|++++.||+|+||+||+|..+. .+++.||||++.........+.+.+|+.+|++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 55567789999999999999999998753 34678999999876666667889999999999999999999999999
Q ss_pred CCEEEEEeccCCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Q 010624 98 DSRLWVVMPFMSCGSLQSIISSCF----------------------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVK 155 (506)
Q Consensus 98 ~~~~~lV~Ey~~ggsL~~~i~~~~----------------------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIK 155 (506)
.+..+++|||+.+|+|.+++.... ...+++..+..++.|++.||+|||+++++|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999997532 1248899999999999999999999999999999
Q ss_pred CCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCC-C
Q 010624 156 AGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR-P 234 (506)
Q Consensus 156 p~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~-~ 234 (506)
|+|||++.++.+||+|||+|...... ..........||+.|+|||.+.+.. |+.++|||||||++|||++|. +
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSA-----DYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGG-----GCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccceEECCCCcEEEccchhheeccCC-----ccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999997643211 1111223456889999999998765 999999999999999999985 6
Q ss_pred CCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 235 PLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 235 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
||...+..+........ .. ...+..+++++.+||.+||+.||++|||+.+|++
T Consensus 242 p~~~~~~~e~~~~v~~~-~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDG-NI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTTSCHHHHHHHHHTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-CC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78776665544332222 11 1234578899999999999999999999999953
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=398.95 Aligned_cols=264 Identities=27% Similarity=0.454 Sum_probs=216.3
Q ss_pred cccccCCCCCCeeEEeeecccCCeeEEEEEEeCCC------CeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCcee
Q 010624 18 QKIQYPLDPSSYKILDEIGVGVSAIVYKAICIPMD------STVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILN 90 (506)
Q Consensus 18 ~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~------~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 90 (506)
..++|.++.++|++.+.||+|+||.||+|.+...+ +..||||.+..+........+.+|...++++ +|||||+
T Consensus 4 ~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp CCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 34569999999999999999999999999875332 3579999998877777778889999999888 7999999
Q ss_pred eeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCC
Q 010624 91 AHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP--------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKA 156 (506)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~--------------~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp 156 (506)
+++++.+++.+|+|||||.+|+|.++|..... ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 99999999999999999999999999976532 3589999999999999999999999999999999
Q ss_pred CCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-CCCC
Q 010624 157 GNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-GRPP 235 (506)
Q Consensus 157 ~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G~~P 235 (506)
+|||++.++.+||+|||++....... .........||+.|+|||.+.+.. |+.++|||||||++|||++ |.+|
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCC-----TTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cceeecCCCCeEeccchhhccccccc-----cccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCC
Confidence 99999999999999999976543221 112234556899999999998755 9999999999999999998 7889
Q ss_pred CCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 236 LSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 236 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
|...+.... ...+...... ..+..+++++++||.+||+.||.+|||+.+|++
T Consensus 238 ~~~~~~~~~-~~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 238 YPGVPVEEL-FKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp STTCCHHHH-HHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHH-HHHHHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 887665543 3333332221 134568899999999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=400.86 Aligned_cols=268 Identities=23% Similarity=0.396 Sum_probs=223.7
Q ss_pred ccccccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCce
Q 010624 15 TIAQKIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNIL 89 (506)
Q Consensus 15 ~~~~~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 89 (506)
.+....+|++..++|++.+.||+|+||.||+|.+.. .+++.||||++...........+.+|+.+++.+ +|||||
T Consensus 11 ~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp TSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEE
Confidence 344456789999999999999999999999998742 456799999998777777778899999999999 699999
Q ss_pred eeeeEEEeCCEEEEEeccCCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Q 010624 90 NAHCSFSVDSRLWVVMPFMSCGSLQSIISSCFP----------------DGLPEPCIAIVLKETLSALSYLHNQGHLHRD 153 (506)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~----------------~~l~e~~i~~i~~qil~gL~yLHs~givHrD 153 (506)
++++++.++..+|+|||||++|+|.+++..... ..+++..+..++.||+.||+|||++|++|||
T Consensus 91 ~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999999999999999999976421 2589999999999999999999999999999
Q ss_pred CCCCCEEeCCCCCeEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHh-C
Q 010624 154 VKAGNILSDSDGSVKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAH-G 232 (506)
Q Consensus 154 IKp~NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLlt-G 232 (506)
|||+|||++.++.+||+|||++....... .........||+.|+|||++.+.. ++.++|||||||++|||+| |
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCT-----TSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccCcccccccchheeccCCC-----cceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCC
Confidence 99999999999999999999976433221 122234457899999999998654 8999999999999999998 6
Q ss_pred CCCCCCCChHHHHHHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 233 RPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 233 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
.+||............+....+. ..+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus 245 ~p~~~~~~~~~~~~~~i~~~~~~----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 245 SSPYPGMPVDSKFYKMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66676655555544444443321 134567899999999999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=403.09 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=207.1
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCe--EEEEEEeccCCChhhHHHHHHHHHHHhhC-CCCCceeeeeEEEeCCE
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDST--VVAIKAIDLDQSRTDLDSIRRETKTMSLL-SHPNILNAHCSFSVDSR 100 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~--~vAIK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 100 (506)
++.++|++.+.||+|+||+||+|.++. ++. .||||.+.........+.+.+|+.+|+++ +|||||++++++.+++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 677899999999999999999999864 444 57888876555555667899999999998 79999999999999999
Q ss_pred EEEEeccCCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 101 LWVVMPFMSCGSLQSIISSC--------------FPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 101 ~~lV~Ey~~ggsL~~~i~~~--------------~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
+|+|||||+||+|.+++... ....+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999999753 1356999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCC-CCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGR-PPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~-~Pf~~~~~~~~~ 245 (506)
+||+|||+|..... ........||+.|+|||.+.+.. |+.++|||||||++|||++|. +||...+..+.
T Consensus 166 ~kl~DfG~a~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~- 235 (309)
T d1fvra_ 166 AKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL- 235 (309)
T ss_dssp EEECCTTCEESSCE--------ECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-
T ss_pred eEEccccccccccc--------cccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHH-
Confidence 99999999753221 11123446899999999998755 899999999999999999965 56766554443
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
...+....+. ..+..+++++++||.+||+.||++|||+.+|++|
T Consensus 236 ~~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 YEKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHGGGTCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333332221 2345688999999999999999999999999865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=407.32 Aligned_cols=264 Identities=27% Similarity=0.359 Sum_probs=202.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe------CC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQ-SRTDLDSIRRETKTMSLLSHPNILNAHCSFSV------DS 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 99 (506)
++|+++++||+|+||+||+|.++ .+|+.||||++.... .......+.+|+.+|++++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 67999999999999999999995 678999999997654 34456678999999999999999999999964 46
Q ss_pred EEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeecccccccc
Q 010624 100 RLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIY 179 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~ 179 (506)
++|+|||||.++.+ +.+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 89999999976554 4442 468999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhccc-----
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFR----- 254 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~----- 254 (506)
. ........||+.|+|||++.+. .++.++||||+||++|+|++|++||...+........+.....
T Consensus 171 ~--------~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 171 T--------SFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ------------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred c--------ccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 2 2233455689999999999875 4899999999999999999999999876554443332211110
Q ss_pred -----------------ccchhhhhh--------hhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHcCcccccc
Q 010624 255 -----------------FSDYEKTLK--------IKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 255 -----------------~~~~~~~~~--------~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~hp~f~~~ 305 (506)
......... ........++++++||.+||..||++||||+|||+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 000000000 000123468889999999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=398.86 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=219.5
Q ss_pred ccccCCCCCCeeEEeeecccCCeeEEEEEEeC----CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeE
Q 010624 19 KIQYPLDPSSYKILDEIGVGVSAIVYKAICIP----MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCS 94 (506)
Q Consensus 19 ~~~~~~~~~~Y~i~~~IG~G~fg~Vyka~~~~----~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 94 (506)
.-+|+++.++|++.+.||+|+||+||+|.++. .+++.||||+++..........+.+|+.++++++|||||+++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 44689999999999999999999999998742 23578999999876666667789999999999999999999999
Q ss_pred EEeCCEEEEEeccCCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCC
Q 010624 95 FSVDSRLWVVMPFMSCGSLQSIISSCF--------PDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGS 166 (506)
Q Consensus 95 ~~~~~~~~lV~Ey~~ggsL~~~i~~~~--------~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~ 166 (506)
+..+...++|||||++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999986531 134789999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhC-CCCCCCCChHHHH
Q 010624 167 VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHG-RPPLSHLPPEKSL 245 (506)
Q Consensus 167 vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG-~~Pf~~~~~~~~~ 245 (506)
+||+|||+|...... ..........||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||...+..+..
T Consensus 172 ~Kl~DFGla~~~~~~-----~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYET-----DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp EEECCTTCCCGGGGG-----GCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EEEeecccceeccCC-----cceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999997543221 1122233446899999999998765 89999999999999999998 5778776665544
Q ss_pred HHHHhhcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 246 LMKMTQRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
...... .. ...+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus 246 ~~i~~~-~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 246 RFVMEG-GL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhC-CC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 333221 11 1234568899999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=394.80 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=204.6
Q ss_pred eEEeeecccCCeeEEEEEEeCCCC--eEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEe-CCEEEEEec
Q 010624 30 KILDEIGVGVSAIVYKAICIPMDS--TVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSV-DSRLWVVMP 106 (506)
Q Consensus 30 ~i~~~IG~G~fg~Vyka~~~~~~~--~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E 106 (506)
.+.++||+|+||+||+|.+...++ ..||||.++........+.+.+|+.+|++++||||+++++++.. ++.+|+|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 347789999999999999854333 36899999876677778899999999999999999999999765 568999999
Q ss_pred cCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEeeccccccccCCCCCCC
Q 010624 107 FMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLADFGVSASIYEPSHHHH 186 (506)
Q Consensus 107 y~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~DFGls~~~~~~~~~~~ 186 (506)
||++|+|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||++........
T Consensus 110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~--- 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--- 185 (311)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC---
T ss_pred EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc---
Confidence 99999999998864 45688899999999999999999999999999999999999999999999999865432211
Q ss_pred CCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhhhhhc
Q 010624 187 HGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTLKIKD 266 (506)
Q Consensus 187 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
..........||+.|+|||.+.+.. ++.++|||||||++|||+||..||............+....+ ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----------~~ 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------LL 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----------CC
T ss_pred ccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----------CC
Confidence 1122233457899999999998755 899999999999999999988877654333322222222211 11
Q ss_pred cchhhhHHHHHHHHhhcccCCCCCCCHHHHHcC
Q 010624 267 KNKKFSRAFKDMVASCLDQDPSKRPSAEKLMKH 299 (506)
Q Consensus 267 ~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~h 299 (506)
.+..+++.+.+||.+||+.||++|||+.+|++|
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 345678999999999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-47 Score=377.85 Aligned_cols=266 Identities=18% Similarity=0.260 Sum_probs=202.0
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-eeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-NAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~ 105 (506)
++|++.+.||+|+||+||+|.++ .+|+.||||++...... +.+.+|+.+++.++|+|++ .+++++..++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 57999999999999999999985 56899999998765432 3467899999999877654 5567778889999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC---CCCeEEeeccccccccCCC
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS---DGSVKLADFGVSASIYEPS 182 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~---~g~vKL~DFGls~~~~~~~ 182 (506)
||+. ++|.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|.......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp ECCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9994 6666666543 467999999999999999999999999999999999999864 4579999999987654432
Q ss_pred CCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcccccchhhhh
Q 010624 183 HHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKSLLMKMTQRFRFSDYEKTL 262 (506)
Q Consensus 183 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (506)
..............||+.|||||++.+.. |+.++|||||||++|||++|..||................. .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~----~~~~~ 235 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KKMST 235 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH----HHHHS
T ss_pred cccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc----ccCCC
Confidence 22222223344567999999999998765 89999999999999999999999987654433221111000 00000
Q ss_pred hhhccchhhhHHHHHHHHhhcccCCCCCCCHHHH---HcCcccc
Q 010624 263 KIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKL---MKHSFFK 303 (506)
Q Consensus 263 ~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~ei---L~hp~f~ 303 (506)
........+|+++.+||.+||+.||++||++.++ |+|+|.+
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1122345688999999999999999999998755 5566543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=379.44 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=192.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCceeeeeEEEeCC----EEE
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNILNAHCSFSVDS----RLW 102 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~ 102 (506)
.+|.+.+.||+|+||.||+|.. +|+.||||+++... .......+|+..++.++|||||++++++.+++ .+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4699999999999999999986 57899999986432 11122334565667889999999999997653 689
Q ss_pred EEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCccCCCCCCCEEeCCCCCeEEeeccc
Q 010624 103 VVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN--------QGHLHRDVKAGNILSDSDGSVKLADFGV 174 (506)
Q Consensus 103 lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs--------~givHrDIKp~NILld~~g~vKL~DFGl 174 (506)
+|||||++|+|.+++.+ .++++..+..++.|++.||+|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999987 479999999999999999999996 5999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcccccCCCCCccCChhhhhccC-----CCCccccHHHHHHHHHHHHhCCCCCCCCChH-------
Q 010624 175 SASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHT-----GYSFKADIWSFGITALELAHGRPPLSHLPPE------- 242 (506)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-----~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~------- 242 (506)
+........ ..........||+.|+|||++.+.. .++.++|||||||++|||+||.+||......
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 155 AVRHDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CEEEETTTT---EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cccccCCCc---ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 765433211 1111223457999999999987542 1567899999999999999998887432211
Q ss_pred -------HHHHHHHh-hcccccchhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHHc
Q 010624 243 -------KSLLMKMT-QRFRFSDYEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLMK 298 (506)
Q Consensus 243 -------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL~ 298 (506)
........ ...+ +..+ ........+..+.+|+.+||+.||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLR-PNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCC-CCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHhccccC-CCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11111111 1111 0000 01112345567999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-45 Score=367.62 Aligned_cols=259 Identities=18% Similarity=0.273 Sum_probs=205.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCC-CCceeeeeEEEeCCEEEEE
Q 010624 26 PSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSH-PNILNAHCSFSVDSRLWVV 104 (506)
Q Consensus 26 ~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV 104 (506)
.++|++.+.||+|+||+||+|.++ .+|+.||||++...... ..+++|+++++.+.| +||+.+++++..+...|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999985 67899999998654322 346789999999975 8999999999999999999
Q ss_pred eccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCC-----CCCeEEeecccccccc
Q 010624 105 MPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDS-----DGSVKLADFGVSASIY 179 (506)
Q Consensus 105 ~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~-----~g~vKL~DFGls~~~~ 179 (506)
|||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|....
T Consensus 80 me~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 69999998764 457999999999999999999999999999999999999974 5789999999987654
Q ss_pred CCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcccccc
Q 010624 180 EPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPEKS--LLMKMTQRFRFSD 257 (506)
Q Consensus 180 ~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~~~--~~~~~~~~~~~~~ 257 (506)
.................||+.|||||++.+.. ++.++|||||||++|+|++|..||........ ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--- 233 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH---
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC---
Confidence 33222222222334557999999999998754 89999999999999999999999975433221 1111111100
Q ss_pred hhhhhhhhccchhhhHHHHHHHHhhcccCCCCCCCHHHHH
Q 010624 258 YEKTLKIKDKNKKFSRAFKDMVASCLDQDPSKRPSAEKLM 297 (506)
Q Consensus 258 ~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~Rpt~~eiL 297 (506)
..........+|+++.+++..|+..+|++||+++.+.
T Consensus 234 ---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 0111223456889999999999999999999987663
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-43 Score=362.42 Aligned_cols=268 Identities=25% Similarity=0.365 Sum_probs=199.5
Q ss_pred CCCCCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-----------CCCceeee
Q 010624 24 LDPSSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-----------HPNILNAH 92 (506)
Q Consensus 24 ~~~~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~ 92 (506)
+..++|+++++||+|+||+||+|.++ .+|+.||||+++.. ....+.+.+|+.+++.++ |+||++++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 44467999999999999999999985 67899999998654 334467788999998875 57899998
Q ss_pred eEEEe--CCEEEEEeccCCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCCCCEEeCCCCC--
Q 010624 93 CSFSV--DSRLWVVMPFMSCG-SLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN-QGHLHRDVKAGNILSDSDGS-- 166 (506)
Q Consensus 93 ~~~~~--~~~~~lV~Ey~~gg-sL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs-~givHrDIKp~NILld~~g~-- 166 (506)
+++.. ....++++.++.++ +............+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88754 45666777666544 44444444446789999999999999999999998 89999999999999986654
Q ss_pred ----eEEeeccccccccCCCCCCCCCCcccccCCCCCccCChhhhhccCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Q 010624 167 ----VKLADFGVSASIYEPSHHHHHGSAMITDMAGTPYWMAPEVIRSHTGYSFKADIWSFGITALELAHGRPPLSHLPPE 242 (506)
Q Consensus 167 ----vKL~DFGls~~~~~~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~sDIwSlGiil~eLltG~~Pf~~~~~~ 242 (506)
+|++|||.|..... ......||+.|+|||++.+.. |+.++||||+||++++|++|+.||......
T Consensus 167 ~~~~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp TEEEEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccceeeEeeccccccccc----------ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 99999998754321 223456899999999998654 899999999999999999999999743221
Q ss_pred ------HHHHHHHh--hcc---------------------------cccchhhh-hhhhccchhhhHHHHHHHHhhcccC
Q 010624 243 ------KSLLMKMT--QRF---------------------------RFSDYEKT-LKIKDKNKKFSRAFKDMVASCLDQD 286 (506)
Q Consensus 243 ------~~~~~~~~--~~~---------------------------~~~~~~~~-~~~~~~~~~~s~~l~~Li~~~L~~d 286 (506)
......+. ... ........ ..........++.+++||.+||..|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 11111100 000 00000000 0011223567889999999999999
Q ss_pred CCCCCCHHHHHcCcccccc
Q 010624 287 PSKRPSAEKLMKHSFFKNC 305 (506)
Q Consensus 287 P~~Rpt~~eiL~hp~f~~~ 305 (506)
|.+|||+.|+|+||||++.
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999965
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.1e-24 Score=201.34 Aligned_cols=133 Identities=17% Similarity=0.182 Sum_probs=106.1
Q ss_pred eeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCC-----------------hhhHHHHHHHHHHHhhCCCCCceee
Q 010624 29 YKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQS-----------------RTDLDSIRRETKTMSLLSHPNILNA 91 (506)
Q Consensus 29 Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~-----------------~~~~~~~~~Ei~il~~l~HpnIv~l 91 (506)
|.+.+.||+|+||+||+|.+ .+|+.||||+++.... ........+|+..+..+.|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~--~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC--CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 57899999999999999988 4689999998753221 0112345678999999999999987
Q ss_pred eeEEEeCCEEEEEeccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCCCCEEeCCCCCeEEee
Q 010624 92 HCSFSVDSRLWVVMPFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHNQGHLHRDVKAGNILSDSDGSVKLAD 171 (506)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs~givHrDIKp~NILld~~g~vKL~D 171 (506)
+++. . .+++|||+.+..+. .++...+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|
T Consensus 80 ~~~~--~--~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 80 YAWE--G--NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EEEE--T--TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred EEec--C--CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEE
Confidence 7653 2 26999999876543 24455678899999999999999999999999999999865 489999
Q ss_pred cccccc
Q 010624 172 FGVSAS 177 (506)
Q Consensus 172 FGls~~ 177 (506)
||+|..
T Consensus 146 FG~a~~ 151 (191)
T d1zara2 146 FPQSVE 151 (191)
T ss_dssp CTTCEE
T ss_pred CCCccc
Confidence 998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=5.1e-07 Score=84.63 Aligned_cols=138 Identities=15% Similarity=0.122 Sum_probs=91.2
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCC-CCCceeeeeEEEeCCEEEEEe
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLS-HPNILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 105 (506)
..|++.+..+.++.+.||+.. .++..+.+|....... .....+.+|..++..+. +--+.+++++...++..|+||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~---~~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV---GENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE---CSSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE---eCCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 467777776666668899874 3456677887653321 12234668888887764 333567788888899999999
Q ss_pred ccCCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 010624 106 PFMSCGSLQSIISSCFPDGLPEPCIAIVLKETLSALSYLHN--------------------------------------- 146 (506)
Q Consensus 106 Ey~~ggsL~~~i~~~~~~~l~e~~i~~i~~qil~gL~yLHs--------------------------------------- 146 (506)
++++|.++...... ... ...++.++...++.||+
T Consensus 90 ~~l~G~~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 90 SEADGVLCSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred Eecccccccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999887654322 111 12223333333344431
Q ss_pred --------------C------CCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 147 --------------Q------GHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 147 --------------~------givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
. .++|+|+.|.||+++.++.+-|+||+.+
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 1 2689999999999997766779999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.86 E-value=1.4e-05 Score=79.87 Aligned_cols=78 Identities=19% Similarity=0.079 Sum_probs=49.3
Q ss_pred EeeecccCCeeEEEEEEeCCCCeEEEEEEeccC------CChhhHHHHHHHHHHHhhCC-C--CCceeeeeEEEeCCEEE
Q 010624 32 LDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLD------QSRTDLDSIRRETKTMSLLS-H--PNILNAHCSFSVDSRLW 102 (506)
Q Consensus 32 ~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~------~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~ 102 (506)
.+.||.|....||++.+. .+++.+++|.-... .-+...++...|...|+.+. + ..+.+++.+ ++...+
T Consensus 31 ~~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 567999999999998763 45678889975321 11223445667888887663 2 334555544 444557
Q ss_pred EEeccCCCCC
Q 010624 103 VVMPFMSCGS 112 (506)
Q Consensus 103 lV~Ey~~ggs 112 (506)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 8999998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.86 E-value=5.3e-06 Score=77.03 Aligned_cols=78 Identities=17% Similarity=0.223 Sum_probs=52.3
Q ss_pred eeEEeeecccCC-eeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCC--CceeeeeEEEeCCEEEEEe
Q 010624 29 YKILDEIGVGVS-AIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHP--NILNAHCSFSVDSRLWVVM 105 (506)
Q Consensus 29 Y~i~~~IG~G~f-g~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~ 105 (506)
+.+. .+..|.. +.||+... .++..+.+|....... ..+.+|...++.+... .+.+++++..+++..|+||
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA--QGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC--TTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe--CCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 4443 3444544 68898865 4566788897653322 2356777777766533 3566788888888999999
Q ss_pred ccCCCCCH
Q 010624 106 PFMSCGSL 113 (506)
Q Consensus 106 Ey~~ggsL 113 (506)
+|++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99988654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.81 E-value=0.0014 Score=64.65 Aligned_cols=79 Identities=14% Similarity=0.189 Sum_probs=51.8
Q ss_pred CCeeEEeeecccCCeeEEEEEEeC------CCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-eeeeeEEEeCC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIP------MDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-LNAHCSFSVDS 99 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~------~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~ 99 (506)
+..+ ++.|+.|-.-.+|++.... .....|.+++...... . -...+|..+++.+.-.++ .++++++..
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--E-SHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 4454 4678999999999987632 1235677887653222 2 234578999988864444 466776642
Q ss_pred EEEEEeccCCCCCH
Q 010624 100 RLWVVMPFMSCGSL 113 (506)
Q Consensus 100 ~~~lV~Ey~~ggsL 113 (506)
++|++|++|.+|
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 589999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.80 E-value=0.0015 Score=62.64 Aligned_cols=70 Identities=14% Similarity=0.101 Sum_probs=47.0
Q ss_pred cCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCce-----ee--eeEEEeCCEEEEEeccCCC
Q 010624 38 GVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNIL-----NA--HCSFSVDSRLWVVMPFMSC 110 (506)
Q Consensus 38 G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv-----~l--~~~~~~~~~~~lV~Ey~~g 110 (506)
+.--.||++.. .+|..|++|+.+... ...+.+..|...+..|...+|. .. -..+..++..+.+++|+.|
T Consensus 33 s~EN~vy~v~~--~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD--EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC--TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc--CCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 44568999876 578889999976442 2345677888888777533221 11 1234567788999999987
Q ss_pred C
Q 010624 111 G 111 (506)
Q Consensus 111 g 111 (506)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.60 E-value=0.029 Score=52.62 Aligned_cols=143 Identities=15% Similarity=0.126 Sum_probs=75.3
Q ss_pred CCeeEEeeecccCCeeEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHHhhCCCCCc-----eee---eeEEEeC
Q 010624 27 SSYKILDEIGVGVSAIVYKAICIPMDSTVVAIKAIDLDQSRTDLDSIRRETKTMSLLSHPNI-----LNA---HCSFSVD 98 (506)
Q Consensus 27 ~~Y~i~~~IG~G~fg~Vyka~~~~~~~~~vAIK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l---~~~~~~~ 98 (506)
....-.+.|..|.--+.|++.. .+| .+++|+...... .+.+..|+.+|..|...++ +.. ..+....
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t--~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~ 91 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHT--TKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 91 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEE--SSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred CCceEeecCCCCcccCeEEEEE--CCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeee
Confidence 3455566677888899999875 344 589998754322 2344566667766653322 211 0122335
Q ss_pred CEEEEEeccCCCCCHH--------------HHHHhh---CCC----CCCH------------------HHHHHHHHHHHH
Q 010624 99 SRLWVVMPFMSCGSLQ--------------SIISSC---FPD----GLPE------------------PCIAIVLKETLS 139 (506)
Q Consensus 99 ~~~~lV~Ey~~ggsL~--------------~~i~~~---~~~----~l~e------------------~~i~~i~~qil~ 139 (506)
...+.++.+..|.... ..++.. ... .... ......+..+..
T Consensus 92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 171 (316)
T d2ppqa1 92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 171 (316)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred cccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHH
Confidence 5667777777654321 011110 000 0000 111122222223
Q ss_pred HHHHHHH----CCCccCCCCCCCEEeCCCCCeEEeecccc
Q 010624 140 ALSYLHN----QGHLHRDVKAGNILSDSDGSVKLADFGVS 175 (506)
Q Consensus 140 gL~yLHs----~givHrDIKp~NILld~~g~vKL~DFGls 175 (506)
.+.-.+. .|+||+|+.+.||+++.+...-|+||+.+
T Consensus 172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 172 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred hhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 3333222 46899999999999998877789999974
|